{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "ERROR: Could not find a version that satisfies the requirement stringio (from versions: none)\n",
      "ERROR: No matching distribution found for stringio\n",
      "WARNING: You are using pip version 21.1.1; however, version 21.1.2 is available.\n",
      "You should consider upgrading via the 'c:\\python\\python.exe -m pip install --upgrade pip' command.\n"
     ]
    }
   ],
   "source": [
    "import sys\n",
    "!{sys.executable} -m pip install --upgrade stringio"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "!{sys.executable} -m pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.4.0/en_core_sci_lg-0.4.0.tar.gz"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import spacy\n",
    "import scispacy\n",
    "import en_core_sci_lg\n",
    "import numpy as np\n",
    "from scispacy.linking import EntityLinker"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [],
   "source": [
    "dataframe = pd.read_csv(\"final_dataframe.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>abstract</th>\n",
       "      <th>doi</th>\n",
       "      <th>tokens</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>Frateuria aurantia (ex Kondo and Ameyama 1958)...</td>\n",
       "      <td>['10.4056/sigs.4338002 [doi]', 'sigs.4338002 [...</td>\n",
       "      <td>['frateuria', 'aurantia', 'ex', 'kondo', 'and'...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Acinetobacter spp. have become of increased cl...</td>\n",
       "      <td>['AAC.00514-21 [pii]', '10.1128/AAC.00514-21 [...</td>\n",
       "      <td>['acinetobacter', 'spp', 'have', 'become', 'of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>OBJECTIVES: To investigate if adding calcium t...</td>\n",
       "      <td>['S1198-743X(21)00197-X [pii]', '10.1016/j.cmi...</td>\n",
       "      <td>['objectives', 'to', 'investigate', 'if', 'add...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>BACKGROUND: Knowledge on the epidemiology, gen...</td>\n",
       "      <td>['10.1186/s13756-021-00936-5 [doi]', '10.1186/...</td>\n",
       "      <td>['background', 'knowledge', 'on', 'the', 'epid...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>The coffee berry borer, the most economically ...</td>\n",
       "      <td>['10.3389/fmicb.2021.644768 [doi]']</td>\n",
       "      <td>['the', 'coffee', 'berry', 'borer', 'the', 'mo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>5</td>\n",
       "      <td>Background: Hospital infections in pediatric u...</td>\n",
       "      <td>['10.4314/ejhs.v30i6.4 [doi]', 'jEJHS.v30.i6.p...</td>\n",
       "      <td>['background', 'hospital', 'infections', 'in',...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6</td>\n",
       "      <td>BACKGROUND: Bloodstream infection (BSI) result...</td>\n",
       "      <td>['10.1186/s12887-021-02661-9 [doi]', '10.1186/...</td>\n",
       "      <td>['background', 'bloodstream', 'infection', 'bs...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>7</td>\n",
       "      <td>The accurate identification of Acinetobacter s...</td>\n",
       "      <td>['S0890-8508(21)00039-6 [pii]', '10.1016/j.mcp...</td>\n",
       "      <td>['the', 'accurate', 'identification', 'of', 'a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8</td>\n",
       "      <td>BACKGROUND: SARS-CoV-2 predisposes patients to...</td>\n",
       "      <td>['S0195-6701(21)00151-1 [pii]', '10.1016/j.jhi...</td>\n",
       "      <td>['background', 'sars', 'cov', '2', 'predispose...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>9</td>\n",
       "      <td>OBJECTIVE: The aim: To obtain the first estima...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>['objective', 'the', 'aim', 'to', 'obtain', 't...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>10</td>\n",
       "      <td>The ESKAPE pathogens (Enterococcus spp., Staph...</td>\n",
       "      <td>['10.1080/20477724.2021.1916158 [doi]']</td>\n",
       "      <td>['the', 'eskape', 'pathogens', 'enterococcus',...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>11</td>\n",
       "      <td>Stachys species belonging to Lamiaceae family ...</td>\n",
       "      <td>['S0001-37652021000500702 [pii]', '10.1590/000...</td>\n",
       "      <td>['stachys', 'species', 'belonging', 'to', 'lam...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>12</td>\n",
       "      <td>The Acinetobacter trimeric autotransporter adh...</td>\n",
       "      <td>['10.1007/s00203-021-02343-1 [doi]', '10.1007/...</td>\n",
       "      <td>['the', 'acinetobacter', 'trimeric', 'autotran...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>13</td>\n",
       "      <td>BACKGROUND: Thiopeptides are a class of antibi...</td>\n",
       "      <td>['6256240 [pii]', '10.1093/jac/dkab124 [doi]']</td>\n",
       "      <td>['background', 'thiopeptides', 'are', 'a', 'cl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>14</td>\n",
       "      <td>PURPOSE: Nowadays, Acinetobacter baumannii is ...</td>\n",
       "      <td>['S0255-0857(21)00061-X [pii]', '10.1016/j.ijm...</td>\n",
       "      <td>['purpose', 'nowadays', 'acinetobacter', 'baum...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>15</td>\n",
       "      <td>Given the global panorama of demands in the he...</td>\n",
       "      <td>['10.1177/08853282211011921 [doi]']</td>\n",
       "      <td>['given', 'the', 'global', 'panorama', 'of', '...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>16</td>\n",
       "      <td>Four new aromatic polyketides including two di...</td>\n",
       "      <td>['10.1080/14786419.2021.1915309 [doi]']</td>\n",
       "      <td>['four', 'new', 'aromatic', 'polyketides', 'in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>17</td>\n",
       "      <td>Acinetobacter baumannii is an opportunistic pa...</td>\n",
       "      <td>['10.3389/fmicb.2021.622704 [doi]']</td>\n",
       "      <td>['acinetobacter', 'baumannii', 'is', 'an', 'op...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>18</td>\n",
       "      <td>Objective: This work attempted to isolate, ide...</td>\n",
       "      <td>['10.1016/j.jtumed.2020.10.007 [doi]', 'S1658-...</td>\n",
       "      <td>['objective', 'this', 'work', 'attempted', 'to...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>19</td>\n",
       "      <td>The aim of the present work was the comparison...</td>\n",
       "      <td>['10.1080/09603123.2021.1919292 [doi]']</td>\n",
       "      <td>['the', 'aim', 'of', 'the', 'present', 'work',...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>20</td>\n",
       "      <td>Prophylactic administration of broad-spectrum ...</td>\n",
       "      <td>['10.1111/lam.13493 [doi]']</td>\n",
       "      <td>['prophylactic', 'administration', 'of', 'broa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>21</td>\n",
       "      <td>Chronic otitis media with effusion (OME) has b...</td>\n",
       "      <td>['6/2/e00056-21 [pii]', '10.1128/mSystems.0005...</td>\n",
       "      <td>['chronic', 'otitis', 'media', 'with', 'effusi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>22</td>\n",
       "      <td>Many pathogenic organisms do produce different...</td>\n",
       "      <td>['S0255-0857(20)30001-3 [pii]', '10.1016/j.ijm...</td>\n",
       "      <td>['many', 'pathogenic', 'organisms', 'do', 'pro...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>23</td>\n",
       "      <td>Ligninolytic bacteria degrading lignin were is...</td>\n",
       "      <td>['10.33073/pjm-2020-037 [doi]', 'exeley [pii]']</td>\n",
       "      <td>['ligninolytic', 'bacteria', 'degrading', 'lig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>24</td>\n",
       "      <td>Metabolites of azo dyes are often carcinogenic...</td>\n",
       "      <td>['10.1016/j.sjbs.2020.11.012 [doi]', 'S1319-56...</td>\n",
       "      <td>['metabolites', 'of', 'azo', 'dyes', 'are', 'o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>25</td>\n",
       "      <td>Background: Protective lead garments (PLG) wor...</td>\n",
       "      <td>['10.1177/1757177420947466 [doi]', '10.1177_17...</td>\n",
       "      <td>['background', 'protective', 'lead', 'garments...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>26</td>\n",
       "      <td>Jordan is one of the lowest countries in the w...</td>\n",
       "      <td>['10.2166/wh.2020.193 [doi]']</td>\n",
       "      <td>['jordan', 'is', 'one', 'of', 'the', 'lowest',...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>27</td>\n",
       "      <td>Bacteria of the genus Acinetobacter, with thei...</td>\n",
       "      <td>['10.3389/fmicb.2020.588410 [doi]']</td>\n",
       "      <td>['bacteria', 'of', 'the', 'genus', 'acinetobac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>28</td>\n",
       "      <td>NaN</td>\n",
       "      <td>['10.7883/yoken.JJID.2020.806 [doi]']</td>\n",
       "      <td>['nan']</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>29</td>\n",
       "      <td>ABSTRACT: To explore a new surgical treatment ...</td>\n",
       "      <td>['00001665-202102000-00115 [pii]', '10.1097/SC...</td>\n",
       "      <td>['abstract', 'to', 'explore', 'a', 'new', 'sur...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1501</th>\n",
       "      <td>1501</td>\n",
       "      <td>Chronic Fatigue Syndrome/Myalgic Encephalomyel...</td>\n",
       "      <td>['10.1038/s41598-021-86425-6 [doi]', '10.1038/...</td>\n",
       "      <td>['chronic', 'fatigue', 'syndrome', 'myalgic', ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1502</th>\n",
       "      <td>1502</td>\n",
       "      <td>We describe a case of subacute bacterial endoc...</td>\n",
       "      <td>['14/3/e240349 [pii]', '10.1136/bcr-2020-24034...</td>\n",
       "      <td>['we', 'describe', 'a', 'case', 'of', 'subacut...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1503</th>\n",
       "      <td>1503</td>\n",
       "      <td>BACKGROUND: Rothia sp. are Gram-positive bacte...</td>\n",
       "      <td>['S1438-4221(21)00007-2 [pii]', '10.1016/j.ijm...</td>\n",
       "      <td>['background', 'rothia', 'sp', 'are', 'gram', ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1504</th>\n",
       "      <td>1504</td>\n",
       "      <td>The endogenous microbiome of healthy individua...</td>\n",
       "      <td>['jcm9124068 [pii]', '10.3390/jcm9124068 [doi]']</td>\n",
       "      <td>['the', 'endogenous', 'microbiome', 'of', 'hea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1505</th>\n",
       "      <td>1505</td>\n",
       "      <td>A 65-year-old male patient with a history of h...</td>\n",
       "      <td>['10.4103/jgid.jgid_136_19 [doi]', 'JGID-12-15...</td>\n",
       "      <td>['a', '65', 'year', 'old', 'male', 'patient', ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1506</th>\n",
       "      <td>1506</td>\n",
       "      <td>The effect of xylitol tablets with (XPT) and w...</td>\n",
       "      <td>['10.1080/08927014.2020.1858063 [doi]']</td>\n",
       "      <td>['the', 'effect', 'of', 'xylitol', 'tablets', ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1507</th>\n",
       "      <td>1507</td>\n",
       "      <td>In the last decades, resistant microbial infec...</td>\n",
       "      <td>['10.3389/fmicb.2020.592265 [doi]']</td>\n",
       "      <td>['in', 'the', 'last', 'decades', 'resistant', ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1508</th>\n",
       "      <td>1508</td>\n",
       "      <td>OBJECTIVE: To describe the epidemiological, cl...</td>\n",
       "      <td>['S0399-077X(20)30761-7 [pii]', '10.1016/j.med...</td>\n",
       "      <td>['objective', 'to', 'describe', 'the', 'epidem...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1509</th>\n",
       "      <td>1509</td>\n",
       "      <td>Aim: This study evaluated the influence of per...</td>\n",
       "      <td>['10.1080/20002297.2020.1814674 [doi]', '18146...</td>\n",
       "      <td>['aim', 'this', 'study', 'evaluated', 'the', '...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1510</th>\n",
       "      <td>1510</td>\n",
       "      <td>In this work the development of an inhibitive ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>['in', 'this', 'work', 'the', 'development', '...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1511</th>\n",
       "      <td>1511</td>\n",
       "      <td>A novel obligately organotrophic, facultativel...</td>\n",
       "      <td>['ijs.0.009605-0 [pii]', '10.1099/ijs.0.009605...</td>\n",
       "      <td>['a', 'novel', 'obligately', 'organotrophic', ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1512</th>\n",
       "      <td>1512</td>\n",
       "      <td>New microaerophilic sulfur-oxidizing spirilla ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>['new', 'microaerophilic', 'sulfur', 'oxidizin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1513</th>\n",
       "      <td>1513</td>\n",
       "      <td>In Argentina, legislation to control adverse i...</td>\n",
       "      <td>['10.1002/tox.1027 [pii]', '10.1002/tox.1027 [...</td>\n",
       "      <td>['in', 'argentina', 'legislation', 'to', 'cont...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1514</th>\n",
       "      <td>1514</td>\n",
       "      <td>A hydrogen peroxide-resistant mutant of the ca...</td>\n",
       "      <td>['10.1046/j.1365-2672.1998.00602.x [doi]']</td>\n",
       "      <td>['a', 'hydrogen', 'peroxide', 'resistant', 'mu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1515</th>\n",
       "      <td>1515</td>\n",
       "      <td>A former mercury plant, where mercury salts an...</td>\n",
       "      <td>['10.1039/an9952000721 [doi]']</td>\n",
       "      <td>['a', 'former', 'mercury', 'plant', 'where', '...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1516</th>\n",
       "      <td>1516</td>\n",
       "      <td>Bright-field high-speed cinemicrography was em...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>['bright', 'field', 'high', 'speed', 'cinemicr...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1517</th>\n",
       "      <td>1517</td>\n",
       "      <td>The 16S ribosomal DNA sequence of Taylorella e...</td>\n",
       "      <td>['10.1099/00207713-43-3-618 [doi]']</td>\n",
       "      <td>['the', '16s', 'ribosomal', 'dna', 'sequence',...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1518</th>\n",
       "      <td>1518</td>\n",
       "      <td>A mathematical model employing slender body th...</td>\n",
       "      <td>['S0022-5193(89)80100-6 [pii]', '10.1016/s0022...</td>\n",
       "      <td>['a', 'mathematical', 'model', 'employing', 's...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1519</th>\n",
       "      <td>1519</td>\n",
       "      <td>The ECHA Biocide Monitor, a dipstick procedure...</td>\n",
       "      <td>['0269-7491(89)90125-5 [pii]', '10.1016/0269-7...</td>\n",
       "      <td>['the', 'echa', 'biocide', 'monitor', 'a', 'di...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1520</th>\n",
       "      <td>1520</td>\n",
       "      <td>OBJECTIVES: To explore whether linezolid/dapto...</td>\n",
       "      <td>['6256239 [pii]', '10.1093/jac/dkab095 [doi]']</td>\n",
       "      <td>['objectives', 'to', 'explore', 'whether', 'li...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1521</th>\n",
       "      <td>1521</td>\n",
       "      <td>This narrative review describes the epidemiolo...</td>\n",
       "      <td>['10.1007/s40121-021-00434-6 [doi]', '10.1007/...</td>\n",
       "      <td>['this', 'narrative', 'review', 'describes', '...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1522</th>\n",
       "      <td>1522</td>\n",
       "      <td>ETHNOPHARMACOLOGICAL RELEVANCE: Ma-xing-shi-ga...</td>\n",
       "      <td>['S0378-8741(21)00360-3 [pii]', '10.1016/j.jep...</td>\n",
       "      <td>['ethnopharmacological', 'relevance', 'ma', 'x...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1523</th>\n",
       "      <td>1523</td>\n",
       "      <td>BACKGROUND: Evidence from pandemics suggests t...</td>\n",
       "      <td>['S0899823X21000969 [pii]', '10.1017/ice.2021....</td>\n",
       "      <td>['background', 'evidence', 'from', 'pandemics'...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1524</th>\n",
       "      <td>1524</td>\n",
       "      <td>Pneumococcal capsules are important in pneumoc...</td>\n",
       "      <td>['JCM.00540-21 [pii]', '10.1128/JCM.00540-21 [...</td>\n",
       "      <td>['pneumococcal', 'capsules', 'are', 'important...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1525</th>\n",
       "      <td>1525</td>\n",
       "      <td>BACKGROUND: Antimicrobial-resistant strains of...</td>\n",
       "      <td>['10.1186/s12941-021-00432-z [doi]', '10.1186/...</td>\n",
       "      <td>['background', 'antimicrobial', 'resistant', '...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1526</th>\n",
       "      <td>1526</td>\n",
       "      <td>Within Mycoplasma genus, M. pneumoniae, M. gen...</td>\n",
       "      <td>['10.37201/req/014.2021 [doi]']</td>\n",
       "      <td>['within', 'mycoplasma', 'genus', 'm', 'pneumo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1527</th>\n",
       "      <td>1527</td>\n",
       "      <td>Background and objectives: Ureaplasma urealyti...</td>\n",
       "      <td>['medicina57030211 [pii]', '10.3390/medicina57...</td>\n",
       "      <td>['background', 'and', 'objectives', 'ureaplasm...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1528</th>\n",
       "      <td>1528</td>\n",
       "      <td>BACKGROUND: Sexually transmitted infections (S...</td>\n",
       "      <td>['S0365-0596(21)00015-5 [pii]', '10.1016/j.abd...</td>\n",
       "      <td>['background', 'sexually', 'transmitted', 'inf...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1529</th>\n",
       "      <td>1529</td>\n",
       "      <td>Ureaplasma urealyticum and U parvum are mollic...</td>\n",
       "      <td>['AAC.02342-20 [pii]', '10.1128/AAC.02342-20 [...</td>\n",
       "      <td>['ureaplasma', 'urealyticum', 'and', 'u', 'par...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1530</th>\n",
       "      <td>1530</td>\n",
       "      <td>Background: Gardnerella vaginalis (GV) is most...</td>\n",
       "      <td>['10.3389/fped.2020.593802 [doi]']</td>\n",
       "      <td>['background', 'gardnerella', 'vaginalis', 'gv...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1531 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0                                           abstract  \\\n",
       "0              0  Frateuria aurantia (ex Kondo and Ameyama 1958)...   \n",
       "1              1  Acinetobacter spp. have become of increased cl...   \n",
       "2              2  OBJECTIVES: To investigate if adding calcium t...   \n",
       "3              3  BACKGROUND: Knowledge on the epidemiology, gen...   \n",
       "4              4  The coffee berry borer, the most economically ...   \n",
       "...          ...                                                ...   \n",
       "1526        1526  Within Mycoplasma genus, M. pneumoniae, M. gen...   \n",
       "1527        1527  Background and objectives: Ureaplasma urealyti...   \n",
       "1528        1528  BACKGROUND: Sexually transmitted infections (S...   \n",
       "1529        1529  Ureaplasma urealyticum and U parvum are mollic...   \n",
       "1530        1530  Background: Gardnerella vaginalis (GV) is most...   \n",
       "\n",
       "                                                    doi  \\\n",
       "0     ['10.4056/sigs.4338002 [doi]', 'sigs.4338002 [...   \n",
       "1     ['AAC.00514-21 [pii]', '10.1128/AAC.00514-21 [...   \n",
       "2     ['S1198-743X(21)00197-X [pii]', '10.1016/j.cmi...   \n",
       "3     ['10.1186/s13756-021-00936-5 [doi]', '10.1186/...   \n",
       "4                   ['10.3389/fmicb.2021.644768 [doi]']   \n",
       "...                                                 ...   \n",
       "1526                    ['10.37201/req/014.2021 [doi]']   \n",
       "1527  ['medicina57030211 [pii]', '10.3390/medicina57...   \n",
       "1528  ['S0365-0596(21)00015-5 [pii]', '10.1016/j.abd...   \n",
       "1529  ['AAC.02342-20 [pii]', '10.1128/AAC.02342-20 [...   \n",
       "1530                 ['10.3389/fped.2020.593802 [doi]']   \n",
       "\n",
       "                                                 tokens  \n",
       "0     ['frateuria', 'aurantia', 'ex', 'kondo', 'and'...  \n",
       "1     ['acinetobacter', 'spp', 'have', 'become', 'of...  \n",
       "2     ['objectives', 'to', 'investigate', 'if', 'add...  \n",
       "3     ['background', 'knowledge', 'on', 'the', 'epid...  \n",
       "4     ['the', 'coffee', 'berry', 'borer', 'the', 'mo...  \n",
       "...                                                 ...  \n",
       "1526  ['within', 'mycoplasma', 'genus', 'm', 'pneumo...  \n",
       "1527  ['background', 'and', 'objectives', 'ureaplasm...  \n",
       "1528  ['background', 'sexually', 'transmitted', 'inf...  \n",
       "1529  ['ureaplasma', 'urealyticum', 'and', 'u', 'par...  \n",
       "1530  ['background', 'gardnerella', 'vaginalis', 'gv...  \n",
       "\n",
       "[1531 rows x 4 columns]"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "dataframe[\"mesh\"]= \"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_frame = dataframe[:5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_doc = test_frame[\"abstract\"][1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "mesh_terms = []"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [],
   "source": [
    "def mesh_filter(df, model):\n",
    "    queries_entities = [] \n",
    "    nlp = spacy.load(model)\n",
    "    nlp.add_pipe(\"scispacy_linker\", config={\"resolve_abbreviations\": True, \"linker_name\": \"mesh\"})\n",
    "    liste = list(set(df[\"abstract\"].tolist()))\n",
    "    for i in liste:\n",
    "        doc = nlp(i)\n",
    "        entity = doc.ents\n",
    "        if len(entity) > 0:\n",
    "            queries_entities.append(i)\n",
    "        else:\n",
    "            continue\n",
    "    return queries_entities"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'float'>\n",
      "<class 'float'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n",
      "<class 'str'>\n"
     ]
    }
   ],
   "source": [
    "for i in dataframe[\"abstract\"]:\n",
    "    print(type(i))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>abstract</th>\n",
       "      <th>doi</th>\n",
       "      <th>tokens</th>\n",
       "      <th>mesh</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>Frateuria aurantia (ex Kondo and Ameyama 1958)...</td>\n",
       "      <td>['10.4056/sigs.4338002 [doi]', 'sigs.4338002 [...</td>\n",
       "      <td>['frateuria', 'aurantia', 'ex', 'kondo', 'and'...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Acinetobacter spp. have become of increased cl...</td>\n",
       "      <td>['AAC.00514-21 [pii]', '10.1128/AAC.00514-21 [...</td>\n",
       "      <td>['acinetobacter', 'spp', 'have', 'become', 'of...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>OBJECTIVES: To investigate if adding calcium t...</td>\n",
       "      <td>['S1198-743X(21)00197-X [pii]', '10.1016/j.cmi...</td>\n",
       "      <td>['objectives', 'to', 'investigate', 'if', 'add...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>BACKGROUND: Knowledge on the epidemiology, gen...</td>\n",
       "      <td>['10.1186/s13756-021-00936-5 [doi]', '10.1186/...</td>\n",
       "      <td>['background', 'knowledge', 'on', 'the', 'epid...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>The coffee berry borer, the most economically ...</td>\n",
       "      <td>['10.3389/fmicb.2021.644768 [doi]']</td>\n",
       "      <td>['the', 'coffee', 'berry', 'borer', 'the', 'mo...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0                                           abstract  \\\n",
       "0           0  Frateuria aurantia (ex Kondo and Ameyama 1958)...   \n",
       "1           1  Acinetobacter spp. have become of increased cl...   \n",
       "2           2  OBJECTIVES: To investigate if adding calcium t...   \n",
       "3           3  BACKGROUND: Knowledge on the epidemiology, gen...   \n",
       "4           4  The coffee berry borer, the most economically ...   \n",
       "\n",
       "                                                 doi  \\\n",
       "0  ['10.4056/sigs.4338002 [doi]', 'sigs.4338002 [...   \n",
       "1  ['AAC.00514-21 [pii]', '10.1128/AAC.00514-21 [...   \n",
       "2  ['S1198-743X(21)00197-X [pii]', '10.1016/j.cmi...   \n",
       "3  ['10.1186/s13756-021-00936-5 [doi]', '10.1186/...   \n",
       "4                ['10.3389/fmicb.2021.644768 [doi]']   \n",
       "\n",
       "                                              tokens mesh  \n",
       "0  ['frateuria', 'aurantia', 'ex', 'kondo', 'and'...       \n",
       "1  ['acinetobacter', 'spp', 'have', 'become', 'of...       \n",
       "2  ['objectives', 'to', 'investigate', 'if', 'add...       \n",
       "3  ['background', 'knowledge', 'on', 'the', 'epid...       \n",
       "4  ['the', 'coffee', 'berry', 'borer', 'the', 'mo...       "
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_frame"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [],
   "source": [
    "def mesh_retriever(df, model, col, col2):\n",
    "    mesh_terms = []\n",
    "    nlp = spacy.load(model)\n",
    "    nlp.add_pipe(\"scispacy_linker\", config={\"resolve_abbreviations\": True, \"linker_name\": \"mesh\"})\n",
    "    for i in df[col]:\n",
    "        #print(i)\n",
    "        entity_list = []\n",
    "        try:\n",
    "            doc = nlp(i)\n",
    "            entity = doc.ents\n",
    "            if len(entity) > 0 :\n",
    "                entity_list.append(list(entity))\n",
    "                mesh_terms.append(entity_list)\n",
    "            else:\n",
    "                continue\n",
    "        except:\n",
    "            mesh_terms.append(\"NaN\")\n",
    "    #return mesh_terms\n",
    "    df[col2] = mesh_terms           "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\python\\lib\\site-packages\\sklearn\\base.py:315: UserWarning: Trying to unpickle estimator TfidfTransformer from version 0.22.2.post1 when using version 0.24.1. This might lead to breaking code or invalid results. Use at your own risk.\n",
      "  UserWarning)\n",
      "c:\\python\\lib\\site-packages\\sklearn\\base.py:315: UserWarning: Trying to unpickle estimator TfidfVectorizer from version 0.22.2.post1 when using version 0.24.1. This might lead to breaking code or invalid results. Use at your own risk.\n",
      "  UserWarning)\n",
      "c:\\python\\lib\\site-packages\\scispacy\\candidate_generation.py:284: VisibleDeprecationWarning: Creating an ndarray from ragged nested sequences (which is a list-or-tuple of lists-or-tuples-or ndarrays with different lengths or shapes) is deprecated. If you meant to do this, you must specify 'dtype=object' when creating the ndarray\n",
      "  extended_neighbors[empty_vectors_boolean_flags] = numpy.array(neighbors)[:-1]\n",
      "c:\\python\\lib\\site-packages\\scispacy\\candidate_generation.py:285: VisibleDeprecationWarning: Creating an ndarray from ragged nested sequences (which is a list-or-tuple of lists-or-tuples-or ndarrays with different lengths or shapes) is deprecated. If you meant to do this, you must specify 'dtype=object' when creating the ndarray\n",
      "  extended_distances[empty_vectors_boolean_flags] = numpy.array(distances)[:-1]\n"
     ]
    }
   ],
   "source": [
    "mesh_retriever(dataframe, \"en_core_sci_lg\", \"abstract\", \"mesh\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'list'>\n",
      "<class 'list'>\n",
      "<class 'list'>\n",
      "<class 'list'>\n",
      "<class 'list'>\n"
     ]
    }
   ],
   "source": [
    "for i in test_frame[\"mesh\"]:\n",
    "    print(type(i))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "list"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(test_frame[\"mesh\"][0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\python\\lib\\site-packages\\ipykernel_launcher.py:1: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: http://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  \"\"\"Entry point for launching an IPython kernel.\n"
     ]
    }
   ],
   "source": [
    "dataframe[\"mesh\"] = dataframe.apply(lambda x: str(x[\"mesh\"]), axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>abstract</th>\n",
       "      <th>doi</th>\n",
       "      <th>tokens</th>\n",
       "      <th>mesh</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>Frateuria aurantia (ex Kondo and Ameyama 1958)...</td>\n",
       "      <td>['10.4056/sigs.4338002 [doi]', 'sigs.4338002 [...</td>\n",
       "      <td>['frateuria', 'aurantia', 'ex', 'kondo', 'and'...</td>\n",
       "      <td>[[(Frateuria, aurantia), (ex, Kondo), (bispeci...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Acinetobacter spp. have become of increased cl...</td>\n",
       "      <td>['AAC.00514-21 [pii]', '10.1128/AAC.00514-21 [...</td>\n",
       "      <td>['acinetobacter', 'spp', 'have', 'become', 'of...</td>\n",
       "      <td>[[(Acinetobacter, spp), (increased), (clinical...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>OBJECTIVES: To investigate if adding calcium t...</td>\n",
       "      <td>['S1198-743X(21)00197-X [pii]', '10.1016/j.cmi...</td>\n",
       "      <td>['objectives', 'to', 'investigate', 'if', 'add...</td>\n",
       "      <td>[[(investigate), (calcium), (Mueller-Hinton, a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>BACKGROUND: Knowledge on the epidemiology, gen...</td>\n",
       "      <td>['10.1186/s13756-021-00936-5 [doi]', '10.1186/...</td>\n",
       "      <td>['background', 'knowledge', 'on', 'the', 'epid...</td>\n",
       "      <td>[[(Knowledge), (epidemiology), (genotypic), (p...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>The coffee berry borer, the most economically ...</td>\n",
       "      <td>['10.3389/fmicb.2021.644768 [doi]']</td>\n",
       "      <td>['the', 'coffee', 'berry', 'borer', 'the', 'mo...</td>\n",
       "      <td>[[(coffee), (berry, borer), (insect), (pest), ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>5</td>\n",
       "      <td>Background: Hospital infections in pediatric u...</td>\n",
       "      <td>['10.4314/ejhs.v30i6.4 [doi]', 'jEJHS.v30.i6.p...</td>\n",
       "      <td>['background', 'hospital', 'infections', 'in',...</td>\n",
       "      <td>[[(Hospital, infections), (pediatric, units), ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6</td>\n",
       "      <td>BACKGROUND: Bloodstream infection (BSI) result...</td>\n",
       "      <td>['10.1186/s12887-021-02661-9 [doi]', '10.1186/...</td>\n",
       "      <td>['background', 'bloodstream', 'infection', 'bs...</td>\n",
       "      <td>[[(Bloodstream, infection), (BSI), (ESKAPEEc),...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>7</td>\n",
       "      <td>The accurate identification of Acinetobacter s...</td>\n",
       "      <td>['S0890-8508(21)00039-6 [pii]', '10.1016/j.mcp...</td>\n",
       "      <td>['the', 'accurate', 'identification', 'of', 'a...</td>\n",
       "      <td>[[(accurate), (identification), (Acinetobacter...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8</td>\n",
       "      <td>BACKGROUND: SARS-CoV-2 predisposes patients to...</td>\n",
       "      <td>['S0195-6701(21)00151-1 [pii]', '10.1016/j.jhi...</td>\n",
       "      <td>['background', 'sars', 'cov', '2', 'predispose...</td>\n",
       "      <td>[[(SARS-CoV-2), (patients), (secondary, infect...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>9</td>\n",
       "      <td>OBJECTIVE: The aim: To obtain the first estima...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>['objective', 'the', 'aim', 'to', 'obtain', 't...</td>\n",
       "      <td>[[(OBJECTIVE), (estimates), (data), (occurrenc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>10</td>\n",
       "      <td>The ESKAPE pathogens (Enterococcus spp., Staph...</td>\n",
       "      <td>['10.1080/20477724.2021.1916158 [doi]']</td>\n",
       "      <td>['the', 'eskape', 'pathogens', 'enterococcus',...</td>\n",
       "      <td>[[(ESKAPE), (pathogens), (Enterococcus, spp, ....</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>11</td>\n",
       "      <td>Stachys species belonging to Lamiaceae family ...</td>\n",
       "      <td>['S0001-37652021000500702 [pii]', '10.1590/000...</td>\n",
       "      <td>['stachys', 'species', 'belonging', 'to', 'lam...</td>\n",
       "      <td>[[(Stachys, species), (Lamiaceae), (family), (...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>12</td>\n",
       "      <td>The Acinetobacter trimeric autotransporter adh...</td>\n",
       "      <td>['10.1007/s00203-021-02343-1 [doi]', '10.1007/...</td>\n",
       "      <td>['the', 'acinetobacter', 'trimeric', 'autotran...</td>\n",
       "      <td>[[(Acinetobacter, trimeric, autotransporter, a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>13</td>\n",
       "      <td>BACKGROUND: Thiopeptides are a class of antibi...</td>\n",
       "      <td>['6256240 [pii]', '10.1093/jac/dkab124 [doi]']</td>\n",
       "      <td>['background', 'thiopeptides', 'are', 'a', 'cl...</td>\n",
       "      <td>[[(Thiopeptides), (antibiotics), (Gram-positiv...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>14</td>\n",
       "      <td>PURPOSE: Nowadays, Acinetobacter baumannii is ...</td>\n",
       "      <td>['S0255-0857(21)00061-X [pii]', '10.1016/j.ijm...</td>\n",
       "      <td>['purpose', 'nowadays', 'acinetobacter', 'baum...</td>\n",
       "      <td>[[(PURPOSE), (Acinetobacter, baumannii), (resi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>15</td>\n",
       "      <td>Given the global panorama of demands in the he...</td>\n",
       "      <td>['10.1177/08853282211011921 [doi]']</td>\n",
       "      <td>['given', 'the', 'global', 'panorama', 'of', '...</td>\n",
       "      <td>[[(global, panorama), (demands), (health, area...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>16</td>\n",
       "      <td>Four new aromatic polyketides including two di...</td>\n",
       "      <td>['10.1080/14786419.2021.1915309 [doi]']</td>\n",
       "      <td>['four', 'new', 'aromatic', 'polyketides', 'in...</td>\n",
       "      <td>[[(aromatic, polyketides), (diphenyl, ethers),...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>17</td>\n",
       "      <td>Acinetobacter baumannii is an opportunistic pa...</td>\n",
       "      <td>['10.3389/fmicb.2021.622704 [doi]']</td>\n",
       "      <td>['acinetobacter', 'baumannii', 'is', 'an', 'op...</td>\n",
       "      <td>[[(Acinetobacter, baumannii), (opportunistic, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>18</td>\n",
       "      <td>Objective: This work attempted to isolate, ide...</td>\n",
       "      <td>['10.1016/j.jtumed.2020.10.007 [doi]', 'S1658-...</td>\n",
       "      <td>['objective', 'this', 'work', 'attempted', 'to...</td>\n",
       "      <td>[[(Objective), (isolate), (correlate), (compos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>19</td>\n",
       "      <td>The aim of the present work was the comparison...</td>\n",
       "      <td>['10.1080/09603123.2021.1919292 [doi]']</td>\n",
       "      <td>['the', 'aim', 'of', 'the', 'present', 'work',...</td>\n",
       "      <td>[[(comparison), (antimicrobial, activity), (me...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>20</td>\n",
       "      <td>Prophylactic administration of broad-spectrum ...</td>\n",
       "      <td>['10.1111/lam.13493 [doi]']</td>\n",
       "      <td>['prophylactic', 'administration', 'of', 'broa...</td>\n",
       "      <td>[[(Prophylactic, administration), (broad-spect...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>21</td>\n",
       "      <td>Chronic otitis media with effusion (OME) has b...</td>\n",
       "      <td>['6/2/e00056-21 [pii]', '10.1128/mSystems.0005...</td>\n",
       "      <td>['chronic', 'otitis', 'media', 'with', 'effusi...</td>\n",
       "      <td>[[(Chronic, otitis, media), (effusion), (OME),...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>22</td>\n",
       "      <td>Many pathogenic organisms do produce different...</td>\n",
       "      <td>['S0255-0857(20)30001-3 [pii]', '10.1016/j.ijm...</td>\n",
       "      <td>['many', 'pathogenic', 'organisms', 'do', 'pro...</td>\n",
       "      <td>[[(pathogenic, organisms), (pigments), (presum...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>23</td>\n",
       "      <td>Ligninolytic bacteria degrading lignin were is...</td>\n",
       "      <td>['10.33073/pjm-2020-037 [doi]', 'exeley [pii]']</td>\n",
       "      <td>['ligninolytic', 'bacteria', 'degrading', 'lig...</td>\n",
       "      <td>[[(Ligninolytic, bacteria), (degrading), (lign...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>24</td>\n",
       "      <td>Metabolites of azo dyes are often carcinogenic...</td>\n",
       "      <td>['10.1016/j.sjbs.2020.11.012 [doi]', 'S1319-56...</td>\n",
       "      <td>['metabolites', 'of', 'azo', 'dyes', 'are', 'o...</td>\n",
       "      <td>[[(Metabolites), (azo, dyes), (carcinogenic), ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>25</td>\n",
       "      <td>Background: Protective lead garments (PLG) wor...</td>\n",
       "      <td>['10.1177/1757177420947466 [doi]', '10.1177_17...</td>\n",
       "      <td>['background', 'protective', 'lead', 'garments...</td>\n",
       "      <td>[[(Protective, lead, garments), (PLG), (worn),...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>26</td>\n",
       "      <td>Jordan is one of the lowest countries in the w...</td>\n",
       "      <td>['10.2166/wh.2020.193 [doi]']</td>\n",
       "      <td>['jordan', 'is', 'one', 'of', 'the', 'lowest',...</td>\n",
       "      <td>[[(Jordan), (lowest), (countries), (world), (w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>27</td>\n",
       "      <td>Bacteria of the genus Acinetobacter, with thei...</td>\n",
       "      <td>['10.3389/fmicb.2020.588410 [doi]']</td>\n",
       "      <td>['bacteria', 'of', 'the', 'genus', 'acinetobac...</td>\n",
       "      <td>[[(Bacteria), (genus), (Acinetobacter), (speci...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>28</td>\n",
       "      <td>NaN</td>\n",
       "      <td>['10.7883/yoken.JJID.2020.806 [doi]']</td>\n",
       "      <td>['nan']</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>29</td>\n",
       "      <td>ABSTRACT: To explore a new surgical treatment ...</td>\n",
       "      <td>['00001665-202102000-00115 [pii]', '10.1097/SC...</td>\n",
       "      <td>['abstract', 'to', 'explore', 'a', 'new', 'sur...</td>\n",
       "      <td>[[(ABSTRACT), (surgical, treatment), (infectio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1501</th>\n",
       "      <td>1501</td>\n",
       "      <td>Chronic Fatigue Syndrome/Myalgic Encephalomyel...</td>\n",
       "      <td>['10.1038/s41598-021-86425-6 [doi]', '10.1038/...</td>\n",
       "      <td>['chronic', 'fatigue', 'syndrome', 'myalgic', ...</td>\n",
       "      <td>[[(Chronic, Fatigue, Syndrome/Myalgic, Encepha...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1502</th>\n",
       "      <td>1502</td>\n",
       "      <td>We describe a case of subacute bacterial endoc...</td>\n",
       "      <td>['14/3/e240349 [pii]', '10.1136/bcr-2020-24034...</td>\n",
       "      <td>['we', 'describe', 'a', 'case', 'of', 'subacut...</td>\n",
       "      <td>[[(case), (subacute), (bacterial, endocarditis...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1503</th>\n",
       "      <td>1503</td>\n",
       "      <td>BACKGROUND: Rothia sp. are Gram-positive bacte...</td>\n",
       "      <td>['S1438-4221(21)00007-2 [pii]', '10.1016/j.ijm...</td>\n",
       "      <td>['background', 'rothia', 'sp', 'are', 'gram', ...</td>\n",
       "      <td>[[(Rothia, sp.), (Gram-positive, bacteria), (A...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1504</th>\n",
       "      <td>1504</td>\n",
       "      <td>The endogenous microbiome of healthy individua...</td>\n",
       "      <td>['jcm9124068 [pii]', '10.3390/jcm9124068 [doi]']</td>\n",
       "      <td>['the', 'endogenous', 'microbiome', 'of', 'hea...</td>\n",
       "      <td>[[(endogenous), (microbiome), (healthy), (indi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1505</th>\n",
       "      <td>1505</td>\n",
       "      <td>A 65-year-old male patient with a history of h...</td>\n",
       "      <td>['10.4103/jgid.jgid_136_19 [doi]', 'JGID-12-15...</td>\n",
       "      <td>['a', '65', 'year', 'old', 'male', 'patient', ...</td>\n",
       "      <td>[[(male), (patient), (history, of, heart, valv...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1506</th>\n",
       "      <td>1506</td>\n",
       "      <td>The effect of xylitol tablets with (XPT) and w...</td>\n",
       "      <td>['10.1080/08927014.2020.1858063 [doi]']</td>\n",
       "      <td>['the', 'effect', 'of', 'xylitol', 'tablets', ...</td>\n",
       "      <td>[[(effect), (xylitol, tablets), (XPT), (XT), (...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1507</th>\n",
       "      <td>1507</td>\n",
       "      <td>In the last decades, resistant microbial infec...</td>\n",
       "      <td>['10.3389/fmicb.2020.592265 [doi]']</td>\n",
       "      <td>['in', 'the', 'last', 'decades', 'resistant', ...</td>\n",
       "      <td>[[(decades), (resistant), (microbial), (rate),...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1508</th>\n",
       "      <td>1508</td>\n",
       "      <td>OBJECTIVE: To describe the epidemiological, cl...</td>\n",
       "      <td>['S0399-077X(20)30761-7 [pii]', '10.1016/j.med...</td>\n",
       "      <td>['objective', 'to', 'describe', 'the', 'epidem...</td>\n",
       "      <td>[[(OBJECTIVE), (epidemiological), (clinical), ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1509</th>\n",
       "      <td>1509</td>\n",
       "      <td>Aim: This study evaluated the influence of per...</td>\n",
       "      <td>['10.1080/20002297.2020.1814674 [doi]', '18146...</td>\n",
       "      <td>['aim', 'this', 'study', 'evaluated', 'the', '...</td>\n",
       "      <td>[[(study), (evaluated), (influence), (periodon...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1510</th>\n",
       "      <td>1510</td>\n",
       "      <td>In this work the development of an inhibitive ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>['in', 'this', 'work', 'the', 'development', '...</td>\n",
       "      <td>[[(development), (inhibitive), (assay), (coppe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1511</th>\n",
       "      <td>1511</td>\n",
       "      <td>A novel obligately organotrophic, facultativel...</td>\n",
       "      <td>['ijs.0.009605-0 [pii]', '10.1099/ijs.0.009605...</td>\n",
       "      <td>['a', 'novel', 'obligately', 'organotrophic', ...</td>\n",
       "      <td>[[(obligately, organotrophic), (facultatively,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1512</th>\n",
       "      <td>1512</td>\n",
       "      <td>New microaerophilic sulfur-oxidizing spirilla ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>['new', 'microaerophilic', 'sulfur', 'oxidizin...</td>\n",
       "      <td>[[(New, microaerophilic), (sulfur-oxidizing, s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1513</th>\n",
       "      <td>1513</td>\n",
       "      <td>In Argentina, legislation to control adverse i...</td>\n",
       "      <td>['10.1002/tox.1027 [pii]', '10.1002/tox.1027 [...</td>\n",
       "      <td>['in', 'argentina', 'legislation', 'to', 'cont...</td>\n",
       "      <td>[[(Argentina), (legislation), (impacts), (effl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1514</th>\n",
       "      <td>1514</td>\n",
       "      <td>A hydrogen peroxide-resistant mutant of the ca...</td>\n",
       "      <td>['10.1046/j.1365-2672.1998.00602.x [doi]']</td>\n",
       "      <td>['a', 'hydrogen', 'peroxide', 'resistant', 'mu...</td>\n",
       "      <td>[[(hydrogen, peroxide-resistant, mutant), (cat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1515</th>\n",
       "      <td>1515</td>\n",
       "      <td>A former mercury plant, where mercury salts an...</td>\n",
       "      <td>['10.1039/an9952000721 [doi]']</td>\n",
       "      <td>['a', 'former', 'mercury', 'plant', 'where', '...</td>\n",
       "      <td>[[(mercury), (plant), (mercury), (salts), (org...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1516</th>\n",
       "      <td>1516</td>\n",
       "      <td>Bright-field high-speed cinemicrography was em...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>['bright', 'field', 'high', 'speed', 'cinemicr...</td>\n",
       "      <td>[[(Bright-field, high-speed, cinemicrography),...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1517</th>\n",
       "      <td>1517</td>\n",
       "      <td>The 16S ribosomal DNA sequence of Taylorella e...</td>\n",
       "      <td>['10.1099/00207713-43-3-618 [doi]']</td>\n",
       "      <td>['the', '16s', 'ribosomal', 'dna', 'sequence',...</td>\n",
       "      <td>[[(16S, ribosomal, DNA, sequence), (Taylorella...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1518</th>\n",
       "      <td>1518</td>\n",
       "      <td>A mathematical model employing slender body th...</td>\n",
       "      <td>['S0022-5193(89)80100-6 [pii]', '10.1016/s0022...</td>\n",
       "      <td>['a', 'mathematical', 'model', 'employing', 's...</td>\n",
       "      <td>[[(mathematical, model), (slender), (body, the...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1519</th>\n",
       "      <td>1519</td>\n",
       "      <td>The ECHA Biocide Monitor, a dipstick procedure...</td>\n",
       "      <td>['0269-7491(89)90125-5 [pii]', '10.1016/0269-7...</td>\n",
       "      <td>['the', 'echa', 'biocide', 'monitor', 'a', 'di...</td>\n",
       "      <td>[[(ECHA, Biocide, Monitor), (dipstick, procedu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1520</th>\n",
       "      <td>1520</td>\n",
       "      <td>OBJECTIVES: To explore whether linezolid/dapto...</td>\n",
       "      <td>['6256239 [pii]', '10.1093/jac/dkab095 [doi]']</td>\n",
       "      <td>['objectives', 'to', 'explore', 'whether', 'li...</td>\n",
       "      <td>[[(linezolid/daptomycin, combinations), (Staph...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1521</th>\n",
       "      <td>1521</td>\n",
       "      <td>This narrative review describes the epidemiolo...</td>\n",
       "      <td>['10.1007/s40121-021-00434-6 [doi]', '10.1007/...</td>\n",
       "      <td>['this', 'narrative', 'review', 'describes', '...</td>\n",
       "      <td>[[(narrative, review), (epidemiology), (invasi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1522</th>\n",
       "      <td>1522</td>\n",
       "      <td>ETHNOPHARMACOLOGICAL RELEVANCE: Ma-xing-shi-ga...</td>\n",
       "      <td>['S0378-8741(21)00360-3 [pii]', '10.1016/j.jep...</td>\n",
       "      <td>['ethnopharmacological', 'relevance', 'ma', 'x...</td>\n",
       "      <td>[[(ETHNOPHARMACOLOGICAL), (Ma-xing-shi-gan-tan...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1523</th>\n",
       "      <td>1523</td>\n",
       "      <td>BACKGROUND: Evidence from pandemics suggests t...</td>\n",
       "      <td>['S0899823X21000969 [pii]', '10.1017/ice.2021....</td>\n",
       "      <td>['background', 'evidence', 'from', 'pandemics'...</td>\n",
       "      <td>[[(Evidence), (pandemics), (influenza), (assoc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1524</th>\n",
       "      <td>1524</td>\n",
       "      <td>Pneumococcal capsules are important in pneumoc...</td>\n",
       "      <td>['JCM.00540-21 [pii]', '10.1128/JCM.00540-21 [...</td>\n",
       "      <td>['pneumococcal', 'capsules', 'are', 'important...</td>\n",
       "      <td>[[(Pneumococcal, capsules), (pneumococcal), (p...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1525</th>\n",
       "      <td>1525</td>\n",
       "      <td>BACKGROUND: Antimicrobial-resistant strains of...</td>\n",
       "      <td>['10.1186/s12941-021-00432-z [doi]', '10.1186/...</td>\n",
       "      <td>['background', 'antimicrobial', 'resistant', '...</td>\n",
       "      <td>[[(Antimicrobial-resistant, strains), (Strepto...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1526</th>\n",
       "      <td>1526</td>\n",
       "      <td>Within Mycoplasma genus, M. pneumoniae, M. gen...</td>\n",
       "      <td>['10.37201/req/014.2021 [doi]']</td>\n",
       "      <td>['within', 'mycoplasma', 'genus', 'm', 'pneumo...</td>\n",
       "      <td>[[(Mycoplasma, genus), (M., pneumoniae), (M., ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1527</th>\n",
       "      <td>1527</td>\n",
       "      <td>Background and objectives: Ureaplasma urealyti...</td>\n",
       "      <td>['medicina57030211 [pii]', '10.3390/medicina57...</td>\n",
       "      <td>['background', 'and', 'objectives', 'ureaplasm...</td>\n",
       "      <td>[[(Background), (objectives), (Ureaplasma, ure...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1528</th>\n",
       "      <td>1528</td>\n",
       "      <td>BACKGROUND: Sexually transmitted infections (S...</td>\n",
       "      <td>['S0365-0596(21)00015-5 [pii]', '10.1016/j.abd...</td>\n",
       "      <td>['background', 'sexually', 'transmitted', 'inf...</td>\n",
       "      <td>[[(Sexually, transmitted, infections), (STI), ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1529</th>\n",
       "      <td>1529</td>\n",
       "      <td>Ureaplasma urealyticum and U parvum are mollic...</td>\n",
       "      <td>['AAC.02342-20 [pii]', '10.1128/AAC.02342-20 [...</td>\n",
       "      <td>['ureaplasma', 'urealyticum', 'and', 'u', 'par...</td>\n",
       "      <td>[[(Ureaplasma, urealyticum), (U, parvum), (mol...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1530</th>\n",
       "      <td>1530</td>\n",
       "      <td>Background: Gardnerella vaginalis (GV) is most...</td>\n",
       "      <td>['10.3389/fped.2020.593802 [doi]']</td>\n",
       "      <td>['background', 'gardnerella', 'vaginalis', 'gv...</td>\n",
       "      <td>[[(Gardnerella, vaginalis), (GV), (associated,...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1531 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0                                           abstract  \\\n",
       "0              0  Frateuria aurantia (ex Kondo and Ameyama 1958)...   \n",
       "1              1  Acinetobacter spp. have become of increased cl...   \n",
       "2              2  OBJECTIVES: To investigate if adding calcium t...   \n",
       "3              3  BACKGROUND: Knowledge on the epidemiology, gen...   \n",
       "4              4  The coffee berry borer, the most economically ...   \n",
       "...          ...                                                ...   \n",
       "1526        1526  Within Mycoplasma genus, M. pneumoniae, M. gen...   \n",
       "1527        1527  Background and objectives: Ureaplasma urealyti...   \n",
       "1528        1528  BACKGROUND: Sexually transmitted infections (S...   \n",
       "1529        1529  Ureaplasma urealyticum and U parvum are mollic...   \n",
       "1530        1530  Background: Gardnerella vaginalis (GV) is most...   \n",
       "\n",
       "                                                    doi  \\\n",
       "0     ['10.4056/sigs.4338002 [doi]', 'sigs.4338002 [...   \n",
       "1     ['AAC.00514-21 [pii]', '10.1128/AAC.00514-21 [...   \n",
       "2     ['S1198-743X(21)00197-X [pii]', '10.1016/j.cmi...   \n",
       "3     ['10.1186/s13756-021-00936-5 [doi]', '10.1186/...   \n",
       "4                   ['10.3389/fmicb.2021.644768 [doi]']   \n",
       "...                                                 ...   \n",
       "1526                    ['10.37201/req/014.2021 [doi]']   \n",
       "1527  ['medicina57030211 [pii]', '10.3390/medicina57...   \n",
       "1528  ['S0365-0596(21)00015-5 [pii]', '10.1016/j.abd...   \n",
       "1529  ['AAC.02342-20 [pii]', '10.1128/AAC.02342-20 [...   \n",
       "1530                 ['10.3389/fped.2020.593802 [doi]']   \n",
       "\n",
       "                                                 tokens  \\\n",
       "0     ['frateuria', 'aurantia', 'ex', 'kondo', 'and'...   \n",
       "1     ['acinetobacter', 'spp', 'have', 'become', 'of...   \n",
       "2     ['objectives', 'to', 'investigate', 'if', 'add...   \n",
       "3     ['background', 'knowledge', 'on', 'the', 'epid...   \n",
       "4     ['the', 'coffee', 'berry', 'borer', 'the', 'mo...   \n",
       "...                                                 ...   \n",
       "1526  ['within', 'mycoplasma', 'genus', 'm', 'pneumo...   \n",
       "1527  ['background', 'and', 'objectives', 'ureaplasm...   \n",
       "1528  ['background', 'sexually', 'transmitted', 'inf...   \n",
       "1529  ['ureaplasma', 'urealyticum', 'and', 'u', 'par...   \n",
       "1530  ['background', 'gardnerella', 'vaginalis', 'gv...   \n",
       "\n",
       "                                                   mesh  \n",
       "0     [[(Frateuria, aurantia), (ex, Kondo), (bispeci...  \n",
       "1     [[(Acinetobacter, spp), (increased), (clinical...  \n",
       "2     [[(investigate), (calcium), (Mueller-Hinton, a...  \n",
       "3     [[(Knowledge), (epidemiology), (genotypic), (p...  \n",
       "4     [[(coffee), (berry, borer), (insect), (pest), ...  \n",
       "...                                                 ...  \n",
       "1526  [[(Mycoplasma, genus), (M., pneumoniae), (M., ...  \n",
       "1527  [[(Background), (objectives), (Ureaplasma, ure...  \n",
       "1528  [[(Sexually, transmitted, infections), (STI), ...  \n",
       "1529  [[(Ureaplasma, urealyticum), (U, parvum), (mol...  \n",
       "1530  [[(Gardnerella, vaginalis), (GV), (associated,...  \n",
       "\n",
       "[1531 rows x 5 columns]"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[Frateuria aurantia, ex Kondo, bispecific genus, Frateuria, family Xanthomonadaceae, targeted, non-type strain genome sequencing, Strain Kondo 67(T), identified, Acetobacter aurantius, type strain, acetogenic, species, Frateuria aurantia, strain, triterpenoids, hopane family, F. aurantia Kondo 67(T), genus, Frateura, genome sequence, features, organism, complete, genome sequence, annotation, long chromosome, protein-coding, RNA genes, G enomic E ncyclopedia, Bacteria, Archaea project]]\n",
      "[[Acinetobacter spp, increased, clinical, studies, antimicrobial resistant, potential, species, Efflux, pumps, reduced, susceptibility, antibiotics, Acinetobacter spp, families, efflux, pumps, clinical, relevance, Major Facilitator Superfamily (MFS, Small, Multidrug Resistance, SMR, family, ATP-binding cassette, Multidrug, Toxic Compound Extrusion, MATE, Proteobacterial Antimicrobial Compound, Efflux, PACE, Resistance-Nodulation-Division, RND, family, efflux, pumps, antimicrobial resistance, physiology, bacteria, RND, efflux, pumps, substrate, profiles, Acinetobacter spp, antimicrobial resistance, discoveries, complex regulation, efflux, pumps, potential, reduced, susceptibility, bacterial species]]\n",
      "[[investigate, calcium, Mueller-Hinton agar, gradient, MIC, disk diffusion tests, improve, separation, colistin, susceptible, resistant, populations, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp, method, screening test, colistin, resistance, routine, laboratories, isolate, collection, E. coli, K. pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp, tested, Ca(2+), concentrations, Mueller-Hinton agar, plates, gradient, MIC, disk diffusion tests, Broth microdilution, ISO, MIC, determination, reference, E. coli, K. pneumoniae, investigated, colistin, resistance genes, Results, gradient tests, disk diffusion, species, Correlation, phenotypic, expression, resistance, resistance genes, absolute, Ca(2+), Mueller-Hinton agar, improved, separation, colistin, susceptible, resistant, isolates, E. coli, K. pneumoniae, separation, improved, isolates, mcr genes, isolates, colistin, resistance, mechanisms, increase, concentrations, Ca(2+), separation, susceptible, resistant, isolates, E. coli, K. pneumoniae, P. aeruginosa, Acinetobacter species, Ca(2+), separation, susceptible, resistant, populations, results, study, Ca(2+), Mueller-Hinton agar, improve, detection, colistin, resistance, gradient, MIC, disk diffusion tests, routine, laboratory]]\n",
      "[[Knowledge, epidemiology, genotypic, phenotypic, features, antimicrobial-resistant, AMR, ESKAPEE, pathogens, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., Escherichia coli, association, hospital-acquired infections, HAIs, Malaysia, evaluated, AMR, features, resistance, mechanisms, ESKAPEE, pathogens, tertiary hospital, capital, Malaysia, AMR-ESKAPEE strains, convenience sampling, nine-month study, period, strains, disk diffusion, broth microdilution assays, antimicrobial susceptibility profiles, Polymerase chain reaction, PCR, DNA sequence analyses, AMR, genes, profiles, non-susceptible, strains, Chi-square test, logistic regression analyses, AMR, profiles, clinical data, risk factors, associated with, HAIs, rates, multidrug resistance, MDR, A. baumannii, K. pneumoniae, E. coli, S. aureus, organisms, E. coli, associated with, HAIs, Non-susceptibility, last-resort drugs, vancomycin, Enterococcus spp., S. aureus, carbapenems, A. baumannii, P. aeruginosa, Enterobacteriaceae, colistin, Enterobacteriaceae, observed, A. baumannii, K. pneumoniae, extended-spectrum beta-lactamase genes, blaTEM, blaSHV, blaCTX-M, blaOXA, Metallo-beta-lactamase genes, blaVEB, blaVIM, blaNDM, detected, carbapenem-resistant strains, frequency, local reports, detected, mutations, quinolone-resistant, gyrA, fluoroquinolone-resistant E. coli, Leu-102-Ala, Microbial, resistance, ampicillin, methicillin, cephalosporins, risk factors, associated with, HAIs, hospital, findings, microbial, resistance, pattern, risk factors, ESKAPEE-associated HAIs, tertiary hospital, central Peninsular Malaysia, data, study, hospital infection, control, region]]\n",
      "[[coffee, berry borer, insect, pest, coffee, worldwide, insect, feeding, reproducing, coffee, seed, food source, purine alkaloid, caffeine, bacterial species, associated with, coffee, berry, borers, Hawai'i, Mexico, laboratory colony, Acinetobacter sp. S40, S54, S55, Bacillus aryabhattai, Delftia lacustris, Erwinia sp. S38, S43, S63, Klebsiella oxytoca, Ochrobactrum sp. S45, S46, Pantoea sp. S61, Pseudomonas aeruginosa, P. parafulva, Pseudomonas sp. S30, S31, S32, S37, S44, S60, caffeine, N-demethylation genes, ndmA, ndmB, ndmC, ndmD, ndmE, Pseudomonas spp., S32, S37, S60, P. parafulva, genes, bacteria, ndm genes, detected, eggs, vertical transmission, presence, caffeine-degrading bacteria, frass, P. parafulva, Bacillus aryabhattai, ndmA, horizontal, transmission, insect, life stages, bacterial species, associated with, insect, Acinetobacter sp. S40, S54, S55, B. aryabhattai, B. cereus, group, Bacillus sp. S29, S70, S71, S72, S73, D. lacustris, Erwinia sp. S38, S43, S59, S63, Kosakonia cowanii, Ochrobactrum sp. S45, S46, Paenibacillus sp. S28, Pantoea sp. S61, S62, P. aeruginosa, P. parafulva, Pseudomonas sp. S30, S31, S32, S37, S44, S60, S75, Stenotrophomonas sp. S39, S41, S48, S49, caffeine, breakdown, C-8 oxidation pathway, presence, genes, pathway, caffeine-degrading bacteria, associated with, coffee, berry, epiphytes, endophytes, coffee, plant, microbiota]]\n",
      "[[Hospital infections, pediatric units, increase, length of hospital stay, antibiotics, exposure, procedures, study, microorganisms, hand flora, pediatric, patients, hospitalization, discharge, study, prospective cross-sectional study, prospective study, pediatric, patients, completion, admission procedures, sample, hands, hospitalized, patients, sample, patients, discharging, Growth, coagulase-negative staphylococcus, CNS, culture samples, patients, Cultures, patients, microorganisms, Staphylococcus aureus, Escherichia coli, S. epidermis, Examination, discharge cultures, CNS, patients, S. aureus, patients, E. coli, patients, Acinetobacter baumannii, patients, Kocuria rhizophila, K. kristinae, Candida spp., Pseudomonas spp., Enterococcus, patient, cultures, samples, discharge, presence, antibiotic-resistant, pathogenic, microorganisms, healthcare]]\n",
      "[[Bloodstream infection, BSI, ESKAPEEc, pathogens, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp), relevant, mortality, economic cost, Data, impact, BSI, ESKAPEEc, pediatric population, epidemiology, risk factors, outcomes, ESKAPEEc, BSI, hospitalized children, Inpatients, diagnosed, BSI, etiology, retrospectively, West China, University Hospital, Data, systematically, reviewed, patients, clinical characteristics, laboratory findings, independent, predictors, clinical features, outcomes, patients, BSI, ESKAPEEc, MDR-ESKAPEEc, Multivariate analysis, premature, low birth weight, odds ratio, OR, surgery, trauma, OR, source, urinary tract infection, OR, associated with, ESKAPEEc BSI, independent, risk factor, MRD-ESKAPEEc, BSI, nosocomial infection, OR, mortality rate, patients, ESKAPEEc BSI, no significant difference, mortality, MRD-ESKAPEEc, non-MRD, BSI, groups, surgery, trauma, thrombocytopenia, mechanical ventilation, risk factors, mortality, ESKAPEEc, BSI, BSI, hospitalized children, ESKAPEEc, surgery, trauma, thrombocytopenia, mechanical ventilation, increased, risk rate, mortality, ESKAPEEc, BSI, risk factors, physicians, ESKAPEEc, BSI, MDR ESKAPEEc, BSI]]\n",
      "[[accurate, identification, Acinetobacter spp, phenotypic, biochemical, similarities, clinical, relevance, antibiotic susceptibility, genomic species, Acinetobacter, identification, A. baumannii, prevent, inappropriate, antibiotic, inferior clinical care, project, sequence-specific PCR assay, rpoB region, A. baumannii, non-Acinetobacter baumannii, Acinetobacter species, duplex PCR, assay, detect, blaOXA-51-like, gluconolactonase genes, identification, study, isolates, Acinetobacter spp, identified, PCR-sequencing, rpoB gene, reference test, PCR-sequencing, rpoB, revealed, isolates, A. baumannii, A. baumannii, Acinetobacter strains, PCR amplification, targeting, rpoB gene, method, detected, isolates, A. baumannii, duplex PCR, isolates, A. baumannii, Data analysis, sensitivities, sequence-specific PCR, rpoB gene, duplex PCR, specificities, data, methods, potential, accurate, identification, A. baumannnii, A. baumannii, species, Sequence-specific PCR assay, rpoB gene, duplex PCR, blaOXA-51-like, gluconolactonase genes, reliable, cost-effective, methods, clinical laboratories, accurate, identification, A. baumannii]]\n",
      "[[SARS-CoV-2, patients, secondary infections, impact, coinfections, outcome, hospitalized, COVID-19, patients, AIM, death risk, coinfections, COVID-19, patients, evaluated, Odds, death, severely, COVID-19, patients, risks, pathogen, site, infection, comorbidities, length, hospitalization, FINDINGS, mortality rate, Fungal, bacterial isolation, patients, died, Coinfected, patients, hospitalized, increased, Odds, dying, OR, risk, death, increased, bacterial, OR=11.28, fungal, coinfections, increased, levels, creatinine, leukocytes, urea, C-reactive protein, Coinfections, increased, risk, death, patients, cardiovascular disease, diabetes, obesity, comparison, patients, comorbidities, pathogen, isolation, increased, risk, death, detected, negative-coagulase Staphylococcus, OR=25.39, Candida non-albicans, OR=11.12, S. aureus, OR=10.72, Acinetobacter spp., Pseudomonas spp., C. albicans, high-risk sites, infection, blood, tracheal aspirate, urine, Patients, coinfection, invasive, mechanical ventilation, die, positive, cultures, Severe, COVID-19, patients, secondary, coinfections, hospitalization, risk, death, early diagnosis, coinfections, high-risk, patients, right interventions, reduce, mortality]]\n",
      "[[OBJECTIVE, estimates, data, occurrence, antibiotic-resistant bacteria, fresh vegetables, Kyiv city, markets, Materials, methods, multicenter study, Fresh vegetables, samples, commodity, groups, retail, locatedin Kyiv, Ukraine, Samples, tested, bacteria, concern, susceptibility, antibiotics, disk diffusion method, European Committee, Antimicrobial Susceptibility Testing, Results, antibiotic-resistant bacteria, contamination, fresh vegetables, contamination, organic, conventionally products, Contamination, leafy vegetables, contaminated bacteria, Escherichia coli, Enterobacter spp., Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, E. faecium, Staphylococcus aureus, Acinetobacter spp, proportion, extended, ESBL, production, Enterobacteriaceae, methicillin-resistance, S. aureus, MRSA, prevalence, ESBL, production, E. coli, isolates, K. pneumoniae, Vancomycin, resistance, isolated, enterococci, VRE, Carbapenem, resistance, identified, P.aeruginosa, isolates, Acinetibacter spp, isolates, Resistance, third-generation cephalosporins, E.coli, isolates, Research, fresh vegetables, Kiev markets, contaminated, antibiotic-resistant bacteria, potential, vehicle, transmission, pathogens, consumers]]\n",
      "[[ESKAPE, pathogens, Enterococcus spp., Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., multidrug-resistant, MDR, extensively drug-resistant, XDR, pan drug-resistant, PDR, severe, challenges, treatment, associated infections, ESKAPE, pathogens, colonize, biotic, abiotic surfaces, biofilms, pathogens, source, food contamination, biofilms, development, antimicrobial-resistant, AMR, strains, frequent, isolation, antimicrobial-resistant, ESKAPE, pathogens, food products, globe, threat, public health, comprehensive, adhesion, signaling, polymicrobial, single-species, biofilm, alternative, preservation techniques, therapeutic strategies, ESKAPE, pathogens, review, comprehensive, overview, signaling, mechanisms, ESKAPE, pathogens, adhesion, abiotic, biotic surfaces, molecular mechanisms, associated with, poly-microbial, AMR, ESKAPE]]\n",
      "[[Stachys species, Lamiaceae, family, medicinal purposes, study, investigate, chemical, compositions, antibacterial, anti-tyrosinase activities, essential oil, Stachys macrostachya, essential oil, hydrodistillation, Clevenger-type apparatus, chemical composition, gas chromatography, GC, antibacterial activity, essential oil, disc diffusion, microdilution broth method, Gram-positive, Gram-negative bacteria, tyrosinase inhibitory activity, evaluated, minor, modifications, Masuda's method, results, GC, analyses, compounds, total volatile composition, compounds, germacrene D, globulol, alpha-pinene, valencene, study, essential oil, S. macrostachya, antibacterial activity, Acinetobacter baumannii, MIC, tyrosinase inhibition activity, IC50, results, essential oil, source, natural, antimicrobial agents, bacterium, tyrosinase inhibitors]]\n",
      "[[Acinetobacter trimeric autotransporter adhesin, virulence factor, conserved region, genomic sequence, amino acid, Acinetobacter baumannii, ATCC(R)19606 ata, C-terminal of Ata (rcAta263), expressed, effect, A. baumannii, virulence, murine, model, IgG, IgA, mice, groups, A. baumannii, significant, survival rates, bacterial, spleens, livers, lungs, control, test groups, adhesion, rate, A. baumannii, A549 cells, presence, serum, cytotoxicity, mutagenicity, biofilm, disruption, potential, Intraperitoneally, groups, bacterial, organs, immunized mice, Intranasal, logs, bacterial, CFU/g, test group, immunized, mice, sera, reduced, adherence, A. baumannii, A549 cells, cytotoxic, mutagenic effect, detected, Biofilm, disruption, increased, presence, immunized, mice, sera, Immunization, conserved region, virulence, A. baumannii, therapeutic strategy, control, A. baumannii, infections]]\n",
      "[[Thiopeptides, antibiotics, Gram-positive bacteria, inhibit, translation, inactive, Gram-negative bacteria, outer membrane, class, thiostrepton, TS, activity, Pseudomonas aeruginosa, Acinetobacter baumannii, iron-limiting conditions, TS, hijacks, pyoverdine siderophore receptors, P. aeruginosa, outer membrane, synergizes, iron chelators, thiopeptides, antimicrobial activity, P. aeruginosa, mechanism, uptake, action, spectrum, activity, thiopeptides, screened, chequerboard assays, mutant, P. aeruginosa, PA14, lacking, pyoverdine receptors, Thiopeptides, activity, pyoverdine, receptor-null mutant, siderophore receptors, entry, Susceptibility testing, siderophore receptor, mutants, thiopeptide, mechanism, uptake, thiopeptides thiocillin, TC, micrococcin, MC, ferrioxamine siderophore receptor, FoxA, uptake, inhibit, growth, P. aeruginosa, low, micromolar, concentrations, activity, TC, TonB-ExbBD system, energize, siderophore, uptake, TC, canonical mechanism, action, translation, inhibition, Multiple, thiopeptides, antimicrobial activity, P. aeruginosa, historical, outer membrane, results, potential, thiopeptides, antipseudomonal antibiotics]]\n",
      "[[PURPOSE, Acinetobacter baumannii, resistant, antibiotics, evaluation, synergistic, antibiotics, pathogen, antimicrobial resistance, study, evaluate, synergistic, colistin, ampicillin/sulbactam, antibiotics, clinical, isolates, multi-drug resistant, MDR, A. baumannii, Acinetobacter baumannii, strains, isolated, biological, samples, hospitalized, patients, nosocomial infection, pathogen, MDR strains, resistance, classes, antibiotics, cephalosporins, fluoroquinolones, aminoglycosides, study, MIC, antibiotics, isolates, broth microdilution test, checkerboard method, evaluation, synergistic, colistin, ampicillin/sulbactam, antibiotics, isolates, synergy test, colistin, isolates, ampicillin/sulbacatam, Doxycycline, azithromycin, co-trimoxazole, frequency, synergistic effect, colistin, hand, amikacin, gentamicin, doxycycline, co-trimoxazole, azithromycin, cefepime, frequency, synergistic effect, ampicillin/sulbactam, antagonistic effect, antibiotics, Colistin, ampicillin/sulbactam, synergistic, antibiotics, doxycycline, co-trimoxazole, azithromycin, amikacin, ampicillin/sulbactam, MDR strains, Acinetobacter baumannii]]\n",
      "[[global panorama, demands, health area, development, biomaterials, irreducible, maintenance, improvement, quality of life, human, reduce, impacts, infections, healing processes, dermal structure, development, polydimethylsiloxane, PDMS, membranes, polyhexamethylenebiguanide, PHMB, antimicrobial agent, study, antimicrobial, antibiofilm properties, polydimethylsiloxane, PDMS, films, polyhexamethylene biguanide, PHMB, evaluated, development, protective biomaterial, cutaneous infections, autochthonous, allochthonous microbiota, disk diffusion, PHMB-loaded PDMS, growth inhibition, Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Bacillus subtilis, yeast-like, fungi, Candida albicans, microorganisms, epidermal, surface, study, low, cytotoxicity, PHMB-loaded PDMS, HaCaT, L929 cells, concentrations, material, dressing, wounds, burns, post-surgical procedures]]\n",
      "[[aromatic polyketides, diphenyl ethers, pseudopithoethers A-B, benzofuranone, pseudopithonone, xanthone, pseudopithoxanthone, compounds, hydroquinone, alpha,2,5-trihydroxyacetophenone, isolated, marine-derived fungus, Pseudopithomyces maydicus, structures, analysis, spectroscopic, data, isolated compounds, tested, antimicrobial activity, compound, antibacterial activity, methicillin-resistant Staphylococcus aureus, MIC, S. aureus, Acinetobacter baumannii, A. baumannii, NPRC007, MIC]]\n",
      "[[Acinetobacter baumannii, opportunistic pathogen, associated with, multidrug-resistant nosocomial infections, polymyxins, last-resort antibiotics, study, carbapenem-resistant A. baumannii, strains, extensively drug-resistant, XDR, phenotype, isolates, locally pan drug-resistant, LPDR, isolated, inpatients, outbreak, teaching hospital, Brazil, ApaI, DNA macrorestriction, PFGE, clustered, strains, pulsotypes, carbapenem-resistant A. baumannii, strains, Pulsotypes A, B, clustered, polymyxin-resistant, A. baumannii, strains, MLST, analysis, strains, pulsotypes A, B, C, sequence types, ST1, clonal complex, CC1, ST79, CC79, ST903, Genomic analysis, international clones, ST1, ST79, strains, predicted, resistome, beta-lactams, aminoglycosides, fluoroquinolones, trimethoprim-sulfamethoxazole, bla OXA-23, bla OXA-72 genes, encoding, carbapenem, resistance, Amino acid substitutions, PmrB, Thr232Ile, Pro170Leu, PmrC, Arg125His, polymyxin, resistance, colistin, MICs, MIC, polymyxin B, MICs, strains, Pro170Leu, substitution, PmrB, MICs, Thr232Ile, MICs, clone, polymyxin-resistant A. baumannii, strain, ST79, ST1, strains, endemic, outbreak, polymyxin B, genome, comparison, ST1, strains, patient, susceptible, resistant, polymyxin, mutations, ORFs, pmrBC, ORF, codifying, acyl-CoA dehydrogenase, attention, fatty acid, breakdown, membrane, fluidity, involvement, mutations, polymyxin, resistance, mechanism, dissemination, XDR, bacteria, hospital infection control committee, patient, chlorhexidine, solution, concentration, A. baumannii, chlorhexidine, MICs, emergence, polymyxin, resistance, mutations, chromosome, carbapenem-resistant A. baumannii, ST1, high-risk, spreading, hospital]]\n",
      "[[Objective, isolate, correlate, composition, essential oils, EOs, pharmacological, properties, imported, Amomum subulatum, samples, samples, Indian, KSA, local supermarkets, consistency, therapeutic effects, EOs, Indian, KSA, A. subulatum, samples, hydro-distillation method, identified, gas chromatography-mass spectrometry, GC-MS, Antimicrobial activity, gram-negative bacteria, Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii, minimum inhibitory, MIC, bactericidal, Antioxidant, anti-inflammatory activities, bovine, analyses, evaluate, pharmacological activities, substances, GC-MS, retention, samples, bioactive ingredients, percentages, principal, bioactive compounds, Indian, Saudi Arabian, EO, samples, 1,8-cineole, alpha-terpineol, terpinen-4-ol, geraniol D, beta-pinene, Superior, antimicrobial activity, strains, samples, MIC, Antioxidant assays, moderate, activity, samples, Indian, Saudi, Arabian, samples, IC50, values, albumin, denaturation, inhibition assays, anti-inflammatory, potential, ibuprofen, composition, EOs, samples, qualitative, quantitative, variability, variations, pharmacological, properties, EOs, observed, studies, validation, study, findings]]\n",
      "[[comparison, antimicrobial activity, mechanism, components, ethanol, EE, Lentinula edodes Berk, Pegler, Agaricus bisporus Sing, EE, A. bisporus, dianhydromannitol, isosorbide/dianhydromannitol, detected, rate, L. edodes, ethanol, extract, GC-MS, phenolic acids, chlorogenic acid, syringic acid, rutin, p-coumaric acid, ferulic acid, 2-hydroxy cinnamic acid, protocatechuic acid, abscisic acid, trans-cinnamic acid, mushroom extract, HPLC-MWD, MICs, concentration, L. edodes, EE, Klebsiella pneumoniae, Staphylococcus aureus, Enterococcus faecalis, Acinetobacter baumannii, MICs, A. bisporus, EE, pathogens, DRA, decrease, E. faecalis, L. edodes, S. aureus, A. bisporus, minute, result, L. edodes, A. bisporus, antibacterial effect, pathogens, inhibition effect, DNA, protein leakage, destruction, permeability, bacterial cell, bioactive molecules, mushroom extract]]\n",
      "[[Prophylactic administration, broad-spectrum antibiotics, surgery, oral microbiome, induce, colonization, oral cavity, Gram-negative bacteria, multidrug, MDR, extensively- drug resistant, XDR, organisms, respiratory tract infections, study, Gram-negative, isolates, oral cavity, mechanically ventilated, patients, ICUs, prophylactic, antibiotics, resistance, mechanisms, compare, isolates, tracheal aspirates, patients, antibiotic susceptibility, broth dilution method, PCR, detect, genes, encoding, beta-lactamases, diversity, Gram-negative bacteria, resistance, mechanisms, resistance, rates, rate, blaCTX-M, carbapenemase, blaVIM-1, blaOXA-48, Klebsiella pneumoniae, Pseudomonas aeruginosa, blaVIM, strain, blaPER-1 gene, Acinetobacter baumannii, OXA-23-like, OXA-24/40-like oxacillinases, XDR, case, XDR, isolates, international, study, prophlylactic, application, antibiotics, surgery, intensive care units, ICUs, associated with, colonization, oral cavity, lower, respiratory tract, Gram-negative bacteria, identity, Gram-negative bacteria, oral cavity, endotracheal aspirates, oral swab, non-invasive, specimen, colonization, lower, respiratory tract, resistant, Gram-negative organisms, risk, development, ventilator-associated pneumonia]]\n",
      "[[Chronic otitis media, effusion, OME, associated with, shift, microbiome, composition, microbial, interaction, upper respiratory tract, URT, studies, potential, pathogens, study, bacteria, OME, case-control microbiome study, characterization, isolates, healthy subjects, URT, ear microbiome, profiles, chronic, OME, patients, controls, 16S rRNA, Haemophilus influenzae, frequent, middle ear, pathobiont, taxa, Alloiococcus otitis, detected, ear canal, OME, patients, Streptococci, salivarius group, Acinetobacter lwoffii, abundant, nasopharynx, healthy controls, OME, patients, microbiome analysis, taxa, isolated, healthy, individuals, isolates, Streptococcus species, tested, pathobiont-inhibiting potential, Streptococcus salivarius, isolates, superior, capacity, inhibit, growth, H. influenzae, Moraxella catarrhalis, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, A. otitis, Corynebacterium otitidis, S. salivarius, strains, potential, probiotic, prevention, treatment, OME, overrepresentation, healthy, nasopharynx, inhibit, growth, respiratory pathobionts, study, ClinicalTrials.gov, registration, probiotics, marketed, target, gastrointestinal health, study, bacteria, native, human, upper respiratory tract, potential, respiratory, middle ear health, Comparison, microbiomes, children, chronic otitis media, effusion, OME, healthy controls, Streptococcus salivarius, health-associated, prevalent, inhabitant, human, nasopharynx, potential, assessed, strain, level, isolated, S. salivarius, strains, healthy, individuals, study, isolates, safety, efficacy, potential, inhibit, OME, pathogens, in vitro, properties, evaluated, human, clinical studies]]\n",
      "[[pathogenic organisms, pigments, presumptive laboratory diagnosis, microorganisms, pigments, benevolent, mankind, time, pigmented, organisms, resistance, classes, drugs, in vitro, in vivo, Acinetobacter sp, nonpigmented, strains, diffusible brown pigment, rarely, black, indigo, pigments, Liu1, Nizet, Nosanchuk, Casadevall, Moazamian, Saviola, Saviola, German, Indian, human, case report, Viridescent Acinetobacter lwoffii, dark green, pigmented, isolated, central line blood culture, susceptible, classes, drugs, in vitro, correlated, in vivo, compliance]]\n",
      "[[Ligninolytic bacteria, degrading, lignin, isolates, identified, biodegradation, mechanism, alkaline-lignin, investigated, strains, lignin degradation, capability, screened, identified, soil, straw, silage, decolorizing, capacity, aniline blue, colony, size, alkaline-lignin medium, degradation ratio, Bacillus aryabhattai, BY5, Acinetobacter johnsonii, LN2, Acinetobacter lwoffii, LN4, Micrococcus yunnanensis, CL32, assayed, alkaline-lignin, unique, carbon, source, Lip, Mnp (manganese peroxidase, activities, strains, investigated, Lip activity, A. lwoffii, LN4, incubation, M. yunnanensis, CL32, analysis, alkaline-lignin degradation products, GC-MS, revealed, strains, screened, aromatic esters compounds, dibutyl phthalate, DBP, decomposite, monocyclic, aromatic compounds, DBP, aerobic, metabolic pathway, results, B. aryabhattai, BY5, A. johnsonii, LN2, A. lwoffii, LN4, M. yunnanensis, CL32, potential, alkaline-lignin, aromatic compounds, DBP, aerobic, metabolic pathway, process, lignin, degradation]]\n",
      "[[Metabolites, azo dyes, carcinogenic, teratogenic, mutagenic, recalcitrant, nature, study, biofilm consortia, C1, Vitreoscilla sp., ENSG301, Acinetobacter lwoffii, ENSG302, Klebsiella pneumoniae, ENSG303, Pseudomonas fluorescens, ENSG304, C2, Escherichia coli, ENSD101, Enterobacter asburiae, ENSD102, E. ludwigii, ENSH201, C3, E. asburiae, ENSD102, Vitreoscilla sp., ENSG301, Bacillus thuringiensis, ENSW401, C4, E. coli, ENSD101, E. ludwigii, ENSH201, B. thuringiensis, ENSW401, degrade, detoxify, MO, carcinogenic, sulfonated mono azo dye, textile dyeing, industry, worldwide, consortia, C1, C3, C4, decolorization, yeast extract peptone, MO, incubation, static condition, optimum, pH, temperature, decolorization, degrees C, divalent, metal, Mg(2+), Ca(2+), Zn(2+), Mn(2+), stimulate, MO, decolorization, UV-Vis spectral analysis, absorption, peak, azo (N[bond, double bond]N) bond, incubation, Fourier transform infrared spectroscopy, FTIR, results, peaks, azo bond peak, deformed, shifted, Activities, azoreductase, NADH-DCIP reductase, laccase, increased, bacterial cells, incubation, comparison, control, chemical oxygen demand, reduced, consortia, plant, wheat, seed germination, microbial, growth, plant, probiotic bacteria, Pseudomonas cedrina, ESR12, Bacillus cereus, ESD3, biodegraded products, toxicity, studies, biodegraded products, MO, non-toxic, consortia, bioremediation, MO, wastewater, disposal, environment, knowledge, degradation, detoxification, MO, wastewater, bacterial, biofilm consortia]]\n",
      "[[Protective lead garments, PLG, worn, operating room, source, bacterial, colonisation, increase, risk, intraoperative infection, clinical significance, bacterial, contamination, disinfection, protocols, effectiveness, compare, bacterial profile, PLGs, pathogens, surgical site infections, SSI, prosthetic joint infections, PJI, body aprons, neck-thyroid, protective shields, body aprons, neck, PLGs, swabbing, inside, PLGs, Swabs, cultured, media, results, assessed, compared, PLGs, contaminated, neck-thyroid, PLGs, contaminated, body apron, PLGs, loads, Staphylococcus epidermidis, pathogen cultured, Micrococcus spp, Acinetobacter lwoffii, A. lwoffii, Bacillus species, Bacillus spp., Moraxella osloensis, M. osloensis, Pseudomonas stutzeri, P. stutzeri, pathogens, associated with, SSI, PJI, detected, PLGs, contaminated, cleaning protocols, Neck, PLGs, contaminated, infectious agents, neck, PLGs, exposed, surgical sterile gown, surgical field, measures, reduce, exposure, bacterial, users, intraoperative, body exhaust, suits, PLGs]]\n",
      "[[Jordan, lowest, countries, world, water resources, treated, wastewater, alternative, agricultural, water, Jordan, Kherbet, Al-Samra, wastewater, treatment plant, KSWWTP, largest, effluent, irrigation, purposes, study, bacterial, contamination, mutagenic, potential, evaluated, sites, KSWWTP, King Tallal Dam, results, contamination, pathogenic bacteria, coliforms, isolated, pathogenic bacteria, Salmonella sp., Shigella sp., Bacillus cereus, Staphylococcus aureus, isolated, opportunistic, pathogenic bacteria, Acinetobacter lwoffii, Elizabethkingia meningosepticum, Pseudomonas fluorescens, Bacillus licheniformis, bacteria, sampling sites, prevalence, pattern, temperature, seasons, coliform, bacterial count, water samples, positive, mutagenic activity, bacterial, Improving, disinfection, efficiency, wastewater, treatment, plant, potential, toxicity, exposure of, public health, pathogenic bacteria, reduce, water resources, contamination, environmental pollution, effluent, frequency, KSWWTP, bacterial, contamination, toxicity/mutagenicity level, water safety, public, assessments]]\n",
      "[[Bacteria, genus, Acinetobacter, species, habitats, pathogens, living conditions, presence, plasmids, adaptive genes, diversity, Acinetobacter plasmids, evolutionary, dynamics, characterized, plasmids, isolated, permafrost Acinetobacter, strains, relationship, plasmids, modern Acinetobacter strains, identified, groups, plasmids, Acinetobacter plasmids, classification, size, plasmids, presence, structure, rep and mob genes, structure, backbone, accessory regions, analysis, groups, lineages, plasmids, identified, plasmids, plasmids, group, features, organization, backbone region, DNA identity, level, plasmids, group, similarities, organization, accessory regions, plasmids, unique, structure, presence, plasmids, clinical strains, environmental, permafrost, strains, evidence, origin, former]]\n",
      "NaN\n",
      "[[ABSTRACT, surgical treatment, infection, obstruction, ventriculoperitoneal shunt, hydrocephalus, cases, post-operative, infection, ventriculoperitoneal shunt, analyzed, retrospectively, case, cryptococcal infection, case, Acinetobacter lwoffii, cerebrospinal fluid cells, infection, ventriculoperitoneal shunt, abdominal obstruction, hydrocephalus, aggravated, authors, drainage tube, abdominal cavity, external drainage, combined, intravenous antibiotics, infection, shunt device, intraventricular jugular shunt, authors, method, effective, effective, method, treatment, infection, ventriculoperitoneal shunt]]\n",
      "[[gut microbiota, carcinogenesis, treatment, CRC, SW480, SW620 colon cancer, infrared fluorescent proteins, injected, rectal submucosa, nude mice, days, tumor growth, weekly, in vivo, imaging system, bacterial solution, infused, mice, bacterial transplant, Phosphate-buffered saline, Acinetobacter lwoffii, Bifidobacterium longum, solutions, infused, 16S ribosomal DNA, rDNA, polymerase chain reaction, murine, feces, investigated, colonization, target, bacteria, SW620 orthotopic xenograft rectal cancer, model, mice, rectal cancer, days, submucosal, injection, SW480, orthotopic xenograft rectal cancer, model, mice, rectal cancer, days, submucosal, injection, 16S rDNA analysis, mice, bacterial solution, infusion, positive, findings, A. lwoffii, B. longum, establishment, mouse model, orthotopic rectal cancer, transplant, target, bacteria, relationship, gut microbiota, CRC, fecal microbiota, transplant, treatment, alleviation, adverse events, chemotherapy, CRC, studies]]\n",
      "[[case, cerebral actinomycosis, male, right-sided weakness, focal convulsions, MRI scan, solid intra axial space, lesion, left frontal lobe, Left parietal craniotomy, intra-operative USG, guided aspiration, excision, mass, necrotic material, Actinomyces israelii, isolated, aspirated material, Patient, ceftriaxone, clindamycin, weeks, Physiotherapy, anti-epileptic drugs, follow-up, visits, lower limb, proximal, upper limb, distal, Actinomycosis, diverse, clinical manifestations, clinical suspicion, diagnosis, Early diagnosis, treatment, treatment, outcomes]]\n",
      "[[Monitored natural recovery, MNR, in situ technique, conventional, remediation, treatment, contaminated, sediments, natural processes, reduce, bioavailability, toxicity, contaminants, Metabarcoding, bioinformatics, functional, prediction, sediments, tributary drainage channel of Rio de La Plata estuary, assess, biological, MNR, Hydrocarbon, concentration, water samples, surface, sediments, detection, Surface, sediments, phosphorous, alkaline, pH, bacterial, Anaerolineae, Planctomycetia, Deltaproteobacteria, functional, prediction, surface, sediments, increase, metabolic activity, carbon fixation, methanogenesis, synergistic, relationships, Archaeas, Syntrophobacterales, Desulfobacterales, prediction, non-surface sediments, capacity, environmental stresses, oxidative, osmotic, heat, acid pH, heavy metals, predicted, Lactobacillales, capacity, Alphaproteobacteria, Betaproteobacteria, Gammaproteobacteria, Actinomyces, classes, xenobiotic compounds, Canonical correspondence analysis, CCA, depth, phosphate content, redox, potential, pH, variables, structured, bacterial, community, hydrocarbons, characterization, sediments, metabarcoding, functional, assess, microbial, activity, recovery, site]]\n",
      "[[OBJECTIVE, study, investigate, composition, intestinal microbiota, association, fecal short chain fatty acids, SCFAs, children, drug refractory epilepsy, DRE, treatment, ketogenic diet, KD, cross-sectional study, children, DRE, matched, healthy controls, compare, changes, fecal, microbiomes, SCFAs, Disease cohort, analysis, months, KD, treatment, microbial, diversity, increase, Actinobacteria, phylum, level, Enterococcus, Anaerostipes, Bifidobacterium, Bacteroides, Blautia, genus, level, children, DRE, abundance, epileptic-associated genera, months, KD, treatment, decreases, Bifidobacterium, Akkermansia, Enterococcaceae, Actinomyces, increases, Subdoligranulum, Dialister, Alloprevotella, identified, taxa, patients, inadequate response, KD, adequate, response, correlation, change, microbiome, genera, KD, treatment, SCFA, content, fecal, months, KD, treatment, increased, correlated, gut bacteria, SIGNIFICANCES, Dysbiosis, microbiome, pathogenesis, DRE, children, KD, Gut microbiota, microbial, metabolism, antiseizure, effect, KD]]\n",
      "[[Objective, study, evaluate, relationship, sucrose, concentration, bacteria, proportion, multispecies, biofilm model, Streptococcus mutans, S. mutans, Streptococcus oralis, S. oralis, Actinomyces naeslundii, A. naeslundii, multispecies, biofilm, concentration, sucrose, multispecies, biofilm 3 times, day, bacteria, proportion, acid production, biofilms, analyzed, Increasing, sucrose, increased, CFU count, S. mutans, concentration, sucrose, S. mutans, decreased, CFU, counts, S. oralis, A. naeslundii, decreased, sucrose concentration, increase, sucrose, reduction, significant, S. mutans, dominant, species, biofilms, acid production, multispecies, biofilm, increased, decreased, sucrose concentration, increased, concentration, findings, increasing, sucrose, level, increase, competitiveness, S. mutans, multispecies, biofilm, biofilm, cariogenic, sucrose, cariogenic, biofilm, study]]\n",
      "[[Pulmonary actinomycosis, rare, progressive, bacterial infection, lung cancer, case reports, premature diagnosis, malignancy, potential, Actinomyces infection, cases, English literature, coexistence, Actinomyces, lung cancer, cases, patients, culture-positive, Actinomyces, concomitant, biopsy-proven lung adenocarcinoma, workup, lung mass, positive culture, Actinomyces, malignancy]]\n",
      "[[alterations, microbiomes, supragingival, biofilm, saliva, samples, adolescent, patients, induced, spontaneous, gingivitis, healthy controls, relationships, dental health, Supragingival, biofilm samples, teeth, adolescents, gingivitis, induced, orthodontic appliances, dental plaques, adolescents, spontaneous gingivitis, samples, healthy controls, bacterial, metagenomes, analysed, 16S rRNA, gene amplicon sequencing, Salivary, microbiomes, persons, characterized, shotgun metagenome sequencing, data sets, bioinformatics, workflows, databases, composition, diversity, bacterial, communities, study, groups, abundances, genera, Fusobacterium, Akkermansia, Treponema, Campylobacter, gingivitis, patients, controls, genera, Lautropia, Kingella, Neisseria, Actinomyces, Rothia, abundant, controls, gingivitis, groups, abundance, pattern, taxa, individual, strains, features, potential, diagnostic value, Stringent, bioinformatics, treatment, sequencing, data, unintentional, misinterpretations]]\n",
      "[[female, history, poor dental hygiene, aortic insufficiency, aortic valve replacement, chest pain, fevers, portal vein thrombosis, colitis, infective endocarditis, aortic valve thickening, Blood cultures, positive, Actinomyces odontolyticus, Gemella morbillorum, Transesophageal echocardiogram, positive, aortic root thickening, Patient, treated with, ceftriaxone, apixaban, recovery]]\n",
      "[[study, salivary microbiota, caries-free Chinese, preschool children, high-throughput sequencing, Saliva samples, caries-free, boys, girls, primary dentition, 16S ribosomal DNA, hypervariable regions, microorganisms, analyzed, Illumina MiSeq, similarity, level, reads, clustered, operational, OTUs, phyla, Firmicutes, Proteobacteria, Actinobacteria, Bacteroidetes, Candidate division, TM7, genera, Streptococcus, Rothia, Granulicatella, Prevotella, Enterobacter, Veillonella, Neisseria, Staphylococcus, Janthinobacterium, Pseudomonas, Brevundimonas, Devosia, Gemella, dominant, salivary microbiota, core salivary, microbiome, genera, Actinomyces, Capnocytophaga, Gemella, Granulicatella, Lachnoanaerobaculum, Neisseria, Porphyromonas, Rothia, Streptococcus, Analysis, microbial, diversity, community structure, pattern, male, female, subjects, microbial, community, composition, Neisseria, functional, prediction, abundant, genes, amino acid transport, metabolism, results, diversity, composition, salivary microbiota, caries-free, children, male, female, subjects, Identity, core microbiome, coupled, prediction, gene function, oral microbiota, caries-free populations, information, salivary, microecology, oral health]]\n",
      "[[Actinomyces sp. HMT897 strain, isolated, human, saliva, sample, host, ectobiont Saccharibacteria, TM7, HMT351, 3.3-Mb chromosome, sequenced, PacBio long reads, encodes, proteins, RNAs]]\n",
      "[[study, evaluate, cone-beam computed tomographic, CBCT, imaging, histopathological, characteristics, osteoradionecrosis, ORN, medication-related osteonecrosis, MRONJ, Materials, Methods, surgical specimens, segmental mandibulectomy, ORN, MRONJ, analyzed, CBCT, CBCT, parameters, high-resolution mode, tube voltage, tube current, rotation, mmx56, thickness, Histopathological, characteristics, evaluated, histological slides, surgical specimens, Pearson chi-square test, compare, ORN, MRONJ, CBCT, findings, internal texture, sequestrum, periosteal reaction, cortical perforation, histopathological, characteristics, necrotic bone, inflammatory cells, reactive bone formation, bacteria, Actinomyces, osteoclasts, statistical significance, MRONJ, periosteal reaction, CBCT, ORN, histopathological, characteristics, MRONJ, osteoclasts, ORN, study, evaluated, CBCT, imaging, histopathological, characteristics, ORN, MRONJ, findings, CBCT, evaluation, ORN, MRONJ]]\n",
      "NaN\n",
      "[[case, female, medical history, penicillin allergy, brain infection, Actinomyces israelii, therapy, metronidazole, ceftriaxone, chloramphenicol, deterioration, general, neurological condition, patient, scratch skin test, penicillin, negative, penicillin, administrated, parenterally, patient, hypersensitive reaction, Improvement, patient, surgeries, primary, recurrent, brain abscesses, improvement, clinical status, months, re-surgery, control computed tomography, regression, abscess, Brain abscess, Actinomycess israelii, resistant, medication, surgical evacuation, healing, process, medication therapy, cases, drug, penicillin, treating, brain infection]]\n",
      "[[Actinomycosis, rare, infection, misdiagnosed, neoplasia, chronic, granulomatous disease, Actinomyces israelii, species, Cervicofacial actinomycosis, cases, diagnosis, histopathology study, Case Description, case, fronto-orbital osteomyelitis, misdiagnosed, cranial bone meningioma, case, actinomycosis, (99m)Technetium, (99m)Tc, three-phase bone single-photon emission computed tomography/computed tomography, SPECT/CT, (99m)Tc-ubiquicidin, UBI, bone SPECT/CT scans, control, infection, Craniofacial actinomycosis, presentation, actinomycosis, rare, difficult, disease, diagnose, neoplastic process, (99m)Tc-UBI, bone SPECT/CT scan, follow-up, patients]]\n",
      "[[ABSTRACT, woman, septic shock, computed tomography, findings, loculated hepatic abscess, intensive care unit, asystolic, cardiac arrest, resuscitation, surgical exploration, purulent pericardial effusion, tamponade, liver abscess, Microbiological analyses, sites, negative, surgical, exploration, multiorgan, failure, died, autopsy, pus, pericardial cavity, left lobe, liver, infection, Actinomyces spp, extruded, liver, postmortem, examination, cultures, positive, Actinomyces israelii, case, rare, primary, hepatic actinomycosis, infection, death, young, woman, Nonspecific, clinical manifestations, delay diagnosis, sulfur granules, abscess, formation, autopsy, indication, Actinomyces infection]]\n",
      "[[report, case, mixed infection, Actinomyces israelii, Fusobacterium nucleatum, extensive, neck mass, tissue planes, bony destruction, abscess, imaging, serological investigations, causative organisms, course, patient's, long admission, postdischarge, patient, prolonged, course, intravenous antibiotics, complications, report, awareness, presentation, pathogenicity, treatment, Actinomyces, Fusobacteria, infections, difficulty, diagnosis]]\n",
      "[[Dermatological manifestations, actinomycosis, Actinomyces israelii, cases, near, primary focus, cervicofacial area, Systemic dissemination, cutaneous distant metastasis, rare, A. israelii, case, upper limb actinomycosis, associated with, oral, localisation, bacteria, CASE REPORT, man, Department of dermatology, skin lesion, left hand, wrist, Biopsies, actinomycosis, A. meyeri, Dental primary focus, identified, treated, patient, dental eradication, prolonged, antibiotics therapy, cutaneous, improvement, atypical, case, cutaneous actinomycosis, Actinomyces meyeri, dental infection, immunocompetent, smoking adult, poor oral hygiene, literature review, cases, cutaneous A. meyeri infections, distant, dental primary focus, patients, males, immunocompetent, history, poor oral hygiene, prognosis, adequate, treatment, antibiotic therapy, surgical treatment, dental infectious entry points]]\n",
      "[[increasing, emergence, multi-resistant bacteria, search, antimicrobial substances, agents, antimicrobial peptides, host, defense molecules, innate immune system, species, study, assess, activity, nisin, melittin, lactoferrin, parasin-1, LL-37, oral bacteria, Candida albicans, gold, anaerobic, susceptibility testing, activity, peptides, agar dilution method, anaerobic, aerobic, conditions, test media, peptide, concentrations, melittin, lactoferrin, parasin-1, LL-37, nisin, Nisin, inhibited, growth, Megasphaera sp., Bifidobacterium longum, Parvimonas micra, Actinomyces israelii, Actinomyces naeslundii, Actinomyces odontolyticus, Prevotella intermedia, Streptococcus anginosus, Streptococcus constellatus, Staphylococcus aureus, Melittin, lactoferrin, reduced, growth, Megasphaera sp., P. micra, B. longum, melittin, Selenomonas flueggei, lactoferrin, Parasin-1, LL-37, no activity, AMPs, nisin, degree, lactoferrin, antibiotics, antimicrobial activity, resistance, environmental conditions, low, costs]]\n",
      "[[Actinomycosis, rare, infectious disease, Gram-positive bacteria, species, Actinomyces israelii, presentation, thoracic, frequent, Case presentation, patients, thoracic actinomycosis, years, geographical areas, Peru, case, empyema necessitans, lung consolidation, recurrent hemoptysis, degree, difficulty, diagnosis, antibiotics, surgical treatment, diagnosis, histopathological study, species, actinomyces, Thoracic actinomycosis, rare, children, parenchymal, lesion, fistulization, chest wall, Peruvian, literature, knowledge, disease, management, pediatrics]]\n",
      "[[AIM, study, intracanalicular, loading, treatment, canaliculitis, interventional prospective study, study, year, period, patients, canaliculitis, intracanalicular antibiotic ointment, loading, months, study, antibiotic ointment, canaliculus, antibiotic, sensitivity, material, expressed, canaliculus, Patients, demographics, clinical details, microbiological profile, management, outcomes, evaluated, patients, study, age, presentation, years, right eye, cases, incidence, lower canaliculus, involvement, upper canaliculus, Staphylococcus epidermidis, Actinomyces israelii, isolated, organisms, intracanalicular, antibiotic, sessions, Complete, resolution, canaliculitis, cases, Canalicular, antibiotic, ointment, loading, minimally invasive, effective, procedure, anatomy, function, punctum, canaliculus, management, options, canaliculitis]]\n",
      "[[Plant transformation, technology, functional, genomics, crop, genetic improvement, traits, modify, recombine, traits, agricultural technologies, global production, genetically engineered, crops, years, DNA, plant cells, Agrobacterium tumefaciens, transformation, molecular breeding, crop, varieties, traits, market, difficult, breeding, methods, transformation, genetically, crops, technology, agriculture, sequenced plant, information, functional, genomics, data, gene function, gene cloning, tissue culture methods, crop, improvement, trait development, advances, crops, resilient, climate change, secure, yield, feeding, increasing, human, population, success, transformation, bottleneck, plant species, crop, genotypes, recalcitrant, tissue culture, regeneration, conditions, poor transformability, Improvements, morphogenetic transcriptional regulators, applicability, tested, Advances, genome, non-tissue, varietal development, recalcitrant, crops, review, plant transformation, regeneration, opportunities, breeding, technologies, agriculture]]\n",
      "[[Immunization, thetumor-associated antigen GA733 glycoprotein, expressed, colorectal cancer, cancer prevention, treatment, cloned, fusion gene, GA733, immunoglobulin Fc fragment, GA733-Fc, GA733-Fc, endoplasmic reticulum retention motif, GA733-FcK, Cowpea mosaic virus, transient, plant, pEAQ-HT, Agrobacterium tumefaciens, vectors pEAQ-HT-GA733-Fc, pEAQ-HT-GA733-FcK, infiltrated, leaves, Nicotiana benthamiana plants, harvesting, leaf, therapeutic glycoproteins, spatially, temporally, protein expression, levels, leaf, positions, middle, base, days, post-infiltration, dpi, investigated, GA733-Fc, GA733-FcK genes, detected, leaves, dpi, PCR, assessed, western blot, GA733-Fc, GA733-FcK, expressed, levels, leaf, position, dpi, GA733-FcK, expressed, GA733-Fc, proteins, purified, infiltrated, N. benthamiana, leaves, protein A, affinity chromatography, ELISA, anti-GA733 antibody, purified proteins, functional, GA733-Fc colorectal cancer, vaccine protein, expressed, CPMV, virus-based vector, expression, leaf, post-infiltration]]\n",
      "[[environmental pollutants, cadmium, Cd, glyphosate, tetracycline, adverse impacts, plant, productivity, tropical crops, cassava, pollutants, roots, rhizosphere, microbiome, host, pollutants, study, stresses, inhibited, plant growth, triggered, damage, dosage-dependent, toxic, effect, redox, homeostasis, correlated, antioxidant metabolism, metagenomics, technique, rhizosphere, microbiomes, dynamically, dose, stresses, increased, stressor-associated, microbial, metabolic pathways, mobile genetic elements, rhizosphere, microbiomes, co-occurrence, network, physiological, microbiome, features, pollutants, oxidative damage, microbiome, succession, phyllosphere, transplantation, Agrobacterium tumefaciens, Pseudomonas stutzeri, negative, effects of, stresses, cassava growth, redox homeostasis, study, dynamics, rhizosphere, bacterial, microbiome, cassava, environmental stresses, A. tumefaciens, P. stutzeri, bacteria, Cd, glyphosate, tetracycline-triggered damage, cassava]]\n",
      "[[Bacterial canker, disease, threat, kiwifruit, cultivation, production, monomorphic, subpopulation, Pseudomonas syringae pv, actinidiae biovar 3, Psa3, pandemic, Diversity, pathogenicity, pandemic subpopulation, Psa3, subpopulations, epidemics, China, genetic bases, study, Psa3, isolates, Psa-, Psa3-specific primers, evaluated, pathogenicity, isolates, G4, S2, pathogenic, kiwifruit, hypersensitivity, responses, HRs, non-host Nicotiana benthamiana, leaves, isolates, G25, G35, attenuated, HR-eliciting, activity, non-host N. benthamiana, reduced, pathogenicity, host plants, genomes, isolates, sequenced, compared, isolates, MLVA, whole-genome typing methods, genetic loci, changes, pathogenicity, HR, elicitation, allele replacement, experiments, non-pathogenic, isolates, independent, identical, insertion, events, ISPsy36 transposon, hrpR gene, encoding, regulator, type III secretion system, T3SS, type III effectors, T3Es, symptomatic, sample, G4, isolated, HR, negative, isolates, detected, isolate, G25, transposon insertion, ISPsy32, non-coding sequence upstream, hrpR gene, detected, low-virulent, Psa3, M227, isolate, G35, detected, disruptions, T3Es, hopBB1, hopBB1, induce, HR, N. benthamiana, leaves, Agrobacterium tumefaciens, infiltration, phenotype-changed, isolates, low, frequencies, course, pathogen infection, host plants, binding assay, ISPsy32, non-coding DNA sequences, upstream, hrpR gene, co-isolation, virulent, isolates, MLVA, clade, low, levels, transcription, transposon genes, short-term, evolution, transposon insertions, T3SS-related genes, formation, non-pathogenic, low-virulent, Psa3, isolates]]\n",
      "[[Bacterial, metabolites, biologically active compounds, antibacterial, antifungal activities, Bacillus, bioactive, metabolites, plant, pathogens, mutate, resistance, economic losses, agricultural field, natural, antibacterial compounds, microbes, control plant, pathogens, study, investigate, bio-active compounds, Bacillus megaterium L2, activity, Agrobacterium tumefaciens T-37, Erwinia carotovora, EC-1, Ralstonia solanacearum, RS-2, monomeric compounds, erucamide, behenic acid, palmitic acid, phenylacetic acid, beta-sitosterol, fractionated, purified, crude ethyl acetate extract, B. megaterium, knowledge, compounds, isolated, bacterium, antimicrobial activity, compounds, inhibitory, MICs, broth microdilution method, tested, pathogens, palmitic acid, antibacterial activity, erucamide, moderate, antibacterial activity, MIC, Behenic acid, MICs, RS-2 strains, antibacterial activity, beta-sitosterol, antimicrobial activity, RS-2, beta-sitosterol, antimicrobial activity, RS-2, MIC, mug/mL., antimicrobial activity, EC-1, RS-2, strains, phenylacetic acid, prevention, control, phytopathogenic bacteria, findings, isolated, compounds, behenic acid, beta-sitosterol, phenylacetic acid, natural, antimicrobial agents]]\n",
      "[[bacterial cell wall, peptidoglycan, PG, polymer, maintenance, cell, shape, survival, bacteria, PG chemistry, cell wall, environmental, cues, microbes, habitat, soil bacterium, Pseudomonas putida, cell wall modulators, plant extracts, canavanine, CAN, non-proteinogenic amino acid, cell wall, chemical editing, CAN, licensed, P. putida, BSAR, broad-spectrum racemase, catalyzes, production, DL-CAN, L-CAN, legumes, D-CAN, diffuses, extracellular milieu, potential, impact, organisms, inhabiting, niche, results, D-CAN, PG, structure, Rhizobiales, Agrobacterium tumefaciens, Sinorhizobium meliloti, impairing, PG, crosslinkage, cell division, A. tumefaciens, detrimental effect, D-CAN, suppressed, amino acid, substitution, cell division, PG transpeptidase penicillin binding protein 3a, amino acid racemization, cell wall, chemical editing, fitness]]\n",
      "[[Natural, modified versions, 5-enolpyruvylshikimate-3-phosphate synthase, gene, tolerance, broad-spectrum herbicide, glyphosate, commercial, crops, trait, Agrobacterium tumefaciens strain, CP4, commercialized, glyphosate-tolerant crops, EPSPS gene products, enzymes, classes, sequence, similarity, sensitivity, glyphosate, steady-state, catalytic, parameters, informatics-guided, identification, biochemical, structural, characterization, EPSPS, Streptomyces sviceus, EPSPS, data, DGT-28, EPSPS, homologues, class, Class IV, EPSPS, enzymes, intrinsic tolerance, concentrations, glyphosate, dgt-28, epsps, transformed, stable plants, robust, vegetative/reproductive, herbicide, tolerance, systems, commercialized, events]]\n",
      "[[Biotin, micro-nutrient, domains, paradigm, biotin, synthesis, BioC-BioH, pathway, Escherichia coli, BioZ, canonical route, biotin, synthesis, origin, Rhizobiales, protein phylogeny, BioZ, domesticated, atypical, beta-ketoacyl-ACP synthase III, Genetic, biochemical, characterization, BioZ catalyzes, condensation, glutaryl-CoA, ACP, malonyl-ACP, ACP, intermediate, type II fatty acid synthesis, FAS II, initiate, formation, pimeloyl-ACP, precursor, biotin, synthesis, molecular basis, BioZ activity, crystal structure, Agrobacterium tumefaciens BioZ, catalytic triad, substrate-loading tunnel, localize, residues, S84, R147, S287, distant bottom, tunnel, neutralize, charge, free, C-carboxyl group, primer, study, molecular, BioZ biotin synthesis pathway]]\n",
      "[[biology, lichens, symbiotic, association, lichen-forming fungi, mycobiont, photosynthetic partners, grow, harsh, habitats, lack, genetic tools, mycobiont, studies, genetic mechanisms, lichen biology, Agrobacterium tumefaciens-mediated transformation, ATMT, genetic transformation, mycobiont, isolated, Cladonia macilenta, combinations, ATMT, conditions, biomass, mycobiont, co-cultivation, period, Agrobacterium cells, incubation, temperature, ATMT, condition, C. macilenta, mycobiont, result, days, co-cultivation, period, biomass, mycobiont, efficient, ATMT, slow growth, rate, mycobionts, T-DNA copy number variation, transformants, transformants, copy T-DNA insertion, T-DNA insertion sites, gene function, C. macilenta, TAIL-PCR analyses, transformants, hypothetical gene, encoding, ankyrin repeats, C-terminus, interrupted, T-DNA insertion, transformant, dark-brown colored, pigment, identification, pigment, investigation, feasibility, ATMT, construction, random, T-DNA insertion mutant library, mycobionts, genetic mechanisms, lichen, symbiosis, stress tolerance, secondary, metabolite, biosynthesis]]\n",
      "[[Olive, Olea europaea L., characteristic, oil, crop, Mediterranean region, Traditional, olive, cultivation, cultivars, origin, crop, selections, tolerance, biotic, abiotic stress, high-density planting systems, resilient, climate change, breeding, programs, long juvenile, period, species, genotypes, released, Genetic transformation, near, future, varieties, rootstocks, shorter time, functional, genomic studies, recalcitrance, olive tissues, in vitro, manipulation, bottleneck, development, genetic transformation procedures, species, traits, fungal resistance, flowering, lipid composition, manipulated, genetic transformation, somatic embryos, juvenile, adult, origin, potential, technology, olive, improvement, optimization, protocols, explants, adult, origin, materials, olive industry, review, initially, factors, affecting, plant regeneration, somatic embryogenesis, transformation, approaches, olive, reviewed, transgenic experiments, genes, traits]]\n",
      "[[bacterial, environmental conditions, signal transduction pathways, Two-component signal transduction systems, predominant, bacteria, signals, host, plant, interaction, behaviour, open reading frames, two-component response regulators, gram-negative nitrogen-fixing bacteria, Azorhizobium caulinodans ORS571, biological functions, response regulators, symbiotic, interactions, A. caulinodans ORS571, host, Sesbania rostrata, study, identified, investigated, two-component response regulator, AcfR, phosphorylatable N-terminal REC (receiver) domain, C-terminal HTH (helix-turn-helix), LuxR, DNA-binding domain, A. caulinodans ORS571, Phylogenetic analysis, AcfR, evolutionary, NarL/FixJ family regulators, histidine kinases, HATPase_c, HisKA domains, interact, AcfR., biological function, AcfR, free-living, symbiotic conditions, comparing, wild-type strain, DeltaacfR mutant, strain, free-living state, cell motility behaviour, exopolysaccharide, production, DeltaacfR mutant, wild-type strain, symbiotic state, DeltaacfR mutant, competitive, nodule, defect, stems, roots, host, plant, AcfR, A. caulinodans, effective, competitive, symbiotic nodulation, results, AcfR, response regulator, regulates, phenotypes, A. caulinodans, free-living conditions, symbiosis, host, plant, results, study, involvement, REC, HTH_LuxR, two-component response regulator, Rhizobium-host plant, interaction]]\n",
      "[[Chemotaxis, competitiveness, motile bacteria, complex, harsh, environments, localization, chemotactic proteins, cell, maximal, chemotactic signals, chemotaxis protein, subcellular, localization, phosphatase, CheZ., CheZ, localizes, cell poles, binding, CheA, Escherichia coli, enteric bacteria, binding, poorly, protein, ChePep, epsilon-Proteobacteria, alpha-Proteobacteria, CheZ, CheA-binding sites, cellular localization, localization, CheZ, alpha-Proteobacteria Azorhizobium caulinodans ORS571, A. caulinodans, CheZ, CheZAC, cell poles, CheA, N-terminal helix, four-helix bundle, CheZAC, cell poles, motif, AXXFQ, adjacent, phosphatase active motif, DXXXQ, effects, monopolar, localization, CheZAC, motif, AXXFQ, CheZ, Proteobacteria, substitution, phosphatase, polar localization, CheZAC, characterized, localization, pattern, CheZ, motif, mapped, regions, CheZAC, polar localization]]\n",
      "[[Biofilm formation, plants-microbe associations, calcium, biofilm formation, bacteria, rhizobia, study, investigated, calcium, biofilm formation, Azorhizobium caulindans, nodules, stem, root, host, Sesbania rostrata, calcium, A. caulindans, biofilm formation, presence, extracellular matrix, components, eDNA, proteins, biofilm formation, tested, chemotaxis, motility, cyclic di-GMP, synthesis, quorum sensing mutants, calcium, promote, S. rostrata, root, colonization, A. caulinodans, results, calcium, A. caulindans, biofilm formation, interaction, A. caulinodans, host, plant]]\n",
      "[[Glutaredoxin, GRX, control, cellular redox state, pathways, organisms, information, GRXs, model, nitrogen (N2)-fixing bacterium, Azorhizobium caulinodans, identified, functional analyses, monothiol, dithiol GRXs, A. caulinodans, free-living state, symbiosis, Sesbania rostrata, data, monothiol, GRXs, bacterial growth, normal conditions, response, oxidative stress, imbalance, redox state, grx mutants, A. caulinodans, Functional redundancies, monothiol, dithiol GRXs, physiological functions, changes, catalase activity, iron content, grx mutants, maintenance, bacterial resistance, oxidants, nodulation, N2 fixation, efficiency, bacterium, monothiol, GRX12, dithiol, GRX34, symbiotic, associations, A. caulinodans, Sesbania rostrata, study, systematic, evidence, investigations, glutaredoxins, A. caulinodans, rhizobia]]\n",
      "[[AZC_2928 gene, GenBank accession no. BAF88926.1, Azorhizobium caulinodans ORS571, sequence, homology, 2,3-aminomutases, function, study, knock out, gene, A. caulinodans ORS571, advanced, genome, CRISPR/Cas9, results, editing, efficiency, AZC_2928, regulating, formation, chemotaxis, biofilm, CRISPR/Cas9, knockout, AZC_2928, openAZC_2928), enhanced, chemotaxis, biofilm formation, chemotaxis, biofilm formation, nitrogen-fixing bacteria, interaction, host plants, AZC_2928, motility, A. caulinodans ORS571, nodulation, formation, natural, host, Sesbania rostrata, rhizobia, bacteroids, symbiotic, mature, nodules, AZC_2928, influence, nitrogen fixation, efficiency, nodulations]]\n",
      "[[genome, Azorhizobium caulinodans ORS571, encodes, chemotaxis, CheY1, CheY2, cheY1, chemotaxis cluster, cheY2, cluster, contributions, CheY1, CheY2, wild type, WT, mutants, free-living state, symbiosis, host, Sesbania rostrata Swim plate tests, capillary assays, CheY1, CheY2, chemotaxis, CheY2, CheY1, analysis, swimming, paths, free-swimming cells, DeltacheY1 mutant, decreased, frequency, direction, reversal, DeltacheY2 mutant, direction, WT, Exopolysaccharide, EPS, production, DeltacheY1, DeltacheY2, mutants, WT, DeltacheY2 mutant, EPS, defects, DeltacheY1 DeltacheY2, Deltaeps1, mutants, symbiosis, levels, competitiveness, root colonization, nodule, occupation, DeltacheY1, DeltacheY2, mutants, impaired, WT, competitive, colonization, ability, DeltacheY2 mutant, severely impaired, DeltacheY1 mutant, DeltacheY2, phenotypes, severe, DeltacheY1, phenotype, free-living, symbiotic states, double mutant, DeltacheY2, single-mutant, phenotype, defects, DeltacheY1, DeltacheY2, mutants, WT, phenotype, complementation, results, regulatory mechanisms, CheY1, CheY2, CheY2, chemotaxis regulator, free-living, symbiosis, conditions, Azorhizobium caulinodans ORS571, motile, bacterium, capacity, nitrogen, free-living conditions, symbiosis, Sesbania rostrata, nitrogen-fixing root, stem nodules, Bacterial chemotaxis, chemoattractants, host, roots, promotes, infection, nodule, formation, rhizobia, sites, infection, identified, CheY2, chemotactic response regulator, encoded, gene, chemotaxis, chemotaxis, multiple, cell, phenotypes, CheY1, encoded, gene, chemotaxis, chemotaxis, response regulators, bacterial chemotaxis, motility, multiple, Gram-negative bacteria]]\n",
      "[[Azorhizobium caulinodans, symbiotic, root, stem nodules, Sesbania rostrata, nodule, formation, bacteria, organic peroxides, plant, studies, resistance, oxygen radicals, bacteria, knowledge, investigated, process, A. caulinodans, study, identified, characterised, organic hydroperoxide, gene ohr, AZC_2977, regulator, ohrR, AZC_3555, A. caulinodans ORS571, Hypersensitivity, organic hydroperoxide, ohr mutant, lacZ-based reporter system, OhrR, repressed, expression, ohr, electrophoretic mobility shift assays, OhrR, ohr, binding, promoter region, binding, OhrR, oxidation, aerobic, conditions, OhrR, dimerization, activation, ohr, cysteine residues, OhrR, Cys11, sensitivity, organic, hydroperoxides, Plant assays, inactivation, Ohr, decreased, stem nodules, nitrogenase activity, data, Ohr, OhrR, A. caulinodans, organic hydroperoxide, interaction, bacterium, plants, results, study, thiol-based, A. caulinodans, host, organic peroxide, signals, enhance, symbiosis]]\n",
      "[[Establishment, rhizobia-legume, symbiosis, hydrogen peroxide, H2O2, production, legume, host, site, infection, process, detrimental, rhizobia, Azorhizobium caulinodans ORS571, deletion, chp1, gene, encoding, c-di-GMP phosphodiesterase, increased, resistance, H2O2, elevated, nodulation, efficiency, legume, host, Sesbania rostrata, domains, identified, Chp1, PAS, domain, degenerate, GGDEF domain, EAL domain, in vitro, enzymatic activity assay, degenerate, GGDEF, Chp1, diguanylate cyclase, activity, phosphodiesterase activity, Chp1, EAL domain, hydrolyse, c-di-GMP, pGpG., PAS, domain, regulatory domain, sensing oxygen, Deletion, Chp1, increased, intracellular, c-di-GMP, level, decreased, motility, increased, aggregation, increased, EPS, extracellular polysaccharide, production, H2O2-sensitivity assay, increased, EPS, production, ORS571, resistance, H2O2, elevated, nodulation, efficiency, chp1 mutant, correlated, EPS, nodulation, process, data, c-di-GMP, modulate, A. caulinodans-S. rostrata, nodulation, process, regulating, production, EPS, rhizobia, H2O2]]\n",
      "[[Chemotaxis, seed exudates, establishment, microbe-plant, associations, organic acids, seed exudates, Sesbania rostrata, Azorhizobium caulinodans ORS571, plant, rhizosphere, High-performance liquid chromatography, HPLC, organic acid, content, seed exudates, S. rostrata, A. caulinodans, chemotactic response, Succinic, acetic, citric, oxalic, lactic acids, abundant, oxalic acid, A. caulinodans, carbon, source, TlpA1, transmembrane chemoreceptor, chemotactic response, organic acids, Oxalic acid, chemotactic response, indirect, promoting, inhibiting, chemotactic response, chemoeffectors, indirect, oxalic acid, chemoeffectors, concentration-dependent, effect, oxalic acid, concentrations, host, root, colonization, strategies, oxalic acid, early, association, A. caulinodans, host, plant]]\n",
      "[[Legumes, nitrogen, air, rhizobia, root nodules, species, rhizobia, colonize, cereals, nitrogen, native, regulation, nitrogenase, expression, presence, nitrogenous fertilizer, low oxygen, continuous, nitrogenase, production, energy burden, inducible, nitrogenase activity, cereal, endophytes, Azorhizobium caulinodans ORS571, Rhizobium sp. IRBG74, well-characterized, plant, epiphyte, Pseudomonas protegens, Pf-5, maize, seed, inoculant, organism, strategies, ammonium, repression, nitrogenase, expression, control, agriculturally, relevant, signals, root exudates, biocontrol agents, phytohormones, R. sp. IRBG74, engineered, nitrogenase activity, free-living, nif cluster, Rhodobacter sphaeroides, Klebsiella oxytoca, P. protegens, Pf-5, transfer, inducible cluster, Pseudomonas stutzeri, Azotobacter vinelandii, ammonium, tolerance, higher, oxygen tolerance, nitrogenase activity, K. oxytoca, data, transfer, nif gene, diverse, species, Escherichia coli, rhizobia, barriers, bacterium, nitrogen flux, cereal, crop]]\n",
      "[[Nitrogenases, Fe-S clusters, reduce, N2, NH3, Fe, sites, catalytic cofactors, spectroscopic, investigations, electronic structures, mechanisms, biosyntheses, spectroscopic analysis, methods, (57)Fe, sites, nitrogenase cofactors, site-selective, (57)Fe, L-cluster-a carbide-containing, Fe8S9C, precursor, Mo nitrogenase, catalytic cofactor, Treatment, isolated, L-cluster, chelator ethylenediaminetetraacetate, reconstitution, (57)Fe(2+), results, (57)Fe, labeling, terminal, Fe, selectivity, protocol, generation, L-cluster samples, terminal, belt, Fe, labeled, (57)Fe, Mossbauer spectroscopic analysis, samples, nitrogenase maturase Azotobacter vinelandii, NifX, primary coordination sphere, terminal, Fe, sites, terminal, L-cluster, binds, H35, molecular-level, electronic structure, biosynthesis, L-cluster, postbiosynthetic modification, studies, nitrogenase cofactors]]\n",
      "[[increasing, N2-fixing bacteria, biofertilization, crops, Genetically-optimized bacteria, ammonium, release, biofertilization, capacity, strains, cross-feed ammonium, microalgae, concerns, agriculture, potential, risk, higher, longer-lasting, eutrophication, problem, synthetic N-fertilizers, dynamic, algal, properties, genetically-modified Azotobacter vinelandii strain, over-accumulate, levels, glutamine synthetase, GS, EC 6.3.1.20, control, exogenous, inducer, switching cells, overaccumulating, GS, noninducing medium, proliferated, generations, GS, dilution, GS, cell division, growth, ammonium-excretion, cross-fed algae, bacterial population, timing, magnitude, algal N-biofertlization, deferred, tuning, intensity, induction, GS, accumulation, cells, bacterial population, bacterial cell, generations, faster-growing, nonammonium, apparent, improvements, genetic engineering, efficiency, N-biofertilizers, open environment, Ammonium-excreting bacteria, eutrophication agents, GS-dependent, deferred, bacterial growth, ammonium, release, Strong, transient, ammonium, cross-feeding, microalgae]]\n",
      "[[Azotobacter vinelandii, A. vinelandii, model, organism, study, aerobic, respiration, bacterial, production, industrially, compounds, genetics, biochemistry, biological, nitrogen fixation, Laboratory growth, assessments, A. vinelandii, evaluating, impact, environmental, genetic modifications, physiological, properties, diazotrophy, researchers, manual, growth methods, inefficient, protocol, automated, A. vinelandii, microplate reader, studies, diazotrophic growth, pitfalls, strategies, protocol, optimization, protocol's, application, growth, evaluation, strains, modifications, nitrogen-fixation genes, Authors, Basic Protocol 1, Preparation, A. vinelandii, cultures, frozen, Basic Protocol 2, Preparation, A. vinelandii, Basic Protocol 3, Automated growth, experiment, A. vinelandii, microplate reader]]\n",
      "[[Alginates, hydrogels, properties, molecular weight, MW, guluronic, G, mannuronic, composition, study, MW, G/M ratio, evaluated, cultures, Azotobacter vinelandii, L scales, oxygen transfer rates, OTRs, diazotrophic, conditions, increase, maximum, OTR, OTRmax, improved, alginate, production, cultures, OTR, G/M, increased, cell growth phase, decreased, stationary phase, cultures, constant, cultivation, alginate, MW, G/M ratio, cultures, OTR, criterion, alginate, production, replicate, concentration, alginate, rate, MW, G/M ratio, oxygen uptake rate, qO2, alginate, MW, scales, qO2, parameter, adequate, alginate, MW, bioreactor, scales, results, alginate, composition, affected, cellular respiration, technological perspective, design, oxygen consumption, alginates]]\n",
      "[[Reports, report, structure, nitrogenase MoFe protein, binding of N2, N2-derived species, active-site FeMo cofactor, structure, biochemical, evidence]]\n",
      "[[microorganisms, l-rhamnose, carbon, energy source, nonphosphorylative, l-rhamnose 1-dehydrogenase, RhaDH, catalyzes, NAD(P)(+, oxidization, l-rhamnose, l-rhamnono-1,4-lactone, investigated, crystal structures, RhaDH, Azotobacter vinelandii, ligand-free, NAD(+), NADP(+, l-rhamnose-, NAD(+), resolution, interactions, 2'-phosphate, group, NADP(+, 2'-hydroxyl group, NAD(+), consistent with, preference, NADP(+, NAD(+), C5-OH, C6-methyl groups, l-rhamnose, residues, RhaDH, hydrogen bonds, hydrophobic, contact, substrate, specificities, aldose, 1-dehydrogenases, short-chain dehydrogenase/reductase superfamily]]\n",
      "[[Nitrogen fixation, nitrogenase, accumulation, reducing, equivalents, active-site FeMo-cofactor, FeMo-co, state, Fe-H-Fe, hydrides, photolytic reductive elimination, E4(4H) hydrides, enzymatic, E4(4H), hydride, yields, E4(H2,2H, process, 2-electron, reduction, metal-ion core, FeMo-co, electron-density, redistribution, Fe-H bonds, metal ions, N2, bind, concomitant, H2, release, process, QM/MM molecular dynamics simulations, redistribution, E4(H2,2H, trapped, cryogenic photolysis, E4(4H, Photolysis, E4(4H) causes, hydride-re with, release, H2, reduced, FeMo-co, E4(2H)*), electron-density redistribution, formation, E4(H2,2H, reduced, FeMo-co core, E4(2H)* limiting-state by (1)H, (57)Fe, (95)Mo, ENDOR, partial, electron-density, E4(H2,2H, formation, catalysis, results, DFT, computations, Inferences, E4(2H)*, ENDOR, results, DFT, computations, Mo-site, Mo, changes, valency, catalytic cycle, E4(4H), (57)Fe, signals, associated with, identified, anchors, bridging, hydride, anchors, NBO-analysis, anchor, hydride, recipient, electrons, released, Fe-H bonds]]\n",
      "[[Alginates, polysaccharide, constituents, marine brown algae, commercial, manufacturing, content, composition, alginates, parts, macroalgae, impact, concentration, guluronate, commercial, product, Azotobacter vinelandii mannuronan C-5 epimerases, AlgE1, AlgE4, potential, production, guluronate low-molecular-weight, alginates, sources, high, mannuronic acid, alginates, harvested, brown algae, Ascophyllum nodosum, Durvillea potatorum, Laminaria hyperborea, Lessonia nigrescens, mannuronic acid alginate, fermented, production, mutant, strain, Pseudomonas fluorescens NCIMB, mannuronan C-5 epimerases, study, increased, content, guluronate, harvested, seaweed, bacterial, sources, guluronate-rich alginate, oligomers, sources, structural, identity, proton nuclear magnetic resonance ((1)H NMR, high-performance anion-exchange chromatography, pulsed, HPAEC-PAD, size-exclusion chromatography, online multi-angle static laser light scattering, SEC-MALS, Functional, identity, MIC, assays, bacteria, antibiotics, documented, low-molecular-weight guluronate, alginate, OligoG, CF-5/20, comparator, alginates, source, antibiotic, drug, OligoG, CF-5/20, development, mucolytic, anti-biofilm agent, findings, epimerases, alternative, novel, low-molecular-weight alginates]]\n",
      "[[Azotobacter vinelandii, nitrogenase, Mo-, V-, Fe-nitrogenases, two-component enzyme systems, catalytic component, NifDK, VnfDGK, AnfDGK, associates, reductase component, Fe protein, NifH, VnfH, AnfH, AnfDGK, VnfDGK, subunit, NifDK, gamma, AnfG, VnfG, expression, nitrogenase, metal, availability, Mo-, Vnitrogenases, Fenitrogenase, components, substrate, reduction, Monitrogenase counterparts, docking models, nitrogenase complexes, crystal structure, Monitrogenase, HADDOCK, structural determinants, crosstalk, Mo-, Vnitrogenase, Fenitrogenase, salt bridge interactions, identified, binding, complex, positively charged residues, VnfG, interactions, NifH, VnfH, AnfH., negatively charged residues, AnfG, interactions, AnfH, NifH, VnfH. A, G subunit, VnfG, Mo-, Vnitrogenases, AnfG subunit, AnfDGK, interactions, NifH, VnfH, unfavorable, reducing, competition, NifDK, funneling electrons, efficient, nitrogenase]]\n",
      "[[genus Azotobacter, Pseudomonadaceae, family, characterized, formation, cysts, metabolically, adverse conditions, desiccation, developmental process, model, study, cell differentiation, Gram-negative bacteria, molecular basis, regulation, messenger cyclic dimeric GMP, c-di-GMP, formation, cysts, Azotobacter vinelandii, encystment, induction, levels, c-di-GMP, increased, absence, diguanylate cyclase, MucR, levels, messenger, low, developmental process, A. vinelandii, cysts, surrounded, alginate layers, variable, proportions, guluronic residues, alginate chain, extracellular mannuronic C-5 epimerases, AlgE1, AlgE7 family, Pseudomonas aeruginosa, MucR, alginate, polymerization, A. vinelandii, MucR, expression, extracellular alginate C-5 epimerases, MucR-deficient strain, cyst-like, structures, alginate capsule, desiccation, Expression, mucR, dependent, response regulator, AlgR, binds, sites, mucR, promoter, mucR transcription, results, developmental process, A. vinelandii, controlled, signaling module, activation, response regulator, AlgR, c-di-GMP, accumulation, MucR.IMPORTANCE A. vinelandii, experimental model, study, differentiation processes, metabolically, Gram-negative bacteria, c-di-GMP, production, alginates, contents, guluronic residues, structure, rigid laminated layers, cyst envelope, allosteric activation, alginate polymerase complex, Alg8-Alg44, c-di-GMP, results, polymer, modification, controlling, expression, extracellular alginate epimerases, results, c-di-GMP, control, physical properties, alginate, desiccation, resistance, differentiated, cell]]\n",
      "[[Ticks, diminish, productivity, farm, animals, transmit, zoonotic diseases, study, tick, species, infesting, slaughter bulls, Adama City, screen, tick-borne, pathogens, ticks, bulls, Adama, slaughter, Ticks, morphologically, genomic DNA, ticks, test, Rickettsia spp., real-time PCR, Species, identification, phylogenetic analysis, sequencing, targeted, 23S-5S intergenic spacer region, ompA genes, tick, species, genera, Amblyomma, Rhipicephalus, identified, Amblyomma cohaerens, dominant, species, Amblyomma variegatum, Rhipicephalus pulchellus, Rhipicephalus decoloratus, ticks, positive, Rickettsia spp., R. africae, genetic clades, A. variegatum, A. cohaerens, Rickettsia-positive samples, amplified, DNA yield, samples, pathogenic bacteria, Ehrlichia ruminantium, A. cohaerens, Ehrlichia sp., Rh, pulchellus, A. cohaerens, Anaplasma sp., A. cohaerens, Neoehrlichia mikurensis, A. cohaerens, ticks, negative, Bartonella spp., Babesia spp., Theileria spp., Hepatozoon spp, E. ruminatium, N. mikurensis, Ehrlichia sp., Anaplasma sp., A. cohaerens, Medically, veterinarily, pathogens, detected, A. variegatum, A. cohaerens, data, relevant, One-health approach, monitoring, prevention, tick-borne disease, transmission]]\n",
      "[[Anaplasmosis, tick-borne disease, intracellular, Anaplasma marginale, cattle, ruminants, tropical, subtropical regions, world, economic losses, decreasing, livestock, production, surface protein 5, MSP5, A. marginale, immunodominant, encoding, study, full-length of, msp5 coding sequence, A. marginale, strain, cloned, size, Phylogenetic analysis, neigh-joining (NJ) method, msp5 sequence Thailand, strains, clade, compared, strains, results, haplotypes, msp5 genes, entropy analysis, MSP5 amino acid sequences, peaks, recombinant, MSP5, A. marginale, over-expressed, E. coli BL21 Star (DE3, host cell, affinity, SDS-PAGE, molecular weight, antigenicity, rAmMSP5, AmMSP5, rabbit, antisera, A. marginale-infected, cattle, sera, rAmMSP5, AmMSP5, perceived, sera, manifesting, recombinant, native, AmMSP5, epitopes, Immunofluorescence technique, rabbit, antisera, AmMSP5, membrane, infected, erythrocytes, recombinant, MSP5, development, immunodiagnostic assays, vaccine, controlling, anaplasmosis]]\n",
      "[[Tick-borne diseases, California, Lyme disease, Borrelia burgdorferi, infections, Borrelia miyamotoi, human, Anaplasma phagocytophilum, multiple sites, habitats, woodland, grassland, coastal chaparral, California, spatial patterns, tick-borne, pathogen, prevalence, western black-legged ticks, Ixodes pacificus, species, Borrelia, B. burgdorferi, B. americana, B. bissettiae, habitats, coastal chaparral, reservoir, host, tick-borne, pathogen, prevalence, influenced, scale, surveillance, aggregating, data, individual sites, jurisdictional boundaries, county, state, infection, prevalence, pathogen, species, habitat, interpretation, local, pathogen, occurrence, ImportanceUnderstanding, local, host, ecology, prevalence, zoonotic diseases, public health, tick-borne diseases, California, bias, studies, habitats, Lyme disease, oak woodlands, habitats, diversity, tick-borne, pathogens, coastal chaparral, pathogen, prevalence, descriptions, data, local scale, aggregating, data, misrepresent, local, dynamics, tick-borne diseases]]\n",
      "[[Tick-borne, pathogens, TBPs, Anaplasma spp, agents, diseases, domestic ruminants, information, prevalence, factors, affecting, occurrence, anaplasmosis, west, Iran, study, prevalence, risk factors, associated with, Anaplasma, pathogens, Kurdistan province, Iran, spring, summer, blood samples, livestock, animals, farms, distributed, Kurdistan province, data, husbandry, traits, management practices, PCR, examination, prevalence, cattle, sheep, Cattle, infected, A. phagocytophilum, A. bovis, A. marginale, sheep, infected, A. ovis, A. phagocytophilum, occurrence, anaplasmosis, cattle, sheep, results, logistic regression models, risk, Anaplasma infection, crossbreeds, odds ratio, OR, confidence interval, CI, local, cattle, breeds, older, year, associated with, increased, risk, Anaplasma infection, cattle, OR, CI, sheep, OR, CI, younger, individuals, No difference, counties, potential, risk factors, potential, vectors, reservoirs, control, prevention, tick-borne diseases]]\n",
      "[[Ticks, Ixodidae, Argasidae, arthropod, vectors, pathogens, human, animal, infectious diseases, published studies, tick-borne, pathogens, transmitted, ixodid ticks, reports, viral pathogens, associated with, argasid ticks, information, bacterial, pathogens, transmit, molecular study, detect, characterize, Rickettsia, Anaplasmataceae, argasid tick, species, Ornithodoros faini, Ornithodoros moubata, Argas walkerae, Zambia, Rickettsia hoogstraalii, Rickettsia lusitaniae, detected, Ar., walkerae, O. faini, O. moubata, samples, negative, rickettsial infections, Anaplasmataceae, detected, Ar., walkerae, O. moubata, pools, O. faini, Phylogenetic analysis, concatenated sequences, 16S rRNA, groEL genes, Anaplasma spp, detected, study, Anaplasma, species, knowledge, diversity, vector, Anaplasma spp, incomplete, findings, geographical records, R. lusitaniae, R. hoogstraalii, confirm, geographic, distribution, species, African continent, data, increase, knowledge, argasid, tick-borne bacteria, epidemiology]]\n",
      "[[Anaplasma platys, tick-transmitted rickettsial pathogen, etiologic agent, cyclic thrombocytopenia, primary canine, host, Infections, pathogen, cats, cattle, people, Ehrlichia canis, tick-borne, rickettsial pathogen, canine, monocytic ehrlichiosis, infections, people, infections, dogs, pathogens, Caribbean island, Grenada, West Indies, detection, molecular methods, 16S rRNA, gene-based PCR assay, detect, Ehrlichia, Anaplasma, species, screening, canine, blood samples, asymptomatic, dogs, dogs, positive, A. platys, E. canis, Samples, tested, positive, A. platys, assessed, sequence analysis, targeting, 16S rRNA, 23S rRNA, citrate synthase, gltA, heat shock protein, Phylogenetic analysis, correlation, A. platys, 16S rRNA, gltA gene sequences, geographic origins, 23S rRNA, groEL gene sequences, clustered, independent, geographic origins, study, widespread, distribution, active, rickettsial infections, Caribbean, dogs, clinical signs, risk, canine, health, lesser, humans, dogs, Caribbean, free-roaming]]\n",
      "[[Dogs, reservoir, Chagas disease, Trypanosoma cruzi, T. cruzi, companion, vector-borne diseases, ehrlichiosis, Ehrlichia canis, Ehrlichia ewingii, anaplasmosis, Anaplasma phagocytophilum, Anaplasma platys, dirofilariasis, Dirofilaria immitis, Lyme disease, Borrelia burgdorferi, study, seroreactivity, T. cruzi, dogs, town, Colon, Portoviejo, city, central coast of Ecuador, coinfection, frequency, companion, vector-borne diseases, dogs, positive, T. cruzi, Antibodies, T. cruzi, detected, enzyme-linked immunosorbent assays, Diagnostic consensus, ELISA, tests, Cohen's Kappa coefficient, haemoparasitic diseases, detected, IDEXX SNAP(R) 4Dx(R) kit, dogs, diagnosed, T. cruzi-seropositive, dogs, sampled, positive, T. cruzi, Co-infection analysis, dogs, positive, T. cruzi, antibodies, Ehrlichia spp., Anaplasma spp., Dirofilaria immitis, results, perspective, status, pathogens, co-infect, dogs, Colon, pathogens, zoonotic, findings, regional, health authorities, sanitary programs, prevent, control vectors, associated to, pathogens, hand, human, veterinarian doctors, patients, cardiac infection, condition, suffering, co-infections, vector, transmitted, pathogens]]\n",
      "[[man, emergency department, fevers, ankle edema, nausea, insect bite, ankle, month, prior, examination, febrile, left leg pain, passive range, motion, Laboratory studies, anemia, thrombocytopenia, acute kidney injury, elevated, aminotransaminases, travel, Northeastern United States, suspected, tick-borne illness, Serologies, positive, Borrelia burgdorferi, Anaplasma phagocytophilum, Babesia microti, patient, diagnosed, Lyme disease, babesiosis, anaplasmosis, treated with, doxycyline, atovaquone, azithromycin, resolution, symptoms, co-infection, Lyme disease, infection, tickborne, illnesses, rare]]\n",
      "[[study, novel, information, poorly, known/rare tick, species, wild goats, Capra aegagrus, mountains, Eastern Anatolia, Turkey, genetic data, ticks, morphologically, identified, Haemaphysalis kopetdaghica, active stages, Dermacentor raskemensis, adults, Ixodes gibbosus, adults, Rhipicephalus kohlsi, female, R. bursa, nymphs, engorged, ticks, larvae, nymphs, females, molt, next stage, egg laying, larval, hatching, R. kohlsi, female, SEM microscopy, wild goat, neighboring, province, Erzurum, study, genetic comparison, partial, mitochondrial, cytochrome c oxidase subunit 1, barcoding regions, genes, tick, species, sequenced, DNA samples, ticks, PCR, presence, Anaplasma spp., Babesia spp., Borrelia burgdorferi sensu lato, spotted fever group rickettsiae, Theileria spp., negative, Phylogenetic analyses, 16S rDNA, cox1 genes, ML, method, genetic relationship, ticks, result, study, rediscovered, tick records, H. kopetdaghica, D. raskemensis, Turkey, genetic data, H. kopetdaghica, D. raskemensis, revealed, phylogenetic relationships, characterized, cox1 region, I. gibbosus, genetic diversity, R. kohlsi, Anatolia, R. kohlsi, Oman, R. kohlsi, cryptic species]]\n",
      "[[female moose, Alces alces, North Dakota, US, tested, antibodies, pathogens, Antibodies, West Nile virus, WNV, detected, moose, year, human, cases, population, WNV, activity, moose, antibodies, Borrelia burgdorferi, expansion, tick, vector, area, Antibodies, Anaplasma spp, detected, moose, rate, detected, cattle, region, Low, titers, serovars, Leptospira spp, detected, moose, finding, wild ruminants, Exposure to, pathogens, documented, Survival, recruitment, study, period, population-level, impact, levels, exposure, environmental, co-stressors]]\n",
      "[[Anaplasmosis, tick-borne illness, Anaplasma phagocytophilum, review, CDC, reports, increase, Anaplasmosis, cases, cases, cases, May, October, Neurologic manifestations, uncommon, Case, male, acute left-sided weakness, Patient, acute kidney injury, creatinine, thrombocytopenia, platelet count, rhabdomyolysis, CPK, Workup, acute stroke, negative, Peripheral blood smears, Anaplasma, neutrophil, inclusions, buffy coat prep, PCR testing, positive, Anaplasmosis, treated with, doxycycline, days, improvement, discharged home, hospital course, neurological deficits, review, medical system, cases, Anaplasmosis, cases, May, December, fever, unclear, etiology, case, stroke-like symptoms, cases, people, living, wooded, age, years, presentation, Anaplasmosis, nonspecific, febrile illness, leukopenia, thrombocytopenia, headache, stroke-like symptoms, rare, complication, Elderly, immunocompromised, patients, living, wooded, risk, Anaplasmosis, Delayed diagnosis, case review, associated with, prognosis]]\n",
      "[[tick-borne, pathogens, imported, fever, incidence, Anaplasma phagocytophilum, causative agent, human granulocytic anaplasmosis, HGA, travelers, prospective cohort study, investigate, aetiologies, fever, travelers, Polymerase chain reaction, PCR, msp2 gene amplification, indirect, IFA, A. phagocitophilum, travelers, undifferentiated non-malarial fever, travelers, patients, diagnosed, probable, HGA, incidence, HGA, travel, destination, travel, Asia, patients, HGA, Co-infections, patients, HGA, Diagnosis, HGA, empirical treatment, doxycycline, travelers, fever]]\n",
      "[[Anaplasma phagocytophilum, causative agent, granulocytic anaplasmosis, humans, wild, domesticated, mammals, horses, study, preliminary, survey, occurrence, re-emerging, pathogens, horses, Slovakia, sera, animals, ages, sexes, tested, presence, A. phagocytophilum, antibodies, indirect, immunofluorescence assay, detection, 16S rRNA, gene fragment of A. phagocytophilum, polymerase chain reaction, PCR, blood sample, results, presence, antibodies, individuals, changes, animals, ages, sexes, PCR analysis, detect, positive, animals, data, values, seropositivity, A. phagocytophilum, horses, Central Europe, results, circulation, A. phagocytophilum, region, potential, risk, susceptible, species]]\n",
      "[[Anaplasma phagocytophilum, etiological agent, canine, granulocytic anaplasmosis, dogs, human, HGA, Tick-borne anaplasmosis, zoonotic, study, prevalence, A. phagocytophilum, ticks, dogs, UK, map, distribution, Routine, surveillance, tick-borne disease, infectious disease, management, Tick, DNA samples, large-scale tick, surveillance programme, analysed, diagnostic quantitative PCR, A. phagocytophilum, PCR analysis, tick, DNA samples, analysed, positive, A. phagocytophilum, prevalence, CI, tick, DNA samples, Ixodes ricinus, Ixodes hexagonus, Ixodes canisuga, I. ricinus, DNA samples, positive, A. phagocytophilum, DNA, positive, Borrelia spp., DNA, positive, Babesia spp., DNA, co-infection, ticks, positive, pathogen DNA, UK, data, information, prevalence, distribution, A. phagocytophilum, ticks infesting, dogs, UK]]\n",
      "[[Camels, resource, inhabitants, arid regions, world, survival, environment, conditions, risk, parasitic diseases, losses, livestock, production, areas, Camels, parasitized, hematophagous arthropods, vectors, diseases, zoonosis, study, investigate, dromedary camels, ticks, tick-borne hemoparasites, recent, morbidity, camels, Al Dhafra region, Abu Dhabi, UAE, Blood samples, ticks, infected, camels, herds, affected, acute, days, analyzed, molecular techniques, DNA, presence, blood pathogens, Anaplasmamarginale/Anaplasmaovis, Anaplasma phagocytophilum, Coxiella burnetii, Babesia spp., Theileria spp., DNA, ticks, Hyalomma dromedarii, species, negative, blood pathogens, camels, positive, tick-borne hemoparasites, A. phagocytophilum 11, Coxiella burnetii 3, Babesia/Theileria spp., singular, camel, coinfection, C. burnetii, A. phagocytophiulm, Genetic profile, C. burnetii, phylogenetic, relatedness, European, Asian, African C. burnetii, strains, laboratory, investigation, tick-borne, pathogens, camels, UAE, A. phagocytophilum, C. burnetii, detected, pathogens, pathogens, humans, study, zoonotic, risk, humans, working, camel husbandry]]\n",
      "[[Anaplasma phagocytophilum, tick-borne fever, small ruminants, Anaplasma, variants, A. phagocytophilum, ruminants, Tunisia, Italy, South Korea, Japan, China, 16S rRNA, groEL genes, sequencing, screened, frequency, A. phagocytophilum, variants, healthy, Turkey, Anaplasma spp, infection, rates, analyzed, samples, frequency, A. phagocytophilum, A. phagocytophilum-like 1 infections, A. phagocytophilum-like 2, detected, tested, animals, prevalence, Anaplasma spp, species, no significant difference, detected, sheep, goats, prevalence, increased, tick, infestation, Sequencing, PCR-RFLP, data, presence, A. phagocytophilum, A. phagocytophilum-like-1 variant, sampled, animals, Phylogeny-based, 16S rRNA, A. phagocytophilum-like 1, clade, isolates, detected, small ruminants, ticks, A. phagocytophilum-like 1, detected, sheep, goats, Turkey, variant, diagnosis, caprine, ovine anaplasmosis]]\n",
      "[[Multi-subunit SMC ATPases, chromosome superstructure, DNA-loop-extrusion reaction, SMC, proteins, ABC-type ATPase, head, coiled coil, SMC, dimer, co-align, rod-shaped particle, ATP, binding, SMC, heads, engage, arms, separate, study, shape, Bacillus subtilis, Smc-ScpAB, electron-spin resonance spectroscopy, Arm separation, proximal, heads, absence, ligands, separation, near, hinge, ATP, DNA, Artificial blockage, arm, opening, DNA stimulation, ATP, hydrolysis, basal, ATPase, activity, arm, contact, controlling, transformations, Point mutations, arm interface, Smc function, intermediary, conformations, directionality, SMC, DNA translocation, DNA substrates]]\n",
      "[[phytochemical, biological, properties, tangerine, Citrus reticulata L., grapefruit, Citrus paradisi L., lemon, Citrus lemon L., cinnamon, Cinnamomum zeylanicum Blume, essential oils, examined, chemical composition, essential oils, chromatography analysis, D-limonene, cis-cinnamaldehyde, components, antioxidant, antimicrobial activities, essential oils, DPPH, radical-scavenging assay, disc-diffusion method, essential oils, antimicrobial activity, saprophytic, Bacillus subtilis, Penicillium chrysogenum, Fusarium moniliforme, Aspergillus niger, Aspergillus flavus, Saccharomyces cerevisiae, pathogenic, microorganisms, Escherichia coli, Salmonella abony, Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, inhibitory activity, cinnamon oil, grapefruit, zest oil, tangerine, zest oil, lemon, zest oil, MIC, antioxidant activity, antioxidant activity, grapefruit, essential oil, lemon, tangerine, essential oil, cinnamon essential oil, results, antioxidant, antimicrobial activity, essential oils, inclusion, development, bio-preservation, strategies, food emulsion, preservation]]\n",
      "[[Human milk oligosaccharides, HMOs, ingredients, human milk, effect, health, newborns, large-scale production, HMOs, engineered, microbial, routes, availability, safety, low, cost, host, strains, development, molecular biology technology, metabolic engineering, effectiveness, HMOs, production, reports, 2'-fucosyllactose, 3-fucosyllactose, 3-FL, lacto-N-tetraose (LNT, lacto-N-neotetraose (LNnT), 3'-sialyllactose, 3'-SL, 6'-sialyllactose, 6'-SL, fucosylated, HMOs, complex structures, engineered, microbial, uncertainty, metabolic, patterns, selection, host, strains, limitations, expression, glycosyltransferase, microbes, synthesis, HMOs, efficient, glycosyltransferase, engineered, microbial pathways, review, research, production, HMOs, engineered, microbial, routes, selection, host, strains, metabolic pathways, researchers, engineered, microbial, routes, HMOs, production]]\n",
      "[[fungi, organisms, biological, synthesis, metallic, nanoparticles, metal, bioaccumulation, ability, extracellular synthesis, silver, nanoparticles, AgNPs, cell-free filtrate, Penicillium toxicarium KJ173540.1, P. toxicarium, isolated, identified, classical, molecular methods, ribosomal internal transcribed spacer area, 18S rDNA, optimum, conditions, AgNPs, synthesis, AgNO3, concentrations, pH, values, degrees, incubation, dark, Biosynthesized, AgNPs, characterized, microscopic, spectroscopic techniques, transmission electron microscopy, scanning electron microscopy, energy dispersive X-ray analysis, Fourier transform infrared spectrophotometer, ultraviolet-visible spectroscopy, Zetasizer measurements, PDI, excellent, colloidal, nature, AgNPs, long-range stability, high, dispersity, AgNPs, cyto-genotoxicity, Allium cepa, root meristem cells, decreasing, mitotic index, increasing, chromosome aberrations, dose-dependent, concentration, biosynthesized, AgNPs, antibacterial activity, Staphylococcus aureus, Bacillus subtilis, decreasing, biofilm formation, Pseudomonas aeruginosa, mycosynthesized, AgNP]]\n",
      "[[nontuberculous mycobacteria, NTM, Mycobacterium avium, clinically significant, pathogen, maladies, tuberculosis-like pulmonary disease, immunocompromised, genetically, acquired, risk, progressive, NTM, infections, health threat, evaluated, recombinant fusion protein ID91, GLA-SE, glucopyranosyl lipid adjuvant, toll, agonist, oil-in-water, stable, nano-emulsion, protection, C57BL/6, wild type, Beige (immunocompromised, mouse models, aerosol, model, clinical, NTM, isolate, M. avium 2, smt, bacterial growth, kinetics, colony, morphology, drug sensitivity, histopathology, characterized, influx, pulmonary immune cells, immunogenicity, ID91, mouse models, prophylactic, vaccine, efficacy, M. avium, isolate, mice, immunized, ID91, GLA-SE, bacillus Calmette-Guerin, BCG, Immunocompromised, Beige mice, delayed, influx, innate, adaptive immune cells, sustained, increased, bacterial, burden, lungs, spleen, C57BL/6 mice, ID91, GLA-SE, BCG, vaccines, pulmonary, bacterial, burden, mouse strains, subunit, NTM]]\n",
      "[[division, bacterial, physiology, division proteins, nanoscale machine, cell, Cell division, cell wall synthesis proteins, cytoskeleton protein FtsZ, assembles, mid-cell, dense, Z-ring, treadmilling filaments, FtsZ, treadmilling, cell division, function, FtsZ, treadmilling, unclear, systematically, function, FtsZ, treadmilling, stage, division, Gram-positive model, organism, Bacillus subtilis, combination, nanofabrication, advanced microscopy, microfluidics, measure, division-protein dynamics, live cells, ultrahigh sensitivity, FtsZ, treadmilling, functions, condensation, diffuse, FtsZ, filaments, dense, Z-ring, constriction, septal cell wall, synthesis, constriction, initiation, FtsZ, treadmilling, function, accelerating, septal constriction, rate, results, FtsZ, treadmilling, assembling, initiating, bacterial cell division machine]]\n",
      "[[Heterosigma akashiwo, microalgae, studies, control, algicidal components, identified, algicidal bacteria, study, ortho-tyrosine, urocanic acid, identified, Bacillus sp. B1, algicidal effect, H. akashiwo, growth inhibition, rates, H. akashiwo, treatment, o-tyrosine, urocanic acid, non-destructive testing, Pulse Amplitude Modulation fluorometry, flow cytometer, effects, o-tyrosine, urocanic acid, H. akashiwo PS II, physiological, parameters, cell volume, mitochondrial membrane, potential, membrane permeability, estimated, study, o-tyrosine, affected, photosynthesis system, H. akashiwo, decreased, mitochondrial membrane, potential, increased, membrane permeability, algal cells, Treatment, urocanic acid, decreased, mitochondrial membrane, potential, inhibition, algal cell, reproduction, effect, membrane permeability, photosynthetic system, results, uridine, degrades, H. akashiwo cells, reactivated, o-tyrosine, urocanic acid, potential, biological algicides, control, growth, H. akashiwo]]\n",
      "[[invertebrate, compound ascidian, Botryllus, schlosseri, faces, innate immunity, species, identified, components, lectin, complement activation pathways, mining, transcriptome, identified, transcript, codifying, protein, member, C1q-domain-containing protein, signal peptide, globular, C1q, domain organisation, C1q/TNF-related proteins 4, vertebrate, protein family, gC1q domains, gC1q domain-containing protein, BsC1qDC, transcribed, immunocytes, transcription, modulated, Botryllus, blastogenetic cycle, upregulated, injection, Bacillus clausii cells, circulation, injection, bsc1qdc iRNA, vasculature, results, decreased, transcription, gene, impairment, phagocytosis, degranulation, involvement, molecule, immune responses]]\n",
      "[[Nanoparticles, excellent, catalytic, adsorptive, reactive properties, application, wastewater, treatment, study, silver, nanoparticle, neem, leaf, banana peel extract, application, antimicrobial, dye degrading agent, wastewater, treatment, extracts, rapid, environment-friendly method, biosynthesis, silver, nanoparticles, AgNPs, UV-Vis spectroscopy, absorption bands, AgNPs, synthesized, neem, leaf, banana peel, extracts, AgNPs, characterized, XRD, FTIR, ESEM, EDX, DLS, methods, XRD, data, crystalline, nature, synthesized, AgNPs, ESEM, images, synthesized, nanoparticles, spherical, DLS, analysis, average, diameter, AgNPs, banana peel, neem leaf extract, Antibacterial activity, synthesized, nanoparticles, concentration, Escherichia coli, E.coli, Bacillus subtilis, B.subtilis, Staphylococcus aureus, S.aureus, Klebsiella sp., disk diffusion method, zone, inhibitions, observed, degradation, model dye malachite green, banana peels-derived, nanoparticles, concentration, study, eco-friendly, economic approach, AgNP, synthesis, potential, application, removal, hazardous dye, wastewater]]\n",
      "[[S-layers, self-assembled, crystalline, 2D, lattices, enclosing, cell envelopes, bacteria, archaea, abundance, landscape, S-layer structure, function, land, location, bacterial, S-layers, structural stability, cell envelope, S-layers, cell-environment, cell-host interactions, adhesion, cell growth, division, strides, bacterial cell envelope, components, studies, structural, functional, S-layer, S-layer-associated proteins, SLPs, SLAPs, pathogenicity, potential, therapeutic, vaccine, targets, sequence-structure-function, relationships, S-layers, SLPs, SLAPs, Gram-positive pathogens, classes, Bacilli, Bacillus anthracis, Clostridia, Clostridioides difficile, domains, architectures, archetypal, S-layer proteins, Gram-positive genera, experimental findings, flavors, SLPs, Gram-positive pathogens, assemble, bacterial, S-layers, findings, S-layers, translational research, diagnostics, antibacterial therapeutics, vaccines, characteristics, location, cell surface, abundance, lineage-specific signatures]]\n",
      "[[exosporium, outermost spore, layer, Bacillus, Clostridium species, organisms, interactions, spores, environment, modulates, spore, adhesion, germination, pathogenesis, Bacillus cereus, exosporium, crystalline, basal layer, cysteine-rich proteins, CotY, ExsY, surrounded, hairy nap, glycoproteins, morphogenetic protein, CotE, integrity, B. cereus exosporium, CotE, exosporium, assembly, super-resolution fluorescence microscopy, localization, SNAP-tagged, CotE, CotY, ExsY, B. cereus, sporulation, interdependencies, proteins, Complexes, CotE, CotY, ExsY, sporulation stages, proteins, localization, patterns, endospore, formation, localization, pattern, Bacillus subtilis, CotE., B. cereus, CotE, guides, formation, cap, forespore, poles, CotY, forespore encasement, ExsY, exosporium, elongation, actions, CotE, formation, exosporium, assembly, exosporium, formation, caps, B. subtilis, coat morphogenesis, assembly, spore, surface, Bacillaceae, Spores, Bacillaceae, enveloped, outermost glycoprotein layer, B. cereus, group, Bacillus anthracis, B. cereus, pathogens, layer, balloon-like, appearance, separation, coat, interspace, environmental, interactions, spores, host cells, mechanism, assembly, exosporium, super-resolution fluorescence microscopy, formation, exosporium, sporulation, B. cereus, localization, interdependencies, proteins, essential, exosporium, morphogenesis, proteins, morphogenetic, scaffold, exosporium, coat, detectable, proteins, localize, scaffold, assemble, spore, model, assembly, exosporium]]\n",
      "[[Bacillus anthracis, causative agent, anthrax, Gram-positive, non-motile, spore, bacterium, spores, soil, water, years, aerosolized, rapid, sensitive, method, detect, B. anthracis, clinical management, preventing, spread, anthrax, Loop-mediated isothermal amplification, assay, technique, target, DNA, isothermal conditions, sensitivity, specificity, study, LAMP, assay, targeting, chromosomal, plasmid, markers, individual assays, LAMP, targeting, pXO1 plasmid, lef, pXO2 plasmid, capB, chromosome, detect, genomic DNA, copies, DNA, harboured, recombinant plasmids, lef, capB, LAMP, assays, detect, CFU, bacteria, spiked, human, blood samples, BA5345 LAMP assay, detect, CFU, bacteria, spiked blood, amplification, monitored, real-time, turbidimeter, visual detection, normal, UV light, SYBR Green 1 dye, completion, reaction, assay set, sensitive, cross-react, Bacillus spp., bacterial strains, study]]\n",
      "[[Whole-genome-sequencing, WGS, bacterial subtyping, study, pathogen, transmission, investigate, outbreaks, routine, surveillance, Core genome multilocus sequence typing, cgMLST, bacterial subtyping, WGS, data, resolution, strain, characterisation, study, cgMLST scheme, Bacillus anthracis, pathogen, anthrax, livestock, humans, worldwide, genes, B. anthracis, genomes, phylogeny, evaluated, genomes, countries, average, cgMLST, targets, detected, cgMLST results, SNPs, grouping, B. anthracis, clades, subclades, Genetic distances, cgMLST, distances, whole-genome-based SNP, analysis, phylogenetic topology, discriminatory, application, cgMLST scheme, anthrax outbreaks, Germany, Italy, definition, cut-off threshold, allele, differences, epidemiologically, strains, cluster typing, transmission analysis, association, clusters, B. anthracis, human, cases, injectional anthrax, European countries, cgMLST, study, cgMLST scheme, high-resolution strain genotyping, B. anthracis, SNP typing, rapid, harmonised, inter-laboratory, essential, global surveillance, outbreak analysis, application, users, bioinformatics, knowledge]]\n",
      "[[Bacillus cytotoxicus, Bacillus cereus, group, foodborne, Bacillus cereus sensu stricto, Bacillus anthracis, anthrax, biopesticide Bacillus thuringiensis, B. cytotoxicus, isolated, context, severe, food poisoning, outbreak, fatal, cases, diarrheal disease, characterization, outbreak, strain, Bacillus strain, cytotoxic, description, novel, species, toxicity, B. cytotoxicus, isolates, species, characterized, cytotoxic, potential, B. cytotoxicus, causative agent, food poisoning, unclear, study, toxicity, B. cytotoxicus, isolates, mashed potato, powders, characterized, toxin gene profiling, Vero cell, cytotoxicity assays, isolates, cytK1, cytotoxin K1, gene, species-specific variants, nhe, non-hemolytic enterotoxin) gene, isolates, low, toxicity, Vero cells, study, cytotoxic, potential, B. cytotoxicus]]\n",
      "[[NADH-dependent persulfide reductase, Npsr, dissimilatory, sulfur, respiration, reducing, persulfide, sulfane sulfur-containing substrates, H2S, presence, gene, sulfate, thiosulfate-reducing Archaeoglobus fulgidus DSM 4304, hyperthermophilic Archaeoglobales, anomalous, A. fulgidus, respire, S(0), grow, presence, elemental sulfur, Npsr, sulfur metabolism, A. fulgidus DSM 4304, Npsr, A. fulgidus, characterized, AfNpsr, persulfide, polysulfide, substrates, oxidative half-reaction, kinetic, parameters, hyperthermophilic CoA, persulfide reductases, bacterial, Npsr, AfNpsr, low, disulfide reductase, DTNB, bacterial enzymes, detectable, activity, CoA-disulfide, oxidized glutathione, cystine, X-ray structure, AfNpsr, bound, catalytic CoA, active site, Cys, flexible, residues, bacterial homologs, Shewanella loihica, PV-4, Bacillus anthracis, bacterial enzymes, AfNpsr, NADH oxidase, activity, activity, NADPH, Models, steric, electrostatic repulsions, NADPH, 2'-phosphate, preference, NADH, Npsr, nonsulfur-reducing A. fulgidus, enzyme, protection, S(0), metabolic, identified]]\n",
      "[[beta-Lactams, antibiotics, target, synthesis, peptidoglycan, cell wall, beta-Lactams, inhibit, function, penicillin-binding proteins, PBPs, cross-links, strands, peptidoglycan, Resistance, beta-lactams, treatment, bacterial infections, years, spread, beta-lactam resistance, increased, growing intensity, Resistance, beta-lactamases, inactivate, beta-lactams, expression, alternative, beta-lactam-resistant, PBPs, sigma(P, extracytoplasmic function, controls, beta-lactam resistance, species, Bacillus thuringiensis, Bacillus cereus, Bacillus anthracis sigma(P, inactive, anti-sigma factor RsiP. sigma(P, activated, beta-lactams, proteolytic destruction, RsiP., penicillin-binding protein, PbpP, activation, sigma(P, data, PbpP, sigma(P) activation, RsiP, degradation, data, PbpP, beta-lactam, sensor, binding, beta-lactams, PbpP, sigma(P) activation, PbpP, cleavage, RsiP, results, degradation, RsiP, sigma(P) activation, activation, results, increased, expression, beta-lactamases, increased, beta-lactam resistance, report, PBP, sensor, beta-lactams, controlling, activation, ECF sigma factor, bacterial cell envelope, target, numerous, antibiotics, antibiotics, target, synthesis, peptidoglycan, metabolic pathway, essential, bacterial survival, classes, antibiotics, beta-lactams, inhibit, transpeptidase activity, penicillin-binding proteins, decrease, cross-linking, peptidoglycan, strength, cell wall, beta-lactam antibiotics, effective, resistance, beta-lactams, problem, ECF sigma factor sigma(P, beta-lactam resistance, B. thuringiensis, relatives, B. anthracis, mechanism, activation, sigma(P, beta-lactams]]\n",
      "[[human cutaneous anthrax, case-fatality rate, treated, untreated, median, CI, livestock, handling, northern Ghana, veterinary resources, Livestock, vaccination, human, treatment, evaluated]]\n",
      "[[Anthrax, zoonotic disease, Bacillus anthracis, spore-forming pathogen, phenotype, phenotype, virulence factor, B. anthracis, study, serine/threonine protein kinase, B. anthracis, PrkC, kinase, localized, bacteria-host interface, B. anthracis chain length, In vitro, prkC, disruption, strain, DeltaprkC, shorter chains, bacterial growth cycle, comparative analysis, parent, strain, BAS, DeltaprkC, levels, proteins, BslO, Sap, associated with, regulation, bacterial chain, upregulated, BAS, BslO, septal murein hydrolase, catalyzes, Sap, S-layer structural protein, septal localization, BslO., PrkC, disruption, effect, bacterial growth, cell wall, thickness, septa, formation, Upregulation, ftsZ, BAS, DeltaprkC, results, PrkC, optimum, cell wall homeostasis, maintenance, phenotype, IMPORTANCEChaining, phenotype, virulence factor, Bacillus anthracis, study, signal transduction protein, regulate, phenotype, Bacillus anthracis, disruption, surface-localized serine/threonine protein kinase, PrkC, shortening, bacterial chains, upregulation, de-chaining proteins, PrkC, disruption, strain, report, PrkC, disruption, results, attenuated, cell growth, decrease, cell wall, thickness, aberrant, cell septa, formation, logarithmic phase, growth, growth phase, PrkC, expressed]]\n",
      "[[Bacillus ancthracis, cutaneous, pulmonary, gastrointestinal forms, anthrax, B. anthracis, pathogenic, bacterium, bioterrorism, spores, protective antigen (PA)-based, vaccines, prevention, anthrax, effective, vaccines, prolonged, immunization schedules, adverse reactions, lipoprotein, GBAA0190, inducer, host, immune response, anthrax spores, potential, vaccine, candidate, evaluated, immune-stimulating activity, bone marrow-derived macrophages, BMDMs, enzyme-linked immunosorbent assay, ELISA, Western blot analysis, efficacy, GBAA0190, evaluated, guinea pig, model, recombinant, induced, expression, inflammatory cytokines, tumor necrosis factor-alpha, TNF-alpha, interleukin-6, IL-6, monocyte chemoattractant protein-1, MCP-1, macrophage, MIP-1alpha, BMDMs, immune responses, toll-like receptor 1/2, activation, mitogen-activated protein, Nuclear factor-kappaB (NF-kappaB) pathways, immunization, r0190, immunization, r0190, recombinant PA, B. anthracis, spore, challenges, GP model, results, r0190, potential, target, anthrax vaccine]]\n",
      "[[study, bacterial, endophytes, leaves, native, medicinal plant, Pulicaria incisa, isolated, identified, Agrobacterium fabrum, Acinetobacter radioresistant, Brevibacillus brevis, Bacillus cereus, Bacillus subtilis, Paenibacillus barengoltzii, Burkholderia cepacia, isolates, variant, tolerances, salt stress, efficacy, indole-3-acetic acid, IAA, production, tryptophan, maximum, productivity, IAA, B. cereus, BI-8, B. subtilis, BI-10, values, presence, days, isolates, potential, phosphate solubilization, ammonia production, enzymatic activities, amylase, protease, xylanase, cellulase, chitinase, catalase, In vitro, antagonistic, investigation, efficacy, phytopathogens, Fusarium oxysporum, Alternaria alternata, Pythium ultimum, inhibition, percentages, endophytic bacteria, bio-inoculants, maize, seeds, results, bacterial, inoculations, increased, root, length, fresh, dry weights, roots, control plants, Zea mays, plant, inoculated, endophytic, strains, BI-8, BI-10, improved, growth, performance, nutrient, uptake, compared, un-inoculated plant]]\n",
      "[[bacteria, viable, non-culturable state, stresses, dry, salt, soils, YeaZ, Gram-negative bacteria, resuscitation, homologous protein, resuscitate, bacteria, natural environment, VBNC, state, investigate, effect, YeaZ, isolation, viable, non-culturable, bacteria, soil, samples, environments, recombinant, YeaZ, Vibrio harveyi, soil, samples, volcanic soil, saline soil, Northwest China, study, YeaZ, promote, recovery, growth, soil, microorganisms, cultivable, bacteria, volcanic, saline soil, increased, 16S rDNA gene sequencing, phylogenetic analysis, YeaZ, increase, composition, diversity, bacteria, bacterial strains, isolated, volcanic soil, samples, phyla, Actinobacteria, Firmicutes, Gamma-proteobacteria, species, Ornithinimicrobium kibberense, Agrococcus citreus, Stenotrophomonas rhizophila, Pseudomonas zhaodongensis, control group, Micrococcus antarcticus, Kocuria, Salinibacterium xinjiangense, Planococcus antarcticus, Ornithinimicrobium kibberense, Pseudomonas zhaodongensis, isolated, treatment groups, YeaZ, strains, isolated, saline soil, samples, species, control group, species, treatment groups, species, Bacillus oceanisediminis, Brevibacillus brevis, Paenibacillus xylanilyticus, Microbacterium maritypicum, B. subtilis, B. alcalophilus, B. niabensis, Oceanimonas doudoroffii, Zobellella taiwanensis, results, YeaZ, soil, samples, promote, recovery, VBNC, method, discovery, VBNC, bacteria, potential, environmental functions]]\n",
      "[[strains, novel, bacteria, isolated, oil-contaminated sediment, Arabian Gulf (Brevibacillus brevis, Proteus mirabilis, Rhodococcus quinshengi TA13008, isolated, strains, tested, efficacy, low, naphthalene, pyrene, efficacy, two-hydrocarbon degradation, isolates, bacterial, temperature, degrees, degrees, C, pH, inoculated media, Rhodococcus qinshengi, metabolized, naphthalene, pyrene, Brevibacillus brevis, naphthalene, room temperatures, P. mirabilis, R. qinshengi, biodegraded, naphthalene, incubated, media, capacity, pyrene, naphthalene degradation, pH, temperature, conditions, significant, Rhodococcus qinshengi, mineralization, tested, pH, temperature, isolated, strains, biodegradation, contaminated sediment, naphthalene, pyrene]]\n",
      "[[high-gamma-amino butyric acid, Levilactobacillus brevis strain, NPS-QW, Streptococcus thermophilus, starter bacteria, yogurt, proteolytic activity, GABA, production, milk, mechanistic, Levilactobacillus brevis cooperates, S. thermophilus, stimulate, GABA, production, lacking, Comparative peptidomic, metatranscriptomic analyses, casein, lactose, patterns, milk, fermentation, coculture, peptides, hydrolyzed, S. thermophilus, ASCC1275, transported, biodegraded, peptidase, growth, amino acid synthesis, metabolism, Lb., activated, growth, Glucose, lactose, hydrolysis, S. thermophilus, lactose, milk, metabolized, carbon, source, Lb. brevis 145, ATP, production, stationary phase, acidic, accumulation, lactic acid, S. thermophilus, expression, genes, pyridoxal phosphate, coenzyme, glutamic acid decarboxylase, metabolism, glutamic acid decarboxylase, Gad, Lb., induced, GABA, production, market, GABA-rich milk, dietary therapy, management, hypertension, novelty, peptide profiles, metatranscriptomics, pattern, casein, hydrolysis, S. thermophilus, supply, peptides, glucose, S. thermophilus, transportation, peptides, Lb., brevis, degradation, peptides, organism, nonproteolytic, GABA, production, Lb. brevis 145 under, acidic, contribution, lactic acid bacteria, LAB, GABA, human, health, elucidation, interactions, groups, bacterial, communities, production, GABA-rich milk, promoting, development, functional dairy, development, industrial, GABA, production]]\n",
      "[[Microbiomes, associated with, plant structures, members, potential, specialized, metabolites, molecules, antibacterial, antifungal, siderophore activities, microbes, associated with, plants, specialized, metabolites, molecules, intramicrobiome interactions, Root nodules, legume plants, organs, symbiotic bacteria, atmospheric, accessory microbiome, members, specialized, metabolites, in vitro, observations, model, nodule, microbiome system, evaluating, specialized, microbial, metabolism, planta, inoculum, field-grown, Medicago sativa nodules, passaging, gnotobiotic nodules, accessory community, members, Brevibacillus brevis, Paenibacillus sp., Pantoea agglomerans, Pseudomonas sp., members, community, cooperation, planta, antagonistic, disrupting, cooperation, partners, matrix-assisted laser desorption ionization-imaging mass spectrometry, metabolites, associated with, individual, taxa, unique, distributions, members, nodule, community, families, molecules, B. brevis, planta, antibacterial tyrocidines, gramicidin-type molecules, britacidins, results, nitrogen fixation, legume, root nodules, sites, active, antimicrobial, production]]\n",
      "[[Brevibacillus species, environmental organisms, human, pathogens, case, postsurgical, Brevibacillus brevis, bacterial meningitis, bacteremia, debulking surgery, diagnosed, pilocytic astrocytoma, woman, patient, clinical cure, vancomycin, postinfectious course, development, pseudomeningocele, surgical repair, knowledge, case, central nervous system infection, Brevibacillus brevis, literature]]\n",
      "[[graphene oxide, nanosheets, decorated, cuprous oxide nanospheres, GO/Cu2O, silicon, carbide, nanowires, GO/SiC, synthesized, controlled, blade-like antibacterial agents, Preparation, GO, sheets, thickness, modified, Controlled, Cu2O, spheres, size, wet-chemical approach, comparative studies, chemical deposition, GO/Cu2O, GO/SiC, nanocomposites, antibacterial active materials, nanomaterials, biological behavior, bacterial-resistance, assessed, Gram-negative, gram-positive bacteria, yeast, strains, GO/Cu2O, nanocomposite, antibacterial activity, bacterial strains, GO/SiC composite, GO/Cu2O, average activity index, minimum inhibitory concentration, MIC, values, cell numbers, Bacillus subtilis, Brevibacillus brevis, Bacillus thuriginesis, Pseudomonas aeruginosa, Escherichia coli, Candida albicans, antimicrobial, efficiency, blade-like GO/Cu2O, scanning electron microscopy, cell membranes, disrupting, shape, morphology, GO, nanosheets, increase, Cu2O, dispersion, aqueous, solution, prevent, agglomeration, stabilize, action, aqueous, solution, microbial, toxicity]]\n",
      "[[biomedical research, cell culture, contamination, experimental failure, Contamination, sources, concomitant, remedies, numerous, manage, cases, uncommon, contamination, cell cultures, determination, eradication, case, infection, human adenovirus C, pharyngeal tonsils, isolation, primary, viral contamination, in vitro, cell cultures, symptomless, contamination, pervasive, persistent, spread, flow cabinets, apparatus, research projects, loss, sources, Eradication, formalin gas, sterilization, flow cabinet, elimination, infected, cell lines, biobank, PCR-guided, determination, spore-forming bacterium, Brevibacillus brevis, cell culture facility, bacterium, contaminated, pipes, spread, aseptic culture techniques, survival, bacterial spores, ethanol, B brevis, overgrew, cultures, days, seeding, primary cells, Chlorine solution, killed, spore-forming bacterium, cases, contamination, DNA sequencing, deployment, targeted, aseptic techniques, elimination, persistent, contamination]]\n",
      "[[Brevibacillus brevis, GZDF3, gram-positive, plant, PGPR, isolated, rhizosphere, soil, Pinellia ternata, herb, traditional, Chinese medicine, GZDF3, strain, active compounds, siderophores, metabolite, non-ribosomal peptide synthetase (NRPS, independent, non-ribosomal peptide synthetase, activity, study, investigate, siderophore, characteristics, conditions, Bacillus sp. GZDF3, antibacterial activity, siderophores, pathogenic, fungi, investigated, Optimal, synthesis, siderophores, single factor method, sucrose, asparagine 2, degrees, sucrose, increased, production, siderophores, effects of, metal ions, siderophore, production, Fe(3+), Cu(2+), inhibited, synthesis, siderophores, preliminary, separation, purification, siderophores, immobilized-metal affinity chromatography, IMAC, antibacterial activity, Candida albicans, synergistic, siderophores, amphotericin B, results, GZDF3, strain, amount, siderophores, antagonistic activity, development, biological control agents]]\n",
      "[[Fluorophores, SYTO, propidium iodide, PI, medicine, food industry, environmental, monitoring, assess, viability, bacteria, actual, performance, dyes, effects, physiology, cells, characterized, effects, dyes, Brevibacillus brevis, optimized, staining, SYTO, cells, PI, cell wall, cell, results, amount, dyes, physicochemical properties, membranes, improving, breakthrough, results, perspectives, improving, characterization, bacterial, viability, flow cytometry]]\n",
      "[[study, reports, designing, low-cost, colorimetric, fluorometric, sensor, cellulose-based materials, detection, determination, Fe(III), powder cellulose, filter paper, PCel, fluorescent, modified, hexamethylene diisocyanate, HMDI, 4-sulfo-1,8-naphthalimide (Nap, Fluorescent, Cel-Nap, PCel-Nap, materials, spectroscopic detection, Fe(III), working range, sensor, 1.0x10(-5)-4.5x10(-5)M, LOD, Antimicrobial, properties, cel-based compounds, Ag(I)-containing compounds, tested, bacteria, Bacillus cereus, Streptococcus mutans, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, fungi, Candida albicans, Candida tropicalis, materials, antimicrobial effects, antifungal, properties, effective, antibacterial, properties]]\n",
      "[[evaluate, antimicrobial activity, physical characteristics, citral, microencapsulated, dextrin, Dx, spray drying, encapsulation, response surface methodology, RSM, yield, efficiency, variables, citral, inlet, Yield, efficiency, optimal, conditions, Antimicrobial activity, Escherichia coli, Salmonella enterica, Staphylococcus aureus, Bacillus cereus, citral, microparticles, optimal, conditions, free, citral, evaluated, disk diffusion methodology, compounds, Escherichia coli, Bacillus cereus, sensitive, microorganisms, inhibition ratio, antibacterial activity, maintained, microencapsulation, inhibitory, concentrations, free, citral, optimal, citral, microparticles, physicochemical characteristics, broad-spectrum antimicrobial activity, Polymer, emulsifier, microencapsulation, functional activity, citral, microparticles, design, antimicrobial food systems, shelf, life, perishable, foods]]\n",
      "[[Bacillus cereus, human, pathogenic bacterium, emetic, diarrheal, foodborne diseases, study, evaluated, genetic, toxigenic, diversity, B. cereus, group, isolates, powdered foods, public, educational institutions, bakeries, powdered food companies, Medellin, Colombia, B. cereus, detected, powdered food samples, B. cereus, isolated, presence, toxin genes, hblCDAB, nheABC, cytK2, entFM, cesB, evaluated, isolates, multiplex PCR, nheABC operon, isolates, hblCDAB, hblCDA, hblCD, cytK2, gene, detected, isolates, entFM, cesB gene, detected, presence, toxin genes, profiles, identified, toxigenic, toxin genes, cesB., genetic diversity, GTG5 fingerprinting, isolates, grouped, clusters, clustering, relationship, toxigenic, profiles, genetic clusters, genetic clusters, powdered food types, results, genetic, enterotoxigenic, diversity, B. cereus, group, isolates]]\n",
      "[[Quorum sensing, QS, communication system, bacteria, biological functions, cell, density-dependent, Gram-negative, Chromobacterium violaceum, acyl-homoserine lactone, QS, regulate, behaviors, production, proteases, hydrogen cyanide, antimicrobial compounds, violacein, metabolomic, proteomic approaches, QS, modulates, production, antimicrobial, toxic compounds, C. violaceum ATCC 12472, evidence, anisomycin, antibiotic, production, strain, evidence, regulation, QS, AHLs, C. violaceum ATCC 12472, targeting, AHLs, lactonase, QS, disruption, significant, molecular, phenotypic, changes, modifications, drastic changes, social interactions, C. violaceum, Gram-positive bacterium, Bacillus cereus, yeast, Saccharomyces cerevisiae, immune cells, murine macrophages, animal model, planarian Schmidtea mediterranea, results, AHL-based, QS, capacity, C. violaceum, interact, micro-, macroorganisms, quorum quenching, microbial, population, dynamics, AHL-producing, bacteria, Gram-negative bacteria]]\n",
      "[[Cleaning products, live bacteria, spores, Bacillus spp, active substances, probiotic, cleaner formulation, quality, cleaning, performance, production, probiotic, cleaners, potential, bacterial strains, chemical components, formulations, study, surfactants, additives, investigated, biocidal, bacteriostatic, B. subtilis, viability, B. subtilis, pH ranges, microbial, cleaner formulation, result, B. subtilis, microbial, cleaner formulation, growth, viability, neutral, pH, death phase, pH, antagonistic activity, results, Gram-positive S. aureus, K. pneumoniae, sensitive, bacteria, B. cereus, resistant, bacteria, anionic surfactants, linear alkylbenzene sulfonic acid, sodium lauryl ether sulfate, bacteriostatic, Bacillus spp., cell death, results, usage, bacterial cultures, stabilization, formulations, development, microbial, cleaner formulations]]\n",
      "[[Retail foodservice establishments, FSE, washes, sanitizing agents, fresh, preparation, study, evaluated, efficacy, ozonated water, inactivation, viruses, bacteria, viruses, association, bacteria, surfaces, Boston bibb lettuce, BB, cherry tomatoes, inoculated, viruses, murine norovirus, MNV, MS2 bacteriophage, bacteria, Enterobacter cloacae, Bacillus cereus, MNV, associated with, E. cloacae, B. cereus, inoculation, degrees, virus, virus + bacteria, virus, bacteria, treatment, batch, ozone sanitation system, BWOSS, ice, degrees, ozone, concentration, ozone, samples, treated, ozonated water, water-only wash, samples, Samples, microbial, recovery, plaque, PFU, colony forming units, microbial, reductions, ozone, treatments, statistically significant, detected, comparing, ozonated water, water-only wash, log reduction, MNV, bacteria, MNV, BB, ozonated water wash, MNV, B. cereus, reduction, MNV, PFU/ml, ozonated water, increase, microbial, inactivation, water, conditions, Variables, ozone wash, effectiveness, implementing, sanitation systems, FSE]]\n",
      "[[B. cereus, human, pathogen, associated with, food poisoning, gastrointestinal disorders, local, severe, systemic infections, pathogenic spectrum, B. cereus, ranges, strains, probiotics, humans, lethal, toxic, strains, study, collection, strains, representative, pathological, diversity, B. cereus, humans, characterized, strains, cytotoxic, potential, human cells, analyzed, correlation, cytotoxicity, epithelial, macrophage cells, combination, genes, suspected, B. cereus, virulence, genetic differences, isolates, correlations, genetic signature, cytotoxicity, strain, pathological, findings, pathogenicity, B. cereus, improve, clinical diagnosis, food safety]]\n",
      "[[problem, antibiotic resistance, extensive, search, novel, antibiotics, research, priorities, antibiotics, genus, Streptomyces, river, sediments, Bangladesh, source, antibiotic-producing bacteria, APB, study, isolate, novel, APB, Padma, Kapotakkho, river, sediments, potential, antibacterial compounds, scaffolds, self-protection mechanisms, antibiotic, starch-casein-nitrate agar, SCNA, isolate, antibiotic-resistant, APB, river, sediments, colonies, Streptomyces-like morphology, purified, antagonistic activity, screened, test bacteria, cross-streaking method, decrease, colony-forming units, CFUs, antibiotic, SCNA, plates, control plates, antibiotics, absent, observed, azithromycin, resistant, AZR, meropenem, resistant, MPR, isolates, purified, antagonistic activity, investigated, test bacteria, Shigella brodie, Escherichia coli, Pseudomonas sp., Proteus sp., Staphylococcus aureus, Bacillus cereus, AZR, isolates, MPR, isolates, moderate, broad-spectrum activity, isolates, 16S rDNA sequencing, NAr5, NAr6, species, level, analyses, sequences, revealed, genus, Streptomyces, results, studies, manipulation, self-resistance property, APB, novel, APB, potential, antibacterial compounds, scaffolds]]\n",
      "NaN\n",
      "[[Longstanding, industrial, 1-chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene, DDT, environmental threat, Salamanca city, central Mexico, Native bacteria, location, isolated, identified, potential, DDT, biodegradation, isolates, cell lysates, analyzed, matrix-assisted laser desorption/ionization-time of flight mass spectrometry, MALDI-TOF MS, Biotyper(TR, organisms, identified, species, level, genus, abundant, species, Bacillus, Pseudomonas genera, bacteria, grow, presence, DDT, Two-week, exposure, Lysinibacillus fusiformis, Bacillus mycoides, Bacillus pumilus, Bacillus cereus, DDT, pesticide degradation, bacteria, degradation, Gas chromatography-mass spectrometry, GC-MS, analysis, spent media, isolates, conversion, DDT, DDD, DDE, DDMU, 1,1-(2-chloro-1,1-ethenediyl)-bis-(4-chlorobenzene, DDNU, DBP, DBH, bis(4-chlorophenyl)methanol, L. fusiformis, B. mycoides, B. cereus, B. marisflavi, B. megaterium, context, DDT, biodegradation, isolates, studies, experimental conditions, efficient, mineralization, DDT, congeners]]\n",
      "[[Biosurfactants, amphipathic, surface, potential, microorganisms, Biosurfactant, production, Lysinibacillus fusiformis, MK559526, isolated, automobile-mechanic-shop, soil, investigated, potential, production, potential, optimization, Effects of, carbon, nitrogen, sources, pH, temperature, incubation, periods, biosurfactant, production, evaluated, processes, Fourier Transform Infra-Red absorption peaks, Gas chromatography mass spectrometry, functional groups, chemical, make-up, chemical profile, biosurfactant, Lysinibacillus fusiformis surfactant, emulsification index, oil, displacement, zone, haemolysis, positive, Optimized, culture conditions, biosurfactant, production, temperature, masculineC, pH, starch solution, urea, reduction, surface tension, increased, emulsification index, Maximum, biosurfactant, production, biosurfactant, peptides, fatty acids, predominant, fatty acid, 9-Octadecenoic acid, results, emulsification, potential, reduction, surface tension, biosurfactant, attributes, Lysinibacillus fusiformis, MK559526, biosurfactant, production]]\n",
      "[[traits, genus, recognition, agricultural, relevance, genus, Lysinibacillus, studied, study, in vitro, in vivo, planta, in silico, approaches, Lysinibacillus fusiformis strain S4C11, isolated, roots, apple tree, northern Italy, in vitro, in vivo assays, strain, S4C11, antifungal activity, fungal, pathogens, interfering, germination, Botrytis cinerea conidia, inhibiting, growth, production, volatile organic molecules, planta assays, strain, promote, plant growth, host-specific, controlled conditions, commercial nursery, Biocontrol assays, phytopathogenic viruses, results, strain, activate, host's, defense pathways, in silico analyses, sequencing, genome, strain, Illumina, High-Definition Mapping methods, reconstruction, chromosome, plasmids, strain S4C11, analysis, genes, encoded, genome, characterization, strain, detecting, genes, biocontrol, effect, detected, experimental trials]]\n",
      "[[Secondary, metabolites, Bacillus subtilis, increased, competitiveness, microorganisms, nonribosomal peptides, NRPs, antimicrobial, potential, cell lysis, perforation, fungal membranes, enzyme inhibition, disruption, bacterial protein, synthesis, knowledge, in vitro, B. subtilis, microbial, monocultures, ecological, small molecules, study, semisynthetic mock, communities, genera, supplemented, B. subtilis, P5_B1 WT, NRP-deficient strain sfp, single-NRP mutants, surfactin, plipastatin, bacillaene, 16S amplicon sequencing, invasion, NRP-producing, B. subtilis, strains, impact, bacterial, communities, abundance, genera, Lysinibacillus, Viridibacillus, reduced, effect, diminished, communities, NRP-deficient strain, Growth profiling, Lysinibacillus fusiformis M5, B. subtilis, strains, surfactin, sensitivity, strain, biosurfactant, surfactin, study, influence, B. subtilis, NRPs, semisynthetic, bacterial, communities, ecological]]\n",
      "[[bacterial species, isolated, whole body extracts, wax moth, larvae, Galleria mellonella, evaluated, low-density polyethylene, LDPE, carbon, source, in vitro, bacteria, Lysinibacillus fusiformis, Bacillus aryabhattai, Microbacterium oxydans, biodegrade, LDPE, assessed, growth curves, cell biomass, production, polyethylene, PE, weight loss, presence, LDPE, hydrolysis, products, growth media, Consortia, bacteria, bacteria, LDPE, Cupriavidus necator H16, Pseudomonas putida LS46, Pseudomonas putida IRN22, tested, Growth curves, bacteria, LDPE, carbon, source, cell density, Cell, densities, declined, increased, extents, bacteria, Incubation, LDPE, bacteria, isolated, wax moth, larvae, effects, bacterial cell, weight loss, LDPE, PE-containing media, bacterial consortia, LDPE, individual, species, Gas chromatographic analyses, presence, linear alkanes, LDPE, hydrolysis, products, bacterial culture media]]\n",
      "[[effect, milk, bactofugation, counts, microbial, diversity, mesophilic, MT, psychrotrophic, PT, thermophilic, TT, thermoduric bacteria, potential, technological method, spoilage, microorganisms, resistant, pasteurization, batches, raw, milk, dairy farms, sets, B, evaluated, technological process, raw milk, preheated, degrees, bactofugation, effect, bactofugation, comparing, counts, raw, preheated, bactofuged milk, centrifugation, reduce, isolation, MT, preheated milk, PT, reduction, batch, TT, higher, detection, limits, diversity, isolates, molecular approach, species, contaminating, thermoduric bacteria, identified, raw, preheated milk, species, bactofuged milk, MT, bactofuged milk, species, Lysinibacillus fusiformis, Bacillus licheniformis, species, endospore-forming psychrotrophs, proteolytic, lipolytic activity, bactofugation, raw, milk, reduced, isolates, B. licheniformis, Bacillus toyonensis, Micrococcus aloeverae, Aestuariimicrobium kwangyangense, reduced, isolates, Macrococcus caseolyticus, Lysinibacillus varians, Carnobacterium divergens, Microbacterium hominis, Kocuria indica, Micrococcus yunnanensis, Gordonia paraffinivorans, Bacillus invictae, Kocuria kristinae, undetectable, levels, results, study, bactofugation, dairy industry, pasteurization-resistant, microorganisms, combination, prophylactic measures, prevent, contamination, raw, milk, spores, vegetative forms, bacteria]]\n",
      "[[polymicrobial disease, sour rot, decreases, grape, berry, yield, wine, quality, diversity, microbial, communities, sour, rot-affected, grapes, cultivation, site, microbes, disease, eastern coastal China, microbes, sour grape rot, grape-producing region, diversity, abundance, bacteria, fungi, assessed, metagenomic analysis, cultivation-dependent techniques, bacteria, fungi, isolated, sour, rot-affected, grapes, High-throughput sequencing, PCR-amplicons, diseased, grapes, OTUs, bacteria, OTUs, fungi, Proteobacteria, Firmicutes, dominant, phyla, bacterial phyla, identified, Ascomycota, dominant, fungal, phylum, fungi Issatchenkia terricola, Colletotrichum viniferum, Hanseniaspora vineae, Saprochaete gigas, Candida diversa, ofmicrobial species, associated with, sour, rot-affected, grapes, in vitro, spoilage, isolated, bacteria, strains, Cronobacter species, Serratia marcescens, Lysinibacillus fusiformis, isolated, fungi, strains, Aspergillus species, Alternaria tenuissima, Fusarium proliferatum, spoiled grapes, microorganisms, grapes, eastern China, microbes, plant disease, world]]\n",
      "[[mangrove, Rhizophora mucronata, endophytic bacteria, investigated, glutaminase-free L-asparaginase, study, glutaminase-free L-asparaginase-producing, endophytic bacteria, mangrove, enzyme, production, screening, L-asparaginase-producing bacteria, modified M9 medium, potential, analyzed, species, 16S rRNA, gene sequencing, Taguchi experimental design, enzyme, production, factors, L-asparagine, concentration, pH, temperature, inoculum, concentration, levels, results, endophytic bacteria, Lysinibacillus fusiformis B27, isolated, R. mucronata, glutaminase-free L-asparaginase, experiment, pH, temperature, inoculum, concentration, production, essential factors, L-asparagine, optimum, production, L. fusiformis B27, isolated, Rhizophora mucronata, optimized, L-ASNase enzyme, production, optimization factors, L-ASNase, pH, temperature, inoculum, increase, L-ASNase enzyme, production]]\n",
      "[[study, evaluate, composition, microbiota, irreversible pulpitis, primary endodontic infections, clinical, radiographic, findings, cultures, 16s rDNA sequencing, Iranian, patients, cross-sectional study, samples, root canals, groups, patients, Bacterial, identification, polymerase chain reaction, PCR, 16s rDNA sequencing, aerobic, anaerobic, cultivable, colonies, patients, culture plates, presence, bacterial species, nonbacterial species, PCR, species-specific primers, microbial, species, fungus, Candida albicans, Herpes simplex virus, isolated, Species, highest, prevalence, Dialister invisus, Porphyromonas gingivalis, Streptococcus salivarius, Treponema denticola, Lysinibacillus fusiformis, detected, root canals, Candida albicans, cases, Herpes simplex virus, HSV, patients, results, Gram-negative, anaerobic, oral bacteria, microbes, primary endodontic infections, combinations, bacterial species, clinical, radiographic, conditions, Lysinibacillus fusiformis, detected, primary, endodontic infections, results, investigation, clinicians, suspected, endodontic pathogens, etiology, pulpal, periradicular diseases, therapeutic measures]]\n",
      "[[study, investigate, effect, biofertilizers, structure, diversity, rhizosphere, bacterial, community, maize, biofertilizers, maize, physical, chemical, properties, rhizosphere, soil, samples, analyzed, rhizosphere bacteria, analyzed, 16S amplicon sequencing, results, treatment, Bacillus licheniformis, B. amyloliquefaciens, biofertilizers, increased, soil, organic matter, SOM, nitrogen, total phosphorus, TP, phosphorus, AP, potassium, AK, contents, plant, biofertilizers, host, plant, root exudates, return, communities, sugars, amino acids, organic acids, vitamins, polymers, rhizosphere, maize, treated with, B. subtilis, biofertilizer, diversity, richness, rhizosphere, treated with, bacterial, lowest, diversity, richness, directional, increase, abundance, bacteria, functions, decrease, bacterial, community, diversity, soil, dominant, bacterial phyla, Proteobacteria, Acidobacteria, Actinobacteria, Gemmatimonadetes, dominant, bacterial species, Aciditerrimonas ferrireducens JCM 15389 (, Gemmatimonas aurantiaca, Pyrinomonas methylaliphatogenes, bacterial functions, associated with, amino acid metabolism, sugar metabolism, energy metabolism pathways, results, redundancy analysis, SOM, TP, AK, factors, affecting, microbial, community structure, maize, rhizosphere, application, biofertilizers, increased, diversity, richness, bacterial, community, maize, rhizosphere, soil, strain, treatment, failed, lowest, abundance, diversity]]\n",
      "[[Heat stroke, models, rats, associated with, severe, intestinal injury, event, HS, Probiotics, regulate, gut microbiota, inhibiting, colonization, bacteria, promoting, proliferation, bacteria, investigated, preventive effects, probiotic, Bacillus licheniformis strain, BL, CMCC 63516), HS, rats, effects, intestinal barrier, gut microbiota, rats, groups, control, Con, PBS, pre-administration, PBS, day, days, HS, induction, Con, BL, group, pre-administration, BL, day, days, HS, induction, HS + PBS, PBS, HS, induction, HS, BL, BL, HS, induction, study, BL, strain, genomic DNA analysis, Experimental HS, induced, rats, hot, humid chamber, diagnostic criterion, HS, onset, Body weight, core body temperature, survival rate, biochemical, markers, inflammatory cytokines, histopathology, investigated, evaluate, preventive effects, BL, HS, D-Lactate, I-FABP, endotoxin, tight-junction proteins, investigated, fluorescein isothiocyanate-dextran (FD-4) test, administered, assess, degree, intestinal injury, integrity, Gut microbiota, rats, group, analyzed, 16S rRNA sequencing, results, pre-administration, BL, attenuated, hyperthermia, reduced, HS-induced death, multiple-organ injury, decreased, levels, serum, inflammatory cytokines, BL, sustained, intestinal barrier, integrity, HS, rats, intestinal injury, improving, tight junctions, BL, increased, ratios, probiotic bacteria, Lactobacillus, Lactococcus, Romboutsia, biomarker, HS, diagnosis, detected, BL, pre-administration, days, preventative, effects, HS, intestinal barrier, modulating, gut microbiota]]\n",
      "[[Fermented soybean products, Asian, countries, northeastern, India, agents, interruption, Severe, Acute Respiratory Syndrome, Coronavirus 2, SARS-CoV-2, S1, human, angiotensin-converting enzyme 2, interactions, in silico, antiviral prospective, peptides, identified, proteome, kinema, investigated, Soybean, fermented, Bacillus licheniformis KN1G, Bacillus amyloliquefaciens KN2G, strains, Bacillus subtilis, KN2B, KN2M, peptides, screened, in silico, antiviral activity, web servers, AVPpred, meta-iAVP, binding interactions, peptides, receptor-binding domain, RBD, S1 protein, PDB, ID, molecular docking, ZDOCK, results, peptide ALPEEVIQHTFNLKSQ, P13, B. licheniformis, KN1G fermented kinema, contacts, binding motif, RBD, blocking, residues, GLN493, ASN501, binding, human, cell receptor, peptide, affinity, human, toll, receptor 4, Differentiation factor 2, MD2, PDB, ID, cytokine storm, energy properties, docked complexes, analyzed, Generalized Born model, Solvent Accessibility method, MM/GBSA, HawkDock server, results, peptidyl amino acids, GLU5, GLN8, PHE11, LEU13, P13-RBD binding, ARG90, PHE121, LEU61, PHE126, ILE94, significant, P13-TLR4/MD2 complex, findings, study, peptides, fermented soy, B. licheniformis KN1G, potential, antiviral agents, peptide, ALPEEVIQHTFNLKSQ, synthesized, combination, experimental studies, effect, SARS-CoV-2-hACE2, interaction, modulation, TLR4, activity, protein hydrolysate, peptides, prophylaxis, viral diseases, COVID-19]]\n",
      "[[unconventional infectious agents, transmissible spongiform encephalopathies, TSEs, prions, infectivity, co-appears, PrP(Sc, aberrant, depositions, host's, cellular prion protein, PrP(C, heat, treatment, presence, detergent, proteolysis, keratinase, Bacillus licheniformis, PWD-1, PrP(Sc, bovine, TSE, BSE, sheep, scrapie, diseased, brain, data, reduction, infectivity, lacking, transgenic Tgbov XV, mice, BSE, susceptible, quantify, infectivity, bovine, brain, immunochemical analyses, compare, levels, PrP(Sc, heating, degrees, proteolysis, BSE, infectivity, ID50, reduced, infectivity, 10(4.6, ID50, strain, characteristics, unaltered, precipitation, methanol, PrP(Sc, depletion, loss, infectivity, treatment, prion strains, CWD1, bank voles, K scrapie, hamsters, sheep PG127, scrapie, tg338, ovinized, strains, infectivity, heat, findings, heat resistance, BSE, factor, prion formation, prions, PrP(C, Leftover material, PrP(Sc, depleted, BSE, preparation, unique, substrate, elements, prion, infectivity, improving, concept, prions]]\n",
      "[[Probiotics, documented, health benefits, balanced, intestinal, immunity, study, effects, probiotic, Enzimsporin(TM, spore-forming bacteria, Bacillus subtilis B-2998D, B-3057D, Bacillus licheniformis B-2999D, biochemical, hematological, immunological, parameters, intestinal microbiota, growth, dynamics, sheep, lambs, Materials, Methods, Enzimsporin, lambs, sheep, doses, bacteria, probiotic, effects, Sheep, groups, Enzimsporin/per head/day, groups, lambs, Enzimsporin/per head/day, days, ration, day, blood samples, determination, biochemical, hematological, natural resistance, indicators, Fecal samples, intestinal microflora, animals, growth, dynamics, Supplementation, probiotics, Enzimsporin(TM, improved, lambs' body weight, Analysis, clinical, parameters, improvements, levels, total protein, globulins, urea, blood, probiotic-supplemented, lambs, increment, total protein, albumins, globulins, sheep, Enzimsporin(TM, supplementation, decrease, bilirubin, cholesterol levels, blood, increased, bactericidal, phagocytic index, sheep, lambs, probiotic, supplementation, positive, influence, Enzimsporin(TM, liver function, natural resistance, increase, Lactobacillus, Bifidobacterium, decrease, Escherichia coli, Enterococcus, Yeast, fecal, contents, experimental, sheep, lambs, potentiality, Enzimsporin(TM, gut health, Spore-forming bacteria, B. subtilis, B-2998D, B-3057D, B. licheniformis B-2999D, feeding, sheep, lambs, months, age, increase, body weight, intestinal microbiota, immune system, normal, metabolic processes]]\n",
      "[[Bacillus licheniformis, pathogen, peritonitis, peritoneal dialysis, PD, patients, immunosuppressed, traumatized, patients, lady, treated, peritonitis, outpatient, empirical therapy, PD culture, Bacillus licheniformis, hours, intraperitoneal, IP, vancomycin, weeks, patient, clinically, stable, course, therapy, resolution, symptoms, case, Bacillus peritonitis, automated, APD, patient, clinical, biochemical, improvement, evidence, relapse, recurrence]]\n",
      "[[Antioxidant activity, Klunzinger's mullet, Liza klunzingeri, hydrolysates, Bacillus licheniformis fermentation, enzymatic, hydrolysis, Hydrolysates, days, fermentation, B. licheniformis, free, metal chelating ability, ferric, FRAP, Microbial, fermentation, percentage, small peptides, higher, solubility, compared, Alcalase, hydrolysis, Hydrolysates, antioxidant, attenuated, serum, liver, kidney oxidative stress, biomarkers, male, Wister, rats, stressed, carbon tetrachloride, oral administration, hydrolysates, increased, serum, renal, hepatic, TAC, reduced, elevated, levels, malondialdehyde, MDA, nitric oxide, NO, serum liver enzymes, AST, ALP, ALT, hydrolysates, hepatic damage, necrosis, fatty changes, inflammation, Results, antioxidant, hepato-toxic, protective activities, Klunzinger's mullet muscle, hydrolysates, microbial, fermentation, functional food ingredient]]\n",
      "[[Bacteria, solubilize, nutrients, soil, bio-inoculants, promoting, growth, crop, species, influence, potassium, solubilizing bacteria, KSB, saxicolous habitat, rock-dwelling, plant growth, study, isolated, KSB, saxicolous habitats, estimated, plant growth hormone, organic acids, siderophore, plant growth, culturable, saxicolous, bacterial, isolates, K solubilizing ability, isolated, sites, potential, K, solubilizers, identified, 16S rRNA, gene sequencing, bacterial, isolates, Bacillus subtilis, Bacillus cereus, Bacillus licheniformis, Burkholderia cenocepacia, organic acids, indole acetic acid, siderophore, in vitro, conditions, Potassium solubilization, bacterial, isolates, influenced, K, sources, Inoculation, KSB, improved, tomato, plant, parameters, plant height, leaf, root/shoot ratio, tissue K, content, sterilized, unsterilized Alfisol, Vertisol soils, greenhouse, conditions, residual, K, content, KSB, inoculated, post-harvest, soils, KSB, isolates, screened, B. licheniformis, B. cenocepacia, excellent, bio-inoculants, improving, tomato, growth, soil, K, content, post-harvest, soils, growth, crops, sustainable agriculture]]\n",
      "[[Chitinases, catalyze, degradation, chitin, polymer, N-acetylglucosamine, crustacean shells, insect, cuticles, fungal cell walls, development, improved, chitinases, environmental, burden, chitin, waste, food processing, industry, potential, medical, agricultural, industrial, deacetylated, chitosan, products, chito-oligosaccharides, depolymerization, chitin, chemical, physical treatments, enzymatic process, sustainable, chitinases, slow-acting enzymes, biotechnological, exploitation, molecular evolution approaches, enhance, features, applications, goals, study, development, high-throughput screening system, chitinase activity, hydrolytic, enzymes, deployment, method, chitinase, variants, cloned, expressed, Bacillus licheniformis DSM8785 chitinase A, Escherichia coli BL21, cells, mutant library, error-prone PCR, screening method, fluorescence-activated cell sorting, FACS, model, substrate, 4-methylumbelliferyl beta-d-N, N',N''-triacetyl chitotrioside, improved, enzymes, cross-talk, emulsion, compartments, hydrophobicity, 4-methylumbelliferone, fluorescent product, enzymatic reaction, cyclodextrins, aqueous, phases, toxicity, long-term, chiA, expression, E. coli, reaction, time, mutants, mutations, gene, activity, wild-type]]\n",
      "[[study, investigated, effects of, dietary, C. butyricum, ZJU-F1, apparent, digestibility, nutrients, intestinal barrier function, immune response, microflora, weaned, piglets, theoretical, application, Clostridium butyricum, alternative, antibiotics, weaned, piglets, weanling, piglets, treatment groups, piglets, fed, basal diet, antibiotics, CON, Bacillus licheniformis, BL, Clostridium butyricum, ZJU-F1, CB, Clostridium butyricum, Bacillus licheniformis, CB-BL, results, CB, CB-BL, treatment, increased, intestinal, digestibility, nutrients, decreased, intestinal permeability, increased, intestinal, mucin, expression, integrity, intestinal, epithelial barrier, CB, CB-BL, exogenous, probiotics, stimulate, immune response, weaned, piglets, improve, expression, antimicrobial peptides, ileum, dietary, CB, CB-BL, increased, proportion, Lactobacillus, levels, butyric acid, propionic acid, acetic acid, total acid, increased, ceca, piglets, fed, CB, CB-BL, effects, C. butyricum, ZJU-F1, intestinal barrier, immune response, in vitro, C. butyricum, ZJU-F1, improved, intestinal function, enhanced, TLR-2-MyD88-NF-kappaB signaling]]\n",
      "[[Background, Plant, Growth-promoting Bacteria, PGPB, chemical, fertilizers, pesticides, study, isolate, PGPBs, Lycopersicon esculentum, plant, volume, inoculation, Materials, Methods, Plants, samples, tomato, fields, Nitrogen fixing-PGPBs, isolated, rhizoplane, rhizosphere, isolates, screened, growth, abilities, examined, PGPB, traits, phosphate solubilization, IAA, ammonia, HCN, production, cell density, cultivation, cells, centrifugation, freeze dried, resuspension, cryoprotectant, powders, inoculated, sterile soil, dose, 10(8) CFUs/g, Tomato, Lycopersicon esculentum, seeds, sown, soil, days, shoot, length, measured, PGPBs, growth, isolated, rhizoplane, Maximum, phosphate solubilization, NFB12, isolated, rhizoplane, strain, maximum, level, IAA, NFB12, ammonia, production, HCN, strain, enhanced, shoot, length, dosed, dependent, inoculation, soil, 10(8) CFUs/g, decreased, shoot, length, molecular approach NFB12, Bacillus megaterium, Isolation, PGPBS, plant, production, results, NBF12, tomato, plant growth, effect, tomato, plant growth, dependent, Maximum, growth, rate, tomato, soil, inoculation, NFB12, higher, inoculation, negative, effect]]\n",
      "[[heavy metal, prevent, vegetables, absorbing, measure, control heavy metal-polluted, vegetable fields, production, vegetables, experiment, planting, succession, study, effects, Bacillus megaterium N3 (N3, rice husk, biochar, BC, sheep, manure, organic fertilizer, SM, strain N3, biochar, BC+N3, strain N3, sheep manure, SM+N3, Cd, uptake, functional stability, lettuce, heavy metal passivator, planting, comprehensive, applicability, passivation, materials, evaluated, dynamic weighted comprehensive function, results, lettuce, planted, compared, control, heavy metal passivators, Cd, content, edible part, lettuce, cultivation, lettuce, SM+N3, Cd, uptake, lettuce, SM+N3, functional stability, dynamic weighted comprehensive function, evaluate, Cd, content, edible part, fresh lettuce, Cd, content, soil, yield, remediation, cost, results, comprehensive, applicability, SM+N3, SM, BC+N3, BC, comprehensive, evaluation, strain N3, results, study, theoretical basis, technical support, remediation, heavy metal-contaminated]]\n",
      "[[Cytochrome P450 enzymes, years, insert oxygen, saturated carbon-hydrogen bonds, chemistry, activity, field, bacterial, CYP102A1, BM3, Bacillus megaterium, hydroxylating/acting, substrates, industrially, relevant, pharmaceuticals, chemicals, hormones, cytochromes, BM3, soluble, fused, natural, industrial, BM3, instability, requirement, NADPH cofactor, mutations, BM3 mutant, R966D/W1046S, enhanced, turnover, inexpensive, cofactors, NADH, NBAH, mutations, A769S, S847G, S850R, E852P, V978L, localized, reductase domain, BM3, oxidase domain, intact, NBAH-driven reactions, mutant, NTD5, increase, output, BM3 mutant, R966D/W1046S, reactions, NADH, mutant, NTD6, output, BM3 mutant, R966D/W1046S, reactions, NADH, NTD6, mutant, output, wild-type, BM3, NADPH, cofactor, output]]\n",
      "[[natural, biodegradable, polyhydroxyalkanoate, PHA, adjuvanted, vaccine, seed, biomaterial's, ability, enhancing, immune response, rats, adjuvant, potential, PHA, tested, whole-killed, Pasteurella multocida B:2, PMB2, vaccine, Sprague Dawley, SD, rats, detect, changes, serum immunoglobulin G (, IgG, immunoglobulin M, IgM, responses, PHA, poly(3-hydroxybutyrate, P(3HB, Bacillus megaterium, UMTKB-1, microparticles, solvent evaporation method, SD, rats, treatment groups, non-treatment, negative control, adjuvant, PMB2, vaccine, adjuvanted-P(3HB)/PMB2 vaccine, groups, intramuscularly, vaccinated, Immunoglobulins IgG, IgM, levels, markers, immune response, induced, adjuvanted-P(3HB)/PMB2 vaccine, analysed, eight-week study, period, group, vaccinated, adjuvanted-P(3HB)/PMB2 vaccine, higher, concentrations, immunoglobulins, compared, treatment groups, potential, adjuvant, immune response, Findings, delay, delivery, booster, dose, regime, adjuvanted-P(3HB)/PMB2 vaccine]]\n",
      "[[Endophytic bacteria, abilities, promoting, plant growth, suppressing, phytopathogens, agriculture, biofertilizers, biocontrol agents, Bacteria, canola, roots, isolated, screened, plant growth promotion, PGP, traits, biocontrol, Sclerotinia sclerotiorum, isolates, Bacillus, Paenibacillus, Lysinibacillus, Microbacterium genera, isolates, auxin, siderophores, hydrolytic enzymes, fixed nitrogen, solubilized, phosphate, isolates, antifungal activity, S. sclerotiorum, dual culture assay, inhibited, fungal growth, volatile organic compounds, production, antagonistic, isolates, Bacillus genus, genomes, sequenced, search, biosynthetic gene clusters, BGC, antimicrobial, metabolites, isolates, Bacillus safensis, Bacillus pumilus, Bacillus megaterium, genomic metrics, ANI, dDDH, strains, BGCs, bacteriocin, polyketide synthase, PKS, non-ribosomal peptide synthetase (NRPS, pumilacidin, bacillibactin, bacilysin, antimicrobial compounds, Pumilacidin-related mass peaks, detected, acid precipitation extracts, MALDI-TOF analysis, genomic features, potential, isolates, suppression, plant, pathogens, plant-bacterial, interactions]]\n",
      "[[porous, ceramic/agarose composite beads, Ni-NTA Cerose, carrier materials, immobilize, enzymes, metal, affinity, fusion alcohol dehydrogenase, Mu-S5, glucose dehydrogenase, Bacillus megaterium, BmGDH, co-immobilized, Ni-NTA Cerose to construct, packed bed reactor, PBR, continuous synthesis, chiral intermediate (S)-(4-chlorophenyl)-(pyridin-2-yl) methanol, NADPH, recycling, in situ product, adsorption, simultaneously, D101 macroporous resin column, PBR, optimum, enzyme activity, Mu-S5, BmGDH, hydroxypropyl-beta-cyclodextrin, co-solvent, space-time, days, flow rate, substrate, concentration, adsorption, extraction procedures, isolated]]\n",
      "[[study, investigate, effects, Bacillus megaterium, growth performance, serum, biochemical, parameters, antioxidant capacity, immune function, suckling calves, Holstein calves, body weight, BW, health condition, groups, replicates, group, calf, replicate, control group, CON, group, fed, basal diet, B. megaterium group, BM, group, fed, basal diet, mg/day/head, B. megaterium, CFU/g, days, results, BM, group, increase, BW, daily weight gain, feed-to-gain ratio, decrease, diarrhea, rate, concentrations, serum cholesterol, high-density lipoprotein, decreased, BM, group, compared, CON, group, days, level, serum glutathione, BM, group, CON, group, days, level, serum, decreased, BM, group, compared, CON, group, days, compared, CON, group, concentrations, serum, IgA, IgM, IgG, IL-4, higher, concentration, serum, TNF-alpha, decreased, BM, group, days, B. megaterium, effects, improvement, growth, performance, immune function, intestinal, oxidative status, suckling calves]]\n",
      "[[study, investigate, Bacillus megaterium IBBPo17 (, GenBank KX499518, cells, biosurfactant, growth, presence, long-chain n-alkane n-hexadecane, medium, supplemented, yeast extract, proteose peptone, starch, cellulose, B. megaterium, IBBPo17, growth, presence, n-hexadecane, medium, supplemented, yeast extract, proteose peptone, starch, compared, cellulose, Biosurfactant, production, B. megaterium, IBBPo17, presence, n-hexadecane, yeast extract, proteose peptone, starch, medium, compared, biosurfactant, cellulose, medium, correlation, cell growth, biosurfactant, production, growth, B. megaterium, IBBPo17 cells, decrease, pH values, medium, amount, CO2, released, Changes, cell, morphology, aggregation, cells, clusters, biofilm formation, B. megaterium, IBBPo17, presence, n-hexadecane, medium, supplemented, yeast extract, proteose peptone, starch, cellulose, physiological, abilities, Gram-positive bacterium, bioremediation, petroleum hydrocarbon, polluted, environments]]\n",
      "[[Rhizoctonia root-rot disease, severe, economic losses, crops, Vicia faba, worldwide, biosynthesized, nanoparticles, super-growth promoters, antifungal agents, study, biosynthesized, selenium, nanoparticles, Se-NPs, growth promoters, antifungal agents, Rhizoctonia solani RCMB, in vitro, in vivo, Se-NPs, synthesized, biologically, Bacillus megaterium ATCC 55000, characterized, UV-Vis spectroscopy, XRD, dynamic light scattering, DLS, transmission electron microscopy, TEM, DLS, images, Se-NPs, spheres, diameter, Se-NPs, improved, healthy Vicia faba cv, Giza, seed germination, morphological, metabolic, indicators, yield, Se-NPs, antifungal activity, R. solani, in vitro, in vivo, Results, minimum, inhibition, fungicidal, concentrations, Se-NPs, Se-NPs, decrease, post-emergence, R. solani damping-off, minimize, severity, root rot disease, effective, treatment method, soaking, spraying, spraying, soaking, individually, Se-NPs, improve, morphological, metabolic, indicators, yield, infected, control, biosynthesized, Se-NPs, B. megaterium ATCC 55000, effective, agent, R. solani damping-off, root rot diseases, Vicia faba, plant growth, inducer]]\n",
      "[[Decomposed, organic materials, combination, plant growth-promoting bacteria, PGPB, reduce, synthetic fertilizer, rice, production, bio-organic fertilizer, BoF, kitchen waste, chita-dhan (unfilled rice grain, biochar, rock phosphate, consortium, PGPB, supplement, nitrogen, triple superphosphate, TSP, fertilizer, rice, production, improvement, soil, health, PGPB, local, isolates, identified, 16S ribosomal RNA partial gene sequences, Bacillus mycoides, Proteus sp., Bacillus cereus, Bacillus subtilis, Bacillus pumilus, Paenibacillus polymyxa, Paenibacillus spp, Isolates, N2, solubilize, phosphate, indoleacetic acid, performance, BoF, evaluated, field experiments, farmers, trials, year, parts, Bangladesh, Performances, BoF, evaluated, control, T1, synthetic, dose, N, K (T2, BoF, urea, K, muriate, potash, T3, urea, TSP, K, muriate, potash, T4, treatments, research station, average, grain, improved, T3, compared, T2, treatment, seasons, agronomic, efficiency, physiological, efficiency, partial factor productivity, recovery, efficiency, (RE)N, N harvest index, HIN, agronomic, efficiency, partial factor, productivity, AREP, HIP, T3, compared, T2, treatment, Research results, farmers' field, significant, plant height, tiller, panicle, grain, yield, partial factor, productivity, N, treatment, BoF, soil, organic carbon, increased, PGPB, synthetic fertilizer, dose, tested, BoF, green technology, reduce, synthetic N, TSP, requirements, rice, production, improved, soil, health]]\n",
      "[[study, periodontitis, transient, bacteraemia, associates, bacteria, standard blood donations, cross-sectional study, self-reported, healthy, blood donors, aged, years, standard procedures, whole blood, fractionation, plasma, buffy-coat, red blood cell, (RBC)-fractions, buffy-coat, screened, bacterial, contamination, BacT/ALERT, Samples, plasma, RBC-fractions, incubated, anaerobically, aerobically, degrees, days, trypticase soy blood agar, TSA, identification, colony polymerase chain reaction, primers, targeting, 16S rDNA, donors, periodontitis, bacterial growth, plates, inoculated, plasma, RBCs, plates, inoculated, plasma, RBCs, periodontally healthy controls, bacterial growth, relative risk, CI, donors, positive, bacterial, contamination, BacT/ALERT, Cutibacterium acnes, donations, donors, periodontitis, donations, periodontally healthy, Staphylococcus species, Bacillus mycoides, Aggregatibacter aphrophilus, Corynebacterium kroppenstedtii, detected, Periodontitis, increased, risk, bacterial, contamination, blood products, Contaminating bacteria, associated with, RBC-fraction, BacT/ALERT test, platelet products, routine, screening, detect, bacteria, RBC-fraction]]\n",
      "[[elimination, bacterial endospores, foods, food processing environment, resistance, stresses, sporicidal, treatments, insufficient, contaminating, endospore, population, selection pressure, enhanced, endospore, resistance, sporeforming Bacillus cereus, group, Bacillus weihenstephanensis, food spoilage, organism, potential, cereulide, pathogen, psychrotolerant growth, degrees, endospores, B. weihenstephanensis, heat, resistant, compared, mesophilic, thermotolerant relatives, data, non-emetic, B. weihenstephanensis strain LMG 18989(T), reproducibly, enhanced, endospore, heat, resistance, B. weihenstephanensis, mutants, evolution, wet heat, study, endospores, increase, D-value, degrees, compared, parental, strain, mutant, endospores, superior, heat resistance, sporulation, degrees, increased, endospore, heat, resistance, vegetative growth, capacities, mutants, lower, upper, growth, boundaries, correlation, cardinal, growth temperatures, endospore, resistance, bacterial sporeformers]]\n",
      "[[Flagellar motility, virulence factor, pathogenic bacteria, Listeria monocytogenes, transcriptional repressor, MogR, regulates, motility, temperature-dependent, repressing, chemotaxis genes, bacteria, mogR, homolog, members, Bacillus cereus, group, motile species, B. cereus, Bacillus thuringiensis, non-motile species, Bacillus anthracis, Bacillus mycoides, Bacillus pseudomycoides, motility locus, B. cereus, group bacteria, genes, flagellar synthesis, L. monocytogenes, Bacillus subtilis, phylogenetic group, Bacilli, mogR, ortholog, B. thuringiensis, MogR, overexpression, results, non-motile cells, flagella, Global gene expression profiling, genes, MogR, overexpression, flagellar motility genes, genes, associated with, virulence, stress response, biofilm lifestyle, phenotypic assays, MogR, cytotoxicity, biofilm formation, B. thuringiensis, Overexpression, MogR, variant, mutated, amino acids, putative DNA binding domain, phenotypes, empty vector, mutations, loss, MogR, binding, flagellar locus, in vitro, L. monocytogenes, MogR, growth-phase dependent, temperature-independent, B. thuringiensis 407, mogR, non-motile, B. cereus, group, species, B. mycoides, B. pseudomycoides, gene deletions, flagellar motility locus, B. pseudomycoides, mogR, gene, retained, mogR, expressed, non-motile, B. anthracis, indications, functions, MogR, B. cereus, group, species, motility regulation, MogR, novel, B. thuringiensis, pleiotropic transcriptional regulator, repressor, motility genes, affecting, expression, genes, biofilm formation, virulence]]\n",
      "[[shotgun genome sequence, Bacillus mycoides, psychrotolerant bacterium, isolated, soil, Russia, characterized, bacterial genome, genes, GC, content]]\n",
      "[[phylogeny, identification, characterization, B. cereus sensu lato, isolates, agricultural soils, countries, analyzed, whole genome sequencing, Phylogenetic analyses, isolates, groups, phylogenetic division, B. cereus sensu lato, isolates, identification, variation, identity, isolates, isolates, species, identification, phylogeny, isolates, basis, method, identification, presence, identity, protein product, genes, pathogenicity, isolates, groups, phylogenetic division, isolates, pathotypes, differentiate, comparing, identity, proteins, pathogenicity, phylogeny, pathogenicity, geographical distribution, isolates, division, phylogenetic groups, ecotypes, temperature, growth, ranges, analyze, results, B. cereus sensu lato, isolates, phylogenetic, patho-type, ecotype-oriented context, context, identification, species, level]]\n",
      "[[antimicrobial resistant bacteria, exploration, antimicrobial compounds, Reports, antimicrobial, soil anaerobes, Clostridium spp, study, antimicrobial activity, soil, Clostridium, CMs, Bacillus mycoides, Bacillus cereus, Pseudomonas aeruginosa, assessed, turbidimetric growth inhibition assay, results, antimicrobial, potential, soil, Clostridium, conditioned media, pathogenic, spoilage bacteria, Farm, soil, conditioned medium, F4SCM, growth, inhibition, tested, microorganisms, comparison, soil, conditioned media, Non-targeted, metabolite, profiling, soil, conditioned media, intermediate-polar metabolites, F4SCM, consistent with, antimicrobial property, abundant, metabolites, unique, features, detected, F4SCM, specialized, chemical, diversity, study, metabolites, F4SCM, 3-hydroxyphenylacetic acid, gamma-aminobutyric acid, creatine, tryptamine, 2-hydroxyisocaproic acid, Tryptamine, 2-hydroxyisocaproic acid, antimicrobial, properties, study, soil, Clostridium spp, group, bacteria, metabolites, antimicrobial activity, clostridial, metabolic, diversity]]\n",
      "[[Bacillus mycoides, isolated, tomato, rhizosphere, functions, tomato, plant growth, reducing, severity, Fusarium wilt, Fusarium oxysporum f. sp. lycopersici, Fol, Cytological experiments, B. mycoides, BM02, reduced, Fol, invasion, spore, attachment, increasing, hyphal, deformation, hydroponics-grown, tomato, root tissues, volatile antifungal compounds, phenylacetic acid, PAA, methylphenyl acetate, MPA, culture filtrates, B. mycoides, BM02, GC-MS analysis, Chemically synthesized, PAA, MPA, suppressed, spore, germination, no effects, hyphal, growth, Fol, results, biocontrol agent, B. mycoides, BM02, array, bioactive compounds, PAA, MPA, suppress, plant diseases, Fol, pathogenic, microorganisms]]\n",
      "[[Bacterial biofilms, threat, human, health, study, isolate, amylase-producing bacteria, soil, inhibition, pathogenic, bacterial biofilms, serial dilution, streaking method, positive, amylase, isolates, starch-agar plate method, screen, amylolytic activities, isolates, morphological, biochemical methods, isolates, Optimal, amylase, production, purification, Sephadex G-200, SDS-PAGE, monitored, screened, isolates, antagonistic activities, purified amylase, pathogenic, multi-drug-resistant, human bacteria, agar disk diffusion method, standard, antibiotics, controlled, degree, sensitivity, spectrophotometric methods, screen, antibiofilm, application, filtering, purifying, enzymes, efficacy, human, pathogenic bacteria, isolated, Bacillus species, Bacillus megaterium, Bacillus subtilis, Bacillus cereus, Bacillus thuringiesis, Bacillus lentus, Bacillus mycoides, Bacillus alvei, Bacillus polymyxa, Bacillus circulans, Micrococcus roseus, isolates, antagonism, target, pathogens, B. alevi, activity, B. polymyxa, activity, Staphylococcus aureus, MRSA, Escherichia coli, detected, antibacterial activity, purified amylase, supernatant, isolated, amylase-producing bacteria, purified amylase, inhibition, biofilm, supernatant, purified amylase, effective, clinical, environmental, biofilm control, results, soil, bacterial, isolates, Bacillus sp. supernatant, purified amylase, antibiofilm tools, inhibit, multidrug-resistant, strains, pharmaceutical use, purified amylase, effective, antibiofilm, isolated, supernatant, results]]\n",
      "[[Eclipse Farm 4 G test, COMET, device, automatic, screening, antimicrobials, raw, bovine milk, results, system, real-time, smartphone, application, App, cloud platform, study, Eclipse Farm 4 G &, COMET, screening, antimicrobials, raw, bovine milk, AOAC, Performance, MethodSM, procedures, test, inhibition, microbial, growth, Geobacillus stearothermophilus, presence, antimicrobials, sample tubes, incubated, absence, antibiotics, spores germinate, cells, color, purple, yellow, negative, result, presence, antimicrobials, milk, sample, bacterial growth, preventing, tubes, purple, yellow, positive, COMET, assay, steps, incubation, time control, results, interpretation, communications, device, smartphone, cloud, LODs, detection, capabilities, CCbetas, EU-MRL, evaluated, molecules, families, antimicrobials, penicillins, cephalosporins, tetracyclines, sulfonamides, macrolides, aminoglycosides, False positive rate, effect, interfering substances, selectivity/specificity, Eclipse Farm 4 G &, COMET, robust, stable, shelf, life, Eclipse Farm 4 G & COMET system, screening, antibiotics, raw, bovine milk, assay, automatic, system, detection, antibiotics, raw, bovine milk, consistent with, EU-MRLs, results, anytime, smartphone, App, cloud platform]]\n",
      "[[disproportionation, activity, cyclodextrin glucosyltransferase, CGTase, EC 2.4.1.19, small molecules, glycosides, enhancing, solubility, stability, CGTases, hydrolysis, activity, subsite, substrate, binding cleft, disproportionation, hydrolysis, activities, mutations, site, decrease, disproportionation, activity, study, Leu(277), CGTase, Bacillus stearothermophilus, NO2, near, subsite, catalytic acid/base, Glu(253), modified, assess, effect, side chain size, position, disproportionation, hydrolysis, activities, mutant, L277M, reduced, Km, acceptor substrate maltose, increased, compared, wild-type, enzyme, disproportionation, hydrolysis, ratio, L277M, wild-type, structural, data, alignment, Gly(282) mutations, mechanism, effects of, Leu(277)mutations, Gly(282) mutations, molecular-dynamics, analysis, comparison, crystal structures, changes, hydrophobic cluster, Glu(253), hydrophobicity, subsite, observed, effects, ImportanceIn, study, mutations, enhance, disproportionation, hydrolysis, ratio, CGTase, disproportionation, hydrolysis, ratio, L277M, Bacillus stearothermophilus, NO2, CGTase, wild-type, mechanism, effects, mutations, research, disproportionation, hydrolysis, activities, CGTases, Productive mutations, acceptor subsite, mutations, acceptor subsite, enzymatic activity]]\n",
      "[[free antigens, antigens, immobilized, scaffolds, nanoparticles, immunogenicity, antigens, conjugated, scaffolds, genetic fusion, chemical conjugation, impaired, assembly, heterogeneous binding, orientation, antigens, technologies-i.e, self-assembling multimeric protein, MPSPs, bacterial, shortcomings, overcome, antigens, particles, native, conformation, assessed, technology, immunogenicity, subunit vaccine, zoonotic Rift, Valley fever virus, RVFV, head domain, glycoprotein, Gn, target, neutralizing antibodies, MPSPs, immunogenicity, efficacy, in vivo, results, Gn head domain, lumazine, reduced, mortality, lethal, lambs, susceptible, RVFV, target, animals, viremia, clinical signs, immunization, subunit, coupled, MPSPs, Geobacillus stearothermophilus E2, modified, protection, lambs]]\n",
      "[[inactivation, bacterial endospores, curtailment, adoption, high-pressure processing, intrastate, interstate, global food commerce, study, investigated, effects of, elevated, hydrostatic pressure, inactivation, endospore, suspension, indicator, spore-forming bacteria, food industry, effects of, bacteriocin/bactericidal compounds, decontamination, efficacy, treatment, Elevated, hydrostatic pressure, MPa, untreated control, IU, nisin, lysozyme, lactic acid, Citricidal(TM, results, statistically analyzed, Tukey-, Dunnett's-adjusted ANOVA, condition, experiments, well-designed pressure, treatment, synergized, mild heat, bacteriocin/bactericidal compounds, reduce, logs, bacterial endospores, Additions, nisin, lysozyme, decontamination, efficacy, pressure-based, treatments, Bacillus amyloliquefaciens, Bacillus atrophaeus, benefit, reducing, endospores, Geobacillus stearothermophilus, lactic acid, efficacious, pressure-based, reduction, bacterial, endospores, microorganisms]]\n",
      "[[study, evaluated, performance, O3, O2, sterilization, instrument, killing, microorganisms, inactivating, bacterial, endotoxin, low temperatures, Sterility assurance, level, reduction, Geobacillus stearothermophilus ATCC 12980, decimal reduction value, sterilization, mode, reduction, logs, Limulus amebocyte, lysate, purified, endotoxin, Escherichia coli, treatment, endotoxin-inactivation mode, inactivation, ability, treating, dried, bacterial cells, Biomaterials, polymer, metal, cytotoxicity, gas exposure, O3, concentrations, results, human, endotoxin, medical devices, cerebrospinal fluid, EU/device, detected, scissors, washer-disinfector, sterilized, ethylene oxide, autoclaving, endotoxin, decreased, EU/device, O3, O2, sterilization, endotoxin-inactivation mode, gas sterilization methods, O3, O2, sterilization, ability, capacity, inactivate, endotoxin, sterilization, technology, improve, safety, reusable medical devices, utensils, regenerative medicine]]\n",
      "[[study, thermoalkaliphilic lipase, TA, detergents, thermophilic, bacterial strains, fish, wastes, industrial, application, bacterial, isolates, Geobacillus stearothermophilus, FMR12, efficiently, fish, wastes, concentration, lipolytic activity, thermal, alkaline, pH, fermentation, parameters, TA lipase, production, promoting, productivity, TA lipase, Purification, results, TA lipase, activity, purification fold, yield, TA lipase, activity, stability, temperature, range, degrees, C, pH, optimal, activity, degrees, C, pH, molecular weight, enzyme, control, TA lipase, activity, presence, calcium chloride, Triton X-100, enhanced, activity, TA lipase, control enzyme, TA lipase, activity, blending, commercial, detergents, competence, detergent formulations]]\n",
      "[[Bacillus stearothermophilus, alpha/beta-cyclodextrin glycosyltransferase, alpha/beta-CGTase, excellent, transglycosylase, potential, food application, expression, level, Bacillus subtilis, study, optimal, signal peptide, alpha/beta-CGTase, expression, screened, signal peptides, B. subtilis, WS11, alpha/beta-CGTase activity, 3-L fermentor, inclusion bodies, N-terminal 12 amino acids, alpha/beta-CGTase, N-terminal 15 amino acids, beta-CGTase, family, disorder-promoting amino acids, result, inclusion bodies, reduced, enzyme activity, increased, strain, ppsE, sfp genes, B. subtilis, WS11, lipopeptide, B. subtilis, WS13, B. subtilis, WS13, alpha/beta-CGTase, 3-L fermentor, defoaming agent, B. subtilis WS11, enzyme, production, growth, WS13, WS11, study, significance, research, scale-up, production, alpha/beta-CGTase]]\n",
      "[[gas-phase Advanced Oxidation Process, gAOP, evaluated, decontaminating, N95, surgical masks, continuous process, generation, hydroxyl-radicals, UV-C, photo-degradation, hydrogen peroxide, ozone, decontamination, efficacy, gAOP, dependent, orientation, N95 mask, gAOP unit, horizontally, exposure to, hydroxyl-radicals, compared, vertically, lethality, gAOP, hydrogen peroxide, concentration, H2O2, unit, treatment, N95 masks, v/v hydrogen peroxide, gAOP reactor, continuous, introduction, ozone, UV-C dose, processing time, treatment, CFU, decrease, Geobacillus stearothermophilus endospores, reduction, human, detection, Escherichia coli K12, interior, exterior, masks, negative, effect, N95 mask fitting, particulate, efficacy, gAOP system, visual, hydrogen peroxide residues, detected, gAOP, treated, gAOP, treatment, CFU, reduction, endospores, inoculated, interior, exterior, surgical masks, G. stearothermophilus, Apex spore, strips, biological, indicator, performance, gAOP, treatment, chemical indicator, oxidative polymerization, pyrrole, reporting, generation, hydroxyl-radicals, gAOP, treatment, decontaminate, N95, surgical masks, negative, effects, functionality]]\n",
      "[[Malate dehydrogenase, MDH, catalyzes, reversible, reduction, oxaloacetate, OAA, L-malate, nicotinamide adenine dinucleotide hydrogen (, NADH, MDH, mobile loop, catalytic loop, active site, binding, substrate, enzyme, structural change, open-form, open conformation, mobile loop, closed-form, loop, closed conformation, study, crystals, MDH, moderate, thermophile, Geobacillus stearothermophilus, gs-MDH, enzyme structures, resolutions, catalytic states, OAA-unbound structures, open-form, OAA-bound structures, closed-form, structural analysis, binding, OAA, open-form, promotes, conformational change, mobile loop, simultaneously, activates, catalytic loop, mutations, amino acid residues, catalytic, mechanism, affected, gs-MDH, activity, hypothesis, findings, elucidation, molecular mechanism, substrate, recognition, structural switching, MDH, catalytic cycle]]\n",
      "[[Proteases, hydrolysis, proteins, peptides, bioactivities, development, novel, proteases, high activities, bioactive peptides, natural isolation, animal, plant, microbial, sources, quantities, proteases, gene cloning, expression, target protease, study, alkaline serine protease gene, GsProS8, Geobacillus stearothermophilus, cloned, expressed, Bacillus subtilis, recombinant, GsProS8, protease, activity, cell density fermentation, GsProS8, purified, ammonium sulfate, precipitation, chromatographic method, homogeneous protease, molecular mass, GsProS8, sodium dodecyl sulphate-polyacrylamide gel electrophoresis, SDS-PAGE, gel filtration, optimal, activity, GsProS8, pH, protease, substrate, specificity, kinetic, parameters, casein, whey protein, hydrolysis, whey protein, GsProS8, amount, peptides, angiotensin-I-converting enzyme, ACE, inhibitory activity, IC50, GsProS8, industrial, applications, preparation, antihypertensive peptides]]\n",
      "[[Bacillus subtilis strains, benefits, agriculture, viticulture, assets, B. subtilis spp, plant-protectors, pathogens, influencers, adaptations, changing environment, study, reports, draft, genome sequence, Bacillus subtilis, PTA-271, isolated, rhizospheric, soil, healthy, Vitis vinifera cv, Chardonnay, Champagne Region, France, biocontrol, capacity, PTA-271, genome, size, bp, G + C, content, protein coding genes, draft genome, PTA-271, functional, swarming motility system, colonizing, capacity, interacting, capacity, survival, capacities, genes, encoding, bioactive substances, bioactive compounds, stimulate, plant growth, defenses, hormones, elicitors, influence, microbiota, pathogen, aggressiveness, effectors, detoxifying enzymes, Plurality, encoded, biomolecules, Bacillus subtilis, PTA-271, genome, robust, biocontrol, potential, PTA-271, plants, spectrum, pathogens]]\n",
      "[[steady-state cell growth, enzymatic, fluxes, growth rate, mass conservation, inverse, Perturbing, flux, expression, enzyme, pleiotropic effects, impact, cell fitness, quantitatively, dissect, molecular, global responses, expression, translation termination factors, peptide release, RFs, bacterium Bacillus subtilis, endogenous, RF, expression, proliferation, deviations, expression, distal, regulatory responses, fitness, reduction, Molecularly, RF, depletion, expression, imbalance, operons, activates, master regulators, detrimentally, transcriptome, connections, RF, abundances, focal points, regulatory network, case, regulatory entrenchment, predictive, bottom-up, models, expression-fitness, landscapes, near-exhaustive, characterization, parts]]\n",
      "[[Bacillus subtilis, biocontrol bacterium, antifungal activity, broad-spectrum inhibition, general safety, study, inhibitory, effects, volatile organic compounds, VOCs, B. subtilis, CF-3, Colletotrichum gloeosporioides, litchi anthracnose, analyzed, proteomics, transcriptomics, Differentially expressed genes, DEGs, proteins, DEPs, inhibition, C. gloeosporioides, B. subtilis, CF-3, VOCs, downregulated, expression, genes, cell membrane, fluidity, cell wall, integrity, energy metabolism, production, cell wall-degrading enzymes, DEGs, DEPs, ergosterol, biosynthetic, biosynthesis, unsaturated fatty acids, influenced, B. subtilis, CF-3, VOCs, effect, C. gloeosporioides, results, theoretical, potential, application, B. subtilis, CF-3, postharvest, protection, fruits, vegetables]]\n",
      "[[Type 2 diabetic mellitus, T2DM, complicated, metabolic disorder, global, Fucoidan, diverse, biological activities, prevention, metabolic diseases, effect, Sargassum fusiforme fucoidan, SFF, high-fat diet, HFD, streptozotocin, STZ, induced, T2DM, mice, SFF, decreased, fasting, diet, water intake, hyperlipidemia, glucose tolerance, SFF, reduced, epididymal fat, deposition, attenuated, pathological, changes, heart, liver tissues, decreased, oxidative stress, diabetic, mice, mechanisms, ameliorative effects, gut microbiota, analyzed, SFF, benign, microbes, Bacteroides, Faecalibacterium, Blautia, increased, levels, (R)-carnitine, choline, colon, diabetic mice, potential, mechanism, T2DM, benefits, SFF, adjuvant agent, T2DM, treatment, study, application, fucoidan, adjuvant agents, management, T2DM, future]]\n",
      "[[Cesarean-delivered, CD, infants, gut microbiome, vaginally delivered, infants, infancy, driver, infant, gut, microbial, colonization, infant, feeding, studies, breastfeeding, associated with, levels, health-promoting bacteria, Bifidobacterium, Bacteroides, modulation, immune system, production, metabolites, infant, gut, matures, solid foods, duration, breast feeding, loss, taxa, intestinal, microbiota, operatively, New Hampshire Birth Cohort Study, evaluated, longitudinal effect, delivery mode, infant, feeding, taxonomic, composition, functional, capacity, gut microbiota, Microbiota, stool samples, weeks, months, age, infants, characterized, 16S ribosomal RNA sequencing, Shotgun metagenomic sequencing, samples, weeks, months, age, infant, participants, cesarean-delivered, CD, infants, breastfeeding, months, life, breastfed, mixed-fed (, breast milk, formula, foods, age, Alpha, within-sample, diversity, CD infants, vaginally delivered, infants, study, period, Bacterial, clustering, delivery mode, feeding, duration, year, age, CD infants, breast fed, months, VD infants, CD infants, breast fed, months, breastfeeding, modified, longitudinal, impact, delivery mode, taxonomic, composition, microbiota, year, age, increase, abundance, Bacteroides fragilis, Lactobacillus, duration, breastfeeding, CD infants, increase, Faecalibacterium, VD infants, findings, duration, breastfeeding, restoring, health-promoting, microbiome, investigations, association, breast milk, exposure, health outcomes, early life]]\n",
      "[[AIMS, Non-alcoholic fatty liver disease, NAFLD, global, Risk factors, disease severity, older age, increased, body mass index, BMI, diabetes, genetic variants, dietary factors, gut microbiota, alterations, interdependence, factors, individual, impact, disease severity, cross-sectional study, 16S gene sequencing, fecal samples, dietary intake, PNPLA3 gene, variants, clinical, liver, histology, parameters, cohort, NAFLD, patients, Principal component analyses, dimensionality, reduction, dietary, microbiota, data, Complete, data, NAFLD, patients, simple regression analysis, features, associated with, metabolic syndrome, liver disease, severity, multiple regression analysis, BMI, factor, associated with, fibrosis stage, OR, CI, PNPLA3, risk, allele, association, histological, steatosis, OR, CI, dietary patterns, abundances, Faecalibacterium, Bacteroides, Prevotella, abundances, Gemmiger, associated with, degree, inflammation, ballooning, stages, fibrosis, co-factors, BMI, association, histological fibrosis, PNPLA3, gene variants, gut, bacterial, features, dietary factors, associated with, histology, features, multifactorial, pathogenesis, NAFLD]]\n",
      "[[Microbiota, regulating colitis, colorectal cancer, CRC, microbiota, immunity, disease states, loss, innate, adaptive immune signaling molecule, TAK1, myeloid cells, resistance, chemical-induced colitis, CRC, microbiome, alterations, protective immunity, mice, microbiota, resistance, antibiotic-mediated disruption, ablating, protection, Tak1(DeltaM/DeltaM) microbiota, colitis, CRC, microbiota, Tak1(DeltaM/DeltaM), mice, promote, IL-1beta, IL-6, signaling pathways, induction, protective intestinal, Th17, cells, resistance, Odoribacter splanchnicus, abundant, Tak1(DeltaM/DeltaM) mice, induce, intestinal, Th17, cell development, resistance, colitis, CRC, wild-type mice, findings, microbiota, strains, immune mechanisms, colitis, CRC]]\n",
      "[[FMT, attention, years, efficacy, restoring, gut microbiome, groups, post-FMT recipient, piglets, germ-free piglets, early life, characterize, colonization, gut microbiota, composition, enrichment, resistance, gene acquisition, metagenomic analysis, bacterial phyla, bacterial genera, FMT, recipients, early-life, microbial, colonization, spread, resistomes, recipient, piglets, age dependent, AR genes, detected, donors, post-FMT recipients, FMT-3D, group, post-FMT recipients, FMT-15D, group, Genes, encoded, tetracycline, macrolide, chloramphenicol resistance proteins, dominant, AR genes, results, exposure, antibiotic, consumption, farm, Bacteroides, Escherichia, Clostridium, Parabacteroides, Treponema, Lactobacillus, Enterococcus, correlated, distribution, AR genes, abundance, AR genes, positively, correlated, levels, mobile genetic elements, results, early-life, microbial, colonization, persistently, shape, gut microbiota, antibiotic, resistome]]\n",
      "[[Differences, endodontic microbiome, permanent, primary teeth, mixed dentition, period, study, bacterial, diversity, endodontically infected, primary, permanent teeth, 16S rRNA, gene sequencing, QIIME 2, Quantitative, Microbial Ecology 2, bioinformatics, Microbial, samples, endodontically infected, primary, permanent, maxillary, mandibular molar teeth, next-generation sequencing analysis, examination, hypervariable V3 to V4 region, 16S rRNA gene, Statistical analysis, R software, reads, operational, phyla, families, genera, identified, Firmicutes, detected, phyla, endodontically infected, primary, permanent, root canals, Bacteroides, Proteobacteria, primary teeth, Actinobacteria, Verrucomicrobia, permanent teeth, canal, microbiota, composition, endodontically infected, primary, permanent teeth, study, comprehensive, assessment, microbiota, composition, endodontically infected, primary, permanent teeth, origin, root canal infections]]\n",
      "[[Bacteroides fragilis, normal, gastrointestinal flora, anaerobic bacteria, infection, resistant, antibiotics, abundant, antibiotic, mechanisms, antibiotic resistance, pattern, isolates, B. fragilis, strains, clinical samples, strains, colorectal tissue, investigated, agar dilution method, gene, encoding, Bacteroides fargilis toxin bft, antibiotic resistance genes, targeted, PCR assay, rate, resistance, penicillin G, tetracycline, clindamycin, cefoxitin, isolate, resistance, imipenem, cfiA, IS1186 genes, isolates, susceptible, metronidazole, tetQ, cepA, ermF, abundant, antibiotic-resistant genes, identified, study, MIC values, penicillin, cefoxitin, clindamycin, isolates, cepA, cfxA, ermF, compare, lacking, genes, clinical, GIT, isolates, bft gene, finding, study, metronidazole, in vitro, active agent, B. fragilis, isolates, first-line, antimicrobial, empirical therapy]]\n",
      "[[Human milk, gut, microbial, richness, diversity, immune development, Research, microbial, composition, geographic, location, evidence, diverse, biospecimen, data, human, bacterial, communities, research, human, infant, gut, microbial, communities, Africa, study, breastmilk, stool, meconium samples, South African birth, cohort, microbial, diversity, taxonomic, correlations, bacterial, abundance, breastmilk, stool samples, Mother-infant dyads, identified, longitudinal birth, cohort, Vhembe district, Limpopo Province, South Africa, Breastmilk, meconium, stool samples, analyzed, 16S ribosomal RNA sequencing, V4-V5 gene region, MiSeq platform, identification, quantification, bacterial taxa, non-metric multidimensional scaling, Bray-Curtis distances, sample Z-scores, meconium, stool, breastmilk, microbial, communities, genus, Breastmilk, Streptococcus, Staphylococcus, Veillonella, Corynebacterium, Stool samples, levels, Bifidobacterium, Faecalibacterium, Bacteroides, Streptococcus, Alpha, diversity, measures, stool samples, Shannon index score, breastmilk, meconium, abundance, Bifidobacterium, Blautia, Haemophilus, correlated, breastmilk, stool samples, breastmilk, seeding, infant, gut microbiome, evidence, bacterial, communities, breastmilk, stool samples, South African mother-infant, dyads]]\n",
      "[[strains, characterized, Gram-stain-negative, anaerobic, non-motile, rod-shaped, isolated, fresh, faeces, healthy, humans, PR, China, Pairwise sequence, comparisons, 16S rRNA, isolates, clusters, Cluster I, strains, HF-106, Bacteroides xylanisolvens XB1A(T), similarity, Bacteroides ovatus ATCC 8483(T, cluster II, strains HF-5287(T, HF-5300, similarity, Bacteroides finegoldii JCM 13345(T), Bacteroides faecis, MAJ27(T, Bacteroides xylanisolvens XB1A(T, DNA, contents, type strains HF-5141(T), HF-5287(T), strains, anteiso-C15, cellular fatty acid, MK-9, MK-11, predominant, respiratory quinones, phosphatidylethanolamine, aminophospholipids, phospholipids, polar lipids, members, genus, Bacteroides, average, nucleotide, digital, DNA-DNA hybridization, values, phenotypic, biochemical, characteristics, relatives, members, genus, Bacteroides, strains HF-5141(T), HF-5287(T, species, genus, Bacteroides, names, Bacteroides luhongzhouii sp. nov., Bacteroides, HF-5141(T) (=CGMCC 1.16787(T)=GDMCC 1.1591(T)=JCM 33480(T), HF-5287(T) (=CGMCC 1.16724(T)=GDMCC 1.1590(T)=JCM 33481(T), type strains]]\n",
      "[[Experimental, evidence, genotoxic, Escherichia coli, E. coli, enterotoxigenic Bacteroides fragilis, ETBF, development, colorectal cancer, CRC, evidence, epidemiological studies, assessed, association, serological, markers, E. coli, ETBF, exposure with, odds, CRC, European Prospective Investigation, Nutrition and Cancer, study, Serum samples, incident, CRC, cases, matched controls, pairs, analyzed, immunoglobulin (Ig) A, G antibody, responses, E. coli proteins, isoforms, ETBF toxin, multiplex serology, Multivariable-adjusted conditional logistic regression analyses, estimate, odds ratios, ORs, confidence intervals, CIs, association, sero-positivity, E. coli, ETBF, CRC.The IgA-positivity, tested, E. coli, antigens, associated with, odds, CRC, OR, CI, Dual-positivity, IgA, IgG, E. coli, ETBF, associated with, odds, CRC, association, IgG, OR, CI, association, proximal colon cancers, OR, CI, distal colon, OR, CI, pheterogeneity, Sero-positivity, E. coli, ETBF, associated with, CRC, development, co-infection, bacterial species, colorectal carcinogenesis, findings, exploration, prospective studies, population groups]]\n",
      "[[Zwitterionic polysaccharides, isolated, commensal bacteria, unique, immunological, properties, immunotherapeutic agents, vaccine, carriers, synthesis, Bacteroides fragilis, zwitterionic polysaccharide A1, PS A1, rare, AAT, consecutive, 1,2-cis glycosidic, repeating unit, synthesis, d-galactosamine, AAT, building blocks, cheap, abundant, d-mannose, SN2, displacement, 2,4-bistriflates, installation, glycosidic bonds, stereoselective, synthesis, linear sequence, steps, yield]]\n",
      "[[woman, hospital, diagnosis, peritonitis, rupture, abdominal cystic tumor, diameter, Abdominal computed tomography, years, tumor, diameter, examinations, treatment, interim, shock, presentation, hospital, intubated, emergent, laparotomy, ruptured, tumor, adherent, small, intestine, resected, tumor, weighed, solid, cystic components, brown feces-like fluid, Bacteroides fragilis, detected, fluid, specimen, cystic component, tumor, old blood clots, portion, tumor wall, calcified, Old blood, fibrin, blood vessels, sizes, tumor, pathologic, evaluation, malignant, features, pathologic diagnosis, chronic, hematoma, CEH, patient, uneventful, recovery, days, post-operatively, traffic accident, years, hospital admission, abdominal pain, time, CEH, benign, lesion, rupture, CEH, life-threatening]]\n",
      "[[Levornidazole, nitroimidazole, antimicrobial agent, active, anaerobes, investigate, pharmacokinetic, PK, levornidazole, multiple, oral doses, levornidazole tablets, healthy, Chinese, subjects, dosing, regimen, pharmacokinetic/pharmacodynamic, analysis, single-center, randomized, double-blind, placebo-controlled study, multiple doses, q12h, days, Food effect, PK, absolute, bioavailability, investigated, dose, level, Blood, urine samples, PK, parameters, levornidazole, probability, target, attainment, PTA, cumulative, fraction, CFR, Monte Carlo simulation, clinical, efficacy, levornidazole tablets, Plasma, concentration, single dose, levornidazole tablets, maximal, concentration, Cmax, exposure (, AUC0-infinity, levornidazole, increased, dose, High-fat diet, absorption, extent, levornidazole tablets, absolute, oral, bioavailability, levornidazole tablets, associated with, apparent, distribution, long half-life, urinary, excretion, levornidazole, Levornidazole, administered, q12h, q24h, CFR, PTA, B. fragilis, concentration, infections, Levornidazole tablets, absorbed rapidly, completely, distributed, half-life, low, urinary, excretion, dose, multiple doses, healthy, subjects, Levornidazole tablets, food, Levornidazole tablets, q12h, q24h, efficacy, B. fragilis, infections, TRAIL, REGISTRATION, Trial registration number, http://www.chinadrugtrials.org.cn/]]\n",
      "[[Aspirin, chemopreventive agent, colorectal adenoma, cancer, CRC, drugs, inclusive, chemotherapeutics, investigated, effects, bacterial growth, virulence, expression, recognition, bacteria, CRC, investigate, effects, aspirin, oncomicrobe-Fusobacterium nucleatum, aspirin, primary, metabolite, salicylic acid, F. nucleatum strain Fn7, growth, culture, aspirin, kill, stationary, Fn7, levels, inhibit, growth, aspirin, Fn7, gene expression, aspirin, modulation, F. nucleatum, relevant, in vivo, Apc(Min/+), mouse, Fn7, orally, inoculated, aspirin-supplemented chow, inhibit, F. nucleatum-potentiated, characterization, aspirin, sensitivity, F. nucleatum, strains, isolated, human, CRC, tissues, CRC-associated microbes, enterotoxigenic Bacteroides fragilis, colibactin-producing, Escherichia coli, individuals, aspirin, daily, fusobacterial, abundance, colon adenoma, tissues, quantitative PCR, adenoma, DNA, data support, aspirin, antibiotic activity, F. nucleatum, strains, potential, effects, aspirin, microbiome, risk-benefit, assessments, aspirin, CRC, prevention, management, increasing, clinical, correlations, potential, mechanistic roles, members, gut, tumoral microbiota, colorectal cancer, CRC, initiation, progression, survival, knowledge, CRC, outcomes, microbially informed, diagnostic, preventive, therapeutic approaches, aspirin, CRC, chemopreventive, effects, CRC-associated, Fusobacterium nucleatum, culture, animal model, intestinal, tumorigenesis, human, colonic adenoma, tissues, aspirin, CRC-associated bacteria, prevent, colorectal adenomas, cancer, aspirin's, targeting, host, tissues, research, studies, investigating, effects, aspirin, fusobacterial, load, patients, aspirin, modulate, F. nucleatum, in vivo, improving, CRC, outcomes]]\n",
      "[[Genetically, chickens, growth, early, maturation, incidental, increase, abdominal fat deposition, AFD, evidence, association, gut microbiota, adiposity, studies, gut microbiota, chicken, obesity, conventional, breeds, random, broilers, levels, AFD, investigate, gut, microbial, taxa, AFD, 16S rRNA, gene sequencing, samples, microbial, taxa, fat-related metabolism, shotgun metagenomic analyses, high, low, AFD, chickens, results, richness, diversity, gut microbiota, decrease, accumulation, chicken, abdominal fat, increases, decrease, Bacteroidetes, increase, Firmicutes, correlated, accumulation, chicken, AFD, Bacteroidetes, phylum, genera, Bacteroides, Parabacteroides, species, B. salanitronis, B. fragilis, P. distasonis, correlated, obesity, secondary, metabolites, genera, Firmicutes, phylum, circulating, lipoprotein lipase, accumulation, chicken, body fat, genera, Olsenella, Slackia, positively, fat, energy metabolism, genus, Methanobrevibacter, energy capture, associated to, accumulate, chicken, AFD, findings, gut microbiota, complex, traits, development, effective, therapies, reduction, chicken, fat, accumulation]]\n",
      "[[Antimicrobial resistance, anaerobic bacteria, increasing, inexpensive, susceptibility testing, study, suitability, Fastidious Anaerobe Agar, FAA, medium, disk diffusion, anaerobic, bacteria, Reproducibility, zone, diameters, quality, growth, tested, quality control, QC, strains, anaerobic, incubation temperatures, FAA, manufacturers, effect, incubation, hours, hours, tested, Bacteroides fragilis-group, isolates, method, tested, clinical, B. fragilis-group isolates-, agar, dilution, MICs, incubation, QC, strains, confluent, growth, anaerobic, quality, growth, zone, diameters, Incubation, zones, degrees, Acumedia FAA, manufacturers, zone, diameters, B. fragilis-group, isolates, confluent, growth, hours, Metronidazole, inhibition, zones, correlated, MICs, area, poorer separation, meropenem, piperacillin-tazobactam, Prolonged, incubation, clindamycin, separation, area, overlap, reduced, incubation, FAA, medium, disk diffusion, collection, anaerobic, bacteria]]\n",
      "[[PURPUSE, carbapenem-resistant Bacteroides fragilis, group, CR-BFG, bacteria, countries, increasing, global attention, incidence, CR-BFG, isolated, hospitalized patients, problem, frequency, associated factors, intestinal, colonization, carbapenem-non-susceptible, BFG, CNS-BFG, adult, patients, hospitalized, intensive care units, neurosurgery, internal medicine wards, hospital, Rectal swabs, patients, inoculated, kanamycin-vancomycin-leaked blood agar, meropenem, isolates, MALDI-TOF MS, Susceptibility testing, agar dilution method, carbapenemase gene, cfiA, detected, PCR, Logistic regression analysis, evaluate, associated factors, intestinal, colonization, CNS-BFG, non-duplicate, BFG, isolates, patients, species, Parabacteroides distasonis, Bacteroides fragilis, identified, isolates, non-susceptible, meropenem, MIC, prevalence, meropenem, resistant, strains, MIC, detected, B. fragilis, Parabacteroides spp., B. fragilis, strains, cfiA gene, Hospital admission, increasing, Charlson score, antibiotics, carbapenems, months, colonization, carbapenem-resistant Gram negative bacteria, Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, surgical operations, associated with, RCS-, BFG, colonization, carriage, rate, CNS-BFG, hospitalized patients, clinical outcomes, infections, mortality, attention]]\n",
      "[[Oral microbiota, health, diseases, tongue-coating microbiota, aspiration pneumonia, halitosis, oral microbiota, potential, oral health, prevent, diseases, study, simultaneous, monitoring, salivary, tongue, microbiomes, intervention, oral microbiota, study, design, evaluate, effect, single-day, oral care tablets, oral microbiome, healthy, individuals, Tablets, actinidin, protease, reduces, biofilm formation, in vitro, tested, Alpha, diversity, tongue microbiome, salivary, microbiome, amplicon sequence, variants, saliva, tongue, 8.9e-7, Kruskal-Wallis test, Shannon index, saliva, tongue, 2.0e-7, Kruskal-Wallis test, Fusobacterium periodonticum, Saccharibacteria sp. 352, Streptococcus oralis subsp ., dentisani, Prevotella melaninogenica, Granulicatella adiacens, Campylobacter concisus, Haemophilus parainfluenzae, OTUs, sites, salivary, tongue, microbiomes, individual, individuals, tablets, alpha, beta diversity, oral microbiome, abundance, bacterial species, salivary, tongue, microbiomes, bacterial, composition, intra-individual, diversity, usage, oral care tablets, salivary, tongue, microbiomes, healthy, adults, oral tablets, period, healthy people, people, tongue, coating, accumulation, oral microbiome, investigated]]\n",
      "[[information, antimicrobial susceptibility, pattern, oral, anaerobic bacteria, study, attempt, evaluate, antimicrobial susceptibility/resistance, oral, Indian, subjects, Minimum inhibitory concentrations, MIC, isolates, antibiotics, gradient, MIC, strips, organisms, isolated, identified, phenotypic, characteristics, Porphyromonas gingivalis, Prevotella species, Tannerella forsythia, Fusobacterium nucleatum, Aggregatibacter, actinomycetemcoitans, Eickenella corrodens, Capnocytophaga species, antimicrobial agent, MIC50, MIC90, calculated, expressed, Resistance, azithromycin, clindamycin, amoxicillin, anaerobic, bacterial species, degree, susceptibility, amoxillin-clavulanic acid, doxycycline, moxifloxacin, strain, P. melaninogenica, resistant, moxifloxacin, susceptibility, pattern, cephalosporins, species, Ceftriaxone, highest, cefazolin, efficacy, cephalosporins, anaerobic bacteria, tested, susceptible, metronidazole, Strains, T. forsythia, resistant, antibiotics, anaerobic bacteria, species, capnophilic bacteria, degree, resistance, metronidazole, resistance, amoxicillin, azithromycin, clindamycin, cefazolin, cefuroxime, Amoxicillin-clavulanic acid, doxycycline, moxifloxacin, metronidazole, effective, drugs, gram negative, anaerobic, bacteria, MIC50, MIC90, values, metronidazole, higher, normal, potential, resistance]]\n",
      "[[OBJECTIVE, Oral lichen planus, OLP, chronic inflammatory disease, oral mucosa, white striations, lesions, recurrent, erosions, pains, etiology, pathogenesis, OLP, unclear, analyzed, bacterial, buccal mucosa, patients, OLP, normal controls, high-throughput sequencing, Fluorescence in situ hybridization, FISH, detect, Prevotella melaninogenica, P. melaninogenica, OLP, samples, controls, P. melaninogenica, OLP, buccal mucosa, expression, inflammatory cytokines, co-culture, mouse-derived macrophages, P. melaninogenica, detected, RT-qPCR, P. melaninogenica, abundant, OLP, healthy controls, differences, significant, level, phylum, family, genus, species, FISH, P. melaninogenica, invade, epithelium, lamina propria, OLP, invasion, normal mucosa, P. melaninogenica, invade, macrophages, activate, transcription, IL-1beta, IL-6, TNF-alpha, NF-kappaB signaling pathway, P. melaninogenica, pathogenic process, OLP, mechanism, study]]\n",
      "[[Objective, longitudinal study, evaluate, dynamic, oral microbiota, process, halitosis, progression, preschool children, oral examinations, questionnaires, tongue, coating, specimens, baseline, 12-month, follow-up, children, oral healthy, enrollment, 12-month, follow-up, children, halitosis, halitosis, group, children, matched, age, gender, kindergarten, halitosis, control group, 16S rRNA, gene sequencing, tongue, coating, microbiome, children, month, period, Human Oral Microbiome Database, abundance, bacteria, halitosis, development, principal coordinates, alpha diversity analyses, patterns, halitosis, healthy, participants, microbiome structures, bacterial, diversity, 12-month, follow-up, groups, variable, microbiota, community structures, halitosis, Halitosis-enriched species, Prevotella melaninogenica, Actinomyces sp._HMT_180, Saccharibacteria, TM7_G-1_bacterium_HMT_352, biomarkers, halitosis-onset prediction model, screening, prediction, accuracy, microbiome, composition, abundance, tongue, coatings, halitosis, control groups, clinical manifestations, halitosis, halitosis, prediction model, tongue, coating, microbiome, biomarkers, microbial, shifts, halitosis, onset, detection, intervention, halitosis, children]]\n",
      "[[PURPOSE, study, characterized, microbiomes, acute leukemia, AL, patients, remission, remission induction chemotherapy, RIC, outpatients, antimicrobials, treat, prevent, febrile, neutropenia, Saliva, stool samples, patients, acute myeloid leukemia, patients, acute lymphoblastic leukemia, healthy controls, 16S ribosomal RNA sequencing, baseline, months, RIC, patients, remission, months, post-treatment, antimicrobials, months, enrollment, time, study, period, baseline, abundances, species, Prevotella maculosa, Megasphaera micronuciformis, Roseburia inulinivorans, Bacteroides uniformis, saliva, Prevotella copri, stools, controls, AL, patients, RIC, abundances, Eubacterium sp. oral clone, DO008, Leptotrichia sp. oral clone IK040, Oribacterium sp. oral taxon 108, Megasphaera micronuciformis, TM7 phylum sp. oral clone DR034, Roseburia inulinivorans, Actinomyces odontolyticus, Leptotrichia buccalis, Prevotella melaninogenica, saliva, Lactobacillus fermentum, Coprococcus catus, butyrate-producing bacterium SS3/4, Bacteroides coprocola, stools, AL, patients, controls, RIC, taxa, stool, salvia samples, AL, patients, results, large-scale multicenter studies, microbiota, effect, clinical outcomes, AL, patients]]\n",
      "[[Dental fluorosis, endemic disease, oral microbiome, oral diseases, absence, research, relationship, severity, dental fluorosis, oral microbiome, investigated, changes, oral, microbial, community structure, identified, bacterial species, associated with, moderate, severe, dental fluorosis, Salivary samples, individuals, assigned, Healthy, Mild (N = 14), Moderate/Severe, M&S, investigated, V4 region, 16S rRNA gene, oral, microbial, community structure, Bray Curtis, M&S, group, compared, Healthy, Mild, predominant, phyla, Firmicutes, Bacteroidetes, variation, abundance, groups, Firmicutes/Bacteroidetes, F/B, ratio, M&S, group, LEfSe analysis, differentially, taxa, species, level, genera, Streptococcus mitis, Gemella parahaemolysans, Lactococcus lactis, Fusobacterium nucleatum, abundant, patients, moderate/severe, dental fluorosis, Prevotella melaninogenica, Schaalia odontolytica, Healthy group, study, oral microbiome, shift, patients, moderate/severe, dental fluorosis, bacterial species, moderate, severe, fluorosis, Findings, study, bacteria, oral health, diseases, patients, moderate, severe, fluorosis]]\n",
      "[[lungs, cystic fibrosis, CF, patients, chronically, colonized, microbial, species, biofilms, CF, pathogen, Pseudomonas aeruginosa, Herewith, microbial, diversity, CF, airways, associated with, worse, health outcomes, treat, CF, lung infections, patients, antibiotics, microbial, diversity, study, antibiotics, target, P. aeruginosa, influence, microbial, diversity, microaerophilic, multispecies, biofilm model, co-isolated members, CF, lung microbiome, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus anginosus, Achromobacter xylosoxidans, Rothia mucilaginosa, Gemella haemolysans, antipseudomonal antibiotics, antibiotics, affected, dominant, species, ceftazidime, tobramycin, higher, species, evenness, colistin, active, P. aeruginosa, susceptibility, individual, species, multispecies, biofilm, antibiotic treatment, single-species biofilms, anaerobic, species, Prevotella melaninogenica, Veillonella parvula, Fusobacterium nucleatum, multispecies, biofilm, influence, antibiotic susceptibility, study, antibiotic-dependent, effects, microbial, community, diversity, multispecies, biofilms, CF, microbiome members]]\n",
      "[[effect, oral, microbial, composition, periodontal health, systemic, health, oral microbiome, local, systemic diseases, conditions, Gastroesophageal reflux disease, GERD, associated with, increased, acidity, oral cavity, dental erosion, reduced, risk, periodontal disease, presence, GERD, modified, microbial, untreated, GERD, patients, proton pump inhibitor, PPI, drugs, disruptors, gut microbiome, GERD, patients, salivary, microbiome, Untreated, GERD, patients, salivary, microbiome, healthy controls, Taxa, levels, presence, GERD, treated, PPI, Prevotella melaninogenica, Prevotella pallens, Leptotrichia, Solobacterium moorei, GERD, patients, chronically, PPI, salivary, taxa, healthy controls, PPI]]\n",
      "[[Salivary, microbiota, source, microorganisms, respiratory, digestive tracts, trigger, diseases, distant organs, microbiota, tongue, surface, source, salivary microbiota, surgical resection, tongue, definitive, treatment, oral cancer, salivary, bacterial, balance, virulence, investigated, salivary microbiota, surgical resection, patients, tongue cancer, stimulated, saliva, samples, tongue cancer, patients, pre-, post-resection, tongue, bacterial density, composition, quantitative PCR analysis, 16S ribosomal RNA, rRNA, gene sequencing, no significant, bacterial, saliva, pre-, post-surgery, bacterial, composition, analysis, similarity, operational, OTUs, abundance, proportions, OTUs, Streptococcus salivarius, Prevotella melaninogenica, Prevotella histicola, decreased, tongue resection, proportions, OTUs, Lautropia mirabilis, Neisseria flava, Streptococcus sanguinis, Fusobacterium nucleatum, inhabitants, dental plaque, increased, results, surgical resection, tongue, compositional shift, salivary microbiota, characterized, increase, bacterial species, dental plaque, periodontal pathogens, results, frequent, postoperative, oral care, surgical resection, tongue cancer]]\n",
      "[[OBJECTIVE, Microbiota, comparisons, healthy, diseased, dental tissues, cultivating, bacterial species, initiation, progression, dental caries, study, evaluate, bacterial, caries-active, caries-free children, Supragingival, plaque, samples, caries-active, caries-free, Middle Eastern, hypervariable V3-V4, bacterial, 16S rRNA gene, sequenced, Human Oral Microbe, Identification, Next Generation Sequencing, Microbial, community structure, composition analyses, processing, operational, taxonomic, Bioinformatic analyses, analysis, similarity, alpha, beta diversities, principal coordinate analysis, Diversity, indices, caries-active, caries-free groups, Similarity analysis, microbiota, composition, groups, Comparative analysis, species, level, abundance, Leptotrichia shahii, Prevotella melaninogenica, Veillonella dispar, Leptotrichia HOT, Streptococcus mutans, caries-active, children, Corynebacterium matruchotii, Lautropia mirabilis, Neisseria elongata, Corynebacterium durum, abundant, caries-free group, Species, Leptotrichia, Prevotella, Veillonella genera, predominant, caries-active, subjects, lack, association, Corynebacterium spp., dental caries, status, literature, species, caries-free children, research, health-associated, microbial, community, relationship, bacteria, dental biofilms, health, disease, preventing, dental caries, next generation sequencing techniques, study, complexity, caries, microbiome, identified, species/genera, virulence, protective properties]]\n",
      "[[cat, diagnosed, valvular aortic stenosis, acute respiratory distress, continuous heart murmur, physical exam, Echocardiographic examination, vegetative, lesions, aortic valve, shunting, blood flow, aorta, left atrium, treatment, left-sided congestive heart failure, cat died, aortic valve endocarditis, aorto-left atrial shunt, pathological examination, vegetative, lesions, luminal, surface, ascending aorta, antemortem, aerobic, 16s bacterial ribosomal DNA PCR, Bartonella PCR, causative organisms, Escherichia coli, postmortem, tissue culture, aortic, lesion, unique, case, primary valvular aortic stenosis, secondary infective aortic endocarditis, infective aortic endarteritis, aorto-left atrial fistula, cat, potential, adverse outcomes, aortic stenosis, humans, dogs]]\n",
      "[[study, assessed, presence, vector-borne, microorganisms, species, fleas, hosts, diverse, South-Western Europe, molecular methods, fleas, species, tested, presence, microorganisms, Wolbachia spp, endosymbionts, detected, Ctenocephalides felis, Pulex irritans, Archaeopsylla erinacei, Ctenophthalmus baeticus boisseauorum, specimens, Rickettsia felis, pathogen, detected, C. felis, A. erinacei, Ct, boisseauorum, Rickettsia typhi, agent, murine typhus, detected, A. erinacei, Mycobacterium spp, detected, fleas, C. felis, P. irritans, A. erinacei, species, Bartonella, detected, fleas, DNA, study, bacterium, genus, study, knowledge, flea-borne bacteria, South-West, Europe, reinforcing, increase, knowledge, flea-borne, pathogens]]\n",
      "[[knowledge, distribution, richness, epidemiological, soft ticks, genus Argas, incomplete, Spain, Argas species, ornitophilic nidicolous ticks, microorganisms, study, investigate, ticks, bird, nests, microorganisms, Ticks, natural cavities, nest-boxes, European rollers, Coracias garrulus, owls, Athene noctua, Southeastern, Central Spain, Ticks, morphologically, genetically, identified, DNA/RNA tick, extracts, analyzed, pooled, PCR assays, bacteria, Anaplasmataceae, Bartonella, Borrelia, Coxiella/Rickettsiella, Rickettsia spp., viruses, Flaviviruses, Orthonairoviruses, Phenuiviruses, protozoa, Babesia/Theileria spp., Argas, genotypes, identified, Argas reflexus, species, level, genotypes, Argas vulgaris, Argas polonicus, species, Western Europe, genotypes, clustered, Argas persicus, Spain, genotype, sequence, identity, Argas species, African Argas africolumbae, microbiological screening, infection, rickettsial strain, Rickettsia fournieri, Candidatus Rickettsia vini, group, ticks, ticks, genetically, A. vulgaris, A. polonicus, tick, endosymbionts, Coxiella, Francisella, Rickettsiella species, detected, tick, pools, Babesia, genotype, avian, Babesia, species, tick, pool, Anaplasmataceae, Bartonella, Borrelia, viruses, detected, Argas, genotypes, microorganisms, pathogenicity, Spain, nests, years, bird, species, transmission, tick-borne microorganisms, cavity-nesting, birds, semiarid, taxonomy, soft Argas ticks, microorganisms, epidemiology, zoonoses]]\n",
      "NaN\n",
      "[[retrospectively, PCR-confirmed, Bartonella infections, diagnosed, French reference center, bartonellosis, cat-scratch disease, endocarditis, Disseminated forms, bacillary angiomatosis, peliosis, hepatis, solid organ transplant, recipients]]\n",
      "[[Taxonomic, decisions, Rhizobiales, interpretations, 16S rRNA sequences, DNA-DNA hybridizations, DDH, bacterial species, strains, average, ANI, digital DDH, dDDH, ANI, values, genome sequences, type strains, species, Rhizobiales, computed, comparisons, cut-off, extract, genome clusters, maximal, cliques, Coupling, graph-based approach, dDDH, clusters, synonymy, Aminobacter lissarensis, Aminobacter carboxidus, Aurantimonas manganoxydans, Aurantimonas coralicida, Bartonella mastomydis, Bartonella elizabethae, Chelativorans oligotrophicus, Chelativorans multitrophicus, Rhizobium azibense, Rhizobium gallicum, Rhizobium fabae, Rhizobium pisi, Rhodoplanes piscinae, Rhodoplanes serenus, Chelatobacter heintzii, Aminobacter aminovorans, Bartonella vinsonii, arupensis, B. vinsonii, members, species, genome accessions, GCF_003024615.1, Mesorhizobium loti LMG, GCF_003024595.1, Mesorhizobium plurifarium LMG 11,892(T), GCF_003096615.1, Methylobacterium organophilum DSM 760(T), GCF_000373025.1, R. gallicum R-602 sp(T), species, descriptions, Xanthobacter autotrophicus, Py2, Aminobacter aminovorans, cases, misuse, type strain, Aminobacter heintzii, comb, reclassification, Aminobacter ciceronei, A. heintzii, downstream analysis, ANI, matrices, ProKlust, Prokaryotic Clusters, R package, graph-based approach, filter, clusters, identity/similarity matrices, settable, cut-off points, multiple, matrices, entries]]\n",
      "[[reports, prevalence, blood culture negative endocarditis, BCNE, South Africa, Tygerberg Endocarditis Cohort (TEC) study, prospective cohort study, patients, suspected, IE, Tygerberg Academic Hospital, Cape Town, South Africa, analysis, patients, patients, study, patients, BCNE, analysis, patients, BCNE, Bartonella species, causative organism, Mycoplasma species, identified, patients, Bartonella quintana, PCR, valvular tissue, causative organism, patients, urgent surgery, patients, Bartonella IE, age, years, gender, distribution, clinical features, clubbing, anemia, haematuria, acute, chronic severe regurgitant lesion, acute severe regurgitant lesion, aortic valve, patients, follow-up, period, days, diagnosis, adverse events, Bartonella-associated IE, BCNE, Western Cape of South Africa, Imaging, findings, patients, BCNE, significant, valvular destruction, vegetations, aortic valve, congenital, rheumatic valve disease, suspicion, Bartonella-associated IE]]\n",
      "NaN\n",
      "[[ectoparasite, Pthirus pubis, PtP, crab, pubic, louse, primates, Homo sapiens, literature, day, Medline, EMBASE, reviewing, pubic, louse's, origins, evolution, mankind, presentation, management, Medline, EMBASE, literature, databases, PtP, incidence, estimates, prevalence, adults, War, disasters, overcrowding, lice transmission, pubic, hair grooming, reduced, PtP, years, PtP, pubic, hair, infest, scalp, eyebrows, eyelashes, body hair, Reports, PtP, vector, Bartonella spp., Acinetobacter spp, studies, Transmission, contact, sexual abuse, concomitant, STIs, Symptoms, signs, pruritus, red papules, rust/brown deposits, feeding, faecal matter, Visualisation, live lice, diagnosis, treatments, hand-picking, combing, pediculicidal products, resolution, Permethrin, pyrethrins, first-line, recommendations, Resistance, pediculicides, head lice, PtP, data, lacking, Pseudo-resistance, poor, compliance, incorrect, ineffective, dosing, reinfestation, true resistance, pediculicide, class, second-line agents, phenothrin, malathion, ivermectin, Lice, humans, adaptability, habitat, challenges, trends, body hair-removal, survive]]\n",
      "[[Bartonella spp, zoonotic bacteria, small mammals, reservoirs, Bartonella spp, prevalence, small mammals, Myanmar, Sri Lanka, Small mammals, trapped, Sri Lanka, Myanmar, urban, surroundings, Spleens-derived DNA, screened, Bartonella spp, PCR, target, genes, Positive samples, sequenced, Results, small mammals, species, Bandicota bengalensis, Bandicota indica, Rattus exulans, Rattus rattus, Mus booduga, Suncus murinus, Myanmar, Bartonella, prevalence, Bandicoot, rats, Rattus rattus, Rattus exulans, Suncus murinus, prevalence, Myanmar, Sri Lanka, Sri Lanka, Bartonella spp, R. rattus, Myanmar, Bartonella, kosoyi, detected, Bartonella sp. KM2529, Bartonella sp. SE-Bart D, Bartonella henselae, Sri Lanka, B. phoceensis, Bartonella sp. KM2581, predominant, Bartonella spp, detected, investigated, mammal, species, Myanmar, Sri Lanka, Bartonella, kosoyi, B. henselae, zoonotic, mammals, urban, settlements, human bartonellosis]]\n",
      "[[internal microbiome, cat, dog fleas, DNA, evidence, pathogenic bacteria, Fleas, grouped, pools, parasitized, animal, DNA, extracted, investigated, 16S metagenomics, medically relevant, bacteria, definitions, International Statistical Classification of Diseases, WHO, MR, bacterial species, flea-pools, Acinetobacterbaumannii, Bacteroidesfragilis, Clostridiumperfringens, Enterococcusfaecalis, E. mundtii, Fusobacteriumnucleatum, Haemophilusaegyptius, Kingellakingae, Klebsiellapneumoniae, Leptotrichiabuccalis, L. hofstadii, Moraxellalacunata, Pasteurellamultocida, Propionibacteriumacnes, P. propionicum, Proteusmirabilis, Pseudomonasaeruginosa, Rickettsiaaustralis, R. hoogstraalii, Salmonellaenterica, Bartonella, Staphylococcus, Streptococcus species, B. henselae, B. clarridgeiae, fleas, cats, Rickettsiahoogstraalii, Propionibacteriumacnes, preference, fleas, stray animals, MR species, biofilm, human, exposure, flea-host, fitness, pathogenic bacteria, infection, fleas, transmission, diseases, investigated]]\n",
      "[[Cat-associated, Bartonella species, B. henselae, B. koehlerae, B. clarridgeiae, mild, severe, illness, humans, study, evaluated, serum samples, domestic cats, U.S., seroreactivity, species, strain, Bartonella, associated with, cats, B. henselae type 1, B. henselae type 2, B. koehlerae, B. clarridgeiae, indirect, IFA, seroprevalence, cutoff, titer, level, Seroreactivity, titer, level, cutoff, /=1:128, cutoff, /=1:256, observation, seroreactivity, East South-Central, South Atlantic, West North-Central, West South-Central regions, seroreactivity, detected, East North-Central, Middle Atlantic, Mountain, New England, Pacific regions, reactivity, Bartonella spp., antigens, samples, U.S., geographic regions]]\n",
      "[[Bartonella bacilliformis, B. bacilliformis, Bartonella henselae, B. henselae, Bartonella quintana, B. quintana, bacteria, verruga peruana, bacillary angiomatosis, vascular endothelial growth factor, lesions, humans, bacteria's, association, dermal niche, clinical suspicion, occult, infection, dermatologist, patients, melanoma, evidence, Bartonella spp., infection, one-month, period, patients, diagnosed, melanoma, volunteered, tested, evidence, Bartonella spp., exposure/infection, confocal immunohistochemistry, PCR, Bartonella spp, study, melanoma, tissues, patients, Blood, patients, seroreactive, PCR, positive, positive, modalities, Bartonella spp., exposure, Bartonella organisms, co-localized, VEGFC, immunoreactivity, visualized, multi-immunostaining confocal microscopy, skin sections, patients, co-culture, model, B. henselae, melanoma cell, cytoplasm, increased, vascular endothelial growth factor C, VEGFC, interleukin 8, IL-8, production, Findings, patients, investigations, Bartonella spp, melanoma pathobiome]]\n",
      "[[Cats, reservoir, host, Bartonella henselae(B. henselae, etiological agent, human bartonellosis, cat scratch disease, Bartonella DNA, amplified, salivary swabs, cats, dogs, humans, studies, investigating, Bartonella antibodies, oral fluid, inhouse, commercial, immunofluorescence antibody assays, IFA, study, detect, compare, antibodies, B. henselae, paired OF, serum specimens, cats, Specimens, shelter, client-owned cats, serum specimens, B. henselae, seroreactivity, inhouse, commercial, IFA assays, specimens, serum, specimens, moderate, Cohen's k, detection, B. henselae antibodies, Oral fluid antibodies, cats, B. henselae, serum, antibody, titers, compared, low, antibody, titers, B. henselae, IFA antibody, measurements, sensitive, serum IFA, measurements, Oral fluid antibodies, detected, cats, B. henselae, serum, antibody, titers, antibodies, detectable, IFA, epidemiological, diagnostic testing, cats]]\n",
      "[[PURPOSE, evaluate, intraocular, inflammation, Japanese, patients, cat-scratch disease, CSD, Retrospective clinical chart review, cases, consecutive, patients, affected, eyes, Kochi Prefecture, Japan, serologically, positive, Bartonella henselae, Bartonella quintana, infection, association, intraocular inflammation, reviewed, clinical manifestations, ocular complications, treatment, modalities, clinical charts, photographic records, reviewed, evidence, optic disc, lesions, macular star, foci, chorioretinitis, findings, patients, fever, time, presentation, patients, decreased, visual acuity, neuroretinitis, patient, retinochoroiditis, macular, involvement, patient, visual field defect, branch retinal artery occlusion, patients, visual disturbance, fever, cause, retinochoroidal, lesions, findings, eyes, patients, retinal hemorrhage, eyes, patients, optic disc, lesions, eyes, patients, serous retinal detachment, eyes, patients, macular star, eyes, patients, White retinal, retinochoroidal, foci, ocular posterior, manifestations, CSD, patient population, diagnosis, CSD, suspected, patients, fever, chorioretinal, white spots, absence, neuroretinitis, macular, star, intraocular, inflammation, CSD]]\n",
      "[[Liver rupture, pregnancy, acute condition, significant, risk, mother, fetus, tumors, hepatic adenoma, infective, abscess, granulomatous diseases, parasitic infections, rarely spontaneously, conditions, clinicoradiological, findings, histopathological, confirmation, case, ruptured, hepatic, diagnosis, Bartonella henselae infection, cat-scratch disease, pregnant lady]]\n",
      "[[year-round molecular epidemiological survey, hemoplasmas, Bartonella species, zoonotic, potential, client-owned cats, Beijing, Shanghai, specimens, hemoplasma-positive rate, Candidatus Mycoplasma haemominutum, Mycoplasma haemofelis, Candidatus Mycoplasma turicensis, Bartonella-positive rate, B. henselae, B. clarridgeiae, Age, breed, ectoparasiticide, stray history, city, season, gender, associated with, positive, rates, pathogens, prevalence, Candidatus Mycoplasma turicensis, cats, China]]\n",
      "[[Bartonella spp, B. quintana, B. henselae, culture-negative endocarditis, Serology, immunofluorescence assay, IFA, PCR, cardiac tissues, diagnosis, enzyme immunoassay, EIA, multiplex real-time PCR assay, Bartonella genus-specific, B. henselae-specific, B. quintana-specific SimpleProbe probes, diagnosis, Bartonella endocarditis, evaluate, performance, assays, patients, endocarditis, B. henselae, B. quintana, B. koehlerae, Diagnosis, PCR, DNA sequencing, surgical cardiac specimens, IFA, anti-Bartonella IgG, titers, /=1:800, patients, EIA, cross-reactivity, B. henselae, B. quintana, species-specific serodiagnosis, frequent, low-titer, cross-reactivity, Coxiella burnetii antibodies, B. henselae antigen, patients, Q fever endocarditis, Low-titer, cross-reactivity, patients, brucellosis, culture-positive endocarditis, Enterococcus faecalis endocarditis, Real-time PCR, explanted, results, sequence-based diagnosis, characteristic melting curves, genus-specific probe, identified, endocarditis-associated Bartonella spp, genus, level, EIA, coupled, real-time PCR assay, Bartonella endocarditis, diagnosis, diagnostic, disposal, clinical microbiologist, serology, diagnostic tool, incorrect, diagnosis]]\n",
      "[[Bartonella quintana, facultative, relapsing, fever, non-sterilizing immunity, cellular sanctuary, B. quintana, febrile, relapses, detection, B. quintana, dental pulp, specimens, long-term, half-life, dental pulp stem cells, DPSCs, candidates, capacity, DPSCs, internalize, microscopic particles, DPSCs, internalized, B. quintana, bacteria, Gimenez staining, fluorescence microscopy, localized, B. quintana, bacteria, DPSCs, internalization, cellular multiplication, DPSCs, one-month, follow-up, increase, bacterial, load, B. quintana-infected, DPSCs, Tumor Necrosis, Factor-alpha, production, Monocytes, Chemoattractant Protein-1, observations, DPSCs, shelters, long-term, persistence, B. quintana, host, experimental, clinical investigations]]\n",
      "[[outbreaks, trench fever, Bartonella quintana, soldiers, World Wars I and II, trench fever, cases, decreasing, worldwide, disease, homeless population, countries, prevalence, B. quintana, infection, Japan, unclear, blood, body louse, Pediculus humanus humanus, samples, homeless inpatients, body lice, time, emergency hospitalization, Tokyo, Patients, tested, B. quintana, infections, culture method, polymerase chain reaction, indirect, IFA, patients, tested, presence, Bartonella spp, genomic sequencing, DNA, samples, patients, blood culture, patients, body louse, samples, patients, Immunoglobulin G, B. quintana, detected, patients, cut-off titer, 1:256, IFA, B. quintana, infection, detected, samples, Tokyo, differential diagnoses, febrile, homeless, individuals]]\n",
      "[[study, prevalence, IgG antibodies, Bartonella sp., sample, population, patients, North Sanitary District of Jaen, immunofluorescent test, Focus-Technology IFA, Bartonella quintana, B. henselae test, healthy, individuals, sex, age groups, detected, subjects, IgG, seropositive, B. henselae, B. quintana, data, prevalence, Bartonella species, Andalusia, Southern Spain, statistical difference, seropositivity, groups, cases, IgG, antibody, titers]]\n",
      "NaN\n",
      "[[Cat scratch disease, Bartonella species, benign, self-limiting, condition, Systemic infection, immunocompetent, host, case, male, sudden painless, left eye blindness, brown-colored urine, Laboratory findings, serum creatinine, association, nephrotic-range proteinuria, glomerular hematuria, urinalysis, echocardiogram, mitral, tricuspid valve, vegetations, negative, blood cultures, left eye blindness, retinal artery occlusion, septic valvular embolus, Kidney biopsy, membranoproliferative glomerulonephritis, pattern, injury, pattern, immunofluorescent staining, subendothelial deposits, electron microscopy, elevated, immunoglobulin G, titers, B henselae, B quintana, patient, cats, home, Kidney failure, hemodialysis, diagnosis, systemic bartonellosis, doxycycline, months, rifampicin, months, echocardiogram, months, resolution, valvular vegetations, left eye blindness, permanent, case, diagnosis, systemic bartonellosis, institution, antibiotic therapy, partial, recovery, renal function, hemodialysis]]\n",
      "[[World Wars, Bartonella quintana, trench fever, agent, re-emerging infection, reports, B. quintana, exposure, evaluate, prevalence, populations, real-time PCR, detect, B. quintana, DNA, teeth, individuals, dating, centuries, archaeological sites, presence, negative controls, Fisher's exact test, compare, prevalence, B. quintana, civil, military populations, B. quintana, DNA, individuals, citizens, soldiers, positive, B. quintana, bacteraemia, study, analysed, studies, samples, presence, B. quintana, infection, course, human history, sites, European countries, positive, prevalence, positive, rate, soldiers, civilians, centuries, frequency, results, dental pulp, diagnosing, B. quintana, bacteraemia, populations, incidence, B. quintana, civilians, soldiers]]\n",
      "[[modern diphtheria-tetanus-pertussis, DTP, vaccines, vaccine, coverage, resurgence, pertussis, whooping cough, North America, Europe, vaccine, coverage, children, shift, incidence, infection, infants, older children, adolescents, prevalence, pertussis, older children, adults, Middle East, systematic, MEDLINE, EMBASE, BIOSIS, studies, published, January, information, pertussis, epidemiology, burden, illness, mortality, school-aged children, adolescents, adults, Middle East, Studies, identified, inclusion, reviewed, narratively, statistical, methodologies, results, surveillance data, weak, Middle Eastern countries, epidemiological studies, identified, Iran, Israel, Turkey, United Arab Emirates, Iraq, surveillance, clinical definitions, antibody, cut-off values, studies, seroprevalence, pertussis antibodies, adolescents, adults, exposed, pertussis, community, vaccine-acquired, immunity, childhood, countries, Middle East, diphtheria-tetanus-acellular pertussis, Tdap, booster, adolescents, national schedule, Israel, country, epidemiological data, population, Tdap, study, introduction, adolescent, booster, dose, decrease, pertussis, children, aged, years, results, Middle East, regions, pertussis, circulating, older age, groups]]\n",
      "[[PURPOSE OF REVIEW, intracellular, phase, extracellular, bacterial, pathogens, host's, immune system, antibiotics therapy, bacteria, bacterial, pathogens, airway diseases, extracellular infection, infectious diseases, lung, life-threatening, control, intracellular, persistence, pathogens, molecular adaptations, pathogens, niche, host's, response, potential, targets, relevance, examples, extracellular, pathogens, respiratory airway, intracellular, survival, proliferation, documented, infections, Staphylococcus aureus, Bordetella pertussis, Haemophilus influenzae, Pseudomonas aeruginosa, FINDINGS, studies, bacterial factors, adhesion, iron acquisition, intracellular, survival, target, combatting, bacterial infections, investigation, mechanisms, pathogenesis, persistence, bacteria, host, investigations, identifications, relevant, factors, bacterial, mechanisms, blocked, treat, improve, prevention strategies]]\n",
      "[[PURPOSE OF REVIEW, RTX, toxin, action, outcome, bacterial infections, progress, impacts, RTX, toxin, activities, host, immunity, FINDINGS, Bordetella pertussis, CyaA, activity, paralyzes, sentinel, phagocytic cells, cellular, levels, blocks, differentiation, infiltrating, monocytes, bactericidal macrophages, de-differentiation, resident, alveolar macrophages, monocyte-like cells, Vibrio cholerae, multifunctional autoprocessing repeats-in-toxins, MARTX, Rho, inactivating, alpha/beta-hydrolase, domain action blocks, mitogen-activated protein kinase signaling, epithelial cells, dampens, inflammatory responses, intestinal epithelia, blocking, immune cell, recruitment, action, actin crosslinking effector domain, Ras/Rap1-specific endopeptidase, RRSP, MARTX, phagocytic, ability, macrophages, Aggregatibacter actinomycetemcomitans, LtxA, action, neutrophil elastase, release, periodontal tissue, epithelial barrier, bacterial, spreads, tissue, Action, RTX, toxins, bacterial, pathogens, host, immune defenses, RTX, toxins, block phagocytosis, bactericidal reactive oxygen species, NO, production, RTX, toxins, reprogram, macrophages, bactericidal cell types, Autophagy, activity, V. cholerae, ABH effector, MARTX protein, Subversion, immune functions, RTX, toxins, bacterial survival, proliferation, host]]\n",
      "[[Rodents, reservoirs, carriers, infectious diseases, rats, predominant, cities, staying, humans, pets, animals, increase, transmission, risk, pathogens, Case Description, case, bacterial pneumonia, street rat, Rattus norvegicus, rat, dead, street, chief town of Marseille (France, car, necropsy, corpse, generalized granulomatous pneumonia, pulmonary lobes, Lung lesions, fibro-inflammatory areas, witness, infectious etiology, Bacterial isolation, lung tissues, Colonies, MALDI-TOF MS, 16S rRNA sequencing, bacteria, Staphylococcus cohnii, Bordetella bronchiseptica, Bordetella parapertussi, Corynebacterium glucuronolyticum, Pelistega suis, Rodentibacter rarus, histopathological, diagnosis, avoidance approach, etiological agent, pneumonia, R. rarus, Pasteurellales bacterium, Rodentibacter pneumotropicus, data, severity, R. rarus infection, rodents, potential, risk, animals, dogs, cats, birds, humans, health monitoring program, rodents, rabbits, pasteurellosis, R. rarus, pathological, Rodentibacterspecies, strains]]\n",
      "[[Pertussis, Bordetella pertussis, severe, respiratory disease, fatal, young infants, Vaccines, implemented, reduced, pertussis, incidence, disease, pertussis, vaccines, prevent, infection, transmission, B. pertussis, immunity, natural infection, live, attenuated, nasal vaccine, BPZE1, prevents, disease, B. pertussis, infection, preclinical models, vaccine, clinical development, clinical studies, vaccine, antibodies, pertactin, pertactin-deficient, BPZE1, derivative, BPZE1P, overcome, limitation, BPZE1P, colonized, murine, respiratory tract, BPZE1, induced, antibodies, levels, BPZE1, presence, antibodies, induced, acellular, pertussis, vaccination, BPZE1P, colonized, mouse, respiratory tract, BPZE1, vaccines, murine, lungs, noses, laboratory, clinical strains, B. pertussis, pertactin-deficient strains, acellular, pertussis, vaccines, efficient, BPZE1P, BPZE1, vaccine, limitations, antibodies, pertactin]]\n",
      "[[Background, Pertussis, infectious disease, Gram-negative bacterium, Bordetella pertussis, Peru, actual, public, vaccination, B. pertussis, mandatory, generalized, detected, cases, study, prevalence, B. pertussis, children, years, age, presumptive diagnosis, whopping cough, Cajamarca, region, northern Peru, Materials, Methods, population, cross-sectional study, children, years, cases, pertussis, nasopharyngeal samples, analyzed, real-time PCR, detection, B. pertussis, B. pertussis, PCR, sample, clinical presentation, paroxysmal coughing, difficulty breathing, cyanosis, post-tussive emesis, pneumonia, complication, patients, PCR+, B. pertussis, lymphocytosis, leukocytosis, patients, decreased, leukocytosis, lymphocytes, patient, leukopenia, relative lymphocytosis, percentage, unvaccinated, children, PCR+, group, mother, frequent, symptom carrier, population, rate, PCR+, cases, B. pertussis, Laboratory values, leukopenia, lymphopenia, patients, pertussis, laboratory diagnostic tests, infants, respiratory symptoms, B. pertussis, clinical diagnosis, overestimates, diagnosis, pertussis]]\n",
      "[[Global Pertussis Initiative recommends diphtheria-tetanus-pertussis, DTP3, vaccination, infants, aged, year, African countries, vaccination, pregnant women, primary prevention strategy, older children, adults, transmission, pertussis, Africa, systematic, MEDLINE, EMBASE, BIOSIS, studies, published, January, information, pertussis, epidemiology, burden, illness, mortality, school-aged children, adolescents, adults, Africa, Studies, identified, inclusion, reviewed, narratively, statistical, methodologies, Studies, North Africa, Morocco, Tunisia, Algeria, DTP4, vaccine, coverage, severe, pertussis-related, complications, young, children, vaccine-acquired immunity, adolescents, household contacts, transmitters, infection, serosurvey, Gambia, general population, pertussis, antibody, levels, infection, studies, Senegal, pertussis, infection, endemic, DTP3, coverage, pertussis, outbreak, Ethiopia, case fatality rate, overall, children, aged, years, study, South Africa, incidence, pertussis, hospitalized children, infection, rates, HIV-exposed, children, compared, uninfected, children, burden, pertussis, Africa, infants, surveillance, lacking, African countries, burden, pertussis, infants, infection, rates, older children, adults]]\n",
      "[[Bordetella bronchiseptica, rare, cause, respiratory tract infection, humans, immunocompromised, individuals, infected, animals, colonizes, respiratory tract, infection, dogs, cats, rabbits, immunocompromised, patients, life-threatening, infections, immunocompetent, individuals, report, case, B. bronchiseptica, bacteremia, patient, decompensated, liver cirrhosis, animal, exposure]]\n",
      "[[Neuromedin U, NMU, peptide, mammals, physiological processes, impairment, pancreatic beta-cell function, induction, mitochondrial dysfunction, endoplasmic reticulum, stress, suppressing, insulin secretion, NMU, receptors, NMU receptor 1, NMUR1, NMUR2, G-protein-coupled receptors, GPCRs, NMUR1, expressed, mouse, islets, beta cell-derived MIN6-K8 cells, molecular mechanisms, insulinostatic action, NMUR1, beta cells, study, molecular mechanism, impairment, insulin secretion, beta cells, NMU-NMUR1, axis, Pretreatment, Galphai/o inhibitor, Bordetella pertussis toxin, PTX, Galphaq inhibitor, YM254890, NMU-induced, suppression, glucose-stimulated, insulin secretion, calcium response, beta cells, Knockdown, Galphai2, Galphao, beta cells, NMU-induced, suppression, insulin secretion, gene alterations, mitochondrial fusion, Mfn1, Mfn2, fission, Fis1, Drp1, mitophagy, Pink1, Park2, mitochondrial dynamics, Pgc-1alpha, Nrf1, Tfam, ER stress, Chop, Atp2a3, Ryr2, Itpr2, intracellular, ATP, level, mitochondrial membrane, potential, NMU, decreased, forskolin-stimulated, intracellular, cAMP, mouse, human, islets, NMUR1, coupled, PTX-sensitive, Galphai2, Galphao proteins, beta cells, intracellular, Ca2, influx, cAMP, level, beta-cell dysfunction, impairment, results, signaling, mechanism, NMU, investigation, NMU, functions, beta-cell biology]]\n",
      "[[Bordetella species, isolated, animals, humans, asymptomatic infection, lethal pneumonia, isolation, bacteria, extra-host, environmental niche, characterized, genomic plasticity, antibody response, Bordetella bronchiseptica strain HT200, isolated, thermal, spring, Genomic ANI value, SNPs-based, phylogenetic tree, divergent, evolution, strain HT200, human-adapted, lineage, B. bronchiseptica, Growth, survivability, strain HT200, viability, weeks, filter-sterilized spring, water, genes, loci, encoding, Bordetella virulence factors, DNT, ACT, LPS, O-antigen, absent, strain HT200, genes, encoding, virulence factors, divergent, Phenotypically, strain HT200, non-hemolytic, weak, hemagglutination, activity, colonize, respiratory organs, mice, infection, vaccination, strain HT200, induced, protective antibody, mouse, infection, virulent, B. bronchiseptica, strain RB50, genome, strain HT200, presence, accessory genes, operons, encoding, metabolic functions, ecological, thermal, spring]]\n",
      "[[respiratory pathogens, Bordetella pertussis, Bordetella bronchiseptica, type III secretion system, T3SS, BteA effector protein, host cells, effector, functional domains, N-terminal lipid raft-targeting (LRT) domain, cytotoxic, C-terminal domain, induces, non-apoptotic, caspase-1-independent, host cell, molecular mechanisms, interaction, BteA, plasma membrane, cytotoxic activity, course, Bordetella infections, protein-lipid overlay assay, surface plasmon resonance, recombinant, negatively-charged membrane phospholipids, dissociation, constants, LRT domain binding, phosphatidylinositol 4,5-bisphosphate, PIP2, phosphatidic acid, PA, phosphatidylserine, PS, PS, PIP2, target, LRT domain, BteA, plasma membrane, yeast cells, membrane, association, electrostatic, hydrophobic, interactions, LRT, leucine, residue, L1 loop, helices, four-helix bundle, charge-reversal substitutions, L1 region, disrupted, plasma, localization, BteA effector, cytotoxic activity, B. bronchiseptica, infection, HeLa cells, LRT-mediated, targeting, BteA, cytosolic leaflet, plasma membrane, host cells, effector, cytotoxicity]]\n",
      "[[Bordetella species, respiratory infections, humans, animals, Bordetella bronchiseptica, B. bronchiseptica, infection, pathogen, humans, clinical spectrum, infections, SARS-CoV-2, viral pneumonia, variable, severity, patients, acute respiratory distress syndrome, ARDS, mechanical ventilation support, Transplant, patients, coronavirus disease, COVID-19, mortality, Bacterial, coinfection, pneumonia, patients, COVID-19, renal transplant, patient, COVID-19, pneumonia, B. bronchiseptica, superinfection, clinical, radiological response, azithromycin, treatment]]\n",
      "[[C-reactive protein, CRP, acute-phase protein, dogs, bacterial, bronchopneumonia, pulmonary conditions, Bronchopneumonia, Bordetella bronchiseptica, Bb, increase, CRP, concentration, infected, dogs, CRP, concentrations, dogs, Bb infection, radiographic, pulmonary lesions, dogs, aspiration bronchopneumonia, ABP, ANIMALS, dogs, Bb infection, dogs, ABP, Retrospective study, C-reactive protein, concentrations, thoracic radiographs, dog, dogs, Bb infection, alveolar lesions, dogs, CRP, concentration, increased, dogs, alveolar, lesions, CRP, concentration, dog, increased, CRP, concentration, dogs, alveolar lesions, dogs, alveolar lesions, dogs, Bb infection, median, duration, clinical signs, dogs, CRP, concentration, dogs, increased, concentration, dogs, Bb infection, alveolar lessions, median, CRP, concentration, dogs, ABP, dogs, APB, CRP, marker, diagnosis, dogs, suspected, bordetellosis, Confirmation, Bb infection, lower, airway, sampling]]\n",
      "[[Antibiotic resistance, bacteria, global threat, animal, public health, detecting, occurrence, control strategies, Monitoring programmes, antibiotic resistance, food-producing, animals, European Union, zoonotic bacteria, Salmonella enterica, Campylobacter coli, Campylobacter jejuni, indicator, bacteria, Escherichia coli, Enterococcus faecalis, Enterococcus faecium, pan-European statutory, antibiotic susceptibility, veterinary, bacterial, pathogens, food animals, issue, stimulate, Recommendations, authors, scientific literature, expert, international meetings, monitoring, susceptibility, veterinary, pathogens, veterinary, pathogens, Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, E. coli, Histophilus somni, Mannheimia haemolytica, Pasteurella multocida, Staphylococcus aureus, Streptococcus spp, food, animal, species, cattle, pigs, poultry, organisms, tested, harmonised panels, antibiotics, dilution, ranges, broth microdilution method, antibiotics, dilution, ranges, rationale, inclusion, ranges, incorporation, microtitre plates, organism, tested, single plate, recommendations, UK, monitoring, susceptibility, veterinary, bacterial, pathogens]]\n",
      "[[Bordetella bronchiseptica, B. bronchiseptica, obligately aerobic, oxidase-, catalase-positive, nonfermentative Gram-negative coccobacillus, study, immune effects, Rg1, Rg1, oil, adjuvants, inactivated, B. bronchiseptica, vaccine, rabbits, mechanism, adjuvant effect, Rg1, oil, vaccine, Rg1, oil, improved, immune effect, B. bronchiseptica, vaccine, humoral, cellular levels, increased, levels, IL-2, IL-4, rabbits, immunization, Rg1, plus oil, increased, TLR2, expression, downregulated, NF-kappaB, splenocytes, Rg1-oil adjuvant, increase, levels, IL-2, IL-4, upregulating, TLR2, enhancing, immune effect, B. bronchiseptica, vaccine, Rg1, oil, potential, vaccine adjuvant, rabbit, B. bronchiseptica, vaccine]]\n",
      "[[comparative study, pharmacokinetics, long-acting, enrofloxacin, injectable formulations, investigated, healthy, pigs, intramuscular, injection, body weight, drug concentrations, plasma, computed, high-performance liquid chromatography, HPLC, fluorescence detection, WinNonLin5.2.1 software, experimental data, compared, one-way ANOVA, SPSS software, confidence interval, CI, pharmacokinetic, parameters, maximum, plasma, concentrations, Cmax, maximum, concentration, Tmax, area, time curve concentration, AUCall, Terminal, half-life, T1/2, 694.84 +/- 163.49, enrofloxacin, Alkali, enrofloxacin, Acidic, Yangkang, control drug, Nuokang(R, Cmax, Tmax, AUCall, formulations, compare, reference formulation, No significant, T1/2, tested, formulations, compare, reference formulation, pharmacokinetic, parameters, tested, formulations, calculated, PK/PD, effective, bacteria, Actinobacillus pleuropneumoniae, Pasteurella multocida, values, cut-off points, Cmax/MIC90>/=10, AUC/MIC90, bacteria, Haemophilus parasuis, Streptococcus suis, E. coli, Bordetella bronchiseptica, lower values]]\n",
      "[[emergence, coronavirus, SARS-CoV-2, evaluation, potential, SARS-CoV-2 infection, dogs, cats, data set, evaluated, frequency, SARS-CoV-2, respiratory pathogens, samples, respiratory testing, SARS-CoV-2 real-time PCR, validated, canine, feline, samples, respiratory pathogen panel testing, laboratories, Asia, Europe, North America, tested, SARS-CoV-2, frequency, respiratory pathogens, February-April, period, Samples, patients, study, canine, feline, samples, PCR, positive, Mycoplasma cynos, Bordetella bronchiseptica, Mycoplasma felis, feline calicivirus, SARS-CoV-2 infections, identified, Positive results, respiratory samples, years, data, study, emergence, SARS-CoV-2 pandemic, early, respiratory diseases, tested, pet, cats, dogs, veterinary, pathogens, SARS-CoV-2 infections, dogs, cats, rare]]\n",
      "[[Evaluation, short-term, long-term, immunological, responses, preclinical model, targeted, relevant, vaccination schedule, human, vaccine, development, Gottingen minipig model, assessed, pertussis, vaccines, vaccine, antigen-specific, humoral, cellular responses, IgG, titers, functional antibodies, Th polarization, memory B cells, assessed, longitudinal study, vaccination, priming, whole cell, DTwP, acellular, DTaP, pertussis, vaccine, neonatal, infant minipigs, Tdap acellular, vaccine, Single cell RNAsequencing, long-term, maintenance, immune memory cells, functionality, animal model, DTaP, DTwP, vaccination, induced, pertussis toxin, PT, neutralizing antibodies, cellular immune response, characterized, Th, polarization, Th-2-biased, response, DTaP, Th-1/Th-17-biased, response, DTwP., No difference, maintenance, pertussis-specific, memory B cells, DTaP-, DTwP-primed animals, months, post, Tdap, boost, increase, pertussis-specific, T cells, DTaP, primed minipigs, up-regulation, genes, antigen, presentation, interferon pathways, minipig, model, humoral, cellular immune responses, induced, humans, DTwP, DTaP, priming, Tdap, boosting, data, Gottingen minipig, preclinical model, long-term, immunogenicity, human, vaccines, Bordetella pertussis, vaccines, pathogens]]\n",
      "[[Whooping cough, pertussis, Bordetella pertussis, respiratory disease, age groups, severe, fatal, pertussis, young children, whole-cell, acellular, vaccines, reduced, disease, incidence, world, rebound, Cocoon, maternal, immunization, countries, intrinsic, limitations, pertussis, novel, vaccines, disease, prevent, B. pertussis, infection, transmission, case, vaccines, approaches, administration, routes, nasal immunization, improvement, acellular, vaccines, antigens, T-cell-promoting, adjuvants, development, novel, vaccines, outer membrane, live, attenuated, vaccines, live, attenuated, vaccine, assessed, safety, immunogenicity, preclinical models, mice, clinical development, vaccines, neonates, safety, immunogenicity, assessment, pre-clinical, neonatal, models, clinical trials, review, pertussis, problem, animal models, vaccine, approaches]]\n",
      "[[Rapid, antibiotic susceptibility testing, AST, fighting, multidrug-resistant bacteria, organisms, oscillate, nanometers, oscillations, nanomotion, stop, organism dies, development, AST, techniques, monitoring, oscillations, exposure to, antibiotics, review, working principle, technique, compare, method, ASTs, application, advice, implementation, application, technique, pathogenic, Bordetella pertussis bacteria]]\n",
      "[[Lyme disease, vector-borne illness, Switzerland, Lyme arthritis, manifestation, late-stage, Lyme disease, monoarthitis, oligoarthritis, joints, knee, clinical presentation, positive, polymerase chain reactions, synovial fluid/tissue, diagnostic, tick bite, erythema migrans, patient's, diagnosis, differential diagnoses, initial, treatment, prolonged, course, oral antibiotics]]\n",
      "[[Lyme neuroborreliosis, peripheral facial palsy, LNB, PFP, idiopathic peripheral facial palsy, Bell's palsy, BP, facial palsy, borrelia-endemic areas, clinically, Early treatment, corticosteroids, effective, Bell's palsy, antibiotics, improve, outcome, LNB, knowledge, corticosteroids, antibiotic, treatment, outcome, LNB, PFP, prospective open trial, historical controls, hospitals, western Sweden, Adults, LNB, PFP, study group, treated with, oral doxycycline, days, prednisolone, days, tapered, days, historical controls, adult, patients, LNB, PFP, studies, treated with, oral doxycycline, groups, follow-up, lumbar puncture, recovery, months, patients, study group, control group, patients, study group, patients, control group, sequelae, statistically significant, groups, proportion, patients, sequelae, decline, CSF, mononuclear cell count, Adjunctive corticosteroids, impair, outcome, patients, Lyme neuroborreliosis, peripheral facial palsy, treated with, doxycycline]]\n",
      "[[Spirochetes, family Borreliaceae, tick-borne, pathogens, vertebrates, family, genera, Borrelia, Swellengrebel, agents, relapsing, fever, avian, spirochetosis, bovine borreliosis, Borreliella, agents, Lyme disease, Borrelia burgdorferi sensulato complex, genera, disease, associations, biological, features, tick, vector, tissue, location, unfed ticks, transovarial transmission, Borrelia species, transmitted, argasid, ticks, relationships, tick, vectors, Borrelia species, Borreliella species, ixodid, ticks, vectors, division, genera, phylogenomic, evidence, genomes, molecular markers, phylogenetic criteria, species, isolates, Borrelia, ixodid ticks, reptiles, monotreme, birds, deep branching, family, spirochetes, inferences, evolution, family, discovery, microorganisms, gut microbiota, arachnids, ancestral origin, family, symbionts, ticks, arachnids]]\n",
      "[[Lyme disease, tick-transmitted disease, northern hemisphere, spirochete, Borrelia burgdorferi, Borrelia species, constellation, symptoms, malady, result, vascular dissemination, B. burgdorferi, body, invade, tissue types, mechanism, spirochetes, blood vessel wall, distant tissues, process, observation, spirochetes, microvasculature, living mice, multilaser spinning-disk intravital microscopy, results, experimental system, phagocytizing, B. burgdorferi, host, neutrophils, production, cytokines, activate, endothelium, potentiate, B. burgdorferi, escape, tissue, Spirochete, escape, induced, paracellular permeability, transcellular pathway, Neutrophil, repurposing, bacterial, extravasation]]\n",
      "[[Peptidoglycan, cell wall, Lyme disease, LD, spirochete, Borrelia burgdorferi, Bb, structural, morphological, integrity, Bb, persistent antigen, LD, patients, pentapeptide, L-Ornithine, amino acid, cross-links, glycan, polymers, borrelial homolog, BB_0167, borrelilal PG, peptidoglycan, MHELSEKRARAIGNYL, localized, protoplasmic cylinder, Bb, Borrelia peptidoglycan interacting Protein, BpiP, bpiP, mutant, in vitro, growth, conditions, levels, virulence-related proteins, burden, bpiP, mutant, C3H/HeN mice, day, post-infection, control strains, bpiP, mutant, re-isolated, tissues, day, post-infection, bpiP, mutant, colonize, immunodeficient, SCID, day, post-infection, Acquisition, transmission, bpiP mutant, Ixodes scapularis, larvae, nymphs, mice, control strains, analysis, bpiP mutant, increased, sensitivity, vancomycin, osmotic stress, lysosomal extracts, human, antimicrobial peptide cathelicidin-LL37, complement-dependent, killing, presence, day, post-infection, mouse serum, increased, internalization, CFSC-labeled bpiP mutant, macrophages, dendritic cells, control strains, studies, accessory protein/s, integrity, PG, cell envelope, phases, Bb infection]]\n",
      "[[literature, Lyme disease, paradoxical, changing, deer, populations, decrease, deer, reduce, incidence, Lyme disease, decreasing, host, populations, ticks, tick, populations, enhance, incidence, Lyme disease, reservoir-incompetent, hosts, ticks, forcing, vector, reservoir-competent, diseased, hosts, feed, review, field studies, impact, changing, deer, populations, results, manuscript, investigate, hypothesis, balance, responses, deer, populations, relative population, sizes, reservoir-competent, reservoir-incompetent, hosts, presence, host, preference, larval, adult, stages, temperature, seasonal model, Borrelia burgdorferi sensu stricto, Lyme disease, transmission, host, reservoir-competent infected, uninfected, hosts, reservoir-incompetent, hosts, system, nonlinear ordinary differential equations, model, results, tick, vector, Ixodes scapularis Say, hosts, investigate, effects, reservoir-incompetent, host, removal, tick, populations, disease prevalence, sizes, reservoir-competent hosts, reservoir-incompetent, hosts, simulation, results, model, host, preference, accurate, host, preference, results, removal, adult, hosts, questing, nymph populations, levels, questing, adult, abundance, lack, adult, hosts, dilution, effect, low, reservoir-competent, host, populations, amplification, effect, reservoir-competent, host, populations]]\n",
      "[[Arthritis, symptoms, late-stage borreliosis, untreated, patients, Lyme disease, manifestation, orthopedic surgeons, authors, case, patient, working, forester, left hip replacement arthroplasty, contracted, Borrelia burgdorferi infection, hospitalized, years, infectious ward, suspected, neuroborreliosis, treated with, Ceftriaxone, intravenously, weeks, time, tomographic examination, spinal cord, herniated nuclei, levels, L4/L5, L5/S1, left lateral recess, narrowing, intervertebral holes, compressing, nerve, roots, left side, L5, total hip replacement, patient's, left hip joint, neuroborreliosis, process, hip joint, destruction]]\n",
      "[[DOI]]\n",
      "[[Lyme borreliosis, LB, vector-borne diseases, transmitted, ticks, Borrelia burgdorferi sensu lato, genospecies, Almaty oblast, Kazakhstan, endemic, LB, gaps, tick, surveillance, LB agents, region, evaluated, B. burgdorferi s.l, prevalence, ixodid ticks, bitten, people, seroprevalence, antibodies, B. burgdorferi s.l, residents, Almaty oblast, Kazakhstan, samples, Borrelia burgdorferi s.l., DNA, detected, I. persulcatus ticks, humans, city, Almaty, Talgar, Karasay, districts, Multilocus sequence typing, identified, B. afzelii sequence types, I. persulcatus, seroprevalence, IgG antibodies, B. burgdorferi s.l, analyzed, population, detected, results, active, circulation, B. burgdorferi s.l, Almaty oblast, Kazakhstan, LB, preventive measures, region]]\n",
      "[[Rocky Mountain elk, Cervus canadensis, populations, economic, cattle, industry, reservoir, Brucella abortus, Yellowstone, Vaccination, intracellular, bacterial diseases, elk populations, negligible, adaptive cellular immune response, lack, genomic resources, vaccination, induce, protective immunity, limitation, PacBio, Illumina, Hi-C sequencing, coverage, assemble, elk, genome, pseudomolecules, robust, gene annotation, gene models, mRNAs, accuracy, assembly, assessed, synteny, red deer, cattle, genomes, chromosomal rearrangements, fusions, fissions, genome assembly, annotation, genome-enabled, exploration, Cervus species, conservation, immune system-related genes, cattle, immune system-related genes, elk, genome, elk]]\n",
      "[[Brucellosis, species, genus, Brucella, zoonotic disease, humans, animal, species, worldwide, Information, Brucella species, circulating, hosts, Kenya, adoption, targeted control strategies, study, multi-host, livestock, populations, Kenya, detect, circulating, Brucella species, assess, evidence, host-pathogen, associations, Serum samples, cattle, goats, sheep, camels, humans, Narok, Marsabit, counties, Kenya, Information, age, location, history of, abortion, placenta, sampled, livestock, Data, age, gender, location, residence, human, participants, samples, tested, genus, level, primers, IS711, bcsp31, targets, detection, Brucella, genus, positive, targets, speciation, assay, AlkB, BMEI1162, targets, B. abortus, B. melitensis, Samples, adequate, quantities, aggregating, tested, Rose Bengal Test, RBT, livestock, human, positive, genus, Brucella, Animal, Brucella PCR, positively, RBT, positive, OR, CI, Humans, aged, years, higher, odds, OR, CI, Brucella PCR, positive, age, categories, data, detection, Brucella species, B. abortus, detected, cattle, OR, CI, camels, OR, CI, B. melitensis, detected, sheep, OR, CI, goats, OR, CI, B. abortus, B. melitensis, DNA, detected, humans, livestock, host, species, cross-transmission, species, hosts, detection, zoonotic, Brucella species, humans, Health prevention strategies, target, host, species, multi-host, livestock, populations]]\n",
      "[[Brusellosis, world's, bacterial, zoonotic infection, endemic, countries, clinical, appearance, brucellosis, course, severity, infection, study, relationship, laboratory, parameters, clinical response, organ, involvement, patients, Brucellosis, diagnosed, diagnostic tests, study, patients, diagnosis, Brucellosis, admitted, Department of Infectious Diseases, Clinical Microbiology, positive, Brucella tube agglutination tests, clinic, Brucellosis, Patients, weeks, Patients, hip pain, low back pain, evaluated, sacroiliac magnetic resonance imaging, MRI, lumbar MRI, sacroiliitis, spondylodiscitis, Patients, liver, bone marrow, sacroiliitis, spondylodiscitis, orchitis, patients, organ, involvement, weeks, decline, complaints, clinical response, week, treatment, platelet distribution width, PDW, mean platelet volume, MPV, levels, patients, clinical response, patients, clinical response, statistically significant, Platelet, platelet lymphocyte ratio, PLR, level, patients, organ, involvement, weeks, treatment, patients, organ, involvement, statistically significant, week, week, patients, organ, involvement, non-organ, involvement, area, ROC curve analysis, PLR, treatment, cut-off value, sensitivity, specificity, level, platelet, treatment, ROC curve analysis, patients, organ, involvement, non-organ, involvement, area, cut off value, sensitivity, specificity, week, treatment, area, ROC curve analysis, PDW, level, patients, clinical responses, cut-off value, sensitivity, specificity, ROC curve analysis, MPV, clinical response, area, cut-off value, sensitivity, specificity, result, evaluation, clinical response, termination, treatment, patients, Brucellosis, MPV, PDW, values, evaluation, organ, involvement, platelet level, PLO, biomarkers, clinically]]\n",
      "[[sense, environmental, cues, adaptation, survival, living organisms, bacteria, process, multidomain, sensor, histidine kinases, autophosphorylation, response, stimuli, downstream signaling cascades, molecular mechanism, allosteric activation, sensor, proteins, crystal structure, blue light photoreceptor, LOV histidine kinase, LOV-HK, light-dependent, virulence, pathogenic, Brucella abortus, dark, light structures, signaling states, LOV-HK, transitions, symmetric dark, structure, asymmetric light state, local, structural signal, chromophore-binding LOV domain, dimer asymmetry, coiled-coil rotary switch, helical bending, helical spine, amplified, structural, enhanced, conformational, flexibility, large-scale rearrangements, phosphoryl transfer reaction, HK, domain, Bacteria, two-component systems, TCSs, sense, changes, surroundings, core, TCS signaling pathway, multidomain, sensor, histidine kinase, enzymatic activity, output domain, allosterically controlled, perceived, sensor, domain, structures, dynamics, light-sensitive histidine kinase, pathogen, Brucella abortus, full-length, truncated constructs, comparisons, structures, signaling states, protein motions, asymmetric dimer framework, response to light, Findings, mechanistic, modular sensory proteins, modular, architecture]]\n",
      "[[genetic diversity, host, species, Brucella genus, concept, Brucella, ocean, fishes, marine mammals, pond dwelling, amphibians, forest foxes, desert rodents, cave-dwelling, bats, Brucella, niches, microbiological techniques, strains, true relationships, species, relatives, Brucella, soil bacteria, adaptations, Brucella spp, live, intracellularly, genus, live, vertebrate, hosts, species, phenotypes, intermediate, soil bacteria, core, Brucella, ancestral, traits, lost, traditional, species, relationships, Brucella species, sequence, fragment-based approaches, genomics, genomes, genomes, fine-scale, resolution, relationships, evolutionary history, genus, decades, hosts, diversity, environments]]\n",
      "[[Brucellosis, infectious, zoonotic disease, severe, threats, human, health, social-economic development, comparing, low, sensitive, non-quantitative, protein G, prG, europium nanospheres, EuNPs, detection probe, Brucella lipopolysaccharide, LPS, capture antigen, time-resolved fluorescence lateral flow immunoassay, TF-LFIA, anti-Brucella IgG, antibody, human, plasmas, testing, purity, purified, LPS, cross-reacted, Y. enterocolitica O9, diagnostic antibody, sera, patients, Gram-negative bacterial infections, coefficient of determination, R(2)=0.9961, limit of detection, LOD, Serological Agglutination Test, SAT, Rose-Bengal Plate Agglutination Test, RBPT, colloidal, gold, LFIA, CG-LFIA, Intra-day, inter-day precisions, CV, coefficient variation, TF-LFIA, intra-day, inter-day, accuracies, correlation coefficient, TF-LFIA, measurement, concentrations, spiked, Brucella antibody, TF-LFIA, reliability, reproducibility, TF-LFIA, specificity, sensitivity, accuracy, detection, Brucella antibody, clinical samples, SAT, RBPT, TF-LFIA, rapid, quantitative immunoassay, early diagnosis, epidemiological surveillance, Brucella infection, humans]]\n",
      "[[Objective, study, seroprevalence, Brucella spp, goats, Bangladesh, Materials, Methods, study, goat-populated regions, Bangladesh, serum samples, goats, Jashore, Jhenidah, Tangail, Savar, Thakurgaon, Bandarban, samples, presence, antibodies, Brucella spp, bengal plate test, RBPT, competitive, enzyme-linked immunosorbent assay, c-ELISA, seroprevalence, Brucellosis, goats, RBPT, c-ELISA, seroprevalence, brucellosis, RBPT, buck, doe, Jashore, buck, doe, Jhenidah, buck, doe, Tangail, buck, doe, Savar, buck, doe, Bandarban, buck, doe, Thakurgaon, seroprevalence, brucellosis, c-ELISA, buck, doe, Jashore, buck, doe, Jhenidah, buck, doe, Bandarban, buck, doe, Thakurgaon, Brucellosis, prevalent, aging, years, Goats, Bangladesh, caring antibodies, Brucella organisms, bacteriological investigations]]\n",
      "[[matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry, rapid, accurate, clinical, isolates, gaps, rare, pathogenic, species, databases, multicenter study, evaluated, accuracy, VITEK MS v3.2 database, isolates, identification, DNA sequence analysis, isolates, species, group/complex level, isolates, genus, level, tests, identification, tests, discordant, identification, reference, identification, VITEK MS, MALDI-TOF MS system, members, Acinetobacter baumannii complex, species, level, protocol, special analysis method, findings, VITEK MS v3.2 database, accurate, identification, bacteria, fungi, clinical laboratory, species, Candida auris, pathogenic, Brucella species]]\n",
      "NaN\n",
      "[[Brucellosis, zoonotic diseases, distribution, incidence, brucellosis, regions, public health, world, study, prevalence, quantity, Brucella spp, sheep, goat, milk, artisanal, cheeses, North-west, Iran, evaluate, intrinsic, parameters, survival, Brucella spp, cheese, properties, pH, salt, moisture, storage, time, selling, assessed, samples, sheep, milk, goat raw milk, local, artisanal, samples, artisanal cheeses, manufactured, raw, sheep, goat milk, results, quantitative real-time PCR, qPCR, sheep, milk, goat raw milk, artisanal, samples, positive, Brucella spp, comparison, culture assay, qPCR, sensitive, detection, Brucella spp, results, Brucella spp., load, sheep, goat, milk, artisanal cheeses, positive, correlation, Brucella, load, detection, Brucella spp, culture assay, Data, correlation, load, Brucella spp, qPCR, pH value, salt, content, storage, period, cheese, samples, Brucella spp., load, moisture, content, results, cheese, samples, pH value, storage, period, months, contamination, Brucella spp, detected]]\n",
      "[[Issues, re-emerging, infectious diseases, antimicrobial resistance, food security, biosafety, biosecurity, associated with, changes, land use, population growth, urbanization, global travel, trade, climate change, result, trans-disciplinary approach, human, animal, environmental, health disciplines, Indian Council of Medical Research (ICMR, Indian, ICAR, National Institute of One Health at Nagpur, Maharashtra, India, context, collaborative research projects, ICAR, ICMR, epidemiological, surveillance, zoonotic diseases, Central India, Disease surveillance, molecular detection, standard techniques, enzyme linked immunosorbent assay, ELISA, immuno-fluroscent assay, IFA, standard tube agglutination test, STAT, Rose Bengal plate test, RBPT, polymerase chain reaction, PCR, disease, screened, animals, seropositivities, listeriosis, brucellosis, occurrence, tuberculosis, leptospirosis, detected, PCR, cross-sectional studies, suspected, human, population, associated risk factors, zoonotic diseases, seropositivity, brucellosis, listeriosis, leptospirosis, scrub typhus, investigations, scrub typhus, bimodal pattern, months, pre-monsoon, post-monsoon, season, post-monsoon, human, cases, Ornithonyssus bacoti, mites, rodents, vector, Orientia tsutsugamushi, bovine tuberculosis, detected, human, cases, molecular assay, Interpretation, conclusions, data, occurrence, zoonotic diseases, affecting, livestock, health, human wellbeing, scientific collaboration, veterinary, medical faculties, effective, implementation, One Health (OH) programme, establishment, National Institute of OH]]\n",
      "[[study, effects, vaccination, brucellosis, clostridia, intake, performance, feeding behavior, blood parameters, immune responses, dairy heifers, calves, heifers calves, Gyr, Zebu, Bos taurus indicus, Holstein x Gyr, days, age, animals, groups, B, vaccinated, brucellosis, C, vaccinated, clostridia, CB, vaccinated, Rectal, RT, thermographic temperatures, evaluated, days, relatives, vaccination, day, Feed, water intake, body weight, BW, feeding behavior, daily, electronic feeding system, Blood, days, vaccination, day, determination, glucose, GLC, beta-hydroxybutyrate, BHBA, concentrations, Blood sampled, day, pre-vaccination, day, evaluate, immune response, Brucella abortus, clostridia, increase, rectal, temperature, post-vaccination, groups, thermography, increase, local, temperature, days, groups B, CB, Group C, increased, local, temperature, period, Dry mater, intake, reduced, groups B, CB, alteration, group, alterations, BW, BW, average, ADG, feed, efficiency, observed, vaccination, groups, blood parameters, evaluation, period, concomitant, vaccination, brucellosis, clostridia, neutralizing antibody, titers, epsilon toxin, C. perfringens, botulinum toxin type C of C. botulinum, cellular proliferation assay, serological tests, B. abortus, evaluated, groups B, CB, results, concomitant, vaccination, brucellosis, clostridia, impact, intake, performance, feeding behavior, dairy calves, concomitant, vaccination, vaccines, pathogens, impacts, animal, immunity, clostridial infections]]\n",
      "[[evaluated, hemolyzed, bacterially contaminated, Nobuto filter paper-derived serum, Rocky Mountain elk, Cervus elaphus nelson, treatments, antibody, retention, Serum, analyzed, Brucella, plates, tubes, titers, serostatus, serum, frozen, blood, elk rumen, content, serum, eluted, Nobuto filter paper, Cohen's kappa test, agreement, plate assay, serostatus, agreement, treatments, Serostatus, agreement, treatments, tubes, score, treatment, reference, negative, bias, serosuspect, seropositive, animals, frozen, rumen, rumen, treatments, plate assay, day, rumen, treatments, tube assay, result, animal, misclassified, serosuspect, seronegative, category, Serum, eluted, Nobuto filter paper, inconsistent, results, alternative, serum, blood, potential, misclassification, animals, low, titers, hemolyzed, bacterially contaminated serum, Brucella abortus, increase, sample size, potential, detect, seropositive, animals]]\n",
      "[[Brucella abortus, facultative, extracellular-intracellular, encounters, diversity, environments, host cell, report, bacteria, infected, cells, late stages, post-infection, intracellular, life cycle, increase, target cells, increase, early, interaction, cell surface, bacteria, adherent, penetrate, in vitro, bacteria, late stage, infection, bacterium, autophagosome-like compartment, starving, acidic conditions, two-component system, BvrR/BvrS, activated, expression, transcriptional regulator, VjbR, type IV secretion system, VirB, increased, bafilomycin, inhibit, BvrR/BvrS, activation, inhibitors, VjbR, VirB, BvrR/BvrS, VjbR systems, increased, interaction, host cells, VirB system, Bacteria, released, infected, cells, natural conditions, phenotype, intracellular, bacteria, model, B. abortus, BvrR/BvrS system, transition, replicative niche, endoplasmic reticulum, autophagosome-like, compartment, activation, expression, VirB, participating, release, bacterium, cells, increase, VjbR, expression, results, efficient, interaction, host cells]]\n",
      "[[Brucellosis, public, economic losses, livestock, animals, study, assessed, Brucella spp, isolated, aborted ovine, caprine, fetuses, parts, Iran, classic, molecular methods, Brucella species, risks, abortion, complications, animals, samples, cases/case series, milk, sheep, goats, abomasum, content, sheep, aborted fetuses, sheep, goats, bacteriologically, examined, Brucella, isolates, characterized, phenotypic, molecular approaches, multiplex Polymerase chain reaction, PCR, Bruce-ladder, IS711-based PCR, DNA, evaluate, presence, Brucella spp, results, isolates, ovine, caprine, abortion, samples, B. melitensis, B. abortus, issue, concern, B. melitensis, vaccine, Rev1, small portion, sheep, goat abortion, cases, B. abortus, burden, ovine, aborted, cases, associated with, B. melitensis, infections, ovine, caprine, B. melitensis biovar 1, cases, data, techniques, implemented, study, level, implication, Brucella species, ovine, caprine, abortion, Iran, study, Brucella agents, abortion, small ruminants, biovar, level, information, control programs, vaccination, Middle Eastern regions]]\n",
      "[[Brucella, foodborne, pathogen, affecting, economy, healthcare, Surface, SERS, nano-biosensing, detection, high-performance, quasi-crystal, patterned nanocavities, Raman, enhancement, covalently, immobilized, Tbilisi bacteriophages, bio-receptors, efficient, SERS, Raman system, on-field, phage-based, bio-sensing, monitoring, target, bacteria, biosensor, Brucella abortus, milk, portable, SERS, device, bacterial, samples, signal, pathogen recognition, concrete, applicability, system, on-site, in-food detection]]\n",
      "[[availability, whole genome sequences, public databases, genome-wide comparative studies, bacterial species, Whole genome, sequence-single nucleotide polymorphisms, analysis, studies, discrimination, Brucella species, strains, study, Brucella spp, strains, cattle, locations, provinces, South Africa, typed, discriminated, WGS-SNP analysis, maximum, pairwise distance, single nucleotide polymorphisms, SNPs, South African, Brucella abortus, strains, South African B. abortus, strains, grouped, B. abortus, strains, Mozambique, Zimbabwe, Eurasian countries, Portugal, India, WGS-SNP analysis, South African B. abortus, strains, genotype, circulated, farm, farm, Farm 2, province, genotypes, brucellosis, South Africa, spreads, herd, farms, introduction, infected, animals, mode, transmission, farms, B. abortus, S19 strains, isolated, tissue, aborted material, identical, herds, regions, South Africa, vaccination, animals, older, age, months, problem, associated with, vaccine, production]]\n",
      "[[Brucellosis, United States, occupational, hazard, workers, livestock, processing, systemic infectious disease, liver, benign, subclinical, increases, serum, ominous, chronic suppurative disease, endemic, countries, Mediterranean region, treated with, antibiotics, case, female, Brucella, diagnosis, management]]\n",
      "[[intracellular, bacterial pathogen, Brucella, persistent, infections, mammalian, species, survive, replicate, macrophages, bacteria, oxidative stresses, express, type IV secretion system, T4SS, host, immune responses, extracytoplasmic function, signal, transduction, mechanism, bacteria, environmental, cues, gene expression, study, ECF sigma bcrS, cognate anti-sigma factor abcS, Brucella melitensis, M28, conserved domain analysis, protein interaction assay, BcrS, activates, adjacent, operon, bcrXQP, encodes, methionine-rich peptide, methionine sulfoxide reductase system, AbcS, negative, regulator, bcrS, bcrXQP, bcrS/abcS, bcrXQP operons, induced, hypochlorous acid, hypochlorous acid, in vitro Next, RNA sequencing analysis, genome-wide recognition sequence, identified, regulons, BcrS, AbcS., BcrS, positively, influences, T4SS, expression, AbcS-dependent manner, AbcS, T4SS, expression, BcrS., abcS, maintenance, persistent, infection, bcrS, mouse infection, model, BcrS, AbcS, influence, expression, multiple genes, Brucella virulence, traits, Brucella, intracellular, pathogen, induces, chronic infections, animals, humans, survive, replicate, macrophages, bacteria, capacity, oxidative stresses, type IV secretion system, T4SS, host, immune responses, study, characterized, extracytoplasmic function, ECF, regulates, resistance, reactive chlorine species, T4SS, expression, potential, virulence, traits, Brucella, anti-sigma factor, AbcS, Brucella, persistent, mice, Brucella virulence regulation, potential, drug, target, fighting, Brucella infections]]\n",
      "[[Exosomes, extracellular vesicles, released, cells, function, intercellular, communication, interferon-inducible transmembrane protein 3, IFITM3, effective, anti-intracellular, inhibit, invasion, pathogenic, microorganisms, Brucella infection, induces, secretion, exosomes, exosomes, IFITM3 protein, immune function, extracellular IFITM3 protein, process, Brucella infection, study, Brucella melitensis, Brucella M5, stimulate, macrophages, secrete, exosomes, exosomes, Brucella M5-infected cells, molecules, IFITM3, exosomes, transmit, IFITM3, cell, inhibiting, intracellular, survival, Brucella, immunization, exosomes, IFITM3, decreased, mouse, spleen tissue, damage, spleen colony forming unit, CFU, anti-Brucella state, mice, findings, anti-Brucella mechanism, IFITM3-containg, exosomes, theoretical, systematic elaboration, mechanisms, Brucella infection, host, immunity, results, development, vaccines, Brucella]]\n",
      "[[prevalence, human brucellosis, Qinghai Province, China, increasing, cases, distributed, counties, epidemiology, brucellosis, transmission, infecting, strains, isolated, humans, multiple-locus variable-number tandem repeats analysis, MLVA, whole-genome single-nucleotide polymorphism, approaches, Strains, isolated, males, blood cultures, Brucella melitensis, positive, biotyping, MLVA, Genomic DNA, strains, whole-genome sequencing, SNP-based, phylogenetic analysis, compare, strains, B. melitensis, strains, complete, genome, draft genome, online databases, Brucella, isolates, B. melitensis biovar 3, QH2019001, QH2019005, biotyping, differences, variable number tandem repeats, VNTRs, MLVA-16, Phylogenetic examination, assigned, strains, genotype, groups, QH2019001, QH2019005, assigned, group, subgroups, QH2019005, strain, subgenotype, IIj, genotype II, findings, geographic origin, Brucella strains, B. melitensis, strains, resolved, elucidation, evolutionary, histories, QH2019005, subgenotype, IIj, origin, eastern Mediterranean, Sea]]\n",
      "[[Camels, livestock, pastoralists, reeling, effects of, climate change, semi-arid, arid parts, Kenya, population, camels, rises, epidemiology, zoonotic diseases, Kenya, public, Rift Valley fever, RVF, brucellosis, Q fever, country, involvement, camels, transmission, dynamics, diseases, analyzed, camel serum, samples, northern Kenya, seropositivity, rates, pathogens, infecting, Brucella species, molecular assays, seropositivity, confidence interval, CI, Brucella, CI, CI, Coxiella burnetii, Rift valley fever virus, CI, animals, seropositive, pathogen, CI, seropositive, pathogens, B. melitensis, Brucella spp, detected, sero-positivity, rates, endemicity, pathogens, camel populations, species, epidemiology, zoonotic diseases, association, human, infection, contact, livestock, zoonotic infections, Kenya, research, camels, transmission, zoonoses, livestock species, humans, information, designing, effective, surveillance systems, intervention, measures]]\n",
      "[[Brucella strain, Brucella, Croatian, cattle, testing, brucellosis, eradication programme, CASE PRESENTATION, Standardised serological, brucellin skin test, bacteriological, molecular diagnostic screening, Brucella infection, positive, detection, dairy cattle, herd, isolates, herd, species, level, Bruce ladder method, strains, typed, B. melitensis, B. abortus, multiplex PCR, IS711, Suis ladder, B. melitensis, combination, whole-genome, multi-locus sequencing, Multi-Locus, tandem repeats Analysis, MLVA, proximity, phylogenetic branch, B. melitensis, strains, isolated, Croatia, Albania, Kosovo, Bosnia, Herzegovina, isolates, B. melitensis, unique, phylogenetic profile, growth profile, dyes, bacteriophage typing, results, isolate, 609-bp omp31 sequence, omp31, sequence, isolates, B. melitensis, Identification, Brucella variant, geographic region, predictable, historic, endemicity, brucellosis, emergence, variant, combination, high, prevalence, domestic ruminants, humans, weak, eradication, zoonotic, potential, reservoirs, transmission pathways, Brucella, variants]]\n",
      "[[Human brucellosis, public health, Hulun Buir, comprehensive, epidemiologic analysis, control measures, study, case numbers, ratios, incidence, rate, human brucellosis, bio-typing, abortus, melitensis, ovis, suis (AMOS)-PCR, multi-locus variable-number tandem-repeat analysis, MLVA, characterize, Brucella strains, human, brucellosis, cases, incidence, rate, 56.03/100, country's, average, incidence, incidence, increased, year, year, decreased, Hulun Buir, nomadic, livestock, brucellosis, spreads, animal, species, humans, Xin Barag Left Banner and Xin Barag Right Banner, incidence rates, areas, cases, (25-45)-year old group, cases, farmers, male, female, incidence ratio, incidence, younger people, gender ratio, traditional, production, lifestyle, nomads, cases, cases, delivery, domestic livestock, biotyping, isolated, strains, B. melitensis, Brucella melitensis biovar, B. melitensis, strains, genetic similarity, hypothesis, human, brucellosis, outbreak, region, infection, investigation, epidemic, human brucellosis, Hulun Buir, surveillance, control, animals, brucellosis, priority]]\n",
      "[[Brucella ovis, ovine, intracellular, pathogen, tropism, male, genital tract, infection, B. ovis, survive, stressful conditions, host cells, low, pH, nutrient, limitation, reactive oxygen species, conditions, axenic, cultures, stationary phase, Studies, stationary phase, Brucella infection, biology, genes, pathways, Brucella, physiology, poorly, fitness, B. ovis, Tn-himar mutants, function, growth phase, identified, cysE, fitness, stationary phase, CysE, catalyzes, cysteine biosynthesis, serine, genetic evidence, enzymes, CysK1, CysK2, function, catalyze, cysteine synthesis, downstream, CysE. Deleting, cysE, DeltacysE, cysK1, cysK2, DeltacysK1 DeltacysK2, results, premature entry, stationary phase, reduced, culture, sensitivity, exogenous, hydrogen peroxide, phenotypes, chemically complemented, cysteine, glutathione, DeltacysE, DeltacysK1, strains, host cell, in vitro, intracellular, fitness, post infection, study, redundancy, CysK, cysteine biosynthesis, B. ovis, cysteine anabolism, peroxide stress, survival, fitness, intracellular, niche]]\n",
      "[[chimera, BLSOmp31, chitosan, microspheres, Poloxamer407-Chitosan, administered, nasal, ocular mucosa, partial, protection, sheep, B. ovis, delivery system, mucosal, immunization, BLSOmp31, murine, model, improve, efficacy, formulations, evaluated, B. ovis, induced, BLSOmp31, administered, subcutaneous route, BLSOmp31, co-administered, immunostimulatory, unmethylated cytosine-guanine motifs, CpG-ODN, CpG-ODN, nanostructure, Coa-ASC16, compared, BLSOmp31, emulsified, Incomplete, Freund Adjuvant, evaluated, protection, formulation, BLSOmp31/CpG-ODN/Coa-ASC16, administered, subcutaneous, ocular, routes, BLSOmp31/CpG-ODN/Coa-ASC16, injected, subcutaneously, induce, IgG, antibody, levels, BLSOmp31, BLSOmp31/CpG-ODN, stimulate, response, levels, IFN-, protection, B. ovis, challenge, ocular, instillation, BLSOmp31/CpG-ODN/Coa-ASC16, degree, protection, parenteral route, protection, induced, lower, levels, serum, IgG, IgG1/IgG2a, IgA antibodies, IFN-, IL-4, subcutaneous route, No antibodies, detected, vaginal lavages, saliva, Fecal, antigen-specific, IgA, mice, immunized, BLSOmp31/CpG-ODN/Coa-ASC16, subcutaneously, compared, ocular route, results, BLSOmp31/CpG-ODN/Coa-ASC16, effective, vaccine, B. ovis, mice]]\n",
      "[[Gram-negative bacteria, release, nanovesicles, outer membrane vesicles, OMVs, outer membrane, Proteomics, composition, OMVs, proteins, immune response, model, acellular, vaccines, study, OMVs, Brucella suis, B. ovis, B. canis, B. neotomae, purified, analyzed, SDS-PAGE, transmission electron microscopy, liquid chromatography, mass spectrometry, pan-proteome, vesicles, antigenic proteins, detected, western blot, anti-Brucella sera, in silico, analysis, pan-proteome, revealed, homologous proteins, Omp16, Omp25, Omp31, SodC, Omp2a, BhuA. Proteins, vesicles, Brucella species, detected, anti-Brucella sera, occurrence, immunogenic proteins, OMVs, vesicles, evaluated, acellular brucellosis, vaccine]]\n",
      "[[Brucella melitensis, Brucella abortus, cases, brucellosis, Turkish, population, fourplex quantitative real-time PCR, electrophoresis-free, rapid, cost-effective, differentiation, B. abortus, B. melitensis, Brucella spp, 4-plex species, differentiation, assay, qPCR assay, targeting, single nucleotide polymorphism, loci, Brucella genomes, combination, qPCR assay, genotyping, B. abortus, B. melitensis, Brucella, analyzed, qPCR assay, 21-VGL profile, database, database, profiles, B. abortus, B. melitensis, B. ceti, B. neotomae, B. ovis, B. pinnipedialis, B. suis, B. canis strains, 21-VGL, Brucella genotyping, B. abortus, B. melitensis, B. neotomae, B. ovis, 21-VGL, B. pinnipedialis, B. ceti, B. suis, genotypes, B. canis, results, Brucella, isolates, Turkey, B. melitensis, 21-VGL, genotyping, reduced, B. melitensis, genotyping, loss, genotyping, resolution, knowledge, lowest-cost, B. abortus, B. melitensis, genotyping, species, differentiation, methodology, literature]]\n",
      "[[Childhood brucellosis, malaria, co-endemic febrile, illnesses, sub-Saharan African countries, Malaria, brucellosis, co-infection, brucellosis, infections, malaria, lack, diagnostic infrastructure, Brucellosis, dogs, contact, humans, pets, study, investigated, brucellosis, children, dogs, confirmatory serological testing, screens, Brucella sp. Methods, Residual, blood samples, malaria, smear-negative febrile, children, collected, tested, Brucella sp, malaria, parasite, period, residual blood samples, veterinary, microbiology, laboratory, area, tested, brucellosis, human, canine, blood samples, tested, brucellosis antibodies, seroprevalence, brucellosis, children, dogs, Card, buffered acidified plate antigen, standard plate agglutination tests, rivanol precipitation plate agglutination test, brucellosis, smooth, rough, colony strains, modify, serological surveillance strategy, targeted, Brucella abortus, smooth colony, Brucella strains, rough, colony, Brucella strains, B. ovis, B. canis, Uganda, endemic, brucellosis, modify, brucellosis, surveillance strategy]]\n",
      "[[molecular mechanisms, Brucella ovis, pathogenicity, transcriptome, DEGs, RAW264.7 macrophage, infected, B. ovis, DEGs, immune pathway, Kyoto Encyclopedia of Genes, Genomes, KEGG, Gene Ontology, GO, functional, Quantitative real-time PCR, qRT-PCR, transcriptome sequencing, data, up-regulated, down-regulated, DEGs, B., group, mock group, pathways, KEGG, analysis, GO, functional enrichment analysis, DEGs, molecular function, cellular component, biological process, immunological pathways, RAW264.7 macrophage cells, response, B. ovis infection, inflammatory response, immune system process, immune response, cytokine activity, chemotaxis, chemokine-mediated signaling pathway, chemokine activity, CCR, chemokine receptor binding, qRT-PCR, results, Ccl2, ENSMUST00000000193, Ccl2, ENSMUST00000124479, Ccl3, ENSMUST00000001008, Hmox1, ENSMUST00000005548, Hmox1, ENSMUST00000159631, Cxcl2, ENSMUST00000075433, Cxcl2, ENSMUST00000200681, Cxcl2, ENSMUST00000200919, Cxcl2, ENSMUST00000202317, findings, pathways, B. ovis-induced, host, immune response, bacteria-host, interaction, pathogenic, mechanism, B. ovis]]\n",
      "[[Brucellosis, zoonotic disease, Brucella melitensis, species, associated with, human infection, Vaccination, efficient, controlling, animal brucellosis, consequent, decrease, incidence, human infections, attenuated, vaccines, degree, protection, residual, pathogenicity, human, animals, study, Brucella ovis abcBA, BoabcBA, live, attenuated, vaccine, strain, tested, formulations, encapsulated, alginate, alginate plus, vitelline protein B, immunize, mice, experimental, B. melitensis, strain, M, week, infection, livers, spleens, immunized mice, reduced, strain, B. melitensis, M, compared, nonimmunized mice, reduction, approximately, B. melitensis, count, spleens, immunized, mice, splenocytes, stimulated, B. melitensis, antigens, in vitro, secreted, IFN-gamma, mice, immunized, BoabcBA, encapsulated, alginate plus, VpB, alginate, Body, liver weights, groups, spleens, mice, immunized, BoabcBA, encapsulated, alginate, immunized, BoabcBA, encapsulated, alginate plus, VpB, nonimmunized mice, study, vaccine, formulations, BoabcBA, mice, experimental, B. melitensis]]\n",
      "[[single-tube method, dual-electrostatic interaction, EI, bacteria, capture, DNA extraction, sensitive, detection, nucleic acids, magnetic nanoparticles, requirements, single-tube method, EI, efficient, bacteria, capture, weak, EI, DNA extraction, minimal, DNA adsorption, dual-EI, single-tube, method, bacteria, enrichment, bacteria cell, DNA recovery, single tube, reducing, handling time, evaluated, performance, concentrations, colony-forming units, (CFU)/10, human, urine, milk, samples, method, sensitive, detection, Salmonella enterica serovar Typhimurium, human, urine, milk, samples, CFU, quantitative PCR, method, Brucella ovis, Escherichia coli, human, urine, detection, Graphical abstract]]\n",
      "[[Brucella ovis, facultative, bacterium, non-zoonotic ovine brucellosis, characterized, male, genital, lesions, economic losses, sheep farming, Studies, virulence, mechanisms, Brucella, smooth, O-polysaccharide, lipopolysaccharide, zoonotic, species, B. ovis, similarities, differences, strains, isolated, unconventional hosts, Brucella species, non-motile, genes, flagellum, organized, loci, loci, pseudogenes, non-motile, Brucella species, smooth B. melitensis, sheathed flagellum, culture conditions, flagellar genes, virulence, Brucella strains, B. ovis PA, mutants, defective, flagellar loci, assess, virulence, rough, O-polysaccharide, Brucella species, growth, outer, membrane-related, intracellular, behavior, cellular models, flagellar mutants, parental, strain, results, B. melitensis, single-gene mutants, B. melitensis, mutants, chronic infection, mice, removal, flagellar loci, B. ovis, virulence, mouse model, results, evidence, relevant, B. ovis, B. melitensis, species, homologous, DNA level, ovine brucellosis, differences, zoonotic, potential, pathogenicity, tissue, tropism]]\n",
      "[[function, bacterial carbonic anhydrases, CAs, EC 4.2.1.1, increased, years, CAs, metalloenzymes, modulate, CO2, HCO3, H(+) concentration, catalysis, reversible, CO2, hydration, CO2, H2O right arrow, left arrow HCO3, H(+), living organisms, CA activity, physiological processes, transport, supply, CO2, HCO3, pH homeostasis, secretion, electrolytes, biosynthetic processes, photosynthesis, processes, rate, non-catalyzed reaction, CO2, hydration, CAs, biomolecules, bacteria, human infections, Vibrio cholerae, Brucella suis, Salmonella enterica, Pseudomonas aeruginosa, Helicobacter pylori, species, CA activity, microorganism, growth, adaptation, host, modulates, bacterial toxin, production, virulence, review, literature, research field, CAs, bacterial, pathogens, microorganism, growth, virulence, druggability, enzymes, CA inhibitors, CAIs, sulfonamide-type, examples, Helicobacter pylori, CAs, acid tolerance/adaptation, microbe, human, abdomen, CAs, outer membrane, H. pylori, planktonic, biofilm, phenotypes, H. pylori, CAIs, combination, probiotic strains, anti-ulcer treatment approach, innovative, gastric infections, era, increasing, resistance, pathogenic bacteria, antibiotics]]\n",
      "[[Brucellosis, zoonosis, Brucella species, Wild boar, Sus scrofa, infected, species, reservoir, B. suis biovar 2, study, investigate, prevalence, Brucella spp, serological, molecular assays, wild boar, hunted, Tuscany, Italy, hunting, seasons, animals, sera, lymph nodes, livers, spleens, reproductive system organs, sera, positive, bengal test, RBT, complement fixation test, CFT, titres, Brucella spp., DNA, detected, lymph nodes, epididymides, fetus, pool, positive, PCR, samples, Brucella suis biovar 2, results, investigation, wild boar, host, B.suis biovar, epidemiology, brucellosis, central Italy, epididymis, localization, venereal transmission]]\n",
      "[[Brucellosis, Brucella spp, zoonotic disease, economic losses, livestock, threat, public health, worldwide, live, attenuated, Brucella suis, B. suis) strain S2, effective, vaccine, animals, China, S2, vaccination, animals, debates, concerns, safety, primates, humans, study, cynomolgus monkey, animal model, evaluate, safety, S2, vaccine, strain, primates, transcriptome analysis, gene expression profiling, cynomolgus monkeys, immunized, S2, vaccine, results, S2, vaccine, cynomolgus monkeys, transcriptome analysis, DEGs, upregulated, downregulated, Gene Ontology, classification, Kyoto Encyclopedia of Genes, Genomes, DEGs, biological processes, BPs, chemokine signaling pathway, actin cytoskeleton regulation, defense response, immune system processing, type-I interferon signaling pathway, molecular functions, DEGs, 2'-5'-oligoadenylate synthetase, double-stranded RNA binding, actin-binding, cellular components, DEGs, integrin complex, myosin II complex, blood microparticle, findings, concerns, safety, S2, vaccine, primates, genetic basis, response, mammalian, host, vaccination, S2, vaccine]]\n",
      "[[Brucellosis, endemic, zoonotic, countries, economic losses, immunogenic, protective antigens, surface, Brucella spp., outer membrane proteins, Omps, vaccine, relevant, host-pathogen interactions, Omp16, homolog, peptidoglycan-associated lipoproteins, Pals, Brucella, survival, in vitro, functions, Omp16, gene expression profile, RAW264.7 cells, infected, Brucella suis, vaccine strain 2, B. suis S2, DeltaOmp16, analyzed, RNA-seq, investigate, cellular response, Brucella entry, RNA-sequence, analysis, genes, B. suis S2, post-infection, DEGs, upregulated, DEGs, downregulated, DEGs, innate immune signaling pathways, pattern recognition receptors, PRRs, proinflammatory cytokines, chemokines, Kyoto Encyclopedia of Genes, Genomes, analysis, DeltaOmp16-infected cells, expression, total cells genes, upregulated, total cells genes, downregulated, B. suis S2-infected RAW264.7 cells, KEGG pathway, analysis, upregulated, proinflammatory cytokines, chemokines, interleukin (IL)-6, IL-11, IL-12beta, C-C motif chemokine, CCL2, CCL22, DeltaOmp16, macrophage, immune-related pathways, increase, proinflammatory cytokines, chemokines, Brucella]]\n",
      "[[study, knowledge, wildlife brucellosis, Africa, predictors, infection, Preferred Reporting Items, Systematic Reviews, guidelines, Information, species, test, test results, area, rainfall, livestock, wildlife, contact, year, study, systematic review, prevalence studies, disease control articles, articles, epidemiology, Brucella abortus, Brucella melitensis, Brucella inopinata, Brucella suis, wildlife, prevalence studies, serological, evidence, brucellosis, buffalo, antelope, positive, species, carnivores, species, decades, Buffalo populations, infected, seroprevalence, species, pooled, seroprevalence, CI, buffalo, CI, carnivores, CI, antelope, Wildlife, rainfall, infected, infected, populations, seroprevalence, rainfall, studies, published, Domestic, animal, contact, associated with, increased, seroprevalence, antelope, carnivore, species, buffalo, hypothesis, buffalo, reservoir species]]\n",
      "[[BAX, BI-1, evolutionarily, identified, screening process, human proteins, suppress, BAX-induced, apoptosis, yeast cells, Eukaryotic, BI-1, cytoprotective protein, suppresses, cell death, induced, multiple, stimuli, eukaryotes, Brucella, causative agent, brucellosis, public health, animal, husbandry, conserved gene, encodes, BI-1-like protein, Brucella homolog, BI-1, BrBI, Brucella suis S2, brbI, deletion mutant, strain, strain, brbI, deletion, membrane, properties, Brucella suis S2, decreased, resistance, acidic, pH, H2O2, polymyxin B, lincomycin, deleting, brbI, defective growth, cell division, viability, Brucella suis S2, effect, brbI, deletion, physiological, characteristics, Brucella suis S2, transcriptomic, proteomic analyses, integrated analysis, brbI, deletion, affected, expression, multiple genes, mRNA, protein levels, affected, divisome proteins, FtsB, FtsI, FtsL, FtsQ, molecular basis, impaired, cell division, brbI, mutant strain, membrane proteins, transporter-associated proteins, consistent with, phenotype, membrane, properties, alterations, brbI, mutant strain, results, BrBI, bacterial, cytoprotective protein, membrane homeostasis, cell division, stress resistance, Brucella suis S2]]\n",
      "[[Brucella species, brucellosis, extended, zoonosis, brucellae, free-living, plant-associated, alpha2-Proteobacteria, host cells, metabolism, adaptation, investigate, rodent-associated Brucella suis biovar 5, ruminant-associated, Brucella abortus, Brucella melitensis, B. suis biovars, ancestral Entner-Doudoroff pathway, EDP, plant-associated relatives, mutants, Edd, glucose-6-phosphate dehydratase, EDP, PpdK, pyruvate phosphate dikinase, phosphoenolpyruvate right harpoon, left harpoon pyruvate, Pyk, pyruvate kinase, phosphoenolpyruvate, pyruvate, chemically, medium, glucose, source, Edd mutant, reduced, growth rates, triple, triple mutant, grow, ribose, xylose, B. suis biovar 5 sugar catabolism, Pentose Phosphate shunt, EDP, EDP, absence, shunt, reduced, growth rates, B. melitensis, B. abortus, triple, attenuated, mice, anabolic, hexose/pentose catabolism, pyruvate, B. suis biovar 5, multiplication, host cells, hypothesis, consistent with, lack, glycolysis, Brucella species, EDP, B. melitensis, B. abortus, results, cells, brucellae, substrates, fed, anaplerotic pathways, C sugars, EDP, loss, species]]\n",
      "[[study, MLVA, multiple-locus variable-number tandem repeat analysis, genotype, data, Brucella strains, countries, Silk Road, MLVAbank, MLVA, data, strains, Minimum Spanning Tree, species/biovars distribution, geographic origins, genetic relationships, strains, analyzed, whole-genome sequencing-single-nucleotide polymorphism, WGS-SNP, phylogenetic analysis, genome, Brucella melitensis, strains, GenBank, discriminate, relatedness, strains, investigate, transmission, pattern, B. melitensis, brucellosis, Brucella strains, analyzed, study, Brucella abortus strains, B. melitensis, strains, Brucella suis strains, B. melitensis biovar 3, dominant, species, widespread, regions, prevention, surveillance, B. melitensis, population, countries, host, spectrum, Brucella population, animal reservoirs, potential, continuous, brucellosis, circulation, countries, B. abortus, strains, regions, geographic origins, genotypes, countries, data, B. abortus, strains, spreading, national borders, B. melitensis, strains, Italy, Western Mediterranean lineage, strains, countries, Eastern Mediterranean lineage, lineage, strains, countries, introduction, reintroduction, disease, countries, MLVA-16, genotypes, B. melitensis, strains, China, Kazakhstan, Turkey, introduction, trade, sheep, goats, countries, WGS-SNP analysis, B. melitensis, study, Malta, territorial, affiliation, clade, strains, countries, genotype B, absence, differentiation, strains, spread, countries, Silk Road, Active exchange, trade, animals, sheep, goats, countries, B. suis, strains, nations, geographic origins, epidemiological characteristics, control, transfer, trade, infected, sheep, goats, countries, Silk Road, entry-exit quarantine, sheep, goats, improvements, diagnosis, animal brucellosis]]\n",
      "[[Phosphorus-solubilizing microorganisms, microbial, fertilizer, potential, study, endophytic phosphate, Chinese fir, characterized, plant, traits, morphological, 16S rRNA sequence analysis, endophytes, genera, Pseudomonas, Burkholderia, Paraburkholderia, Novosphingobium, Ochrobactrum, HRP2, SSP2, JRP22, plant, traits, evaluation, Chinese fir, growth, enhancement, growth, parameters, Chinese fir, seedlings, inoculation, uninoculated, control group, results, PSBs, HRP2, SSP2, JRP22, increased, plant height, stem diameter, biomass, roots, stems, leaves, control, TN, TP, total K (TK, Mg, Fe, contents, leaf, positively, affected, PSBs, relationship, strain, dilution ratio, content, TN, TP, TK, phosphorus, AP, potassium, AK, soil, increased, Treatment, HRP2, SSP2, JRP22, increased, leaf, root, biomass, N, K, uptake, affecting, soil urease, acid phosphatase activities, content, nutrients, soil, PSB, biological agents, chemical, fertilizers, agroforestry, production, environmental pollution, increase, yield, Chinese fir]]\n",
      "[[Bioprospecting, sub-explored, environments, Antarctic, locations, diverse, activities, reducing, chemical, human, health, environment, study, cold-adapted, isolated, samples, Melchior Antarctic Base, degrees, C, degrees, colony, morphotypes, evaluated, antimicrobial, production, isolates, antibacterial, antifungal activities, isolate, Burkholderia gladioli, 16S rDNA, gyrB, Cpn60, gene sequence analysis, antimicrobial spectrum, pathogenic, phytopathogenic bacteria, antifungal activity, inhibits, growth, plant, pathogenic, fungi, Penicillium digitatum, Macrophomina phaseolina, causal agents, blue mould, postharvest fruits, charcoal rot, soybean crops, antibacterial compound, molecular weight, resistance, lytic enzymes, stability, temperature, pHs, Observations, B. gladioli, MB39, antifungal, effects, M. phaseolina, mycelia, scanning electron microscopy, alterations, hyphal, structures, reduced, hyphal, extension, severe, cell, morphology, changes, cytoplasmic, leakage, flattened, empty, mycelia, isolation, identification, cold-adapted, B. gladioli, strain, results, effectiveness, antarctic strain, bacterial, fungal, phytopathogens, biocontrol, potential, crop]]\n",
      "[[Melioidosis, bacterial infection, Gram-negative bacillus, Burkholderia pseudomallei, Southeast Asia, Northern Australia, Sri Lanka, endemic belt, melioidosis, Melioidosis, spectrum, clinical presentations, results, mortality rates, severe, infection, Case Report, healthy, Lankan farmer, septicemia, cut injury, right leg, working, paddy field, mild, wound sepsis, condition, deteriorated, patient, organ support, cardiovascular instability, acute liver failure, acute kidney injury, acute respiratory distress syndrome, coagulopathy, patient's, blood culture, negative, admission, day, blood culture, ICU, contaminated, commensal, flora, initially, isolated, Burkholderia pseudomallei, wound swab culture, day, isolated, organism, days, Burkholderia pseudomallei, patient, severe, melioidosis, severe, sepsis, multiorgan, failure, treatment, meropenem, case report, melioidosis, differential diagnosis, patient, risk factors, melioidosis]]\n",
      "[[European woodwasp, Sirex noctilio, Fabricius, invasive, quarantine pest, attacks, kills, pine, trees, native, Insect, gut structure, gut microbiota, life activities, reports, nutrition, survival, study, S. noctilio, larval, gut microbiome, lacking, gut structure, stereo microscope, throughput sequencing, bacterial, 16S rRNA, fungal, ITS2, investigate, gut microbiota, developmental stages, S. noctilio, larvae, adults, larval frass, PICRUSt2, functional profiles, larval gut, thin, thread-like, oral cavity, anus, xylem, particles, crop, Pseudomonas, Ralstonia, Burkholderia s.l, dominant, bacteria, guts, larvae, adults, frass, Pseudomonas, abundant, bacteria, Zoogloea, Ruminobacter, Nitrosospira, degrading, organic matter, nitrogen, larval gut, growth, development, larvae, pine tree, xylem, Fungal, communities, developmental stages, frass, Amylostereum, dominant, woodwasp's, larval gut, Functional, prediction, bacterial, fungal, communities, encod, enzymes, degrading, lignocellulose, nitrogen, Ours, study, gut, microbial, communities, S. noctilio, larvae, adults, frass, study, larval, nutrient, acquisition, nutrient-deficient, host, xylem, extent, study, strategies, development, pest management, approaches, interfering, gut microbiota, restricting, larval, survival, development]]\n",
      "[[case, melioidosis, alcoholic, diabetic, male, patient, multiple, hepatic, splenic abscesses, Melioidosis, environmental bacterium, Burkholderia pseudomallei, clinical manifestations, asymptomatic, infection, fulminant, septic shock, abscesses, multiple, internal organs, treatment, prolonged, parenteral antibiotics, intensive phase, oral antibiotics, eradication phase, disease resolution, clinical presentations, high index, suspicion, adequate, laboratory support, diagnosis, prompt, initiation, optimal, antibiotic therapy]]\n",
      "[[Lung transplant, LTx, recipients, increased, risk, airway infections, infection, culture-based techniques, study, compare, airway, microbiome, LTx, patients, airway infection, differences, microbiome, composition, LTx, recipients, bronchoalveolar lavage, BAL, year, transplantation, likelihood, airway infection, time, sampling, graded, clinical criteria, BAL, cultures, BAL fluid, levels, inflammatory, markers, heparin-binding protein, HBP, IL-1beta, IL-8, ELISA, bacterial, microbiome, samples, analysed, 16S rDNA sequencing, characterized, richness, evenness, distance, microbiome, composition, samples, Bray-Curtis, weighted, unweighted, UniFrac, samples, patients, study, Samples, infection, samples, levels, inflammation, characterized, loss, bacterial, diversity, species, composition, Burkholderia, Corynebacterium, Staphylococcus, infection, inflammation, anaerobes, normal, oropharyngeal flora, abundant, findings, BAL, cultures, Pseudomonas aeruginosa, infection, study, dynamics, airway, microbiome, LTx, recipients, lung infections, associated with, disruption, homeostasis, microbiome]]\n",
      "[[biological, herbicide, antibiotic 4-formylaminooxyvinylglycine, FVG, isolated, rhizosphere-associated, strains, Pseudomonas fluorescens, Biosynthesis, FVG, dependent, biosynthetic gene cluster, P. fluorescens, investigation, genomics, strains, genetic potential, FVG, presence, gvg gene cluster, strains, groups, Pseudomonas, P. fluorescens, P. syringae, strains, gvg cluster, Pseudomonas, Mass spectrometry, strains, P. fluorescens, species, group, FVG, P. syringae, strains, FVG, standard, conditions, lines, evidence, transmission, gvg cluster, robust, phylogenetic analysis, horizontal gene transfer, Pseudomonas lineage, lineages, Thiomonas, Burkholderia, Pantoea, data, evolution, diversity, FVG, biosynthesis, course, investigation, gene clusters, genes, FVG, identified, bacteria, non-pseudomonads]]\n",
      "[[Burkholderia cepacia complex, Bcc, group, bacteria, species, accurate, identification, context, infectious diseases, industry, contaminate, non-food products, home, personal care products, cosmetics, Bcc, contaminants, presence, intrinsic, antimicrobial resistance, preservation systems, non-sterile products, Burkholderia lata, Burkholderia contaminans, Bcc bacteria, industrial, contaminants, identification, species, group, taxon K, analysis, recA gene, multilocus sequence typing, MLST, genomics-based, accurate, Bcc, classification, average, ANI, core-gene analysis, workflow, Burkholderia taxon K industrial strains, MLST, B. lata, B. contaminans, Bcc strains, genomic identification, B. contaminans, strains, classification, strains, Burkholderia aenigmatica sp. nov., taxonomic, identification, industrial, contaminants, issue, Application, testing, genomic workflow, classification, Bcc, strains, B. aenigmatica sp. nov., B. lata, contaminant species, study, non-food manufacturing, industry, whole-genome sequencing, antimicrobial-resistant, bacteria, affecting, products]]\n",
      "[[AIMS, solubilising bacteria, PSB, 1-aminocyclopropane-1-carboxylate (ACC) deaminase, investigated, association, plant, properties, in vitro, conditions, bacterial, isolates, enrichment, isolation, ACC deaminase, investigated, in vitro methods, sequencing, acdS gene, effect, ACC deaminase, solubilisation, investigated, efficient, PSB, ACC, deaminase, production, ability, bacteria, genera Bacillus, Burkholderia, Pseudomonas, Variovorax, amount, ACC deaminase, PSB, associated with, liberation, Pi, Ca-P, ACC, Ca-P, solubilisation, associated with, degree, acidification, medium, solubilisation, potential, PSB, NH4, SO4, carboxylates, in-planta, experiment, Burkholderia sp. 12F, chickpea cv, Genesis-863, sand, vermiculite, rock phosphate, inoculation, efficient, PSB, increased, growth, nodulation, chickpea, fertilised, rock phosphate, ACC, deaminase, activity, influenced, capacity, PSB, solubilise, Ca-P, ACC, Burkholderia sp. 12F, promoted, chickpea-Mesorhizobium symbiosis, SIGNIFICANCE, IMPACT, ACC, deaminase, activity, enhance, solubilising activity, rhizobacteria, improve, plant growth]]\n",
      "[[bacterium Burkholderia multivorans, opportunistic, humans, study, molecular detection, bacterium, specimens, Cimex lectularius L., elderly care facility, U.S.A., questions, vector-borne transmission, B. multivorans, colonize, bed bugs, bed bugs, transmit, bacteria, knowledge, experiments, persistence, shedding, B. multivorans, ingestion, bed bugs, blood meal, isolated, B. multivorans, bodies, bed bugs, days, post-ingestion, bacterial load, time, days, post-ingestion, bacteria, isolated, B. multivorans, saliva, infected, bugs, feeding, transmitted, vertically, infected, insects, progeny, results, biological, mechanical transmission, B. multivorans, humans, bed bugs, bacteria, environment, defecation, process, transmission, indirect, contamination, rare, circumstances]]\n",
      "[[promoter-assisted glycosidation approach, stereoselective synthesis, 6-deoxy-beta-d-manno-heptopyranose oligosaccharides, SphosAuNTf2-promoted glycosidation, 6-deoxy-d-manno-heptopyranosyl o-hexynylbenzoate, alcohols, 6-deoxy-d-manno-heptosides, beta-selectivities, counterion, ligand, SPhosAuNTf2, formation, 6-deoxy-d-manno-heptosides, stereocontrolled synthesis, oligosaccharides, relevant, Burkholderia pseudomallei, Burkholderia mallei]]\n",
      "[[Burkholderia mallei, etiologic agent, glanders, diagnose, zoonotic disease, early stages, methods, complement fixation test, CFT, problems, veterinary authorities, financial losses, animal owners, false-positive results, mallein test, laboratory equipment, skilled personnel, diagnose, disease, animals, methods, Western blot test, WBT, disease, study, optimized, Western blot, sera, glanderous equids, sensitivity, specificity, ELISA, CFT, WBT, ELISA tests, B. mallei, antigens, purified, B. mallei antigen, WBT, sensitivity, specificity, tests, cut-off values, test developers, WBT, ELISA, CFT, ELISA, B. mallei, antigens, sensitive, CFT, sensitivities, specificities, CFT, WBT, ELISA, CFT, prescribed, technique, serological, investigation, equids, trade, individual, animals, glanders, improve, optimize, WBT, ELISA, tests]]\n",
      "[[Glanders, Burkholderia (B.) mallei, notifiable, zoonotic disease, equidae, international trade, movement, equids, certificates, negative, results, antibodies, B. mallei, complement fixation test, CFT, mandatory test, issue, health certificates, CFT, standardize, poor specificity, false-positive reactions, trade, restrictions, financial, consequences, study, ID, Screen Glanders, Double Antigen Multispecies ELISA, GLANDA- ELISA, IDvet, Grabels, France, evaluated, negative, glanders, positive field samples, equidae, GLANDA-ELISA, specific, CFT, sensitivities, CFT, ELISA, GLANDA-ELISA test, confirmatory test, alternative, serological testing, horses, trade, movement]]\n",
      "[[Bacillus anthracis, Yersinia pestis, causative pathogens, anthrax, plague, Burkholderia mallei, B. pseudomallei, bioterrorism, threats, Tebipenem, pivoxil hydrobromide, TBP, HBr, SPR994, orally, prodrug, tebipenem, carbapenem, activity, multidrug-resistant, MDR, gram-negative pathogens, quinolone-resistant, extended-spectrum-beta-lactamase-producing, Enterobacterales, evaluated, in vitro, activity, in vivo, efficacy, tebipenem, biothreat, pathogens, Tebipenem, active, in vitro, diversity, B. anthracis, pestis, B. mallei, B. pseudomallei, minimum inhibitory concentration, MIC, values, B. anthracis, pestis, B. mallei, B. pseudomallei, B. anthracis, murine, model, control animals, died, post, survival rates, groups, treated with, tebipenem, dosed, post, survival rates, positive control groups, treated with, ciprofloxacin, dosed, dosed, post, Survival rates, tebipenem, groups, treated, post, ciprofloxacin, group, post-challenge, vehicle-control group, pestis, survival rates, animals, tebipenem, ciprofloxacin, groups, vehicle-control group, results, development, tebipenem, treating, biothreat, pathogens]]\n",
      "[[Burkholderia pseudomallei, soil-dwelling Gram-negative bacterium, causative agent, endemic tropical disease, melioidosis, Clinical manifestations, B. pseudomallei, infection, acute, chronic, organ, fulminant, septicaemia, multiple organs, clinical manifestations, factors, genome, plasticity, B. pseudomallei, strains, characterized, B. pseudomallei, strains, isolated, Malaysia, levels, virulence, model, hosts, virulence, variance, genome, level, study, sequenced, assembled, Malaysian, clinical, B. pseudomallei, isolates, UKMR15, UKMD286, UKMH10, Phylogenomic analysis, Malaysian subclades, Asian subclade, Malaysian strains, Asian region, low-virulence, strain, UKMH10, Malaysian, isolates, Genomic island, GI, prediction analysis, identified, GI9c, B. pseudomallei, Burkholderia mallei, Burkholderia thailandensis, Genes, encoding, B. pseudomallei, virulence factors, genomes, comparative analysis, content, Malaysian strains, identified, genes, absent, UKMH10, genes, virulence factors, reduced, virulence, strain, investigation, identity, proteins, B. pseudomallei, pathogenicity, design, therapeutics, treating, melioidosis]]\n",
      "[[protein O-glycosylation pathway, species, Burkholderia genus, results, synthesis, incorporation, trisaccharide glycan, membrane-exported proteins, system, construct, evaluate, diagnostic tool, glanders, Burkholderia mallei, causative agent, glanders, infectious, fatal, zoonotic pathogen, infects, horses, mules, donkeys, humans, sensitive, diagnostic tool, control, elimination, eradication, B. mallei infections, plasmids, synthetic genes, encoding, modified, unannotated, Burkholderia glycoprotein, glycosylation, sequons, fused, cholera, toxin B-subunit, proteins, glycosylated, B. cenocepacia K56, parental, strain, glycosylation-deficient, mutants, SDS-PAGE, fluorescent lectin, blots, glycoproteins, antigen, ELISA, western blots, serum samples, glanders-infected, healthy, horses, investigated, complement fixation test, indirect, ELISA, semi-purified, fraction, B. mallei, ELISA, western blot assays, glycoprotein antigen, specificity, sensitivity, glycoprotein antigen, serum samples, patients, infected, B. pseudomallei, B. mallei, B. multivorans, B. cenocepacia, results, protein O-glycosylation, Burkholderia, biomarker, diagnosis, Burkholderia-associated infections]]\n",
      "[[increasing, threat, antibiotic-resistant, pathogens, antibiotics, combat, Burkholderia, genus, Gram-negative, non-sporulating bacteria, ubiquitous, plants, groundwater, soil-dwelling organisms, virulent, Burkholderia, Burkholderia mallei, Burkholderia pseudomallei, Burkholderia cepacia complex, Bcc, review, synopsis, research, natural products, isolated, genus, Burkholderia, authors, research, drug discovery, natural products, Burkholderia, opinion, Burkholderia, pathogenic species, genus, avirulent, members, genus, antimicrobial products, development, novel, therapeutics, infectious diseases, discovery, antibiotics, prevalence, antibiotic-resistant, pathogens, decline, discovery, antibiotics]]\n",
      "[[Burkholderia pseudomallei, phylogenetic cluster, B. pseudomallei, B. mallei, B. thailandensis, B. oklahomensis, B. humptydooensis, B. singularis, Regarded, pathogenic members, group, B. pseudomallei, B. mallei, diseases, melioidosis, glanders, variant, strains, B. pseudomallei, B. thailandensis, geographically, B. pseudomallei, B. mallei-like BimA protein, BPBM, B. thailandensis, B. pseudomallei-like, BTCV, PCR-based assay, detection, pathogenic, Burkholderia species, variants, PCR primers, species-specific sequences, bimA, Burkholderia intracellular motility A) gene, multiplex PCR assay, pathogenic, B. pseudomallei, BPBM, non-pathogenic, B. thailandensis, BTCV, strains, singleplex PCR, discriminated, BTCV, B. thailandensis, B. humptydooensis, specificity testing, Burkholderia spp, Gram-negative, Gram-positive bacteria, negative, result, detection, multiplex PCR, soil, samples, quantities, B. pseudomallei, B. thailandensis, CFU/g soil, comparison, standard, bacterial culture, multiplex PCR, detect, B. pseudomallei, soil, samples, endemic area, melioidosis, sensitivity, specificity, robust, sensitive, PCR assay, epidemiological study, B. pseudomallei, members, pathogenic, potential, soil]]\n",
      "[[genus, Burkholderia, Gram-negative, bacterial, pathogenic, humans, vertebrates, pathogenic, species, Burkholderia mallei, Burkholderia pseudomallei, members, Burkholderia cepacia complex, Bcc, B. mallei, B. pseudomallei, glanders, melioidosis, potential, bioweapons, Bcc, Burkholderia species, associated with, respiratory infections, people, chronic granulomatous disease, cystic fibrosis, Antimicrobial treatment, Burkholderia infections, intrinsic, multidrug antibiotic, bacteria, prophylactic vaccines, alternative, infections, commercial, vaccines, Burkholderia infections, years, development, vaccines, B. pseudomallei, B. mallei, review, advances, vaccine, development, B. mallei, B. pseudomallei, Bcc]]\n",
      "[[Gram-negative, bacterial, Burkholderia, human, pathogens, biothreat, species, Burkholderia mallei, glanders, B. pseudomallei, melioidosis, B. cepacia complex, BCC, B. gladioli, chronic lung infections, persons, cystic fibrosis, Burkholderia spp, Ambler class A Pen beta-lactamase, resistance, beta-lactams, beta-lactam-beta-lactamase inhibitor, combination sulbactam-durlobactam, SUL-DUR, clinical development, treatment, Acinetobacter infections, study, evaluated, SUL-DUR, in vitro, in vivo, activity, Burkholderia clinical, isolates, MICs, SUL-DUR, BCC, B. gladioli, B. mallei, B. pseudomallei, kinetics, inhibition, PenA1 beta-lactamase, B. multivorans, PenI beta-lactamase, B. pseudomallei, durlobactam, tested, bla, induction, SUL-DUR, evaluated, in vivo, efficacy, mouse model, melioidosis, SUL-DUR, inhibited, growth, BCC, B. gladioli, strains, B. mallei, B. pseudomallei, strains, Durlobactam, inhibited, PenA1, PenI, second-order rate constant, inactivation, values, apparent, stable, sulbactam, durlobactam, SUL-DUR, increased, production, PenA1, SUL-DUR, activity, in vivo, murine, melioidosis, model, data, SUL-DUR, treatment, Burkholderia infections]]\n",
      "[[taurultambenzenesulfonamides 1, prepared, inhibitory activity, in vitro, Carbonic Anhydrases, Vibrio cholerae, VchCA-alpha, VchCA-beta, VchCA-gamma), Burkholderia pseudomallei, BpsCA-beta, BpsCA-gamma), compounds, tested, derivatives 4, effective, VchCAalpha inhibitors, KI values, excellent, Selectivity Indexes, SIs, KI VchCA-alpha/KI hCA II, in vitro, inhibitors, BpsCA-gamma, identified, KIs, results, development, CA-based, antibiotics, integrated, free, resistance, mechanisms, action, drugs]]\n",
      "[[time-gated immunoassay, low-energy excitable, fluorescence, Mn, AgZnInS/ZnS, nanocrystals, signal transducers, detection, capsular polysaccharide, CPS, Burkholderia pseudomallei, Gram-negative bacterium, causative agent, melioidosis, CPS, molecular weight antigen, displayed, outer membrane, B. pseudomallei, immunoassay, time-gated platform, detection, CPS, spiked, human, serum]]\n",
      "[[Melioidosis, life-threatening disease, humans, Gram- negative, bacterium, Burkholderia pseudomallei, septicemic, melioidosis, death, hours, diagnosis, melioidosis, optimal, antibiotic course, prescribed, patients, development, evaluation, bacteriophage tail, fiber-based latex agglutination assay, detection, B. pseudomallei, infection, Burkholderia phage E094, isolated, rice paddy, fields, northeast Thailand, genome, tail fiber, complex, characterized, identification, tail assembly protein, mature, fiber, Recombinant 94TF, conjugated, latex beads, agglutination-based assay, tested, library, Burkholderia, bacterial strains, field evaluation, routine, clinical testing, sensitivity, specificity, assessed, biochemical analyses, patient, endemic area, melioidosis, months, minutes, positive, agglutination, CI, sensitivity, CI, specificity, biochemical-based, detection, Burkholderia-specific phage, fiber, detection, B. pseudomallei, potential, development, diagnostic, clinical identification, life-threatening, pathogen, IMPORTANCERapid diagnosis, melioidosis, optimal, antibiotic, courses, prescribed, patients, development, cost-effective, easy-to-use tests, implementation, under-resourced areas, Northeast Thailand, tropical regions, Phage tail fibers, alternative, antibodies, diagnostic assays, pathogenic bacteria, exposed appendages, phages, tail fibers, physically robust, manufacture, tail fibers, investigated, target, bacterial species, specificity, effectiveness, latex agglutination assay, Burkholderia-specific tail fiber, biochemical-based detection methods, standard, diagnostic, endemic, meilodosis]]\n",
      "[[Melioidosis, severe, disease, Burkholderia pseudomallei, B. pseudomallei, Gram-negative environmental bacterium, endemic, Southeast Asia, Northern Australia, underreported, countries, principal, routes, entry, B. pseudomallei, skin penetration, inhalation, ingestion, immunocompromised populations, patients, type 2 diabetes mellitus, laboratory diagnosis, melioidosis, clinical manifestations, severe, infections, culture method, gold, diagnosis, melioidosis, low, sensitivity, Antibody, detection, low, sensitivity, specificity, seropositivity, healthy people, endemic regions, Antigen detection, proteins, tested, determination, B. pseudomallei, limitations, sensitivity, specificity, review, knowledge, potential, target, Burkholderia invasion protein D, BipD, directions, detection, aptamer-based sensor, aptasensor]]\n",
      "[[Prokaryotic cell, transcriptomics, sub-population, dynamics, individual cells, heterogeneous, populations, spatiotemporal, stage-specific processes, prokaryotic cells, complex, environments, TRANSITomic, transcriptomes, single Burkholderia pseudomallei cells, transit, host, stages, pathophysiological, insights, B. pseudomallei, transits, host cells, infection, observable stages, vacuole entry, cytoplasmic, escape, replication, membrane protrusion, cell-to-cell spread, B. pseudomallei 'TRANSITome', dynamic, gene-expression flux, transit, host cells, genes, pathogenesis, hypothetical proteins, virulence, mechanisms, attachment, cytoskeletal modulation, autophagy, evasion, B. pseudomallei 'TRANSITome', prokaryotic, information, high-resolution, host-pathogen interactions]]\n",
      "[[Burkholderia pseudomallei, soil-dwelling organism, tropics, causative agent, melioidosis, disease, kill, people, year, resistant, antibiotics, weeks, intravenous treatment, ceftazidime, imipenem, meropenem, months, orally, co-trimoxazole, treatment, burden, middle-income nations, disease, occurs, high-throughput assay, compounds, co-therapy, potentiate, effect, ceftazidime, non-pathogenic, Burkholderia thailandensis, surrogate, Optimization, assay, Z' factor, screened, library, compounds, identified, compounds, pIC50, investigation, compounds, licensed, drug chloroxine, Co-treatment, B. thailandensis, ceftazidime, chloroxine, reduced, culturable, magnitude, hours, treatment, ceftazidime, Hit, expansion, chloroxine, compounds, Minor, modifications, structure, activity, chloroxine, target, study, chloroxine, co-therapy, potentiate, effect, ceftazidime, B. pseudomallei, potential, co-therapies, recalcitrant, Gram-negative, bacterial, species, assay, chemotherapy, treat, infections, bacteria]]\n",
      "[[trends, manifestations, treatment, outcomes, children, culture-confirmed, melioidosis, years, pediatric hospital, northern Cambodia, Bacteremia, presentation, pneumonia, risk factors, death, children, recovered, oral, antimicrobial drug, treatment]]\n",
      "[[Cefiderocol, CFDC, S-649266, injectable, siderophore cephalosporin, Shionogi & Co., in vitro, activity, Gram-negative pathogens, multidrug-resistant, MDR, Enterobacteriaceae, non-fermenting organisms, Pseudomonas aeruginosa, Acinetobacter baumannii, Burkholderia cepacia, Stenotrophomonas maltophilia, Characterized, siderophore catechol-moiety, CFDC, trojan-horse approach, bacterial, evading, beta-lactam, enzymes, mechanisms, resistance, Gram-negative bacteria, carbapenem-resistant Enterobacteriaceae, CFDC, activity, ESBLs, CTX-type, SHV-type, TEM-type, Ambler classes, beta-lactamases, class A (KPC, class B, NDM, IMP, VIM, class C, AmpC, class D, OXA, OXA-24, OXA-48, OXA-48-like, activity, CFDC, MDR P. aeruginosa, activity, OXA-23, OXA-24, OXA-51, beta-lactamases, MDR, A. baumannii, Cefiderocol, US, FDA, complicated, urinary tract infections, cUTI, pyelonephritis, patients, years, older, limited, treatment, evaluated, phase III trial, nosocomial pneumonia, Gram-negative pathogens, features, enhanced, activity, CFDC, therapeutic, treatment, MDR, Gram-negative infections, review, overview, published literature, CFDC's, pharmacology, pharmacokinetic, pharmacodynamic, PK, PD, properties, microbiologic activity, resistance, mechanisms, safety, parameters, dosing, administration, clinical data, potential, therapy]]\n",
      "[[Burkholderia cepacia, gram-negative bacillus, associated with, pneumonia, immunocompromised, patients, organisms, associated with, pancreatic infections, Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., Enterococcus spp., case, gentleman, acute pancreatitis, hypoglycemia, mental status, worsening, epigastric pain, early satiety, diagnosed, peripancreatic, infected, cyst, multidrug-resistant, MDR, Burkholderia cepacia, Candida glabrata, Candida dubliniensis, case report, risk factors, MDR, organism, patient care]]\n",
      "[[study, investigating, association, gene expression, multidrug efflux pumps, MexA, MexC, MexE, MexX, outer membrane, OprD, beta-lactamase AmpC, antimicrobial susceptibility, clinical, isolates, Burkholderia cepacia complex, Bcc, Increased, expression, ampC gene, association, reduced, susceptibility, chloramphenicol, reduced, susceptibility, chloramphenicol, correlated, overexpression, genes, ampC, mexC, mexE, mexX, Bcc, isolates, Increased, mexA, expression, association, reduced, susceptibility, beta-lactam antimicrobials, ceftazidime, piperacillin-tazobactam, meropenem, co-trimoxazole, Reduced, susceptibility, meropenem, correlation, overexpression, mexC, mexX, reduced, susceptibility, ceftazidime, associated with, mexE, overexpression, Reduced, susceptibility, levofloxacin, associated with, overexpression, mexX., involvement, efflux, pumps, levofloxacin, ceftazidime, resistance, finding, efflux, inhibitor, carbonyl cyanide m-chlorophenylhydrazone, reduced, inhibitory, concentrations, antimicrobials, study, high-level, expression, mexC, mexE, mexX, efflux, pumps genes, ampC, clinical, isolates, Bcc, targeted, treating, infections, Bcc]]\n",
      "[[Burkholderia cepacia complex, Bcc, group, pathogens, cystic fibrosis, patients, causes, life threatening, infections, immunocompromised, patients, Species, Bcc, environment, survive, presence, disinfectants, antiseptics, multidrug resistant, MDR, Dhaka Medical College Hospital, DMCH, patients, B. cepacia, positive, blood culture, outbreak, cases, Blood stream infections, BSIs, detected, BacT/ALERT 3D, DMCH, B. cepacia, isolated, chromogenic UTI, media, MALDI-TOF, MIC, clinically, antibiotics, agar, dilution, Whole genome sequencing, Illumina MiSeq platform, Patients, demographic, clinical data, Patients, clinical history, genomic data, outbreak, strains, merged, investigate, outbreaks, B. cepacia, genomes, Burkholderia Genome Database, genomic background, global strains, outbreak, strains, BSIs, B. cepacia, Outbreak, cases, burn, critical care unit, lesser, paediatrics department, continuum, cases, DMCH, Core genome, SNPs, outbreak, strains, clone, ST1578, strains, MDR, associated with, mortality, discharge, medical advice, MIC, profiles, strains, antibiotics, deployed, empirical therapy, inappropriate, genetic background, outbreak, strains, variations, presence, virulence genes, global, strains, Burkholderia Genome Database, Bangladeshi, strains, genetically, Environmental, surveillance, investigate, aetiology, mode, transmission, B. cepacia, outbreak, Systematic management, nosocomial outbreaks, resource limited regions, mitigate, transmission, patients, outcomes]]\n",
      "[[Burkholderia multivorans, Burkholderia cepacia complex, members, resistant, antibiotics, chronic, patients, cystic fibrosis, treatment, chronic infections, collateral sensitivity, resistance, treatment, antibiotic, decreased, resistance, nontreatment, antibiotic, CS patterns, bacteria, chronic infections, sustainable, treatment regimens, reduce, development, multidrug-resistant, bacterial strains, CS, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, B. multivorans, antibiotic CS, cross-resistance, CR, CS, CR, networks, antibiotics, ceftazidime, chloramphenicol, levofloxacin, meropenem, minocycline, trimethoprim-sulfamethoxazole, genes, CS, Characterization, CS, CR, patterns, antibiotics, clusters, treatment drug, strain, primary resistance, antibiotic therapy, switching, members, clusters]]\n",
      "[[Cefiderocol, injectable, siderophore cephalosporin, discovered, Shionogi & Co., Japan, beta-lactam antibiotics, principal antibacterial/bactericidal activity, cefiderocol, inhibition, Gram-negative bacterial cell wall, synthesis, binding, penicillin binding proteins, unique, bacterial, siderophore-like property, stability, beta-lactamases, chemical structure, cefiderocol, ceftazidime, cefepime, third-, fourth-generation cephalosporins, stability, beta-lactamases, AmpC, extended-spectrum beta-lactamases, ESBLs, Cefiderocol, pyrrolidinium group, side chain at position, cefepime, carboxypropanoxyimino, group, side chain, cephem nucleus, ceftazidime, chemical structures, cefiderocol, ceftazidime, cefepime, presence, catechol, group, side chain at position 3, stability, beta-lactamases, ESBLs, AmpC, carbapenemases, microbiological activity, cefiderocol, aerobic, Gram-negative bacilli, superior, ceftazidime-avibactam, meropenem, Ambler class A, B, Cefiderocol, ceftazidime-avibactam, meropenem, Acinetobacter baumannii, meropenem, non-susceptible, multidrug-resistant, MDR, isolates, Cefiderocol's activity, meropenem-non-susceptible, Klebsiella pneumoniae carbapenemase, Enterobacteriales, superior, ceftazidime-avibactam, Cefiderocol, ceftazidime-avibactam, meropenem, resistance, phenotypes, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, dosing, regimen, phase III studies, administered, intravenously, infusion, pharmacokinetics, cefiderocol, three-compartment linear model, plasma, half-life, t(1/2, protein binding, single-, multi-dose, infusions, renally, excreted, unchanged, Cefiderocol, renally, excreted, unchanged, clearance, correlates, creatinine, clearance, Dosage, adjustment, augmented, renal clearance, patients, moderate, severe, renal impairment, In vitro, in vivo, pharmacodynamic studies, cephalosporins, pharmacodynamic index, clinical outcome, percentage, free, concentrations, concentration, fT, MIC, In vivo, efficacy, cefiderocol, humanized drug, murine, rat, models, infection, MDR, drug resistant, strains, Cefiderocol, comparator agents, ceftazidime, cefepime, phase II, prospective, multicenter, double-blind, randomized clinical trial, assessed, safety, efficacy, cefiderocol, imipenem/cilastatin, administered, intravenously, days, treatment, complicated, urinary tract infection, cUTI, pyelonephritis, acute uncomplicated pyelonephritis, hospitalized adults, patients, study, cefiderocol arm, imipenem/cilastatin arm, primary outcome measure, composite, clinical cure, microbiological, eradication, test-of-cure, TOC, visit, days, treatment, microbiological intent-to-treat, MITT, population, Secondary outcome, microbiological response, pathogen, patient, early assessment, EA, treatment, EOT, TOC, follow-up, FUP, clinical response, pathogen, patient, EA, EOT, TOC, FUP, plasma, urine, concentrations, cefiderocol, participants, adverse events, composite, clinical, microbiological response, rates, cefiderocol, imipenem/cilastatin, MITT, population, Clinical response rates, patient, TOC, visit, cefiderocol, imipenem/cilastatin, MITT, population, Microbiological, eradication, cefiderocol, imipenem/cilastatin, MITT, population, phase III clinical trials, Shionogi & Co., Japan, trials, evaluating, efficacy, cefiderocol, treatment, infections, adult, patients, carbapenem-resistant, Gram-negative pathogens, evaluating, efficacy, cefiderocol, treatment, adults, hospital-acquired bacterial pneumonia, ventilator-associated pneumonia, healthcare-associated pneumonia, Gram-negative pathogens, Cefiderocol, tolerated, adverse effects, gastrointestinal, phlebitis, side effect profile, cephalosporin antimicrobials, Cefiderocol, infections, carbapenem-resistant, MDR, Gram-negative bacilli, ESBL-, carbapenemase-producing strains, metallo-beta-lactamase producers, cefiderocol, activity, resistant, P. aeruginosa, A. baumannii, S. maltophilia, Burkholderia cepacia]]\n",
      "[[efficacy, antibiotic, treatment, pulmonary, systemic infections, cystic fibrosis, CF, increased, prevalence, MDR strains, Pseudomonas aeruginosa, Burkholderia cepacia complex, Ceftazidime/avibactam, combination, in vitro, activity, MDR strains, P. aeruginosa, B. cepacia complex, retrospective analysis, adult, patients, CF, course, ceftazidime/avibactam, pulmonary exacerbations, antibiotic, treatment, Treatment, ceftazidime/avibactam, associated with, reduction, inflammatory, markers, improvement, lung function, episodes, acute kidney injury, elevation, transaminase, Ceftazidime/avibactam, tolerated, improved, patients, outcomes, studies, assess, combination, CF]]\n",
      "[[in vitro, activity, investigational, siderophore cephalosporin, cefiderocol, S-649266, 52-country, collection, clinical, isolates, carbapenem-nonsusceptible, Enterobacteriaceae, multidrug-resistant, MDR, Acinetobacter baumannii, MDR Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Burkholderia cepacia, Clinical and Laboratory Standards Institute (CLSI) standard, broth microdilution method, Iron-depleted cation-adjusted Mueller-Hinton broth, ID-CAMHB, published, CLSI, protocol, test cefiderocol, antimicrobial agents, tested, CAMHB, concentration, cefiderocol, inhibiting, MIC90, isolates, carbapenem-nonsusceptible, Enterobacteriaceae, cefiderocol, MICs, 991/1,022, isolates, cefiderocol, MICs, MIC90s, cefiderocol, MDR, A. baumannii, MDR, P. aeruginosa, S. maltophilia, isolates, cefiderocol, MICs, Cefiderocol, MICs, B. cepacia, cefiderocol, in vitro, activity, collection, clinical, isolates, carbapenem-nonsusceptible, Enterobacteriaceae, MDR, A. baumannii, MDR, P. aeruginosa, S. maltophilia, B. cepacia, isolates, isolates, tested, cefiderocol, MICs]]\n",
      "[[Burkholderia cepacia complex, opportunistic bacteria, group, immunocompromised, patients, level, intrinsic resistance, antibiotic classes, Hydrolysis, beta-lactam antibiotics, beta-lactamases, resistance, mechanism, Gram-negative bacteria, presence, enzymes, selection, therapy, study, investigating, antimicrobial resistance profile, presence, beta-lactamase, B. cepacia complex, isolated, Brazilian, soils, High-level, ceftazidime, resistance, beta-lactamase, genes, report, blaKPC genes, bacteria, isolated, soil]]\n",
      "[[Healthcare associated infections, HCAI, antimicrobial resistance, threats, patients, intensive care units, factors, patient outcome, associated with, increased, morbidity, mortality, excess, hospitalization, financial costs, study, investigate, spectrum, antimicrobial resistance, bacterial, isolates, healthcare, HCAI, patients, critical care unit, tertiary care university hospital, Kathmandu, Nepal, laboratory, study, period, months, patients, intensive care unit, Tribhuvan University Teaching Hospital, Kathmandu, Nepal, Clinical specimens, patients, suspected, healthcare-associated infection, processed, bacterial, isolates, microbiological methods, Antimicrobial susceptibilities, isolated, strains, CLSI, guidelines, beta-lactamases, ESBL, AmpC, MBL, KPC, detected, phenotypic tests, clinical specimens, patients, suspected, HCAI, patients, bacterial growth, Specimens, patients, suspected, hospital-acquired pneumonia, bloodstream infections, surgical site infections, urinary tract infections, Acinetobacter spp, Klebsiella spp., Escherichia coli, Burkholderia cepacia, bacterial, pathogens, level, drug resistance, production, beta-lactamases, ESBL, AmpC, MBL, KPC, Gram negative, bacterial, isolates, Healthcare, ICU, Gram negative, bacterial, pathogens, associated with, infections, state, drug resistance, isolates, Continuous surveillance, establishment, preventive, control measures, healthcare, infections]]\n",
      "[[CRISPR-Cas systems, foreign genetic material, CRISPR RNAs, crRNAs, Type II systems, trans-activating crRNA, tracrRNA, crRNAs, processing, utilization, Cas9, Cas9-RNA, complexes, Campylobacter jejuni, tracrRNA, hybridizing, cellular RNAs, formation, noncanonical, crRNAs, DNA, targeting, Cas9, discovery, engineering, reprogrammed, tracrRNAs, presence, RNA-of-interest, DNA, targeting, Cas9, orthologs, capability, multiplexable, diagnostic platform, LEOPARD, Engineered tracrRNAs, On-target, DNAs, PArallel RNA Detection, LEOPARD, simultaneous, detection, RNAs, viruses, test, SARS-CoV-2, D614G, single-base resolution, patient samples]]\n",
      "[[PURPOSE, etiology, infective diarrheaoften, undiagnosed, multiplex polymerase chain reaction, PCR, detection, etiological agents, diarrhoea, Fast track diagnostics, bacterial, viral pathogens, test, stool samples, patients, diarrhoea, Stool samples, patients, immunocompetent, immunocompromised, diarrhoea, healthy controls, tested, Bacterial culture, positive, samples, agents, isolated, Shigella sonnei(2), Shigella dysentriae(1), SalmonellaParatyphi, Vibrio cholerae, Multiplex PCR panel, Vibrio cholerae, panel, target, pathogens, identified, patients, multiplex PCR, bacterial, viral agents, bacteria, Shigella(20, Salmonella(3), Campylobacter(4), Clostridium difficile(1), Viral targets, identified, Norovirus, GII, Adenovirus(4, Astrovirus(3, Sapovirus(2, controls, negative, enteropathogens, conventional methods, multiplex PCR, detection, rates, increased, conventional methods, multiplex PCR, bacterial, viral targets]]\n",
      "[[classification, periodontal disease, consensus-based, data-driven classifications, study, microbiological signatures, latent, periodontal stratification system, Periodontal Profile Class, taxonomy, demographic, microbial, subgingival, biofilm composition, immunological, data, serum IgG, antibody, levels, checkerboard immunoblotting technique, adult, participants, Dental Atherosclerosis, Risk, Communities, ARIC, study, PPC, classifications, Analyses, tests, generalized linear models, Bonferroni correction, Men, African Americans, systemic, antibody, levels, microorganisms, women, Caucasians, Healthy, individuals, PPC-I, low, levels, biofilm bacteria, serum IgG, levels, periodontal pathogens, Subjects, mild, PPC-III, mild/moderate, colonization, multiple, biofilm pathogens, Individuals, severe disease, PPC-IV, levels, biofilm pathogens, antibody, levels, orange/red, complexes, High gingival index, individuals, PPC-V, levels, biofilm, Campylobacter rectus, Aggregatibacter actinomycetemcomitans, Biofilm composition, individuals, reduced, periodontium, PPC-VI, health, moderate, antibody, responses, severe, tooth loss, PPC-VII, levels, multiple, biofilm pathogens, systemic, response, microorganisms, health, results, biologic, elevated, risk, periodontal disease, men, African Americans, Periodontally healthy, individuals, biofilm pathogen, low, systemic, burden, presence, PPC disease, microbial-host, imbalance, characterized, microbial, biofilm, colonization, systemic IgG, responses, identified, results, subgroups, identified, PPC system, microbial, profiles, designing, biological, interventions]]\n",
      "[[Marinades, seasoned liquids, tenderness, palatability, flavor, color, texture, meats, sensory characteristics, marinates, inactivate, food microorganism, study, assess, state, knowledge, effect, marinades, meats, food pathogens, systematic review, literature, marinades, evaluated, ingredients, concentrations, temperature, marinating, effect, Salmonella, Escherichia coli, Listeria monocytogenes, Campylobacter, Vibrio, Findings, marinades, meats, prevents, growth, pathogens, inactivates, food pathogens, marinades, reduce, CFU/g, pathogens, Vibrio populations, reductions, CFU/g, pH, parameter, pathogens, inactivation, ingredients, storage, temperature, pathogen, reduction, marinades]]\n",
      "[[Campylobacter, gastroenteritis, humans, asymptomatically, colonises, intestinal tract, animals, antimicrobial, treatment, severe, cases, increase, antimicrobial resistance, AMR, contribution, ruminants, reservoirs, resistant, Campylobacter, Illumina whole-genome sequencing, mechanisms, AMR, Campylobacter jejuni, Campylobacter coli, recovered, beef cattle, dairy cattle, sheep, northern Spain, Genome analysis, genetic diversity, species, Resistance genotypes, screening, BLASTn, ABRicate, sequence alignments, search, frameshift mutations, gene modifications, correlation, phenotypic, resistance, antimicrobial, presence, resistance genes, sequence analysis, detect, mosaic tet(O/M/O) gene, C. coli, alleles, blaOXA-61-like genes, genetic context, aminoglycoside, resistance genes, plasmid/chromosomal, location, AMR, genes, resistance, spread, resistance, gene databases, analysis, matched, errors, WGS-based analysis, pipelines, AMR, detection, absence, phenotypic, data]]\n",
      "[[effective, therapeutics, preventive interventions, health threats, enhanced, models, assessment, clinically, outcomes, non-human model, inexpensive, in vivo, small, animal, models, mice, relevant, efficacy, potential, interventions, acute diarrhea, long-term, growth, developmental, effects, enteric infections, overt, diarrhea, diverse, effects, inexpensive, animal models, review, clinical, enteric, parasitic, bacterial infections, worldwide, vulnerable, young, children, living, impoverished areas, murine, models, infections, outcomes, dietary deficiencies, children, effects, diarrhea, enteropathy, outcomes, mice, effects, pathogens, effects of, protein, zinc deficiency, protozoal, bacterial, pathogens, pathogenetic pathways, intervention, effects, pathogens, reviewed, parasitic, bacterial, pathogens, children, Cryptosporidium, Giardia, Campylobacter, Shigella, enterotoxigenic Escherichia coli, ETEC, enteroaggregative E. coli, EAEC, enteropathogenic E. coli, EPEC]]\n",
      "[[microbial, quality, groundwater, sources, borehole, risks, quantitatively, assessed, Water samples, borehole, period, weeks, concentrations, Escherichia coli, faecal coliforms, Salmonella, Shigella, Clostridium, Bifidobacterium, Campylobacter, microbiological methods, membrane filter technique, water samples, mum membrane filter, vacuum pump pressure, plated, selective agar, bacteria, test, colonies, bacterial growth, observed, incubation, period, counted, recorded, physicochemical properties, water, standard methods, risk, Salmonella, Shigella, Clostridium, Campylobacter infections, ingestion, water, borehole, estimated, results, levels, enteric bacteria, borehole, levels, E. coli, water, borehole, negative, relationship, salinity, risks, infection, associated with, pathogens, water, borehole, acceptable, risk limit, Clostridium, Salmonella, Campylobacter, Shigella, findings, study, continuous, faecal, contamination, groundwater, sources, residents, water, drinking, potential, risks, gastrointestinal infections]]\n",
      "NaN\n",
      "[[Campylobacter jejuni, food poisoning, United States, Europe, exterior cell, C. jejuni, coated, capsular polysaccharide, CPS, maintenance, integrity, bacterial cell wall, evasion, host, immune response, identity, sequences, monosaccharide, components, CPS, variable, dependent, strain, C. jejuni, immediate, precursor, multiple, variations, heptose moieties, C. jejuni, CPS, GDP-d-glycero-alpha-d-manno-heptose, C. jejuni, NCTC 11168, heptose moiety, d-glycero-l-gluco-heptose, Cj1427, catalyzes, oxidation, GDP-d-glycero-alpha-d-manno-heptose, GDP-d-glycero-4-keto-alpha-d-lyxo-heptose, alpha-ketoglutarate, cosubstrate, Cj1430, catalyze, double epimerization, product, C3, C5, GDP-d-glycero-4-keto-beta-l-xylo-heptose, Cj1428, catalyzes, stereospecific, reduction, GDP-linked heptose, NADPH, GDP-d-glycero-beta-l-gluco-heptose, three-dimensional, crystal structure, Cj1430, resolution, presence, bound, GDP-d-glycero-beta-l-gluco-heptose, product analogue, structure, cupin superfamily, three-dimensional, crystal structure, Cj1428, presence, NADPH, resolution, short-chain dehydrogenase/reductase superfamily, members, family display, sequence, YXXXK, tyrosine, catalysis, Cj1428, residue, phenylalanine]]\n",
      "[[Helicobacter pylori, associated with, chronic gastritis, gastric, duodenal ulcers, gastric cancer, oral cavity, entry port, gastrointestinal system, oral cavity, potential, reservoir, H. pylori, oral-oral transmission, H. pylori, contact, kissing, meal, transmission, H. pylori, investigated, studies, techniques, detection, H. pylori, oral samples, molecular techniques, immunological, biochemical methods, traditional, culture techniques, molecular, immunological, biochemical methods, detection, rates, evidence, H. pylori, isolated, oral cavity, specificity, methods, potential, cross-reactivity, H. pylori-like microorganisms, Campylobacter spp, influence, gastroesophageal reflux, investigated, review, studies, investigating, potential, colonization, H. pylori, oral cavity, research, targeting]]\n",
      "[[Ribonucleases, central players, post-transcriptional regulation, level, gene expression regulation, cells, characterized, 3'-5' exoribonuclease RNase R, bacterial pathogen, Helicobacter pylori, prototypical, Escherichia coli, RNase R, exoribonuclease, helicase activities, RNA unwinding function, bacterial, H. pylori, HpRNase R protein, domains, helicase activity, purified protein, in vitro, RNA molecules, secondary structures, RNase R helicase domains, Campylobacterota, Helicobacter, Campylobacter, genera, loss, evolution, in vivo, interaction, HpRNase R, RhpA, DEAD-box RNA helicase, H. pylori, Purified, RhpA, degradation, double stranded RNA, HpRNase R, complex, functional, 5S, rRNA, maturation, targets, H. pylori, RhpA, regulon, evolution, HpRNase R, RhpA, helicase, lack, helicase activity]]\n",
      "[[Consumption, contaminated, poultry, products, sources, human, campylobacteriosis, Campylobacter jejuni subsp., jejuni, C. jejuni, C. coli, cases, turkeys, ceca, anatomical site, Campylobacter, asymptomatically, colonizes, commercial, turkey, poults, colonized, C. jejuni, acute, changes, cytokine gene, expression profiles, histological, intestinal, lesions, days, post-inoculation, dpi, Cecal tonsils, CT, gastrointestinal-associated lymphoid tissue, surveil material, ceca, immune responses, intestinal, pathogens, CT, immune response, Campylobacter, study, kanamycin-resistant, C. coli construct, CcK, enumeration, cecal, contents, experimental, In vitro, analysis, CcK, motility, parent, isolate, Poults, inoculated, oral gavage, CcK, sterile-media, mock-colonized, euthanized, dpi, time points, CcK, cecal, contents, mock-colonized group, marker, acute inflammation, serum alpha-1 acid glycoprotein, elevated, dpi, CcK, inoculated, poults, mock-infected, samples, histological, lesions, detected, cecal, CT, tissues, CcK, colonized, poults, dpi, RNAseq, analysis, identified, DEG, CT, CcK, colonized, poults, dpi, upregulated, downregulated, DEG, biological pathways, identified, platelet aggregation, response, oxidative stress, negative, regulation, oxidative, stress-induced, data, C. coli, induced, acute inflammatory response, intestinal tract, poults, platelet aggregation, oxidative stress, CT, turkey's, Campylobacter, colonization, findings, test, Campylobacter, mitigation, promote, food safety, commercial, turkeys]]\n",
      "[[Campylobacter, foodborne, bacterial infections, poultry, sources, bacteria, ruminants, cattle, human, Campylobacter jejuni, lesser, Campylobacter coli, infections, study, bovine, pig, carcasses, Poland, investigated, presence, Campylobacter, antimicrobial resistance, swabs, bovine, carcasses, swab samples, pig, carcasses, tested, Campylobacter, pig, bovine, carcasses, pig, isolates, C. coli, C. jejuni, bovine, Campylobacter, C. jejuni, isolates, C. coli, strains, Resistance, isolates, erythromycin, ciprofloxacin, nalidixic acid, streptomycin, tetracycline, revealed, C. coli, resistant, streptomycin, isolates, tetracycline, nalidixic acid, ciprofloxacin, C. jejuni, isolates, resistance, rates, antibiotics, C. coli, origin, C. coli, isolates, pig, carcasses, isolates, bovine, samples, multiresistant, C. coli, isolates, ciprofloxacin+nalidixic acid+streptomycin+tetracycline, results, pig, bovine, carcasses, reservoir, Campylobacter, C. coli, pigs, antimicrobial, rates, strains, streptomycin, quinolones, tetracyclines, monitoring, bacteria, food, food products]]\n",
      "NaN\n",
      "[[Game, birds, zoonotic bacteria, intestines, transmit, hunters, bird, handling, handling, consumption, contaminated meat, study, prevalence, foodborne bacteria, screened, game, bird, faeces, mallard, breast meat, PCR, sampling, southern Finland, hunting, season, Isolates, characterized, multi-locus sequence typing, Mesophilic, Escherichia coli, counts, assess, microbial, contamination, mallard, meat, woodpigeon, Columba palumbus, pheasants, Phasianus colchicus, mallards, Anas platyrhynchos, teals, Anas crecca, screened, hunting, season, mallard, breast meat, samples, Campylobacter, Listeria, detected, faeces, Listeria, mallard, meat, L. monocytogenes of sequence types, associated with, human, listeriosis, game, bird, faeces, mallard, meat, Good hygiene, game, bird, handling, game, bird, frozen, heat, treatment, measures, health risk, hunters, consumers]]\n",
      "[[Campylobacter spp, causal agent, diarrheal illness, humans, Detection, Campylobacter spp, food, reduce, foodborne illness, foods, evaluate, AtlasTMCampylobacter Detection, Assay, AOAC, Performance, Tested, MethodsSM, certification, detecting, C. jejuni, C. coli, C. lari, foods, enrichment, Atlas, Campylobacter Detection, Assay, ISO 10272-1:2017, reference culture method, chicken, carcass, rinse, turkey, sponge, raw ground, poultry, raw ground pork, ready-to-eat, Inclusivity, exclusivity, product, consistency, product stability, robustness studies, laboratory, evaluated, performance, Atlas, Campylobacter Detection, Assay, method, chicken, carcass, rinse, No significant, Atlas, Campylobacter Detection, Assay, reference ISO method, spiked food matrixes, Atlas, Campylobacter Detection, Assay, detected, organisms, organisms, Product consistency, stability studies, statistical differences, lots, shelf-life, accelerated, robustness study, statistical difference, sample, volumes, storage, time, sample transfer, results, study, Atlas, Campylobacter Detection, Assay, ISO 10272-1:2017, Campylobacter, chicken, carcass, rinse, turkey, sponge, raw ground, poultry, raw ground pork, RTE, meats, Atlas, Campylobacter Detection, Assay, rapid, accurate, molecular method, detect, C. jejuni, C. coli, C. lari, chicken, carcass, rinse, turkey, sponge, raw ground, poultry, raw ground pork, RTE, meats]]\n",
      "[[Campylobacter fetusfetus, Cff, infectious, abortion, sheep, worldwide, opportunistic, human, Information, Cff, ovine, abortifacient, South America, case, abortion, multidrug resistant, strain, Cff, sheep, Uruguay, pregnant ewes, aborted, whithin, week, Histopathologic examination, placenta, aborted ewe, severe, neutrophilic, fibrinonecrotizing placentitis, vasculitis, thrombosis, chorionic arterioles, Cff, isolated, microaerobic, culture, Skirrow agar, 16S rDNA PCR amplification, sequencing, endpoint, real time PCR assays, Antimicrobial sensitivity testing, resistance, tetracyclines, nalidixic acid, telithromycin, clindamycin, abortifacients, detected, studies, geographic, distribution, ecology, epidemiology, economic impact, antimicrobial resistance, Cff, sheep, flocks, Uruguay]]\n",
      "NaN\n",
      "[[Campylobacter, genus, species, C. jejuni, C. coli, C. fetus, human, pathogens, C. jejuni/coli, self-limited, enteritis, immunocompetent, hosts, seldomly, associated with, bacteriemia, C. fetus, human, pathogen, identified, fecal samples, isolated, blood samples, patients, comorbidities, immunosuppression, Campylobacter, fetus, bacteriemia, associated with, endovascular, deep-seated infections]]\n",
      "[[Campylobacter, fetus, causal agent, sporadic, abortion, bovines, infertility, economic losses, livestock, infectious diseases, immune response, invasion, proliferation, bacterial, pathogens, Innate immune sensing, microorganisms, pattern-recognition receptors, PRRs, pathogen-associated molecular patterns, PAMPs, induces, secretion, proinflammatory cytokines, IL-1beta, TNF-alpha, IL-8, study, expression, IL-1beta, TNF-alpha, IL-8, IFN-gamma, bovine, endometrial, infected, C. fetus, Salmonella Typhimurium, bacterial invasion control, analyzed, results, expression, levels, IL-1beta, IL-8, infection, decreased, intracellular, period, assay, expression, levels, IFN-gamma, increased, time, post infection, cells, infected, S. Typhimurium, results, IL8, expression, levels, induced, infection, IFN-gamma, cells, infected, S. Typhimurium, C. fetus, fetus, results, TNF-alpha, expression, infection, cytoskeleton inhibition assay, cytokine, expression, modified, C. fetus subsp, fetus, intracellular, invasion, IL-1beta, IL-8, expression, downregulated, intracellular, invasion, results, study, bovine, endometrial, epithelial cells, C. fetus, fetus, early, proinflammatory response]]\n",
      "[[cross-sectional survey, districts, Bangladesh, estimate, prevalence, risk factors, molecular detection, Campylobacter, isolates, farmed cattle, herds, sample, feces, sample, milk, samples, feed samples, water samples, manure, samples, animal attendants, hand-rinse water, collected, tested, culture, biochemical, molecular assays, pretested semi-structured questionnaire, herd-level, data, risk factors, herd owners, herd-level, data, risk factors, analyzed, univariate, multivariate analyses, p-value, statistically significant, analyses, farm-level, prevalence, bovine, Campylobacter, confidence interval, CI, feces, sample, level, contamination, CI, manure, swab, pooled, CI, Campylobacter jejuni, documented, abundant, species, Campylobacter coli, Campylobacter fetus, Older farms, years, age, no/minimum cleaning, disinfection, practices, animal, roaming, farm, documented, risk factors, farm-level, Campylobacter, occurrence, Evidence-based control, biosecurity, hygienic measurement, load, Campylobacter pathogen, farm, environment, prevent, transmission, animals, humans]]\n",
      "[[estimations, Arcobacter, A. butzleri, A. cryaerophilus, A. skirrowii, Campylobacter, C. jejuni, C. coli, C. fetus, species, retail, chicken, pork, beef meat, PCR-MPN, Arcobacter butzleri, A. cryaerophilus, C. jejuni, chicken, samples, Arcobacter, Campylobacter species, chicken, MPNs, A. butzleri, A. cryaerophilus, C. jejuni, samples, MPN, A. butzleri, C. jejuni, samples, pork, A. butzleri, A. cryaerophilus, detected, samples, Arcobacter, Campylobacter species, pork, pork, sample, MPN, A. cryaerophilus, beef, samples, positive, A. cryaerophilus, MPN, presence, MPNs, Arcobacter species, chicken, positive, ratios, Arcobacter, pork, chicken, samples, MPNs, chicken]]\n",
      "[[transgenic, pigs, enhanced, growth rate, reduced, nutrient, composition, gut microbiome, study, EGFP, MF-TG, pigs, expression, levels, microbial beta-glucanase, xylanase, phytase, parotid gland, intestinal, contents, ileum, cecum, colon, MF-TG, wild-type, sows, investigated, gut microbiome, transgenic pigs, metagenomic analysis, Results, levels, probiotics, Lactobacillus reuteri, Streptococcus, abundant, cecum, MF-TG, pigs, higher, WT, pigs, levels, microorganisms, Campylobacter, Chlamydia trachomatis, Campylobacter, fetus, viruses, cecum, WT pigs, MF-TG, pigs, unigenes, eggNOG database, microorganisms, colon, MF-TG, pigs, fractional, abundance, DNA (cytosine-5)-methyltransferase 1, serine-type, aspartate carbamoyltransferase, regulatory subunit, outer membrane protein pathways, WT, pigs, microorganisms, cecum, MF-TG, pigs, active, GlycosylTransferase Family 8, GT8, Glycoside Hydrolase Family 13, GH13, Glycoside Hydrolase Family 32, GH32, levels, numerous, carbohydrases, glucan 1,3-beta-glucosidase, xylan 1,4-beta-xylosidase, exo-1,3, 1,4-glucanase, cecum, MF-TG, pigs, WT pigs, results, intestinal, microbes, secretion, transgenic enzymes, benign, cooperation, host, cooperation, improving, feed, efficiency]]\n",
      "NaN\n",
      "[[isolation, characterization, Campylobacter, bacteriophage, isolates, broiler, swine, sources, study, Genome size, characterization, PFGE, isolates, CAM1-CAM304, campylophages group II, group III, Host range, host, specificity, lytic spectrum, isolates, group, Campylophages, group II, infected, C. jejuni, C. coli, C. fetus, strain, group III, infected, C. jejuni, strains, campylophage, candidates, lytic activity, genetic diversity, analyzed, RFLP, SmiI, HhaI endonucleases, group II, III campylophages, RAPD-PCR technique, assessed, genetic characterization, campylophages, effective, group II, Bacteriophage, isolates, grouped, genotype, host, ranges, campylophages, group II, group III, approaches, assayed, in-depth analysis, bacteriophages, potential, biocontrol, Campylobacter, farm, fork process]]\n",
      "[[Campylobacter, fetus, subspecies, C. fetus, subspecies, fetus, C. fetus subsp, ruminants, inhabit, niches, pathogenicity, pathogens, international trade, reporting, criteria, properties, situation, differentiate, C. fetus, subspecies, phenotypic, characterisation, isolates, methods, time-consuming, inconsistent, results, isolate, misidentification, development, robust, genetic markers, discrimination, C. fetus subsp, fetus, subsp., gene complement, genomes, levels, sequence, repetition, closed, lack, standardisation, discriminatory, biochemical tests, comparative purposes, genomic differences, C. fetus, strains, isolates, phenotypically, genetically, compared, characterised, isolates, Analysis, C. fetus, samples, adaption, C. fetus subsp., bovine reproductive tract, correlated, increasing, genome, length, plasticity, acquisition, propagation, mobile elements, prophages, transposons, plasmids, virulence factors, repertoire, CRISPR, clustered regularly interspersed, C. fetus, strains, deficiency, adaptive immune system, emergence, extensive, genome, plasticity, changes, host, tropism, gene disruption, changes, gene expression, sub-species, DNA adenine methylase, impact, data, studies, genetic differences, phenotypic, virulence, animal, pathogens, markers, diagnosis, sub-typing]]\n",
      "[[study, efficiency, culture-based methods, membrane filtration, real-time PCR, digital droplet PCR, ddPCR, detection, Campylobacter, fresh, Alfalfa, sprouts, clover sprouts, coleslaw, lettuce, salad, spiked, Campylobacter jejuni, C. jejuni, Bolton broth, enrichment, cultures, inoculated, modified, charcoal-cefoperazone-deoxycholate agar, membrane filters, surface, plating media, Bolton broth cultures, extract, DNA, real-time, ddPCR, assays, bacterial community analysis, no significant difference, detection, efficiency, positive, Campylobacter, isolates, coleslaw, lettuce, salad, detection, methods, sprout samples, detection, efficiency, culture method, PCR assays, filtration method, analysis, presence, Pseudomonas, Acinetobacter, microbiota, culture, Acinetobacter, agar, plates]]\n",
      "[[Broiler meat, source, foodborne, pathogen, Campylobacter jejuni, Exposure to, stress conditions, slaughtering, process, induce, bacterial, adaptation, mechanisms, enhance, decrease, pathogen, resistance, stress, adaptation, changes, bacterial, expression, study, quantify, expression, C. jejuni, genes, stresses, poultry, slaughtering, RT-qPCR, quantify, gene expression, genes, strains, heat, cold stresses, results, genes, expressed, thermal stresses, clusters, genes, expressed, strain, stress condition, Up-regulated genes, genes, heat shock response, down-regulated genes, metabolic pathways, lipid, amino-acid metabolisms, genes, overexpressed, strains, indicators, thermal stress response, species, Advances, molecular, stress response, pathogenic bacteria, Campylobacter, real-life processing, conditions, technological levers, mitigate, microbial, risk]]\n",
      "[[Guillain-Barre syndrome, GBS, acute inflammatory polyradiculoneuropathy, patients, cranial nerve, involvement, facial nerve, involvement, delayed facial palsy, DFP, asymmetric facial palsy, manifestation, GBS, mechanism, unclear, case, GBS, combined, delayed, unilateral, review, cases, GBS, combined, DFP, cases, GBS, DFP, case, report, study, occurrence, DFP, subclinical, demyelination, facial nerve, blood-nerve barrier, facial nerve, facial movement, reversible, paralysis, occurrence, unilateral, facial palsy, Campylobacter jejuni, anti-ganglioside antibodies, site, central nervous system, anatomical, involvement, evidence, immunotherapy, shortening, DFP, course, improving, patients, prognosis]]\n",
      "[[H. pylori, chronic atrophic gastritis, premalignant lesion, staging, OLGA, OLGIM systems, patients, increased, risk, gastric cancer, optimize, follow-up, GastroPanel(R, serum, pepsinogen I, PGI, pepsinogen II, PGII, Gastrin 17, G17, H. pylori antibodies, noninvasive test, adenocarcinoma, risk assessment, chronic, H. pylori, gastritis, patients, Prospective study, evaluate, concordance, OLGA, OLGIM, grading systems, evaluate, GastroPanel, performance, patients, premalignant lesions, secondary to, H. pylori, chronic gastritis, Brazil, Patients, H. pylori, chronic gastritis, premalignant lesions, histology, gastrointestinal clinic, University Hospital, participants, endoscopic examination, biopsies, Sydney system, premalignant, lesions, grading systems, OLGA, OLGIM, Blood samples, biomarkers, serological analysis, GastroPanel(R, Biohit, Helsinki, Finland, cut off values, risk, patients, manufacturer, PGI, PGI/PGII, patients, women, men, age, SD, years, OLGA system, OLGA, OLGA I, OLGA II, OLGA III, OLGA IV, OLGIM system, OLGIM, OLGIM I, OLGIM II, OLGIM III, OLGIM IV, histological staging, patients, staged, low risk, OLGA/OLGIM, I, high risk, OLGA/OLGIM III and IV, gastric cancer, development, concordance rate, classifications, risk, patients, patients, systems, distribution, sample, low-risk, high-risk, patients, development, gastric cancer, GastroPanel(R, patient, low, high risk, gastric cancer, PGI, sensitivity, specificity, accuracy, PGI/PGII, sensitivity, specificity, accuracy, histological, classifications, OLGA, OLGIM, concordance rate, Simultaneous, histological, increased, identification's, rate, high-risk, patients, Biomarker analysis, risk, patients, population, studies, clinical practice, Brazil]]\n",
      "[[Helicobacter pylori, etiological agent, malignant tumors, infectious disease, dominant, factor, pathogenesis, spectrum, diseases, acute, chronic gastritis, gastric, duodenal ulcers, gastric carcinoma, lymphoma, Epidemiological, experimental studies, H. pylori, chronic infection, extragastric diseases, colorectal neoplasms, association, H. pylori infection, colorectal cancer, adenoma, epidemiological findings, diagnostic methods, detect, H. pylori, virulent factors, mechanisms, data, integration, inference, Bradford-Hill causality criteria, weak, global, strength, epidemiological positive, association, H. pylori infection, colonic neoplasms, associated to, mechanisms, interaction, intestinal dysbiosis, studies, Prospective confirmatory studies, H. pylori, eradication, process, carcinogenic transformation, colonic epithelium, treatment, prevention, colonic neoplasms]]\n",
      "NaN\n",
      "[[BACKGROUND, AIM, reports, non-Helicobacter pylori, Helicobacter, gastritis, Japanese, patients, prevalence, clinical features, esophagogastroduodenoscopy, EGD, findings, patients, facility, Subjects, patients, gastric mucosal, endoscopically, Kenwakai Hospital, years, NHPH, infection, diagnosed, microscopic findings, Giemsa staining, specimens, PCR analysis, urease genes, detect, NHPH, consent, Helicobacter pylori-diagnostic tests, NHPH-infected, patients, symptoms, animal, contact, NHPH, gastritis, patients, percentage, increased, patients, years, months, increasing, recognition, endoscopic, findings, endoscopists, PCR analysis, patients, detected, NHPH, patients, Helicobacter suis, Helicobacter heilmanii/Helicobacter ailurogastricus, Helicobacter pylori-diagnostic tests, negative, anti-H. pylori, antibody, high-negative titer, patients, men, woman, asymptomatic, pets, EGD, findings, patients, crack-like mucosa, nodular gastritis, gastric antrum, venules, RAC, gastric corpus, patients, infected, NHPH, co-infected, H. pylori, prevalence, Helicobacter suis, NHPH, species, Crack-like mucosa, nodular gastritis, gastric antrum, RAC, gastric corpus, H. pylori-negativity, H. pylori-diagnostic tests, high-negative titer, anti-H. pylori, antibody, NHPH, infection]]\n",
      "[[AIMS, Coeliac disease, CD, autoimmune disorder, prevalence, immune reaction, gluten, Growth retardation, GR, CD, gastrointestinal complications, treated, early, initiation, gluten-free diet, study, indicators, GR, patients, CD, retrospective study, paediatric, outpatients, CD, patients, diagnosed, CD, serological analysis, upper gastrointestinal endoscopy, Patient records, Adana City, Research Hospital, Patients, diagnosed, GR, CD, oral, nutritional, followed-up, months, Statistical relationships, demographics, anthropometric measurements, duration, breastfeeding, gluten contact time, diet duration, complaints, serological findings, evaluated, study, paediatric, outpatients, ages, symptom duration, shorter, breastfeeding, duration, correlated, GR, CD, Vomiting, symptom, correlated, presence, GR, Helicobacter pylori, infection, correlated, presence, GR, GR, treated, early, reduce, severity, CD, months, breastfeeding, solid foods, breastfeeding, years, preventing, GR, vomiting, complaint, patients, CD, presence, GR]]\n",
      "[[Helicobacter pylori, infection, peptic ulcer disease, gastric cancer, knowledge, epidemiology, H. pylori infection, military personnel, cross-sectional study, estimate, prevalence, H. pylori infection, military personnel, compare, prevalences, military, civilian groups, Patients, Methods, retrospectively, subjects, (14)C-urea breath tests, Department of Gastroenterology, General Hospital, Northern Theater Command, Subjects, military, civilian groups, H. pylori infection, endoscopic, findings, reviewed, subjects, eligible, subjects, military group, subjects, civilian group, analysis, prevalence, H. pylori infection, military, civilian groups, population, aged, years, prevalence, H. pylori infection, military group, civilian group, (14)C-UBT, endoscopy, inpatients, military inpatients, civilian, inpatients, prevalence, H. pylori, inpatients, peptic ulcer, gastric cancer, adolescent, population, H. pylori infection, military personnel, civilians, Well-designed prospective studies, prevalence, potential]]\n",
      "[[Gastric ulcer, GU, digestive system disease, clinical manifestations, nausea, epigastric pain, years, increased, life pressure, unhealthy, environment, incidence, gastric ulcer, increased, year, year, disease, long treatment cycle, relapse, controlled, time, disease, daily, life, health, patient, complications, upper gastrointestinal bleeding, ulcer perforation, pyloric obstruction, Helicobacter pylori, infection, GU, Clinically, curative effect, western medicine, traditional, Chinese medicine, ideal, level, years, combination, traditional, Chinese, western medicine, systematic review, evaluate, effectiveness, safety, Chinese medicine, combined, omeprazole, GU, data, information, databases, PubMed, Embase, Cochrane Library, CNKI, VIP, Wanfang, data, Literature search, Chinese, English, search time range, database, combination, subject, free, search, omissions, subject, keywords, reviewers, substandard articles, extract, data, risk, bias, assessed, Cochrane Handbook 5.1.0, Systematic Reviews of Interventions, systematic review, meta-analysis, protocol, Preferred Reporting Items, Systematic Reviews, statement, systematic review, PRISMA statement, efficacy, safety, Chinese medicine, combined, omeprazole, treatment, GU, evaluated, medical, evidence, clinical, patients, GU]]\n",
      "[[Helicobacter pylori, H. pylori, causative factor, gastric cancer, expansion, insurance, coverage, increase, patients, treated, H. pylori, population, impact, eradication, treatment, H.pylori, investigated, study, long-term, responses, H. pylori, antibody, titer, eradication, treatment, cross-sectional data, Japan Public Health Center-based Prospective Study, Next Generation, JPHC-NEXT Study, Japanese, participants, aged, years, blood samples, treated, n=6,276, untreated subjects, seropositive, H. pylori, serological atrophy, study population, Seropositivity, anti-H. pylori, IgG, titer, Antibody, level, subjects, self-reported, treatment history, untreated, treated, year, years, 5Y, years, serum, titer, Untreated, 5Y, groups, treated, H.pylori, year, antibody, titer, untreated subjects, subjects, seropositive, reduction, H.pylori, antibody, titer, year, eradication, treatment, long period, negative, conversion]]\n",
      "[[OBJECTIVE, study, prevalence, risk factors, Helicobacter pylori, infection, age groups, Wuwei City, high-risk area, gastric cancer, Northwest China, study, urban, rural community, Wuwei City, Stool antigen, targeted, individuals, aged, years, C-urea breath tests, targeted, individuals, aged, years, participants, hierarchical cluster sampling, assessed, association, variables, H. pylori infection, logistic regression models, results, participants, age, years, minors, adults, analysis, prevalence, H. pylori infection, increased, age, age group, decline, multivariate analysis, age, positively, associated with, prevalence, H. pylori infection, factors, negatively, associated with, prevalence, drinking running water, frequency, yoghurt, consumption, annual, household, subgroup, analyses, variables, age groups, boarding, eating, school cafeterias, week, drinking, predictors, H. pylori infection, junior, senior, prevalence, H. pylori infection, moderate, associated with, socioeconomic conditions, Wuwei City, sanitary, situations, dietary habits, participants, city, Boarding, eating, school, drinking untreated water, factors, rising, infection, rate, junior-senior]]\n",
      "[[Severe, Helicobacter pylori-linked gastric disorders, East Asia region, H. pylori, clinical outcomes, associated with, sets, genetic features, genetic features, gastrointestinal pathologies, Genome, heterogeneity, clinical, H. pylori, strains, patients, gastric disorders, population structure, molecular genomic features, association, pathogenicity, Population analysis, Shanghai, H. pylori, isolates, clustered, East Asia, group, genes, detected, genomes, genes, core genome, genes, detected, disease groups, genes, peptic ulcer, gastric cancer, groups, inorganic ion transport, metabolism function, gene clusters, virulence genes, detected, statistically, detection, rates, disease groups, clustered regularly interspaced, rates, disease groups, genomic islands, identified, genomic islands, strains, genomic islands, metabolism-associated genes, genes, function, sequence types, detected, Shanghai, H. pylori, isolates, study, mapping, genomic features, functions, factors, induce, gastric disorders, H. pylori]]\n",
      "[[Oropharyngeal squamous cell carcinoma, OPSCC, cervical cancer, site, HPV-related cancer, United States, HPV-positive, OPSCCs, HPV-negative tumors, early, lymph node, involvement, bacterial microbiome, HPV-associated, OPSCC, carcinogenesis, bacteria, influence, spread, cancer, primary site, regional, lymphatics, bacterial microbiome, patients, HPV-associated, tonsil, SCC, compare, benign, tonsil specimens, microbiome, primary, lymph nodes, benign tonsillectomy, specimens, pan-pathogen microarray, PathoChip, patients, study, Patients, OPSCC, microbiome, gram-negative, signatures, bacterial family, species, associated with, primary tumors, lymph nodes, cancer, patients, urogenital pathogens, Proteus mirabilis, Chlamydia trachomatis, Neisseria gonorrhoeae, Shigella dysenteriae, Orientia tsutsugamushi, results, detection, urogenital pathogens, associated with, lymph node metastasis, patients, HPV-positive, OPSCCs, studies, effects of, OPSCC, microbiome, disease progression, clinical outcomes]]\n",
      "[[pharyngeal Neisseria gonorrhoeae, pharyngeal Chlamydia trachomatis, men, sex, men, MSM, reviewed, cases, pharyngeal chlamydia, MSM, prevalence, pharyngeal chlamydia, confidence interval, CI, sexual partners, throat symptoms, HIV, positive, Multi-site, concomitant, infection, rectal chlamydia, urethral chlamydia, early syphilis, gonorrhoea, HIV-positive, MSM, pharyngeal chlamydia, older, syphilis, odds ratio, CI, research, characteristics, pharyngeal chlamydia, benefits, increased, screening, asymptomatic, pharyngeal chlamydia, MSM]]\n",
      "[[Young, men, sex, men, YMSM, impacted, HIV, sexually transmitted infections, STIs, United States, US, rates, HIV/STI testing, Provision, HIV self-testing, STI, self-collection, increase, testing, rates, kits, mobile applications, apps, YMSM, HIV self-testing, STI, self-collection, Data, study, randomized controlled trials, RCTs, mobile apps, Adolescent Trials, Network-LYNX, MyChoices-aimed, increase, HIV/STI testing, YMSM, age, tested, HIV, high risk, HIV, acquisition, US, cities, apps, HIV, self-test, results, kit, STI, self-collection, mailing, samples, syphilis, gonorrhea, chlamydia, lab, testing, assessments, app users, pre-randomization, post-randomization, online interview, data, purposive sample, app users, experiences, lessons, HIV self-testing, STI, self-collection kits, ordered, apps, Participants, years, age, SD, non-White, multiple race/ethnicity, HIV test, STI, test, tested, months, HIV self-testing kit, self-test kit, study, period, STI, self-collection kit, rates, STI, self-collection kit, return rates, rate, HIV, STI, self-collection kits, acceptable, extremely/very, kits, apps, HIV/STI kits, test, clinic, interviews, participants, expressed, test, home, concerns, STI, sample, collection, HIV, STI, self-collection kit, ordering, mobile apps, acceptable, increasing, testing, rates, YMSM, LYNX, MyChoices, apps, tested, full-scale, efficacy, trial, mobile apps, scaled, increase, HIV/STI testing, youth, US]]\n",
      "[[Infection, inflammation, reproductive tract, Chlamydia trachomatis, CT, risk factors, male, infertility, study, evaluate, CT infection, effects, seminal, parameters, cytokines, asymptomatic, patients, teratozoospermia, Material, methods, Semen samples, male, patients, CT, detection, polymerase chain reaction, PCR, quality, volume, sperm, concentration, pH, motility, morphology, leucocytes, semen, measured, standard procedures, World Health Organization, WHO, Pro-inflammatory cytokines, interleukin (IL)-1 beta, IL-6, IL-8, tumor necrosis factor alpha, TNF-alpha, interferon gamma, IFN-gamma, anti-inflammatory cytokines, IL-4, IL-10, enzyme-linked immunosorbent assay, ELISA, frequency, CT infection, expressed, percentage, Descriptive statistics, comparison, cytokines, infertile, men, Mann-Whitney U test, seminal, parameters, cytokines, CT-infected, non-CT, infected, men, ratio, patients, positive, CT infection, ejaculate, positive, CT infection, increased, pH, pH, non-CT, infected, CT-infected, men, levels, pro-inflammatory cytokines, population, infected, males, levels, IL-1 beta, IL-6, CT infection, increased, seminal, pH, IL-1 beta, IL-6, cytokines, infection, inflammation, asymptomatic, patients, teratozoospermia]]\n",
      "[[Lymphogranuloma venereum, LGV, sexual transmitted infection, STI, endemic, population, men, sex, men, MSM, Western Countries, variant, strain, LGV, epidemics, L2, European countries, evaluate, characterize, population, LGV, infection, diagnosed, Centro Hospitalar Universitario de Lisboa Central, Lisbon, Portugal, retrospective analysis, LGV, diagnoses, diagnosis, samples, positive, Chlamydia trachomatis, CT, samples, clinician, activity, swabbing, urine analysis, CT infection, diagnosis, real-time PCR, period, CT, diagnostics tests, increase, diagnoses, CT, LGV, infections, evolution, LGV, strains, genotyped, L2/434, LGV, affected, MSM, men, sex, men, women, Anorectal infection, proctitis, clinical presentation, Absence, symptoms, cases, concomitant, infection, human immunodeficiency virus, dominant, prevalence, STI, co-infections, increasing, evolution, CT, LGV, testing, diagnosing, period, Characteristics, population, LGV, epidemics, European studies, L2, genotype, identified]]\n",
      "[[Expedited partner therapy, chlamydia trachomatis, efficacy, populations, data, lacking, efficacy, pregnant population, Evaluate, effectiveness, prenatal, partner therapy, program, eradicating, chlamydia, delivery, maternal, neonatal, outcomes, women, treated, chlamydia, pregnancy, compared, partner therapy, partner-referral testing, treatment, partner therapy, program, public hospital, county, chlamydia, prevalence, Pregnant women, single-dose packets, azithromycin, treat, partner(s), diagnosis, chlamydia, pregnant, women, treated, partner therapy, program, institution, year, compared, outcomes, historical, cohort, year, partner-referral, testing, treatment, women, concurrent, gonorrhea, human immunodeficiency virus, syphilis, intimate partner, violence, primary outcome, chlamydia reinfection, no-cure, weeks, treatment, 36-week prenatal care, screening, Secondary outcomes, obstetric, maternal, neonatal, outcomes, prelabor rupture of membranes, chorioamnionitis, endometritis, neonatal, intensive care unit, admission, neonatal, sepsis, pneumonia, conjunctivitis, rate, chlamydia, period, delivered population, year, implementation, expedited partner therapy, women, SD, age, years, diagnosed, chlamydia, institution, compared, women, SD, age, years, year, race, parity, prenatal care, attendance, concomitant, sexually transmitted infections, pre-expedited, partner therapy, group, frequency, reinfection, post-expedited partner therapy, group, OR, per-protocol, analysis, pre-expedited partner therapy, post-expedited partner therapy, groups, partner therapy, reinfection, groups, secondary outcomes, improved, rates, endometritis, post-expedited partner therapy group, OR, Implementation, prenatal, partner therapy, program, frequency, chlamydia, reinfection, delivery, Treatment, chlamydia, inner-city population, multiple factors, treatment, reduce, sexually transmitted, infection, chlamydia, reinfection, rates, at-risk, population, patient education, sex practices, partner therapy, pregnancy]]\n",
      "[[Expedited partner therapy, chlamydia trachomatis, efficacy, populations, data, lacking, efficacy, pregnant population, Evaluate, effectiveness, prenatal, partner therapy, program, eradicating, chlamydia, delivery, maternal, neonatal, outcomes, women, treated, chlamydia, pregnancy, compared, partner therapy, partner-referral testing, treatment, partner therapy, program, public hospital, county, chlamydia, prevalence, Pregnant women, single-dose packets, azithromycin, treat, partner(s), diagnosis, chlamydia, pregnant, women, treated, partner therapy, program, institution, year, compared, outcomes, historical, cohort, year, partner-referral, testing, treatment, women, concurrent, gonorrhea, human immunodeficiency virus, syphilis, intimate partner, violence, primary outcome, chlamydia reinfection, no-cure, weeks, treatment, 36-week prenatal care, screening, Secondary outcomes, obstetric, maternal, neonatal, outcomes, prelabor rupture of membranes, chorioamnionitis, endometritis, neonatal, intensive care unit, admission, neonatal, sepsis, pneumonia, conjunctivitis, rate, chlamydia, period, delivered population, year, implementation, expedited partner therapy, women, SD, age, years, diagnosed, chlamydia, institution, compared, women, SD, age, years, year, race, parity, prenatal care, attendance, concomitant, sexually transmitted infections, pre-expedited, partner therapy, group, frequency, reinfection, post-expedited partner therapy, group, OR, per-protocol, analysis, pre-expedited partner therapy, post-expedited partner therapy, groups, partner therapy, reinfection, groups, secondary outcomes, improved, rates, endometritis, post-expedited partner therapy group, OR, Implementation, prenatal, partner therapy, program, frequency, chlamydia, reinfection, delivery, Treatment, chlamydia, inner-city population, multiple factors, treatment, reduce, sexually transmitted, infection, chlamydia, reinfection, rates, at-risk, population, patient education, sex practices, partner therapy, pregnancy]]\n",
      "[[AIM, Chlamydia trachomatis, oxidative stress, host cells, intracellular, survival, mechanism, anti-oxidative stress, C. trachomatis, unclear, activation, nuclear factor erythroid 2-related factor 2/quinone oxidoreductase, signal pathway, efficient, antioxidant, defensive, mechanism, host cells, oxidative stress, Pgp3, virulence factor, C. trachomatis, intracellular, survival, study, Pgp3, Nrf2/NQO1 signal pathway, oxidative stress, HeLa cells, stimulated, Pgp3 protein, Nrf2, location, inclusion bodies, C. trachomatis, detected, indirect, immunofluorescence, western blotting, Oxidative stress assay kits, protein expression, content, malondialdehyde, MDA, superoxide dismutase, SOD, T-AOC, interference, Nrf-2, NQO1, Pgp3, promoted, nuclear translocation, Nrf2, increase, NQO1, expression, reduced, oxidative stress, induced, LPS, survival, C. trachomatis, Inhibition, Nrf2/NQO1 signal pathway, Nrf2, inhibitor, down-regulation, NQO1, siRNA-NQO1, suppressed, oxidative stress resistance, induced, Pgp3, Pgp3, oxidative stress, promote, infectivity, C. trachomatis, activation, Nrf2/NQO1 signal pathway, effects, Pgp3, pathogenesis, C. trachomatis]]\n",
      "[[Sexually transmitted infections, STIs, pregnancy, adverse delivery, birth outcomes, study, estimate, prevalence, STIs, Chlamydia trachomatis, CT, Neisseria gonorrhoeae, NG, Treponema pallidum, syphilis, Trichomonas vaginalis, trichomoniasis, Human Immunodeficiency Virus, HIV, pregnant women, visiting, antenatal care center, Nepal, piloted, WHO, prevalence, survey, STIs, pregnant women, visiting, antenatal care, Nepal, Patient, recruitment, data collection, specimen testing, catch, urine, eligible, woman, GeneXpert platform, CT, NG testing, Wet-mount microscopy, urine sample, detection, trichomoniasis, Serological test, HIV, rapid, enzyme-linked immunosorbent assay tests, Serological test, syphilis, nonspecific, non-treponemal, treponemal, antibody tests, Tests, CT, NG, trichomoniasis, prevalence study, tests, syphilis, HIV, routine, antenatal testing, women, participate, study, eligibility criteria, consented, participate, prevalence, STIs, CI, CI, CT, CI, trichomoniasis infection, samples, positive, NG, HIV, syphilis, Prevalence, STI, women, age, years, women, age, years, prevalence, trichomoniasis, pregnant women, sub-urban population, Nepal, cases, CT, NG, syphilis, HIV, WHO, framework, STI, surveillance, countries, populations]]\n",
      "[[National guidelines, sexually active people, human immunodeficiency virus, PWH, men, sex, men, MSM, tested, hepatitis C virus, annually, Hepatitis C virus testing, rates, race/ethnicity, general population, data, PWH, analyzed, medical records, data, MSM, HIV, human immunodeficiency virus, HIV, clinics, observation time, documented, HCV, infection, HCV, antibody testing, calendar year, HCV-seronegative, MSM, assessed, testing, generalized estimating equation analyses, eligible, MSM, PWH, non-Hispanic/Latino white, NHW, non-Hispanic black, NHB, Hispanic/Latino, race/ethnicity, privately insured, CD4 cell, CD4, /=350, HIV, viral load, HCV antibody test, average, annual, HCV, percentage, tested, NHB, NHW, Multivariable factors, positively, associated (, HCV, HIV, diagnosis, public insurance, lower, CD4, chlamydia, gonorrhea, syphilis, hepatitis B virus, diagnoses, elevated, liver enzyme, levels, race/ethnicity, disparities, race/ethnicity, HCV, testing, low, HCV, rates, suboptimal, recommended, HCV, testing, MSM, HIV care]]\n",
      "[[immunodominant antigens, humoral immune response, primary, secondary, genital infection, rhesus monkeys, inoculated, Chlamydia trachomatis serovar D., Serum, samples, collected, protein microarray, expressing, open reading frames, C. trachomatis serovar D genome, antibody response, primary infection, analyzed, serum, samples, inoculated monkeys, criteria, immunodominant antigens, proteins, infected, monkeys, elevations, signal intensity, week, week, post infection, infected, monkeys, Chlamydia, serum antibodies, proteins, selection criteria, immunodominant antigens, CT242, OmpH-like protein, CT541, mip, CT681, ompA, CT381, artJ, CT443, omcB, CT119, incA, CT486, fliY, CT110, groEL, antigens, CT119, CT486, CT381, immunodominant antigens, non-human primate, sera, secondary infection, antibody, responses, immunodominant antigens, analyzed, intensity, duration, primary infection, immunodominant antigens, tested, individuals, primary, C. trachomatis, genital infection, design, vaccine, strategies, primary infection, pathogen]]\n",
      "[[OBJECTIVE, Infections, genitopathogens, frequent, consultation, Primary Health Care, specialties, Infectious Diseases, Urology, Gynecology, Dermatology, opportunistic microorganisms, sexually transmitted infections, associated with, unprotected, sex, objective, microorganisms, infections, patients, treated, Hospital Universitario Virgen de las Nieves, Granada, Neisseria gonorrhoeae, susceptibility, antibiotics, transversal-descriptive, retrospective study, results, January, Microbiology Laboratory, episodes, standardized working procedures, detected, microorganisms, Gardnerella vaginalis, Candida spp., females, N. gonorrhoeae, Ureaplasma urealyticum, males, combination, herpes simplex viruses, infection, species, prevalence, males, prevalent, females, antibiotics, N. gonorrhoeae, cefotaxime, cefixime, Tetracycline, active, antibiotic, frequent, pathogens, infections, females, N. gonorrhoeae, frequent, males, mixed infections, accidental finding, HSV-1 infections, frequent, HSV-2, change, epidemiology, genital herpes]]\n",
      "[[study, abortion, outbreak, ruminant, herd, goats, sheep, cows, scenarios, consecutive, years, abortions, goats, positive, Coxiella burnetii, C. burnetii, goats, positive, Chlamydophila abortus, C. abortus, herd, abortion, rate, positive, C. burnetii, C. abortus, Toxoplasma gondii, goat milk, samples, positive, C. burnetii, molecular analysis, family members, positive, C. burnetii, C. burnetii, abortions, year, Animals, infection, abortion, secondary infections, Vaccination, interventions, animals, humans]]\n",
      "[[prevalence, drug-resistant, Mycobacterium tuberculosis, Mtb, strains, disease control, complicated, death, tuberculosis, TB, patients, Early detection, standard, treatment, prevention, control, drug-resistant TB, years, continuous advancement, drug-resistant, TB, diagnostic technology, clinical, rapid, accurate, diagnosis, development, sequencing technology, research, human, microecology, study, rRNA sequencing, detect, analyze, upper respiratory flora, TB, patients, anti-TB drug sensitivity, DS, monoresistance isoniazide, MR-INH, monoresistance, rifampin, MR-RFP, multidrug resistance, MDR, polyresistance, PR, southern China, microbial, diagnostic, markers, TB, drug resistance, screening, flora, significance, drug resistance, diagnosis, clinical drug, TB, results, pulmonary, microenvironment, TB, patients, susceptible, infection, pathogens, infection, drug-resistant, Mtb, changes, flora, microorganisms, Leptotrichia, Granulicatella, Campylobacter, Delfitia, Kingella, Chlamydophila, Bordetella, 16S rRNA sequencing, diagnostic markers, drug resistance, TB, Leptotrichia, Granulicatella, Campylobacter, diagnostic marker, TB, patients, INH, single-resistance, Delftia, potential, diagnostic marker, TB, patients, RFP, drug-resistance, Kingella, Chlamydophila, diagnostic markers, TB, patients, PR, Bordetella, potential, diagnostic marker, identification, TB, patients, MDR]]\n",
      "[[Psittacosis, mild febrile, respiratory illness, infection, bacterium Chlamydia psittaci, transmitted, humans, infected, birds, average, psittacosis, cases, year, United States, August-October, U.S., psittacosis, outbreak, years, cases, identified, poultry, slaughter plants, Virginia, Georgia, farms, CDC, C. psittaci, real-time polymerase chain reaction, PCR, human, specimens, outbreak, human, specimens, outbreak, tested, C. psittaci, real-time PCR, faster, sensitive, serologic tests, rare, assess, multiple, specimen, real-time PCR, detection, C. psittaci, C. psittaci, detected, respiratory specimens, stool, upper respiratory specimens, patients, sputum, nasopharyngeal swabs, tested, C. psittaci, detected, sputum, patients, Cycle threshold, bacterial, load, respiratory specimens, nasopharyngeal swabs, findings, respiratory specimens, real-time PCR, detection, C. psittaci, Stool specimens, diagnosis, psittacosis]]\n",
      "[[Mycoplasma pneumoniae, atypical, pneumonia, associated with, erythema multiforme, mycoplasma infection, cutaneous, mucosal, lesions, mucosal respiratory syndrome, condition, Available reviews, association, mucosal respiratory syndrome, atypical, bacterial, pathogens, Chlamydophila pneumoniae, Chlamydophila psittaci, Coxiella burnetii, Francisella tularensis, Legionella species, systematic review, literature, issue, National Library of Medicine, Excerpta Medica, Web of Science databases, patients, years, years, males, females, affected, mucosal respiratory syndrome, cases, associated with, M. pneumoniae, C. pneumoniae infection, associated with, C. psittaci, C. burnetii, F. tularensis, Legionella species, infection, cases, associated with, Epstein-Barr virus, influenzavirus B]]\n",
      "[[microbiological point, empirical, targeted, antimicrobial, treatment, respiratory infection, sensitivity, isolated, microorganisms, resistance, mechanisms, geographic areas, prescription profiles, vaccination programs, Beta-lactam antibiotics, fluoroquinolones, macrolides, antimicrobials, exacerbations, chronic obstructive pulmonary disease, community-acquired pneumonia, prescription, intrinsic activity, bactericidal effect, prevent, development, resistance, PK/PD, parameters, mutant prevention, concentration, selection, potential, ecological, impact, intestinal microbiota, respiratory, state, eubiosis, antimicrobials, low profile, action, anaerobic bacteria, resilience, bacterial populations, microbiota, state, resistance, colonization, collateral damage, emergence, resistance, antimicrobials, pathogens, infections, bacterial populations, microbiota]]\n",
      "[[Uncontrolled, diabetes, results, metabolic, alterations, hyperglycemia, preclinical, clinical studies, condition, induce, susceptibility, development, aggressive, infectious diseases, bacteria, Chlamydophila pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, viruses, coronavirus 2, CoV2, Influenza A virus, Hepatitis B, mechanisms, glycemia, exacerbated, infections, hyperglycemia, induce, changes, immune system activity, alterations, microenvironment, immune cells, pH, blood viscosity, biochemical, parameters, supply, energy, infectious bacteria, inflammatory response, oxidative stress, bacterial, proliferative metabolism, Consistent with, evidence, bacterial infections, prognosis, patients, hypercaloric diets, stressful lifestyle, conditions, promote, hyperglycemic, episodes, review, diabetes, development, bacterial, viral infections, preclinical, clinical findings, mechanisms, hyperglycemia, increase, susceptibility, infections, impact, hyperglycemia, immune system]]\n",
      "[[Healthcare Informatics, phenomenon, early, era, living, evolution, computing, amount, data, healthcare, opening, research areas, massiveness, data, knowledge, decision making, task researchers, explorations, deep learning, machine learning, deep neural nets, predictive, analytics, algorithms, innovation, healthcare, disease, prediction, anticipation, cure, unrealistic, Dengue Fever, DF, Covid-19, outbreak, infectious lethal diseases, diagnosing, stages, decrease, mortality rate, Diabetes, clinicians, experts, diagnosis, chances, diseases, Louvain Mani-Hierarchical Fold Learning healthcare analytics, hybrid deep learning technique, medical diagnostics, tested, real-time dataset, patients, dengue fever, Holy Family Hospital, Pakistan, infectious diseases, prognosis, Covid-19, SARS, ARDS, Pneumocystis, Streptococcus, Chlamydophila, Klebsiella, Legionella, Lipoid, GitHub, Louvain Mani-Hierarchical Fold Learning healthcare analytics, correlations, clusters, Spearman, comorbidities, diagnostic data model, endocrine records, multiple visits, patients, identified, unique, ID, Accuracy, induced, rules, evaluated, Laplace, rules, Endocrine diagnostic, data, Shifa International Hospital, Islamabad, Pakistan, results, algorithm, tested, diagnostics, healthcare big, data]]\n",
      "[[Chlamydia psittaci, zoonotic agent, systemic wasting disease, birds, atypical, pneumonia, mammalians, humans, public, health risk, diagnostic assay, screening, C. psittaci, field, study, probe-based recombinase polymerase amplification, assay, detection, C. psittaci, primer, pairs, probe, targeting, conserved region, outer membrane protein A gene, real-time real-time RPA assay, test, portable device, sensitivities, copies, DNA molecules, reaction, cross-reaction, pathogens, clinical performance, RPA, assay, evaluated, outbreak, C. psittaci, accuracy, levels, field applications, epidemic, C. psittaci, strains, genotypes, C., study, screening, C. psittaci, laboratory setting, field settings, RPA, effective, clinical test, outbreaks, domestic, fowl, populations]]\n",
      "NaN\n",
      "NaN\n",
      "[[OBJECTIVE, Intravenous azithromycin, AZM, children, worldwide, off-label use, regulated, advice, guideline, China, recommendations, intravenous, AZM, children, guideline, antimicrobial therapy, intravenous, AZM, children, Delphi research method, questions, systematic literature review, Data, pooled, GRADE system, Recommendations, expert, clinical, patients, values, preferences, evidence, availability, external review, recommendations, revised, guideline, recommendations, domains, Indications, treatment, pneumonia, atypical, pathogens, Mycoplasma pneumoniae, Chlamydia trachomatis, Chlamydophila pneumoniae, Legionella pneumophila, bacteria, treatment, bronchitis, bacterial, aetiologies, Usage, dosage, administration route, infusion, concentrations, treatment duration, course, sequential, treatment, dosage, stratified, age, Adverse reactions, treatment, management, gastrointestinal reactions, arrhythmias, pain, phlebitis, infusion site, anaphylaxis, Special population, children, renal, liver dysfunction, congenital heart disease, obesity, guideline, promote, intravenous, AZM, children, worldwide, guideline, evidence, recommendations, intravenous, AZM, children, worldwide, attention, well-designed researches, off-label use, intravenous, AZM, children]]\n",
      "[[Leukocytoclastic, vasculitis, skin, systemic, involvement, infections, cold, tonsillopharyngitis, otitis media, document, pediatric, years, cases, symptomatic, atypical, bacterial pathogen, literature, Preferred Reporting of Systematic Reviews, guidelines, reports, cases, females, males, median, years, age, associated with, Mycoplasma pneumoniae infection, case, Chlamydophila pneumoniae, Chlamydophila psittaci, Coxiella burnetii, Francisella tularensis, Legionella pneumophila, Patients, systemic vasculitis, skin-limited, vasculitis, gender, age, recovery, weeks, patients, information, cutaneous small-vessel vasculitis, systemic, involvement, childhood, infection, atypical, bacterial, Mycoplasma pneumoniae, clinical picture, course, cases, triggers, atypical, pathogen, indistinguishable]]\n",
      "[[Patients, acute respiratory tract infections, prescribed, antimicrobials, rates, virus, detection, Physicians, antimicrobials, bacterial infections, atypical, pathogens, investigated, accuracy, clinical predictions, atypical, pathogen infections, adult, patients, fever, cough, outpatient clinics, history, physical examinations, physicians, predicted, respiratory infections, atypical, pathogens, Disease probabilities, categorized, grades, intermediate, low, physicians, taking care, patients, Confirmation, atypical, pathogens, comprehensive, molecular analyses, respiratory samples, Atypical, pathogens, detected, patients, odds ratio, OR, confidence interval, CI, presence, pneumonia, OR, CI, associated with, detections, Atypical, pathogens, detected, high-probability cases, atypical, pathogens, detected, intermediate-probability cases, low-probability, cases, study, physicians, predictions, associated with, detection, atypical, pathogens, overestimation]]\n",
      "NaN\n",
      "[[Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila, development, chronic obstructive pulmonary disease, exacerbations, study, nonspecific, atypical, pathogens, associated with, acute exacerbations, COPD, patients, analyzed, inpatient, outpatient, treatment group, nonspecific, culture, results, causative organism, detected, patients, detection, rate, increased, polymerase chain reaction, PCR, fluorescent antibody, culture methods, causative agent, COPD, exacerbation, patients, agents, agents, agents, H. influenzae, detected, patients, S. pneumoniae, P. aeruginosa, L. pneumophila, L. pneumophila, isolated agent, inpatient, group, Patients, continuous oxygen therapy, noninvasive, mechanical ventilation, exacerbation, associated with, P. aeruginosa, DFA, Legionella, multiplex PCR, combination, nonspecific, microbiological, improves, infectious agents, acute exacerbations, COPD, high index, suspicion, P.aeruginosa, causative organism, subjects, continuous oxygen therapy, NIV, L. pneumophila, severe, COPD, exacerbations]]\n",
      "[[OBJECTIVE, clinical characteristics, pneumonia, infected, Chlamydophila psittaci, C. psittaci, retrospective analysis, cases, C. psittaci, pneumonia, admitted, People's Hospital, Tongling City, patients, contact history, clinical manifestations, laboratory examination, imaging, characteristics, evolution, etiology, treatment process, outcome, analyzed, experience, diagnosis, prevention, C. psittaci, pneumonia, patients, infected, pet, zoonotic, exposures, symptoms, fever, body temperature, centigrade, cough, sputum, chest tightness, dyspnea, disease, acute respiratory distress syndrome, ARDS, shock, manifestations, damages, heart, liver, kidney, mild, Laboratory tests, C-reactive protein, CRP, neutrophil, proportion, Neut%, increased, white blood cell count, WBC, procalcitonin, PCT, increased, Chest computed tomography, CT, inflammatory infiltration, interstitial changes, unilateral, bilateral, Chest X-ray, inflammatory infiltrations, fan-shaped, wedge-shaped, edge, pleura, days, treatment, bedside computed X-ray (, CR, absorption, infiltration, days, CT, reexamination, lung infection, Metagenomic next-generation sequencing, mNGS, presence, C. psittaci, patients, sputum, sensitive, quinolones, tetracyclines, patients, body temperature, normal, days, antibiotics, patients, extubated, transferred, normal ward, days, illness, days, patients, C. psittaci, pneumonia, critically ill, clinical manifestations, moderate, severe, ARDS, shock, Early diagnosis, mNGS, treatment, prognosis]]\n",
      "[[Chlamydia psittaci, pathogen, birds, disease, species, Equine, reproductive loss, C. psittaci, identified, Australia, cases, human disease, individuals, exposed to, foetal membranes, ill neonatal foal, New South Wales, Hypothesis/Gap Statement, prevalence, C. psittaci, association, equine, reproductive, time, regions, Australia, study, detect, C. psittaci, equine, abortion, cases, Australia, samples, years, Methodology, tested, C. psittaci, equine, abortion, cases, Australia, Chlamydiaceae, targeting, 16S rRNA, high-resolution melt curve analysis, Genotyping, phylogenetic analysis, positive, samples, Results, prevalence, C. psittaci, material, equine, abortion, cases, C. psittaci-positive, detected, years, study, Victoria, prevalence, New South Wales, prevalence, South Australia, prevalence, Genotyping, phylogenetic analysis, C. psittaci, detected, equine, abortion, cases, clustered, parrot-associated 6BC clade, genotype, infection, horses, spillover, native, Australian, parrots, C. psittaci, signi, equine, abortion, Australia, decades, protective measures, infection, equine, aborted material]]\n",
      "NaN\n",
      "[[Chlamydia psittaci, Chlamydiales, zoonotic, bacterium, fatal, birds, humans, Parrots, host, prevalence, risk factors, infection, wild parrots, research, diverse, novel, Chlamydiales, circulating, wildlife, abundant, parrot, species, south-eastern Australia, cloacal swabs, serum, wild adults, C. psittaci, Chlamydiales, prevalence, seroprevalence, tested, host, species, sex, geographical, seasonal differences, temporal, changes, individual, infection, species, Chlamydiales, prevalence, CI, C. psittaci, prevalence, CI, C. gallinacea, prevalence, CI, Chlamydiales species, species, level, C. psittaci, strains, 6BC clade, virulent, humans, Seroprevalence, CI, Host species, crimson rosellas, galahs, sulphur-crested cockatoos, blue-winged parrots, seroprevalence, Chlamydiales, prevalence, Galahs, Chlamydiales, prevalence, seroprevalence, Seroprevalence, sites, males, females, chlamydial, prevalence, wild parrots, potential, reservoirs, transmission, risks, humans, avian, hosts]]\n",
      "[[Chlamydia psittaci, disease, domestic cats, knowledge, C. felis infection, domestic cats, results, conjunctivitis, upper respiratory tract infection, pneumonia, pathologic, findings, diagnostic features, fatal, case, psittacosis, domestic, kitten, animal, litter, queen, pet rescue center, Wyoming, period, kittens, queen, sick, thin, icteric, death, antimicrobial treatments, Postmortem, evaluation, kitten, necrosuppurative hepatitis, Gimenez stain-positive intracellular bacteria, nonsuppurative pneumonia, mild leptomeningitis, diagnosis, psittacosis, 16S rRNA PCR, multiple primer sets, sequencing, liver, Psittacosis, differential diagnosis, domestic cats, intracellular, bacterial hepatitis, interstitial pneumonia]]\n",
      "[[Chlamydia psittaci, detected, PCR, lung, equine, foetal membranes, aborted, equine, foetuses, weak, foal, studs, Victoria, Australia, abortions, mares, paddock northeast of Melbourne, weak, foal, born, geographical region, died, birth, veterinary care, detection, C. psittaci, DNA, lung, equine, foetal membranes, aborted, weak, foals, absence, factors, associated with, abortion, neonatal, death, pathogen, reproductive loss, detection, C. psittaci, cases, consistent with, detection, C. psittaci, association, equine, abortion, New South Wales, cases, Victoria, C. psittaci, zoonotic, risk, association, equine, reproductive loss, Australia]]\n",
      "[[Chlamydia trachomatis, bacterial, Chlamydia pneumoniae, community-acquired respiratory infections, In vivo, host, immune system, gamma interferon, IFN-gamma, combat, infection, IFN-gamma, activates, human cells, tryptophan, enzyme indoleamine 2,3-dioxygenase, IDO, reduction, cytosolic Trp, IFN-gamma-activated, host cells, obligate, intracellular, dependence, Chlamydia, genome size, content, host cell, nutrients, C. trachomatis, C. pneumoniae, Trp auxotrophs, nutrient, human, host cell, IFN-gamma, chlamydiae, alternative, developmental state, persistence, Chlamydial, persistence, characterized, division cycle, aberrant, morphology, case, IFN-gamma-induced, persistence, Trp codon-dependent changes, transcription, changes, transcription, dependent, amino acid starvation state, investigate, chlamydial response, mechanisms, amino acids, limiting, tested, efficacy, prokaryote-specific tRNA synthetase inhibitors, indolmycin, AN3365, starvation, Trp, leucine, drugs block, chlamydial growth, induce, changes, morphology, transcription, consistent with, persistence, growth inhibition, compounds, removed, medium, data, indolmycin, AN3365, tools, persistent state, IFN-gamma]]\n",
      "[[prevalence, Chlamydia psittaci, Chlamydia pneumoniae, Chlamydia trachomatis, ocular adnexa lymphoma, OAL, molecular testing, countries, potential, association, Chlamydia infection, mucosa-associated lymphoid tissue, MALT, histotype, systematic review, meta-analysis, Electronic databases, studies, presence, Chlamydia, OAL, Pooled, prevalence, Chlamydia species, calculated, country, odds ratio, association, Chlamydia, MALT, histotype, studies, OALs, Pooled, prevalence, C psittaci, C pneumoniae, C trachomatis, country, Chlamydia infection, associated with, MALT histotype, odds ratio, involvement, C psittaci, OAL, variable, highest, prevalence, Italy, Korea, Chlamydia, associated with, MALT, histotype]]\n",
      "[[Cross-reactivity, chlamydial antigens, Chlamydia, pneumoniae serology, testing, human, antisera, C. pneumoniae-specific B-cell, epitopes, peptide antigens, C. pneumoniae, immunodominant proteins, detection, antibodies, C. pneumoniae, ELISAs, peptide antigens, mixtures, peptides, comparison, composite, CRS, anti-C. pneumoniae, status, human, sera, CpnMixF12 peptide, sensitivity, specificity, anti-C. pneumoniae IgG, ELISAs, sensitivity, specificity, Human, C. pneumoniae, Cpn, C. trachomatis, Ctr, seroreactivity, co-positivity, commercial, Cpn, Ctr, ELISAs, Cpn, Ctr peptide, cross-reactivity, commercial, ELISAs, hyperimmune, mouse, sera, Chlamydia spp., commercial, Cpn, Ctr, ELISA antigens, cross-reactive, Chlamydia spp., Cpn, Ctr peptide, react, antisera, cognate, chlamydial species, high, specificity, sensitivity, non-specialized laboratories, ELISAs, potential, serodiagnosis, C. pneumoniae infection]]\n",
      "[[phenazines, isolated, marine microorganism, phenazines, antibacterial activities, synthesized, 4-substituted phenazines, block, infectivity, chlamydiae, host, toxicity, study, design, synthesize, novel, 3-substituted phenazines, antichlamydial agents, 3-substituted phenazines, synthesized, Buchwald-Hartwig cross coupling reaction, Suzuki reaction, antichlamydial activity, synthesized, compounds, evaluated, effect, infectious, progeny, EBs, Cytotoxicity, compounds, host cells, assessed, treatment, uninfected, HeLa cells, WST-1 method, 3-substituted phenazines, antichlamydial activity, IC50, values, Chlamydia trachomatis L2, C. muridarum, MoPn, C. pneumoniae, AR39, 7d, antichlamydial activity, IC50, values, apparent, cytotoxicity, host cells, Biological assay, 7d, inhibited, chlamydial infection, reducing, elementary, chlamydial growth, chlamydial, developmental cycle, findings, 3-substituted phenazine derivatives, therapeutic agents, chlamydial infections, effective, phenazines, low, toxicity, chemical modification, C-3 position, C-4 position, phenazine]]\n",
      "[[Chlamydia trachomatis infections, sexually transmitted, infections, debilitating, sequelae, infertility, Mouse models, vaccine, development, study, immune response, histopathology, associated with, Chlamydia infection, murine, models, in vivo, identification, murine, host genes, elimination, murine, human, Chlamydia strains, RNA sequencing, Chlamydia muridarum, infected, BALB/c, lung, transcriptome, genes, antichlamydial functions, induced, tissue, level, members, murine, interferon-inducible GTPase family, CXCL, chemokines, CXCL9, CXCL11, immunoresponsive gene 1, nitric oxide synthase-2, iNOS, lipocalin-2, Indoleamine 2,3-dioxygenase 1-2, IDO1, antichlamydial, host, enzymes, expressed, infected, murine, lungs, finding, novel, IDO, human, antichlamydial defense gene, level, epithelial cell, positivity, immunohistochemistry, IDO1, proteins, expressed, macrophages, Detection, tryptophan degradation, product, kynurenine, impact, IDO, inhibition, Chlamydia muridarum, growth, IDO1, proteins, active, IDO1, activity, increased, Chlamydia muridarum, infected, C57BL/6, lung tissues, phenomenon, mouse, strain, specific, study, murine, antichlamydial response, up-regulated, defense genes, in vivo, genes, antichlamydial effectors, IDO1, identified, potential, impact, murine, IDO1, expression, Chlamydia propagation, investigation]]\n",
      "[[research group, Borrelia burgdorferi, Lyme disease bacterium, biofilms, Borrelia-infected human, skin lesions, Borrelia lymphocytoma, BL, Biofilm structures, multiple, organisms, symbiotic, relationship, goal, shelter, environmental, stressors, antimicrobial agents, multiple, co-infections, Lyme disease, questions, study, BL, tissues, pathogenic species, co-existence, Borrelia biofilms, reports, Chlamydia-like organisms, ticks, Borrelia-infected human, skin tissues, Chlamydia-specific polymerase chain reaction, analyses, Borrelia-positive BL, tissues, Analyses, sequence, positive, Chlamydia spp., DNAs, tissues, sequences, identity, Chlamydophila pneumoniae, Chlamydia trachomatis, Fluorescent immunohistochemical, in situ hybridization methods, presence, Chlamydia antigen, DNA, Borrelia biofilms, Confocal microscopy, Chlamydia, center, Borrelia biofilms, pathogenic, study, Borrelia-Chlamydia mixed biofilms, infected, human, skin tissues, questions, human, pathogens, symbiotic, relationship, mutual survival]]\n",
      "[[AIM, study, characteristics, health state, family-members, ENT-patients, identified, Chlamydia infection, members, families, otorhinolaryngological, patients, verified, families, families, Chlamydia infection, Laboratory methods, research, identification, Chlamydia trachomatis, Chlamydophila pneumoniae, Chlamydia diagnostics, immune fluorescence, immune enzyme analyses, polymerase chain reaction, Health state, ENT-patient, family-members, evaluated, complex method, questionnaire, family-member, health category, calculation, health average coefficient, family member, determination, family identity, health category, families, otorhinolaryngological, patients, Chlamydia infection, family-members, acute, chronic, pathology, organs, systems, associated with, functional disorders, health status, family members, ENT, patients, respiratory Chlamydia, families, patients, negative, Chlamydia, healthy, family members, people, risk factors, health]]\n",
      "[[Atherosclerosis, progressive, disease, characterized, chronic inflammation, arterial walls, associated with, genetic, infectious factors, study, investigated, involvement, Chlamydia trachomatis, Chlamydia pneumoniae infections, immunological, markers, C-reactive protein, CRP, TNF-alpha, IL-6, IL-8, IL-10, process, atherosclerosis, evaluation, patients, surgical revascularization, CAD, patients, surgical heart valve disease, HVD, hospitals, Belem, Brazil, control group, CG, healthy, individuals, Blood samples, surgery, antibodies, detection, enzyme immunoassay, CRP, immunoturbidimetry, IL-6, levels, enzyme immunoassay, Tissue fragments, atheroma, plaque, heart valve, ascending aorta, surgery, qPCR, detection, bacterial DNA, Promoter region, polymorphisms, marker, quantification, TNF-alpha, IL-8, IL-10, gene expression, Demography, social information, general population, diseases, Antibody, prevalence, C. trachomatis, CAD, HVD, CG, C. pneumoniae, CAD, HVD, CG, C. trachomatis, cryptic plasmid, DNA, detected, samples, Frequency, IL6, polymorphism, CAD, HVD, CG, exposure to, Chlamydia, C. trachomatis infection, involvement, HVD, CAD, association, disease, C. pneumoniae, infection, HVD, GG, genotype, IL6, risk factor, heart disease, AT genotype, IL8, T, valvulopathies, patients, exposure to, C. pneumoniae]]\n",
      "[[Chlamydia pneumoniae, species, Chlamydiaceae, family, effect, human, health, C. pneumoniae, severe, acute, chronic diseases, upper, lower, respiratory tract, pneumonia, asthma, bronchitis, infection, pathogen, lung cancer, adhesion, Chlamydiae, secrete, effector proteins, host, cytoplasm, modulate, actin cytoskeleton, internalization, infection, TarP, effector proteins, polymerize actin, case, C. trachomatis, TarP protein, pathogenesis, study, bacterial invasion, C. pneumoniae, TarP, family member, CPn0572, secreted, host, cytoplasm, recruits, associates, actin, actin-binding domain, TarP, proteins, analysis, CPn0572, CPn0572 actin, modulating, capability, complex, fission yeast system, actin, domain, actin binding domain, Microscopic analysis, HEp-2 cells, expressing, CPn0572, deletion, variants, mapped, C-terminal part, protein, CPn0572536, binds, F-actin, in vitro, colocalizes, aberrantly thickened actin, in vivo, microscopic, bioinformatic analysis, vinculin binding sequence, CPn0572, findings, function, TarP, family, actin binding domains, vinculin binding site, host, modulation]]\n",
      "[[Extended-spectrum beta-lactamase, ESBL, AmpC-producing Enterobacterales, bloodstream infection, ESBL-producing bacteria, resistant, third-generation cephalosporins, result, economic, public, burden, AmpC-producing Enterobacterales, third-generation, cephalosporin resistance, enzyme, hyper-expression, observational study, outcome, treatment, infections, carbapenems, carbapenems, development, carbapenem-resistant Gram-negative bacilli, study, multicentre, parallel group, non-inferiority trial, ceftolozane-tazobactam, meropenem, adult, patients, bloodstream infection, ESBL, AmpC-producing Enterobacterales, Trial, recruitment, sites, countries, Australia, Singapore, Italy, Spain, Saudi Arabia, Lebanon, sample size, quantity, ceftolozane-tazobactam, Merck, Sharpe, Dohme, MSD, trial, patients, primary outcome analysis, non-inferiority, non-inferiority margin, mortality, randomised groups, randomised, definitive, treatment, days, maximum, days, treating, clinicians, Data, demographic information, risk factors, concomitant, antibiotics, illness scores, microbiology, multidrug-resistant, discharge, mortality, collected, Participants, bloodstream infection, third-generation cephalosporin, non-susceptible, E. coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp., Serratia marcescens, randomised, ceftolozane-tazobactam, meropenem, Secondary outcomes, comparison, mortality, clinical, microbiological success, day, functional, bacteraemia, score, microbiological relapse, bloodstream infection, length of hospital stay, adverse events, C. difficile, infection, multidrug-resistant, organism, colonisation, trial, completion, MERINO-3 trial, US, National Institute of Health ClinicalTrials.gov register, reference number]]\n",
      "[[Tumour progression locus 2, TPL-2, Toll-like receptor, TLR, activation, ERK1/2, p38alpha MAP kinases, myeloid cells, modulate, expression, cytokines, innate immunity, study, MAP, TPL-2, phagosome, maturation, essential process, killing, phagocytosed, microbes, TPL-2, catalytic activity, induce, phagosome acidification, proteolysis, primary mouse, human, macrophages, uptake, latex beads, Quantitative proteomics, blocking, TPL-2, catalytic activity, protein composition, phagosomes, reducing, abundance, V-ATPase proton pump subunits, TPL-2, stimulated, phosphorylation, DMXL1, regulator, V-ATPases, induce, V-ATPase assembly, phagosome acidification, Consistent with, results, TPL-2, catalytic activity, phagosome, acidification, efficient, killing, Staphylococcus aureus, Citrobacter rodentium, phagocytic, uptake, macrophages, TPL-2, controls, innate immune responses, macrophages, bacteria, V-ATPase, induction, phagosome, maturation]]\n",
      "[[Biosynthesis, zinc oxide, nanoparticles, ZnO-NPs, microalgae, novel, cost-effective, production, molecular characterization, antibacterial activity, Filtrates, isolated, microalgae strain, ZAA1, MF140241, ZAA2, MF114592, ZAA3, MF114594, Incubation, strains, solution, zinc, nitrate, synthesis, ZnO-NPs, Fourier-transform infrared, UV-visible spectroscopy, scanning electron microscopy, characterize, nanoparticles, antibacterial activity, ZnO-NPs, Escherichia coli, Staphylococcus aureus, Micrococcus luteus, Klebsiella pneumoniae, Citrobacter freundii, microalgae, ZnO-NPs, production, procedure, biomedical, applications]]\n",
      "[[forest, musk deer, Moschus berezovskii, nationally, species, economic, China, captive, breeding, programmes, die, diarrhoea, study, M. berezovskii, groups, probiotics, group, placebo, control, group, groups, fed, basal diet, probiotics, probiotic group, whey powder, placebo group, days, Faecal samples, day, evaluated, microbial, diversity, species, richness, metabolic function, Probiotic, intervention, gut health, M. berezovskii, community structure, gut microbiota, Intake, probiotics, reduced, abundance, pathogenic bacteria, Escherichia coli, Citrobacter freundii, intestinal flora, increased, abundance, Bifidobacterium species, lactic acid bacteria, time, gut microbiota, probiotics, group, regulating degradation, phenylacetic acid, dTDP-L-rhamnose synthesis, processes, potential, immunity, M. berezovskii, preliminary study, effects, probiotics, gut microbiota, M. berezovskii, potential, improve, health, wellbeing, economic value, M. berezovskii]]\n",
      "[[Listeria monocytogenes, death, food poisoning, studies, steroid receptor coactivator 3, SRC-3, host defense, extracellular, bacterial, pathogens, Escherichia coli, Citrobacter rodentium, intracellular, bacterial, unclear, SRC-3(-/-) mice, resistant, L. monocytogenes infection, tail, L. monocytogenes, compared, wild-type mice, infecting, L. monocytogenes, SRC-3(-/-) mice, decreased, mortality rate, decreased, bacterial, less body weight loss, proinflammatory cytokines, severe, tissue damage, wild-type mice, SRC-3(-/-) mice, ROS, decreased, L. monocytogenes-induced lymphocyte, apoptosis, Mechanically, SRC-3(-/-), mice, decreased, expressions, negative, ROS, NRROS, interferon (IFN)-beta, target, genes, Daxx, Mx1, TRAIL, associated with, apoptosis, SRC-3, deficiency, host, L. monocytogenes infection, increasing, ROS, production, decreasing, lymphocyte, apoptosis, affecting, expressions, NRROS, IFN-beta]]\n",
      "[[resistance, rates, detected, uropathogens, frequent, Gram-negative, uropathogenic bacteria, seldom, study, resistance, rates, uropathogenic, Gram-negatives, population, patients, treated, Department, Urology, tertiary referral centre, Central Europe, period, years, Data, positive, urine samples, urological, out-patients, Department of Clinical Microbiology database, susceptible, resistant, isolates, year, calculated, uropathogens, Acinetobacter spp., Citrobacter spp., Enterobacter spp., Morganella morganii, Providencia spp., Serratia spp., Stenotrophomonas maltophilia, Antimicrobial agents, survey, ampicillin, amoxicillin/clavulanic acid, piperacillin/tazobactam, cefuroxime, cefotaxime, ceftazidime, cefepime, ciprofloxacin, ofloxacin, gentamicin, amikacin, ertapenem, meropenem, imipenem, trimethoprim-sulfamethoxazole, co-trimoxazole, nitrofurantoin, colistin, Penicillin derivatives, poor effect, piperacillin/tazobactam, Cefuroxime, efficient, cefotaxime, Acinetobacter spp., S. maltophilia, Susceptibility, fluoroquinolones, Amikacin, efficient, gentamicine, susceptibilities, Nitrofurantoin, efficiency, Cotrimoxazole, Citrobacter spp, Serratia spp., treatment, S. maltophilia, UTIs, carbapenems, ertapenem, efficient, meropenem, imipenem, S. maltophilia, isolates, suceptible, carbapenems, Uropathogenic microorganisms, report, multi-drug, resistant, phenotypes, Knowledge, resistance, patterns, clinicians, right empirical antibiotic treatment, taxonomical, assignment, isolate, sensitivity, results]]\n",
      "[[Klebsiella pneumoniae, frequent, KPC-producing, bacteria, blaKPC gene, Tn4401 transposon, non-Tn4401 elements, NTEKPC, variants, I-III, case, KPC, UC-CHRISTUS Clinical Hospital, detected, Pseudomonas aeruginosa, event, KPC, detected, Pseudomonas aeruginosa, Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Citrobacter freundii, isolated, patients, mechanisms, genetic transfer, dissemination, blaKPC gene, isolates, multispecies outbreak, molecular epidemiology analysis, clinical, isolates, Multi-Locus Sequence Typing, plasmid, analysis, Pulsed-Field Gel-Electrophoresis, Whole-genome sequencing, WGS, High-risk sequence types, K. pneumoniae, ST11, P. aeruginosa, ST654, E. cloacae ST114, enterobacterial, isolates, clonal, E. coli, isolated, patient, WGS, analysis, enterobacterial, isolates, blaKPC, embedded, variant, NTEKPC, NTEKPC-IIe, blaKPC gene, blaTEM-1 gene, insertion sequence, ISEc63, Tn3 family, Downstream, blaKPC gene, truncated ISKpn6 gene, inverted repeat right sequence, Tn4401, ISec63-like element, blaKPC gene, Tn4401 remnants, Tra operon, conjugative transfer, plasmid, NTE, host-range IncN plasmid, P. aeruginosa, isolates, blaKPC gene, embedded, Tn4401b, transposon, plasmid, plasmid, transfer, Enterobacteriaceae, P. aeruginosa, hypothesized, enterobacterial, isolates, blaKPC, embedded, NTEKPC-IIe, element, multispecies, KPC, outbreak, horizontal gene, clonal spread, infection control, measures, containment, clonal, spread]]\n",
      "[[Objective, bacterial species, risk, bla CTX-M genes, antibiotic, treatment, identified, species-specific prevalence, bla CTX-M genes, clinical, isolates, United States, microbiology, laboratories, hospitals, GenMark Dx ePlex(R), Blood Culture Identification Gram-Negative (BCID-GN) Panel, blood culture, BCID-GN Panel, Gram-negative, targets, bla CTX-M genes, carbapenemase gene, families, Gram-negative blood cultures, bla CTX-M genes, specimens, species-specific prevalence, bla CTX-M genes, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Salmonella spp., Acinetobacter baumannii, Enterobacter species, Proteus mirabilis, Serratia marcenscens, Pseudomonas aeruginosa, bla, CTX-M, prevalence, hospitals, District, Columbia, New York, Florida, Carbapenemase genes, identified, organisms, distribution, bla KPC, bla VIM, bla OXA, bla NDM, bla IMP, species-specific prevalence, carbapenemase genes, A. baumannii, K. pneumoniae, P. mirabilis, Enterobacter species, Citrobacter spp., P. aeruginosa, E. coli, K. oxytoca, S. marcescens, (<1%).Conclusion, Gram-negative organisms, US, cohort, bla CTX-M genes, bla CTX-M genes, organisms, E. coli, K. pneumoniae, K. oxytoca, molecular diagnostic panels, benefit, inclusion, plasmid-mediated ampC, SHV, TEM, ESBL, targets]]\n",
      "[[Infected, diabetic foot ulcer, IDFU, public health, non-traumatic limb amputation, published data, IDFU, West African countries, study, investigated, aetiology, antibacterial drug resistance, burden, IDFU, tertiary hospitals, Osun state, Nigeria, Isolates, cultured, tissue biopsies, aspirates, patients, IDFU, Bacterial, identification, antibiotic susceptibility testing, phenotypic, detection, extended-spectrum beta-lactamase, carbapenemase, production, protocols, resistance genes, detected, polymerase chain reaction, Results, microorganisms, isolated, IDFUs, Gram-negative bacilli, GNB, Gram-positive cocci, anaerobic bacteria, facultative, anaerobic bacteria, isolated, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Citrobacter spp., anaerobes, Bacteroides spp., Peptostreptococcus anaerobius, IDFUs, infected, multidrug-resistant bacteria, methicillin-resistant S. aureus, GNB, extended-spectrum beta-lactamases, CTX-M, GNB, carbapenemases, encoded, bla VIM, Factors, associated with, presence, multidrug-resistant bacteria, peripheral neuropathy, odds ratio, AOR, duration, foot infection, month, AOR, Multidrug-resistant, facultative, anaerobic bacteria, agents, IDFU, proportion, aetiological agents, anaerobic bacteria]]\n",
      "[[Western-style diet, WSD, fat, low, fiber, nutrients, gut microbiota, WSD, reduces, microbiota, density, promotes, microbiota, encroachment, colonization, resistance, immune system, readiness, host defense, pathogenic bacteria, impact, WSD, infection, colitis, response, Citrobacter rodentium, mice, consuming standard, rodent, grain-based chow, GBC, feeding, WSD, dynamics, Citrobacter infection, initial, colonization, inflammation, persistent, infection, associated with, low-grade, inflammation, insulin resistance, WSD's, reduction, Citrobacter virulence, colons, GBC-fed mice, microbiota, metabolites, short-chain fatty acids, acetate, Citrobacter growth, virulence, Citrobacter, persistence, WSD-fed, mice, inability, resident, microbiota, gut lumen, impacts, WSD, microbiota, composition, studies, potential, microbiota, metabolites, diet, impact, course, consequence of, infection, exposure to, gut pathogen]]\n",
      "[[review, classes, antimicrobial peptides, AMP, gastrointestinal (GI) tract, avian, species, antimicrobial, immunomodulatory activities, benefits, synthetic, AMP, poultry, production, context, AMP, antimicrobial growth, (AGP).Since, mid-1950s, antibiotic growth promoters, AGP, feed, prophylactic doses, modulate, homeostasis, intestinal microbiota, decreasing, risk, intestinal dysbacteriosis, growth, pathogens, avian, gut, decades, AGP, regulatory, concerns, antimicrobial resistance, AMR, rate, infectious disease, outbreaks, flocks, prophylactic antibiotics, compensatory, increase, antimicrobial, therapeutic purposes, Endogenous, natural, AMP, production, associated with, presence, microbiota, interaction, intestinal, epithelial, lamina propria, lymphoid cells, antimicrobial activity, shapes, microbiota, population, control intestinal, pathogens, Clostridium, Salmonella spp, stimulates, development, maturation, local immune system, AGP, AMP, gut, microbiota, adequate, immune-competence, animal, health, high, growth, performance, parameters, feed intake, daily weight, feed, conversion, mortality, Antimicrobial proteins, peptides, innate immune system, organisms, host, invading, pathogenic bacteria, viruses, fungi, parasites, interacting, negatively]]\n",
      "[[Collagen, player, vitreoelasticity, vitreoretinal adhesions, Molecular reorganization, spontaneous, weakening, adhesions, age, separation, posterior hyaloid membrane, PHM, retina, posterior, PVD, separation, posterior hyaloid, tight adherence, retinal detachment, vitreomacular traction syndrome, epiretinal membrane formation, surgical intervention, Pharmacological vitrectomy, potential, surgical vitrectomy, adjunct, retinal surgery, induce, PVD, enzymatic reagents, collagenase, Clostridium histolyticum, nonspecific, toxic, collagenase, Vibrio mimicus, VMC, active, VMA, deletion, C-terminal amino acids, activity, VMA, vitreous cavity, fusion construct, inhibitor, hyaluronic acid-VMA, iHA-VMA, iHA, binds, HA, fused, N-terminus, VMA, construct, evaluated, context, PVD, VMA, iHA-VMA, expressed, Escherichia coli, purified, characterized, gelatin zymography, collagen degradation assay, fluorescamine-based assay, cell-based assays, experiments, New Zealand, Group A, iHA-VMA, group B, dose, VMA, groups, saline, injected, control, contralateral, eyes, Animals, monitored, indirect ophthalmoscopy, optical coherence tomography, OCT, B-scan ultrasonography, Retinal, toxicity, assessed, hematoxylin and eosin (H&E) staining, retinal tissue, activity, iHA-VMA, VMA, C. histolyticum collagenase Type IV, iHA-VMA, group, rabbits, PVD, PVD, animals, histomorphological, changes, VMA, group, rabbits, PVD, retinal, morphological, changes, animals, iHA-VMA, targeted action, vitreous, potential, pharmacologic, vitreolysis]]\n",
      "NaN\n",
      "[[AIMS, woody, plant, resources, silage, ruminants, Pacific Biosciences, study, microbial, network, fermentation, characteristics, paper mulberry, PM, silage, prepared, corn meal, CM, rice bran, RB, exogenous additives, PM, nutrients, crude protein, dry matter, ensiling, microbial, diversity, abundance, PM, CM, RB, decreased, anaerobic, environment, acidic conditions, CM-treated, PM, silage, accelerated, conversion, dominant, microbial, community, bacteria, lactic acid bacteria, promoted, lactic acid fermentation, RB, treat, PM, silage, Enterobacter, Clostridium species, bacterial, community, ensiling, butyric acid fermentation, protein decomposition, RB, CM, increased, amount, fermentation, substrates, microbial, community structure, affected, metabolic pathways, global metabolism, carbohydrate metabolism, amino acid metabolism, improved, flavour, quality, PM, silage, CM, improved, fermentation, quality, PM, silage, PM, CM, combination, SMRT sequencing technology, microbial, networks, fermentation, characteristics, results, PM, high-protein silage, animal production, SIGNIFICANCE, IMPACT, tropics, effective, abundant, natural, biomass, resources, woody plants, silage, feed preservation, problem, livestock, production, shortage, feed, dry season, SMRT sequencing technology, analyze, microbial, network, fermentation, characteristics, woody, silage, CM, exogenous, improve, fermentation, quality, silage]]\n",
      "[[nutritional value, dog, microbiological, quality, dog, food, healthy, foods, study, quality, dry food, adult, dogs, evaluating, nutritional value, compliance, nutritional guidelines, dogs, comparing, nutritional value, dog, foods, division, cereal, cereal-free foods, evaluating, microbiological safety, evaluated, dry dog, foods, minimum European Pet Food Industry, FEDIAF, requirement, total protein, fat, content, aerobic, microbial, analyzed, dry dog, foods, dog, foods, presence, staphylococci, detected, coagulase positive Staphylococcus (CPS, Mold, presence, cereal-free dog, food, cereal, foods, analyzed, foods, Enterobacteriaceae, coliforms, Escherichia coli, Salmonella spp, Bacteria, genus, Listeria, Clostridium, yeasts, detected, evaluated, dry dog, foods, microbiological quality, detected, microorganisms, long-term, consumption, contaminated food, European, microorganisms, pet food, insufficient, quality control, products]]\n",
      "[[Anaerobic, digestion, AD, protein-rich grass, silage, experimental, low, increased, organic, OLRs, mesophilic, thermophilic, degrees C) temperatures, adaptive response, biomass-attached cellulolytic/hydrolytic biofilms, increasing, ammonium/ammonia, contents, metagenomics, transcriptional profiling, metagenome, MAGs, bacterial, archaeal, MAGs, abundant, members, communities, quality criteria, characterized, Determination, MAG, abundances, tested, conditions, mapping, metagenome, MAGs, revealed, MAG, abundance, profiles, shaped, temperature, OLR, OLR, effect, mesophilic systems, thermophilic, metatranscriptome mapping, MAGs, MAG, abundances, thermophilic, conditions, MAGs, increased, OLRs, transcriptional activities, proliferation, rates, behavior, microbiome, mesophilic, conditions, response, increased, OLRs, proliferation, rates, transcriptional activities, analysis, identification, MAGs, positively, increased, OLRs, MAGs, OLRs, associated conditions, Clostridiales, Acetivibrio sp., mesophilic, biofilm, Bacteroidales, Prevotella sp., species, Lachnospirales, Herbinix sp., Kineothrix sp., Clostridiales, Clostridium sp., thermophilic, biofilm, Genome-based, metabolic reconstruction, transcriptional profiling, positively, MAGs, hydrolysis, grass silage, acidogenesis, acetogenesis, integrated, identification, AD, biofilm, keystone, species, performance, stress, conditions, increased, OLRs, Genome-based knowledge, metabolic, potential, transcriptional activity, responsive, microbiome members, development, improved, microbiological, AD, management, strategies, biomethanation, renewable, biomass]]\n",
      "[[Hypertension, HTN, cardiovascular, risk factors, increasing, target, organ, damages, cardiovascular, morbidity, mortality, Isolated systolic HTN, ISH, isolated diastolic HTN, IDH, subtypes, HTN, researches, alteration, fecal bacteria, HTN, sub-types, composition, bacterial taxa, functional modules, ISH, IDH, metagenomic sequencing analysis, fecal samples, controls, ISH, IDH, control, ISH, IDH, patients, decreased, gene number, bacterial richness, evenness, bacterial, alterations, statistical significance, Shannon index, genus, level, beta-diversity, intestinal flora, IDH, ISH, taxonomic, composition, ISH, IDH, healthy control, genus, species, levels, Patients, IDH, ISH, Rothia mucilaginosa, reduced, Clostridium sp. ASBs410, KEGG, modules, decreased, IDH, compared, control group, sodium transport system, ISH, functions, relevant, biotin, biosynthesis, decreased, results, disordered, profiles, subjects, ISH, IDH, significance, early intervention, IDH]]\n",
      "[[effects of, temperature, degrees, pH, uncontrolled, volatile fatty acid, VFA, anaerobic, codigestion, food waste, thermal-hydrolysed, sewage, sludge, investigated, study, results, optimal, conditions, VFA, production, pH, degrees, pH, dominant, bacterial genera, associated with, VFA, production, temperature, pH, Prevotella, Lactobacillus, Bifidobacterium Megasphaera, Clostridium XlVa, Coprothermobacter, temperature, pH, acid-type fermentation, temperature, pH, degrees, pH, butyric acid-type fermentation, maximal, polyhydroxyalkanoate, content, dry cell, pH, fermentative, liquids, 3-hydroxybutyrate, 3-hydroxyvalerate]]\n",
      "[[OBJECTIVE, Lithium chloride, LiCl, mood stabilizer, bipolar affective disorders, activate, Wnt/beta-catenin, signaling pathway, in vivo, in vitro, Colon, susceptible, tissues, Wnt signaling pathway, toxic, effect, dose, LiCl, colon, C57BL/6 mice, injected, intraperitoneally, LiCl, dose, day, days, activate, signal pathway, intestines, H&E, staining, assess, colonic tissues, mice, treated with, dose, LiCl, expression, inflammation-associated genes, measured, qPCR, Western blot, immunostaining methods, gut microbiome, tested, 16S rDNA gene analysis, differentiation, enteroendocrine cells, colon, inhibited, treatment, LiCl, F4/80 positive macrophages, colon, activated, dose, LiCl, migrated, submucosa, lamina propria, expression, pro-inflammatory genes, TNFalpha, IL-1beta, increased, colon, high dose, LiCl, treated, mice, Clostridium_sp_k4410MGS_306, Prevotellaceae_UCG_001, specific, predominant, dose, LiCl, treated, mice, expression, IgA, coding genes, Pigr, Claudin-15, decreased, colon, tissues, high dose, LiCl, treated, mice, LiCl, inflammation, colon, mice, activating, F4/80, inhibiting, expression, IgA, coding genes, plasma cells, expression, Pigr, Claudin-15, colonic epithelial cells, evidences, toxic, effects, high dose, LiCl, colon]]\n",
      "[[Wound botulism, rare, life-threatening illness, toxin, Clostridium botulinum, spore-forming anaerobic bacterium, cases, United States, year, California, wound botulism, cases, drug injectors, black tar heroin, presentation, botulism, overlap, diagnoses, opioid, intoxication, neurological disease, accurate, diagnosis, difficult, healthy, patient, history, injecting, black tar heroin, emergency department, complaining, generalized weakness, throat discomfort, antibiotics, home, patient, emergency department, complaints, slurred speech, blurring, vision, admitted, cerebrovascular injury, absence, positive, findings, laboratory, imaging studies, botulism, patient decompensated, intubated, Botulism, antitoxin, patient, Prompt, decision-making, clinical suspicion, presumptive diagnosis, administration, botulism, antitoxin, aggressive provision, supportive care, arrest, progression, paralysis, life-saving, opioid, United States, reversion, heroin, opioids, cases, wound botulism, Clinician, attentiveness, substance history, botulism, presentation, treatments, patients]]\n",
      "[[ObjectiveBotulism, rare, life-threatening, paralytic disease, Clostridium botulinum neurotoxin (, BoNT, Available treatments, equine, antitoxin, human, immune globulin, post-exposure, administer, NTM-1632, human IgG, monoclonal antibodies, B1, B2, B3, targeting, BoNT, serotype B, BoNT/B, first-in-human study, assessed, safety, tolerability, pharmacokinetics, PK, immunogenicity, double-blind, single-center, placebo-controlled dose, escalation, randomized 3 cohorts, healthy volunteers, intravenous dose, NTM-1632, saline placebo, Safety, monitoring, physical examinations, clinical laboratory studies, vital signs, Blood sampling, PK, immunogenicity analyses, ResultsTwenty-four, subjects, study product, NTM-1632, placebo, no deaths, adverse events, Adverse events, NTM-1632, groups, mild, frequency, severity, placebo, group, identified, NTM-1632, PK, profile, half-life, days, dose, linear relationship, maximum, concentration, area, concentration-time curve, AUC0, ->t), NTM-1632, low, immunogenicity, treatment-emergent, anti-drug antibody, responses, low, middle dosing, groups, highest, dose, InterpretationNTM-1632, administered, doses, safety, PK, immunogenicity profile, NTM-1632, clinical development, treatment, BoNT/B, intoxication, post-exposure prophylaxis]]\n",
      "[[Botulinum neurotoxins, BoNTs, soil bacterium, Clostridium botulinum, botulism, biohazard agents, screening assays, countermeasures, fashion, gold, mouse, analysis, time, days, prompt, management, food safety, medical diagnosis, paper-based, antibody-free sensor, reliable, detection, BoNT/A, BoNT/C, cleavage, capability, synthetic peptide, natural, substrate, SNAP-25, peptide, labelled, electroactive molecule methylene blue, immobilized, paper-based, modified, gold, nanoparticles, BoNT/A, BoNT/C, cleave, peptide, removal, methylene blue, electrode, surface, presence, neurotoxins, sample, signal, decrease, proportional, BoNT, amount, biosensor, peptide, combined, smartphone, detect, BoNT/A, BoNT/C, linearity, detection, applicability, biosensor, evaluated, spiked samples, orange juice, recovery values, BoNT/A]]\n",
      "[[Clostridium botulinum neurotoxin serotype A, BoNT/A, neurotoxin, effective, therapeutic, neuromuscular disorders, induction, temporary, muscular, paralysis, binding, internalization, BoNT/A, neuronal cells, binding domain, HC/A, binds, gangliosides, GT1b, protein cell surface receptors, SV2, recombinant, HC/A, bind, FGFR3, FGFR, dimerization, indirect, measure, ligand-receptor binding, FCS, TIRF receptor dimerization assay, measure, rHC/A-induced dimerization, fluorescently tagged, FGFR, subtypes, FGFR1, cells, rHC/A, dimerized, FGFR, subtypes, rank, FGFR3c, EC50, FGFR2b, EC50, FGFR1c, EC50, rHC/A, dimerized, FGFR3c, potency, native, FGFR3c, FGF9, EC50, Mutating, ganglioside binding site, HC/A, removal, GT1b, media, decreased, dimerization, reduced, dimerization, SV2, variant, HC/A., results, FCS, FGFR, dimerization, novel, ligands, model, HC/A, indirectly, FGFRs, induces, receptor dimerization]]\n",
      "[[cardinal, parameter growth, growth boundary model, non-proteolytic C. botulinum, fresh, seafood, poultry, products, growth rates, broth, cardinal, parameter values, temperature, pH, NaCl/water, activity, acetic, benzoic, citric, lactic, sorbic acids, growth, growth boundary model, inhibiting, interactive, factors, growth curves, tests, unprocessed, seafood, model, evaluation, tests, characterized, fresh, seafood, Comparison, growth curves, growth rates, mumax-values, model, bias factor, Bf, accuracy factor, Af, model, evaluated, growth rates, toxin, formation, data, scientific literature, seafood, poultry, meat, pasta, prepared, meals, data, responses, toxigenic, strains, non-proteolytic C. botulinum, Bf-/Af-values, mumax-values, toxin, formation, model, growth responses, fail-safe, fail-dangerous, cocktail, non-toxin, Clostridium spp, isolates, model, isolates, 16S rRNA, gene similarity, non-proteolytic C. botulinum, Group II, environmental factors, model, development, reformulation, seafood, poultry, products, growth, non-proteolytic C. botulinum, evaluation, model, characterized, products, meat, vegetables, pasta, prepared, meals, dairy products, study]]\n",
      "[[Botulism, neuroparalytic disease, neurotoxin, Clostridium botulinum, study, genetically, C. botulinum strain, isolated, case, infant, botulism, Korea, isolated, C. botulinum strain, CB-27, stool sample, patient, analyzed, toxin, types, toxin gene, compositions, strain, mouse bioassay, real-time PCR, genome sequencing, Toxin gene cluster analysis, strain, CB-27, C. botulinum, B gene, nucleotide, amino acid sequences, toxin genes, toxin gene cluster, arrangements, strain, CB-27, strain CDC_69094, total nucleotide sequences, toxin gene, CB-27, CDC_69094, genetic diversity, toxin gene, CB-27, C. botulinum strains, knowledge, description, C. botulinum strain, toxin gene, Korea]]\n",
      "[[Botulinum toxin, protease, bacterium, Clostridium botulinum, chemical denervation, skeletal muscles, temporary, weakening, muscle activity, transitory effect, application, botulinum toxin, alternative, excessive, EGD, studies, evaluating, maintenance, long-term, results, botulinum toxin, study, evaluate, effectiveness, duration, botulinum toxin type A, treatment, anterior EGD, Botulinum toxin Type A, patients, EGD, measurement, triplicate, Castro Viejo dry point compass, central cervical portion, upper lateral incisors, lower portion, upper lip, bilaterally, measurements, application, toxin, days, procedure, data, analyzed, repeated-measures ANOVA, Bonferroni, statistically significant, reduction, measurements, Baseline, days, application, botulinum toxin, days, patients, sample, EGD, Mild adverse effects, patients, botulinum toxin type A, effective, treat, EGD, days, effect, gingival, exposure]]\n",
      "[[Preservation, excitability, spiral ganglion, neurons, SGN, improved, speech perception, cochlear implantation, application, exogenous, neurotrophic factors, neurotrophin brain-derived neurotrophic factor, BDNF, increase, SGN, survival, in vitro, in vivo, pharmacological approach, cochlear implant, CI, research, pharmacokinetic profile, proteins, BDNF, small molecules, survival, SGN, increase, efficacy, BDNF, C3 exoenzyme, Clostridium botulinum, potential, protection, regeneration, SGN, Inhibition, RhoA GTPase pathway, C3, axonal regeneration, pro-survival, signals, neurons, Nanomolar, concentrations, C3, enzymatically inactive, C3(E174Q, 26mer C-terminal peptide fragment covering, amino acid, C3(156, potentiated, neuroprotective effect, SGN, BDNF, in vitro, neuroprotective effect, C3/BDNF, reduced, neuroprotective effect, BDNF, treatment, wortmannin, inhibitor, phosphatidylinositol-3-kinase (PI3K).The exoenzyme C3, wild-type, enzyme-deficient, C3 peptide fragment, C3(154-181, biologically active compounds, protection, SGN, intracellular, mechanisms, neuroprotective effect, combination, BDNF, TrkB stimulation, C3 exoenzyme, RhoA inhibition, SGN, in vitro]]\n",
      "[[Fermented meat products, sensory characteristics, nutrient, content, cultural heritage, stability, convenience, aroma, fermented meat products, unique, formation, mechanisms, presence, nitrite, nitrate, development, cured, aroma, nitrite, nitrate, curing agents, meat products, preservation activity, presence, associated with, risks, formation, nitrosamines, antimicrobial action, Clostridium botulinum, trends, recommendations, international, associations, nitrite, minimum, concentration, antimicrobial activity, Clostridium botulinum, actual, limits, nitrite, nitrite, content, curing agents, meat products, impact, dry fermented products, Regulatory considerations, antimicrobial mechanisms, actual, trends, nitrite, reduction, effect, sensory, aroma, properties]]\n",
      "[[Class D beta-lactamases, notoriety, spread, bacterial, pathogens, inactivate, clinically, beta-lactam antibiotics, inhibition, beta-lactamase inhibitors, catalytic, mechanism, enzymes, development, novel, antibiotics, inhibitors, active, infections, antibiotic-resistant bacteria, crystallo time-resolved study, interaction, class D beta-lactamase, CDD-1, Clostridioides, difficile, diazobicyclooctane inhibitor, avibactam, catalytic, lysine, residue, acylation, deacylation, beta-lactams, sequestered, internal sealed pocket, enzyme, Time-resolved snapshots, study, decarboxylation, lysine, movement, CO2, water molecules, transient channel, lysine pocket, substrate, binding site, rotation, side chain, leucine, residue, studies, avibactam, binding, CDD-1, catalytic, mechanism, class D beta-lactamases]]\n",
      "[[Faecal microbiota transplantation, FMT, therapy, chronic diseases, associated with, gut microbiota, alterations, FMT, cures, recurrent, Clostridioides difficile, infections, complex diseases, inflammatory bowel disease, irritable bowel syndrome, metabolic syndrome, efficacy, variable, donor selection, sample administration, determinants, FMT, success, recipient factors, Perspective, effects, recipient, parameters, genetics, immunity, microbiota, lifestyle, donor microbiota, engraftment, clinical efficacy, evidence, controlling, inflammation, recipient, intestine, engraftment, reducing, host, immune system pressure, FMT, engraftment, therapeutic strategies, priorities, burden, chronic diseases, associated with, gut microbiota, inflammatory bowel disease]]\n",
      "[[Clostridiodes difficile, CDI, healthcare-associated diarrhea, decreasing, CDI, Italian Hospital of Desio, period, prevention strategies, data, surveillance studies, CDI]]\n",
      "[[Clostridium difficile, C. difficile, obligate, anaerobic, gram-positive Bacillus, intestinal diseases, antibiotic treatment, study, C. difficile, genome, genomic technology, Genome sequencing, C. difficile, LCL126, bp, GC, content, coding genes, prophages, gene islands, detected, gene function analysis, aspect, function annotation, effector, virulence, cluster, orthologous groups, proteins genes, categories, class, metabolic process, catalytic activity, carbohydrate-active enzymes, detected, genes, pathogenicity analysis, reduced, increased, virulence, hypervirulence, genes, unaffected, loss, pathogenicity genes, visualization, methylation, expression, dominant, m4C, m5C, m6C, genome, information, C. difficile, LCL126, functional, prediction, toxicological, genes, existence]]\n",
      "[[Clostridioides, difficile, antimicrobial resistance, AMR, threat, report, CDC, AMR, evolution, C. difficile, emergence, spread, C. difficile, Antimicrobial Resistance Surveillance, study, nationwide, longitudinal, surveillance, C. difficile, infection, CDI, Australia, antimicrobial susceptibility, C. difficile, isolated, Australia, strains, C. difficile, year, period, network, diagnostic, microbiology, laboratories, Australian, states, strains, tested, susceptibility, antimicrobials, CLSI agar, strains, susceptible, metronidazole, fidaxomicin, rifaximin, amoxicillin/clavulanate, resistant, strains, meropenem, moxifloxacin, vancomycin, Resistance, clindamycin, resistance, ceftriaxone, in vitro, activity, fidaxomicin, geometric mean, MIC, GM, vancomycin, metronidazole, prevalence, MDR, C. difficile, resistance, antimicrobial, low, C. difficile, isolated, Australia, reduced, susceptibility, antimicrobials, recommended, treatment, CDI, vancomycin, metronidazole, fidaxomicin, Resistance, carbapenems, fluoroquinolones, low, MDR, clindamycin, resistance, frequent, fluoroquinolone-resistant ribotype 027 strain, detected]]\n",
      "[[metagenomic, quantitative polymerase chain reaction, evaluate, profiles, ARGs, plasmids, anaerobically, manure, in situ, persistence, elevation, ARGs, plasmids, disposal facilities, CAFOs, results, ARGs, plasimd, sul2, mefa, tetm-01, tetm-02, tetw, aph3iiia, clostridioides, difficile, strain, plasmid, CAFOs, AD, residue, storage, sul1, sul2, Meantime, AD, slurry, recycling, bacteria, ARGs, soil, Romboutsia, genus, sul2, tetm-01, tetm-02, aphiiia, mefa, study, ARGs, occurrence, persistence, distribution, in situ analysis, profiles, dairy, manure, AD, treatment, disposals, CAFOs, controlling, potential, environmental, risks, dairy, manure, recycling]]\n",
      "[[Clostridioides difficile, Gram-positive, spore-forming, toxin-producing anaerobe, nosocomial, antibiotic-associated intestinal disease, production, toxin A, TcdA, toxin B, TcdB, pathogenesis, C. difficile, mechanism, TcdA, TcdB, release, cell, unclear, study, identified, characterized, cell wall hydrolase Cwl0971, CDR20291_0971, C. difficile R20291, bacterial, autolysis, gene, deletion mutant, R20291Delta0971, CRISPR-AsCpfI, autolysis, increased, cell viability, R20291, purified, Cwl0971, hydrolase activity, Bacillus subtilis cell wall, gene deletion, impaired, TcdA, TcdB, release, decreased, cell autolysis, stationary/late phase, cell growth, sporulation, mutant strain, decreased, wild type strain, In vivo, defect, Cwl0971, decreased, fitness, parent, strain, mouse infection, model, Cwl0971, cell wall lysis, cell viability, toxin, release, sporulation, germination, pathogenicity, R20291, Cwl0971, target, C. difficile, infection, therapeutics, prophylactics]]\n",
      "[[man, hospital, ambulance, fever, translucent pink color, serum, severe, hemolysis, His blood pressure, cardiopulmonary arrest, died, hospital, day, patient's death, Clostridium perfringens, detected, blood culture, time, hospital admission, serum, sample, translucent pink, red color, bacilli, bacteria, peripheral blood smear, Clostridium perfringens, medical treatment]]\n",
      "[[Clostridium, Gram-positive, rod-shaped, anaerobic, spore-forming bacterium, environments, world, Clostridium species, botulism, tetanus, enterotoxaemia, gas gangrene, necrotic enteritis, pseudomembranous colitis, blackleg, black disease, Clostridium infection, severe, economic losses, livestock, poultry, industries, Vaccination, effective, control, Clostridial diseases, review, toxins, vaccine, development, pathogenic, Clostridium species, animals, Clostridium perfringens, Clostridium novyi, Clostridium chauvoei, Clostridium septicum, comprehensive study, review, clostridial toxins, vaccines, experimentally, description, vaccine, applications, disadvantages]]\n",
      "[[Clostridial myonecrosis, gas gangrene, lethal necrotizing, soft tissue infection, associated with, trauma, clostridial myonecrosis, parenteral injection, medications, Epinephrine, medication, gas gangrene, CASE REPORT A 60-year-old, man, Emergency Department, ED, right thigh, site, auto-injected epinephrine, multiple bee, stings, arrival, Initial, heart rate, beats/min, vital signs, unremarkable, presentation, pain, computed tomography, ordered, gas, anterior, compartment, right thigh, vastus lateralis, rectus femoris, necrotizing fasciitis, Antimicrobials, patient, surgical debridement, CT, results, Clostridium perfringens, cultured, patient's, tissue, surgical debridement's, antimicrobial therapy, supportive care, wound care, patient's, limb, intact, discharged, days, epinephrine auto-injectors, prescribed, yearly, United States, awareness, clostridial gas gangrene, epinephrine auto-injection, provider, decision-making, patients, extreme pain, redness, swelling, near, injection site, epinephrine, injection]]\n",
      "[[study, characterize, prevalence, genotypes, distribution, antibiotic resistance, genetic diversity, Clostridium perfringens, C. perfringens, stages, chicken, production, chain, samples, broiler farm, samples, slaughterhouse, large-scale rearing, slaughter, Weifang, China, samples, farm, samples, slaughterhouse, positive, C. perfringens, contamination, chicken products, rate, carcasses, positive, rate, carcass, samples, evisceration process, C. perfringens, contamination, isolates, C. perfringens, recovered, recovered, isolates, type A, isolates, Antimicrobial susceptibility testing, isolates, antibiotic resistance, resistant, classes, antibiotics, Multilocus sequence typing, results, isolates, isolates, sequences types, STs, isolates, clonal complexes, CCs, isolates, type A, genetic diversity, Simpson's diversity index, ST, isolates, farm stage, slaughter stage, ST, CC, chicken products, contaminated, ST, CC, C. perfringens, farm stage, contamination, rates, chicken products, antibiotic resistance, isolates, potential, public, health, risks, control measures, rearing, slaughtering stage, reduce, risk]]\n",
      "[[bacterium, Clostridium perfringens, severe, lethal gastrointestinal disorders, humans, enteritis, enterotoxemia, Type F strains, enterotoxin, CpE, foodborne illness, United States, CpE, induces, gut, breakdown, disrupting, barriers, cell-cell contacts, tight junctions, TJs, maintained, claudins, Targeted binding, CpE, claudins, encoded, C-terminal domain, TJ, barriers, molecular leaks, cells, Cytotoxicity, results, claudin-bound CpE, complexes, pores, cell membranes, mammalian, tissues, claudins, TJ, barriers-but, CpE's, targeting, claudins, gut, structure, human, claudin-4, complex, cCpE, enterotoxin, targets, motif conserved, receptive claudins, motif, high-affinity, binding, subtypes, structural, CpE, targeting, binding, affinities, kinetics, half-lives, claudin-enterotoxin complexes, cytotoxic, effects, CpE, claudin-expressing cells, correlating, binding residence, claudin-CpE complexes, claudin, expression, gut, primary, CpE receptors, mice, humans, sequence, changes, target, motif, findings, molecular, structural element, CpE, targeting, claudins, pathogenicity, C. perfringens, gut, framework, treat, CpE-based illnesses, domesticated, mammals, humans]]\n",
      "[[Foodborne diseases, FBDs, global, Climatic factors, wind-chill, temperature, rainfall, relative humidity, incidence, FBDs, study, factors, climate, influence, incidence, severity, FBDs, study, retrospectively, results, multiplex polymerase chain reaction, mPCR, diarrhea-causing bacteria, fecal samples, patients, Dankook University Hospital, Cheonan, Clostridioides difficile, toxin B infection, rate, positively, correlated, intensity, sunshine, content, particulate matter, Campylobacter spp., infection, positively, correlated, wind-chill, temperature, content, particulate matter, Escherichia coli, O157:H7, infection, rate, positively, correlated, relative humidity, findings, dynamics, risks, Clostridioides difficile, toxin B, Clostridium perfringens, Campylobacter spp, Escherichia coli, O157:H7, infection, interrelationships, climatic factors, national environmental health policies, research, large-scale data, molecular biology, epidemiology, research, indicators, changes, prevalence, FBD-causing, microbial, pathogens, effective, prevention, management, bacterial infections]]\n",
      "NaN\n",
      "[[Clostridium perfringens, pathogen, humans, livestock, wound infections, gas gangrene, clostridial myonecrosis, enteritis/enterocolitis, human, food-borne illnesses, enterotoxemia, toxins, intestine, absorbed, damage, brain, virulence, Gram-positive, spore-forming, anaerobe, copious, toxin, production, diverse, actions, infection, toxins, C. perfringens, toxin genes, encoded, conjugative plasmids, pCW3-like, pCP13-like plasmid, families, Production, C. perfringens, toxins, processes, two-component regulatory systems, quorum sensing, sporulation-related alternative sigma factors, Non-toxin factors, degradative enzymes, sialidases, pathogenicity, bacterium, factors, toxin, action, in vitro, in vivo, C. perfringens, intestinal, colonization, NanI, sialidase, increases, C. perfringens, adherence, intestinal tissue, nutrients, growth, in vitro, virulence, contributions, factors, adhesins, capsule, biofilms, study]]\n",
      "[[Gas gangrene, infectious disease, Clostridium perfringens, infection, rare, case, gluteal clostridial myonecrosis, intramuscular, injection, diclofenac, immunocompromised, young, patient, corticosteroid therapy, sepsis, clinical, severe, anaerobic infection, delayed diagnosis, treated with, aggressive, removal, necrosed, tissue, targeted, antibiotic therapy, improvement, application, negative-pressure wound therapy device, favorable outcome, report, diagnosis, imaging, surgical debridement, antibiotic therapy, treatment, negative-pressure wound therapy, accelerated, closure, incisions, tissue loss, adverse effects, complex, reconstructive procedures]]\n",
      "[[study, QMRA, quantitative, microbial, Clostridium perfringens, soy sauce, consumption, soy sauce, samples, markets, analyzed, detect, C. perfringens, Temperature, time, measured, transportation, display, soy sauce, primary model, fitting, Weibull model, C. perfringens, counts, soy sauce, delta, decrease, rho, shape, calculated, parameters, analyzed, Exponential model, secondary model, function, temperature, consumption amount, percentage, soy sauce, surveyed, dose-response model, data, simulation model, program, estimate, probability, C. perfringens, foodborne illness, soy sauce, consumption, C. perfringens, negative, samples, contamination, level, log CFU/ml, predictive, models, C. perfringens, decreased, transportation, display, average, consumption, percentage, soy sauce, simulation, probability, C. perfringens, foodborne illness, consumption, soy sauce, person, day, risk, C. perfringens, consumption, soy sauce, low, Korea]]\n",
      "[[Tetanus, rare, disease, Clostridium tetani, tetanolysin, tetanospasmin, tetanus, cases, Indonesia, vaccination, low-middle-income countries, tetanus, adults, lack, immunization, religious tenets, cultural belief, inaccessibility, medical care, tetanus, pediatric population, features, adult, group, case, girl, institution, history of falling, days, admission, skin laceration, forehead, day, admission, patient, drowsy, stiffness, jaw, diagnosed, unimmunized, child, open depressed, skull fracture, frontal bone, wound infection, complicated, lockjaw, Perioperative, management, rare, case, pediatric, intensive care, patients, halting, toxin, production, neutralization, circulating, toxin, control, clinical, manifestation, induced, toxin, central nervous system, anesthetic care, case, well-managed, planned, surgery]]\n",
      "[[positive, MRZ, reaction, intrathecal IgG, production, constituents, measles virus, M, rubella virus, R, varicella zoster virus, Z, detectable, patients, multiple sclerosis, MS, laboratory marker, specificity, positive, MS, M, R, Z, constituents, intrathecal, humoral immune response, MS, anti-microbial antibodies, inclusion, MRZ, increased, sensitivity, marker's, specificity, MS, antibody indices, AIs, viral, bacterial agents, M, R, Z, herpes simplex virus, Epstein-Barr virus, mumps virus, cytomegalovirus, parvovirus B19, Bordetella pertussis, Corynebacterium diphtheriae, Clostridium tetani, paired cerebrospinal fluid, serum samples, patients, MS, disease controls, positive, MRZ, reaction, MS, patients, positive, AIs, patients, MS, M, Z, R, parvovirus B19, mumps, parvovirus B19, mumps virus, MRZ panel, increase, sensitivity, MS, group, MRZ-negative, patients, MRZ panel, MS, AIs, positives, controls, diagnoses, migraine, vasculitis, AIs, median, AI, MS, group, parvovirus B19, measles virus, Inclusion, parvovirus B19, mumps virus, test panel, increase, sensitivity, discriminatory, MRZ, results, prospective studies, investigating, MRZ, panels, differential diagnosis, MS]]\n",
      "[[Tetanus, preventable disease, protein neurotoxin, Clostridium tetani, Spores, C. tetani, necrotic, wound, germinate, vegetative bacterium, releases, toxin, tetanus, neurotoxin, TeNT, TeNT, general circulation, binds, peripheral, sensory neurons, transported, retroaxonally, spinal cord, inhibitory, interneurons, blocks, release, glycine, GABA, spastic paralysis, review, metalloprotease activity, TeNT, trafficking, localization, vertebrate body, nature, sequence, appearance, symptoms, tetanus]]\n",
      "[[Clostridium tetani, tetanus toxin, TeNT, bacterial, toxins, humankind, tetanus, regulation, toxin, expression, complex, alternative sigma factor, TetR, regulators, transcriptional analysis, TeNT-encoding, plasmid, C. tetani, identified, sRNA, untranslated region, tent gene, northern blot experiment, sRNA, size, nucleotides, Sequence analysis, sRNA, 14-nucleotide region, tent, investigate, function, sRNA, RNA, targeting, sRNA, C. tetani, wild-type, strains, antisense, C. tetani, strains, increase, extracellular, TeNT, production, wild-type, strains, recombinant C. tetani, strains, tent-locus, plasmids, sRNA, tent-locus, sRNA, C. tetani, strain, lacking, wild-type, TeNT-encoding, plasmid, TeNT, production, strain, recombinant tent-locus, sRNA, expression, effect, sRNA, modulated, C. tetani, genetic background, wild-type, TeNT-encoding, plasmid, recombinant strains, modulated, growth patterns, characterized, premature bacterial cell lysis, data, sRNA, negative, regulator, TeNT, synthesis, impact, growth, C. tetani, sRNA, toxin, levels, exponential growth phase, premature]]\n",
      "[[Clostridium tetani, life-threatening, disease, tetanus, neurotoxin, TeNT, toxic, protein substances, Toxicosis, prevented, cured, administration, anti-TeNT neutralizing antibodies, identified, monoclonal antibodies, mAbs, memory B cells, healthy, adult, immunized, C-terminal domain, TeNT, TeNT-Hc, mAbs, tetanus toxoid, TT, TeNT-Hc, mAbs, TT, VH3, germline gene, TT-binding mAbs, pairwise identity values, VH gene sequences, mAbs-T3, T7, T9, 6-completely, mice, LD50, TeNT, T2, T18, prolonged, survival time, mAbs, epitopes, TT, binding, affinities, study, therapeutic, tetanus]]\n",
      "[[hypothesis, scientific community, clinical trials, public, control, pandemic, Tetanus, vaccination, reduced, severity, COVID-19, infection, urge, research, effectiveness, tetanus, vaccine, COVID-19, hypothesis, artificial intelligence system, public, biomedical, datasets, scientific rigor, data, artificial intelligence system, document, provenance, methodology, hypothesis, relevant, data/evidence, studies, correlations, causation, correlations, sources, coincidence, investigation]]\n",
      "[[Tetanus, vaccine-preventable disease, endemic, countries, cases, tetanus, unvaccinated, individuals, case, young, goat herder, benzodiazepine, muscle relaxants, Magnesium sulphate, inadequate control, patient, improved, case, farmer, magnesium sulphate, benzodiazepine, clinical recovery, case, cases, pharmacological options, management, generalized tetanus, magnesium sulphate]]\n",
      "[[Tetanus, acute onset neurological disease, lethal, burden, low, middle-income countries, Tetanus, toxin, spores, bacterium, Clostridium tetani, soil, dust, animal, feces, toxin, impairs, motor neurons, muscle stiffness, development, toxoid vaccine, incidence, declined, vaccine-preventable disease, treatment, tetanus, supportive, complications, effects, toxins, CASE REPORT, report, case, farmer, sustained, laceration injury, days, emergency department, abdominal pain, rigidity, comprehensive, evaluation, items, differential diagnoses, diagnosed, tetanus, clinical symptoms, mechanical ventilation, patient, intensive care unit, uneventful, recovery, case, presentation, tetanus, latency, infectious process, patients, atypical, symptoms, diagnostic dilemma, clinicians, history, contaminated injury, case, prophylactic vaccine, low, middle-income countries, disease-related, mortality, morbidity]]\n",
      "[[Tetanus, fatal disease, Clostridium tetani infections, infections, toxoid vaccine, humans, animals, vaccine, World Health Organisation list, Essential Medicines, administered, US, Dollar per dose, developments, analytical tools, frameworks, systems, biology, industry, parameters, C. tetani, virulence, physiological behaviour, bioreactors, fermentation, process, fermentation, supplemented, amino acids, experiment, amino acid catabolism, virulence, C. tetani, amino acids, growth, decreased, toxin, production, changed, C. tetani, morphology, transcriptomics, fermentation map, tetanus toxin, transcriptional regulator, BotR, P21, tetanus toxin gene, downregulated, analysis, potential, genes, C. tetani, virulence regulation, differential, expression, genes, cell separation, surface/cell adhesion, pyrimidine biosynthesis, salvage, flagellar motility, prophage genes, fermentation map, free, amino acid, concentrations, virulence, C. tetani, transcriptional, level, metabolic functions]]\n",
      "[[Tetanus, gastrointestinal surgery, rare, disease, infection, Clostridium tetani, Tetanus, bacterial infection, surgery, dressing change, bacteria, patient's, intestines, discharged, feces, report, woman, tetanus 3, days, hemorrhoidal ligation, Clinicians, symptoms, C. tetani, infection, patients, gastrointestinal procedures]]\n",
      "[[Membranous tonsillitis, infection, palatine tonsils, exudation, crypts, coalesce, membrane, tonsillar, surface, stage, acute follicular tonsillitis, etiologies, membrane formation, tonsils, cause, scenario, Corynebacterium diphtheriae, year, prospective study, patients, membranous tonsillitis, tertiary referral centre, North-East India, history, clinical examination, investigations, patients, conservatively, patients, tracheostomy, year, study, patients, acute membranous tonsillitis, males, females, cases, years, age, lower, socioeconomic group, Assam belt, cases, months, January, prospective study, etiologies, acute membranous tonsillitis, presentation, management, outcome, patients, mortality, morbidity, study, diphtheria, Indian, scenario, implementation, vaccination programs, cases, prevent, outbreaks]]\n",
      "[[request, European Commission, Panel, Additives, Products, Substances, Animal Feed, FEEDAP, scientific opinion, safety, efficacy, feed, additive, l-valine, fermentation, non-genetically modified strain, Corynebacterium glutamicum, CGMCC, additive, feed, water, drinking, animal species, categories, production, strain, presumption, safety, QPS, safety, assessment, FEEDAP, l-valine, C. glutamicum CGMCC, target, species, supplemented, diet, nutritional, target, species, FEEDAP, concerns, amino acids, water, drinking, hygienic reasons, risk, imbalances, administered, simultaneously, feed, l-valine, C. glutamicum CGMCC, animal, nutrition, consumer, environment, potential, l-valine, C. glutamicum CGMCC, toxic, inhalation, irritant, skin, eyes, dermal, sensitiser, lack, data, l-valine, fermentation, C. glutamicum CGMCC, efficacious, essential, amino acid l-valine, non-ruminant, nutrition, l-valine, efficacious, ruminants, non-ruminant species, protection, degradation, rumen]]\n",
      "[[request, European Commission, Panel, Additives, Products, Substances, Animal Feed, FEEDAP, scientific opinion, safety, l-lysine monohydrochloride, l-lysine sulfate, Corynebacterium glutamicum CCTCC M, animal species, FEEDAP Panel, opinion, safety, efficacy, products, assessment, Panel, safety, additives, target, species, consumers, environment, uncertainties, genetic modification, strain, production, strain, C. glutamicum, CCTCC M 2015595, presence, viable cells, DNA, production, strain, products, absence, data, FEEDAP, safety, additives, users, applicant, data, strain, production, strain, assessment, uncertainties, origin, history of, modification, genetically, modified, production, strain, C. glutamicum, CCTCC M, presence, antimicrobial resistance, toxin, virulence factors, genes, cells, DNA, production, strain, detected, formulations, l-lysine, HCl, l-lysine sulfate, safety, concerns, production, strain, FEEDAP, l-lysine, HCl, l-lysine sulfate, C. glutamicum, CCTCC M 2015595, target, species, consumers, environment, data, safety, additives, users, conclusions, Panel, absence, data, safety, additives, user]]\n",
      "[[Corynebacterium glutamicum, synthetic, biological, biomanufacturing, bioremediation, genetic manipulation, C. glutamicum, genetic parts, elements, replicons, promoters, reporter genes, selectable markers, characterized, continuous, improvement, molecular genetic manipulation techniques, allelic exchange, single/double-crossover, nuclease-mediated site-specific recombination, RecT-mediated single-chain recombination, actinophages, integration, transposition mutation, accelerated, molecular study, C. glutamicum, gene editing tools, CRISPR/Cas system, pattern, genetic manipulation, C. glutamicum, gene reprogramming, insertion, deletion, replacement, point mutation, efficient, review, progress, molecular genetic manipulation, development, C. glutamicum, bottlenecks, perspectives, research, C. glutamicum, microbial, chassis]]\n",
      "[[study, clinical, microbiological, characteristics, Corynebacterium bacteremia, hematological, patients, retrospectively, reviewed, medical records, patients, Corynebacterium bacteremia, causative, Corynebacterium species, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Drug susceptibility tests, broth microdilution method, Clinical, cases, Corynebacterium bacteremia, study, period, Corynebacterium striatum, frequent, pathogen, Catheter-related bloodstream infection, diagnosed, patients, moderate/severe oral, severe, gastrointestinal mucosal, detected, Polymicrobial infection, cases, Enterococcus faecium, frequent, isolate, mortality, Multivariate analysis, E. faecium, co-infection, odds ratio, OR, confidence interval, CI, systemic corticosteroids, OR, CI, immunosuppressive drugs, OR, CI, Pitt bacteremia score, OR, CI, risk factors, mortality, drug susceptibility, rates, beta-lactam antimicrobial agents, low, isolates, susceptible, glycopeptides, linezolid, C. striatum, isolates, resistant, daptomycin, Corynebacterium bacteremia, presence, mucosal impairment, drug susceptibility, data, Corynebacterium bacteremia, hematological, patients, treated, glycopeptides, linezolid]]\n",
      "[[Corynebacterium striatum, nosocomial pathogen, associated with, infections, immunocompetent, immunocompromised, patients, virulence factors, mechanisms, establishment, long-term, survival, Corynebacterium striatum, hospital environment, study, investigated, multidrug-resistant, C. striatum, clinical, isolates, human, epithelial cells, biofilm, polystyrene plates, glass, tracheostomy tubes, tested, virulence, strains, nematode, Caenorhabditis elegans, adhesion, epithelial, infection, C. striatum, biofilms, positively, negatively, abiotic, surfaces, degrees, infect, kill, Caenorhabditis elegans, days, infection, virulence, condition, associated with, presence, SpaDEF operon, encoding, pili, strains, study, virulence, mechanisms, persistence, C. striatum, hospital environment, increasing, probability, nosocomial infections]]\n",
      "[[development, systems, synthetic biology, non-model bacteria, Halomonas spp., cost-competitive, products, polyesters, chemicals, proteins, contamination, resistance, ability, cell density growth, alkaline, pH, salt, concentration, salt-loving microbes, industrial, CIB, sterilization, prevent, contamination, CIB, chassis, Escherichia coli, Bacillus subtilis, Pseudomonas putida, Corynebacterium glutamicum, status, Halomonas spp, molecular biology, metabolic engineering, applications, reviewed, systematic strain engineering, product-based host development, genetic parts, mining, static, dynamic, optimization, modularized pathways, bioprocess-inspired cell engineering, developments, result, next-generation industrial biotechnology, NGIB, cell factories, powered, synthetic biology, biomanufacturing strategy, open, continuous processes, cost-reduction, process, complexity, energy, substrates, fresh, water, consumption]]\n",
      "[[Host-pathogen interactions, in vitro, primary, immortal cell lines, ethical problems, animal testing, lower, costs, influence, cell culture media, bacterial growth, metabolism, investigated, cases, growth, proteome, adaptation, Corynebacterium diphtheriae strain ISS3319, investigated, study, Bacteria, cultured, standard, growth medium, cell culture medium, fetal calf, serum, Mass spectrometric analyses, label-free protein, quantification, increased, bacterial, pathogenicity, cell culture medium, influence, growth medium, cell envelope]]\n",
      "[[Gram-positive bacteria, pili, fimbriae, surfaces, host, tissues, polymicrobial, interactions, hair-like structures, tensile, strengths, protein components, pilins, covalently crosslinked, lysine-isopeptide bonds, pilus-specific sortase, enzymes, atomic structures, isolated, pilins, sortases, interpilin crosslinks stabilize, pilus structure, reconstituted pilus, hybrid structural biology methods, solution, structure, dynamics, crosslinked, prototypical, SpaA pilus, Corynebacterium diphtheriae, sortase-catalyzed introduction, K190-T494 isopeptide bond, adjacent, SpaA pilins, rigid interface, LPLTG, sorting signal, binding groove, Cellular, quantitative, crosslinking reaction, shed light, mechanism, pilus biogenesis, pilus-specific sortase, C. diphtheriae, latch, mechanism, K190, SpaA, crosslinking, sorting signal, transferred, enzyme, binding groove, SpaA, catalysis, process, SpaA, crosslinking, latch, K190-T494 isopeptide bond, General features, structure, sortase-catalyzed assembly, mechanism, SpaA pilus, Gram-positive bacteria]]\n",
      "[[study, development, electrochemical genosensor, detection, tox gene fragment, toxigenic, Corynebacterium diphtheriae strain, studies, fast, accurate, diagnostic, diphtheria, early stage, infection, electrochemical methods, DNA sensor, potentially, portable device, electrochemical stem-loop probe, structure, optimization, conditions, real asymmetric PCR, aPCR, detection, magnesium, organic, solvent, concentrations, detection buffer, optimal, conditions, detect, sensitivity, biosensor, response, electrode, diethyldithiocarbamate, application, electrochemical genosensors, values, biosensor, response, conditions, magnesium ion, depletion, biosensor, selectivity, samples, genetic material, non-target, bacterial species, human, upper respiratory tract]]\n",
      "[[Diphtheria, respiratory disease, bacterium, Corynebacterium diphtheriae, development, toxin-based vaccine, level, control, disease, cases, increased, years, genomic variation, C. diphtheriae, isolates, countries, territories, years, core gene, phylogeny, presence, antimicrobial resistance genes, variation, tox gene, tox(+, isolates, diverse, clusters, C. diphtheriae, phylogeny, isolates, multiple countries, regions, time, isolation, antimicrobial resistance genes, antibiotic resistance, identified, analysed, tox gene, variants, mutations, estimated, medium, structural, impact]]\n",
      "[[Controlled RNA degradation, process, bacterial cell, biology, transcriptome, homeostasis, adaptation, environments, mRNA, turnover, Gram-positive bacteria, ribonuclease, RNase J, RnJ, process, diphtheria-causative pathogen, Corynebacterium diphtheriae, identity, ribonuclease, organism, C. diphtheriae DIP1463 encodes, RnJ homolog, N-terminal beta-lactamase domain, beta-CASP, C-terminal domains, recombinant protein, beta-lactamase domain, 5'-exoribonuclease activity, alanine-substitution, catalytic residues, His(186), His(188), deletion, DIP1463/rnj, C. diphtheriae, reduces, bacterial growth, cell, shape, abnormality, augmented, cell width, RNA-seq, RnJ, controls, regulon, encoding, factors, biosynthesis, regulation, transport, iron acquisition, upregulated, gene, rnj mutant, ftsH, coding, membrane protease, FtsH, cell division, overexpression, wild-type strain, cell-width augmentation, rnj mutant, severely, attenuated, virulence, Caenorhabditis elegans, model, infection, FtsH-overexpressing, toxin-less strains, virulence, wild-type strain, RNase J, ribonuclease, C. diphtheriae, post-transcriptionally, influences, expression, factors, corynebacterial, cell, physiology, virulence, findings, biological processes, mechanisms, corynebacterial, pathogenesis]]\n",
      "[[diphtheria, outbreak, children, median, years, years, religious minority, urban India, Case-fatality rate, unimmunized, patients, relative risk, CI, immunization, school health programs, reemergence]]\n",
      "[[Background, Diphtheria, fatal, toxigenic, bacterial infection, Corynebacterium diphtheriae, C. diphtheriae, Isolation, C. diphtheriae, lacking, sensitivity, Elek's test, detect, toxin, production, difficulties, associated with, application, Duplex real-time PCR, throat swab, suspected, diphtheria, patients, detect, bacteria, toxin-encoding genes, simultaneously, faster, sensitivity, specificity, Materials, Methods, consecutive, throat swabs, suspected, diphtheria, patients, Sulianti Saroso Infectious Disease Hospital, Jakarta, primers, probes, targeting, rpoB gene, C. diphtheriae, A-subunit, diphtheria toxin gene, study, Parameters, annealing temperature, concentration, primers, probes, inhibitors, cross-reaction, detection, optimized, Elek's toxigenicity test, clinical data, analyzed, comparison, optimum, temperature, degrees, concentrations, Cd primer, Tox primer, Cd probe, Tox probe, DNA elution, template, volumes, microL, detection, cross-reaction, microorganisms, samples, duplex real-time PCR, results, standard test, patients, diagnosed, diphtheria, Duplex real-time PCR, increases, rate, laboratory diagnosis, diphtheria, standard method, detect, toxigenic, C. diphtheriae]]\n",
      "[[Infective endocarditis, disease, mortality rates, pediatric population, case, infant, patient, multiple, vegetation, tricuspid valve, secondary to, infective endocarditis, Corynebacterium diphtheriae, tricuspid valvuloplasty, fenestrated autologous pericardium patch, outcomes, technique, innovative, effective, cases]]\n",
      "[[Foam cells, cellular components, atherosclerotic, plaques, trace, periodontal pathogens, identified, studies, findings, correlation, periodontitis, atherosclerotic, cardiovascular, incidences, evidence, experimental studies, periodontal pathogens, cellular signaling, cardiovascular, events, periodontal pathogens, pathogenesis, atherosclerosis, evolution, macrophages, foam cells, monitored, pattern, lipid, accumulation, macrophages, presence, periodontal pathogens, characterization, lipids, investigation, molecules, lipid homeostasis, cells, stained, lipophilic, fluorescent dye BODIPY, Oil Red O, lipid profile, Oil Red O-positive droplets, neutral lipids, fluorescent lipid, aggregates, increased, periodontal pathogen-infected macrophages, analysis, locate, lipids, endoplasmic reticulum, levels, cholesteryl ester, periodontal pathogen-infected macrophages, increased, disrupted, lipid homeostasis, investigations, messengers, regulatory factors, lipid homeostasis, alterations, cholesterol, efflux-related enzymes, ABCG1, CYP46A1, foam cell, increased, Ca(2+) signaling, reactive oxygen species, ROS, production, events, disrupted, lipid homeostasis, treatment, periodontal pathogen-infected macrophages, ROS, inhibitors, nifedipine, attenuated, accumulation, lipid droplets, periodontal pathogen-induced, Ca(2+), ROS, signaling, dysregulation, lipid homeostasis, regulatory events, evolution, macrophages, foam cells]]\n",
      "[[AIM, necroptosis, apical periodontitis, AP, study, investigated, necroptosis, Fusobacterium nucleatum, AP, model, Balb/c mice, intracellular, signaling pathways, L929 cells, affected, Fn, in vivo, experiments, expression, receptor-interacting protein kinase-3, RIP3, inhibited, adeno-associated virus, Balb/c mice, model, AP, injecting, Fn, root canal, mandibular molars, Bone loss, osteoclasts, measured, micro-computed tomography, tartrate-resistant acid phosphatase staining, expression, RIP3, phosphorylated, pMLKL, detected, immunohistochemistry, western blotting, expression, mRNA, inflammatory cytokines, evaluated, quantitative real-time polymerase chain reaction, qRT-PCR, in vitro, experiments, L929 cells, transfected, RIP3-Mus-siRNA, negative, siRNA, co-cultured, Fn, western blotting, detection, cell death, viability, qRT-PCR, analyses, assess, activation, necroptosis pathway, expression, mRNA, inflammatory cytokines, Data, analysed, unpaired t-test, one-way analysis of variance, significance set, Fn-induced, apical bone loss, increased, osteoclasts, enhanced, expression, pMLKL, increased, mRNA, levels, inflammatory, cytokines(IL-1alpha, IL-1beta, effects, RIP3, inhibition, L929 cells, infected, Fn, increased, expression, pMLKL, increased, decreased, cell viability, transfection, RIP3-Mus-siRNA, decreased, mRNA, expression, inflammatory, cytokines(TNF-alpha, IL-6, Necroptosis, AP, progression, RIP3, inhibition, ameliorated, expression, inflammatory cytokines, bone resorption, Fn-induced, AP, lesions, Balb/c mice]]\n",
      "[[enzyme L-methionine-gamma-lyase, bacteria, catalyzes, alpha-elimination, gamma-elimination, L-methionine, methyl mercaptan, alpha-ketobutyrate, ammonia, Black cumin, BC oil, deodorizing, activity, methyl mercaptan, BC, oil, suppress, methyl mercaptan, production, study, evaluate, inhibitory, effect, BC oil, L-methionine-gamma-lyase activity, Fusobacterium nucleatum, Recombinant L-methionine-gamma-lyase, incubated, appropriate, conditions, BC oil, thymoquinone, L-methionine-gamma-lyase activity, alpha-ketobutyric acid, ammonia, concentrations, concentrations, alpha-ketobutyric acid, ammonia, decreased, mL-1, BC oil, mL-1, thymoquinone, enzyme kinetic assay, inhibition, L-methionine-gamma-lyase, thymoquinone, BC oil, deodorizing, effect, methyl mercaptan, inhibitory, methyl mercaptan, production, suppression, L-methionine-gamma-lyase activity, Thymoquinone, effects, BC oil, application, natural, oil, medical use, life]]\n",
      "NaN\n",
      "[[Changes, oral microbiome, Fusobacterium nucleatum, associated with, oral squamous cell carcinoma, OSCC, F. nucleatum, local, immunity, cancers, assess, association, intratumoral, F. nucleatum, clinico-pathological features, relapse, overall survival, OS, cohorts, patients, OSCC, immune-related genes, retrospectively, analyzed, tissue samples, cohort, patients, head, OSCC, cohort, cohort, OSCC, cohort, sensitivity, analysis, merged, cohort, OSCC, patients, F. nucleatum, 16S rRNA, gene sequences, quantified, real-time quantitative PCR, gram-negative bacteria, macrophages, LPS, CD163, immunostainings, F. nucleatum, positivity, associated with, older age, alcohol, combined, alcohol plus, tobacco consumption, frequent, lymph node invasion, recurrence, F. nucleatum-positive cases, metastatic, relapses, nucleatum-negative tumors, OS, relapse-free, metastasis-free survival, F. nucleatum, status, associated with, OS, multivariate analysis, Immune-related gene, immunohistochemistry analyses, gram-negative bacteria, load, inversely, correlated, M2 macrophages, OSCC, immune microenvironment, frequent, older, non-drinking, patients, associated with, prognosis]]\n",
      "[[OBJECTIVE, Fusobacterium nucleatum, oral pathogen, endodontic infections, study, assess, frequency, Fusobacterium nucleatum, primary, secondary, endodontic infections, associations, clinical features, Brazilian population, culture, nested PCR methods, microbial, samples, patients, primary, secondary, endodontic infections, analyzed, culture, nested PCR methods, anaerobic techniques, culture, identification, F. nucleatum, DNA, samples, analyzed, presence, target, species, species-specific primers, Culture, nested PCR methods, detected, F. nucleatum, root canals, F. nucleatum, isolated, culture, root canals, primary infections, root canal, secondary/persistent infections, Nested PCR, detected, F. nucleatum, root canals, primary infections, root canals, secondary/persistent endodontic infections, F. nucleatum, associated with, spontaneous pain, tenderness, percussion, pain, palpation, swelling, tooth mobility, wet root canals, hemorrhagic exudate, tooth decay, inadequate, restoration, endodontic filling, F. nucleatum, cases, primary, endodontic infections, cases, secondary/persistent ones, prevalence, F. nucleatum, detected, nested PCR method, culture, F. nucleatum, root canals, associated with, clinical features, prevalence, F. nucleatum, root canals, detected, molecular methods, association, clinical features, species, development, apical pathologies, endodontic treatment, bacterial, elimination]]\n",
      "[[Colorectal cancer, CRC, cancers, worldwide, cancers, CRC, multifactorial disease, effect, genetic, environmental factors, cases, sporadic, proportion, hereditary, estimated, tumor, heterogeneous, endothelial, stromal, immune cells, secreting, signals, cytokines, chemokines, growth factors, favorable, tumor, microenvironment, cancer cell invasion, metastasis, evidence, inflammatory processes, carcinogenesis, tumor progression, CCR, profiles, cell activation, tumor, microenvironment, promote, pro, anti-tumor pathways, target, control, cancer progression, intestinal mucosa, contact, microorganism, community, bacteria, bacteriophages, viruses, archaea, fungi, gut microbiota, Aberrant, composition, microbiota, alteration, diet-derived, microbial, metabolites, content, butyrate, polyamines, environmental compounds, CRC, bacteria, pks+ Escherichia coli, Fusobacterium nucleatum, colorectal carcinogenesis, pathomechanisms, induction, genetic mutations, epithelial cells, modulation, tumor, microenvironment, Epithelial, immune cells, intestinal mucosa, Pattern-recognition receptors, G-protein coupled receptors, receptor, butyrate, activation, intestinal microbiota, metabolites, review, dynamics, gut microbiota, metabolites, tumor, microenvironment, interplays, sporadic, hereditary CRC, modulating, tumor progression]]\n",
      "[[Bacterial infection, tumor development, malignant, progression, Fusobacterium nucleatum, F. nucleatum, oral squamous cell carcinoma, molecular bases, F. nucleatum, report, F. nucleatum, down-regulates, p53, E-cadherin, Wnt/NFAT pathway, cisplatin-resistance, migration, oral squamous carcinoma cells, pretreated, Cal-27, HSC-3 cells, F. nucleatum, survival rates, cysplatin, Cis-diamminedichloroplatinum, CDDP, treated cells, expressions, migration, apoptosis-related proteins, E-cadherin, p53, western blot analysis, F. nucleatum, activator, Wnt/NFAT pathway, expression, levels, Wnt pathway, wnt5a, Nuclear factors, activated T cells 3, NFATc3, treated cells, inhibition, effect, NFAT-inhibitory peptide, VIVIT, expressions, E-cadherin, p53, response, F. nucleatum infection, up-regulated, reversely, F. nucleatum, promote, cisplatin-resistance, migration, oral squamous cell carcinoma, cells, Wnt/NFAT pathway]]\n",
      "[[OBJECTIVE, bottleneck, plasmid, instability, microbial, fermentation, L-DOPA, recombinant, Escherichia coli, expressing, heterologous, tyrosine phenol lyase, tyrosine phenol lyase, Fusobacterium nucleatum, constitutively, expressed, E. coli, fed-batch fermentation, process, temperature, cultivation, Efficient, strategies, ampicillin, resistance gene, cer site, active, plasmid, multimers, result, plasmid, stability, increased, cer site, plasmid, kanamycin, culture medium, proportion, plasmid, cells, maintained, fermentation, activity, tyrosine phenol lyase, volumetric, activity, increased, L-DOPA, biosynthesis, plasmid, stability, promoted, applicability, recombinant cells, L-DOPA, production, guidance, industrial, fermentation, microbial, productivity]]\n",
      "[[Corynebacterium silvaticum, animal, pathogen, forest, animals, roe deer, wild boars, species, human, pathogen, Corynebacterium ulcerans, animal, pathogen, Corynebacterium pseudotuberculosis, study, Corynebacterium silvaticum strain W25, characterized, interaction, human cell lines, Microscopy, measurement, transepithelial, electric resistance, cytotoxicity assays, detrimental effects, C. silvaticum, human, epithelial cell lines, invertebrate, Galleria mellonella, larvae, diphtheria toxin-secreting C. ulcerans, results, zoonotic, potential, species]]\n",
      "[[study, microbiological, epidemiological, toxigenic, nontoxigenic, isolates, national reference laboratory, Spain, situation, improve, knowledge, pathogens, Epidemiological, information, Spanish Surveillance System, Microbiological, molecular characterization, phenotypic methods, multilocus sequence typing, MLST, whole-genome sequencing, WGS, core genome MLST, cgMLST, isolates, analyzed, isolates, Corynebacterium diphtheriae, toxigenic, C. belfantii, C. ulcerans, toxigenic, C. rouxii, C. diphtheriae, isolate, nontoxigenic tox gene, NTTB, Ages, patients, years, nontoxigenic, toxigenic, isolates, children, years, patients, males, nontoxigenic, toxigenic, MLST, identified, sequence types, STs, Spain, WGS, analysis, isolates, toxigenic, isolates, antibiotic resistance genes, prevalence, penicillin, resistance, phenotypically, Phylogenetic analysis, isolates, family members, Risk information, toxigenic, isolates, patients, countries, endemicity, contact with, cats/dogs, unvaccinated, child, respiratory diphtheria, fatal, outcome, nontoxigenic, Corynebacterium infections, disease surveillance, WGS, surveillance]]\n",
      "[[molecular typing, Corynebacterium ulcerans, isolate, woman, died, Japan, Genomic DNA modification, affected, isolate, ribotyping profile, Multilocus sequence typing results, sequence type 337, accurate, Whole-genome sequencing, discriminate, lineages, high resolution]]\n",
      "[[Corynebacterium ulcerans, pathogen, severe, diseases, humans, animals, draft, genome, C. ulcerans, strains, isolated, Austria, draft genomes, bp, encoding, RNAs]]\n",
      "[[Respiratory illness, Corynebacterium diphtheriae, C. ulcerans, diphtheria, anti-toxin, United States, Respiratory diphtheria, toxin-mediated disease, Corynebacterium diphtheriae, Diphtheria-like illness, clinically, diphtheria, C. ulcerans, zoonotic bacterium, diphtheria toxin, United States, respiratory diphtheria, notifiable, specimens, suspected, cases, Centers for Disease Control (CDC, species, toxin, confirmation, diphtheria, antitoxin, DAT, CDC, treatment, epidemiology, respiratory diphtheria, diphtheria-like illness, DAT, United States, respiratory diphtheria, cases, National Notifiable Diseases Surveillance System, NNDSS, C. ulcerans-related diphtheria-like illness, identified, specimen, submissions, CDC, reviewed, DAT, requests, respiratory diphtheria, cases, NNDSS, cases, toxigenic, non-toxigenic, C. diphtheriae, culture, Elek, culture-negative, PCR-positive, diphtheria toxin gene, culture-positive, testing, tested, tested, negative, cases, respiratory diphtheria-like illness, toxigenic, C. ulcerans, identified, DAT, healthcare providers, suspected, diphtheria, cases, average, requests, year, year, Respiratory diphtheria, rare, United States, requests, DAT, declined, Incidental, identification, C. ulcerans-related diphtheria-like illness, surveillance, condition]]\n",
      "[[Corynebacterium silvaticum, animal, pathogen, human, pathogen, Corynebacterium ulcerans, Corynebacterium pseudotuberculosis, pathogen, small ruminants, study, proteins, whole cell, shaving fraction, exoproteome, C. silvaticum strain W25, analyzed, proteome, study, species, proteins, proteins, encoded, W25 genome sequence, putative virulence factors, detected, standard, growth, phospholipase D, sialidase, uncharacterized, trypsin-like protease, secreted, protein, species, pathogenicity, proteome, analyses, study, taxonomical, C. silvaticum, zoonotic, Corynebacterium species]]\n",
      "[[Diphtheria, diphtheria-toxin-producing strains, Corynebacterium diphtheriae, Corynebacterium ulcerans, first-line, antibiotic, penicillin, erythromycin, susceptibility, data, WT, MIC, distributions, antimicrobial agents, data, determination, epidemiological, cut-off values, TECOFFs, toxigenic, corynebacteria, evaluate, usefulness, gradient test, Etest, susceptibility testing, penicillin, erythromycin, clindamycin, human, veterinary, isolates, period, MICs, antimicrobial agents, Etest, performance, evaluated, penicillin, erythromycin, clindamycin, MIC, distributions, characterized, TECOFFs, antibiotic/species combinations, EUCAST, clinical breakpoints, Corynebacterium species, C. diphtheriae, C. ulcerans, WT, MIC, distributions, penicillin, clindamycin, susceptibility testing, C. diphtheriae, C. ulcerans, difficult, erythromycin, C. diphtheriae, C. ulcerans, MICs, higher, WT, isolates, detectable, resistance, antibiotics, rare, Etest, MICs, penicillin, lower, concentrations, erythromycin, clindamycin, Etest, MIC, distributions, reference broth microdilution, toxigenic, Corynebacterium spp, agents, TECOFFs, C. diphtheriae, C. ulcerans, Corynebacterium pseudotuberculosis, isolates, low]]\n",
      "[[infection, companion, animals, zoonotic, pathogen, Corynebacterium ulcerans, prevalence, clinically-affected, healthy, animals, clinical presentation, treatment, cases, C. ulcerans, infection, studies, C. ulcerans, prevalence, rates, prospective study, nasal samples, healthy animals, dogs, cats, retrospective analysis, records, nasal samples, period, dogs, cats, affected, respiratory signs, Toxigenic C. ulcerans, isolated, cats, nasal discharge, concurrent, C. ulcerans, mecC methicillin-resistant, S. aureus infection, detected, dog, suffering, chronic nasal discharge, Clinical features, cases, antimicrobial treatment, Multilocus sequence typing, source, isolates, shelter cats, Carriage, rates, C. ulcerans, healthy animals, dogs, cats, animals, signs, upper respiratory tract infection, prevalence, rates, dogs, cats, Clinicians, dogs, cats, infected, carriers, toxigenic, C. ulcerans, potential, zoonotic, assistance, medical, public health, cases]]\n",
      "[[Respiratory diphtheria, characterized, adherent, pseudomembrane, toxin-producing strains, Corynebacterium diphtheriae, illness, toxigenic, Corynebacterium ulcerans, rarely, Corynebacterium pseudotuberculosis, diphtheria, laboratory, confirmation, culture methods, toxigenicity, real-time PCR, RT-PCR, detect, toxin gene, tox, Nontoxigenic tox-bearing (NTTB, Corynebacterium, isolates, impact, isolates, accuracy, molecular diagnostics, characterized, triplex, RT-PCR, assay, detect, tox, C. diphtheriae, species, C. ulcerans, C. pseudotuberculosis, sensitivity, specificity, assay, assessed, comparison, culture, characterized, microbial, isolates, triplex assay, Corynebacterium, isolates, accurately, analytical sensitivity, targets, isolates, tox, Diph_rpoB, CUP_rpoB, targets, NTTB, Corynebacterium, isolates, nontoxigenic isolates, tested, detected, RT-PCR, Whole-genome sequencing, NTTB, isolates, mutations, toxin, production, isolates, mutation, tox, promoter region, Corynebacterium RT-PCR method, isolates, diphtheria, cases, specimens, sporadic, occurrence, NTTB, isolates, diphtheria, culture diagnostics, accurate, case confirmation]]\n",
      "[[genus, Corynebacterium, species, biotechnological, medical, veterinary, atypical, C. ulcerans, strain, W25, isolated, case, necrotizing lymphadenitis, wild boar, study, analysed, genome sequence, strain, compared, phenotypic, virulence, properties, corynebacterial, pathogens, Phylogenomic analyses, strain W25, novel, species, PO100/5, KL1196, strains, isolated, pig, roe deer, species, associated to, animals, isolate, non-toxigenic tox gene, strain, abilities, pharyngeal, laryngeal, potential, loss, gene functions, spaBC, spaDEF pilus gene, corynebacterial, virulence genes, pld encoding phospholipase D., strain, severe, invasive infections, animals, zoonotic infections, humans]]\n",
      "[[Coxiella burnetii, gram-negative bacterium, lives, multiplies, monocytes, macrophages, host, etiologic agent, zoonosis, Q fever, Q fever, acute, chronic forms, percentage, patients, asymptomatic, spectrum, disease, neurological, involvement, rare, peripheral neuropathy, mononeuritis multiplex, presentations, low, rates, occurrence, case, male, fever, multiple mononeuritis, Q fever, short review, C. burnetii, infection]]\n",
      "[[reports, Q fever, horse populations, study, detect, C. burnetii, infection, serologic, molecular confirmation, ELISA kit, real-time PCR, East, Iran, endemic, blood samples, vaginal swabs, horses, East, Iran, sera samples, analyzed, anti C.burnetii Ig G antibodies, ELISA kit, nucleic acid, extraxted, vaginal samples, C. burnetii, DNA, real-time PCR assay, Antibodies, detected, sera, samples, C. burnetii, DNA, detected, horse, vaginal samples, no significant, seroprevalence, sex, age, breed, groups, study, horses, mild, reservoir, C. burnetii, effective, horse, health status, studies, assess, horse, relevant, transmission, indicator, Q fever]]\n",
      "[[research, prevalence, Coxiella burnetii, tank milk, industrial, dairy farms, central, eastern European region, survey, estimate, prevalence, IgG, antibodies, C. burnetii, infection, dairy farm, workers, risk factors, Serum samples, veterinarians, inseminators, animal caretakers, milking, parlor workers, herd managers, working, dairy farms, tested, presence, IgG, phase I, phase II, C. burnetii, indirect, microimmunofluorescence assay, Antibodies phase II, C. burnetii, detected, individuals, tested, occupational groups, C. burnetii, infection, Veterinarians, inseminators, animal caretakers, seropositivity, rate, phase II, seropositivity, rate, herd managers, milking, parlor workers, findings, survey, risk, C. burnetii, infection, correlated, cattle, density, dairy farms, occupational groups]]\n",
      "[[Coxiella burnetii, causative agent, Q fever, coxiellosis, acute, manifestations, latent, chronic course, absence, antibiotic therapy, risk, disability, death, presence, clinical manifestations, infectious diseases, laboratory test methods, LTM, diagnosis, Q fever anthropurgic, foci, Novosibirsk region, laboratory diagnostics, region, study, genetic, serological, markers, causative agent, C. burnetii, patients, Novosibirsk region, admitted, treatment, fever, suspected, tick-borne infections, TBIs, DNA marker, causative agent, Q fever, detected, blood samples, real time PCR, patients, patients, presence, C. burnetii, DNA, sequencing, IS1111, htpB gene, ELISA tests, antibodies, causative agent, coxiellosis, detected, blood sera, patients, positive, results, PCR analysis, Contact with, tick, patients, C. burnetii, DNA, markers, TBIs, people, infected, Novosibirsk region, tick's bite, Altai, case, Republic, Kyrgyzstan, complex, PCR analysis, ELISA, identification, markers, Q fever causative agent, patients, admitted with, suspected, TBIs, infections, Contact with, ticks, cases, infection, C. burnetii, transmissible pathway]]\n",
      "[[Leptospirosis, rickettsial diseases, zoonotic diseases, severe, infection, cases, mortality, epidemiological, data, outbreak, investigations, hospital-based studies, endemic countries, U.S. soldiers, military bases, countries, vulnerable, immunologically, naive, pathogens, No risk assessment, leptospirosis, rickettsial diseases, U.S., military personnel, Honduras, study, prevalence, leptospirosis, rickettsial diseases, U.S., military personnel, Honduras, serological assays, cohort, pre-, post-deployment, sera, military personnel stationed, Honduras, months, identified, study, Serum specimens, eligible, subjects, post-deployment, serum specimens, screened, dilution, 1:100, presence, IgG antibodies, Leptospira, Rickettsia pathogens, pre-deployment, sera, individuals, post-deployment, IgG antibodies, cutoff, seropositive, seroconversion, Seroconversion, conversion, optical density value, cutoff, negative, pre-deployed, specimen, cutoff, positive, post-deployed, specimen, titer, seropositive, post-deployment, specimens, antibodies, Leptospira, leptospirosis, Rickettsia typhi, murine typhus, MT, spotted fever group rickettsioses, SFGR, SFG Rickettsia, Orientia tsutsugamushi, scrub typhus, ST, Coxiella burnetii, Q fever, QF, seroconverted, rate, Honduras, leptospirosis, MT, SFGR, ST, QF, seroconverted, specimens, seroconversion, antibodies, seroconverted, individuals, personnel, medical attention, deployment, results, leptospirosis, seroconversion, rate, seroconversion, Korea, Japan, rate, seroconversion, potential, risk, Leptospira, exposure, testing, water samples, pools, pits, training sites, locate, infected, areas, exposure, Leptospira, trainings, rates, seroconversion, ST, MT, spotted fever Rickettsia, QF, potential, exposure, rickettsial-related pathogens, Testing, vectors, rickettsial, pathogens, areas, effective, vector, countermeasures, prevent, exposure, precaution, protective measures, military personnel, Honduras]]\n",
      "[[ELISA, methods, diagnostic tools, serological diagnosis, Coxiella burnetii infection, ruminants, diagnostic, performances, assess, absence, gold, study, commercial, ELISA, tests, objectives, assess, sensitivity, specificity, sheep, goats, cattle, assess, between-, within-herd, seroprevalence, distribution, species, diagnostic errors, estimate, optimal, sample sizes, sensitivity, specificity, herd, level, tested, cattle, goat, sheep serum, France, analyzed, cross-classified test results, hierarchical zero-inflated beta-binomial latent class model, herd, population, conditional, fixed effect, biases, coverage, probabilities, model, assessed, simulation, seropositive, animals, species, ELISA, methods, Specificity estimates, high, sensitivity, estimates, low, within-herd, seroprevalence, estimates, geographic areas, herds, goats, within-herd, seroprevalence, levels, sheep, cattle, optimal, sample size, herd, sensitivity, herd, specificity, animals, test, ruminant, species, study, interpretation, ELISA, tests, implementation, studies, methodology, human, animal diseases]]\n",
      "[[Coxiella burnetii, causative agent, Q fever, infectious, zoonotic disease, C. burnetii, abortion, livestock, widespread, abortions, animals, studies, prevalence, C. burnetii, infection, cases, animal abortion, Iran, study, investigate, occurrence, C. burnetii, ruminant, abortion, samples, Iran, Abortion, samples, cattle, sheep, goats, parts, Iran, tested, Real-time PCR, targeting, IS1111, element, C. burnetii, study, samples, samples, positive, C. burnetii, prevalence, C. burnetii, samples, sheep samples, cattle, samples, positive, goat abortion, samples, positive, C. burnetii, findings, study, C. burnetii, domestic, ruminant, abortions, Iran, attention, C. burnetii, domestic, animal, abortions, veterinary organizations, risk, transmitting, infection, humans, abortion, animals]]\n",
      "[[Coxiella burnetii, obligate, intracellular, zoonotic bacterium, global distribution, study, investigate, prevalence, C. burnetii, animals, assess, species, reservoirs, infection, transmission, humans, blood samples, beef cattle, dairy cattle, Korean, native, goats, Boer goats, horses, Republic, ROK, C. burnetii, DNA, detected, blood samples, transposon-like repetitive region, IS1111, PCR method, results, Korean-native goats, dairy cattle, beef cattle, Boer, goats, horses, positive, C. burnetii, differences, animal species, univariable binary logistic regression analysis, risk, contracting, C. burnetii, Korean-native goats, confidence interval, CI, dairy cattle, CI, beef cattle, CI, horses, phylogenetic tree, IS1111 gene, sequences, similarity, clustered, detected, humans, cattle, goats, dogs, rodents, ticks, C. burnetii, circulating, ROK, genetic variation, knowledge, study, C. burnetii, DNA, horse, ROK, results, cattle, goats, horses, reservoirs, C. burnetii, transmission, infection, studies, pathogenicity, C. burnetii, circulating, ROK]]\n",
      "[[Q fever, Coxiella burnetii, zoonosis, public, clinical samples, cattle, serum, vaginal swabs, milk, serum, samples, humans, gaushala, cattle, shelter, screened, anti-C. burnetii, IgG, antibodies, sera, indirect-ELISA kit, samples, tested, C. burnetii, DNA, TaqMan real-time, conventional, PCR assays, targeting, com1 gene, ELISA, animal, human, sera, positive, anti-C. burnetii antibodies, pathogen, detection, sera, vaginal swabs, milk, samples, cattle, positive, TaqMan real-time PCR, sera, vaginal swabs, milk, samples, positive, conventional, PCR, humans, serum, positive, PCR assays, PCR positive samples, sequenced, phylogenetic tree, com1 gene sequences, host, geographical areas, study, infection, cattle, human, contacts, gaushala, relationships, strains, identified, gaushala, globe]]\n",
      "[[Infection, intracellular, bacteria, treat, intracellular, targets, delivery methods, therapeutics, Ehrlichia translocated factor-1, Etf-1, type IV secretion system, T4SS, primary virulence factor, intracellular, bacterium, Ehrlichia chaffeensis, study, Etf-1-specific nanobodies, Nbs, immunizing, llama, intracellular, Nbs block, Etf-1 functions, Ehrlichia infection, anti-Etf-1, Nbs, NbD7, blocked, mitochondrial, localization, Etf-1-GFP, cotransfected cells, NbD7, control, NbD3, regions, Etf-1, Size-exclusion chromatography, NbD7, Etf-1 complex, stable, NbD3, Etf-1 complex, Intracellular, expression, NbD7, inhibited, activities, Etf-1, E. chaffeensis, up-regulation, mitochondrial manganese superoxide dismutase, reduction, intracellular, reactive oxygen species, inhibition, cellular apoptosis, intracellular, NbD7, inhibited, Ehrlichia infection, NbD3, Nbs, host cell, NbD7, conjugated, cyclized cell-permeable peptide 12, CPP12-NbD7, CPP12-NbD7, mammalian, abrogated, blockade, cellular apoptosis, E. chaffeensis, inhibited, infection, E. chaffeensis, cell culture, severe, combined-immunodeficiency mouse model, results, development, Nb, interferes, T4SS effector functions, intracellular, pathogen infection, intracellular, delivery method, Nb, barriers, mechanistic, research, therapies, complementary, alternative, broad-spectrum antibiotic]]\n",
      "[[Ehrlichia chaffeensis, expresses, TRP120, multifunctional effector, phagocytic entry, surface, infectious, cognate, host receptor, identified, E. chaffeensis, activates, Wnt signaling, monocytes, bacterial, uptake, intracellular, survival, TRP120, activation, event, mechanism, pathway activation, TRP120, Wnt signaling, ligand, mimetic, initiates, Wnt pathway, activity, interaction, Wnt pathway, Frizzled family of receptors, study, confocal immunofluorescence microscopy, colocalization, E. chaffeensis, Fzd2, coreceptor, LRP5, postinfection, TRP120, multiple, Fzd receptors, enzyme-linked immunosorbent assay, ELISA, surface plasmon resonance, SPR, Interfering RNA, knockdown, Wnt receptors, coreceptors, signaling pathway, components, reduced, E. chaffeensis infection, complex, interactions, Wnt pathway, exploitation, in silico, approaches, repetitive short linear motif, SLiM, TRP120, homologous, Wnt ligands, mutant, alpha-TRP120-Wnt-SLiM antibody, TRP120, Wnt, SLiM, activates, canonical Wnt pathway, promotes, E. chaffeensis, infection, study, reports, bacterial, mimicry, Wnt pathway, ligands, pathogenic, mechanism, potential, targeting, antimicrobial, therapeutics, infecting, mammalian, hosts, Ehrlichia chaffeensis, replicative niche, microbe-eating immune system cells, infection, spread, Ehrlichia, phagocytes, activating, evolutionarily, Wnt pathway, molecular details, pathway, hijacking, study, ehrlichial protein, components, Wnt receptor complex, pathway activity, promoting, infection, Consequentially, Ehrlichia, investigate, pathogens, human, immune cell, cellular processes, health, disease, bacterium, small, genome, survive, cells, pathogens, development, antibacterial, therapeutics, target, Ehrlichia, intracellular agents, human disease]]\n",
      "[[Ehrlichia chaffeensis, human, replicating, phagosomes, monocytes/macrophages, function, disruption, mutation, pathogen's, ECH_0660 gene, encoding, phage, head-to-tail connector protein, clearance, pathogen, in vivo, induce, sufficient, immunity, host, wild-type infection, study, characterization, cluster, genes, ECH_0659, ECH_0665, genes, encoding, bacterial, ECH_0660 gene, Assessment, promoter region, upstream, gene, genes, ECH_0659, Escherichia coli, transcriptional enhancement, zinc, iron starvation, transcription, genes, E. chaffeensis, mutation, ECH_0660 gene, wild-type, pathogen, zinc, iron starving, conditions, transcription, genes, wild-type, moderately, downregulated, ECH_0665 gene mutant, function, disruption, mutation, minimal, impact, pathogen's, in vivo, growth, wild-type, study, zinc, iron, E. chaffeensis, biology, functional, disruption, gene, encoding, head-to-tail connector protein, E. chaffeensis, results, enhanced, transcription, genes, encoding, phage proteins, zinc, iron, limitation, Ehrlichia chaffeensis, tick-transmitted bacterium, human, replicating, phagosomes, monocytes/macrophages, function, disruption, mutation, pathogen's, encoding, phage, head-to-tail connector protein, clearance, pathogen, in vivo, induce, sufficient, immunity, host, wild-type infection, study, investigated, functional, disruption, predicted, head-to-tail connector protein gene, transcriptional, changes, metal ion, limitations, study, zinc, iron, E. chaffeensis, replication]]\n",
      "[[Ehrlichiosis, Gram-negative bacteria, genus, Ehrlichia, infectious disease, cases, Symptoms, non-specific, bite, infected, tick, Confirmatory laboratory diagnostic methods, sensitivity, specimen, requirements, delayed diagnosis, PCR testing, efficient, Ehrlichia, confirmation, acute stage of illness, Published assays, detect, human ehrlichiosis, detections, genomic copies, GC, Ehrlichia DNA, discovery, species, human infection, assays, sensitive, Ehrlichia, sensitive, real-time PCR assays, PanE1, PanE2, detection, Ehrlichia species, real-time PCR assays, ECh2, ECh4, detection, Ehrlichia chaffeensis, detection, GC, reaction, confidence, GC, efficiencies, Accuracy, assessed, correlation, Specificity, exclusivity testing, Ehrlichia species assays, E. chaffeensis, cross reactivity, near, neighbors, environmental bacteria, positive, negative, evaluating, banked, clinical specimens, patients, assays, real-time PCR assays, effective, tools, detect, human, Ehrlichia species, acute stage of illness, Early detection, Ehrlichia infection, real-time PCR assays, diagnosis, treatment]]\n",
      "[[Cutaneous plasmacytosis, rare, disease, clinically, multiple, red-brown papules, plaques, minimal, epidermal change, Histopathologic findings, perivascular, dermal, infiltration, polyclonal plasma cells, etiology, cutaneous plasmacytosis, persistent, antigenic stimulation, Ehrlichia, family, obligate, intracellular, bacteria, associated with, development, plasma cell dyscrasias, veterinary literature, case, male, patient, development, worsening, cutaneous plasmacytosis, prolonged, hospitalization, secondary to, ehrlichiosis sepsis, patient, isolated, cutaneous, involvement, findings, laboratory abnormalities, anemia, hyperproteinemia, elevated, serum creatinine, diagnostic workup, patient, evidence, progression, systemic plasmacytosis, multiple myeloma]]\n",
      "[[Dogs, reservoirs, zoonotic, vector-borne, pathogens, reports, canine, vector-borne diseases, CVBDs, Egypt, Serum samples, pet dogs, breeds, German Shepherd, Rottweiler, Pit Bull, Governates, Cairo, Giza, Al-Qalyubia, Al-Gharbia, Kafr El-Sheikh, hot desert, climate, presence, antibodies, Anaplasma spp., A. phagocytophilum, A. platys, Ehrlichia spp. (E. canis, E. chaffeensis, E. ewingii, Borrelia burgdorferi, Dirofilaria immitis, assessed, IDEXX SNAP((R)) 4Dx((R)), ELISA, tests, pathogen, risk factors, geographical area, condition, sex, age, breed, tick, infestation, weekly, sanitation, dog, enclosures, application, ectoparasiticides, evaluated, logistic regression approach, CI, dogs, scored, seropositive, pathogen, frequent, Ehrlichia spp., CI, Anaplasma spp., CI, Borrelia burgdorferi, CI, D. immitis, CI, tested population, CI, dogs, pathogen, CI, CI, exposed, pathogens, risk factors, associated with, VBDs, living outdoors, Anaplasma spp, Ehrlichia spp., female sex, Ehrlichia spp., German, Anaplasma spp, Ehrlichia spp., tick, infestation, Anaplasma spp, Ehrlichia spp., B. burgdorferi, D. immitis, irregular sanitation, Anaplasma spp, Ehrlichia spp., B. burgdorferi, D. immitis, ectoparasiticides, Anaplasma spp, Ehrlichia spp., B. burgdorferi, knowledge, seroepidemiological study, CVBDs, Egypt, detected, pathogens, zoonotic, effective, ectoparasite, examination, pet dogs, chemoprophylaxis]]\n",
      "[[years, people, infected, causative agents, ehrlichiosis, Rocky Mountain spotted fever, spotted fever group rickettiosis, SFGR, increased, Oklahoma, data, pathogen, prevalence, urban, environments, prevalence, tick-borne, pathogens, environments, Amblyomma americanum, lone star) ticks, environment, parks, Edmond, Oklahoma, presence, Ehrlichia spp., spotted fever group, SFG, quantitative real-time polymerase chain reaction, qPCR, A. americanum ticks, positive, Rickettsia amblyommatis, positive, Ehrlichia chaffeensis, No ticks, positive, SFG Rickettsiae, R. rickettsii, R. parkeri, Ehrlichiae, E. ewingii, Panola Mountain Ehrlichia, studies, increased, potential, risk, tick-borne, pathogens, urban, environments]]\n",
      "[[Rickettsiales, Haemosporida, Rhizobiales agents, diseases, animal species, humans, predation behaviour, carnivorous birds, spreading, etiological, geographically distant areas, migratory, study, investigate, occurrence, phylogenetic, relations, Anaplasmataceae, Ehrlichia, Anaplasma, Neorickettsia, Bartonellaceae, Bartonella spp., Haemosporida, Plasmodium, Haemoproteus, Leucocytozoon, blood samples, carnivorous, birds, sampled, states, Sao Paulo, Brazil, Inclusions, hemoparasites, Giemsa-stained preparations, animals, seropositive, E. chaffeensis, CI:1.17-9.55%, antibodies, A. phagocytophilum, CI, detection, rrs gene, E. chaffeensis, CI, no positivity, qPCR, genes, vlpt, organism, CI, samples, positive, qPCR, Anaplasma spp, groEL gene, negative, qPCR, A. phagocytophilum, msp-2 gene, samples, positive, nPCR, E. canis, rrs gene, samples, positive, Haemoproteus spp, Plasmodium spp, nPCR, cytB gene, birds, CI, co-positivity, Ehrlichia sp., Anaplasma sp., molecular assays, bird, seropositive, E. chaffeensis, positive, PCR, Haemoproteus sp., birds, negative, qPCR assay, Bartonella spp., nuoG, occurrence, Anaplasmataceae agents, hemosporidians, carnivorous birds, southeastern Brazil, animals, dispersion, Anaplasmataceae agents, investigated]]\n",
      "[[Ehrlichia chaffeensis, human monocytic ehrlichiosis, HME, prevalent, life-threatening, infectious, zoonoses, life cycle, E. chaffeensis, ticks, mammals, E. chaffeensis proteins, expressed, bacterial survival, infection, E. chaffeensis, P28-OMP, outer membrane proteins, OMP-1B, P28, expressed, tick cells, mammalian, macrophages, mechanisms, regulating, expression, transcriptional regulators, EcxR, Tr1, regulate, expression, omp-1B, p28, E. chaffeensis, Recombinant, E. chaffeensis, Tr1, promoters, omp-1B, p28, transactivated, omp-1B, p28, promoter-EGFP fusion, Escherichia coli, consensus sequence, Tr1, binding, motifs, A(C)/TTATA, DNase I footprint assay, Tr1, higher, affinity, p28, promoter, omp-1B, promoter, surface plasmon resonance, EcxR, activated, tr1, expression, response, temperature, decrease, degrees, level, Tr1, activated, p28, expression, degrees, level, Tr1, activated, omp-1B, expression, repressing, p28, expression, binding, site, upstream, p28 gene, data, novel, mechanism, Tr1, E. chaffeensis, gene expression, development, therapeutics, HME]]\n",
      "[[Ehrlichia chaffeensis, human monocytic ehrlichiosis, principal vector, Amblyomma americanum tick, cases, ehrlichiosis, southeastern, south central states, United States, study, molecular typing system, genetic differentiation, E. chaffeensis, isolates, multi-locus typing system, sequencing, intergenic regions, ECH0217-ECH0218, plus, variable genes, variable length PCR, target, 120-kDa, hemE., unique, isolates, humans, white-tailed deer, DNA samples, infected, A. americanum, multiple, states, evaluation, E. chaffeensis, isolates, genotypes, findings, sequences, loci, concatenated, compared, samples, genotypes, grouped, phylogenetic, clades, data, study, geographic, alignment, genetic differentiation, strains, result, spread, E. chaffeensis, United States, findings, multiple, strains, distant, geographic, mutations, strains, moved, site, hosts, vectors, northward, shift, lone star tick, distribution, United States, data, minimal, genetic mutations, time, strains, geographical proximity]]\n",
      "[[study, chemical composition, antimicrobial, antioxidant, anticancer effects, Thymus convolutus Klokov oil, compound camphor, investigated, oil, isolated, T. convolutus, hydrodistillation method, analyzed, gas chromatography/mass spectrometry, GC-MS, compounds, identified, camphor, antioxidant, properties, DPPH, radical-scavenging method, DPPH, scavenging, essential oil, antimicrobial activity, Escherichia coli, Enterobacter aerogenes, Proteus vulgaris, Pseudomonas aeruginosa, MIC, values, mug/mL. Aspergillus flavus, sensitive, T. convolutus, essential oil, fungi, cytotoxic effect, oil, analyzed, MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method, Camphor, effective, human, Hep3B, concentrations, essential oil, T. convolutus, effective, concentrations, mug/mL., reduction, cell proliferation, colon carcinoma cells, HT-29, treated with, statistically significant, effect, Umbilical Vein, Endothelial Cells, HUVEC, treated with, essential oil, camphor]]\n",
      "[[Antibiotic resistance, public, health problems, people, living, poverty, countries, Thailand, hill tribe, people, vulnerable population, antibiotic resistance, Thailand, economic, education status, Lahu people, group, hill tribe, Thailand, study, estimate, prevalence, factors, associated with, typing, species, bacteria, antibiotic drugs, resistance, Lahu hill tribe, people, northern Thailand, cross-sectional study, information, participants, questionnaire, data collection, Participants, illness, infectious diseases, participate, study, specimen, sputum, urine, stool, Antibiotic susceptibility, tested, Kirbey Bauer's disc diffusion test, Chi-square, logistic regression, detect, associations, variables, significant, level, alpha, participants, study, urinary tract infection, pathogenic, species, infection, Escherichia coli, Enterobacter cloacae, prevalence, antibiotic resistance, Escherichia coli, Klebsiella pneumoniae species, multidrug resistance, species, ampicillin, drug resistance, knowledge, antibiotic, chance, CI, antibiotic resistance, knowledge, antibiotic, antibiotic, chance, CI, antibiotic resistance, antibiotic, Effective, public, interventions, antibiotic, drug resistance, Lahu people, improving, knowledge, skills, antibiotics, antibiotic resistance, health care professionals, standard, guideline, antibiotics]]\n",
      "[[microorganisms, isolated, patients, wearing, fixed orthodontic appliances, evaluate, resistance, isolated, bacterial, antimicrobials, healthy, patients, wearing, fixed orthodontic appliance, group, nonwearers, group 2, control group, evaluated, biofilm, orthodontic brackets, samples, plated, chromogenic medium, chromIDT, bioMerieux, Colony-forming units, CFUs, isolated, inoculated, blood-agar medium, Automated, VITEK 2, bioMerieux, genus, species, microorganisms, resistance, drugs, antibacterial, antifungal, microbial, genera, identified, group 1, Streptococcus, Staphylococcus, Enterobacter, Geobacillus, Candida, frequent, species, Enterobacter cloacae complex, Staphylococcus hominis, group 2, genera, Streptococcus, Staphylococcus, Sphingomonas, Enterobacter, antimicrobial resistance, isolated, bacterial strains, resistant, tested, antimicrobials, findings, study, patients, orthodontic treatment, fixed appliances, complex, biofilm, level, bacterial resistance]]\n",
      "[[guideline, antibiotic prophylaxis, pediatric, cardiac surgery, effects of, cardiopulmonary bypass, CPB, low, plasma, cefazolin, concentrations, postoperative, surgical site infections, SSIs, calculated-unbound plasma, concentrations, cefazolin, uncomplicated, pediatric, cardiac surgery, Design, prospective observational study, patients, years, age, elective cardiac surgery, CPB, Materials, Methods, intravenous infusion, cefazolin, administered, patients, minutes, hour, skin incision, dose, infusion, administered, CPB, dose, Blood samples, time points, minutes, T1, aortic cannulation, T2, CPB, initiation, T3, T4, T5, CPB, minutes, CPB, discontinuation, T7, skin closure, T8, plasma, cefazolin, concentrations, measured, liquid chromatography tandem mass spectrometry, unbound, cefazolin, concentrations, 80%-protein binding, median, cefazolin, levels, T1-T8, cefazolin, levels, inhibitory, MICs, Methicillin-sensitive S. aureus, MSSA, S. epidermidis, patients, inadequate, Enterobacter, E. coli, regimen, adequate, plasma, cefazolin, concentrations, organisms, SSIs, cardiac surgery]]\n",
      "[[Powered, flagella, bacterial species, collective motion, solid surface, swarming, natural, active matter, swarming, biological, phenotype, associated with, virulence, chemotaxis, host, pathogenesis, Physical changes, cell elongation, hyper, flagellation, swarming, phenotype, collective motion, swarming cells, planktonic cells, cell density, bacterial, movement, circular microwells, bacterial, swarming, swimming, soft agar plate, bacterial strain, Enterobacter sp. SM3, swarming, planktonic states, motion, patterns, circular microwells, sizes, confinement, diameter, mum, swarming, SM3, pattern, microwells, planktonic, SM3, swirls, differential behavior, species, gram-negative bacteria, rafting, swarming bacteria, dilution, rafting behavior, motion pattern difference, experimental features, numerical simulations, swarming cells, cell-cell, interaction, experimental design, PDMS microchip disk, arrays, bacterial, swarming, murine, intestinal, surface, method, bacterial, swarming, complex, environments, polymicrobial niches, in vivo, swarming, exploration]]\n",
      "[[dried milk products, world, study, evaluate, skim milk, powders, Egyptian, standards, samples, dried milk, milk powder, skim milk powder, retailers, supermarkets, evaluation, quality, safety, parameters, frequent, off-flavors, recovered, milk, samples, cooked ones, case, skim milk, powder, samples, flat ones, samples, whole milk, quality, samples, poor quality, sensory evaluation, compositional parameters, moisture, fat, protein, acidity, milk, powder, samples, /-0.29, skimmed milk, powder, samples, results, requirements, Egyptian, Standard, ES, dried milk products, microbiological safety, milk powder, samples, analyzed, assessment, yeast, mold count, Coliforms count, Enterobacteriaceae, E. coli, C. sakazakii, Staphylococcus aureus, Salmonella, Listeria monocytogenes, Staphylococcus aureus, isolate, Enterobacteriaceae, whole, skim milk, powder, Enterobacteriaceae, isolates, Enterobacter cloacae ssp., Cloacae, Pantoea spp, biochemical tests, Vitek2 system, Enterobacteriaceae, isolated, spp, resistant, cephalothin, neomycin, tobramycin, colistin sulphate, sensitive, chloramphenicol, gentamycin, nalidixic acid, E. coli, C. sakazakii, Salmonella, Listeria monocytogenes, isolated, tested, samples, Inductive Coupled, Plasma, Mass Spectrometer, ICP-MS, measure, lead, mercury, milk, powder, samples, percentage, skim milk, powder, samples, percentage, whole milk, powder, skimmed milk, powder, samples, Egyptian, standards, authorities, attention]]\n",
      "[[composition, physical, chemical properties, sources, temporal, spatial changes, airborne, investigated, studies, bioaerosols, bacteria, fungi, airborne, study, inductively coupled plasma mass spectrometry, ion chromatography, concentrations, trace elements, water-soluble ions, atmospheric particulates, analyses, high-throughput sequencing methods, real-time quantitative polymerase chain reaction, microbial, compositions, PM1.0, PM2.5, PM10, samples, Hefei City, results, bacterial, community, diversity, size, fractions, analysis of variance, ANOVA, bacterial, fungal, community, diversities, sunny, days, rainy, days, bacterial, community, diversity, samples, fungal, community, diversity, ANOVA, bacterial phyla, Proteobacteria, Firmicutes, Bacteroidetes, Cyanobacteria, Actinobacteria, Ascomycota, Basidiomycota, Mortierellomycota, Mucoromycota, dominant, fungal, results, soils, plant leaves, animal, feces, dominant, sources, airborne, bacterial, communities, Hefei City, sources, fungal, communities, plant leaves, soils, bacterial, community, affected, K, Pb, Al, Fe, Mg, Ca, Na(+), NO2(-, wind, speed, factors, fungal, community, V, Mn, Sr, NO2(-, NO3(-), Na(+), Cl(-), air quality index, PM10, bacteria, fungi, human, health, risks, identified, Acinetobacter, Streptococcus, Enterobacter, Pseudomonas, Delftia, Serratia, Trichoderma, Alternaria, Aspergillus, diseases, humans, organisms, research results, characteristics, airborne, microbial, communities, factors, impacts, human, health, research, formulation, government, policies]]\n",
      "[[Water pollution, global, morbidity, mortality, study, assess, microbiological, quality, domestic, brands, bottled water, Kathmandu Valley, Nepal, study, bottled water, samples, volumes, samples, Microbiology laboratory, St. Xavier's College, Maitighar, Kathmandu, microbiological assessments, methods, American Public Health Association, samples, samples, contaminated, coliform, Escherichia coli, predominant, strain, coliforms, Multidrug-resistant, E. coli, Enterobacter aerogenes, Pseudomonas aeruginosa, isolated, bottled water, Treat assessment test, isolated, E. coli, beta hemolytic, colonies, hemolytic, colonies, E. aerogenes, colonies, hemolytic, colonies, P. aeruginosa, colonies, beta hemolytic, colonies, Chi-square test, association, fecal, coliform, volume, vessel, bottle type, unscratched, undented, scratched, dented, season, monsoon, postmonsoon, coliform, Chi-square test, no significant, association, Pseudomonas spp and season, monsoon, postmonsoon, samples, samples, contaminated, coliform, Microorganisms, survive, bottled water, nutrients, microorganism, ionic form, Surveillance, license-providing organizations, governmental organizations]]\n",
      "[[OBJECTIVE, presence, bacteria, seller's, meatball vendors, cart meatball, descriptive study, observational approach, mobile meatball, vendors, participants, bacterias, bowls, hands, swab sampling, bacterias, total plate count method, nutrient agar, Bacteria, Gram staining method, bacteria, assay, hands, bowls swab samples, positive, Gram-positive, Gram-negative bacteria, cases, microorganisms, Acinetobacter calcoaceticus, Klebsiella sp., Alcaligenes faecalis, Enterobacter aglomereus, Pseudomonas aeruginosa, Enterobacter aerogenes, Enterobacter cloacae, Staphylococcus saprophyticus, Serratia rubidaea, Yersinia enterocolitica, E. aerogenes, Staphylococcus epidermidis, bacterias, cart meatball, sellers' hands, phenomenon, affiliated with, emergence, food-borne diseases, consumers]]\n",
      "[[Biological, nitrogen fixation, amount, phosphorus, soils, P-deficient, P-, chemical, fertilizers, threat, environment, context, field experiments, investigate, effect, co-inoculation, Mesorhizobium ciceri, phosphate solubilizing bacteria, PSB, Bacillus sp., Enterobacter aerogenes, chickpea, alternative, chemical nitrogen, phosphorous, fertilizers, P-deficient, soils, dry areas, Morocco, results, inoculation, chickpea, rhizobia, PSB, enhancement, chickpea nodulation, biomass, production, yields, N, protein, content, grains, inoculation, application, N, P. A, increase, inoculating, chickpea, Mesorhizobium sp. MA72, combined, E. aerogenes, P1S6, combination, enhancement, nodulation, shoot dry weight, grain, yield, effect, combination, effect, application, N, fertilizers, Formulation, biofertilizers, tasted, strains, chickpea, co-inoculation, P-deficient, soils, chickpea]]\n",
      "[[Third-generation cephalosporin-resistant, Enterobacteriaceae, threat, human, health, Enterobacteriaceae, clinical, isolates, patients, presenting, regional, Australian hospital, period, routine, mass spectrometry, speciation, antibiotic sensitivity testing, isolates, rapid, real-time PCR assays, targeting, beta-lactamases, ESBLs, bla CTX-M-1, bla, CTX-M-9, groups, bla TEM, bla SHV, internal, 16S ribosomal DNA control, AmpC CMY beta-lactamase, bla CMY, prevalence, Escherichia coli, Klebsiella pneumoniae, dominant, Klebsiella oxytoca, Klebsiella aerogenes, Enterobacter cloacae, identified, Ceftriaxone, cefoxitin, resistance, identified, E. coli, K. pneumoniae, isolates, Consistent with, global findings, Enterobacteriaceae, isolates, beta-lactamase gene, encoding, bla CTX-M-1, group, bla, CTX-M-9, group, bla SHV, bla TEM, bla CMY A subset, isolates, whole-genome sequencing, WGS, presence, cryptic resistance, determinants, genotyping, accuracy, WGS, beta-lactamase negative, carbapenem-resistant, isolates, ESBLs, carbapenemases, bla, NDM, bla IMP, PCR-positive, genotypes, PCR assays, rapid, cost-effective, identification, ESBLs, hospital setting, infection control, therapeutic, implications]]\n",
      "[[porcine, device, microbial, resources, bacterial enzymes, preference, porcine, gelatine, genes, evaluated, bacterial strains, isolated, hot spring, water, wet clay, Malaysia, screened, gelatinase activity, gelatinase enzyme, extracted, purified, ammonium sulphate, precipitation, gelatinase assay, porcine, bovine, fish gelatine, substrates, G2 strain, Enterobacter aerogenes, Strain EA1, genome, sequenced, preference, porcine, gelatine, gelatinase, gene gelEA1_9, cloned, expressed, one-way analysis of variance, ANOVA, POST-HOC Duncan test, alpha, product, gelEA1_9, gelatinase, gelatinase, no significant, activity, porcine gelatine, study, enzyme-substrate interaction, porcine, gelatine, identification]]\n",
      "[[emergence, evolution, antibiotic resistance, accelerated, antibiotics, diagnostic tests, therapeutic treatment, adequate, sensitivity, specificity, antimicrobial susceptibility testing, AST, accuracy, Automated, AST, instruments, clinical, microbiology, labs, workflow, susceptibility testing, pathogenic bacteria, isolated, clinical samples, commercial, systems, Vitek2, BD, Phoenix, results, conventional methods, AST, inoculum, concentrations, optical detection, speed, GeneFluidics ProMax lab automation system, molecular AST, clinical, isolates, detection, inoculum, concentration, automated, molecular quantification, species-specific, 16S rRNA, electrochemical, sensor, microbiological responses, antibiotic exposure, clinical, isolates, species, gram-negative rods, CDC, AR bank, hospitals, New York-Presbyterian Queens, Medical College of Wisconsin, ciprofloxacin, gentamicin, meropenem, reproducibility, clinical studies, categorical agreement, reproducibility, Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae, Pseudomonas aeruginosa, ciprofloxacin, gentamicin, meropenem]]\n",
      "[[Iron, bacterial survival, Bacterial siderophores, small molecules, capacity, scavenge, iron, proteins, extracellular milieu, insoluble, Fe(3+), Siderophores chelate, Fe(3+), uptake, cell, reduced, soluble, Fe(2+), Siderophores, molecules, low, soluble, iron conditions, bacteria, synthesize, proprietary siderophores, increased, bacterial, evolutionary, fitness, bacteria, siderophore structure, polyamine backbones, catechol moieties, Serratia plymuthica V4, siderophores, siderome, action, enzymes, encoded, gene clusters, serratiochelin A, B, diaminopropane, S. plymuthica, putrescine, enzymes, photobactin, siderophore, bacterium, Photorhabdus luminescens, enzymes, encoded, gene clusters, enterobactin, operon, biosynthesis, hydroxamate siderophore aerobactin, Enterobacter aerogenes, Mutant strains, polyamine-siderophores, increased, enterobactin, production, levels, enterobactin, impact, production, serratiochelins, Knocking, SchF0, enzyme, assembly, enterobactin, bacterial, fitness, study, natural, occurrence, serratiochelins, photobactin, enterobactin, aerobactin, bacterial, siderophore biosynthetic pathways, polyamine, production, routes, molecular diversification, natural, yields, diaminopropane, DW, putrescine, DW, S. plymuthica, industrial, production, compounds]]\n",
      "[[study, Enterobacter aerogenes, KCTC2190, isolated, soil, cattle, intracellular, beta-galactosidase, Partially purified beta-galactosidase, immobilized, entrapment, agar-agar gel matrix, Agar-agar, entrapped beads, enzyme-agar solution, ice-cooled toluene-chloroform, activity, beta-galactosidase, immobilization, bead, shape, Maximum, immobilization, presence, agar-agar, concentration, immobilization, optimum, temperature, enzyme-substrate reaction, degrees, optimum, optimum, pH, free, immobilized, beta-galactosidase, pH, Free enzyme, activation energy, comparison, immobilized, free, immobilized, beta-galactosidase, deactivation, rate constant, increased, increasing, temperature, values, decimal reduction time, D-values, half-lives, t1/2, decreased, Immobilization process, increased, t1/2, D-values, beta-galactosidase, decreased, Thermostability, immobilized, beta-galactosidase, enthalpy, DeltaEta(0, Gibb's free energy, free beta-galactosidase, negative entropy, DeltaS(0, free, immobilized, beta-galactosidase, ordered state, temperature, range, degrees, Immobilized beta-galactosidase, 51.65+/-1.61, activity, batches, enzyme-substrate reaction, Immobilized beta-galactosidase, activity, days, storage, degrees]]\n",
      "[[description, OXA-48 type carbapenemase, endemic, Europe, Mediterranean, North African, short time, OXA-48 carbapenemase, accurate, diagnosis, endemic areas, CarbaNP test, phenotypic, carbapenemases, activity, Sensitivity, specifity, test, carbapenemases genes, study, evaluated, efficacy, CarbaNP test, routine, laboratories, endemic area, OXA-48, Enterobacterales, Enterobacterales, isolates, study, Antimicrobial susceptibility, isolates, imipenem, meropenem, ertapenem, Polymerase Chain Reaction, PCR, detection, carbapenemases genes, blaKPC, blaNDM, blaBIC, blaIMP, blaVIM, blaSPM, blaAIM, blaDIM, blaGIM, blaSIM, blaOXA-48, Carba, protocol, isolates, blaOXA-48, positive, Klebsiella pneumoniae, Escherichia coli, Serratia marcescens, Enterobacter aerogenes, Pantoea agglomerans, Morganella morganii, isolates, isolates, positive, blaVIM, blaSPM, sensitivity, specifity, CarbaNP test, determination, positive, isolates, subjective, CarbaNP test, suboptimal, results, low, sensitivity, specifity, detection, OXA-48, Enterobacterales, detection, blaOXA-48, positive, isolates, routine, laboratories, endemic areas]]\n",
      "[[prevalence, multidrug-resistant, MDR, pathogens, adult, pediatric, Pakistan, data, effect, MDR, microbes, gut microbiota, cross-sectional pediatric study, investigate, effect, MDR microbes, infection, gut microbiome, resistome, children, high-throughput next-generation sequencing, NGS, cross-sectional study, tertiary health care hospital, Peshawar, Pakistan, Pediatric, patients, acute gastroenteritis, pediatric, patients, antimicrobial resistance, AMR, screening, disk diffusion method, Children, MDR infections, identified, gut microbiome, resistome profiling, NGS, pediatric, patients, infected, MDR diarrheagenic, Enterobacteriaceae, infections, extended-spectrum beta-lactamase, ESBL, E. coli, MDR Enterobacter, antibiotic-resistant genes, ARGs, resistance, classes, antibiotics, identified, resistomes, MDR diarrheagenic, Enterobacteriaceae, infected, healthy, children, NGS-based, microbial, MDR Enterobacter spp., ESBL, E. coli, infected, pediatric, patients, healthy controls, Proteobacteria, Actinobacteria, increased, abundance, pathogenic, gram-negative bacteria, E. coli, Enterobacter cloacae, Salmonella enterica, gut microbiota, children, infected, MDR, bacterial infections, healthy controls, children, MDR infections, reduced, microbial, diversity, ARGs, healthy controls, emergence, MDR, bacterial strains, association, gut dysbiosis, regulate, antibiotics, usage, Pakistani, children]]\n",
      "[[Antimicrobial resistance, carbapenem, resistance, Enterobacteriaceae, plasmid, mobile, colistin, resistance, issue, study, epidemiological, characteristics, plasmid, colistin, resistance, carbapenem, resistant, Enterobacteriaceae, tertiary A hospital, Hefei, China, carbapenems, resistant, Enterobacteriaceae, CRE, screened, antibiotic susceptibility, mcr-1, ESBLs, metallo-beta-lactamases, MBLs, fosfomycin, resistance genes, PCR, sequencing, sequence types, identified, multilocus sequence typing, MLST, Plasmid, profiles, PCR, replicon typing, PBRT, plasmid, sizes, southern blotting, isolates, MIC50, MIC90, antimicrobials, tigecycline, meropenem, colistin, Carbapenemase genes, bla KPC-2, bla NDM-1(3.7%, bla OXA-48(5.6%, fosA3, bla, CTXM-15, mcr-1, isolates, PBRT, bla KPC-2, K. pneumoniae, IncR, IncFII, IncA/C. bla NDM-1, E. coli, IncFII, E. cloacae, IncHI2 plasmid, mcr-1, IncFIIK, IncFII, IncF, E. coli, K. pneumoniae, E. cloacae, Resistance genes, mcr-1, bla NDM-1, bla KPC-2, plasmids, trans-conjugant, EC-600, incidence, ST11, K. pneumoniae, carbapenem, resistant, isolates, E. coli, STs, identified, mcr-1, ST23, Anhui Province, Enterobacter cloacae, ST270, bla NDM-1, Southern-hybridization, plasmid, sizes, study, co-carrying, mcr-1, bla KPC-2, bla NDM-1, clinical, isolates, prevalence, Enterobacteriaceae, STs, E. coli, resistance profile, threat, humans, animals, transferred, strains, plasmid, transfusion, Persistent control actions, combat, hazard]]\n",
      "[[study, phenotypic, genotypic, characterization, antibiotic-resistant, isolates, Enterobacter cloacae, Escherichia coli, Proteus mirabilis, Salmonella enterica, Proteus penneri, Citrobacter freundii, Citrobacter braakii, Klebsiella pneumoniae, Klebsiella oxytoca, isolates, resistant, antibiotic, resistant, amoxicillin-clavulanate, ampicillin, phenotype, isolates, AmpC(+, phenotype, isolates, blaCTX-M gene, ESBL-positive, isolates, gene, CIT, family, AmpC-positive, isolates, results, attention, antibiotic resistance, food-borne Enterobacterales, presence, transmissible, antibiotic resistance, markers, criterion, evaluation, food safety]]\n",
      "[[AIM, report, phenotypic, genetic data, prevalence, characteristics, extended-spectrum beta-lactamases, ESBLs, Gram-negative species, Mexico, centers, hospital-based laboratories, external laboratories, distribution, antimicrobial resistance, data, Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae complex, Acinetobacter baumannii complex, Pseudomonas aeruginosa, clinical specimens, analyzed, WHONET, clinical, isolates, recovered, specimens, carbapenem-resistant Enterobacteriaceae, ESBL, carbapenem-resistant E. coli, K. pneumoniae, carbapenem-resistant A. baumannii, complex, P. aeruginosa, Strains, genotyped, detect, ESBL, carbapenemase-encoding genes, blood isolates, A. baumannii, complex, resistance, antibiotics, tested, Enterobacteria, E. cloacae complex, resistance, carbapenems, A. baumannii, complex, resistance, pattern, respiratory specimens, amikacin, resistance, K. pneumoniae, isolates, blaTEM, blaSHV, blaCTX, detected, isolates, E. coli, isolates, blaTEM, blaSHV, blaCTX, detected, isolates, species, frequent, genotype, blaCTX-M-15, Enterobacteriaceae, detected, carbapenemase-encoding gene, blaNDM-1, blaOXA-232, A. baumannii, blaOXA-24, P. aeruginosa, blaIMP, blaGES, blaVIM, study reports, NDM-1, frequent, carbapenemase-encoding gene, Mexico, Enterobacteriaceae, circulation, oxacillinase genes, KPC, countries, Latin America, USA, rare, occurrence, circulation, ESBL blaCTX-M-15, E. coli, K. pneumoniae]]\n",
      "[[prevalence, extended-spectrum beta-lactamase, Enterobacteriaceae, dairy calves, routine, health check protocol, data, antimicrobial use, AMU, farm hygiene, farm, management, risks, ESBL, occurrence, farms, study, median, milking, cows, calves, investigated, younger, weeks, age, days, farms, visited, samples, interval, months, Faecal samples, diluted, BrillianceTM ESBL agar, duplicates, degrees, colonies, counted, colony forming units, calculated, Bacteria, species, biochemically, ESBL-production, phenotypically, MICRONAUT-S beta-Lactamases system, antimicrobial susceptibility, tested, VITEK(R) 2 technology, Phylotyping, E. coli, isolates, screening, bla genes, PCR, ESBL-producing enterobacteria, detected, farms, calves, investigated, ESBL-positive bacteria, ESBL-producing, isolates, E. coli, Enterobacter cloacae, Klebsiella pneumoniae subsp., pneumoniae, E. coli, isolates, phylogroup C, phylogroups A, E, CTX-M, group, detected, E. cloacae, blaCTX-M, blaTEM, blaSHV, blaSHV, resistance, penicillins, cephalosporins, isolates, resistant, antibiotic, proportion, resistant, fluoroqinolones, isolates, multidrug resistant, gram-negative bacteria, 3MDR-GNB, German Commission for Hospital Hygiene, Infection Prevention, isolates, 4MDR-GNB, carbapenem-resistance, Penicillins, administered, antibiotics, calves, farms, predominant, substance class, herd, level, farms, calves, treated, sampling, low, Analyses, data, farm, management, weaknesses, biosecurity, cleaning, disinfection, beta-lactam antibiotics, antibiotics, risk factors, identified, prevalence, ESBL-carriers, dairy calves, motivation, strategies, reduction, multidrug-resistant bacteria, farm, animals]]\n",
      "[[Democratic Republic, Congo, DRC, countries, neonatal, rates, DRC, neonatal, sepsis, mortality, data, bacterial, etiology, drug susceptibility, lacking, Hemocultures, neonates, neonatal, sepsis, pEOS, Hopital Provincial General de Reference de Bukavu, HPGRB, Bukavu, DRC, newborns, pEOS, empirical, antimicrobial treatment, ampicillin, cefotaxime, gentamicin, synopsis, international guidelines, management, EOS, WHO, recommendations, Isolates, matrix-assisted laser desorption ionization, time, flight mass spectrophotometry, MALDI-TOF MS, Antibiotic resistance, assessed, disk diffusion method, strains, patients, identified, species, Enterobacter cloacae complex, Klebsiella pneumoniae, Serratia marcescens, Enterobacter cloacae, isolates, resistant, first-line, antibiotics, K. pneumoniae, S. marcescens, isolates, resistant, ampicillin, K. pneumoniae, S. marcescens, isolates, resistant, cefotaxime, gentamicin, E. cloacae complex, strains, K. pneumoniae, S. marcescens, extended-spectrum ss-lactamase, ESBL, phenotype, pathogens, EOS, Bukavu, E. cloacae complex, K. pneumoniae, S. marcescens, isolates, resistant, WHO, antibiotics]]\n",
      "[[Extended-spectrum-beta-lactamase, strains, increasing, worldwide, therapeutic options, Taniborbactam, VNRX-5133, beta-lactamase inhibitor, spectrum, activity, serine, metallo, enzymes, cefepime-taniborbactam activity, ESBL-producing, isolates, concentrations, MIC, determinations, clinical laboratory, in vitro, activity, cefepime, taniborbactam, clinically, molecularly, ESBL-producing, isolates, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterobacter cloacae, Citrobacter freundii, Enterobacter aerogenes, tested, broth microdilution checkerboard method, ISO, standard, MICs, cefepime, combination, percentage, resistance, concentrations, taniborbactam, species, resistance, mechanism, (range)/MIC90, cefepime, Enterobacterales, isolates, resistant, P. aeruginosa, isolates, resistant, concentration, taniborbactam, Enterobacterales, susceptibility, cefepime, MIC, P. aeruginosa, susceptibility, increased, exposure to, cefepime, MIC, concentration, taniborbactam, cefepime, (range)/MIC90, reduced, Enterobacterales, resistant, isolates, 64)/16, P. aeruginosa, isolates, resistant, cefepime-taniborbactam, activity, ESBL, isolates, restoring, susceptibility, Enterobacterales, P. aeruginosa, isolates]]\n",
      "[[analyzed, prevalence, genetic characteristics, extended-spectrum beta-lactamases (ESBLs)-producing Enterobacterales, isolated, adult, patients, hospitalized, oncological center, patients, admitted to, hospital, medical facilities, year, indication, screening test, ESBL-producing Enterobacterales, colonizing, gastrointestinal tract, patients, ESBL, producers, detected, isolates, Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae cplx, Klebsiella oxytoca, CTX-M-1-like enzymes, ESBLs, K. pneumoniae, isolates, New Delhi-metallo-beta-lactamases, NDM, isolates, K. oxytoca, typed, pulsed-field gel electrophoresis, PFGE, genetic diversity, phylogroups, E. coli, B2 group, group, observations, investigate, ESBL-E, colonization, infection, patients, solid tumors]]\n",
      "[[Wildlife, drivers, dissemination, genes, resistances, clinically, antimicrobials, presence, extended-spectrum beta-lactamase-, ESBL, carbapenemase-encoding genes, wild birds, sentinels, antimicrobial resistance, AMR, contamination, long-distance, spreaders, case, migratory, birds, wild birds, France, sampled, period, birds, encompassed, sedentary, migratory, species, wild mammals, center, investigated, carbapenemase-producer, identified, proportion, ESBL-positive, isolates, non-duplicate, isolates, Escherichia coli, Enterobacter cloacae, Citrobacter freundii, bla CTX-M- 9 gene, PFGE, phylogroup, MLST, presence, ESBL-positive clones, circulating, animals, Next-generation sequencing, isolates, Southern blot hybridization, dissemination, IncHI2/ST1 plasmid, bla CTX-M- 9, bla SHV- 12, mcr-9 genes, results, cross transmissions, ESC-resistance, ESC-R, Enterobacteriaceae, center, nosocomial spreads, hospital, bacterial, birds, spread, ESC-R, rescue center, clonal, plasmidic, transmission, animals, nature, days, weeks, issue, ESBL, dissemination, natural environments]]\n",
      "[[Infections, carbapenem-resistant Enterobacterales, CRE, therapeutic problem, effective, therapeutic alternatives, study, phenotypic, genotypic methods, carbapenemase-production, resistance-determinants, AmpC, ESBL-production, efflux, pump-overexpression, isolates, Klebsiella spp, Escherichia coli, Enterobacter cloacae complex, Albert Szent-Gyorgyi Clinical Center (University of Szeged, inhibitory, concentrations, meropenem, sulfamethoxazole/trimethoprim, tigecycline, amikacin, moxifloxacin, colistin, fosfomycin, isolates, AmpC-producers, blaCTX-M ESBL-genes, Carbapenemase-genes, detected, tested, isolates, isolates, blaNDM, isolates, blaOXA-48-like, isolates, blaVIM, detected, PCR, species-distribution, isolates, positive, carbapenemase-genes, Klebsiella pneumoniae, Klebsiella oxytoca, E. coli, E. cloacae complex, Efflux, pump-overexpression, PAbetaN-screening agar, tested, strains, isolates, carbapenemase, ESBL-genes, detected, simultaneously, levels, resistance, fosfomycin, moxifloxacin, isolates, susceptible, colistin, phenotypic tests, study, modified, carbapenem, inactivation, mCIM, accurate, PCR, results]]\n",
      "[[Pasteurella multocida, fowl, cholera, contagious, global concern, ecological, economic challenges, poultry, industry, year, study, evaluated, effects, multi-strain, probiotics, Lactobacillus plantarum, L. fermentum, Pediococcus acidilactici, Enterococcus faecium, Saccharomyces cerevisiae, growth performance, intestinal microbiota, haemato-biochemical, parameters, anti-inflammatory, properties, broilers, experimentally, P. multocida, birds, fed, basal diet, probiotics, orally, 10(8) CFU/mL of P. multocida, Probiotics, supplementation, growth, performance, feed, efficiency, reducing, population, intestinal, P. multocida, enterobacteria, mortality, Haemato-biochemical, parameters, total cholesterol, white blood cells, WBC, proteins, glucose, packed cell volume, PCV, lymphocytes, improved, probiotic, fed, birds, compared, controls, Transcriptional profiles, anti-inflammatory genes, hypoxia, HIF1A, tumor necrosis factor- (TNF, gene-6, TSG-6, prostaglandin E receptor 2, PTGER2, intestinal mucosa, upregulated, probiotics, fed, birds, dietary, inclusion, multi-strain, probiotics, growth, performance, feed, efficiency, intestinal, health, attenuating, inflammatory reaction, clinical signs, mortality, associated with, P. multocida, infection, broilers]]\n",
      "[[Exebacase, CF-301, protein-based antibacterial agents, lysins, peptidoglycan hydrolases, Exebacase, lysin, antistaphylococcal activity, Phase 3, clinical development, clinic, accurate, method, exebacase, MIC, determination, Clinical Laboratory Standards Institute (CLSI, reference broth microdilution, BMD, method, cation-adjusted Mueller-Hinton broth, CAMHB, trailing, MIC, exebacase activity, diminished, frozen, BMD, panels, modified, BMD, method, CAMHB, horse serum, DL-dithiothreitol, CAMHB-HSD, Preliminary, QC, ranges, Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212 of 16, results, CLSI, MIC, QC, study, preliminary, QC, ranges, MIC, data, systematic study testing, S. aureus, strain, collection, CAMHB-HSD, investigate, impact, parameters, influence, susceptibility test, results, evaluate, exebacase, MIC, distribution, clinical, S. aureus, isolates, Presentation, data, CLSI Subcommittee, Antimicrobial Susceptibility Testing, AST, approval, CAMHB-HSD, exebacase susceptibility, commencement, multi-laboratory, QC, study, standard, BMD, method, concomitant, QC, confidence, assessment, test, performance, accurate, susceptibility, data, antibacterial drug development]]\n",
      "[[report, results, INICC, surveillance study, intensive care units, ICUs, cities, countries, Latin-America, Europe, Africa, Eastern-Mediterranean, Southeast-Asia, Western-Pacific, Prospective data, patients, hospitalized, ICUs, INICC, Surveillance Online System, CDC-NHSN definitions, device-associated healthcare-associated infection, DA-HAI, data, patients, aggregate, bed-days, central line, mechanical ventilator, urinary catheter, CL-associated, bloodstream infections, CLAB, ventilator-associated events, VAE, UC-associated, urinary tract infections, CAUTI, Pooled, DA-HAI, rates, bed-days, Pooled, CLAB, rate, CL-days, VAE, rate, MV-days, CAUTI, rate, aeruginosa, non-susceptible, NS, imipenem, cases, colistin, ceftazidime, ciprofloxacin, amikacin, Klebsiella spp, NS, imipenem, ceftazidime, ciprofloxacin, amikacin, coagulase-negative Staphylococci, S aureus, NS, oxacillin, Enterococcus spp, NS, vancomycin, cases, DA-HAI, rates, bacterial resistance, high, continuous, reduce]]\n",
      "[[study, evaluated, influence, ultrasonic activation, US, antimicrobial activity, irrigant, glycolic acid, GA, Extracted teeth, counting, colony-forming units, CFUs, confocal laser scanning microscopy, Samples, inoculated, Enterococcus faecalis, groups, distilled water, US, EDTA, Qmix, GA, EDTA, US, QMix, US, GA, US, contact with, test solution, groups, US, CFUs, bacterial, reduction, QMix, US, group, QMix, GA, US, confocal, evaluation, viable cells, EDTA, US, statistical difference, QMix, QMix, US, GA, US, US, improves, antimicrobial activity, EDTA, GA, isolated, irrigants, evaluation tests]]\n",
      "[[scenario, compounds, antimicrobial activity, bacteriocin, bacteriocin-like inhibitory substances, BLIS, tools, deteriorating, pathogenic, microorganisms, potential, applications, food industry, infectious disease control, report, genetic, phenotypic, characteristics, BLIS, Enterococcus faecium E86, strain, isolated, sequenced, group, structural genes, bacteriocins, identified, enterocin TW21, enterocin P. Transcription, genes, associated with, biosynthesis, immunity, enterocin P, enterocin TW21, RT-PCR, Sanger sequencing, truncation, structural gene, enterocin TW21, base pair deletion, A/T, E. faecium, E86, bacteriocinogenic gene clusters, cluster, encodes, functional, bacteriocin, enterocin P. Enterocin, inhibit, strains, Listeria monocytogenes, vancomycin-resistant enterococci, Enterococcus faecalis, Enterococcus faecium, bacteriolytic activity, cases]]\n",
      "[[study, comparing, evaluating, biocompatibility, antibacterial activities, mineral trioxide aggregate, MTA, iRoot BP Plus, retro-filling materials, Discs, materials, prepared, incubated, material, extracts, medium, Flow cytometry, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, assess, rate, apoptosis, proliferation, human, hPDLSCs, eluates, materials, expression, levels, alkaline phosphatase, collagen type I, osteocalcin, Runt-related transcription factor-2, Osterix, tested, evaluating, osteogenic, differentiation, hPDLSCs, antibacterial activities, materials, hPDLSCs, stimulated, MTA, iRoot BP Plus, eluates, cell viability, control group, eluates, No significant, percentages, necrotic, apoptotic cells, stimulated, MTA, iRoot BP Plus, eluates, control group, expression, osteogenic, differentiation, markers, hPDLSCs, experimental groups, control group, increment, values, MTA, group, iRoot BP, Plus group, antibacterial activity, Enterococcus faecalis, no significant, MTA, iRoot BP Plus, materials, retro-filling applications]]\n",
      "[[Gut-associated sepsis, problem, patients, abdominal radiation therapy, pathogens, sepsis, translocated, gut microbiota, treating, sepsis, bacterial, clearance, patient, survival, hepatic, immune response, process, Kupffer cells, hepatic, immune response, infectious agents, populations, Kupffer cells, liver-resident macrophages, Mvarphi, F4/80(+, hepatic Mvarphi, circulating, monocytes, F4/80(+, properties, hepatic Mvarphi, irradiated, normal mice, sepsis, Hepatic F4/80(+) CD11b(-) CD68(+) cells, normal, irradiated, mice, antibacterial activity, F4/80(+, mice, effector cells, sepsis, Enterococcus faecalis, irradiated, mice, lost, ability, hepatic F4/80(+) CD11b(+) CD68(-) cells, infected, mice, IL-12(+) IL-10(-) CD206(-) CCL1(-), hepatic F4/80(+) CD11b(-) CD68(+) cells, mice, IL-12(-) IL-10(+) CD206(+) CCL1(-), M2aMvarphi, normal mice, exposed to, radiation, hepatic F4/80(+) CD11b(+) CD68(-) cells, phenotype, IL-12(-) IL-10(+) CD206(-) CCL1(+), M2bMvarphi, infection, hepatic F4/80(+) CD11b(-) CD68(+) cells, IL-12(-) IL-10(+) CD206(+) CCL1(-), M2aMvarphi, hepatic F4/80(+) CD11b(+) CD68(-) cells, irradiated, mice, antibacterial activity, treatment, CCL1, antisense oligodeoxynucleotides, characteristics, hepatic F4/80(+) CD11b(+) CD68(-) cells, antibacterial response, gut-associated sepsis]]\n",
      "[[gut, pathogenesis, sepsis, Changes, gut microbiota, occurrence, development, human diseases, studies, taxonomic, composition, gut microbiota, septic, patients, Knowledge, changes, gut microbiota, issue, intensive care, Clinicians, gut microbiota, susceptibility, prognosis, septic, patients, Measurements, single-center case control study, septic, patients, healthy, children, taxonomic, composition, gut microbiota, 16S rRNA, gene sequencing, Gut microbiota, diversity, children, sepsis, compared, healthy, children, taxonomic, composition, gut microbiota, children, sepsis, healthy children, taxa, gut microbiota, increased, guts, children, sepsis, compared, healthy, children, increased, abundances, Enterococcaceae, Enterococcus, Enterococcus durans, gut, septic, patients, correlated, blood inflammation, indicators, CRP, WBC, abundances, bacteria, decreased, guts, septic children, compared, healthy, children, decreased, abundance, Bifidobacteriales, gut, septic, patients, correlated, blood inflammation index, WBC, machine-learning classifier, sepsis, AUC, composition, gut microbiota, potential, diagnosis, sepsis, Gut microbiota, alterations, septic, patients, proliferation, opportunistic, pathogenic bacteria, reduction, commensal flora, decrease, diversity, gut microbiota, Dysbiosis, changes, inflammation, indexes]]\n",
      "[[compare, dromedary yogurt's, characteristics, co-fermentation, process, plant, carob powder, autochthonous bacteria, Enterococcus faecium, Streptococcus macedonicus, ultrafiltration process, UF, increase, rate, total solids, dromedary milk, margin, yogurt, Carob powder, autochthonous, bacteria, level, UF milk, mixtures, fermented, strains Lactobacillus bulgaricus, Streptococcus thermophiles, products, CFC, yogurt, carob, CFS, yogurt, autochthonous, strains, control, yogurt, L. bulgaricus, S. thermophilus, weeks, cold, CFC, CFS, maintained, Streptococcus, levels, CFU/g, CFC, lowest, syneresis, cohesiveness, springiness, values, oleic acid, C18:1n9, CFS, yogurt, higher, volatile compound, formation, CFC, control, isobornyl propionate]]\n",
      "[[Peritonitis, complication, peritoneal, dialysis, Peritonitis, gram-positive organisms, coagulase-negative staphylococci, Streptococcus spp, Enterococcus spp, rare, case, peritoneal, dialysis-associated peritonitis, abdominal pain, worsening, laboratory findings, antibiotic therapy, identification, Enterococcus avium, Tenckoff catheter, removal, temporary transfer, haemodialysis, literature reports, cases, peritonitis, agent, atypical, microbial agents, heterogeneous, clinical course]]\n",
      "[[Abstract, Phenotyping, microbiological, physiological, molecular analysis, ARDRA technique, assess, pathogenic, microbial, load, associated with, stages, periodontal disease, global, antimicrobial resistance, isolated, bacterial strains, evaluated, antibiotic susceptibility profile, pathogenic, bacterial, community, Gram-negative strains, species, Citrobacter freundii, Bacillus sp., Raoutella sp., Klebsiella ozaenae, Pseudomonas sp., healthy control group, Staphylococcus spp., isolated, stages, periodontitis, Multidrug resistance, beta-lactam antibiotics, Streptococcus pneumoniae, Raoutella sp., Enterococcus avium, statistically significant, relationship, periodontitis stages, diversity, bacterial, community, Patients, periodontitis, diverse, bacterial, community, healthy, patients, biofilms, multidrug-resistant bacteria, restoring, patient, health, prophylactic measures, oral health, reduce, risk, disease, Graphic Abstract]]\n",
      "[[hexahydrocurcumin-producing, 2a1-2b, isolated, human, feces, bacterium, similarity, Enterococcus avium, ATCC14025(T, 16S ribosomal DNA, strain, 2b, optically active 5R-hexahydrocurcumin, enantiomeric, excess, tetrahydrocurcumin, curcumin, results, intestine, hexahydrocurcumin]]\n",
      "[[florfenicol-resistant enterococci, isolated, swine fecal samples, pig, farms, investigated, presence, optrA, cfr, poxtA genes, PCR, florfenicol-resistant Enterococcus, isolates, linezolid, optrA, linezolid, cfr, poxtA, detected, enterococcal, isolates, WGS, analysis, presence, cfr(D) gene, Enterococcus faecalis, isolates, Enterococcus avium, isolate, linezolid, resistance genes, hybridized, chromosome, plasmids, isolates, linezolid, enterococci, recipient, WGS, analysis, variability, optrA, genetic contexts, identical, transposons, Tn6628, Tn6674, plasmids, pWo27, chromosomal regions, cfr, environments, identities, Tn6644-like transposon, region, p12, plasmid, cfr(D, genetic, plasmid, Enterococcus faecium E8014, poxtA, Tn6657, Circular forms, optrA-, poxtA-carrying, genetic, Clonality analysis, presence, E. faecalis, ST16, ST27, ST476, ST585, E. faecium, ST21, clones, isolated, humans, results, dissemination, linezolid, resistance genes, enterococci, swine origin, Central Italy, confirm, spread, linezolid, resistance, animal settings]]\n",
      "[[report, fatal, septic shock, associated with, Clostridium perfringens, Enterococcus avium bacteremia, infective gastroenteritis, case, hepatic infarction, abscess, death, gastroenteritis, Aboriginal, man, rural hospital, suspected, food poisoning, patient, persistent, fever, empirical, antibiotics, His blood culture results, positive, Clostridium perfringens, Enterococcus avium, tertiary center, organ failure, refractory shock, computed tomography, abdomen, unremarkable, imaging, small bowel enteritis, hepatic abscess, infarction, portal vein, septic thromboembolism, maximal, intensive care, treatment, percutaneous drainage, hepatic abscess, antibiotic, patient, died, days, presentation, case, rare, fatal, course, sepsis, associated with, Clostridium perfringens, bacteremia, detrimental, effects, coinfection, Enterococcus avium, potential, seeding, abscess, formation, rural practice, urgent, early referral, intensive care support, patients, complex, comorbidities]]\n",
      "[[study, lactic acid bacteria, strains, infants, feces, evaluate, probiotic, potential, antimicrobial activity, isolates, inhibited, growth, enterotoxigenic, Escherichia coli K88, Salmonella enterica ATCC 13076, 16S rRNA sequence analysis, isolates, Lactobacillus casei, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus, Enterococcus avium, Enterococcus faecium, Enterococcus lactis, species, strains, antimicrobial activity, investigated, presence, probiotic, properties, physiological-biochemical characteristics, antimicrobial susceptibility, hemolytic activity, hydrophobicity, aggregation activity, Wide-spectrum, antimicrobial activity, strains, inhibited, pathogens, strains, ZX221, ZX633, ZX3131, ZX3875, probiotic, properties, exposed to, simulated, gastrointestinal tract, conditions, investigated, influence, pH, antimicrobial activity, strains, inhibited, pathogens, pH, pH, ZX633, inhibitory, Bacillus subtilis ATCC 6633, Micrococcus luteus ATCC 4698, pH, Lact, casei ZX633, antimicrobial activity, potential, probiotic]]\n",
      "[[oxazolidinone resistance genes, cfr, optrA, enterococcal, isolates, enterococcal, isolates, screened, presence, cfr, optrA, polymerase chain reaction, transferability, cfr, optrA, conjugation, S1 nuclease pulsed-field gel electrophoresis, Southern blotting, location, cfr, Enterococcus faecalis, isolate, cfr, optrA, sequenced, cfr, optrA, detected, enterococcal, isolates, enterococcal, isolates, E. faecalis, Enterococcus avium, Enterococcus mundtii n=1, cfr, cfr-carrying fragment, res, theta, plasmid, p4, identity, region, plasmid pEF120805, vancomycin-resistant Enterococcus faecium, optrA-carrying segment, tnpB, optrA, plasmid, identity, region, genomic DNA, E. faecalis A101, Plasmid, p4, plasmid, conjugated, E. faecalis JH2-2, optrA-positive enterococci, identified, enterococcal, isolates, swine, farm, environment, co-existence, cfr, optrA, E. avium, E. mundtii, cfr, optrA, identified, conjugative plasmids, E. faecalis, isolate, optrA-carrying segment, IS1216E-optrA-IS1216E, enterococcal plasmids, ISEnfa5 and IS1216E elements, dissemination, cfr, optrA]]\n",
      "[[Peritonitis, severe, complication, patients, peritoneal dialysis, morbidity, mortality, vigilance, healthcare providers, management, patients, prevent, complication, recognition, peritonitis, organisms, improved, microbiological detection, techniques, Gram-positive organisms, frequent, peritonitis, Gram-negative organisms, rare, case, peritonitis, Enterococcus avium, male, peritoneal, dialysis, palpitations, abdominal pain, diarrhea, cloudy, effluent, peritoneal fluid, analysis, consistent with, peritonitis, peritoneal fluid, culture, E. avium, patient, treated with, linezolid, vancomycin, peritoneal, removed, dialysis, modality, hemodialysis, refractory peritonitis]]\n",
      "[[Enterococcus species, bacteremia, liver transplant, recipients, Vancomycin-resistant enterococci, VRE, nosocomial infection, study, analyzed, incidence, antibiotic resistance, outcomes, enterococcal bacteremia, living donor liver transplant, recipients, risk factors, VRE, single-center, retrospective review, patients, liver transplant, January, patients, enterococcal, episodes, Enterococcus faecium, Enterococcus faecalis, Enterococcus casseliflavus, Enterococcus, avium, Enterococcus raffinosus, cases, enterococcal bacteremia, months, transplant, cases, VRE, bacteremia, month, transplant, E. faecium, isolates, rate, vancomycin, resistance, E. faecalis, isolates, susceptible, vancomycin, multivariate analysis, post-transplant dialysis, odds ratio, CI, length, post-transplant hospital stay, odds ratio, CI, associated with, VRE, bacteremia, One-year, mortality, recipients, enterococcal bacteremia, nonbacteremic, patients, patients, nonenterococcal bacteremia, study, enterococcal bacteremia, incidence, liver transplant, recipients, vancomycin, resistance, early period, transplant, associated with, increased, mortality, rates, resistance, vancomycin, enterococcal infection, liver transplant, recipients, center]]\n",
      "[[Diet, diversity, composition, gut microbiota, Usage, antibiotics, food production, human, veterinary medicine, emergence, commensal, antibiotic, resistant, bacteria, human, gut, incidence, erythromycin-resistant lactic acid bacteria, LAB, feces, healthy, vegans, ovo-lacto vegetarians, omnivores, analyzed, LAB, isolated, characterized, phenotypic, genotypic resistance, erythromycin, isolates, species, Enterococcus, Streptococcus genera, Enterococcus faecium, dominant, species, isolates, dietary, categories, isolates, resistant, erythromycin, Minimum Inhibitory Concentration, MIC, determination, isolates, vegans, ovo-lacto vegetarians, omnivores, erm(B) gene, copresence, erm(B), erm(A) genes, Enterococcus avium, omnivores, transferability, erythromycin, resistance genes, multidrug-resistant, MDR, cultures, groups, assessed, isolates, transfer, erm(B) gene, isolates, omnivore samples, resistance, antibiotics, tested, antibiotic resistance, isolates, ovo-lacto vegetarians, vegans, results, diet, occurrence, erythromycin-resistant bacteria, commensal, strains, reservoir, antibiotic resistance, source, antibiotic resistance, spreading]]\n",
      "[[AIM, study, lactic acid bacteria, LAB, rabbits, autochthonous, probiotic, faecal samples, wild, laboratory rabbits, isolates, collected, tested, inhibitory, pathogenic bacteria, Enterococcus, isolates, inhibit, pathogen, Enterocine genes, entA, entB, entP, detected, isolates, isolates, tested, antibiotic susceptibility, genes, encoding, virulence factors, phenotypes, antibiotic resistance, ampicillin, vancomycin, linezolid, virulence genes, detected, positive, isolates, hyl, esp, gelE, agg, ace, efa, CylLL/s, cob, cpd, ccf, isolates, tolerance, acid, bile salt, Bacteriocinogenic enterococci, isolates, rabbits, resistance, phenotypes, virulence factors, Enterococcus durans, isolate, autochthonous, probiotic, SIGNIFICANCE, IMPACT, study, properties, E. durans, isolate, utilization, autochthonous, probiotic, rabbit, husbandry]]\n",
      "[[investigate, Antimicrobial Resistance, AMR, enterococci, isolated, raw ewes, cows, milk, samples, semi-extensive, sheep, cow farms, western Sicily, Plate counts, Rapid, Enterococcus Agar, detect, food enterococci, maximal, enterococcal, concentration, approximately, Colony Forming Unit, (CFU)/mL., Colonies, isolated, differentiated, genetic analysis, Randomly Amplified Polymorphic DNA (RAPD)-PCR, strains, identified, Analysis, species-specific multiplex PCR assay, grouped, strains, Enterococcus species, Enterococcus durans, Enterococcus faecalis, Enterococcus faecium, strains, investigated, antimicrobial resistance, phenotypic approach, Enterococcus, resistance, antimicrobials, tested, dairy enterococci, vector, dissemination, antimicrobial resistance, enterococci, AMR, traits, semiextensive dairy, sheep, cow farms, western Sicily, relevance, dairy, veterinary, antimicrobial, mitigate, problems, public health, veterinary medicine]]\n",
      "[[Probiotics, host-microbe interactions, natural, ecosystem, controlling, bacterial infections, aquaculture, veterinary systems, isolation, characterization, pathogenic, Vibrio spp., lactic acid bacteria, intensive culture system, Litopenaeus vannamei, natural, ecosystem, pathogen, isolated, gut, L. vannamei, symptoms, white gut disease, V. parahaemolyticus, V. campbelli, pathogens, expressed, virulence genes, rtxA, tcpA, antibiotic resistance, MAR, lactic acid bacteria, isolated, sediment, gut, benthic organisms, shrimp, polychaetes, tropical estuary, OTUs, Pediococcus stilessi, Lactobacillus fermentum, L. rhamnosus, Weissella cibaria, Enterococcus durans, E. fecalis, Streptococcus gallolyticus, L. garvieae, isolates, facultative, nature, gastric juice, bile salt, bacteria, isolated, sediment, gut, abilities, reduce, pH, culture medium, isolates, production, hydrolytic, enzymes, secondary, metabolites, antagonistic activity, pathogens, V. parahaemolyticus, V. campbelli, study, natural, ecosystem, source, lactic acid bacteria, probiotic, potentials, prevent, vibriosis disease, outbreaks, shrimp aquaculture systems, studies, abilities, lactic acid bacteria, colonize, shrimp intestine, stimulate, immune system, microbiome, online version]]\n",
      "[[Himalayan people, dry, oval, round-shaped starter, cultures, ferment, cereals, mild-alcoholic beverages, lactic acid bacteria, LAB, essential, microbiota, probiotic, characters, LAB, isolated, dry starters, screened, probiotic, functional, properties, LAB strains, isolated, dry starters, Eastern Himalayas, phab, paa, pee, phut, LAB strains, high survival rate, pH, bile salts, Enterococcus durans, BPB21, SMB7, highest, hydrophobicity, percentage, E. durans, DMB4, SMB7, maximum, cholesterol, assimilation activity, LAB strains, beta galactosidase, strains, phytase, activity, strain, amylase activity, LAB strains, optimum, tolerance, ethanol, concentration, Genetic screening, probiotic, functional, analysed, occurrence, clp, L gene, agu A gene, survival, gastrointestinal tract, conditions, apf, mub1, map A gene, adhesion genes, genes, occurrence, bsh gene, bile salt tolerance, detected, Pediococcus pentosaceus, SMB13, Enterococcus faecium, BPB11, Gene ped B, pediocin, amplicon size, detected, E. durans, DMB13, Pediococcus acidilactici, AKB3, Detection, nutritional marker, gene rib A, strains, potential, synthesize, riboflavin, folic acid, LAB, probiotic, functional, properties, food industry]]\n",
      "[[Enterococcus durans strain, OSY-EGY, isolated, artisanal cheese, comparative genomic, phenotypic analyses, assess, safety, characteristics, probiotic, traits, bacterium, genomic analysis, strain, pathogenic, Enterococcus spp, genome, genes, encoding, antibiotic resistance, marker, virulence factors, associated with, Enterococcus spp, Phenotypically, bacterium, susceptible, vancomycin, ampicillin, tetracycline, chloramphenicol, aminoglycosides, hemolytic, gelatinase activity, cytotoxic effect, Caco-2, cells, findings, lack, hazardous, traits, E. durans, Mining, E. durans, genome, probiotic-related sequences, genes, associated with, acid, bile salts tolerance, adhesion, competitiveness, antioxidant activitiy, antimicrobial activity, essential, amino acids, production, vitamins biosynthesis, Phenotypically, E. durans, OSY-EGY, tolerant, acidic, pH, presence, bile salts, bacterium, adhesion, capability, Caco-2, cells, cholesterol-lowering effect, DPPH, scavenging activity, antimicrobial activity, Gram-positive pathogenic bacteria, E. durans, OSY-EGY, strain, probiotic, antimicrobial, traits, investigated, strain, industrial, applications]]\n",
      "[[Enterococcus durans, rare, cause, infective endocarditis, case, female, late prosthetic valve infective endocarditis, mechanical mitral valve, Medical management, failed, demise, patient]]\n",
      "[[Practices, intensive, animal, farming, antimicrobials, impacts, genetic, make-up, bacterial, communities, human/animal commensals, report, whole genome sequencing, vancomycin-resistant enterococci, VRE, isolates, cattle, feedlot, North West Province, South Africa, threats, antimicrobial, usage, intensive, animal, rearing, environmental, microbiomes, food chain, genomic DNA, strains, DNA extraction kit, Whole-genome sequencing, next-generation sequencing, genomes, Enterococcus durans, NWUTAL1, Enterococcus gallinarum, strain S52016, bp, G + C, contents, Antibiotic resistance genes, ARG, plasmids, virulence factors, biofilm formation, colonization, copper/silver efflux system, detected, genomes, strains, genetic determinants, strains, disseminate, food chain, horizontal gene transfer, bacteria, ecological niches, Issues, nature, undermined, relevant, food safety]]\n",
      "[[AIM, Microwave-assisted condensation, acetophenone 1, aromatic aldehydes 2, chalcone, cyclized, pyrazole derivatives 6a-f, reaction, hydrazine hydrate, oxalic acid, presence, catalytic amount, acetic acid, ethanol, structural, features, synthesized, compounds, characterized, melting point, FT-IR, 1H, 13C NMR, elemental analysis, antibacterial activities, synthesized, pyrazoles, evaluated, gram-positive bacteria, Enterococcus durans, Staphylococcus aureus, Bacillus subtilis, gram-negative bacteria, Escherichia coli, Salmonella typhimurium, synthesized, pyrazoles, antibacterial activity, S. aureus, strain, antibacterial activity, E. coli]]\n",
      "[[Consumer's, vigilance, health-promoting foods, taste, nutrition, increased, recognition, probiotic products, study, parameters, probiotic, properties, cultures, isolated, fermented products, samples, screened, antimicrobial compound, AMC, isolates, overlay-plate assay, Micrococcus luteus, zone, isolates, cultures, Gram-positive, catalase negative, non-spore forming, non-motile rods, cocci, strains, non-hemolytic, absence, biogenic, gelatinase, lecithinase negative trait, isolates, biochemical assays, RAPD-PCR, cultures, DB-1aa, DB-b2-15b, Cu2-PM7, Cu3-PM8, IB-pM15, 16S rDNA sequencing, Enterococcus durans, Enterococcus faecium, Lactobacillus plantarum, Lactobacillus fermentum, in vitro, experiments, acid, bile tolerance, survival, simulated, gastrointestinal condition, adhesion, assay, evaluate, probiotic, potential, isolates, isolates, competent, properties, antibacterial, antioxidant activity, enzyme, production, functional, application, results, study, efficiency, isolates, probiotic, cultures, recommended, application, functional food formulations]]\n",
      "[[Objective, Urinary tract infections, UTIs, infections, antibiotic intervention, Antibiotic, surveillance programs, resistance, patterns, microorganisms, associated with, UTIs, antibiotic therapy, study, investigate, prevalence, uropathogens, antimicrobial susceptibility, Ha'il region, retrospective study, hospitals, Ha'il, period, Laboratory reports, clinical data, patients, positive, urine culture, study, patients, study, positive, cultures, female, patients, adults, outpatients, Escherichia coli, pathogen, Klebsiella pneumoniae, Staphylococcus aureus, Extended-spectrum beta-lactamase, strains, E. coli, K. pneumoniae, resistance, tested, antibiotics, Gram-negative uropathogens, ESBL strains, low, resistance, cefoxitin, imipenem, meropenem, strains, Staphylococcus aureus, Enterococcus faecalis, resistant, trimethoprim/sulfamethoxazole, methicillin-resistant Staphylococcus aureus, MRSA, vancomycin-resistant Enterococcus faecalis, VRE, activity, linezolid, strains, Gram-positive uropathogens, surveillance study, period, Ha'il region, UTI-associated, pathogen, E. coli, sensitivity, profiles, surveillance, carbapenems, linezolid, therapeutic choice, treating, UTIs, Ha'il, Gram-negative, positive, uropathogens, Frequent, targeted, antibiotic-resistant, pathogens, susceptibility profiles, empirical, treatment, patients]]\n",
      "[[Enterococci, opportunistic, pathogens, bacteria, hospital-acquired infections, resistance, antibiotics, vancomycin, life-threatening, difficult-to-treat, nosocomial infections, true prevalence, clinical settings, Nigeria, lack, comprehensive, antibiotic surveillance system, study, estimate, prevalence, vancomycin-resistant enterococci, VRE, clinical infections, Nigeria, Databases, PubMed, African Journal Online, Google scholar, Preferred Reporting Items, Systematic review, meta-analysis protocols, PRISMA-P, statements, articles, VRE, prevalence, published, Data, studies, extracted, analyzed, Microsoft Excel, CMA, pooled, prevalence, VRE, random-effects model, confidence interval, CI, heterogeneity, level, assessed, Cochran Q and I, tests, articles, scanned, eligibility, study, eligibility criteria, studies, analyzed, enterococci, isolates, VRE, strains, prevalence, Enterococcus faecium, E faecalis, study, E faecium, E faecalis, vancomycin, resistant, pooled, prevalence, VRE, estimated, CI, prevalence, VRE, western Nigeria, CI, prevalence, VRE, Nigeria, reports, study, report, study, policymakers, measures, spread, VRE, resistant, genes, clinical, pathogens, Staphylococcus aureus]]\n",
      "[[Enterococcus faecalis, environmental agent, bovine mastitis, cows, cytopathic, effects, urinary tract, humans, animals, study, lytic bacteriophage, vB_EfaS-DELF1, isolated, E. faecalis, isolated, bovine mastitis, vancomycin-resistant E. faecalis, VRE, vB_EfaS-DELF1 bacteriophage, E. faecalis, lytic effects, Enterococcus spp., Gram-negative, Gram-positive bacteria, no activity, yogurt, starters, phage, suspension, stable, pH, salinity, temperature, activity, fat milk, vB_EfaS-DELF1, phenotypic, features, Siphoviridae, double-strand DNA, length, G + C, content, genome, encodes, ORFs, tRNA, lysogenic mediators, antibiotic resistance, virulence factor genes, detected, genome, genomic analysis, similarity, phage, genomes, similarity, phages, coverage, identities, IME-EFm1, coverage, identities, IME-EFm5, clade, phages, high, distant clusters, specificity, bacteriophage, tested, E. faecalis, isolates, vancomycin-resistant, absence, antibiotic resistance, virulence genes, genome, vB_EfaS-DELF1, biocontrol, E. faecalis infections]]\n",
      "[[membrane-bound protease Eep, virulence factor, pathogenic enterococci, protein, stress response, RIP, pathway, pathogenic, enterococci, host, immune attacks, infection, Eep, receptor, bacteriocins enterocin K1, enterocin EJ97, bacteriocins, kill, Enterococcus faecium, E. faecalis, antibiotic resistant derivatives, vancomycin, resistant, enterococci, VRE, functional, duality, Eep, enterocins, options, prospective treatment, enterococcal infections, wildtype enterococcal cells, intact, Eep, sensitive, bacteriocins, bacteriocin-resistant-mutants, functional, Eep, virulent, therapeutic, potential, treatment, systemic, enterococcal infections, investigated, compatibility, bacteriocins, human blood, phenotypic, changes, eep-mutants, stress conditions, bacteriocins, blood, haemolysis, bacteriocins, antibacterial effect, incubated, blood, bacteriocins, autoclavable, criterium, development, parenteral administration, Eep-mutants, resistant, bacteriocin, stress conditions, exposure to, lysozyme, desiccation, chain, trait, niche, adaptation, genetic transfer, conjugation, severely, affected, results, bacteriocins, treatment, VRE, infection]]\n",
      "[[IS, vancomycin-resistant enterococci, VRE, health problem, countries, world, Asia, discovery, data, VRE, countries, Asia, pooled, estimates, systematic review, meta-analysis, estimate, pooled, prevalence, VRE, Asia, literature, search, electronic databases, PubMed, Embase, Google Scholar, manual, references, grey literature, information, prevalence, VRE, species, enterococci, countries, Asia, random-effect model, CIs, calculate, pooled, prevalence, Subgroup, sensitivity, meta-regression analyses, heterogeneity, Egger's test, publication, bias, studies, enterococcal, isolates, analysis, pooled, prevalence, VRE, Asia, CI, Resistance, vancomycin, strains, E. faecium, strains, E. faecalis, regions, Asia, prevalence, VRE, Western Asian region, lowest, South-east Asian region, rate, VRE, European countries, lower, USA, IS, VRE, Asia, years, efficient, infection control programmes, robust, surveillance systems, adherence, antibiotic, stewardship, VRE]]\n",
      "[[vancomycin-resistant Enterococci, VRE, severe, medical problem, clinics, vancomycin, prescription, vancomycin, resistance, transfer, vancomycin, resistance, Enterococcus faecalis, increased, treatment, streptomycin, treatment, antibiotic, bacteria, resistant, response, stronger, plasmid, pCF10, transconjugants, increased, antibiotics, induced, conjugal response, mathematical model, gene regulation, explanation, quorum sensing, cell density, triggers, conjugation, generality, Bacillus subtilis, outcome, study, antibiotics, overused]]\n",
      "[[Vancomycin-resistant enterococci, VRE, Centers for Diseases Control and Prevention, antibiotic resistance, threat, study, characterize, epidemiology, associated conditions, outcomes, VRE, infections, hospitalized patients, U.S., military health system, MHS, retrospective cohort study, patients, VRE, infection, MHS, database, Cases, patients, admitted, military treatment facility, days, clinical culture, Enterococcus faecalis, Enterococcus faecium, Enterococcus species, resistant, vancomycin, Co-morbid conditions, procedures, associated with, VRE, infection, identified, multivariable conditional logistic regression, Patient case-mix, outcomes, in-hospital mortality, length of stay, hospitalization, cost, evaluated, high-dimensional propensity score, adjustment, period, hospitalized, patients, MHS, identified, patients, VRE, infection, VRE, infections, urinary tract infections, bloodstream, site/device-related, respiratory, wound infections, Risk factors, VRE, infection, invasive, pulmonary, urologic procedures, indwelling devices, exposure to, 4th generation, cephalosporins, glycopeptides, Patients, hospitalized, VRE, infection, hospitalization, costs, AD, prolonged, AD, days, higher, in-hospital mortality, case-mix, odds ratio, confidence interval, VRE, infections, burden, hospitalized patients, impact, length of stay, hospitalization, costs, in-hospital mortality, Active surveillance, infection control, target, high-risk, VRE, infection, Antimicrobial, stewardship, programs, exposure to, 4th generation cephalosporins]]\n",
      "[[Enterococcus faecalis, Enterococcus faecium, community-acquired, nosocomial infections, antibiotic therapies, monotherapies, synergistic effect, study, investigate, in vitro, activity, vancomycin, combined, fosfomycin, agar dilution method, VRE, strains, clinical, VRE, strains, study, Bacterial, identifications, strains, routine, resistance, vancomycin, investigated, broth microdilution method, fosfomycin, agar dilution method, results, CLSI, guidelines, experiments, glucose-6-phosphate, fosfomycin, fractional inhibitory concentration, FIC, indexes, FICI, synergism, FICI, strains, VRE, time-kill curves, synergistic, results, antibiotics, MIC, tests, Viable counts, 24-hour intervals, Time-kill curves, colony forming unit, time, Susceptibility, rate, fosfomycin, MIC50,90, MICrange, values, antimi-crobials, vancomycin, fosfomycin, rate, synergism, result, combination, vancomycin, fosfomycin, treatment, infections, VRE]]\n",
      "[[increasing, prevalence, VRE, detection, low-level, resistance, vanB, Enterococcus faecium, prospective study, analysed, vanB-mediated, vancomycin, resistance, detected, Vitek2, enterococcal, isolates, clinical specimens, tested, Vitek2, bioMerieux, Nurtingen, Germany, bacterial suspension, turbidity, equivalent, McFarland standard, inoculated, chromID, VRE, screening agar, bioMerieux, incubated, vancomycin, tested, susceptible, Vitek2, growth, detected, screening agar, PCR, vanA/vanB, GeneXpert vanA/B test, Cepheid, Frankfurt, Germany, isolates, tested, susceptible, vancomycin, Vitek2, vanA/B, positive, MICs, cultivation, broth, increasing, concentrations, vancomycin, E. faecium, VRE, vanB, positive, Vitek2, VRE, sensitivity, broth microdilution, isolates, MICs, vancomycin, MICs, increase, vancomycin, exposure, isolates, growth, chromID, VRE, vancomycin, exposure seven, isolates, grow, chromID, VRE, Vitek2, detect, vanB-mediated, vancomycin, resistance, low-level, resistance, treatment failure, dissemination, vanB, VRE, methods, culture, VRE, screening agar, PCR, vanB-positive enterococci, clinical routine]]\n",
      "[[Vancomycin-resistant enterococci, VRE, nosocomial pathogens, life-threatening, infections, hospital-associated infections, skin antisepsis, bathing, chlorhexidine, VRE, patients, acute care hospitals, exposure to, inhibitory, chlorhexidine, levels, induced, expression, vancomycin, resistance genes, VanA-type Enterococcus faecium, vancomycin, susceptibility, increased, VanA-type E. faecium, presence, chlorhexidine, synergistic, antimicrobials, study, approaches, investigate, mechanism, synergism, chlorhexidine, vancomycin, VanA-type VRE, strain, E. faecium 1,231,410, clean deletions, pbp, transpeptidase, carboxypeptidase genes, strain, ponA, pbpF, pbpZ, pbpA, ddcP, ldtfm, vanY, Deletion, ddcP, encoding, membrane-bound carboxypeptidase, synergism, phenotype, in vitro, evolution, isolated, spontaneous, escaper mutant, genome sequencing, mutation, pstB, encoding, ATPase, phosphate-specific transporters, synergism, excess, D-lactate, D-alanine, enhanced, synergism, vancomycin, MIC, levels, factors, chlorhexidine, vancomycin, synergism, model, VanA-type VRE, strain]]\n",
      "[[Vancomycin-resistant Enterococcus faecium, nosocomial enterococcal infections, therapeutic problem, susceptibility, antibiotics, resistance, glycopeptide antibiotics, so-called van genes, resistance type, Germany, vanB-type, data, molecular epidemiology, Germany, epidemiological typing, Enterococcus faecium, isolates, vanB-type resistance, German, hospitals, Essen, Nuremberg, outbreaks, sporadic, cases, investigated, isolates, vanB-type resistance, characterized, multilocus sequence typing, MLST, pulsed-field gel electrophoresis, PFGE, ST, sequence type, ST, hospitals, PFGE, isolates, study, PFGE, genetic diversity, epidemiologically, in-hospital outbreaks, genetically, in-hospital transmissions, events, results, MLST, allocation, STs, Germany, PFGE, genetic diversity, vanB, VRE, hospitals, hospital, In-hospital transmissions, rare, outbreaks, data, screen, isolate, patients, transmission, events, detect, monoclonality, source, hygiene, mismanagement]]\n",
      "[[Colitis, chronic gastrointestinal system disease, characterized, inflammation, inner lining, colon, Infectious colitis, colitis, associated with, significant, mortality, morbidity, rare, colitis, vancomycin-resistant Enterococcus faecium, VRE, prevalence, VRE, increased, hospitals, case, American man, admitted, bilateral, hospital course, complicated, acute hypoxic respiratory failure, secondary to, pneumonia, patient, intubated, broad-spectrum antibiotics, patient, severe, diarrhea, clostridium difficile, infection, Patient symptoms, course, antibiotics, Colonoscopy, patient, severely, vascular, congested, erythematous, friable, contact bleeding, hemorrhagic, inflamed, nodular, ulcerated mucosa, sigmoid colon, descending colon, transverse colon, biopsy, patient, VRE, effective, treatment, VRE, Hospitals, active surveillance program, patients, infection, spread, patients]]\n",
      "[[Vancomycin-resistant Enterococcus faecium, VRE, sequence type 80 (, ST80, disseminating, hospital settings, study, whole-genome sequencing, approaches, epidemiological typing, VRE, investigating, collection, ST80 strains, VRE, isolates, suspected, transmission chains, WGS, genetic relationship, isolates, analysed, core genome multilocus sequence typing, cgMLST, single nucleotide polymorphism, (SNP)-based typing, published genome sequence, predominant, ST80 clone, Copenhagen, analyses, Group, isolates, recovered, geographic area, isolates, outbreak, vanA, genotype, Group, isolates, detected, outbreak, Group, non-outbreak, isolates, isolates, outbreak, vanB, genotype, findings, allelic, difference, SNPs, VRE, strains, outbreak, alleles, genomes, Copenhagen clone, outbreak, strains, study, findings, SNP, analysis, typing, samples, groups, ST, optimal, reference, genome, cgMLST, SNPs, epidemiological discrimination, isolates, suspected, transmission chain, diverse, isolates, SNP, analysis, suboptimal, cgMLST, first-line typing method, SNPs]]\n",
      "[[screening, intestinal, carriage, vancomycin-resistant Enterococcus spp., VRE, risk, patients, Balkan, region, molecular epidemiology, VRE, investigated, infection control, study, baseline, data, VRE, intestinal, carriage, high-risk, patients, Serbian, university hospitals, phenotypic/genotypic profiles, isolated, VRE, knowledge, local resistance, bridge, gaps, VRE, surveillance, VRE, reservoir, investigated, stool samples, inpatients, Characterization, isolated, VRE, stains, BD, Phoenix system, genotypic, identification, glycopeptide, quinupristin-dalfopristin, Q-D, resistance, probing, virulence gene, esp, hyl, efaA, asa1, gelE, cpd, detection, MLVA, Biofilm formation, evaluated, microtiter plate method, VRE, carriage, prevalence, at-risk, patients, VRE, strains, vanA positive, Enterococcus faecium, VRfm, ermB-1, esp, efaA, hyl, asa1, gelE, cpd, Ability, biofilm production, detected, Genetic relatedness, isolates, clusters, heterogeneous, picture, unique, MTs, profiles, prevalence, VRE, intestinal, carriage, high-risk inpatients, Serbia, European, average, multidrug resistance, emergence, resistance, Q-D, concern, monitoring, pattern, resistance, adherence, guidelines, Serbia]]\n",
      "[[study, evaluated, short-, long-term, effects, dietary supplementation, Enterococcus hirae, UPM02, growth, performance, immunity, disease resistance, hybrid catfish, Clarias gariepinus, Clarias macrocephalus, Aeromonas hydrophila, infection, long-term, fingerling fish, fed, diets, control, E. hirae, days, Administration, E. hirae, UPM02, effects, growth rate, SGR, feed, efficiency, body indices, gut villus, physiology, catfish, E. hirae, UPM02, application, increased, complete blood cell counts, phagocytic activity, respiratory burst, lysozyme, ACH50, activity, tested, catfish, experimental periods, Dietary, E. hirae, UPM02, concentrations, increased, expression, levels, alpha-2-macroglobulin, alpha2M, CC, chemokines, CXC, chemokines, lysozyme c, LYZC, myeloperoxidase, MYE, NF-kappa-B1 p105 subunit, NF-K, bactericidal permeability-increasing protein, head kidney, liver, spleen, days, application, heat shock protein 70, HSP70, gene expression, downregulated, organs, fish, fed, diets, E. hirae, UPM02, postchallenge, mortality rates, days, A. hydrophila, control fish, short-term, days, juvenile catfish, concentrations, E. hirae, growth, parameters, concentrations, elevated, immune, parameters, long-term, application, Immune-related, gene expression, upregulated, day, head kidney, day, liver, day, spleen, fish, treated with, concentrations, probiotics, Mortality, days, A. hydrophila, groups, concentrations, probiotic, control group, results, dietary, supplementation, E. hirae, CFU/g, influenced, immune responses, enhanced, disease protection, stimulated, immunity-related, gene expression, hybrid catfish, short-, long-term, application, growth enhancement, long-term, application]]\n",
      "[[Whole genome analysis, species, enterococci, Enterococcus lacertideformus, multi-systemic, fatal, endangered, Christmas Island, reptiles, genetic elements, potential, mechanisms, pathogenic, biofilm-forming, capabilities, immune recognition avoidance, inability, grow, in vitro, clinically significant, enterococci, evolutionary history, bacterium, genes, novel, absent, genome, G + C, content, circular chromosome, plasmids, bp, length, genes, tRNAs, rRNAs, Multi-locus sequence typing, MLST, single nucleotide polymorphism, analysis, multiple, E. lacertideformus, samples, indistinguishable, clonal, E. lacertideformus, Enterococcus faecium, species, clade, Enterococcus villorum, F1129D, 16S rDNA, MLST, house-keeping gene analysis, Antimicrobial resistance, DfreE, EfrB, tetM, bcrRABD, sat4, virulence genes, Fss3, ClpP, genes, metals, biocides, identified, detection, genes, encoding, antimicrobial resistance, virulence, bacterium, exposure, clinically significant, antibiotics, Genes, functional, properties, identified, prophages, insertion elements, integrative conjugative elements, genomic islands, Functional, CRISPR-Cas arrays, defective, prophage region, identified, genome, study, genomic loci, E. lacertideformus, genes, cell, biogenesis, carbohydrate metabolism, transport functionality, finding, detection, enterococcal, EfaAfs, srtC, biofilm, phenotype, bacterium, Comparative analysis, E. lacertideformus, phylogenetically related, clinically significant, enterococci, E. villorum, F1129D, Enterococcus hirae R17, E. faecium AUS0085, Enterococcus faecalis, OG1RF, absence, genes, E. lacertideformus, encode, metabolic, functionality, nutrient, acquisition, utilization, bacterium, growth, in vitro, data, genetic, phenotype, pathogenic, bacterium]]\n",
      "[[Enterococci, opportunistic, pathogens, public, increasing, prevalence, antimicrobial resistance, hospital-adapted enterococci, livestock, association, livestock, hospital-adapted enterococci, unclear, study, investigates, antimicrobial, susceptibilities, enterococci, isolated, pig, cecal samples, genomic characteristics, Enterococcus faecium, pigs, isolates, meat, chickens, human, sepsis, cases, cecal samples, antimicrobial susceptibility testing, E. faecium, E. hirae, E. faecalis, Whole-genome sequencing, E. faecium, isolates, sequences, isolates, meat, chickens, human, sepsis, cases, bioinformatics, analysis, Resistance, non-wild type, erythromycin, gentamicin, tetracycline, ampicillin, daptomycin, virginiamycin, quinupristin-dalfopristin, identified, isolate, vanC, operon, resistance, species, vancomycin, teicoplanin, linezolid, antimicrobials, treat, enterococcal infections, humans, E. faecium, isolates, chickens, genetically, human, pig, isolates, Human, strains, pig, strains, hospital-adapted strains, identified, results, study, enterococci, Australian, finisher, pigs, source, resistance, antimicrobials, E. faecium, pigs, human, hospital-adapted population, Resistance, antimicrobials, vancomycin, teicoplanin, linezolid, enterococci, Australian, finisher, pigs, antimicrobial resistance, resistance, quinupristin-dalfopristin, combination, streptogramin, antimicrobials, identified, absence, streptogramin, Australia-wide, resistance, enterococci, pigs, chloramphenicol, erythromycin, tetracycline, resistance, Genomic comparison, E. faecium, Australian, pigs, isolates, studies, chickens, humans, E. faecium, pigs, genetically, humans, chickens, increased, genetic similarities, E. faecium strains, pigs, phylogenetically, dominant, hospital-adapted strains, sepsis, humans, results, Australian, finisher, pigs, source, hospital-adapted E. faecium, Australia]]\n",
      "[[Linezolid, last-resort antibiotic, treatment, severe, infections, multidrug-resistant, Gram-positive organisms, linezolid, resistance, uncommon, linezolid-resistant enterococci, increased, years, spread, resistance genes, cfr, optrA, poxtA, clinical, animal, environmental settings, study, investigated, occurrence, linezolid-resistant enterococci, marine samples, coastal areas, Italy, Isolates, florfenicol-supplemented Slanetz-Bartley agar plates, investigated, carriage, optrA, poxtA, cfr genes, optrA, Enterococcus faecalis, isolate, poxtA, Enterococcus faecium, isolates, Enterococcus hirae, isolates, cfr, poxtA-carrying, E. faecium, isolates, E. hirae, isolates, pulsed-field gel electrophoresis, PFGE, profiles, E. faecium, isolates, sequence type, clustered, clonal complex, nosocomial strains, PFGE/hybridization assays, double (chromosome and plasmid, location, poxtA, plasmid, location, optrA, Whole-genome sequencing, poxtA, Tn6657-like element, plasmids, pEfm-EF3, pEh-GE2, size, species, poxtA, copies, IS1216, plasmids, mating experiments, strain, E. faecalis EN3, transfer, poxtA gene, E. faecium 64/3, occurrence, linezolid, resistance genes, enterococci, marine samples, improve, practices, transmission, linezolid-resistant strains, humans, environmental reservoirs, Linezolid, antimicrobials, treat, severe, infections, drug-resistant, Gram-positive bacteria, emergence, linezolid-resistant enterococci, resistance, determinants, public health, Linezolid resistance genes, cfr, optrA, poxtA, plasmid, transmitted, horizontal gene transfer, potential, spread, study, detection, enterococci, linezolid, resistance genes, sediment, zooplankton, samples, coastal urban areas, Italy, presence, clinically, resistant, bacteria, linezolid-resistant enterococci, marine, environments, spillover, human, animal reservoirs, coastal seawaters, source, resistance genes]]\n",
      "[[increasing, attention cancer, treatment, molecularly targeted therapies, immunotherapies, targeting, immune checkpoints, advanced treatment, ineffective, reasons, inter, human, microbiome, intestines, bacteria, pathogenic, microorganisms, Microbial, imbalance, dysbiosis, perceived, gateways, cancer, bacteria, metabolites, natural, beneficial, microbiome, oncological treatment, Akkermansia mucinifila, Enterococcus hirae, Faecalibacterium prausnitzii, bacteria, potential, benefits, therapy, cancer, patients, bacterial species, treated with, anti-PD-1, anti-PD-L1, anti-CTLA-4, monoclonal antibodies, review, issues, bacteria, carcinogenesis, therapeutic, potential, anti-cancer therapies, Points* Bacteria, cancer, trigger, Bacterial, metabolites, regulate, pathways, associated with, carcinogenesis, Intestinal bacteria, activate, immune system, cancer]]\n",
      "[[Enterococci, microorganisms, environments, gastrointestinal tracts, humans, animals, fecal enterococci, indicators, monitoring, antimicrobial resistance, dissemination, Resistant, bacterial strains, recovered, fecal samples, wild animals, environmental disturbances, report, investigated, antimicrobial susceptibility, resistance, virulence genes, fecal enterococci, isolated, wild Pampas foxes, Lycalopex gymnocercus, Geoffroy's cats, Leopardus geoffroyi, Brazilian, Pampa biome, Enterococci, isolated, fecal samples, Enterococcus faecalis, animals, E. faecium, E. durans, detected, Pampas foxes, E. hirae, detected, Geoffroy's cats, Antimicrobial susceptibility analysis, resistance, rifampicin, erythromycin, ciprofloxacin/norfloxacin, streptomycin, tetracycline, frequency, multidrug-resistant enterococci, isolated, study, wild animals, no history, therapeutic, antibiotic, exposure, tetM/tetL, msrC/ermB genes, detected, tetracycline-, erythromycin-resistant enterococci, gelE, ace, agg, esp, clyA, virulence genes, detected, enterococci, data, habitat, fragmentation, anthropogenic activities, Pampa biome, frequencies, multidrug-resistant enterococci, gut, communities, wild Pampas, foxes, Geoffroy's cats, authors, knowledge, report, antimicrobial-resistant enterococci, Pampa biome]]\n",
      "[[Enterococcus hirae, E. hirae, enterococci strains, human, clinical specimens, case, urinary tract, infection-related bacteremia, E. hirae, Turkey, male, patient, history, coronary artery disease, hypertension, chronic renal failure, admitted, emergency department, abdominal pain, dysuria, fever, urine sample, urinary catheter, ampicillin-sensitive E. hirae, day, hospitalization, E. hirae, growth, sensitivity, pattern, blood culture, Intravenous ampicillin, treatment, growth, blood, urine cultures, Fever, resolved, general condition, improved, patient, day, clinical improvement, moxifloxacin, treatment, days, ampicillin, treatment, days, patient's, medical history, risk factors, enterococcal bacteremia, reports, literature, human infections, E. hirae, rare, isolation, E. hirae, clinical specimens, difficulty, diagnostic approaches, diagnostic purposes, case, rapid, sensitive, diagnostic methods, Matrix-assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF, molecular techniques, selection, toxic, optimal, duration, antibiotic, treatment]]\n",
      "[[study, investigated, Slovak, dry fermented meat products, salami, sausages, market, producers, regions, Slovakia, enterococci, products, species, identified, enterococcal strains, Enterococcus faecium, strains, Enterococcus faecalis, Enterococcus hirae, hemolysis-negative, gamma-hemolysis, biofilm-forming, evaluated, low-grade, biofilm formation, susceptible, antibiotics, susceptible, lantibiotic bacteriocins, gallidermin, nisin, susceptibility, gallidermin, nisin, susceptible, enterocin-durancin, strains, resistance, enterocin A/P., study, bacteriocins, preventing, bacterial, multiplication, contamination, food industry, potential, experimental]]\n",
      "[[Enterococcus hirae, Enterococcus genus, infections, infective endocarditis, IE, animal species, humans, E. hirae, pathogen, associated with, severe, recurrent disease, Danish, E. hirae, native, aortic valve IE, woman, no history of, heart disease, hospital, symptoms, gastroenteritis, heart disease, blood culture, growth, E. hirae, transoesophageal echocardiography, mobile mass, adherent, aortic valve, vegetation, patient, treated, E. hirae, native, aortic valve IE, weeks, intravenous benzylpenicillin, combination, gentamicin, weeks, knowledge, documented, case, E. hirae, IE, Denmark, documented, case]]\n",
      "[[Research, lactic acid bacteria, LAB, bind, aflatoxin B1, AFB1, lactobacilli, bifidobacteria, study, AFB1, binding, capacities, Enterococcus strains, E. casseliflavus, E. faecalis, E. faecium, E. hirae, E. lactis, E. mundtii, Pediococcus strains, species, P. acidilactici, P. lolii, P. pentosaceus, P. stilesii, strain, Lactococcus formosensis, L.garviae, strains, Weissella soli, investigated, MRS broth, degrees, mycotoxin, concentration, results, non-lactobacilli, LAB, genera, AFB1, binding, abilities, genus, Pediococcus, maximum, binding, P. acidilactici, OR83, genus, Lactococcus, AFB1, bio-detoxification, lactobacilli, pediococci, strain, binding, properties, average, genus, Pediococcus strains, compare, sterigmatocystin, ST, binding, abilities, AFB1, binding, difference, findings, lactobacilli, strain, P. acidilactici, OR83, ST, capacity, ST, binding, capabilities, non-Lactobacillus LAB strains]]\n",
      "[[Francisella tularensis, zoonotic disease, tularemia, humans, infect, organisms, arthropods, Francisella transmission, mammalian, in vitro, in vivo, infection, models, investigate, Francisella pathogenicity, characterization, Francisella virulence factor, non-canonical, T6SS, arthropod, in vivo, infection, model, Galleria mellonella, larvae, Francisella T6SS, effectors, F. novicida virulence, G. mellonella, larvae, killing, functional, T6SS, infectious dose, mammalian, in vivo, infection, models, PdpC, PdpD, OpiA, T6SS, effectors, kill, G. mellonella, larvae, sheath, recycling, ClpB, treatment, polyethylene glycol, PEG, activates, Francisella T6SS, liquid culture, response regulator, PEG-activated, IglC, secretion, dependent, T6SS, structural component, PdpB, putative effectors, PdpC, PdpD, AnmK, OpiB1, results, larvae infection, secretion assay, AnmK, T6SS, function, interferes, OpiA-mediated toxicity, T6SS, activity, G. mellonella, larvae, model, function, T6SS, pathogenesis, Francisella]]\n",
      "[[Francisella tularensis, F. tularensis, facultative, intracellular, Gram-negative bacterium, fatal disease, tularemia, virulence, spread, aerosolization, potential, bioterror agent, F. tularensis, CDC, Category A Select Agent, studies, inflammasome sensors, absent, melanoma 2, AIM2, NLRP3, innate immune responses, F. tularensis infection, contributions, AIM2, NLRP3, development, vaccine-induced, adaptive immune responses, F. tularensis, study, contributions, Aim2, Nlrp3-inflammasome, sensors, vaccine-induced, immune responses, mouse model, respiratory tularemia, model, vaccinate, Aim2, Nlrp3-deficient, mice, Aim2(-/-, Nlrp3(-/-), emrA1, mutant, F. tularensis, vaccine strain, LVS, results, innate immune responses, Aim2(-/-), Nlrp3(-/-) mice, vaccinated, emrA1, mutant, wild-type, counterparts, differences, innate immune responses, Aim2(-/-), Nlrp3(-/-) mice, intranasal, dose, F. tularensis, LVS, Aim2, Nlrp3, inflammasome sensors, production, vaccination-induced antibody, cell-mediated responses, study, reports, finding, Aim2, Nlrp3, vaccination-induced, immunity, respiratory tularemia, F. tularensis]]\n",
      "NaN\n",
      "[[SapM, secreted, virulence factor, Mycobacterium tuberculosis, pathogen, survival, persistence, host, potential, target, tuberculosis, treatment, lack, inhibitors, screening, small molecules, inhibitors, SapM, uncompetitive, mechanism, inhibition, inhibitors, trihydroxy-benzene moiety, essential, activity, inhibitors, mycobacterial, burden, infected, human, macrophages, mycobacterial, human phosphatases, inhibitor, intracellular, burden, Francisella tularensis, secretes, virulence factor, AcpA, homologue, SapM, mechanism, catalysis, inhibition, findings, inhibition, SapM, small molecule inhibitors, efficient, intracellular, mycobacterial, survival, host, macrophages, confirm, SapM, therapeutic, target, compounds, physico-chemical, properties, exploration, development, tuberculosis, treatments, efficacy, SapM, inhibitor, reducing, Francisella tularensis, intracellular, burden, potential, broad-spectrum antivirulence agents, treat, microbial infections]]\n",
      "NaN\n",
      "[[national recovery, endangered, Mustela nigripes, Cheyenne River Sioux Reservation, South Dakota, US, ferrets, site, declined, population, decline, pathogen survey, detect, exposure to, West Nile virus, WNV, canine, distemper virus, CDV, plague, Yersinia pestis, tularemia, Francisella tularensis, heartworm, Dirofilaria immitis, coyotes, Canis latrans, sentinel, animal, seroprevalence, WNV, coyotes testing, antibody-positive, Seroprevalence, CDV, plague, evidence, active infection, tularemia, heartworm, coyotes, sampled, study, black-footed, ferrets, decline, population, presence, coyotes, seropositive, diseases, plague, CDV, lethal, black-footed ferrets, potential, exposure, infection, seroprevalence, WNV, coyotes, exposure to, virus, exposure of, black-footed ferrets, virus, WNV, fatal, disease, species, studies, impact, WNV, success, black-footed ferrets, factors, influencing, spread, incidence, disease, prairie, ecosystem]]\n",
      "[[Ubiquitination, proteins, phosphorylation, acetylation, regulatory aspect, numerous, cell processes, immune response signaling, autophagy, study, ubiquitination, learning, host-pathogen interactions, mechanisms, pathogens, ubiquitination processes, host cell, vaccine, development, effective, treatment, diseases, Pathogenic bacteria, Salmonella enterica, Legionella pneumophila, Shigella flexneri, encode, effector proteins, deubiquitinating enzymes, DUBs, targeting, host, machinery, disrupting, ubiquitin-dependent, anti-bacterial response, host, ubiquitination system, integral unit, interconnection, regulation, inflammation, autophagy, pathogens, host, ubiquitination system, bacterial effector proteins, translocated, host cell, regulate, host, defense processes, pathogenic, bacteria, progression, host, virulence factors, essential, bacterial, evasion, cases, Francisella tularensis, host, ubiquitination system, bacterial infection, bacterial effectors]]\n",
      "[[seroepidemiological studies, tularemia, endemic, bacterial zoonosis, Iran, disease, characterized, fever, cervical lymphadenopathy, ocular, involvement, Youzband Village, Kaleybar County, East Azerbaijan Province, northwestern Iran, Diagnostic tests, Francisella tularensis serology, tube agglutination test, ELISA, PCR, culture, case-patients, tularemia tube agglutination test, positive, borderline, PCR, detected, F. tularensis, ISFtu2 elements, fopA gene, rodent, spring, water sample, geographic area, clinical manifestations, disease, oropharyngeal form, tularemia, serology, results, case patients, F. tularensis, detection, local fauna, aquatic environment, water, supply, village, source, tularemia, outbreak, Intervention, dredging, chlorination, water, storage, tank, village, training, villagers, health care workers, preventive measures, treatment, illness, infection]]\n",
      "[[Ticks, Ixodidae, hard ticks, principal vectors, zoonotic diseases, severe, fever, thrombocytopenia syndrome, SFTS, Lyme borreliosis, relapsing, fever, anaplasmosis, ehrlichiosis, babesiosis, coxiellosis, Q fever, tularemia, public, threat, study, distribution profile, ticks, tick-borne, pathogens, Daejeon, adjacent, South Korea, epidemiological study, ticks, genera, species, Haemaphysalis longicornis, Haemaphysalis flava, Ixodes nipponensis, Amblyomma testudinarium, Homogenized samples, ticks, screened, real-time reverse transcription polymerase chain reaction, PCR, real-time PCR, PCR, presence, tick-borne, pathogens, SFTS virus, SFTSV, Borrelia spp., Babesia microti, Coxiella burnetii, Francisella tularensis, Anaplasma phagocytophilum, Ehrlichia spp, result, SFTSV, cases, Borrelia spp., cases, Babesia microti, cases, detected, findings, study, prevention, management, tick-borne zoonoses]]\n",
      "[[genitourinary syndrome, GSM, signs, symptoms, effects of, estrogen deficiency, female, genitourinary tract, vagina, labia, urethra, bladder, Signs/symptoms, associated with, GSM, reproductive stage, multiple etiologies, menopause, low, estrogen, Vaginal microbiota, Lactobacillus spp., female, genital tract, abundance, declines, menopause, longitudinally, vaginal microbiota, characterized, 16S rRNA, gene amplicon sequencing, GSM-associated, endpoints, reproductive stages, two-year, cohort study, women, aged, years, enrollment, semiannual, person-visits, low-Lactobacillus vaginal microbiota, communities, person-visits, pre-, postmenopausal, women, communities, Gardnerella vaginalis, abundance, diverse, anaerobes, communities, associated with, covariate-adjusted, vaginal atrophy, L. crispatus-dominated communities, postmenopausal, women, odds, confidence interval[CI, L. gasseri/L. jensenii, L. iners, perimenopausal, women, L. iners-dominated communities, premenopausal, women, Postmenopausal, women, L. gasseri/L. jensenii-dominated communities, lowest, odds, vaginal dryness, low, libido, Findings, urinary incontinence, inconsistent, Associations, vaginal microbiota, GSM, signs/symptoms, menopause, treatment, prevention]]\n",
      "[[vaginal microbiome, intricate, dynamic, microecosystem, fluctuations, female, menstrual cycle, woman's entire life, healthy, vaginal microbiome, Lactobacillus, antimicrobial compounds, Bacterial vaginosis, BV, characterized, loss, decline, Lactobacillus, increase, concentration, anaerobic, microbes, BV, disorder, vaginal microbiota, women, reproductive age, BV, associated with, adverse gynecologic, obstetric outcomes, sexually transmitted infections, pelvic inflammatory disease, preterm birth, Gardnerella vaginalis, microorganism, identified, BV, predominant, microbe, polymicrobial biofilms, shelter, G. vaginalis, BV-associated microbes, adverse, host, environments, increase, vaginal microbiome, health, BV, novel, accurate, diagnosis, therapeutic strategies, BV, review, features, vaginal microbiome, BV, BV-associated diseases, strategies, diagnosis, treatment, BV, research, progresses]]\n",
      "[[OBJECTIVE, study, influence, quantitative, qualitative, composition, gingival microbiota, status, immune system cells, localized, gums, chronic generalized catarrhal gingivitis, children, Materials, methods, study, children, aged, years, patients, chronic generalized catarrhal, gingivitis, mild, moderate, severity, CGCG, children, intact, gums, comparison, group, hygienic indices, Fedorov, Silness-Loe, PMA, bleeding index, Myuleman, intensity, caries, CFD, CFD, Histological, immunohistochemical studies, serial sections, biopsy, gingival papillae, Microbiological study, crown plaque, multiplexed PCR, real time, Results, hygienic indices, children, CGCG, higher, healthy, difficulty of care, presence, periodontal inflammation, immunohistochemical studies, HLA-DR, cells, conditions, active disease, migrate, mucosal lamina propria, epithelium, CD3 + cells, epithelium, CGCG, intact, epithelium, population, biopsy, affected, children, reduced, CD4 + cells, CGCG, quantitative, Lactobacillus spp., Enterobacteriaceae, Gardnerella vaginalis, Prevotella bivia, Porphyromonas spp, sample, CROWN, dental plaque, rates, physiological conditions, diagnostic criteria, dysbiosis, CGCG, disease, etiology, microbial factor, quantitative, ratios, microorganisms, dental plaque, bacterial, plaque, comprehensive, treatment, CGCG, drugs, children, natural, immunostimulation, restoration, local, immunity, gum tissue, drugs, quantitative, qualitative, composition, normal microflora, child, therapeutic effect, justification]]\n",
      "[[Bacterial vaginosis, BV, condition, vaginal microbiome, lactobacilli, abundant, anaerobic, bacteria, genus, Gardnerella, abundant, bacteria, BV, BV, associated with, poor, health outcomes, women, women, BV, detectable, elevated, levels, sialidase activity, vaginal fluids, bacteria, associated with, condition, activity, culture, Mounting, evidence, diverse, methodologies, BV, associated with, reduction, intact, sialoglycans, cervico-vaginal secretions, review, evidence, contributions, vaginal bacteria, Gardnerella, processes, mucosal sialoglycan, degradation, uptake, metabolism, depletion, impacts, vaginal sialoglycan, degradation, potential, sialic acid, depletion, sialoglycans, vaginal physiology]]\n",
      "[[Gardnerella vaginalis, bacterial vaginosis, ecological, imbalance, vaginal microbiota, depletion, Lactobacillus sp., Lactobacillus supplementation, treat, bacterial vaginosis, investigated, applicability, Lactobacillus sp. strains, Lactobacillus delbrueckii DM8909, Lactiplantibacillus plantarum, ATCC14917, Lactiplantibacillus plantarum, ZX27, probiotic, abilities, in vitro, Lactobacillus sp. strains, bacterial vaginosis therapy, properties, auto-aggregation, ability, hydrophobicity, adhesion, cervical epithelial cells, survivability, hydrogen peroxide, Lpb, ZX27, yield, short-chain fatty acids, lactic acid, strains, Lactobacillus sp. strains, inhibited, growth, adhesion, G. vaginalis, culture supernatant, Lactobacillus sp., anti-biofilm activity, G. vaginalis, Lpb, plantarum, ZX27 supernatant, decreased, expression, genes, virulence factors, adhesion, biofilm formation, metabolism, antimicrobial resistance, biofilm-forming cells, suspended cells, Lactobacillus sp., decreased, upregulated, expression, interleukin-8, HeLa cells, induced, G. vaginalis, hydrogen peroxide, results, efficacy, Lactobacillus sp., application, treating, bacterial vaginosis, growth, adhesion, biofilm formation, virulence, properties, G. vaginalis]]\n",
      "[[description, Gardnerella vaginalis, species, genome species, Gardnerella, genome sequences, matrix, fast, techniques, Gardnerella species, research, clinical practice, characterized, Gardnerella, isolates, species, partial, chaperonin, cpn60 sequences, MALDI Biotyper, Bruker Daltonik GmbH, capability, phylogenetically diverse, groups, G. vaginalis/G. piotii, G. leopoldii/G. swidsinskii, phenotypic, properties, Gardnerella species, sialidase, beta-galactosidase activities, data, NanH3, enzyme, sialidase activity, Gardnerella spp, isolates, G. piotii, isolates, sialidase, phenotype, G. vaginalis, strains, sialidase negative, G. leopoldii, G. swidskinskii, sialidase, negative, phenotype, beta-galactosidase, G. vaginalis, strains, phenotypic, characteristics, associated with, virulence, Gardnerella, isolates, species, diverse, species, vaginal microbiome]]\n",
      "[[Gardnerella vaginalis, bacterium, bacterial vaginitis, women, case report, woman, infected, G. vaginalis, suspected, Dengue fever, similarity, clinical symptoms, disease, symptoms, tropical infectious diseases, travel history, complicated, identification, disease, patient, epidemiological, clinical description, case, diagnosis, septic, gardnerellosis]]\n",
      "[[Gardnerella vaginalis, causative agent, bacterial vaginosis, complete, genome sequence, Gardnerella phage, vB_Gva_AB1, induced, vaginal, woman, suffering, bacterial vaginosis, phage double-stranded DNA, dsDNA, genome, GC, content, open reading frames]]\n",
      "[[Smoking, risk factor, bacterial vaginosis, parameters, vaginal environment, affected, smoking, triggers, disease, AIM, primary, objective, estimate, effect size, smoking, vaginal, pH, Nugent score, patients, chronic vulvovaginal discomfort, development, episode, vaginosis, secondary goal, investigate, effect, smoking, microscopic, parameters, vaginal environment, subjectively, symptoms, vaginal discomfort, Smoking, patients, predictor, multivariate logistic, ordinal logistic regression analysis, dataset, visit, randomized trial, patients, intermediate vaginal environment, tested, primary hypothesis, odds ratio, OR, vaginal pH, Nugent score, smokers, significance, level, exploratory analyses, effect, smoking, parameters, vaginal environment, Bonferoni, cross-sectional sample, women, risk factors, smoking, impact, Nugent score, OR, pH, OR, Smoking, associated with, prevalence, clue cells, Gardnerella spp., Mobiluncus spp., prevalence, Lactobacillus, unchanged, assumptions, vaginal Lactobacillus, affected, smoking, promotes, growth, bacteria, Gardnerella, Mobiluncus spp, parameters, smoking, vaginal dysbio-sis, favourable, opportunistic, pathogens]]\n",
      "[[AIMS, Investigations, patients, diabetes, diabetic nephropathy, DN, gut microbiome, research, diabetes mellitus, chronic kidney disease, gut, microbial, DN, stage-3, patients, healthy controls, systematically analyzed, discrepancies, microbial, profiles, disease stages, gender, BMI, DN, Fecal samples, healthy volunteers, HG, DN, patients, PG, gut microbiota, 16S rDNA V3-V4 regions analysis, disease stage, gender, BMI, PG, HG, subgroups, DN, stage, random forest model, genera, PG, HG, samples, Gut bacterial, richness, diversity, PG, HG, gut microbiota, composition, PG-III, middle level, HG, PG-IV, gender, BMI, impact, gut microbiota, profile, disease, random forest model, microbe genera, area under curve, AUC, operational curve, ROC, DN, DN, patients, dysbiosis, decrease, gut, bacterial, richness, diversity, compared, HG, characterized, genera, Megasphaera, Veillonella, Escherichia-Shigella, Anaerostipes, Haemophilus, potential, microbial, biomarkers, DN]]\n",
      "[[Bronchiectasis, cystic fibrosis, non-CF bronchiectasis, respiratory disease, nations, dilated mucus, airways, bacterial overgrowth, chronic infection, bronchial inflammation, lung injury, re-infection, Accurate, pathogen, identification, antimicrobial susceptibility, appropriate, treatment, vicious cycle, study, spectrum, antimicrobial spectrum, pathogen, respiratory specimens, adult, patients, acute exacerbation, non-cystic fibrosis, CF, bronchiectasis, cross-sectional study, pulmonology clinics, Aga Khan University, Karachi, Pakistan, Respiratory specimens, adult, patients, acute exacerbation, non-CF bronchiectasis, pulmonology clinics, Microbial cultures, standard methodology, Susceptibility testing, interpreted, Clinical Laboratory Standard Institute criteria, positive, cultures, patients, acute exacerbation, evaluated, frequent, organisms, Pseudomonas aeruginosa, Hemophilus influenzae, Staphylococcus aureus, rates, antimicrobial resistance, pathogens, Proportion, Pseudomonas aeruginosa, strains, resistant, ciprofloxacin, imipenem, ceftazidime, piperacillin-tazobactam, Hemophilus influenzae strains, resistant, cotrimoxazole, ciprofloxacin, Staphylococcus aureus strains, resistant, methicillin, antimicrobial resistance, non-CF bronchiectasis, patients, antimicrobials, concern, community, interventions, clinical outcome, patients]]\n",
      "[[Mohamed Soussi SOLTANI, Professor, Faculty of Medicine of Monastir, Tunisia, generations, specialty, Greater, Maghreb, teacher, Center-East of Tunisia, Monastir, testimonies, companions, indexed, publications, colleagues, SOLTANI, human, professional qualities, perseverance, commitment, thinking, integrity, professionalism, scientific life, late Professor Soltani, themes, Public Health and Family Medicine, deceased, preventive activities, first-line structures, anonymous, free, HIV, screening, family planning, drugs, breast cancer, screening, smoking cessation, prevention, rheumatic heart disease, general practitioners, Monastir region, Faculty's Community Medicine Department, movement, academic, professional development, general medicine, authentic, specialty, family medicine, publications, Professor SOLTANI, indexed, PubMed, signed, maternal, health, prenatal surveillance, education, maternal, health, pregnancy referral system, infant, low birth weight, vaccination, mother-to-child transmission, hepatitis B, meningitis, Haemophilus influenzae, life, prospering, innovations, research, public health, Professor SOLTANI, model, young people, specialty, followers, obligation, biography, generations, public health]]\n",
      "[[results, epidemiological studies, statistical data, years, dental morbidity, rate, world, stable, level, Inflammatory diseases, periodontal tissues, generalized forms, periodontitis, world, increasing, prevalence, rate, diseases, Ukraine, AIM, study, antimicrobial activity, gel-based medicinal products, periodontology, Abigel, herbal remedy, fir oil, oak bark extract, Fitoron, oak bark extract, President gel, chlorhexidine, Gram-positive, gram-negative bacteria, taxonomic groups, Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Bacillus subtilis ATCC 6633, Proteus vulgaris ATCC 4636, Candida albicans ATCC, substrate, examinations, suspensions, microorganisms, optical density, microbial cells, turbidity standard, McFarland standard, Densi-La-Meter device, PLIVA-Lachema, Czech Republic, suspension, device guidance, information sheet, innovations, health care system, Standardization, preparation, microbial, suspensions, activity, Staphylococcus aureus, President gel, chlorhexidine, Abigel gel, Fitoron, minimum activity, growth zone, Bacillus subtilis, inhibited, President gel, chlorhexidine, Fitoron's, inhibition, Abigel gel, President gel, chlorhexidine, antifungal effect, inhibition, zone, Fitoron's, inhibition, Abigel gel, Enterococcus faecalis, activity, President gel, chlorhexidine, inhibition, zone, Abigel gel, inhibition, zone, Fitoron, Haemophilus influenzae, influenced, President gel, chlorhexidine, inhibition, zone, Abigel gel, growth inhibition, lowest, growth, inhibition, Fitoron, President gel, chlorhexidine, Abigel gel, influence, growth, Streptococcus pyogenes, figures, Fitoron, Abigel gel, activity, Streptococcus mutans, inhibition, zone, President gel, chlorhexidine, Fitoron, growth, Neisseria sp, inhibited, President gel, chlorhexidine, Abigel gel, results, Fitoron, President gel, chlorhexidine, Fitoron, Abigel gel, antimicrobial, properties, testing, cultures, microorganisms, study, Abigel, effective, method, conservative treatment, inflammatory periodontal diseases]]\n",
      "[[YhcB, poorly, protein, gamma-proteobacteria, DUF, N-terminal transmembrane domain, integrated approach, X-ray crystallography, genetics, molecular biology, investigate, function, structure, YhcB., E. coli, yhcB, knock-out strain, degrees, hypersensitive, cell-wall, antibiotics, stationary phase, deletion, yhcB, filamentation, abnormal, FtsZ, aberrant, septa, development, Z-ring, septa, initiation, cell division, YhcB, proteins, divisome, FtsI, FtsQ, elongasome, RodZ, RodA, interactions, Yersinia pestis, Vibrio cholerae, mapped, amino acid residues, interactions, YhcB, FtsI, RodZ., crystal structure, cytosolic domain, Haemophilus ducreyi, YhcB, tetrameric alpha-helical coiled-coil structure, Z ring, septal peptidoglycan synthesizing, complexes, YhcB, conserved, cell division, envelope biogenesis, findings, YhcB, ZapG (Z-ring associated protein G, study, studies, protein family, cells, transit, exponential, stationary survival]]\n",
      "[[Pneumonia, death, Malaysia, studies, aetiology, pneumonia, Western countries, epidemiology, pneumonia, Malaysia, carriage, disease, improve, carriage, antimicrobial resistance, AMR, respiratory tract, pathogens, Malaysia, rural, communities, Sarawak, Malaysian population, study, bacterial, epidemiology, population, population-based survey, bacterial, carriage, participants, ages, rural communities, Sarawak, Malaysia, Nasopharyngeal, nasal, mouth, oropharyngeal swabs, Bacteria, isolated, swab, identified, culture-based methods, antimicrobial susceptibility testing, disk diffusion, E test, participants, rural communities, Klebsiella pneumoniae, isolated, participants, Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Pseudomonas aeruginosa, Neisseria meningitidis, S. pneumoniae, isolated, serotypes, valent, PCV, PCV13, PCV, PCV10, species, resistant, antibiotic, bacterial species, S. pneumoniae, susceptible, antibiotic, knowledge, bacterial, East Malaysia, data, epidemiology, AMR, respiratory pathogens, associated with, pneumonia, surveillance, Malaysia, changes, carriage, prevalence, upper respiratory tract, pathogens, emergence, AMR, PCV, National Immunisation Programme, NIP]]\n",
      "[[BACKGROUND/AIMS, Patients, achalasia, incidence, esophageal squamous cell carcinoma, ESCC, associated with, alterations, oral, esophageal microbiota, food stasis, study, oral, esophageal microbiota, patients, achalasia, peroral, POEM, patients, achalasia, ESCC, study, patients, achalasia, superficial, ESCC, Oral samples, buccal mucosa, swab, esophageal, mid-esophagus, brush, endoscopy, analyzed, 16S rRNA, metagenome sequencing, endoscopic, histological, findings, patients, achalasia, POEM, patients, achalasia, Streptococcus, abundant, oral, esophageal microbiota, microbiota, structure, oral, esophageal microbiota, POEM, abundance, Haemophilus, Neisseria, increased, esophagus, endoscopic, findings, inflammation, improved, POEM, abundance, microbiota, patients, achalasia, ESCC, oral, esophageal microbiota, patients, achalasia, composition, esophageal microbiota, POEM, findings, disease-specific microbiota, evaluated, large-scale studies]]\n",
      "[[Haemophilus influenzae, mucosal infections, accurate, surveillance, assess, prevalence, species, clinical specimens, population structure, resistance, aminopenicillins, genome sequencing, assessed, prevalence, database records, day, Denmark, examined, genome sequences, nationwide, isolates, day, prevalence, H. influenzae, clinical samples, January, person-days, samples, hospital bed-days, hospital samples, bacteria, clinically, relevant, collected, action, Danish departments, clinical microbiology, H. influenzae, isolates, phylogenetic group I, unencapsulated, strains, Danish regions, identical, core genome sequences, intergenic mutations, circulating, clones, individual, cases, patient-to-patient, transmission, TEM-1 beta-lactamase gene, strains, strains, genetically categorised, ampicillin-resistant, substitutions, penicillin-binding protein 3, patterns, amino acid substitutions, strains, putative lateral transfer, chromosomal resistance, Circulating, clones, H. influenzae, frequent, host factors, transmission, epidemic, strains, primary, infection, bleak, presence, ampicillin, resistance, sequencing, point prevalence, strains, necessity, examination, testing methods]]\n",
      "[[Patients, type 2 diabetes mellitus, T2DM, ocular surface infections, characterized, conjunctival microbiome, T2DM, patients, influence, topical, levofloxacin, investigate, dysbiosis, associated with, phenomenon, Conjunctival microbiome, T2DM, patients, non-diabetic controls, 16S rDNA sequencing approach, T2DM, non-diabetic, patients, cataract surgeries, perioperatively, influence, pre-, post-operative, levofloxacin, conjunctival microbiome, investigated, compared, longitudinally, alpha-diversity, conjunctival microbiota, T2DM, patients, controls, composition, function, conjunctival microbiome, ocular surface, T2DM, patients, non-diabetic controls, phylum, Bacteroidetes, Fusobacteria, genus, Pseudomonas, Haemophilus, Empedobacter, genus, Streptococcus, reduced, T2DM, ocular surface, Microbial genes, functioning, bacterial chemotaxis, elevated, conjunctival microbiome, T2DM, patients, status, genera, Staphylococcus, abundant, conjunctival microbiome, T2DM, patients, preoperative, levofloxacin, topically, genus, abundant, non-diabetic, follow-up, group, No difference, initial, status, days, postoperative, medications, diabetic, non-diabetic, follow-up, groups, conjunctival microbiome, T2DM, patients, complex, topical antibiotics]]\n",
      "[[Human, lymphocytes, Aggregatibacter actinomycetemcomitans, toxin, Cdt, cell cycle arrest, apoptosis, studies, active, Cdt subunit, CdtB, phosphatidylinositol, PI, AaCdt-treated cells, evidence, PI-3-kinase, PI-3K) signaling, blockade, characterized, reduced, levels, PIP3, pAkt, pGSK3beta, PI-3K, blockade, AaCdt-induced, toxicity, lymphocytes, study, observations, assessment, Cdts, Haemophilus ducreyi, HdCdt, Campylobacter jejuni, CjCdt, report, CdtB subunit, HdCdt, CjCdt, AaCdt, PIP3 phosphatase, activity, Jurkat cells, treated with, Cdts, PI-3K, blockade, reduced, levels, pAkt, pGSK3beta, non-phosphorylated, GSK3beta, active form, kinase, Cdts, dependence, GSK3beta activity, GSK3beta inhibitors, LY2090314, CHIR99021, inhibitors, blocked, Cdts, induce, cell cycle arrest, AaCdt, increases, CDK inhibitor, p21(CIP1/WAF1, toxin-induced cell death, apoptosis, HdCdt, CjCdt, requirement, p21(CIP1/WAF1, Cdts, induce, cell cycle arrest, AaCdt, HdCdt, dependent, host cell protein, cellugyrin, toxicity, internalization, CdtB, CjCdt, protein, findings, Cdt's, molecular mode, action]]\n",
      "[[Infections, genital ulcers, themes, Clinical Protocol, Therapeutic Guidelines, Comprehensive Care, People, Sexually Transmitted Infections, published, Brazilian Ministry of Health, Protocol, Guidelines, scientific evidence, validated, discussions, specialists, clinical, sexually transmitted infections, etiological agents, Treponema pallidum, syphilis, herpes simplex virus-2, genital herpes, herpes simplex virus-1, perioral herpes, Haemophilus ducreyi, chancroid, Chlamydia trachomatis, L2, venereal lymphogranuloma, Klebsiella granulomatis, donovanosis, Epidemiological, clinical aspects, infections, guidelines, diagnosis, treatment, strategies, surveillance, prevention, control actions, health managers, professionals, qualification]]\n",
      "[[South African, women, reproductive age, burden, sexually transmitted infections, STIs, human papillomavirus, information, prevalence, sexually transmitted, pathogens, women, rural Eastern Cape Province, South Africa, study, prevalence, sexually transmitted, pathogens, co-infection, high-risk, HR, HPV, women, rural Eastern Cape Province, South Africa, cervical specimens, women, aged, years, rural community-based clinic, samples, tested, pathogenic, STIs, Chlamydia trachomatis, serovars A-K & L1-L3, Haemophilus ducreyi, Herpes Simplex Virus, Neisseria gonorrhoeae, Treponema pallidum, Trichomonas vaginalis, TV, pathobionts, Mycoplasma genitalium, MG, Mycoplasma hominis, MH, Ureaplasma spp., UP, multiplex PCR, STD, flow chip, manual, Master Diagnostica, Granada, Spain, HR-HPV, detection, Hybrid Capture-2 assay, High-risk, HPV, prevalence, HIV-1, prevalence, prevalence, pathogenic, STIs, TV, highest, prevalence, UP, MH, detected, pathobionts, Co-infection, pathogens, pathobionts, participants, pathogenic, STIs, participants, STI, presence, MH, UP, HSV-2, OR, CI, HIV infection, OR, CI, STIs, associated with, HR-HPV infection, prevalence, pathogenic, STIs, syndromic management, policy, implementing, effective, strategies, prevention, screening tests, management, HSV-2, HIV, positive, associated with, HR-HPV infection]]\n",
      "[[obligate, human, Haemophilus ducreyi, cutaneous ulcers, children, sexually transmitted, genital ulcers, chancroid, adults, Pathogenesis, dependent, phagocytosis, exploiting, suppurative, granuloma-like niche, innate immune cells, memory T cells, immune infiltrate, long-lived, immune protection, H. ducreyi, strain, infectious skin diseases, infections, animal models, H. ducreyi, information, experimental model, infection, human volunteers, decades, model, mirrors, progression, natural disease, composition, immune cell infiltrate, early, disease, host, bacterial factors, establishment, infection, disease progression, holistic, investigation, experimentally, infected, skin microenvironment, multiple, omics, techniques, non-canonical, bacterial, genes, central metabolism, relevant, disease progression, immune system, host, H. ducreyi, nutrient, availability, invading, bacteria, gene expression, inflammatory, metabolic niche, findings, host-pathogen interaction, network, effector-based, virulence, paradigms, adaptations, metabolic, environment, host, bacterial factors, interact, infection, outcome, field, review, learned, experimental, H. ducreyi infection, host-pathogen interactions, comparisons, skin pathogens, novel, technologies, infection]]\n",
      "[[Outbreaks, yaws-like ulcerative, skin lesions, children, tropical, sub-tropical countries, origin, lesions, traumatic, infectious, case, Treponema pallidum subspecies pertenue, yaws agent, Haemophilus ducreyi, agent, chancroid, pathogens, associated with, aetiology, skin ulcers, investigated, presence, T. p. pertenue, H. ducreyi DNA, skin ulcers, children, living, yaws-endemic regions, Cameroon, Skin lesion swabs, children, yaws-suspected skin lesions, outbreaks, DNA, swabs, target, genes, human beta2-microglobulin gene, sample collection, DNA extraction, polA gene, subspecies, T. pallidum, hddA gene, H. ducreyi, target, tprL gene, differentiate, T. p. pertenue, agents, human treponematoses, polA-positive samples, samples, analysed, study, sample, negative, beta2-microglobulin, analysis, T. p. pertenue, detected, samples, outbreak, H. ducreyi DNA, amplified, samples, outbreaks, outbreak, outbreak, outbreak, results, H. ducreyi, associated to, skin lesions, children, T. p. pertenue, yaws, Cameroon, findings, continuous, aetiology, ulcerative, skin lesions, outbreaks, planned, mass treatment, yaws, Cameroon]]\n",
      "[[Exudative cutaneous ulcers, CU, yaws-endemic areas, associated with, Treponema pallidum subsp., TP, Haemophilus ducreyi, HD, CU, cases, idiopathic, IU, mass drug administration, MDA, azithromycin, yaws, eradication, Lihir Island, Papua, Guinea, reduced, yaws, IU, rates, constant, campaign, potential, etiologies, IU, swabs, CU, lesions, skin, asymptomatic controls, AC, Lihir Island, cohort, characterized, microbiomes, metagenomics, CU, bacterial, communities, diverse, AC, real-time multiplex PCR, pathogen-specific primers, CU, specimens, HD-positive (HD+), TP+, HD+TP+, IU, groups, CU, subgroup, bacterial, community, species, detected, abundances, species, group, Streptococcus pyogenes, abundant, organism, IU, IU, ulcer groups, Follow-up samples, nonhealed ulcers, abundance, S. pyogenes, ulcers, improved, ulcers, S. pyogenes, ulcers, azithromycin, resistant, Catonella morbi, IU, S. pyogenes, S. pyogenes, TP strains, macrolide, resistant, penicillin, drug, CU azithromycin, treatment failures, study, design, diagnostic tests, therapies, CU.IMPORTANCE Cutaneous ulcers, CU, children, tropics, year, CU, Treponema pallidum subspecies pertenue, Haemophilus ducreyi, cause(s), failure, mass drug, azithromycin, CU, World Health Organization, integrated disease, control, CU, Success, cause(s), CU, 16S rRNA, gene sequencing, swabs, CU, skin, asymptomatic, children, identified, skin ulcers, Streptococcus pyogenes, S. pyogenes, impetigo, cellulitis, organism, causal agent, CU, Inclusion, S. pyogenes, integrated disease, plan, diagnostic testing, treatment, painful, debilitating, children, elimination]]\n",
      "[[Cutaneous ulcers, tropics, painful, debilitating, condition, anchors, people, poverty, rural regions, South Pacific, infectious cutaneous ulcers, bacteria, Treponema pallidum pertenue, yaws, Haemophilus ducreyi, polymicrobial ulcers, group, infections, cutaneous ulcer disease, CUD, infections, malformations, bone, permanent, impact, lives, endemic, communities, characterization, CUD, design, diagnostic tools, effective, antimicrobial therapies, review, updates, knowledge, CUD, terminology, syndromic management]]\n",
      "[[Gram-negative bacteria, folding, insertion, beta-barrel outer membrane proteins, OMPs, outer membrane, beta-barrel assembly machinery, BAM, models, process, hybrid barrel model, claims, lateral, BamA's, beta-barrel, template, incoming, OMPs, passive model, claims, thinned, near, lateral, gate, BamA, spontaneous, OMP, insertion, models, equilibrium, BamA, POTRA domains, Escherichia coli, Salmonella enterica, Haemophilus ducreyi, Neisseria gonorrhoeae, BamA's, homolog, TamA, E. coli, native, species-specific outer membranes, equilibrium simulations, membrane thinning, near, lateral, proteins, spontaneous, opening, sliding, beta-strands, gate interface, N. gonorrhoeae, gate, dynamic, free-energy calculations, energy, lateral, BamA/TamA, species, Omp85 homolog, FhaC., OMP, insertion, hybrid barrel, passive models]]\n",
      "[[Yaws, skin debilitating, Treponema pallidum subspecies, cases, children, World Health Organization, WHO, eradication, disease, mass treatment, suspected, cases, intensive follow-up program, effective, diagnosis, implementation, control program, Recombinase polymerase amplification, RPA, isothermal nucleic acid amplification technique, differentiation, pathogens, isolated, chronic skin ulcers, characteristics, Haemophilus ducreyi, H. ducreyi, RPA, assay, simultaneous, detection, Treponema pallidum, T. pallidum, H. ducreyi, TPHD-RPA, assay, cross-reaction, pathogens, detection, T. pallidum, H. ducreyi, degrees, RPA, assay, clinical samples, individuals, yaws, serological tests, assay, commercial multiplex real-time PCR, assay, sensitivity, T. pallidum, H. ducreyi, specificity, TPHD-RPA, assay, detection, T. pallidum, H. ducreyi, yaws-like lesions, test, yaws, eradication, diagnosis, monitoring, program, success, planning, follow-up, interventions, community, level]]\n",
      "[[MtsZ, molybdenum-containing methionine sulfoxide, virulence, human, respiratory pathogen, Haemophilus influenzae, Hi, HiMtsZ, group, structurally, spectroscopically, uncharacterized, S/N-oxide reductases, bacterial, pathogens, crystal structure, HiMtsZ, HiMtsZ, substrate-binding site, MetSO, side chain, interaction, His182, Arg166, Charge, amino acid, composition, side-chain binding region, electrochemical, kinetic, docking studies, diverse, substrate, specificity, enzymes, type, HiMtsZ, Mo, active site, structural, flexibility, dissociation, Ser187, ligand, affected, catalysis, low, pH., HiMtsZ electron paramagnetic resonance, species, resembled, DMSO reductase, nitrate reductase, Asp-Mo, ligand, views, geometry, Mo center, primary ligands, amino acid environment, EPR, properties, mononuclear, Mo-enzymes, flexibility, electronic structure, Mo centers, apparent, HiMtsZ, EPR-active, Mo(V) species, catalytically, off-pathway, oxidized]]\n",
      "[[guidelines, Infectious Diseases Society of America, American Society for Microbiology, pediatric, hospitals, weight-based collection, guidelines, blood cultures, process, culture collection, adult, blood culture, low, volumes, size, bottle, study, clinically, organisms, Staphylococcusaureus, Streptococcus pneumonia, Streptococcus agalactiae, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Pseudomonas aeruginosa, Candida glabrata, Candida albicans, BD BacTec system, inoculation, volumes, dilutions, assess, performance, positivity, adult, blood culture, pediatric, blood culture, detection, H. influenzae, adult, blood culture, inoculated, low, volumes, pediatric bottles, detected, H. influenzae, dilution-volume combinations, tested, Exclusive use of, adult, blood culture, detect, H. influenzae bacteremia, low-volume inoculum]]\n",
      "[[airway, bacterial, LABC, COPD, patients, associated with, increased, exacerbation, frequency, faster, lung function, decline, Defective, macrophage, phagocytosis, COPD, inflammation, defective, macrophage, exacerbations, study, investigated, association, macrophage, phagocytosis, exacerbation, frequency, LABC, clinical parameters, Monocyte-derived macrophages, MDM, stable, COPD, patients, exacerbation, patients, Macrophages, fluorescently labelled, Haemophilus influenzae, Streptococcus pneumoniae, phagocytosis, measured, fluorimetry, cytokine, ELISA, Sputum, bacterial, colonisation, measured, PCR, Phagocytosis, H. influenzae, negatively, correlated, exacerbation, frequency, reduced, frequent, infrequent, exacerbators, RFU, RFU, correlation, S. pneumoniae, association, phagocytosis, bacteria, age, lung function, smoking history, treatment, inhaled corticosteroids, long-acting bronchodilators, Phagocytosis, exacerbation, weeks, post-exacerbation, response, phagocytosis, MDM, exacerbating, patients, increased, release, CXCL-8, TNFalpha, stable state, Impaired, COPD, macrophage, phagocytosis, H. influenzae, S. pneumoniae, associated with, exacerbation, frequency, pro-inflammatory macrophages, disease progression, Targeting, frequent, exacerbators, drugs, macrophage, phagocytosis, beneficial]]\n",
      "[[mechanisms, antimicrobial resistance, prevalence, polysaccharide capsule, urogenital, respiratory Haemophilus parainfluenzae, isolates, Antimicrobial susceptibility, tested, microdilution, MDR strains, WGS, phylogenetically, H. parainfluenzae, genomes, NCBI database, identification, capsular bexA gene, PCR, non-MDR strains, ampicillin-resistant strains, blaTEM-1, Tn3, identified, cefuroxime-resistant strains, PBP3, substitutions, catS gene, tet(M)-MEGA element, FolA substitutions, associated with, resistance, chloramphenicol, tetracycline, macrolides, co-trimoxazole, isolates, Tn10, tet(B)/(C)/(D)/(R) genes, catA2, Putative transposons, Tn7076-Tn7079, aminoglycoside, co-trimoxazole, resistance genes, identified, strains, transposons, integrative, conjugative elements, ICEs, resistance-associated transposons Tn3, Tn10, capsular operon, urogenital isolates, phylogenetic clustering, capsular operons, identified, Haemophilus influenzae serotype c, Haemophilus sputorum type 2, identification, ICEs, resistance-associated, transposons, transferable elements, acquisition, multidrug resistance, H. parainfluenzae, presence, polysaccharide capsules, urogenital isolates, concern]]\n",
      "[[AIMS, fecal microbiota, profiles, associated with, metabolic abnormalities, metabolic syndrome, MS, high count, white blood cells, WBCs, insulin resistance, IR, young, patients, obesity, stratified, percentile distribution, MS abnormalities, MS, risk score, low, medium, MS, risk, WBCs, count, severe, obesity, body mass index Z-score, IR, homeostatic assessment model algorithm, IR, HOMA, Stool samples, analyzed, 16S rRNA-based, metagenomics, reduced, bacterial, richness, fecal microbiota, patients, IR, BP, microbial, markers, associated to, Clostridium, Clostridiaceae, low high-density lipoprotein cholesterol, Lachnospiraceae, Gemellaceae, Turicibacter, MS, risk, Coriobacteriaceae, WBCs, Bacteroides caccae, Gemellaceae, severe, obesity, Lachnospiraceae, impaired glucose tolerance, Bacteroides ovatus, Enterobacteriaceae, taxa, Faecalibacterium prausnitzii, Parabacterodes, Bacteroides caccae, Oscillospira, Parabacterodes distasonis, Coprococcus, Haemophilus parainfluenzae, MS, risk score, triglycerides, fasting glucose, HOMA-IR, Supervised, grouped, variable, patients, MS, risk, opening, identification, fecal microbiota, signatures, associated with, cardiometabolic, risk factors, young, patients, obesity, gut bacteria, exacerbating, metabolic, risk factors, ameliorating, cardiovascular, host, health]]\n",
      "[[Salivary gland, epithelial cells, SGECs, pathogenesis, Sjogren's syndrome, aberrant, antigen-presentation function, study, hypothesis, oral dysbiosis, modulates, antigen-presentation function, SGECs, regulates, CD4 T cell, proliferation, primary Sjogren's syndrome, pSS, Saliva samples, pSS, patients, healthy subjects, analyzed, bacterial, 16S ribosomal DNA, result, abundant, taxa, identified, phylum, Proteobacteria, taxa, phylum, healthy controls, proteobacterium Haemophilus parainfluenzae, healthy controls, effect size, species, level, Treatment, A253 cells, in vitro, H. parainfluenzae, upregulated, PD-L1, expression, H. parainfluenzae-pretreated A253 cells, suppressed, CD4 T cell, proliferation, suppression, PD-L1, blockade, low-grade, xerostomia, patients, salivary, abundance, H. parainfluenzae, decreased, pSS, patients, non-pSS, sicca, patients, findings, H. parainfluenzae, immunomodulatory, pSS]]\n",
      "[[homogeneous, polysaccharide, SHNP, apparent, molecular weight, purified, brown algae, Sargassum henslowianum, ethanol, precipitation, ion-exchange chromatography, gel-filtration column chromatography, Structural analyses, SHNP, glucose, backbone, beta-D-(1-->3)-Glcp with, side chains, t-beta-D-Glcp, O-6 position, SHNP, laminarin-type polysaccharide, In vitro, fermentation test, results, SHNP, digested, gut microbiota, pH, fecal culture, SHNP, decreased, short-chain fatty acids, acetic, propionic, n-butyric acids, increased, SHNP, intestinal, microbiota, composition, stimulating, growth, species, Enterobacteriaceae, depleting, Haemophilus parainfluenzae, Gemmiger formicilis, results, SHNP, potential, regulating, gut microbiota, regulation, investigated]]\n",
      "[[BACKGROUND/PURPOSE, study, investigate, clinical characteristics, outcomes, bacteremia, Haemophilus, Aggregatibacter species, patients, treated, medical center, Haemophilus, Aggregatibacter, isolates, species, level, Bruker Biotyper MALDI-TOF analysis, 16S rRNA, gene sequencing analysis, ambiguity, Clinical characteristics, outcomes, patients, bacteremia, organisms, evaluated, Haemophilus, Aggregatibacter species, isolates, bacteremia, nonduplicated, patients, Haemophilus influenzae, Haemophilus parainfluenzae, Haemophilus haemolyticus, A. aphrophilus, A. segnis, Hospital mortality, patients, bacteremia, Haemophilus, Aggregatibacter species, patients, bacteremia, community-acquired disease, low, severity, Sequential, Organ Failure Assessment, SOFA, low, SOFA, odds ratio, confidence interval, factor, clinical outcomes, patients, community-acquired, H. influenzae bacteremia, hospital mortality, patients, bacteremia, Haemophilus, Aggregatibacter species, SOFA, score, predictor, clinical outcomes, patients, community-acquired, H. influenzae bacteremia]]\n",
      "[[Inhaled corticosteroids, ICS, asthma, treatment, evidence, ICS, usage, increased, rates, respiratory infections, assessed, composition, asthmatic airways, microbiome, asthma, patients, low, high dose, ICS, stability, microbiome, week, period, individuals, asthma, low-dose, ICS, high-dose, ICS, budesonide, fluticasone propionate, Sputum, subject, DNA extraction, amplification, 16S rRNA, gene sequencing, bacterial, microbiome, subjects, sputum induction, weeks, sequencing reads, bacterial taxa, asthmatic airway, samples, abundant, Streptococcus spp, No significant, sputum, bacterial, community composition, low-, high-dose, ICS, groups, Streptococcus spp, abundance, subjects, low-dose, ICS, Haemophilus parainfluenzae, abundant, subjects, high-dose, fluticasone propionate, high-dose budesonide, statistically significant, changes, microbiota, composition, period, no significant, low-, high-dose, ICS, groups, increased, abundance, potential, pathogen, H. parainfluenzae, patients, high-dose, fluticasone propionate, high-dose budesonide, microbiota, stable, days, evidence, community, bacteria, asthmatic airways]]\n",
      "[[increasing, availability, microbial, genomes, environmental, metagenomes, genomic differences, bacteria, human, oral microbiome, diverse, habitats, abundant, well-characterized, microbial, inhabitants, investigate, bacterial population, ecosystem scale, metapangenomic, public genomes, Human Microbiome Project, HMP, metagenomes, study, diversity, microbial, residents, oral habitats, tongue dorsum, buccal mucosa, supragingival, plaque, taxa, Haemophilus parainfluenzae, genus, Rothia, metapangenomes, genomic groups, genome, content, H. parainfluenzae, genomes, subgroups, differential, abundance, oral habitats, Functional enrichment analyses, operon, encoding, oxaloacetate decarboxylase, diagnostic, tongue-abundant, subgroup, genus, Rothia, grouping, genome, content, species-level, taxonomy, habitat, preferences, R. mucilaginosa, tongue, genomes, cryptic population, R. mucilaginosa, buccal, samples, H. parainfluenzae, genus, Rothia, limitations, cultivated organisms, populations, native, environment, cultivar gene sequences, absent, ubiquitous, findings, population structure, biogeography, mouth, hypotheses, habitat, adaptation, results, power, metagenomes, pangenomes, investigate, ecology, evolution, bacteria, analytical scales]]\n",
      "[[Purulent pericarditis, rare, disease, pericarditis, cases, Purulent pericarditis, hemodyamically unstable tamponade, untreated, fatal, idiopathic polymicrobial disease, documented, Haemophilus parainfluenzae, Prevotella buccae, Citrobacter freundii, literature, authors, case, male, emergency department, ED, features, bedside pericardiocentesis, pericardiocentesis, techniques, emergency department]]\n",
      "[[extensive, literature, oral, bacterial, pathogens, Porphyromonas gingivalis, Fusobacterium nucleatum, oral squamous cell carcinoma, OSCC, health-associated species, study, assessed, effect, Streptococcus mitis, Rothia mucilaginosa, Neisseria flavescens, Haemophilus parainfluenzae, Lautropia mirabilis, Veillonella parvula, proliferation, expression, marker genes, IL-6, TNF-alpha, MMP3, CD36, CCD1, NANOG, OSCC, cell lines, CAL27, SCC25, SCC4, Porphyromonas gingivalis, pathogenic control, bacterial lysates, concentrations, live cells, MOIs, tested, S. mitis, H. parainfluenzae, N. flavescens, dose-dependent, reduction, proliferation, H2O2, former, intracellular, infection, species, H. parainfluenzae, antiproliferative effect, cancer cell lines, normal control, TIGKs, gene expression assays, health-associated species, downregulated, CD36, gene, tumor growth, metastasis, P. gingivalis, upregulated, IL6, TNF, expression, hand, upregulated, species, Gram-negatives, P. gingivalis, effect, genes, cell line, exploratory study, health-associated bacteria, interact, OSCC, studies, effects, prevention, treatment, oral cancer]]\n",
      "[[Klebsiella pneumoniae, human, pathogen, urinary tract infections, pneumonia, increase, resistant, strains, opportunistic pathogen, virulence, cellular damage, host, immunological, level, host, study, invertebrate infection, Galleria mellonella, larvae, investigate, cellular damage, antioxidant response, changes, biochemical, parameters, K. pneumoniae infection, activity, cell damage, indicators, alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, increased, hemolymph, G. mellonella, larvae, K. pneumoniae, virulence, Creatine kinase, alkaline phosphatase, gamma glutamyl transferase, amylase activities, increased, regulate, disrupted, energy metabolism, infection, damage, K. pneumoniae infection, changes, amount, non-enzymatic antioxidants, uric acid, bilirubin, albumin, K. pneumoniae infection, amount, calcium, potassium, magnesium, phosphorus, altered, study, G. mellonella, larvae, infection model, investigation, infectious cell damage, physiological effects, opportunistic, K. pneumoniae, pathogen, lack, adequate, animal models]]\n",
      "[[study, evaluated, antibiotic, ASP, intervention, reducing, inpatient, fluoroquinolone, FQ, examined, impact, ciprofloxacin, susceptibilities, gram-negative bacteria, community hospital, two-step, ASP, intervention, electronic medical record algorithm, physicians, FQ, admission, institutional, guidelines, options, FQs, first-line, empiric, antibiotic therapy, FQ, ciprofloxacin, susceptibilities, non-duplicate cultured, isolates, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, admission, reviewed, Ambulatory care, isolates, comparison, group, FQ, utilization, rates, relationships, ciprofloxacin, susceptibility, evaluated, interrupted, time series, models, period, FQ, decreased, days, days, risk, pre-intervention, estimated, post-intervention, reduction, FQ, utilization, CI, days, days, risk, Reduced, FQ, utilization, correlated, increase, susceptibilities, ciprofloxacin, hospital onset, isolates, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, No significant, susceptibility, ambulatory care, isolates, Persuasive interventions, ASP, modified, physicians, inpatient, empiric, antibiotic, reduction, FQ, utilization, rates, increased, ciprofloxacin, susceptibility, gram-negative bacteria, community hospital]]\n",
      "[[efficient, industrial, production, glutarate, C5 platform, chemical, chemical, pharmaceutical industries, five-enzyme cascade pathway, reconstructed, in vitro, synthesize, glutarate, L-lysine, enzyme, expression, L-lysine decarboxylase, Escherichia coli, EcCA, putrescine aminotransferase, KpcPA, gamma-aminovaleraldehyde dehydrogenase, KpcPD, Klebsiella pneumoniae, catalytic, efficiency, KpcPA, bottlenecks, ribosome binding site, coordinate, enzyme molar, EcCA, KpcPA, KpcPD, optimum ratio, in vitro, volume scanning, hydrophobicity scanning, increase, KpcPA, activity, cadaverine, extracellular, accumulation, 5-aminovalerate (5AVA, reduced, overexpressing, gabP, encoding, 5AVA importer, strategies, engineered, Glu-02, glutarate, titer, E. coli, L-lysine, yield, productivity, L-lysine, 5-L scale, results, novel, potential, enzymatic process, industrial-scale, glutarate, amino acids, KEY POINTS: * The, bioconversion, l-lysine, glutarate, Cad pathway, Enhancing, conversion, efficiency, Cad route maximizes glutarate, E. coli, titer, glutarate, E. coli]]\n",
      "[[evaluated, distribution, carbapenem, colistin, resistance, mechanisms, clinical, E. coli, K. pneumoniae, isolates, Iran, non-duplicate, isolates, K. pneumoniae, E. coli, hospitalized, patients, admitted, Iran's, tertiary care hospitals, isolates, cultured, clinical specimens, wound, urine, blood, tracheal aspirates, Antibiotic susceptibility testing, disc diffusion, microdilution method, Clinical, guideline, extended, ESBLs, carbapenemase genes, fosfomycin, resistance genes, colistin, resistance genes, PCR-sequencing, biofilm formation, assessed, crystal violet staining method, expression, colistin, resistance genes, measured, quantitative reverse transcription-PCR, analysis, evaluate, association, gene upregulation, colistin, resistance, Genotyping, multi-locus sequencing typing, MLST, Colistin, tigecycline, effective, antimicrobial agents, susceptibility, isolates, resistance, colistin, isolates, moderate, weak, biofilm-producer, blaTEM, blaSHV, blaCTX-M, blaNDM-1, blaOXA-48-like, blaNDM-6 resistance genes, detected, isolates, Inactivation, mgrB gene, nonsense mutations, insertion, IS, elements, colistin, resistant, isolates, Colistin, resistance, upregulation, pmrK, phoP, phoQ, genes, blaNDM-1, blaNDM-6, variants, IncL/M, IncF, plasmid, MLST, blaNDM, positive, isolates, clonal complexes, ST147, ST15, ST3299, large-scale surveillance, effective, infection control, measures, prevent, outbreak, diverse, carbapenem-, colistin-resistant, isolates, future]]\n",
      "[[Multi-Drug Resistant, MDR, uropathogenic bacteria, increased, years, development, treatment options, infections, field, medicine, studies, bacteriophage, phage, potential, alternative, MDR, Urinary Tract Infections, UTI, resistance, mechanism, phages, antibiotics, side effects, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, uropathogenic bacteria, phage therapy, Phages, lysing, bacterial, pathogens, prevent, formation, biofilms, inducing, polysaccharide depolymerase, phages, penetrate, layers, biofilm, phage therapy, results, inhibiting, multiple-species, biofilm, efficient, weapon, catheter-associated UTI, hosts, limits, phage therapy, phage cocktail, combination therapy, positive, treatments, studies, phage-resistant strains, phage-host interactions, complicated, research, investigations, limited, clinical trials, treatment, human, review, phage therapy, context, treating, UTIs, considerations, application]]\n",
      "[[Pyogenic liver abscess, PLA, occult, malignant tumors, life-threatening disease, Studies, occurrence, cancer, hepatobiliary, colorectal cancer, risk, occult, primary liver cancer, cholangiocarcinoma, gastrointestinal cancer, PLA, patients, Malignant, PLA, specific, symptoms, signs, iodine concentration, ratio, energy spectrum, CT, lesions, normal, liver tissue, differentiation, liver cancer, liver abscess, Computed tomography colonography, patients, PLA, occult, colorectal cancer, treatment response, abscess, lesions, Klebsiella pneumoniae, Escherichia coli, microorganism, PLA, colorectal cancer, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, PLA, treatment, hepatobiliary malignant tumor, complications, mortality, poor prognosis, occult, colorectal cancers, early stage, early detection, prognosis, PLA, patients, combined, hepatobiliary malignancies]]\n",
      "NaN\n",
      "[[molecular assay, detection, Klebsiella granulomatis, ulcer specimens, surveillance period, diagnosis, donovanosis, genital ulcer disease, GUD, aetiology, genital ulcer, specimens, sexually transmitted, STI, pathogens, STI, aetiological, surveys, provinces, South Africa, Giemsa-stained ulcer, smears, participants, analysed, presence, Donovan bodies, mononuclear cells, Klebsiella screening assay, targeting, phoE, phosphate porin, gene, combination, restriction digest analysis, sequencing, presence, K. granulomatis, Klebsiella screening assay, positive, genital ulcer, specimens, Restriction digest analysis, nucleotide sequencing, phoE gene, specimens, positive, K. granulomatis, DNA, Donovan bodies, Giemsa, smears, specimens, study, K. granulomatis, genital ulceration, South Africa, surveillance period, molecular methods, results, K. granulomatis, GUD, population]]\n",
      "[[Donovanosis, chronic infectious disease, Gram-negative bacteria, Klebsiella granulomatis, skin, mucous membranes, genital, perigenital, inguinal regions, venereal granuloma, granuloma inguinale, endemic, tropical, subtropical regions, globe, associated with, sexual transmission, case, female, victim, chronic, sexual abuse, diagnosed, donovanosis, therapeutic response, doxycycline]]\n",
      "[[South Africa, treatment, genital ulcer disease, GUD, syndromic management, GUD, aetiological studies, Johannesburg, GUD, pathogen, prevalence, sero-prevalence, STI, co-infections, aetiological, trends, GUD, patients, community-based, Johannesburg, period, FINDINGS, GUD, surveys, year, Consecutive, genital ulcers, sampled, adults, Swab-extracted DNA, tested, multiplex real-time PCR assays, herpes simplex virus, HSV, Treponema pallidum, TP, Haemophilus ducreyi, HD, Chlamydia trachomatis, CT, HSV-positive, DNA extracts, subtyped, HSV-1, HSV-2, PCR assay, CT-positive, extracts, tested, PCR, specific, serovars L1-L3, lymphogranuloma venereum, Sera, tested, HIV, HSV-2, syphilis, co-infections, Giemsa-stained ulcer, smears, screened, Klebsiella granulomatis, microscopy, Data, analysed, STATATM, GUD, specimens, detectable, pathogen, HSV, TP, CT L1, HD, aetiological agents, detected, ulcer specimens, Seroprevalence, rates, HIV, HSV-2, syphilis, association, GUD, pathogen, detection, HIV, seropositivity, cases, HSV, co-infected, HIV, decline, relative prevalence, ulcer-derived, HSV, p-value, decrease, HIV, seropositivity, rate, p-value, HSV, pathogen-detectable GUD, South Africa, prevalence, HIV, co-infection, GUD, patients, linkage, HIV testing, treatment, primary healthcare settings]]\n",
      "[[Donovanosis, rare, chronic, indolent, sexually transmitted infection, Klebsiella granulomatis, ulcers, donovanosis, malignant transformation, longstanding, ulcers, case, male, two-month, history, progressive, large, foul-smelling ulcers, groin, distal penile shaft, scrotum, Crushed tissue, smears, ulcers, basophilic, intracellular, extracellular Donovan bodies, Fine needle aspiration, cytology, inguinal lymph nodes, biopsy, ulcers, squamous cell carcinoma, case, clinicians, donovanosis, rare, cutaneous malignancy, pathogenesis, malignant transformation, donovanosis, research]]\n",
      "[[Donovanosis, granuloma inguinale, bacterial infection, Klebsiella granulomatis, genital area, sexually transmitted, tropics, case, disease, contracted, metropolitan France, man, painless ulceration, glans, month, progressive, extension, trip, Skin biopsy, Whartin-Starry, Giemsa staining, Donovan bodies, cytoplasm, macrophages, findings, questioning, patient, unprotected, sexual contact, months, France, Treatment, azithromycin, day, day, weeks, clinical outcome, regression, ulcer, days, case, donovanosis, metropolitan France]]\n",
      "[[Donovanosis, rare, sexually transmitted, infection, sporadic, cases, Papua, South Africa, India, Brazil, Australia, causative organism, Calymmatobacterium granulomatis, proposal, organism, Klebsiella granulomatis comb nov, incubation, period, days, genital papules, ulcers, increase, size, lesions, described, ulcerogranulomatous, hypertrophic, necrotic, sclerotic, diagnosis, microscopic, identification, Donovan bodies, stained, tissue, smears, polymerase chain reaction methods, recommended, treatment, azithromycin, weekly, healing]]\n",
      "[[Biosynthesis, silver, nanoparticles, AgNPs, nest extract, paper wasp, Polistes sp, investigated, AgNPs, characterized, UV-Vis spectroscopy, Fourier transform infrared spectroscopy, FTIR, transmission electron microscopy, TEM, evaluated, antibacterial, antifungal, dye degradation, blood anticoagulation, blood clot dissolution, thrombolytic, crystalline, polydispersed, AgNPs, size, anisotropic structures, sphere, triangle, hexagon, rod, rhombus, FTIR, data, peaks, involvement, phenolics, compounds, proteins, synthesis, AgNPs, Ag, EDX spectra, AgNPs, AgNPs, antibacterial activities, multi-drug strains, Pseudomonas aeruginosa, Klebsiella granulomatis, growth, Aspergillus flavus, Aspergillus niger, suppressed, AgNPs, growth inhibition, Aspergillus fumigatus, AgNPs, degraded, malachite green, AgNPs, coagulation, blood, dissolved, blood clots, anticoagulation, thrombolytic activities, study, nest extract, paper wasp, synthesis, nanoparticles, biosynthesized, AgNPs, deployed, biomedical, catalytic, applications]]\n",
      "[[Phytochemical, investigation, Azorella madreporica, isolation, compounds, chalcone, structure, compound, spectroscopy, two-dimensional NMR techniques, comparison, published spectral data, antioxidant activity, chalcone, measured, 1,2-diphenyl-2-picryl-hydrazyl, DPPH, bioactivity, evaluated, bacteria, Mycobacterium smegmatis ATCC 14468, clinical, isolates, Staphylococcus aureus, Klebsiella granulomatis, Morganella morganii, Escherichia coli, cancer cell lines, Docking studies, tested cancer, proteins, nearby values, energy, doxorubicin, compound 1, protein-ligand interactions, energy values]]\n",
      "[[Wastewater, WWTPs, reservoirs, bacterial resistance, determinants, resistance, Gram-negative bacteria, influent, effluent, WWTPs, Portugal, wastewater, samples, aerobic, fecal, bacteria, evaluated, genomic features, polymerase chain reaction, PCR, Next-Generation Sequencing, NGS, Enterobacteriaceae, isolates, identified, 16sRNA, frequent, isolates, Escherichia spp., Aeromonas spp., Klebsiella spp., isolates, genera, resistant genes, detected, isolates, ESBL, blaCTX-M-15, predominant, isolates, KPC-3, identified, blaKPC-3, transposon Tn4401 isoform, virulence genes, VG, genes, E. coli 5301, O25b-ST131-B2, isolate, commensal, E. coli, genes, VG, Enterobactin, Aerobactin, CFA/1 (clade alpha, Type1, Type IV, relevant, clinical bacteria, WWTPs, KPC-3-producing K. oxytoca, CTX-M-15-producing Ochromobactrum intermedium, human, opportunistic pathogen, SED-1-producing Citrobacter farmeri, CTX-M-type extended-spectrum beta-lactamase]]\n",
      "[[global, extended-spectrum-beta-lactamase, ESBL, morbidity, mortality, associated with, invasive infections]]\n",
      "[[OBJECTIVE, susceptibility, ceftolozane-tazobactam, comparators, Enterobacterales, Pseudomonas aeruginosa, isolates, recovered, intraabdominal, IAI, urinary, UTI, respiratory, RTI, bloodstream infection, BSI, SMART, Monitoring, Antimicrobial Resistance, Trends, study, susceptibility, isolates, Spanish, hospitals, analysed, EUCAST-2020 criteria, broth microdilution, phenotypically, presence, extended-spectrum beta-lactamases, ESBL, Ceftolozane-tazobactam, carbapenem, resistant, isolates, genetically, characterized, ESBL, carbapenemases, Escherichia coli, frequent, pathogen, IAI, UTI, RTI, BSI, Klebsiella pneumoniae, P. aeruginosa, isolated, frequency, isolates, ESBLs, E. coli, Klebsiella oxytoca, Proteus mirabilis, Ceftolozane-tazobactam, susceptible, ESBL-(95.2, E. coli, K. pneumoniae, isolates, CTX-M-15, ESBL, E. coli, K. pneumoniae, associated with, OXA-48-like carbapenemase, P. aeruginosa, isolates, susceptible, ceftolozane-tazobactam, activity, isolates, resistant, beta-lactams, resistant, meropenen, ceftazidime-avibactam, GES-5, PER-1, VIM-1/2, enzymes, isolates, resistant, ceftolozane-tazobactam, Ceftolozane-tazobactam, activity, isolates, recovered, SMART study, affected, K. pneumoniae, P. aeruginosa, isolates, ESBL, carbapenemases]]\n",
      "[[OBJECTIVE, pediatric, patients, pediatric centers, Bogota, isolate, urine culture, community-acquired extended-spectrum b-lactamase, (ESBL)-producing enterobacteriaceae, Review, microbiological, data, children, January, December, WHONET, software, Escherichia coli, Klebsiella spp and, Proteus mirabilis, positive, urine cultures, period, data, patients, Frequency, ESBL-producing bacteria, infections, community-acquired urinary tract infections, UTI, E. coli, K. pneumoniae, P. mirabilis, female, sex, preschool children, lower tract, urinary infections, frequency, comorbidities, Adequate, sensitivity, amikacin, nitrofurantoin, study]]\n",
      "[[OBJECTIVE, information, OXA-48-producing, Klebsiella oxytoca, study, phenotypic, molecular characterization, OXA-48-producing, isolates, outbreak, hospital, Tunisia, OXA-48-producing K. oxytoca, isolated, University Hospital Farhat Hached, Sousse, Tunisia, Antibiotic susceptibility testing, broth microdilution, Carbapenemase activity, investigated, modified, carbapenem, inactivation, mCIM, Phenotypic tests, detect, extended-spectrum beta-lactamases, PCR, test, presence, carbapenemase genes, blaIMP, blaVIM, blaNDM, blaSPM, blaAIM, blaDIM, blaGIM, blaSIM, blaKPC, blaBIC, blaOXA-48, Genetic relatedness, isolates, investigated, rep-PCR, Whole genome sequencing, WGS, isolates, mCIM, positive, isolates, isolates, ESBL, phenotype, strains, susceptible, cefoxitin, ceftazidime, cefepime, aztreonam, imipenem, meropenem, fluoroquinolones, aminoglycosides, colistin, resistant, piperacillin-tazobactam, ertapenem, ticarcillin, ampicillin-sulbactam, isolates, blaOXA-48 gene, IncL, plasmid, resistance genes, ST220, Isolates, study, co-express, ESBL, detection, clinical laboratories, OXA-48, K. pneumoniae, risk, production, enzyme, suspected, species, K. oxytoca, difficulties, spread, enzyme]]\n",
      "[[Respiratory tract infection, Gram-negative bacteria, morbidity, mortality, worldwide, study, antimicrobial susceptibility, pattern, Gram-negative bacteria, patients, lower, respiratory tract infection, Kathmandu University Hospital, respiratory samples, sputum, endotracheal aspirates, processed, antibiotic resistance, pattern, Clinical Laboratory Standard Institute guidelines, Patients, information, consent, Growth, Gram-negative bacteria, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Acinetobacter species, Klebsiella oxytoca, Enterobacter species, Proteus mirabilis, Haemophilus influenzae, isolates, multidrug resistant, strains, resistant, colistin, resistant, carbapenem, metallo-, lactamase, producers, patients, pneumonia, respiratory illnesses, years, age, age, predisposing factor, patients, age, years, multidrug resistant, isolates, age, predisposing factor, getting infection, multidrug resistant, isolates, diabetic, patients, multidrug resistant, isolates, non-diabetic, patients, multidrug resistant, isolates, Multidrug-resistant Gram negative bacteria, respiratory samples, Effective, treatment, lower, respiratory tract, microbiological diagnosis, drug susceptibility testing]]\n",
      "[[antimicrobial susceptibility testing, surveillance, data, ceftaroline, comparative agents, AWARE, global surveillance programme, bacterial, pathogens, skin, soft tissue infections, SSTIs, lower, RTIs, Middle East, African countries, Pathogens, MALDI-TOF/MS, Antimicrobial susceptibility testing, Clinical and Laboratory Standards Institute (CLSI) broth microdilution method, MICs, CLSI, M100, European Committee, Antimicrobial Susceptibility Testing, EUCAST, breakpoints, MSSA, MRSA, susceptible, ceftaroline, MIC, CLSI, EUCAST, ceftaroline, MIC, MRSA, ceftaroline-resistant MRSA, identified, SSTI, CLSI, EUCAST, RTI, CLSI, isolates, isolates, beta-haemolytic Streptococcus, penicillin-susceptible, PSSP, Streptococcus pneumoniae, PISP, susceptible, ceftaroline, Rates, susceptibility, ceftaroline, penicillin-resistant, S. pneumoniae, penicillin, MIC, beta-lactamase-negative, BLNHI, beta-lactamase-positive Haemophilus influenzae, CLSI, EUCAST, Rates, susceptibility, ceftaroline, ESBL-negative, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Ceftaroline-resistant, isolates, MRSA, SSTIs, Middle East, African countries, CLSI, EUCAST, breakpoint criteria, bacterial, pathogens, SSTIs, Staphylococcus aureus, beta-haemolytic Streptococcus, lower, RTIs, PSSP, PISP, BLNHI, resistance, low, levels, resistance, ceftaroline]]\n",
      "[[large-scale dairy farm, countermeasure, prevention, mastitis, dairy cows, hygiene, risk management, prevent, emergence, spread, antibiotic-resistant bacteria, study, bacteriological testing, clinical, subclinical mastitis, investigation, antimicrobial resistance bacteria, large-scale farm, year, bacteria, isolated, samples, cow, cows, recurring mastitis, Staphylococcus non-aureus, SNA, Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, isolated, milk, sample, methicillin-resistant S. aureus, incidence, extended-spectrum beta-lactamase, E. coli, ESBL-producing K. pneumoniae, samples, third-, fourth-generation cephalosporins, antimicrobial, treatment, mastitis, farm, genotypes, ESBL-producing E. coli, K. pneumoniae, CTX-M-15, TEM-1, CTX-M-2, TEM-116, spread, predominant, clonal type, farm, management, segregation, culling, infected, animals, monitors, trends, antimicrobial resistance, mastitis, pathogens, results]]\n",
      "[[characteristics, Klebsiella pneumoniae complex, hereafter KP, isolates, healthy, pigs, farm workers, household members, Thailand, individual, rectal swabs, pigs, farms, faecal samples, humans, working, pig, farms, persons, living, household, Khon Kaen, Thailand, screened, gut colonization, KP, Genomic sequences, investigated, antibiotic resistance, virulence genes, Phylogenetic analyses, comparison, isolates, studies, Thailand, KP, detected, pig, human, samples, KP, isolates, pigs, farmers, individuals, living, farm, animal, contact, MLST, genetic, diversity, STs, distributed, phylogroups, Low, prevalence, ESBL-KP, colistin-resistant KP, pigs, humans, convergent, MDR, hypervirulent strains, pigs, ST290, humans, ST35, ST3415, ST17, Sharing, KP clones, pigs, humans, identified, STs, ST4788, ST661, ST3541, ST29, study, low, prevalence, ESBL, mcr genes, KP, isolated, pigs, healthy, humans, Thailand, zoonotic, transmission, circulating, KP clones]]\n",
      "[[study, correlation, antibiotic resistance genes, antibiotic susceptibility, carbapenem-resistant, Gram-negative pathogens, CRGNPs, patients, diagnosed, acute pneumonia, Egypt, isolates, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, recovered, isolates, MDR, carbapenem, resistant, K. pneumoniae, MDR, isolates, blaNDM, carbapenemase, blaOXA-48, blaVIM, association, multidrug efflux pump, AcrA, resistance, beta-lactams, aminoglycoside acetyl transferase gene, resistance, ciprofloxacin, azithromycin, beta-lactams, aztreonam, P. aeruginosa, association, presence, blaSHV gene, multidrug efflux pump, MexA, resistance, fluoroquinolones, amikacin, tobramycin, co-trimoxazole, beta-lactams, aac-6'-Ib gene, resistance, aminoglycosides, P. aeruginosa, isolates, MexAB-OprM, multidrug efflux pump, K. pneumoniae, isolates, AcrAB-TolC pump, results, medical, guidance, healthcare practitioners, effective, antibiotic, prescription]]\n",
      "[[Gastrointestinal carriage, multidrug-resistant, MDR, bacteria, risk factors, serious, difficult-to-treat infections, colonization, MDR bacteria, dynamic process, colonization, development, novel, decolonization, study, metataxonomic analyses, gut microbiota, dynamics, colonization, extended-spectrum beta-lactamase, carbapenemase-producing, Klebsiella pneumoniae, ECKP, strain, mice, effects, antibiotic administration, ampicillin, ceftazidime, ciprofloxacin, establishment, elimination, ECKP, intestinal, colonization, phyla, Bacteroidetes, Firmicutes, dominant, treatment groups, Bacteroidetes, groups, treated with, antibiotics, compared, control group, differences, antibiotic-treated groups, beta, diversity, difference, abundance, bacterial, Bacteria, Lachnospiraceae, family, Agathobacter, Anaerostipes, Lachnoclostridium, Lachnospiraceae, UCG-004, Lachnospiraceae, Lachnospiraceae, NK4A136 group 11319, Roseburia, Tyzzerella, inverse, relationship, carriage, rate, ECKP, strain, members, Enterobacteriaceae, ECKP, strain, correlational, relationship, results, composition, microbial, community, MDR-colonization, rate, antibiotic susceptibility, individual, MDR strains, lesser, bacterial, families, microbial, clusters, taxonomically, species, survival benefits, gut, associations, random, presence, metabolomic networks, concept, endeavors, MDR decolonization, supplemented, knowledge, composition, host, bacterial, community, identification, bacterial clusters, suppressing, enhancing, invader, species]]\n",
      "[[emergence, multidrug-resistant, MDR, Klebsiella pneumoniae, hypervirulent, traits, severe, infections, mortality, global, concern, hypermucoviscous strains, K. pneumoniae, optimal, treatment, management, control policies, answered, extensively drug-resistant, XDR, hypervirulent, ST5235, isolates, resistance, carbapenems, polymyxins, neonatal, sepsis, tertiary care hospital, India, K. pneumoniae, isolates, cases, neonatal, sepsis, clinical, relevance, antimicrobial susceptibility profile, presence, extended, spectrum beta lactamase, ESBL, production, genes, carbapenemases, classes, B, D, aminoglycoside-resistant genes, Hypervirulence genes, encoding, hypermucoid, nature, iron uptake, siderophores, detected, multiplex PCR, plasmid, profile, replicon typing, Isolates, typed, multilocus sequence typing, MLST, enterobacterial repetitive intergenic consensus (ERIC) PCR, study, sequence types, STs, clonal, relation, neonates, cases, history of, pre-maturity, low birth weight, maternal, complications, cases, treated with, piperacillin-tazobactam, amikacin, imipenem/meropenem, vancomycin, polymyxin B, resort, neonates, condition, isolates, XDR, resistance, polymyxins, ESBL genes, carbapenemase genes, bla NDM, bla OXA-48, Hypervirulence genes, combinations, rmpA/A2 genes, isolates, IncFI plasmids, detected, isolates, ST5235, ERIC PCR, clusters, study, emergence, burden, XDR, hypervirulent, isolates, K. pneumoniae, neonatal, sepsis, tertiary care hospital]]\n",
      "[[decrease, incidence, resistance, rates, extended-spectrum beta-lactamases, ESBL, Klebsiella pneumoniae, KP, restriction, third-generation cephalosporins, 3GCs, fluoroquinolones, Consumption, 3GCs, fluoroquinolones, carbapenems, association, ertapenem, fluoroquinolone-resistant KP, isolates, analyzed, months, autoregressive integrated moving average, models, follow-up, analysis, years, Consumption, 3GCs, decreased, postintervention, period, restriction, associated with, decrease, ertapenem-resistant KP, isolates, Fluoroquinolone, 3GCs, carbapenem, percentage, ertapenem-resistant KP, isolates, Fluoroquinolone, cephalosporin, percentage, fluoroquinolone-resistant, isolates, increase, DDD, OBDs, increase, fluoroquinolone-resistant, isolates, decrease, DDD, carbapenem/100 OBD, associated with, increase, fluoroquinolone-resistant, isolates, years, consumption, antimicrobial, increased, period, ertapenem-resistant KP, rates, decreased, study, intricate, association, antibiotic, consumption, bacterial resistance, spectrum, results, research, interventions, effects]]\n",
      "[[multidrug-resistant organisms, extended-spectrum beta-lactamases, ESBLs, globe, severe, problem, Knowledge, prevalence, antibiogram, isolates, appropriate, treatment methodology, study, study, prevalence, Gram-negative, isolates, ESBL, tertiary care hospital, study, antibiogram, profile, cross-sectional study, Shahid Gangalal National Heart Centre, Kathmandu, Nepal, clinical samples, collected, identified, conventional, biochemical tests, Clinical, Laboratory Standard Institute (CLSI) guidelines, Antimicrobial susceptibility testing, AST, standardized Kirby-Bauer disk diffusion method, screening test, ESBL, producers, CLSI, confirmatory test, phenotypically, E-test, isolates, multidrug-resistant, ESBL, producers, isolates, ESBL, producers, E-test, Escherichia coli, Klebsiella pneumoniae, predominant, isolates, ESBL, producers, polymyxin B, sensitive, meropenem, imipenem, efficacy, ESBL, producers, Multidrug resistance, ESBL, production, low, Polymyxin B, carbapenems, drugs, ESBL, producers]]\n",
      "[[Ceftolozane/tazobactam, C/T, countries, United States, treatment, patients, hospital-acquired, ventilator-associated bacterial pneumonia, susceptible, Gram-negative pathogens, C/T, agent, treatment, multidrug-resistant, MDR, Pseudomonas aeruginosa, infections, study, data, United States, respiratory tract, isolates, Gram-negative bacilli, SMART, CLSI, in vitro, susceptibility, C/T, comparators, isolates, P. aeruginosa, Enterobacterales, C/T, inhibited, P. aeruginosa, susceptible, MIC breakpoint, meropenem-nonsusceptible, piperacillin/tazobactam, isolates, MDR, isolates, Comparator agents, activity, C/T, P. aeruginosa, meropenem, susceptible, cefepime, ceftazidime, P/T, levofloxacin, C/T, active, ICU, susceptible, non-ICU, isolates, P. aeruginosa, C/T, inhibited, Enterobacterales, susceptible, MIC breakpoint, isolates, susceptible, cefepime, susceptible, P/T., extended-spectrum beta-lactamase, ESBL, screen-positive, isolates, Klebsiella pneumoniae, Escherichia coli, MDR Enterobacterales, susceptible, C/T., C/T, active, ICU, susceptible, non-ICU, Enterobacterales, isolates, Data, study, C/T, treatment, lower, respiratory tract infections, MDR, P. aeruginosa]]\n",
      "[[Infections, carbapenem-resistant Enterobacterales, CRE, problem, pets, threat, public health, genetic relationships, carbapenemase-producing, Klebsiella pneumoniae, CPKp, strains, infections, hospitalized pets, veterinary clinic, environment, WGS, Illumina, Nanopore platforms, Searches, genetic features, databases, bioinformatics, tools, phylogeny, assessed, whole-genome MLST, SeqSphere, SNP, calling, Snippy, WGS, analysis, CPKp, strains, identified, environmental, animal, strains, high-risk, ST11, strains, ST307, CPKp, complex types, CTs, conjugative 63 kb IncL, plasmid, encoding, carbapenemase gene, blaOXA-48, yersiniabactin, virulence factors, CPKp, ST11, strains, IncR, plasmids, antimicrobial resistance genes, ARGs, plasmid-mediated blaDHA-1, AmpC gene, structural variations, observed, ST307 strains, identical, MDR IncFIB(K), plasmids, ARGs, blaCTX-M-15 ESBL gene, wgMLST, cgSNP analysis, CPKp, strains, ST, genetically, independent, source, isolation, study, clinical, CPKp, strains, contaminating, clinical environment, findings, nosocomial spread, veterinary hospitals, source, CPKp, spread, animals, environment, humans]]\n",
      "[[global, spread, antibiotic-resistant bacteria, resistance genes, hospital settings, environmental, food safety, study, microbiological, genomic investigation, pathogens, resistant, broad-spectrum cephalosporins, endophytic, lifestyles, fresh vegetables, sold, country, endemicity, extended-spectrum beta-lactamases, ESBLs, isolation, international, high-risk clones, CTX-M-15-producing, Escherichia coli, clonal complexes, CC38, CC648, Klebsiella pneumoniae, complex, CC307, macerated, tissue, surface-sterilized, leaves, spinach, cabbage, arugula, lettuce, species, ESBL-positive, isolates, endophytically, colonize, bean, Phaseolus vulgaris, seedlings, resistance, acid pH, multidrug-resistant, MDR, clinically, antibiotics, broad-spectrum cephalosporins, aminoglycosides, fluoroquinolones, Genomic analysis, CTX-M-producing, endophytic, resistome, antibiotics, biocides, disinfectants, pesticides, virulome, genes, endophytic, fitness, acidic conditions, Transferable, IncFIB, IncHI2A plasmids, bla, CTX-M-15 genes, IncFIB plasmid, pKP301cro, genes, encoding, resistance, heavy metals, data, hypothesis, fresh vegetables, marketed, consumption, figurative, spread, international clones, WHO, priority, pathogens, ESBLs, resistance genes, humans, animals, food safety, public, environmental, Extended-spectrum beta-lactamases, Enterobacterales, human, animal infections, pathogens, World Health Organization, Epidemiological studies, spread, ESBL-producing bacteria, problem, hospitals, environmental, food safety, CTX-M-type beta-lactamases, distributed, clinically, ESBLs, worldwide, investigated, occurrence, genomic features, ESBL-producing Enterobacterales, surface-sterilized, international, high-risk clones, CTX-M-15-producing, Escherichia coli, Klebsiella pneumoniae, resistome, virulome, genes, endophytic, fitness, resistance, acidic conditions, CTX-M-15-positive, isolates, endophytically, colonize, plant tissues, fresh vegetables, figurative, spread, pathogens, endophytic, lifestyles]]\n",
      "[[study, evaluate, effects, synbiotic, formulation, Cichorium intybus root powder, Lactobacillus acidophilus NCDC15, LA, Lactobacillus reuteri BFE7, LR, growth, performance, Murrah buffalo, calves, monitoring, selective gut health indices, Murrah buffalo, calves, days, body weight, groups, randomized design, CRD, group I, control, CON, basal diet, group II, synbiotic, formulation, L. acidophilus, NCDC15 fermented, Cichorium intybus root powder, LAC, basal diet, group III, synbiotic, formulation, L. reuteri BFE7 fermented milk, Cichorium intybus root powder, LRC, basal diet, BW, average, dry matter intake, DMI, structural body measurements, increased, LAC, LRC, groups, synbiotic, CON, No effect, apparent, nutrient, coefficient, nutrients, supplemented groups, Faecal score, reduced, supplementation, synbiotic, LRC, LAC, CON, Calves, synbiotic, lower, faecal, pH, ammonia, concomitant, increase, faecal lactate levels, faecal, SCFA, control, faecal Lactobacillus, Bifidobacterium population, increased, synbiotic, fed, groups, control, coliform, clostridia count, decreased, treatment groups, CON, synbiotic, supplementation, effective, improving, growth, performance, Murrah buffalo, calves]]\n",
      "[[Paocai, Chinese, ingredient, salt, effects, bacterial, community, volatile compounds, paocai, effects of, salt, fermentation, paocai, bacterial, composition, volatile compounds, investigated, high-throughput sequencing, GC-MS, salt, no significant, effects, bacterial, community, phylum, level, Proteobacteria, Bacteroidetes, decreased, fermentation, Firmicutes, increased, dominant, bacteria, late stage, fermentation, genus, level, Lactobacillus, Lactococcus, increased, abundance, fermentation, dominant, bacteria, paocai, salt, growth, Lactobacillus, dominant, genus, paocai, salt, concentration, affected, profiles, volatile compounds, paocai, fermentation, volatile components, detected, GC-MS, phenols, aldehydes, nitriles, salt, concentration, increase, content, volatile compounds, aldehydes, alcohols, improve, flavor, paocai, time, electronic tongue analysis, salt, concentration, flavor, paocai, data, effects of, salt, quality, paocai, improve, quality, reduce, salt]]\n",
      "[[Gut microbiota, associated with, progression, brain tumors, alterations, gut microbiota, glioma growth, temozolomide, TMZ, therapy, C57BL/6, male, mice, implanted, GL261 glioma cells, TMZ/sodium carboxymethyl cellulose, SCC, administered, gavage, consecutive, days, days, implantation, Fecal samples, T0, days, T1, T2, T3, implantation, gut microbiota, analyzed, 16S ribosomal DNA sequencing, absolute, genera, glioma progression, changes, Firmicutes, Bacteroidetes, phyla, glioma growth, Lactobacillus, abundance, decreased, early stage, T1, increased, T2, T3, Intestinimonas, abundance, persistent, increase, Anaerotruncus, transient, increase, T2, decrease, T3, longitudinal changes, Intestinimonas, Anaerotruncus, abundance, TMZ-treated, mice, decrease, Anaerotruncus, T3, TMZ-treated, group, vehicle-treated group, No significant change, Lactobacillus, TMZ, treatment, vehicle control, TMZ, treatment, enrichment, Akkermansia, Bifidobacterium, Glioma development, progression, composition, gut microbiota, Induction, Akkermansia, Bifidobacterium, prevention, reduction, Anaerotruncus, anti-tumor effect, TMZ, study, association, levels, microbial, species, gut, anti-tumor effect, TMZ]]\n",
      "[[vaginal microbiota, women's, reproductive, urogenital health, healthy, vaginal microbiome, Lactobacillus species, Disturbances, microbial, community, adverse outcomes, pelvic inflammatory disease, bacterial vaginosis, BV, increased, susceptibility, sexually transmitted infections, miscarriage, preterm births, vaginal communities, women, microorganisms, absence, overt, clinical symptoms, diverse, vaginal, microbiomes, women's, health, Rhesus macaques, translational, animal model, questions, physiological, genetic homology, humans, study, longitudinal analysis, clinical, microbiome, data, reproductive-age, female, rhesus macaques, taxonomic, functional, rhesus macaque, vaginal microbiome, women, diverse, vaginal community, associated with, asymptomatic/symptomatic, bacterial vaginosis, rhesus macaque, vaginal, microbiomes, anaerobic, Gram-negative bacteria, Sneathia, Prevotella, Porphyromonas, Mobiluncus, animals, colonized, Lactobacillus, Gardnerella, comprehensive, analysis, model, health, diverse, vaginal microbiome, test interventions, community, healthy, vaginal microbiome, women, Lactobacillus species, asymptomatic, women, diverse, vaginal, microbial, communities, associated with, bacterial vaginosis, questions, drivers, health, diverse, vaginal, microbial, community, Rhesus macaques, excellent, translational model, questions, physiological, genetic homology, humans, study, longitudinal analysis, clinical, microbiome, data, cohort, reproductive-age rhesus macaques, taxonomic, genomic, functional levels, rhesus macaque, vaginal microbiome, humans, diverse, vaginal community, associated with, asymptomatic/symptomatic, bacterial vaginosis, comprehensive, analysis, macaques, model, study, diverse, vaginal community state, test, interventions, vaginal microbiome]]\n",
      "[[synergistic, microencapsulation, pectin, microgels, inulin, native, crops, Jerusalem artichoke, JAI, evaluated, natural strategy, increase, survival, Lactobacillus paracasei subsp., probiotic, properties, Oncorhynchus mykiss, strain, grow, ferment, JAI, modified, MRS broth, increasing, cell population, log units, decrease, pH, Encapsulation, F2, pectin, microgels, presence, JAI, improved, survival, strain, storage, exposure to, simulated, gastrointestinal conditions, entrapped cells, presence, prebiotic, CFU/g, CFU/g, days, degrees, results, implementation, techniques, formulation, functional, feeds, natural, sources, inulin, viability, storage, conditions, digestibility]]\n",
      "[[strains, YZ01(T, YZ02, YZ03) of Gram-stain-positive, facultatively anaerobic rods, isolated, forestomach, contents, captive, male, proboscis monkey, Nasalis larvatus, Yokohama Zoo, Japan, Phylogenetic analysis, 16S rRNA, gene sequences, strains, genus, Lactobacillus, sequence, similarity, 16S rRNA gene, Lactobacillus delbrueckii subsp., phylogenetic neighbour, YZ01(T), Sequence analyses, partial, RNA polymerase alpha subunit, rpoA, phenylalanyl-tRNA synthase alpha subunit, pheS, strains, genus, Lactobacillus, average, nucleotide, digital DNA-DNA hybridization, dDDH, L. delbrueckii subsp., indicus, YZ01(T, phylogenetic tree, genomic, data, strains, YZ01(T), YZ02, YZ03, strains, monophyletic cluster, genus, Lactobacillus, species, DNA, strain YZ01(T), fatty acids, C16, C18, phylogenetic, phenotypic, physiological, evidence, strains, YZ01(T), YZ02, YZ03, species, genus, Lactobacillus, Lactobacillus nasalidis sp. nov., type strain YZ01(T) (=JCM 33769(T)=DSM 110539(T)]]\n",
      "[[OBJECT, relevance, article, breast cancer, oncological disease, women, countries, highest, mortality, malignant neoplasms, women, study, evaluate, vaginal microbiota, women, breast cancer, subtypes, compared, groups, study, women, breast cancer, patients, combination therapy, control group, patients, breast cancer 2, years, decrease, Lactobacillus spp, statistically significant, changes, microorganisms, patients, subtypes, breast cancer, results, comparative analysis, representatives, obligate, anaerobic, flora, Peptostreptococcus spp, vaginal microbiota, luminal A, luminal B, subtypes, facultative, Staphylococcus spp. -, outcomes, Her2/Neu+, triple-negative subtypes, features, vaginal microbiota, women, subtypes, breast cancer, studies, preventive]]\n",
      "[[PROBLEM, Preterm birth, PTB, increased, morbidity, mortality, newborns, spontaneous, PTB, sPTB, activation, inflammatory response, ascending, genital tract infection, studies, effects of, vaginal microbiome, PTB, clinical application, case-control study, Korean, women, PTB, term birth, TB, cervicovaginal fluid, CVF, sampled, bacteria, analyzed, multiplex quantitative real-time PCR, qPCR, PTB, TB, groups, compared, PTB, prediction model, bacterial risk scores, machine learning techniques, decision tree, support vector machine, predictive, performance, model, random subsampling, Bacterial risk scoring model, differences, PTB, risk, low, Lactobacillus iners, ratio, groups, ratio, moderate, high risk, U. parvum, ratio, sensitivity, specificity, PTB, prediction model, bacteria, risk score, white blood cell, WBC, data, machine learning, bacterial risk score, CVF, PTB]]\n",
      "[[experiment, investigate, effects, dietary supplementation, coated, granules, CG, performance, in vitro, digestibility, gastrointestinal functionality, laying, hens, Hisex, Brown laying hens, weeks, age, groups, control, experimental groups, CG, day, hens, target, feed, intake, basal, day, egg production, egg weight, groups, feed, conversion, ratio, improved, linearly, dose, level, CG, diet, Dietary CG, increased, jejunal weight, linear, quadratic, decreased, ileal, weight, linearly, statistical interaction, dietary, CG, activity, intestinal, digestive enzymes, patterns, dietary, treatments, positive, in vitro, protein digestibility, crude enzyme extract, dietary, CG, supplementation, Dietary CG, decreased, caecal, Escherichia coli, population, Lactobacillus spp., E. coli, increased, quadratic fit, CG, supplementation, hand, intestinal, morphology, increasing, height, duodenal, ileal, villi, linearly, duodenal, antioxidant, observed, linearly, CG, garlic, encapsulation, feed supplementation, commercial, egg production, CG, day, adverse effects, performance, improving, nutrient, digestibility, utilization, feed, intake, amount, diet, observations, study]]\n",
      "[[AIM, evaluate, caries, preventive, antibacterial effects, Gum Arabic, Licorice mouthwashes, chlorhexidine, caries-risk, patients, prevalence, oral, mouthwashes, assessed, participants, categorized, caries-risk, CAMBRA caries-risk model, groups, mouthwash, G1, Gum Arabic, G2, Licorice, G3, Chlorhexidine, Baseline, DMF, scores, saliva samples, DMF, scores, salivary, Streptococcus mutans, SM, Lactobacillus acidophilus, LA, counts, oral, months, results, statistical analysis, significance level, DMF, scores, statistically significant, groups, baseline, months, months, statistically significant, G3, G1, G2, G3, DMF, scores, statistically significant, G1, G2, antibacterial activity, months, mouthwashes, statistically significant, antibacterial effect, SM, LA, statistically significant, months, G1, G2, statistically significant, reduction, SM, LA, counts, G3, statistically significant, increase, SM, LA, counts, bacterial resistance, G1, G2, oral side effects, G3, Gum Arabic, Licorice mouthwashes, caries, preventive, antibacterial effects, Natural mouthwashes, substitutes, chemical agents, chlorhexidine, effective, caries, control, long-term]]\n",
      "[[Surface-engineered encapsulation, non-genetic method, living organisms, harsh, environmental, cell encapsulation methods, shells, interfacial-interactions, encapsulated, bacterial, surfaces, impact, interfacial-interactions, protection, shells, unclear, bacteria, surface, composition, Probiotic bacteria, protection, gastro-intestinal fluids, antibiotics, encapsulated, probiotic, strains, ZIF-8, zeolitic imidazolate framework, biomineralization, strong-interaction, coordinate-covalent bonding, alginate gelation, intermediate-interaction, hydrogen bonding, protamine-assisted packing, SiO2, nanoparticles, yolk-shell, weak-interaction, void, shells, bacterial, surfaces, surface, probiotic, Lactobacillus acidophilus, protein, hydrophilic, positively-charged surface, negatively-charged, pH, Probiotic, Bifidobacterium infantis, hydrophilic, uncharged surface, polysaccharides, proteins, amino groups, coordinate-covalent, bonding, zinc, hydrogen bonding, alginate, L. acidophilus, B. infantis, encapsulated, ZIF-8, biomineralization, alginate gelation, intermediately, interacting, shells, porous shells, interacting, ZIF-8, biomineralized, shell, encapsulated, bacteria, susceptible, antibiotics, cell wall, damage, inflicted, Zif-8, biomineralization, interacting, yolk-shells, interacting, alginate gels, maintained, probiotic, activity, encapsulated, bacteria, impact, interfacial-interactions, shells, encapsulated, bacteria, aspect, protection, development, effective, surface-engineered shells, application, bacteria]]\n",
      "[[effect, bioprotective extracts, BEs, Lactobacillus acidophilus CRL641, BE-1, Latilactobacillus curvatus CRL705, BE-2, exopolysaccharide producer, Latilactobacillus sakei CRL1407, vacuum-packaged meat, degrees, evaluated, Lat, sakei CRL1407, grow, control samples, CFU/g, days, BE-1, BE-2, reduced, bacterial growth, CFU/g, combination, growth reduction, CFU/g, antimicrobial activity, detected, treated, samples, BE-1, BE-1, BE-2, day, BE-2, time, pH values, constant, discs, treated with, BEs, combination, drop, pH, control samples, lipid oxidation, color, changes, detected, presence, BE-1, BE-1, BE-2, combination, BEs, biocontrol agent, preservation, barriers, fresh, meat, shelf-life, quality loss]]\n",
      "[[study, investigate, effects, commercial, probiotic, supplementation, water, performance, parameters, carcass, traits, immune function, antioxidant capacity, broiler, chicks, experiment, Arbor Acres, broilers, male, female, groups, G, G1, basal diet, G2, G3, G4, basal diet, Lactobacillus casei, L. acidophilus, Bifidobacterium, water, days, experimental results, probiotic additives, positive, impacts, body weight, average, ADFI, average, weight gain, female, chicks, probiotics, reduced, ADFI, feed, conversion, ratio, male, chicks, Probiotics, improved, eviscerated, yield, breast yield, reducing, abdominal fat, male, broiler, chicks, increase, weight, spleen, bursa, Fabricius, thymus, treatment group, probiotics, effect, concentrations, immune-related proteins, increased, concentrations, antioxidase, digestive enzymes, control, probiotics, reduced, Escherichia coli, Salmonella, increased, quantity, Lactobacilli, results, study, increase, growth performance, carcass, traits, immune function, gut, microbial, population, antioxidant capacity, probiotics, L. casei, L. acidophilus, Bifidobacterium, water, broilers]]\n",
      "[[Producing, ferulic acid, FA, natural, substrate, feruloyl esterase, industries, screening, engineering, enzymes, efficiency, increase, FA, yield, feruloyl esterase, Lactobacillus acidophilus, FAELac, heterologous, expressed, FAELac, oligomerization, states, activity, dimer, high-polymer, efficiency, FAELac, mutants, simulated structure, Q198A, Q134T, enhanced, catalytic, efficiency, comparison, wild type, yields, FA, substrate, mutants, de-starched wheat, insoluble, wheat, arabinoxylan, steam-exploded corn stover, results, improving, purification process, engineering, FAELac, substrates, bias, studies, potential, increasing, FA, production, yield]]\n",
      "[[study, method, encapsulation, acid-labile drug, Omeprazole, Lactobacillus acidophilus, L. acidophilus) ATCC 4356 S-layer protein, Omeprazole, suspension, preliminary studies, Omeprazole powder, parameters, melting point, IR spectrum, UV, spectrum, particle size, Omeprazole powder, investigated, size, reduction, ideal, formulation, powder, average, particle size, mum, uniform, amount, S-layer protein, drug particles, effect, factors, drug coating process, investigated, factor, time method, stability, coated, Omeprazole, evaluated, acetate buffer, pH, maximum, coat, drug particles, S- layer protein, Lactobacillus acidophilus ATCC 4356, degrees, shaking rate, ratio, S-layer protein, Surface, Tris hydrochloride buffer medium, pH, coating, Omeprazole, S-layer protein, decreased, drug decomposition, rate]]\n",
      "[[equine, hindgut, ecosystem, dietary fibers, fermentation, horses, energy, health, antibiotics, disrupt, hindgut, microbiota, affecting, fibrolytic, activity, bacteria, intestinal, immune balance, diseases, in vivo study, comprehensive, hindgut, ecosystem, healthy, horses, days, response, oral trimethoprim-sulfadiazine, TMS, microbial, fibrolytic, host, immune response, Horses, supplemented, doses, Lactobacillus acidophilus, Ligilactobacillus salivarius, L. salivarius, Bifidobacterium lactis, blend, placebo, design, Changes, fecal microbiota, investigated, 16S rRNA sequencing, Clostridioides difficile, quantified, feces, quantitative polymerase chain reaction, Anaerobic, microbiological culture, functional, bacterial groups, cellulolytic, amylolytic, lactic acid-utilizing, environmental dimensions, assessed, measuring, concentrations, volatile fatty acids, VFAs, lactic acid, biochemical methods, changes, pH, dry matter weight, Systemic, local, inflammation, evaluated, determination, cytokine, immunoglobulin (Ig)A, concentrations, serum, secretory IgA, SIgA, concentrations, feces, immuno-enzymatic methods, Oral, TMS, treatment, hindgut, ecosystem, days, administration, Bacterial, diversity, decreased, proportion, abundance, fibrolytic, genera, decrease, concentration, cellulolytic bacteria, time, composition, microbiota members, reorganized, abundances, alteration, fibrolysis, C. difficile, DNA, horses, abundances, potential, pathobiont genera, increased, days, TMS, administration, fecal concentrations, VFAs, SIgA, increased, fecal water, content, alteration, integrity, hindgut mucosa, Recovery, bacterial composition, functions, immune biomarkers, days, TMS, administration, Supplementation, bacterial, blend, bacterial, alteration, mucosal, immunomodulatory]]\n",
      "[[Chocolates, functional food, enrichment, probiotics, probiotics, processing, storage, conditions, harsh, gastrointestinal environment, study, overcome, formulations, cocoa powder, encapsulants, Na-alginate, A1, Na-alginate, fructooligosaccharides, A2, probiotic, strains, encapsulated, formulations, viabilities, encapsulated, probiotics, assessed, chocolates, encapsulation, efficiencies, formulation A1, Lactobacillus casei, formulation A2, Lactobacillus acidophilus La5, encapsulated, probiotics, formulations, maintained, higher, viability, therapeutic level, days, storage, degrees, tested, encapsulants, probiotics, survival, thermal stress, maintained, Logs, CFU/g, degrees, probiotics, fortified, chocolates, Logs CFU/g, days, storage, degrees, formulations, survivability, probiotics, Logs CFU/g, in vitro, gastrointestinal, digestion, study, cocoa powder, Na-alginate, FOS, potential, probiotic, encapsulating, material, chocolates, excellent, carrier, development, healthy, probiotic chocolate products, introduction, cocoa powder, effective, encapsulating, agent, probiotics, chocolate industry, healthy, functional snacks, health-conscious consumers]]\n",
      "[[Heat-killed lactic acid bacteria, immunomodulatory functions, probiotics, long product, shelf-life, storage, transportation, study, heat, treatments, industrial, preparation, probiotics, antioxidant activity, heat-killed strains, Lactococcus lactis, MG5125, nitric oxide inhibition, Lactobacillus acidophilus, MG4559, Lactobacillus plantarum MG5270, Lactobacillus fermentum MG4510, L. plantarum MG5239, L. plantarum MG5289, L. plantarum MG5203, heat-killed, strains, inhibited, lipopolysaccharide-induced nitric oxide synthase, cyclooxygenase-2, expression, heat-killed bacteria, intact, bio-functionality, elongate, shelf-life, food processing, probiotic foods, stability, antioxidant, immune-modulatory activities, heat-killed strains, study, potential, utilization, probiotic products, manufacturing]]\n",
      "[[Lactobacillus ssp, conjugated, linoleic acid, CLA, producers, Lactobacillus delbrueckii subsp., bulgaricus strains, CLA, fermented milk, fermented dairy food chain, study, reports, draft, genome sequence, L. bulgaricus strain, LBP, isolated, Italian, Padano cheese, Draft genome sequence, paired-end reads, quality, trimmed, assembled, contigs, 604,745,873 bp, 2086 protein coding genes, average, GC, content, Draft genome sequence, enzymes, strain's, CLA, metabolism, gene, encoding, enzyme, biohydrogenation, linoleic acid pathway, oleate hydratase]]\n",
      "[[Lactic acid, EPS, food industry, improve, stability, rheological, properties, fermented dairy products, beta-Lactoglobulin, BLG, dominant, bovine milk, bind, small molecules, fatty acids, vitamins, flavors, interact, neutral, anionic polysaccharides, food, pharmaceuticals, data, affinity, EPS-milk protein, interactions, structural information, BLG-EPS, complexes, EPS, binding sites, lacking, binding sites, BLG, variant A, BLGA, oligosaccharides, mild acid, hydrolysis, EPS, Streptococcus thermophilus, LY03, Lactobacillus delbrueckii ssp., NMR spectroscopy, supplemented, isothermal titration calorimetry, ITC, molecular docking, complexes, Evidence, binding sites, site, site 2, surface, BLGA, oligosaccharides, LY03-OS, NMR, perturbations, multivalency, BLGA, EPS, affinities, LY03-OS, BLGA, K D values, NMR, pH, ITC, pH, Molecular docking, BLGA, EPS, complexes, hydrogen bonds, hydrophobic, interactions, findings, BLGA, structurally, EPS-derived, oligosaccharides, design, BLG-EPS, complexation, relevance, formulation, dairy products, BLGA, coacervation]]\n",
      "[[intestinal flora, influence, behavior, microbiota-gut-brain axis, occurrence, development, nervous system diseases, depression, Probiotics, Lactobacillus, regulate, balance, intestinal flora, preventing, treating, depression, C57BL/6J mice, randomly, normal control group, control, Lac group, model, group, model, Lac group, model, model, Lac groups, intraperitoneally, lipopolysaccharide, days, behavior, mice, assessed, normal, model, groups, intragastric, administration, saline, daily, control, Lac, model, Lac groups, Lac intragastrically daily, days, inhibitory, Lac, fermentation, depression-related bacteria, in vitro, Lac, inhibited, production, depression-like behaviors, mice, expression, levels, zonula occludens-1, ZO-1, E-cadherin, small intestine, model, group, decreased, Lac, effect, Overactivation, microglia, decreased, expression, dopamine transporter, DAT, brain tissues, depression, Lac treatment, expression, toll-like receptor 4, TLR4, nod-like receptor protein-3, NLRP3, level, interleukin-1 beta (, IL-1beta, intestine, brain, increased, effects, Lac, Lac inhibited, dysbiosis, metabolites, Lac, antidepressant, inhibition, dysbiosis, metabolites, pattern recognition receptor, TLR4, signaling]]\n",
      "[[Probiotics, ferment, nondigestible, carbohydrates, short-chain fatty acids, SCFA, acetate, propionate, butyrate, human colon, study, levels, SCFA, yogurts, fermented, combinations, probiotics, cocultures, Streptococcus thermophilus, Lactobacillus bulgaricus, control, C, S. thermophilus, L. bulgaricus, Bifidobacterium bifidum, S. thermophilus, L. bulgaricus, Lactobacillus acidophilus, S. thermophilus, L. bulgaricus, Lactobacillus gasseri, Results, acetate levels, C-Bb, C-La,, C-Lg yogurts, C yogurt, Fermentation, physicochemical characteristics, yogurts, identical, Treatment, mucus-secreting colon, epithelial cells, HT29-MTX, C-Bb, C-La,, C-Lg yogurt, supernatants, increase, expression, MUC2, CDX2, production, mucin proteins, adhesion, probiotics, HT29-MTX, cells, increased, treatment, C-Bb, C-La,, C-Lg yogurt, supernatants, data, yogurt diet, acetate, improves, protective function, intestinal epithelium]]\n",
      "[[Oxidative stress, player, pathogenesis, intestinal pathologies, probiotics, study, investigated, effects, dietary supplementation, Lactobacillus delbrueckii, LAB, intestinal, integrity, oxidative damage, lipopolysaccharide, piglets, crossbred, weaned, piglets, Duroc, Landrace, Yorkshire, groups, non-challenged controls, CON, LPS-challenged controls, LPS, LAB, LPS, treatment, LAB, LPS, day, experiment, LPS, CON, groups, injected, intraperitoneally, LPS, saline, body weight, results, LPS-induced, elevation, serum diamine oxidase, level, small, intestinal, depth, CD, dietary, LAB, increased, ileal, expression, tight junction proteins, occludin, ZO-1, claudin-1, LPS-challenged, piglets, LAB, supplementation, LPS-induced, changes, decreasing, malondialdehyde, MDA, serum, intestinal mucosa, 8-hydroxy-2-deoxyguanosine, 8-OHdG, jejunal mucosa, increasing, glutathione reductase, GR, glutathione peroxidase, GSH-Px, serum, intestinal mucosa, increasing, glutathione, GSH, superoxide dismutase, SOD, jejunal mucosa, LAB, activated, Toll-like receptor, (TLR)-Bruton's tyrosine kinase, signaling pathways, intestine, ameliorative, antioxidant, capacity, weaned, piglets, LAB, increased, intestinal, integrity, improving, intestinal structure, tight junctions, antioxidant functions, activation, TLR-Btk-Nrf2 signaling pathway]]\n",
      "[[workflow, physicochemical characteristics, mammalian, protein species, protein aggregates, inclusion bodies-IBs, MMP-9, recombinantly, prokaryotic, Clearcoli, engineered, Escherichia coli, Lactococcus lactis, IBs, recovered, non-denaturing conditions, purification, affinity chromatography, solubilized, MMP-9, protein peaks, conformational protein, IBs, isolated, characterized, physicochemical characteristics, isolated, peaks, biological activity, methodological approach, dynamic light scattering, DLS, circular dichroism, CD, spectrofluorometric analysis, separation, subpopulations, conformers, characteristics, protein purification procedures, analysis, individual, physicochemical properties, biological activity, protein peaks, chromatographic techniques, source, information, best-fitted protein populations]]\n",
      "[[Nono, fermented dairy, cow's milk, Nigeria, microbial, diversity, starter, development, industrial, production, polyphasic approach, phenotypic, genotypic methods, 16S rRNA, gene sequencing, repetitive element PCR, metagenomics, whole genome sequencing, identified, Lactobacillus (Lb.) helveticus, Limosilactobacillus (L.) fermentum, Streptococcus, bacterial species, milk fermentation, nono, production, Nigeria, yeast, species, nono, Saccharomyces cerevisiae, metagenomics, Shigella, potential, pathogens, enterobacteria, detected, low, levels, abundance, Strains, predominant, lactic acid bacteria, LAB, starter cultures, combination, capacities, growth, milk, reduction, pH, gelling, characteristic, S. thermophilus, strains, Whole genome sequence analysis, bacterial strains, assembled, genome size, genome size, Genes, encoding, bacteriocins, detected, strains, LAB, genes, diacetyl, production, citrate metabolism, bacteria, isolated, nono, improve, microbial, safety, quality, nono, Nigeria, improving, technological parameters, gelling viscosity, palatability, product, consistency]]\n",
      "[[Objective, Kawasaki disease, KD, pediatric heart disease, KD, patients, resistant, front-line therapy, interventions, secondary, complications, myocardial fibrosis, proteins, pathways, associated with, disease, anti-IL-1, treatment, mouse model, KD, Vasculitis, induced, Lactobacillus casei cell wall extract, LCWE, injection, male, mice, Groups, mice, injected, LCWE, LCWE, IL-1 receptor, anakinra, saline, controls, Upper heart tissue, assessed, quantitative mass spectrometry analysis, Expression, activation, STAT3, assessed, immunohistochemistry, immunofluorescence, Western blot, IL-6, expression, RNA-seq, ELISA, STAT3, molecular inhibitor, anti-IL-6R, antibody, evaluate, STAT3, IL-6, disease development, STAT3, expressed, phosphorylated, cardiac tissue, LCWE-injected mice, reduced, anakinra, treatment, Il6, Stat3, gene expression, enhanced, abdominal aorta, LCWE-injected mice, reduced, Anakinra, treatment, IL-6, serum, levels, enhanced, LCWE-injected mice, normalized, anakinra, inhibition, STAT3, blockade, IL-6, disease development, Proteomic analysis, cardiac tissues, protein, expression, KD-like, control, anakinra, treated, cardiac tissue, STAT3, IL-6, upregulated, LCWE, normalized, anakinra, treatment, STAT3, IL-6, disease development, bystanders, inflammation]]\n",
      "[[Aqueous, glutathione, selenium, nano-incorporation, gamma radiation, presence, microbial glutathione, GSH, selenium dioxide, UV-vis spectroscopy, TEM, DLS, XRD, EDX, FTIR, spectrum, presence, GSH, moiety, coating, selenium, nanoparticles, SeNPs, GSH-SeN-Inco, XRD analysis, presence, metallic, SeNPs, nucleation, radiolysis, mechanism, GSH-SeN-Inco formation, size, factors, concentration, GSH, selenium dioxide, absorbed dose, gamma radiation, study, positive, antitumor activity, HepG-2, MCF-7, IC50, concentration, scavenging activity, antimicrobial, potential, Gram-negative, Gram-positive bacteria, significant, MIC, Escherichia coli ATCC 25922]]\n",
      "[[diagnosis, control, Aeromonas infections, economic, aquaculture, loss, study, DNA vaccine, efficacy, Aeromonas infections, fused DNA fragment, OmpAI gene, Aeromonas veronii, A. veronii, gene, carp, splicing, PCR, SOE-PCR, expressed, Lactobacillus casei, CC16, Protein, molecular adjuvant, antigen, OmpAI, fusion antigens, anchored, secretory, anchored-type antigens, effective, inducing, immune responses, fish, secretory antigens, Western blot analysis, bands, antigens, oral, immunization, DNA vaccines, enhanced, serum, levels, AKP, ACP, SOD, LZM, immunized carp, genes, IL-10, IL-1beta, TNF-alpha, IFN-gamma, heart, liver, spleen, head kidney, intestinal tract, upregulated, phagocytic response, immunized fish, carp, administered, fused antigens, Aeromonas, protection, Recombinant Lactobacillus bacteria, expressing, fused protein, propensity, colonization, intestinal tract, immunized fish, controls, DNA vaccine, immunogenicity, carp, A. veronii infections]]\n",
      "[[allergy medication, asthma, allergic rhinitis, AR, side effects, patients, quality of life, therapy, probiotic bacteria, Lactobacillus species, anti-allergic effects, mouse, human studies, administration, Lactobacillus species, nasal, ocular, improvement, quality of life, children, adults, suffering, rhinitis, changes, cytokine profiles, elevated, Th1, decreased, Th2, cytokines, reduced, allergy-related immunoglobulins, cell immigration, human, murine, studies, Positive effects, patients, activity, limitations, rhinitis, episodes, asthma, rhinitis, oral administration, Lactobacillus bacteria, lactic acid bacteria, changes, immune system, inhibits, development, allergies, symptoms, review, overview, studies, usage, probiotic, Lactobacillus strains, AR]]\n",
      "[[Probiotics, Lactobacillus, lactic acid bacteria, LAB, strains, clinical practice, probiotics, GRAS, presumption, safety, QPS, statuses, safety, strains, study, evaluate, safety, Lact, casei, B-7280 strain, investigating, toxicity, effects, gut microbiota, experimental, Male, BALB/c mice, weeks, treated with, Lact, casei, B-7280 strain, CFU/animal, day, days, amount, CFU/animal, day, days, probiotic, doses, humans-from 10(8), CFU, monitored, days, Blood tests, serum, biochemistry, cecal, content, mice, experimental, control groups, freshly, collected, analyzed, experiments, day, presence, LAB, heart, liver, kidney, mesenteric lymph nodes, peripheral blood, histology, brain, liver, heart, fragments, small, intestine, mesenteric lymph nodes, Survival rate, BALB/c mice, treated with, Lact, casei, B-7280 strain, concentrations, toxicity, experiments, days, toxicity, changes, gait, lethargy, sleep, somatomotor activity, changes, fur, eyes, skin, mucous membranes, tremors, behavior pattern, convulsions, salivation, diarrhea, local injuries, mice, experimental groups, administration, probiotic strain, opportunistic bacteria, cecal, contents, Staphylococcus spp., Candida spp., Pseudomonas spp., aerobic, anaerobic, decreased, controls, population, bacteria, lactobacilli, increased, cecal, contents, mice, LAB, detected, peripheral blood, heart, liver, kidneys, mesenteric lymph nodes, administration, strain, intact, mice, Lact, casei, B-7280 strain, dose, CFU/animal, oral administration, mice, positive, effect, gut microbiota, composition, probiotic, humans]]\n",
      "[[SCOPE, Probiotics, drug-induced, liver injury, animal experiments, clinical, evidence, absent, objective, investigate, effect, adjunctive Lactobacillus casei, tuberculosis-drug-induced liver injury, post hoc analysis, randomized controlled trial, trial, Chinese Clinical Trial Registry, patients, standard, tuberculosis therapy, control group, colony-forming units, CFU, day, low-dose group, CFU, day, L. casei, high-dose group, tuberculosis, treatment, L. casei, supplementation, reduced, incidence, abnormal, increase, cholestasis-related liver indices, alkaline phosphatase, bilirubin, Plasma, lipopolysaccharide, intestinal permeability, biomarkers, zonula occludens-1, intestinal fatty acid binding protein, reduced, gut microbiota, composition, reduction, Bacteroidetes, increase, Actinobacteria, Firmicutes, L. casei, supplementation, suppressing, abnormally, cholestasis-related liver indices, tuberculosis, treatment, modification, blood lipopolysaccharide, intestinal barrier, gut microbiota]]\n",
      "[[study, effect, grape seed protein hydrolysate, GPH, physicochemical, sensory, properties, stirred, yogurt, evaluated, antioxidant, properties, degree, hydrolysis, DH, GPH, microbial protease, enzymes, alcalase, flavourzyme, results, alcalase, enzyme, GPH, DH, antioxidant, properties, increasing, hydrolysis, time, positive, effect, properties, DH, free radical scavenging DPPH, ferric reducing power, GPH, alcalase, treatment, experiments, GPH, stirred, yogurt, concentrations, physicochemical properties, viability, Lactobacillus casei, sensory properties, measured, days, storage, results, GPH, treatment, higher, pH, viscosity, texture, firmness, acidity, syneresis, compared, control sample, samples, decreasing, L. casei, viability, control treatment, storage, period, parameters, results, increasing, concentration, GPH, treatments, acceptable, sensory, properties, yogurt, GPH, functional food, consumers, dairy products, taste, nutritional, properties, consumption]]\n",
      "[[cofermentation, starter, cultures, probiotics, milk, study, analyzed, effects of, probiotics, Lactobacillus casei Zhang (Zhang, Bifidobacterium animalis ssp., combination, Zhang and M8, starter cultures, volatile, nonvolatile, metabolomic profiles, storage, degrees, C, compared, liquid chromatography-tandem mass spectrometry, LC-MS, GC-MS-based, metabolomics, Principal component analysis, heatmap plots, Spearman correlation results, Zhang, effect, volatile, nonvolatile, combination, Zhang and M8, additive effects, production, metabolites, volatile metabolites, levels, acetaldehyde, diacetyl, acetoin, acetic acid, combination, Zhang and M8, probiotic, culture, increased, nonvolatile components, induced, Zhang, identified, galactose, amino-, nucleotide sugar, fructose, mannose, purine, phenylalanine metabolism, arginine, pathways, metabolism, biosynthesis, starch, sucrose, tyrosine, galactose metabolism, aminoacyl-tRNA biosynthesis, upregulated, combination, Zhang and M8, effects, Zhang and M8, combination, volatile, nonvolatile, metabolomic profiles, yogurts]]\n",
      "[[Plasmid, vectors, homologous, heterologous, gene expression, characterization, promoter, regulatory regions, genetic manipulation, labeling, bacteria, years, vectors, promiscuous, replicons, pMV158 family, employment, Gram-positive bacteria, applications, lactic acid bacteria, plasmid, vectors, knowledge, replicative, features, growth, bacteria, acidification, culture medium, lactic acid, production, Initiation, pMV158 rolling-circle, replication, catalyzed, plasmid-encoded RepB protein, sequence-specific cleavage, parental, DNA strands, covalent bond, DNA, covalent, adduct, leading-strand termination stage, cleavage, regenerated, nick site, strand-transfer reaction, result, rejoining, ends, cleaved, parental strand, hydrolysis, adduct, release, protein, nicked double-stranded DNA plasmid, analyzed, effect, pH, in vitro reactions, catalyzed, RepB, in vivo, replication, ability, plasmid pMV158, acidic, pH, impairs, catalytic activity, protein, reduces, hydrolysis, covalent, RepB-DNA adduct, nucleophilic, nature, reactions, pMV158, replicate, in vivo, copy number, segregational stability, plasmid, Lactococcus lactis, intact, extracellular, pHs, reduction, plasmid, copy number per chromosome, equivalent, pH, RepB, pMV158 molar ratio, increased, pH, compensatory, mechanisms, in vivo, pMV158, replication, pH values, severely, disturb, catalytic activity, initiator protein]]\n",
      "[[liver abscess, Lactococcus lactis ssp lactis, male, patient, history, right hypochondrium pain, days, physical examination, right hypochondrium pain, hepatomegally, ultrasound, hepatomegaly, liver abcess, segments IV, VII, VIII, measuring, computed tomography, CT, abscess, segments IV, V, VI, VII, measuring, surgical drainage, radiologic drainage, antibiotherapy, failure, success, Liver abscesses, rare, men, years, co-morbidities, L. Lactis ssp lactis, exceptional, prevalence, autopsies, hospitalized patients, germs, gram-negative bacilli, anaerobic bacteria, Ultrasound, CT scan, diagnosis, cases, etiology, Percutaneous drainage, treatment, surgical drainage, percutaneous drainage failures, Liver abscess, Lactococcus lactis ssp lactis, clinic, diagnostic methods, treatment, abscess, abscesses, etiologies, antibiotics, percutaneous drainage, abscesses, improved, death, rate]]\n",
      "[[AIMS, Increases, antimicrobial resistance, antimicrobial, potential, lantibiotics, investigated, nature, organism, study, investigate, natural, nisin, variants, GRAS, strains, nisin H, nisin J, nisin P, expressed, characterized, GRAS, host, study, cloning, nisin A, promoter, leader sequence, nisin H, nisin J, nisin P structural gene sequences, Streptococcus hyointestinalis DPC 6484, Staphylococcus capitis, APC, Streptococcus agalactiae DPC, expression, Lactococcus lactis NZ9800, genetically, strain, nisin A., Induction, nisin controlled, gene expression system, nisin, variants, nisin A machinery, host, strain, SIGNIFICANCE, IMPACT, Describes, heterologous, production, natural, nisin, variants, GRAS, strain, systems, lantibiotic production, expansion, structural, diversity, development, biotherapeutics]]\n",
      "[[Mycobacterium tuberculosis, Mtb, global epidemic, BCG, novel, vaccines, reduction, Mtb, morbidity, mortality, PilVax, peptide delivery, generation, mucosal, immune responses, food-grade bacterium, Lactococcus lactis, peptides, engineered, Streptococcus pyogenes, M1T1 pilus, peptide amplification, stabilisation, enhanced, immunogenicity, study, dominant, T cell epitope, Mtb protein, Ag85B, genetically engineered, pilus backbone subunit, expressed, surface, L. lactis, Western blot, flow cytometry, formation, pilus, peptide DNA sequence, B cell, responses, intranasally, vaccinated, mice, analysed, ELISA, T cell responses, analysed, flow cytometry, Serum titres, peptide, IgG, IgA, detected, vaccination, antibodies, cognate peptide, Peptide-specific IgA, detected, mucosal sites, sampled, CD4(+) T cells, detected, levels, mice, immunised, BCG, PilVax, immunisation, increase, CD3(+) CD4(-) CD8(-), double negative, DN, T cells, lungs, vaccinated, mice, Analysis, cytokine, production, stimulation, cognate peptide, cytokine, cells, CD4(+) T cells, DN T cells, study, antibody, peptide, cellular immune responses, PilVax, vaccination, suitability, vaccine, protection study]]\n",
      "[[complete, genome sequences, virulent, phages, Skunavirus genus, Siphoviridae, infect, Lactococcus lactis, cheddar cheese, production, Canada, linear genomes, bp, GC, contents, open reading frames, ORFs]]\n",
      "[[Acetoin, food, cosmetics, industries, taste, fragrance, enhancer, (R)-acetoin, Saccharomyces cerevisiae, acetoin, biosynthetic genes, encoding, alpha-acetolactate synthase, AlsS, alpha-acetolactate decarboxylase, AlsD, Bacillus subtilis, water-forming NADH oxidase, NoxE, Lactococcus lactis, delta-sequences, JHY605, strain, production, ethanol, glycerol, R)-2,3-butanediol, BDO, eliminated, acetoin, production, increasing, acetoin, tolerance, adaptive laboratory evolution, byproducts, meso-2,3-BDO, 2,3-dimethylglycerate, byproduct, Ara1, Ypr1, Ymr226c, Ora1, (S)-alcohol-forming reductases, reduce, meso-2,3-BDO, in vitro, Ara1, Ypr1, meso-2,3-BDO, production, in vivo, Ora1, substrate, preference, (S)-acetoin, reduces, (S)-alpha-acetolactate to 2,3-dimethylglycerate, AlsD-mediated (R)-acetoin, production, deleting, ARA1, YPR1, ORA1, (R)-acetoin, maximum, theoretical yield, high, stereospecificity]]\n",
      "[[study, seed endosphere, bacterial wilt, tolerant, chilli cv, Firingi Jolokia, agents, bacterial wilt disease, biocontrol, endophytic bacteria, isolated, freshly, seeds, isolates, R. solanacearum, isolates, Bacillus subtilis, KJ-2, Bacillus velezensis, KJ-4, Leuconostoc mesenteroides, KP-1, Lactococcus lactis, LB-3, Bacillus amyloliquefaciens, WK-2, Bacillus subtilis, WK-3, 16S rRNA, gene sequencing, planta, R. solanacearum, seedling, root bacterization method, Bacillus subtilis, KJ-2, biocontrol, efficacy, day, post, R. solanacearum, inoculation, biocontrol, efficacy, Leuconostoc mesenteroides, KP-1, GC-HRMS analysis, detected, antimicrobial compounds, extract, culture supernatant, Bacillus subtilis, KJ-2, inhibition, R. solanacearum, growth promotion assay, isolates, Bacillus subtilis, KJ-2, Bacillus amyloliquefaciens, WK-2, growth promotion, plants, seed, endophytic, isolates, bacterial wilt, tomato, seedling stage, Bacillus subtilis, KJ-2, effective, controlling, disease, results, study, seed endosphere, bacterial wilt, tolerant, cultivar, R. solanacearum, bacterial, isolates]]\n",
      "[[c-di-AMP, bacterial, messenger, pool, c-di-AMP, diadenylate cyclase, phosphodiesterase activities, binding, c-di-AMP, proteins, riboswitches, regulation, spectrum, cellular processes, c-di-AMP, impact, intrinsic, beta-lactam, antibiotic resistance, Gram-positive bacteria, unclear, genetic studies, suppressor mutations, decrease, activity, potassium, importer, KupB, glutamine importer, cefuroxime, CEF, resistance, diadenylate cyclase, cdaA, mutants, Lactococcus lactis, Metabolite analyses, glutamine, GlnPQ, glutamate, GlnPQ, mutations, c-di-AMP, negatively, pools, abundant, free, amino acids, glutamate, aspartate, growth, high-c-di-AMP mutant, GlnPQ, activity, increased, internal, K(+) level, overexpression, c-di-AMP-insensitive, KupB variant, results, c-di-AMP, GlnPQ, activity, level, free, anions, L. lactis, inhibition, K(+) import, Excessive, ion, accumulation, cdaA, mutants, results, spontaneous, hypotonic, conditions, CEF-resistant, suppressors, reduced, cell lysis, lower, osmoresistance, overaccumulation, counter-ion osmolyte, pools, c-di-AMP-defective mutants, L. lactis, cefuroxime, sensitivity, bacterial, c-di-AMP, global regulator, potassium homeostasis, solute, uptake, Gram-positive bacteria, osmoregulation, c-di-AMP, beta-lactam resistance, identified, overaccumulation, potassium, free amino acids, cefuroxime, sensitivity, Lactococcus lactis, defective, c-di-AMP, synthesis, c-di-AMP, negatively, levels, abundant, free, amino acids, glutamate, aspartate, L. lactis Regulation, free, anions, glutamine transporter, GlnPQ, activity, increased, response, intracellular, potassium levels, c-di-AMP, control, Evidence, osmolytes, enhance, osmoresistance, cell lysis, regulatory, c-di-AMP, free, anions, bacteria]]\n",
      "[[Sjogren's syndrome, SjS, autoimmune diseases, impacts, people, annually, SjS, results, autoimmune attack, exocrine, salivary, lacrimal, women, affected, men, vaccine, therapeutic, treat, SjS, patients, therapies, symptoms, Oral treatment, adhesin, enterotoxigenic, Escherichia coli, autoimmune diseases, antigen (Ag)-independent, Lactococcus lactis, CFA/I fimbriae, LL-CFA/I, suppresses, inflammation, induction, infectious tolerance, Ag-specific regulatory T cells, Tregs, IL-10, TGF-beta, hypothesis, CFA/I fimbriae, development, inflammatory T cells, Treg, induction, oral treatments, LL-CFA/I, spontaneous, genetically, model, SjS, C57BL/6.NOD-Aec1Aec2 mice, salivary flow, Six-week, C57BL/6.NOD-Aec1Aec2 mice, orally, dosed, LL-CFA/I, treated, control groups, L. lactis vector, PBS, LL-CFA/I-treated mice, salivary flow, age, reduced, incidence, inflammatory infiltration, submandibular, lacrimal glands, PBS-treated, mice, increase, Foxp3(+), IL-10-, TGF-beta-producing, Tregs, LL-CFA/I, expression, proinflammatory cytokines, IL-6, IL-17, GM-CSF, IFN-gamma, Adoptive transfer, CD4(+) T cells, LL-CFA/I-treated, LL, vector-treated mice, restored, salivary flow, diseased, SjS, mice, data, oral LL-CFA/I, SjS, progression, studies, testing, SjS, patients]]\n",
      "[[ATP-binding cassette transporter, GlnPQ, transports, glutamine, glutamic acid, asparagine, Gram-positive bacteria, features, extra-cytoplasmic substrate-binding domains, SBDs, transmembrane domain, transporter, SBDs, ligand, specificities, binding, affinities, distance, transmembrane domain, effects of, tandem, arrangement, domains, biochemical, biophysical, structural, properties, protein, crystal structure, ligand-free tandem, SBD1, protein, Lactococcus lactis, absence, transporter, compared, isolated, SBDs, isothermal titration calorimetry, ligand-binding, affinity, SBDs, single-molecule Forster resonance energy transfer, smFRET, ligand, conformational changes, domains, tandem, substrate, binding, conformational changes, affected, presence, domain, wild-type protein, changes, linker, domains, shortened, experiment, smFRET, protein-induced, PIFE-FRET, decrease, SBD, linker, length, linear increase, donor-brightness, SBD2, conformational states, SBD1, results, feasibility, PIFE-FRET, protein-protein interactions, conformational states, simultaneously]]\n",
      "[[Leclercia adecarboxylata, motile, gram negative bacillus, Enterobacteriaceae, family, isolated, disease, nature, review, identified, cases, immunocompromised, patients, organism, susceptible, antibiotics, multiantibiotic resistant, strains, case, Caucasian, man, multiple, co-morbidities, treated, L. adecarboxylata endocarditis, intravenous ceftriaxone]]\n",
      "[[OBJECTIVES-AIM, Pulmonary infections, bacterial microorganisms, Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, Burkholderia cepacia complex, cystic fibrosis, CF, patients, Unusual, bacteria, UB, isolation, techniques, respiratory samples, CF, patients, investigate, effects, presence, UB, respiratory cultures, CF, patients, clinical outcomes, necessity, treatment, prognosis, UB, MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight) mass spectrometry technology, Rhizobium radiobacter, detected, Chyrseobacterium species, gleum, indolgenes, Aeromonas hydrophila, Orchobacterium anthropy, Leclercia adecarboxylata, Delftia acidovorans, Cupriavidus Gilardi, R.radiobacter twith, Elizabethkingia miricola, R.radiobacter, C.gleum, patient, age, UB, growth, years, UB, growth, median, follow-up, months, UB, growth, patients, respiratory colonization, methicillin-susceptible S.aureus (, MSSA, UB, growth, MSSA, patients, FEV1, UB, growth, patients, spirometry, Median body mass index, UB, growth, UB, follow-ups, patient, UB, growth, symptoms, decrease, BMI, FEV1, patients, CF, MSSA, factor, UB, growth, patients, MSSA, colonization, UB, growth]]\n",
      "[[Leclercia adecarboxylata, gram-negative rod, water, food, pathogen, immunocompromised, patients, patients, hematological malignancies, chemotherapy, L. adecarboxylata, low-virulence, pathogen, excellent, susceptibility profile, strains, resistant, multiple, antibiotics, b-lactams, L. adecarboxylata, isolated, polymicrobial cultures, immunocompetent, individuals, cases, isolate, CASE REPORT A 74-year-old, woman, non-immunosuppressed, multiple, comorbidities, admitted with, acute decompensated heart failure, pneumonia, treated with, courses, antibiotics, amoxicillin-clavulanate, ciprofloxacin, pneumonia, infection, worsened, cardiopulmonary arrest, resuscitation, stable, days, hypotensive, septic screen, L. adecarboxylata bacteremia, treated, meropenem, days, meropenem, course, patient, diarrhea, severe, Clostridium difficile, infection, oral, vancomycin, intravenous metronidazole, died, case, infection, non-immunosuppressed, individual, organism, opportunistic pathogen, affecting, immunocompromised, patients, patient's, blood culture, L. adecarboxylata, sensitive, antibiotics, resolved, meropenem, treatment, increasing, L. adecarboxylata infections, studies, organism's, pathogenesis, risk factors, resistance, pattern]]\n",
      "[[Leclercia adecarboxylata, human, pathogen, affecting, immunocompromised, individuals, microbe, polymicrobial infections, immunocompetent, patients, L. adecarboxylata, isolated, urinary tract, case, pan-sensitive L. adecarboxylata, isolated, polymicrobial, urinary tract infection, immunocompetent, older adult, diagnosed, bladder cancer]]\n",
      "[[study, epidemiological, microbiological, molecular characteristics, outbreak, carbapenem-resistant Leclercia adecarboxylata, hospitals, associated with, contaminated, TPN, days, patients, intravenous, TPN, batch, formula, sepsis, blood cultures, positive, L. adecarboxylata, Antimicrobial susceptibility, carbapenemase, production, isolates, unopened bottle, TPN, Carbapenemase-encoding genes, extended-spectrum beta-lactamase-encoding genes, screened, PCR, plasmid, profiles, Horizontal transfer, carbapenem, resistance, solid mating, Clonal, diversity, pulsed-field gel electrophoresis, resistome, whole-genome sequencing, strains, comparative genomics, Roary, isolates, resistant, aztreonam, cephalosporins, carbapenems, trimethoprim/sulfamethoxazole, susceptible, gentamicin, tetracycline, colistin, susceptibility, levofloxacin, ciprofloxacin, observed, isolates, carbapenemase, producers, positive, blaNDM-1, blaTEM-1B, blaSHV-12 genes, lineage, detected, clone, A1, A2, blaNDM-1 gene, Tn125-like element, Genome analysis, genes, encoding, resistance, aminoglycosides, quinolones, trimethoprim, colistin, phenicols, sulphonamides, presence, IncFII, Yp, IncHI2, IncHI2A, incompatibility, groups, genomics, phylogenetic, relationship, L. adecarboxylata I1, USDA-ARS-USMARC-60222 genomes, strains, epidemiological, microbiological, molecular evidence, outbreak, carbapenem-resistant L. adecarboxylata, hospitals, western Mexico, associated with, contaminated, TPN]]\n",
      "[[Pathogen reduction technology, enhanced, bacterial, screening, risk, transfusion-associated septic reactions, contaminated, platelets, reports, interventions, efficacy, post-collection, processing, contamination, environmental organisms, storage, bag, integrity, CASE REPORT, fatal, septic transfusion reaction, patient, chronic kidney, liver disease, pathogen, reduced, platelet transfusion, anticipation, surgery, residual, platelet, cultured, detected, microorganisms, 16S genotype sequencing, pathogen, recovered, bacteria, assessment, amotosalen photoproducts, storage container, pressure testing, microscopic examination, Environmental culture, screening, hospital, Gram negative rods, detected, platelet unit, cultures, platelet component, patient's, blood, Acinetobacter baumannii complex, Leclercia adecarboxylata, Staphylococcus saprophyticus, strains, inactivated, kill, platelet storage container, leak, visible, pressure testing, Hospital environmental cultures, negative, contamination, source, A. baumannii, complex, S. saprophyticus, 16S genotyping sequences, septic reaction, Findings, post-processing, environmental, contamination, pathogen, reduced, platelet concentrate, non-visible, storage, leak, prevent, damage, detect, defects, platelet storage containers, transport components, clean environments]]\n",
      "[[Plant, ecological alternatives, fertilization, gramineous, plant, bacteria, interaction, genotype, strain, dependent, strains, development, biofertilizers, plant, capacity, Leclercia adecarboxylata strain, Palotina, isolated, group, corn, isolated, colony, genome, sequenced, Illumina technology, genome, Leclercia adecarboxylata strains, biological, growth-promoting, traits, solubilization, auxin, production, tested, genome, L. adecarboxylata strain, Palotina, assembled, functional, annotation, report, genes, associated with, plant growth, in vitro, indole acid, production, strain, results, project, endophyte, potential, biofertilizer, commercial, exploitation]]\n",
      "[[Leclercia adecarboxylata, L. adecarboxylata, uncommon, misdiagnosed, multiple infection, skin, soft tissue, cholecystitis, septicemia, immunocompromised hosts, individuals, trauma, aquatic environments, case, bacteria, necrotizing fasciitis, injecting, street, testosterone, supplements, patient, treated, excisional debridement, wound, week, course, Linezolid, Bactrim]]\n",
      "[[Infection, complication, childhood nephrotic syndrome, NS, spontaneous, bacterial peritonitis, SBP, boy, NS, decreased, urine output, generalized body swelling, abdominal pain, Urine analysis, proteinuria, Ascitic tap, sugar, protein, Gram stain, gram-negative bacilli, pus cells, culture grown, Leclercia adecarboxylata, LAD, LAD, matrix-assisted laser desorption ionization-time of flight mass spectrometry, MALDI-TOF MS, identification, organism, susceptibility, antibiotics, boy, contact, livestock, source, infection, Devitalized, skin, massive edema, site, entry, organism, patient, ceftriaxone, improved, LAD, opportunistic pathogen, Enterobacteriaceae, soft tissue infections, case, peritonitis, child, NS, reviewed, pediatric, cases]]\n",
      "[[Anatomic adaptations, birds, open fractures, exposed bone, vascularization, exposure, fractures, colonized, microorganisms, bacteria, aerobic, anaerobic, osteomyelitis, cases, antibiotic treatment, antibiotic treatment, antibiogram, increased, resistance, antibiotics, migratory, wild birds, bacterial counts, fracture type, bacterial, identification, antibiotic resistance, analysed, wild birds, wildlife, rehabilitation centres, Spain, results, open fractures, higher, bacterial counts, closed, Bacteria, family, Enterobacteriaceae, identified, Escherichia spp., Enterobacter spp., Shigella spp., Hafnia alvei, Proteus mirabilis, Leclercia adecarboxylata, Pantoea agglomerans, bacteria, wild birds' fractures, Aeromonas spp., Enterococcus spp., Bacillus wiedmannii, Staphylococcus sciuri, species, resistance, antibiotics, Wild birds, introduction, maintenance, global, antibiotic, bacteria, public, Results, antibiotic administration, wild animals, increase, bacteria, resistant, antibiotics]]\n",
      "[[metabolism, Legionella pneumophila, strain Paris, time intervals, growth, natural, host, Acanthamoeba castellanii, amoebae, bacterial infection, [U-(13)C3]serine, incubation, time intervals, bacterial, amoebal, fractions, fractions, hydrolyzed, acidic, (13)C-Enrichments, isotopologue, distributions, amino acids, 3-hydroxybutyrate, gas chromatography, mass spectrometry, Comparative analysis, labelling patterns, substrate, preferences, metabolic pathways, carbon, fluxes, intracellular, bacteria, amoebal, host, time course, infection cycle, bacterial infection, increased, usage, exogenous, glycolysis, A. castellanii, carbon, fluxes, amoebal citrate cycle, affected, whole infection cycle, intracellular, L. pneumophila, amino acids, host, bacterial proteins, partial, bacterial, biosynthesis, exogenous, (13)C-Ser, minor, rates, (13)C-glucose, bacterial, Ala, Asp, Glu, Gly, catabolic, usage, Ser, increased, post-exponential phase, intracellular, growth, glucose, bacteria, infection cycle, infection, in vitro, experiments, usage, (13)C-glucose, intracellular, bacteria, glucose, availability, replication, L. pneumophila, vacuoles, host cells]]\n",
      "[[Bacterial pneumonia, inhalation, aerosols, contaminated, Legionella spp, Legionnaires' disease, study, case, pneumonia, Legionella pneumophila, man, sea, water-filled whirlpool, hotel, spa, complex, patient's, Legionella urine antigen test, positive, L. pneumophila sg.1, field study, samples, outdoor, indoor, sea, Samples, whirlpool, culture positive, L. pneumophila sg.1, Typing, results, sea water, isolate, Sequence type, ST82, Allentown/France, MAb, subgroup, In vitro, experiments, L. pneumophila, strains, survive, sea water, days, survival time, prolonged, sea water, dilution, results, L. pneumophila, Allentown strain, resistant, adverse conditions, sea water, values, DT50, DT90, source, infection, potable water, filling, whirlpool, survival, L. pneumophila, conditioned, sea water, study]]\n",
      "[[screening, results, detection, co-infections, Legionella pneumophila, patients, infected, acute respiratory syndrome, coronavirus 2, patients, tested, positive, L. pneumophila, serogroup 1, Co-infections, L. pneumophila, coronavirus disease, patients, missed]]\n",
      "[[detection, pathogens, aquatic environments, issues, prevent, spread, diseases, point-of-care, POC, fast, efficient, detection, Legionella pneumophila, water, method, generation, immunocomplexes, bacteria, species, concentration, pathogens, membrane filter, filtration membrane, method, detect, fluorescence intensity, pathogen, concentration, efficient, evidence, presence, bacteria, evaluated, system, fluorescent, Escherichia coli, accurate, determination, cells, technique, tested, Legionella pneumophila, cells, labelled, fluorescence-labelled antibodies, principle, method, presence, bacteria, species, detect, bacteria, cells, hour, prevailling state, art detection method, cultivation, Legionella pneumophila, system, developments, analysis, pathogens]]\n",
      "[[intracellular, bacterial, Legionella pneumophila, host, cellular systems, effector proteins, replicative niche, Legionella-containing vacuole, LCV, infection, host, bacterial proteins, interactively function, LCVs, proteins, associated with, LCVs, host cells, protocol, protein, influences, subcellular, localization, LCV-associated proteins, infection, execution, protocol]]\n",
      "[[AIMS, detection, enumeration, Legionella spp, water samples, cultural technique, standardized, ISO, method, days, specificity, confirmation, study, multiplex PCR, presumptive, Legionella, colonies, culture plate, response time, days, results, colony forming units, CFU, laboratories, analyzed, colonies, compare, confirmation, Legionella spp., Legionella pneumophila, ISO, culture growth, agglutination, multiplex PCR, results, swiss national reference laboratory, data, evaluated, ISO 16140, PCR-technique, higher, specificity, confirmation, Legionella spp., Legionella pneumophila, Legionella pneumophila, serogroup, multiplex PCR, detection, positive, colonies, higher, specificity, SIGNIFICANCE, IMPACT, study, response time, enumeration, Legionella spp, higher, specificity, legally, CFU]]\n",
      "[[Secretion, bacterial effector proteins, host cells, bacterial virulence, dynamics, secretion systems, activity, machineries, export, numerous, effectors, multi-effector secretion, Legionella pneumophila, T4SS, translocates, effectors, kinetic translocation assay, beta-lactamase translocation reporter system, effect, protonophore, CCCP, translocation analysis, Icm/Dot, substrates, constitutively, L. pneumophila, assay, monitoring, secretion, activity, T4SS, expression control, effectors, effectors, translocated, timing, control, docking/translocation, T4SS, delivery, effective, manipulation, host cell, sequential, translocation, effectors, targeting, Rab1, SidM/DrrA, LidA, LepB., timed delivery, effectors, interaction, chaperone proteins, cyclic-di-GMP, signaling, diguanylate cyclase, Lpl0780/Lpp0809, timing, translocation]]\n",
      "[[Bacteria, genus, Legionella, natural, pathogens, amoebae, severe, pneumonia, humans, Legionnaires' Disease, Human disease, results, inhalation, Legionella-contaminated aerosols, bacterial, replication, alveolar macrophages, Legionella pathogenicity, humans, co-evolution, diverse, genera, amoebae, replicate, intracellularly, Legionella, replication-permissive compartment, Legionella-containing vacuole, LCV, action, Dot/Icm-translocated effector proteins, review, Legionella, pathogenicity, infection, mechanisms, secretion systems, translocated effector function, innate, adaptive immune responses, L. pneumophila, Legionella, genome, diversity, field]]\n",
      "[[male, admitted, hospital, severe, sepsis, secondary to, pneumonia, presentation, coronavirus disease, COVID-19, travel history, diagnosed, radiological, findings, dexamethasone, ceftriaxone, azithromycin, antibiotics, condition, worsened, diagnosed, Legionella pneumonia, resistant, macrolides, improved, antibiotics, levofloxacin, community-acquired pneumonia, CAP, COVID-19, era, case, unique, scenario, patient's, concurrent, COVID-19, infection, failure, improve, administration, azithromycin]]\n",
      "[[study, national level, presence, circulating, Legionella, artificial aquatic systems, facilities, state-owned centers, Spain, months, water samples, state-owned centers, Samples, cooling, towers, evaporative condensers, CTC, water distribution, networks, domestic, hot water, DHW, cold water, human, CW, sprinkler irrigation systems, SIS, fire sprinkler systems, FSS, water, decorative fountains, DF, facilities, regulations, systems, bacteria, sources, infection, generation, droplets, aerosols, isolation, counting, Legionella, water samples, microbiological culture, international, ISO, UNE-EN, ISO, ISO, quantification, Legionella, colonization, annual, distribution, geographical distribution, Legionella, isolates, recovered, water, analyzed, molecular techniques, characterization, Legionella non-pneumophila, isolates, Legionella, analyzed, water samples, colonization, detected, water samples, CTC, DHW, CW, DF, geographic, distribution, positive, samples, Legionella, Spanish, locations, analyzed, Legionella non-pneumophila, prevalent, isolated, water samples, geographical locations, Legionella anisa, Legionella jordanis, non-pneumophila, species, isolated, Legionella donaldsonii, isolated, water, networks, Spain, Legionella pneumophila, detected, locations, Legionella pneumophila, locations, study, presence, Legionella pneumophila, Legionella non-pneumophila, species, systems, potential, threat, public health, complementary techniques, molecular techniques, screen, routine, diagnosis]]\n",
      "[[Leptospirosis, zoonosis, pathogenic, Leptospira spp, Canine, human, leptospirosis, Amami Oshima Island, Nansei Archipelago, southwestern Japan, information, causative Leptospira spp, island, study, investigate, molecular, serological, characteristics, Leptospira spp, isolated, wild animals, dog, Amami Oshima Island, Leptospira strains, culturing, tissues, wild animals, black rats, wild boars, rabbit, blood, symptomatic, dog, flaB sequencing, microscopic agglutination test, antisera, serovars, isolates, Leptospira borgpetersenii serogroups Javanica, black rat, L. interrogans serogroup Australis, black rat, dog, L. interrogans serogroup Hebdomadis, wild boar, rabbit, sequence type, ST, L. borgpetersenii serogroup Javanica, ST143, multilocus sequence typing, MLST, housekeeping genes, L. interrogans, MLST, multiple-locus variable-tandem repeat analysis, MLVA, identical, ST, MLVA, rat, canine, isolates, STs, MLVA, identified, wild boar, isolates, STs, MLVA, rabbit, wild boars, identical, Bacterial culture, flaB-nested polymerase chain reaction, rate, Leptospira infection, wild boars, Leptospira spp, detected, black rats, study, Leptospira, genotype, serotype, maintenance, wild mammals, Amami Oshima Island, MLST, MLVA, black rats, source, canine, infection, Wild boars, L. interrogans, maintenance, host, antibodies, serogroup Hebdomadis, detected, human, canine, leptospirosis, patients, island]]\n",
      "[[Bacterial, pathogens, epithelial cell, apical junctional complexes, AJCs, infect, epithelial cells, Leptospirosis, zoonotic infection, Leptospira interrogans, dissemination, host, barriers, pathogenesis, mechanism, bacterial, dissemination, epithelial cell, barriers, poorly, characterized, study, analyzed, interaction, L. interrogans, renal proximal tubule epithelial cells, RPTECs, post-infection, L. interrogans, contact, plasma membrane, RPTEC, extracellularly, crawling, L. interrogans, cleaved, E-cadherin, induced, endocytosis, release, soluble, N-terminal fragment, extracellular medium, decrease, transepithelial, electrical resistance, TEER, mislocalization, AJC proteins, occludin, claudin-10, ZO-1, cingulin, cytoskeletal rearrangement, Inhibition, clathrin-mediated E-cadherin, endocytosis, prevented, decrease, TEER, disassembly, AJCs, epithelial cells, transmigration, bacteria, paracellular route, dissemination, L. interrogans, host]]\n",
      "[[Leptospira interrogans serovar Copenhageni, CRISPR-Cas I-B locus, CRISPR, array, cas-operons, reverse transcription-PCR, in vitro, endoribonuclease assay, Cas6, Leptospira, LinCas6, CRISPR, transcriptionally active, conventionally processed, LinCas6, excises, site, synthetic cognate repeat RNA, repeats, precursor-CRISPR RNA, pre-crRNA, sense direction, antisense repeat RNA, cleaved, multiple sites, LinCas6, functions, RNA, substrate, substitution, active site residues, His38, reduced, activity, study, comprehensive, Leptospira CRISPR array transcription, processing, LinCas6, RNA-mediated, CRISPR-Cas I-B, adaptive immunity]]\n",
      "[[spirochete, Leptospira interrogans serovar Pomona, enzootic, California, sea lions, CSL, Zalophus californianus, periodic, epizootics, Leptospirosis, CSL, associated with, fatality rate, rehabilitation, Evidence-based tools, prognosis, early, euthanasia, animals, low, probability, survival, reducing, severity, duration, animal, suffering, Classification, regression tree, analysis, clinical data, survival outcomes, CSL, leptospirosis, rehabilitation, Classification tree, outputs, binary decision trees, interpreted, clinician, Models, trained, data, cases, treated, Marine Mammal Center, Sausalito, CA, tested, data, cases, treated, classification, data, euthanized, animals, data, natural deaths, euthanasias, model-building, classification, outcomes, cases, variables, appetite, days, care, blood urea nitrogen, BUN, creatinine, sodium, admission, natural deaths, model, outcomes, cases, BUN, creatinine, admission, study, CART, analysis, wildlife, rehabilitation, evidence-based, goal, animal, suffering, epizootic, limits, facility's, capacity, care, models, allocation, resources, animals, predicted, probability, survival, technique, diseases, wildlife, rehabilitation]]\n",
      "[[Dogs, hosts, Leptospira interrogans, spread, bacterium, environment, Canicola, chronic disease, dogs, affected, incidental, serogroups, Icterohaemorrhagiae, acute disease, clinical signs, hepatic, renal changes, endemic areas, public, study, estimate, incidence, duration, elimination, leptospires, urine, dogs, study, group, longitudinal, long-term, molecular approach, dogs, apparent, symptoms, leptospirosis, study, dogs, PCR-negative, seronegative, study, Blood samples, hematological, examinations, urine, amplification, lipL32 gene, PCR, time points, year, Results, dogs, lipL32, PCR-positive, CI, study, day, negative, day, CI, day, CI, day, CI, day, CI, amplicons, sequenced, targeting, short region, secY gene, L. interrogans serovar Icterohaemorrhagiae, Leptospira noguchii, leptospires, Icterohaemorrhagiae serogroup, characterized, animals, clinically asymptomatic, study, asymptomatic, dogs, leptospires, characterized, strain, impressive, impact, public health]]\n",
      "[[modern medicine, increasing, cases, bacterial infection, leptospirosis, exploration, alternative, medicines, sources, plants, study, investigate, in vitro, anti-leptospiral activity, Phyllanthus amarus, extracts, combined, penicillin G, ceftriaxone, doxycycline, Antimicrobial susceptibility testing, microdilution broth technique, methanol extract, ME, aqueous extract, AE, antibiotics, Leptospira interrogans serovars Australis, Bataviae, Canicola, Javanica, inhibitory, MICs, bactericidal concentrations, MBCs, results, analyzed, ELISA microplate reader, microscopic analysis, Synergy testing, checkerboard assay, fractional inhibitory concentration index, values, extracts, combined, antibiotics, leptospires, Scanning electron microscopy, SEM, investigate, morphological, changes, leptospires, potential, anti-leptospiral agents, combined, antibiotics, MICs, MBCs, P. amarus, extracts, AEs, MEs, Penicillin G, effective, anti-leptospiral drug, MICs, MBCs, ceftriaxone, MICs, MBCs, doxycycline, MICs, MBCs, Combinations, P. amarus, extracts, antibiotics, synergistic, effects, Leptospira serovars, combinations, antagonistic effects, SEM, analysis, distorted, Leptospira, surfaces, P. amarus, AE, anti-leptospiral activity, P. amarus, ME, morphological, effects, P. amarus, extract, combination, antibiotic, Leptospira cells, anti-leptospiral properties]]\n",
      "[[early, symptoms, leptospirosis, dengue fever, distinguish, diagnostic, confusion, dengue, epidemics, Brazil, years, cases, leptospirosis, retrospective study, detect, leptospirosis, patients, tested, dengue, laboratory diagnoses, negative, Sera, samples, patients, cities, central region, Sao Paulo state, Brazil, samples, microscopic agglutination test, MAT, patients, days, onset of, symptoms, real-time polymerase chain reaction, PCR, prevalence, leptospirosis, cases, MAT, Icterohaemorrhagiae, Cynopteri serogroup, PCR, amplicon sequencing, Leptospira interrogans, criteria, cases, leptospirosis, Brazilian notification system, health surveillance, no records, patients, positive, leptospirosis, cases, Statistical analyses, prevalence, leptospirosis, men, women, age, positive, patients, years, negative, years, results, patients, suspected, dengue fever, evidence, leptospirosis, Leptospira infection, cases, Brazilian notification system, burden, dengue, misdiagnosis, leptospirosis, health professionals, increase, awareness, leptospirosis, diagnosis, patients, suspicion, dengue]]\n",
      "[[Leptospira, pathogen, adult, community-acquired pneumonia, nonspecific, manifestations, diagnostic tests, penicillin, efficacious, treat, leptospirosis, failure, early diagnosis, treatment, progression, deadly syndrome, multiple organ dysfunction, Next generation sequencing, cases, infection, cause, diagnosis, Leptospira infection, patient, fever, cough, dyspnea, admission, persistent, adult, respiratory distress syndrome, hemoptysis, hematuria, admission, case, Leptospira infection, positive, influenza tests, admission, early, Leptospira-targeted, antibiotics, administration, Next generation sequencing, molecular diagnostic tool, pathogen, Leptospira interrogans, occupational exposure history, penicillin, mechanical respiratory support, administrated, cure, patient, sequela, Clinicians, exposure history, Leptospira, pneumonia]]\n",
      "[[publications, pathogen, bonobos, Pan paniscus, living relatives, reservoirs, human, infectious agents, stool samples, semicaptive bonobos, bonobos, wild, Democratic Republic, Congo, screened, infectious agents, viruses, bacteria, parasites, presence, zoonotic, viral, bacterial, parasitic agents, stool samples, coinfecting, individuals, prevalence, Human mastadenoviruses, HAdV-C, HAdV-B, HAdV-E, Encephalomyocarditis viruses, identified, semicaptive bonobos, genotypes, identified, fatal, myocarditis, epidemic, site, Non-pallidum Treponema spp, symbiotic, T. succinifaciens, T. berlinense, potential, species, pathogenicity, identified, detected, DNA, non-tuberculosis, Mycobacterium spp., Acinetobacter spp., Salmonella spp, pathogenic, Leptospira interrogans, Zoonotic, parasites, Taenia solium, Strongyloides stercoralis, wild bonobos, Giardia lamblia, bonobos, contact, humans, exchange, bonobos, Oesophagostomum spp., zoonotic, O. stephanostomum, O. bifurcum-like species, uncharacterized, Nematoda, Trypanosoma theileri, identified, semicaptive bonobos, Pathogens, transmitted, sexually, identified, results, reasonably-sized, DNA/RNA sequence, evidence, pathogenic viruses, microorganisms, bonobo, noninvasive sampling method, feces, PCR, diagnostics]]\n",
      "[[Rats, maintenance, host, Leptospira spp, causative agents, leptospirosis, zoonotic disease, distribution, Rats, food, Mekong Delta, Cambodia, exports, tons, rats, Vietnam, wild rats, potential, health risk, information, Leptospira spp, rats, region, study, investigated, carriage, Leptospira spp, rats, exported, Cambodia, Vietnam, bacterial culture, nested PCR, DNA sequencing, Isolates, assessed, serological analysis, whole-genome sequencing, WGS, Leptospira DNA, detected, rat, kidney, tissues, analysed, multilocus sequence typing, MLST, rats, Bandicota indica, Rattus argentiventer, R. losea, R. norvegicus, R. rattus, bacterial culture, L. borgpetersenii serogroup Javanica, isolates, R. argentiventer, WGS, revealed, Cambodian, isolates, genetically, L. borgpetersenii serogroup Javanica strains, East, South-East, countries, cluster, strains, L. borgpetersenii sequences, flaB, sequence, L. interrogans, detected, R. argentiventer, R. losea kidney tissue samples, nested PCR, DNA sequencing, L. interrogans flaB-positive samples, MLST, housekeeping genes, glmU, pntA, sucA, tpiA, pfkB, mreA, caiB, sequences, lineages, sequence types, study, prevalence, Leptospira spp, rats, exported, Cambodia, Vietnam, potential, risk, people, engaging, rat, trade, fastidious, L. interrogans strain, circulates, Cambodian, rats]]\n",
      "[[D-lactic acid, chiral three-carbon, organic acid, improve, thermostability, polylactic acid, systematically, engineered, Saccharomyces cerevisiae, D-lactic acid, glucose, carbon, source, near, theoretical yield, screened, D-lactate dehydrogenase, DLDH, variants, lactic acid bacteria, genera, identified, Leuconostoc pseudomesenteroides variant, LpDLDH, activity, yeast, single-gene deletions, production, side products, ethanol, glycerol, prevent, conversion, D-lactic acid, pyruvate, results, DLDH, screening, single-gene deletions, strain, ASc-d789M, overexpresses, LpDLDH, deletions, glycerol pathway, GPD1, GPD2, lactate dehydrogenase gene DLD1, downregulation, ethanol, gene ADH1, L-methionine repressible, promoter, impact, growth, ASc-d789M, D-lactic acid, titer, shake-flasks, glucose consumed, theoretical yield, Fed-batch, fermentation, D-lactic acid, titer, glucose consumed, progress, efficient, microbial, production, D-lactic acid]]\n",
      "[[Lactic acid bacteria, synthesize, dextran, oligosaccharides, functionality, strain, fermentation, conditions, natural structure-forming agent, dextran, food additive, improving, properties, raw, materials, technological quality, cereal, by-products, fiber-and protein-rich matrices, food applications, study, assessed, dextran biosynthesis, in situ, fermentation, brewers, spent grain, BSG, beer, industry, Leuconostoc pseudomesenteroides DSM20193, Weissella confusa A16, starters, performance, primary, metabolites, fermentation, sucrose, starters, growth, acidification, kinetics, sugar, utilization, presence, sucrose, Viscosity, increase, fermented BSG, sucrose, increasing, dextran formation, Dextran, content, BSG, Oligosaccharides, degree, polymerization, dextran, dextransucrase genes, identified, L. pseudomesenteroides DSM20193, upregulated, active, fermentation, time, dextransucrase gene, W. confusa A16, induction profile, upregulation, lactic acid bacteria, starters, amount, dextran, brewers, grain, oligosaccharides, degree, polymerization, Putative dextransucrase genes, identified, starters, induction, Formation, dextran, oligosaccharides, BSG, lactic acid bacteria, fermentation, technological properties, raw material, reintegration, food chain]]\n",
      "[[Bioprocessing, lactic acid bacteria, LAB, by-products, food ingredient, LAB, capability, metabolize, carbohydrates, metabolism, metabolic, routes, fermentation, potential, pathways, phospho-beta-glucosidase genes, redundancy, LAB, genomes, enzymatic activity, fermentation, plant-based foods, release, phenolic compounds, beta-D-glycosylated precursors, degradation, beta-glucopyranosyl, carbohydrates, phenomic approach, characterize, metabolism, drift, Lactiplantibacillus plantarum, Leuconostoc pseudomesenteroides, lignocellulosic, by-product, brewers, BSG, Rich De Man, Rogosa and Sharpe (MRS) broth, increased, metabolic activity, gentiobiose, cellobiose, beta-glucoside, conjugates, phenolic compounds, BSG, fermentation, Gene expression analysis, cellobiose metabolism, release, lignin-derived aglycones, BSG, fermentation, comprehensive, LAB 6-phospho-beta-glucosidases, metabolic, routes, plant-based fermentations, controlled, characterization, pbg gene, expression, correlated, metabolism, beta-glucosides, aglycone, moieties]]\n",
      "[[study, taxonomic, positions, strains, C, LMG, LMG 18969, LMG, Leuconostoc pseudomesenteroides, polyphasic approach, analyses, 16S rRNA, pheS, rpoA gene sequences, cellular fatty acids, average, nucleotide, amino acid, identities, ANI, AAI, digital DNA-DNA hybridization, dDDH, phenotypic, features, rpoA sequence analysis, strains, L. pseudomesenteroides LMG 11482(T, groups, strains C, LMG, LMG, strains, LMG, LMG 11482(T, groups, identical, rpoA sequences, rpoA sequence, similarity, strain LMG, L. pseudomesenteroides LMG 11482(T, Strains LMG, ANI, values, dDDH, values, AAI, L. pseudomesenteroides LMG 11482(T, threshold, species, demarcation, strains, LMG, L. pseudomesenteroides, Strains LMG 18969 and C, ANI, values, dDDH, values, AAI, values, strain LMG, threshold, species, demarcation, strains, LMG 18969 and C, species, ANI, dDDH, AAI, values, strain LMG, type strains, phylogenetically, species, thresholds, species, demarcation, strain LMG, novel, species, genus, Leuconostoc, results, strains, LMG, L. pseudomesenteroides, strains, LMG 18969 and C, novel, species, genus, Leuconostoc, Leuconostoc falkenbergense sp. nov., type strain LMG 10779(T) (=CCUG 27119(T)]]\n",
      "[[Legume-based sourdough, potential, ingredient, manufacture, novel, baked products, lack, gluten, legume, flours, technological properties, issue, in situ, production, bacterial exopolysaccharides, EPS, fermentation, study, EPS-producing, lactic acid bacteria, in situ, production, chickpea sourdough, isolated, backsloppings, spontaneously, chickpea flour dough, dominant, strain, Weissella confusa, isolated, identified, W. confusa, Ck15, linear dextran, branches, sucrose, Temperature, degrees, C, dough, yield, sucrose, fermented chickpea, sourdoughs, acidification, rheology, sourdoughs, inoculated, W. confusa Ck15, Leuconostoc pseudomesenteroides DSM 20193, positive control, Lactobacillus plantarum F8, negative control, compared, in situ, dextran, production, W. confusa, Ck15 fermentation, highest, viscosity, increase, Pa.s, EPS, percentage, doughs, doughs, in situ, dextran, production, potential, improving, legume flour, bakery products, experiment, exploitation, microbial, EPS, baking, process, chickpea, product]]\n",
      "[[Kefir, health-promoting beverage, kefir, grains, traditional method, natural, cultures, kefir, backslopping method, study, microbial, dynamics, volatilome profile, kefir, production, traditional, backslopping, methods, kefir, grains, Bosnia, Herzegovina, results, conventional, amplicon-based sequencing, combined, kefir, drinks, characterized, physico-chemical, colorimetric, parameters, bacterial shift, Lactobacillus kefiranofaciens, Acetobacter syzygii, Lactococcus lactis, Leuconostoc pseudomesenteroides, kefir, grains, kefir, backslopped kefir, observed, differences, samples, dominant, mycobiota, backslopped kefir, samples, kefir, grain, samples, lactic acid, acetic acid bacteria, yeast, counts, decreased, grains, backslopped kefir, backslopped kefir, samples, protein, lactose, ash, content, ethanol, content, kefir, samples, coupled, optimal, pH values, pleasant sensory profile, volatilome, backslopped kefir, samples, correlated, cheesy, buttery, floral, fermented, odors, kefir, samples, correlated, alcoholic, fruity, fatty, acid odors, data, study, evidence, kefir, traditional, backslopping, quality, characteristics, product, functional, traits, backslopped kefir, investigated, suitability, potential, scale-up methodology, backslopping]]\n",
      "[[study, investigate, influences, fermentation, degrees, days, lactic acid bacterium, strains, Lactobacillus plantarum, 17a, Weissella cibaria, Leuconostoc pseudomesenteroides, W. cibaria, L. plantarum, color, pH, soluble, solids, TSS, phenolic compounds, antioxidant activity, African nightshade, leaves, Results, fermentation, L. plantarum 75 strain, decreased, pH, soluble, solids, increased, concentration, ascorbic acid, days, L. plantarum 75 strain, color, modification, fermented nightshade, leaves, increased, polyphenol, content, antioxidant activity, raw, nightshade, leaves, L. plantarum75, enhanced, functional, potential, nightshade, leaves, improved, bioavailability, gallic, vanillic acid, coumaric, ferulic ellagic acids, flavonoids, catechin, quercetin, luteolin, ascorbic acid, compared, lactic acid bacterium, strains, Correlation analysis, vanillic acid, p-coumaric acid, increased, antioxidant activity, Proximate analysis, fermented nightshade, leaves, reduced, carbohydrate, content, low calculated energy]]\n",
      "[[Fructophilic lactic acid bacteria, FLAB, group, D-fructose, D-glucose, study, laboratory cocoa, beans, fermentation, analyzed, Illumina-based amplicon sequencing, presence, potential, FLAB, genera Fructobacillus, Lactobacillus, efficient, fructose-fermenting isolates, fermenting cocoa, pulp beans, mass, 16S rRNA, gene sequencing, Pediococcus acidilactici, Lactobacillus plantarum, Pediococcus pentosaceus, Bacillus subtilis, Leuconostoc pseudomesenteroides, growth, characteristics, L. plantarum strains, facultatively, fructophilic bacteria, glucose, external electron acceptor, growth, fructose, faster, L. plantarum LPBF 35, characterized, aroma-impacting compounds, acetaldehyde, ethyl acetate, nonanal, octanoic acid, cocoa fermentation, process, process, glucose, fructose, concomitant, utilization, fructose, cocoa fermentation, L. plantarum LPBF 35, fructose, observed, control fermentation, glucophilic, strain, residual, fructose, spontaneous process, residual, fructose, L. plantarum LPBF 35, organic acid metabolism, citric acid, consumption, lactic acid production, associated with, cocoa fermentation, results, cocoa, microbial, activity, perspectives, lactic acid bacteria, starter culture]]\n",
      "[[re-emerging, RNA viruses, world, licensed, vaccines, antiviral drugs, Zika virus, ZIKV, virus, association, severe, congenital malformations, neurological disorders, adults, polyphenol-rich extracts, plants, nutraceuticals, in vitro, antiviral effects, papaya, pulp, extracted, Carica papaya fruit, inhibits, infection, ZIKV, human cells, loss, cell viability, non-cytotoxic concentrations, papaya pulp, extract, reduce, virus, progeny, production, ZIKV-infected, human cells, viral strains, tested, Time-of-drug-addition assays, papaya, pulp, extract, interfered, attachment, viral particles, host cells, properties, papaya, pulp, time, lactic fermentation, bacterial strains, Weissella cibaria, Lactobacillus plantarum 75, Leuconostoc pseudomesenteroides 56, fermented papaya, pulp, samples, tested, ZIKV, lactic fermentation, papaya, pulp, moderate, loss, antiviral activity, ZIKV, bacterial, strain-dependent, IC50, papaya pulp, extract, fermentation, IC50, papaya, pulp, antiviral activity, ZIKV, fermentation, process, moderate, effect, antiviral effect]]\n",
      "[[Coffee, pulp, coffee, production, phenolic compounds, cascara, antioxidant beverage, fermentation, drying, conditions, coffee pulp, influence, bioactive compounds, cascara, study, investigate, effect, natural fermentation, simultaneous, aeration, phenolic, content, antioxidant activity, cascara, systematic study, response surface methodology, face-centered central composite, design, effect, fermentation, time, temperature, bacteria, coffee, pulp, natural fermentation, simultaneous, aeration, air flowrate, phenolic, content, antioxidant activity, cascara, experimental dataset, empirical model, multi-variable non-linear regression, model, experimental data, optimum, conditions, degrees C, phenolic, content, antioxidant activity, Indigenous, lactic acid bacteria, isolated, coffee, pulp, Leuconostoc pseudomesenteroides, isolated, bacteria, starter, controlled fermentation, coffee, pulp, increased, antioxidant activity, antioxidant activity, cascara, optimum, conditions, natural fermentation, simultaneous, aeration, fresh, coffee, pulp]]\n",
      "[[Cerium oxide, CeO2, zirconium/tin-dual, doped, CeO2, nanoparticles, Zr/Sn-dual, doped, CeO2, NPs, synthesized, aqueous, leaf, extract, Pometia pinnata, UV-visible diffuse reflectance spectroscopy, band gap energies, materials, average, crystallite, sizes, fluorite, phase, X-ray diffraction, X-ray photoelectron spectroscopy, analysis, synthesis, CeO2, Sn-doped, CeO2, NPs, spherical, shapes, nanomaterials, average, particle size, scanning electron microscopy, transmission electron microscopy, studies, Photoantioxidant activities, synthesized, materials, photoantioxidant response, visible light, irradiation, comparison, dark, conditions, dose- and time-dependent, CeO2, NPs, antibiofilm activity, Gram-positive bacteria, Staphylococcus aureus, S. aureus, Listeria monocytogenes, L. monocytogenes, Zr/Sn-dual doped-CeO2, NPs, inhibit, S. aureus, biofilm formation, concentrations, Zr/Sn-dual, doped, CeO2, NPs, concentration-dependent, biofilm inhibition, L. monocytogenes, bactericidal activity, S. aureus, nanomaterials, photoantioxidant activities, antibacterial properties, biological, applications]]\n",
      "[[consumption, fresh, RTE, fruits, increasing, year, Listeria monocytogenes, identified, raw, minimally processed, fruits, food product, contaminated, L. monocytogenes, pathway, food production, planting, harvesting, packaging, distribution, assess, microbiological, risks, associated with, consumption, ready- to- eat, fruit, melon, pineapple, coconut, fruit salad, Escherichia coli, Salmonella spp., L. monocytogenes, evaluated, Microbiological challenge tests, evaluation, L. monocytogenes growth, potential, RTE, fruit, stored, degrees, C. E. coli, counts, detection, CFU, Salmonella, L. monocytogenes, absence, growth, coconut, melon, delta>0.5, growth, capacity, Listeria, temperatures, low, load, hygiene practices, storage, temperatures, bacterial growth, RTE, fruit, RTE, fruit, commercial, life, growth, potential, food, stored, temperatures, degrees]]\n",
      "[[Listeriosis, foodborne diseases, fatality rate, study, isolate, Listeria, species, factors, contamination, beef, antibiogram, Listeria monocytogenes, Ambo, Holeta towns, Central Ethiopia, Materials, Methods, meat, samples, abattoirs, butchers, restaurants, isolation, identification, Listeria species, Logistic regression analysis, assess, association, occurrence, Listeria, species, meat, potential, risk factors, antimicrobial susceptibility test, Kirby Bauer test, occurrence, Listeria, species, Ambo, Holeta towns, confidence interval, CI, isolation, rate, Listeria monocytogenes, Listeria ivanovii, Listeria seeligeri, Listeria welshimeri, Listeria innocua, Listeria grayi, probability, contamination, meat, butchers, restaurants, Holeta, Ambo, dry, wet season, hygiene, cutting boards, OR=7.7, Listeria monocytogenes, isolates, resistant, oxacillin, amikacin, nalidixic acid, chloramphenicol, tetracycline, Listeria monocytogenes, isolates, susceptible, amoxicillin, vancomycin, clindamycin, Listeria monocytogenes, isolates, multidrug-resistant, isolate, resistance, classes, antimicrobial drugs, Listeria, species, widespread, study towns, season, hygiene, cutting boards, predictors, isolation, Listeria species, Multidrug resistance, Listeria monocytogenes, adequate, cooking, meat, training, beef handlers, drugs, molecular studies, Listeria, species]]\n",
      "[[Listeria monocytogenes, opportunistic pathogen, environment, aquatic environment, potential, source, transmission, L. monocytogenes, animals, food chain, study, assessed, occurrence, L. monocytogenes, surface, samples, rivers, streams, inland canals, Switzerland, surface, L. monocytogenes, Whole genome sequence, WGS, data, isolates, isolates, lineages I, II, serotype 1/2a, 4b, CCs, identified, hypervirulent serotype 4b clones, CC1, CC4, serotype CC412, listeriosis, outbreaks, sporadic, cases, human, animal infection, worldwide, isolates, CC6, hypervirulent clone, isolates, intact, associated with, invasion, infection, inlA/B, prfA., CC4, isolates, Listeria, LIPI-4, hypervirulence, occurrence, L. monocytogenes, river ecosystems, dissemination, introduction, clinically, strains, food chain]]\n",
      "[[Listeria monocytogenes, bacteria, associated with, foodborne diseases, soft cheese, L. monocytogenes, vehicle, Ecuador, soft cheese, urban, households, prevalence, L. monocytogenes, serogroups, fresh, artisanal, soft cheese, samples, Ecuadorian, provinces, Listeria spp, detection, culture-dependent, independent, methods, samples, positive, L. monocytogenes, Serogroup IVb, food isolates, Serogroups IIb, IIa, isolates, knowledge, L. monocytogenes serogroups, associated with, food, Ecuador, serogroup, similarities, cheese, isolates, clinical, isolates]]\n",
      "[[frequency, foodborne, outbreaks, epidemiologically, associated with, Listeria monocytogenes, fresh, increased, years, L. monocytogenes, transferred, environment, vegetables, farming, contamination, food products, food processing facilities, L. monocytogenes, processing equipment, study, data, occurrence, L. monocytogenes, identity, endogenous, microbiota, fresh, processing facility, information, L. monocytogenes, detected, facility, Experiments, conditions, processing environment, examination, bacterial growth, nutrients, vegetables, salad juice, nutrients, fish, meat, Results, endogenous, microbiota, Pseudomonas, lettuce, rocket salad juice, low temperatures, growth inhibition, L. monocytogenes, rocket salad juice, anti-listerial activity, rocket salad juice, polar chromatographic fraction, metabolites, Characterization, active fraction, LC-MS/MS, identification, compounds, nucleosides, amino acids, molecular mechanism, inhibitory activity, rocket salad, constituents, study, nutrients, low, temperature, bacterial flora, influence, prevalence, L. monocytogenes, fresh, processing facilities]]\n",
      "[[Listeria monocytogenes, isolated, food processing, environments, endemic, facilities, Bacteriophage, potential, biocontrol, strategies, L. monocytogenes, study, lytic, capacity, Listeria, phage cocktail, library, Listeria spp, isolates, L. monocytogenes, Listeria spp., genotypic, phenotypic, characteristics, lytic, capacity, Listeria phages, measured, spot assays, lysis, scored, no lysis, lysis, moderate, lysis, confluent lysis, Listeria spp, isolates, L. monocytogenes, moderately, susceptible, score, lysis, Listeria phage, scores, temperature, phage, concentration, treatment, multiplicity, infection, MOI, temperature, characteristic, genotype, sanitizer, tolerance, attachment, capacity, combinations, confluent lysis, score, Odds ratios, susceptibility, lysis, calculated, multinomial logistic regression, odds, susceptibility, lysis, phage, decreased, L. monocytogenes, isolate, phage-bacteria, culture, incubated, degrees, isolate, persistence, temperature, significant, factors, lytic, pulse field gel electrophoresis, PFGE, pulsotypes, affected, host, MOI, no effect, attachment, capacity, sanitizer, tolerance, phage, susceptibility, study, complexity, Listeria phage, biocontrol, Listeria spp, food processing facilities, phage, susceptibility, impacted, genotype, studies, evaluate, findings, processing environment]]\n",
      "[[Science-based, small, federally inspected ready-to-eat (RTE) meat, poultry, processors, Michigan, assessed, Data, level, sanitary control methods, reducing, Listeria, processing environment, compared, interactions, facility, microbial, results, checklist, assess, sanitary, U.S. Department of Agriculture, U.S. Food and Drug Administration, Michigan Department of Agriculture, Rural Development, checklist, items, assess, controls, facilities, post, lethality, contamination, RTE, products, Effectiveness, pre-operational, operational, sanitation, assessed, sampling, non-food, contact, surfaces, adenosine triphosphate, amplified, nucleic single, Listeria spp, Listeria monocytogenes, facility, samples, facilities, ATP, pre-operational, Listeria spp., Microbial, outcomes, recommended, sanitary, type, facility inspection, content, domain, compliance, operational sanitation, sanitation, facility, personal hygiene, segregation, procedures, regulating body, Findings, regulating body, quality, sanitary, microbial, quantity, implemented, Pathogen control, implementing, sanitary control methods, guidance documents]]\n",
      "[[prevalence, Listeria monocytogenes, raw, beef, slaughterhouse environments, investigated, raw, beef, samples, retailers, restaurants, samples, samples, slaughterhouse environments, swabbing, surfaces, gloves, splitting, drains, L. monocytogenes, detected, identified, method, ISO, 16S rRNA sequencing, L. monocytogenes, detected, raw, beef, gloves, carcass splitting, splitting, drain zone, isolates, serotype 1/2a, 1/2c, screening, multiplex PCR-based serogrouping assay, serotyping kit for O-H antigens, Pulsed-field gel electrophoresis, PFGE, ApaI, digestion, PFGE, pulsotypes, PFGE, groups, identified, Biofilm formation analysis, Crystal Violet staining, biofilm formation, strain LM-16, D190613, L. monocytogenes, isolates, susceptible, antimicrobials, resistance, penicillin, tetracycline, PFGE, G190426, G190829, G200210, isolated, location, study, genetically homologous, LM-16, strain, isolated, beef, carcass, results, LM-16, biofilms, slaughterhouse, environments, study, L. monocytogenes, contamination, raw, beef, beef, processing, slaughterhouse environments, contact with, gloves, splitting saws, drains]]\n",
      "[[Lipases, biocatalysts, industrial, applications, acidic lipase, isolated, lipolytic bacteria, Micrococcus luteus EMP48-D (LipEMP48-D) screened, tempeh, lipase gene, overexpressed, Escherichia coli BL21, expression, level, low, improve, expression, level, lipase gene, cloned, Pichia pastoris, native, signal sequence, M. luteus, alpha-mating factor, optimized, synthesized, lipase gene, codon, preference, P. pastoris, LipEMP48-D lipase, expressed, extracellular protein, Codon, optimization, codons, codon adaption index, extracellular lipase, AOX1, promoter, P. pastoris, KM71 strain, activity, E. coli, activity, pH, stable, pH, degrees, C. LipEMP48-D, capability, hydrolyzing, long-chain triglycerides, olive oil, sunflower oil, LipEMP48-D, tolerance, polar, organic solvents, low log P, isopropanol, butanol, metal ions, Na(+), K(+), Ca(2+), Mg(2+), Mn(+), decreased, enzyme activity, Fe(2+), increased, relative activity, enzymes, conversion, free fatty acid, FFA, fatty acid methyl ester, FAME, low, study, report, overexpression, Micrococcus lipase, yeast, extracellular, expression, acidic lipase, potential, biocatalyst, industrial, fields, organic synthesis, food industry, production, biodiesel]]\n",
      "[[formation, extracellular traps, ETs, innate immune, mechanism, combat, invading, pathogens, study, zymosan, induced, formation, ETs, hemocytes, Ruditapes philippinarum, effect, translocation, mitochondria, cell surface, Zymosan stimulation, induced, increase, intracellular, ROS, MPO, production, overexpression, ROS-related genes, PI3K, AKT, HIF, response, ROS, burst, mitochondrial membrane, decreased, mitochondrial permeability, mitochondrial superoxide inhibitor, Mito-TEMPO, inhibited, formation, ETs, mitochondrial, ROS, formation, ETs, zymosan-induced, ETs, antibacterial activities, gram-negative, gram-positive bacteria, Vibrio anguillarum, Vibrio harveyi, Escherichia coli, Micrococcus luteus, findings, antibacterial approach, R. philippinarum, mitochondria, formation, zymosan-induced ETs]]\n",
      "[[study, mesoporous polyacrylonitrile (PAN)/thermoplastic polyurethane, TPU, nanofibers, immobilize, Micrococcus luteus, enhancing, conversion, trehalose, images, SEM, cells, adsorbed, surface, pores, unique, pore structure, results, contact angle, Zeta potential, water holding, ratio, hydrophilicity, stability, biomass, immobilization, efficiency, increased, trehalose, yield, control, multi-batch fermentation, reactive oxygen species, ROS, level, decreased, enzyme, concentration, increased, immobilization, increased, expression, target, MtreY, words, mechanism, immobilized cells, increased, trehalose, yield, PAN/TPU-P, gene expression, MtreY., research, theoretical, metabolic regulation, sufficient, trehalose, production, immobilized cells]]\n",
      "[[study, indigenous, fermented food, isolate, Lactobacillus plantarum, UBLP40, screened, in vitro, probiotic, properties, antibiotic susceptibility, hemolytic activity, production, lactic acid, hydrogen peroxide, bile salt hydrolase, phytase, antioxidative activity, Results, Lact, plantarum UBLP40, simulated, gastrointestinal conditions, mucin, hydrophobic cell, surface, auto-aggregation, antimicrobial activity, Micrococcus luteus MTCC 106, methicillin-resistant Staphylococcus aureus subsp., BAA-1720, Pseudomonas aeruginosa MTCC 1688, Escherichia coli MTCC 1687, Lact, plantarum UBLP40, phytase, lactic acid, hydrogen peroxide, bile salt hydrolase, antibiotic, non-hemolytic activity, safety, strain, intracellular, extract, UBLP40, butylated hydroxytoluene) alpha, alpha-diphenyl-beta-picrylhydrazyl, DPPH, radical scavenging activity, reducing, activity, equivalent, microg, L-cysteine, Fe(2+), chelation, equivalent, ethylenediaminetetraacetic acid, glutathione, protein, study, Lact, plantarum UBLP40, probiotic]]\n",
      "[[honeybees, healthy, essential, bees, honey, production, cross-pollination, agricultural, horticultural crops, bees, economic impact, lethal disease, American foulbrood (AFB, losses, honeybee, decline, global apiculture, studies, natural insect-derived antibiotics, AFB-resistance, antibiotics, studies, investigate, bee-derived, anti-AFB antibiotics, indigenous, honeybee, Apis mellifera jemenitica, immune responses, third instar stage, induced, standards, Micrococcus luteus, Escherichia coli, compared, indigenous, Paenibacillus larvae, ksuPL5, Data, immune response, M. luteus, E. coli, P. larvae, post-P., larvae-injection, detection, lysozyme-like, cecropin-like, prophenoloxidase, PO, activities, plasma, P. larvae-injected third instars, Nodulation, activity, injected, P. larvae, early, post-P. larvae, injection, anti-P., larvae, immune peptide, fractions, high-performance liquid chromatography, HPLC, in vivo, therapeutic effects, P. larvae-infected, instars, Mass spectrophotometric analysis, Orbitrap measurements, P. larvae-injected, plasma, expression, PO, Mr, beta-1,3-glucan-binding protein, Mr, serine protease, Mr, immune peptides, survivorship, P. larvae-infected broods, search, honeybee-derived, therapeutic agents, molecular characterization, description, functional, antimicrobial peptides, broods, adult, honeybee, insect-derived, antibiotics, therapeutic purposes]]\n",
      "[[Marine, actinomycetes, sources, natural, bioactive compounds, antimicrobial, anti-cancer activities, bioactive potential, Streptomyces ovatisporus S4702T, isolated, Streptomyces ovatisporus S4702T, cultured, N-Z Amine broth, extraction, organic solvents, Bioassay, chemical characterization, NMR, LC-MS/MS, compound, evaluated, antibacterial, antioxidant, cytotoxic activities, Etyl acetate, antibacterial activity, chemical, characterization, extract, formula, C15H29O5N3, molecular structure, 4H-chromen-4-one derivative, Bacillus subtilis ATCC 6633, MIC, Micrococcus luteus ATCC 9341, MBC, antioxidant activity, EC50, cytotoxicity, normal cells, EC50, values, chromen, derivative, human colon carcinoma, human, prostate adenocarcinoma, human embryonic kidney cells, 4H-chromen-4-one derivative, bioactive compound, antibacterial, cytotoxic activity, bioactive potential, medicine]]\n",
      "[[encapsulation, bacteria, polymers, results, hybrid materials, long-term, biological activity, bacteria, formulations, applications, problem, bacterial, escape, exchange, metabolism products, hydrogel microparticles, aqueous, environment, Bacteria, encapsulated, chemically, cross-linked, poly(vinyl alcohol), PVA, hydrogel-microparticles, encapsulation, pH-responsive, soft antibacterial shell, poly(N, N-diethylamino ethyl methacrylate), PDEAEMA, polymer, shell, mass transport, microparticle core, environmental, parameters, pH, antibacterial effect, pH-responsive, PDEAEMA shell, porous structure, nutrient transfer, PVA, core, living, Micrococcus luteus, M. luteus, Results, antibacterial effect, PDEAEMA, retards, bacteria, days, shell, permeation, small molecule, gel, methylene blue dye, core/open-shell, structure, certifies, flexible barrier, mass transport, long term, biological activity, encapsulated, M. luteus]]\n",
      "[[formation, mixed-species, biofilms, Yersinia pseudotuberculosis, Listeria monocytogenes, marine saprotrophic bacteria, Flavobacterium sp., Micrococcus luteus, isolated, coastal waters, Sea, Japan, summer, Model experiments, Flavobacterium sp., Micrococcus luteus, single-, mixed-species, biofilms, pathogenic bacteria, stimulating, growth, preservation, pathogens, marine environment]]\n",
      "[[study, isolation, identification, endophytic, strain, Burkholderia cepacia, COPS strain, associated with, Polygala paniculata, roots, Polygala plants, sources, microbiomes, literature reports, pharmacological effects, trypanocidal, antinociceptive, anesthetic, anxiolytics, anticonvulsant activities, B. cepacia, COPS, sequence type, ST, genome, estimated, Mbp, aminoglycosides, beta-lactams resistance genes, aph(3')-IIa, bla TEM-116, Analysis, MLST, average, nucleotide, digital DNA-DNA hybridization, species-level, identification, housekeeping genes, alleles, gyrB, lepA, phaC., root endophyte, B. cepacia, COPS, attention, group, bacterial, isolates, primary screening, Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212, Micrococcus luteus ATCC 9341, Escherichia coli ATCC 25922, Candida albicans ATCC 10231, broad-spectrum activity, phytopathogenic fungi, COPS, strain, production, protease, lipase, esterase, solid media, natural product extract, inhibition, fungal, plant, pathogens, Moniliophthora perniciosa, antagonism index, positive control, Sclerotinia sclerotiorum, Ceratocystis paradoxa, inhibition, COPS, crude extract, inhibited, S. epidermidis ATCC 35984, E. faecium ATCC 700221, MIC values, E. faecalis ATCC 29212, S. aureus ATCC 25923, moderate, antagonistic activity, A. baumannii ATCC 19606, E. coli ATCC 25922, cytotoxic, effects, Leishmania infantum, Leishmania major, promastigote, inhibition, study, isolation, endophytic, B. cepacia, associated with, P. paniculata, evidence, plants, microbes, diseases]]\n",
      "[[research, association, pathogenic bacteria, adenoid culture, clinical characteristics, adenoid-related diseases, children, retrospective study, reviewed, medical records, children, adenoidectomy, adenoid-related diseases, Demographic data, diagnoses, indications, adenoidectomy, bacterial culture, adenoid size, measured, lateral skull X-ray, adenoid-nasopharyngeal ratio, Associations, culture results, demographic data, adenoid size, diagnoses, analyzed, children, adenoidectomy, obstructive sleep-disordered breathing, otitis media, effusion, chronic sinusitis, age, years, pathogenic bacteria, adenoid, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Moraxella catarrhalis, patient's, age, association, prevalence, pathogenic bacteria, S. pneumoniae, young, children, years, S. aureus, children, years, H. influenzae, prevalence, age groups, Size, adenoid, adenoid-related diseases, association, outcome, bacterial culture, Age, patients, associated with, bacteriological, findings, adenoid, size, adenoid-related diseases, associated with, outcome, bacterial culture]]\n",
      "[[Moraxella catarrhalis, bacterial pathogen, respiratory tract infections, humans, increasing, prevalence, antibiotic-resistant, M. catarrhalis, strains, alternative, treatment options, tested, insect, antimicrobial peptides, AMPs, activity, M. catarrhalis, human, in vitro, infection, model, primary macrophages, commensal bacteria, Effects, bacterial growth, colony, counting, growth curve analysis, inflammatory macrophage, characterized, qPCR, multiplex ELISA, AMPs, M. catarrhalis, Defensin 1, red flour beetle, Tribolium castaneum, inhibited, bacterial growth, reduced, colony forming units, AMP, antibacterial activity, in vitro, infection, model, cytokine, expression, release, macrophages, Defensin 1, commensal bacteria, Escherichia coli, Enterococcus faecalis, sarcotoxin 1 C, green bottle fly, Lucilia sericata, active, M. catarrhalis, E. coli, E. faecalis, T. castaneum defensin 1, inhibit, M. catarrhalis, commensal bacteria, absence, cytotoxic, inflammatory, human, blood-derived macrophages, AMP, development, therapeutic, antibiotic-resistant, M. catarrhalis]]\n",
      "[[Chronic respiratory disorders, Australian, Aboriginal, people, living, Top End Health Service region, Northern Territory, Australia, Bronchiectasis, heterogenous disease, features, chronic respiratory conditions, population, Aboriginal, non-Aboriginal, patients, bronchiectasis, region, retrospective study, demographics, clinical characteristics, relevant, laboratory, parameters, adult, Aboriginal, non-Aboriginal, patients, diagnosed, bronchiectasis, adults, radiology-confirmed bronchiectasis, Aboriginal, non-Aboriginal, patients, Aboriginal, patients, younger, age, years, lived, rural, remote, communities, rates, self-reported smoking, alcohol consumption, co-occurrence, chronic obstructive pulmonary disease, chronic, co-morbidities, Sputum, microbiology, groups, Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Aboriginal, patients, Pseudomonas aeruginosa, Aspergillus species, non-tuberculous mycobacteria, non-Aboriginal, patients, Aboriginal, patients, poorer, lung function, non-Aboriginal patients, forced expiratory volume, forced vital capacity, higher, exacerbation, rates, poorer, outcomes, age, death, years, health service, Aboriginal, patients, bronchiectasis, outcomes, manifestations, higher, comorbidities, non-Aboriginal patients, studies, interventions, reduce, inequity]]\n",
      "[[association, early, Staphylococcus aureus, nasal carriage, higher, risk, childhood eczema, relationship, causal, associations, bacterial species, unclear, associations, early, nasopharyngeal, bacterial, carriage, eczema, phenotypes, direction, associations, identified, subjects, population-based prospective cohort study, nasal swabs, Staphylococcus aureus, nasopharyngeal swabs, Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae, collected, cultured, age, weeks, years, Never, early, mid-, late transient, persistent, eczema, phenotypes, identified, parental-reported physician-diagnosed eczema, age, months, years, Multinomial regression models, cross-lagged models, Staphylococcus aureus, nasal carriage, months, associated with, increased, risk, early, transient, persistent, eczema, OR, CI, associations, Staphylococcus aureus, nasal carriage, eczema, cross-sectional, longitudinal, associations, Staphylococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenza nasopharyngeal, bacterial, carriage, eczema, eczema, phenotypes, OR, CI, Early, Staphylococcus aureus, nasal carriage, Staphylococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenza nasopharyngeal, carriage, associated with, transient, persistent, eczema, Staphylococcus aureus, nasal carriage, eczema, cross-sectionally, associated,, relationship, direction]]\n",
      "[[incidence, neutropenia, association, neutropenia, severity, respiratory symptoms, infants, respiratory syncytial virus, RSV, infections, single-center, retrospective study, immunocompetent, infants, months, laboratory-confirmed, RSV, admitted, January, Incidence, neutropenia, days, onset, risk factors, associated with, neutropenia, evaluated, infants, RSV, infection, mild infection, neutropenia, severe, neutropenia, neutropenic infants, infection, hematological disorder, Infants, neutropenia, age, months, C-reactive protein, level, nasopharyngeal microbiota, composition, Moraxella catarrhalis, Streptococcus pneumoniae, Haemophilus influenzae, comparison, infants, neutropenia, age, months, relative risk, RR, confidence interval, CI, C-reactive protein, level, RR, CI, microbiota, Moraxella catarrhalis, Streptococcus pneumoniae, Haemophilus influenzae, RR, CI, Multiple logistic regression analyses, younger age, onset, absence, nasopharyngeal microbiota, associated with, development, neutropenia, age, airway microbiota, risk factors, development, transient neutropenia, infants, RSV, infection, neutropenia, infection, hematological disorder]]\n",
      "[[AIM, evaluate, nasopharyngeal aspirate, cultures, screening, otopathogen, carriage, adenoid, children, years, age, children, years, age, scheduled, adenoidectomy, prospective study, Rockhampton, Australia, Adenoid biopsy, nasopharyngeal aspirate, bacteriology, assessed, conventional culture, Demographic, environmental, data, questionnaire, Statistical analyses, descriptive, comparison, logistic regression tests, microbial, demographic, environmental, clinical groups, Streptococcus pneumoniae, Staphylococcus aureus, non-typeable Haemophilus influenzae, Moraxella catarrhalis, detected, cases, Streptococcus pneumoniae, non-typeable, H. influenzae, S. aureus, colonisation, S. aureus, S. pneumoniae, colonisation, nasopharyngeal aspirate, otopathogen cultures, predictors, otopathogens, adenoid, moderate-high test, accuracy, otopathogens, receiver operator characteristics, otopathogens, tested, Children, positive, H. influenzae, M. catarrhalis, S. pneumoniae, S. aureus, nasopharyngeal aspirate, cultures, species, adenoid cultures, positive, ratios, study, evidence, nasopharyngeal aspirate, cultures, indicator, otopathogens, adenoid, Nasopharyngeal aspirate, cultures, clinicians, information, clinical management, Strategies, improved, management, otopathogen, carriage, reduce, prevalence, chronic upper respiratory infections, adenoidectomy]]\n",
      "[[normal, flora, children, investigated, bacterial, isolates, pharynx, nasopharynx, healthy, children, bacterial, rates, age groups, infants, year, toddlers, years, school-age children, years, Gram-positive cocci, GPC, bacteria, pharynx, Streptococcus mitis/oralis, Streptococcus salivarius, Rothia mucilaginosa, Staphylococcus aureus, infants, Streptococcus salivarius, Neisseria subflava, development, teeth, age groups, S. salivarius, N. subflava, Gram-negative rods, GNR, nasopharynx, Moraxella catarrhalis, Moraxella nonliquefaciens, Corynebacterium pseudodiphtheriticum, gram-positive rods, toddlers, Moraxella catarrhalis, Streptococcus pneumoniae, pathogens, acute otitis media, infant group, bacterial species, pediatric, respiratory infection, Streptococcus pyogenes, isolated, pharyngeal samples, S. pneumoniae, Haemophilus influenzae, isolated, nasopharyngeal samples, normal, flora, respiratory tract, sampling site, age group]]\n",
      "[[M. morganii, bacterium, associated with, urinary infections, humans, human, strains, sequenced, genomes, poultry, strains, characterization, resistant, Morganella morganii, strains, isolated, association, Escherichia coli, diseased, domestic, Austrian, poultry, flocks, geese, turkeys, chicken, layers, sequenced, genomes, strains, NGS, analyzed, phylogenetic clustering, resistance, virulence genes, context, host-specificity, strains, Extended Spectrum Beta Lactamase, ESBL, AmpC beta-lactamases, AMP-C, phenotype, ESBL, negative, genome sequences, poultry, strains, M. morganii, genomes, phylogenetic tree, Morganella genus, clusters, M1, M2, subspecies, classification, morganii, sibonii, association, phylogenetic structure, host, interspecies, transmission, poultry, strains, genes, resistance, aminocoumarins, beta-lactams, colistin, elfamycins, fluoroquinolones, phenicol, rifampin, tetracycline, virulence genes, acquisition, novel, virulence genes, secretion system, adherence, cluster, M2, genes, horizontal gene transfer, Morganellaceae, species, virulence genes, expansion, tissue, tropism, M. morganii, detected, variability, copy number, divergence, toxin genes, evidence, positive, selection, insecticidal, toxins, host-related adaptations, study, isolation, characterization, M. morganii, goose, turkey, genetic analysis, M. morganii, global picture, M. morganii, intraspecific, phylogenetic structure]]\n",
      "[[Antibiotic resistance, global, countries, study, investigate, molecular responses, antibiotic-resistant bacteria, bacterial strains, isolated, identified, disc diffusion, MIC, concentration, determination, investigating, production, beta-lactamases, ESBLs, Extended-spectrum Beta-lactamases, MBLs, Metallo Beta-lactamases, AmpCs, prevalence, antibiotic-resistant genes, ARGs, blaTEM, qnrS., Higher, MIC, values, penicillin(s), fluoroquinolones, ampicillin, amoxicillin, ofloxacin, ciprofloxacin, levofloxacin, Resistance, rates, tested, beta-lactams, tested, strains, ESBL, producers, Aeromonas spp., Escherichia sp., MBL, producers, Stenotrophomonas sp., Citrobacter sp., AmpC, producers, Pseudomonas spp., Morganella sp., ARGs, qnrS2, blaTEM, detected, Aeromonas spp., Escherichia sp., results, Aeromonas, vector, study reports, bacteria, multidrug resistance, nature, wastewater, environment, Pakistan, ARGs, clinical, relevance, public health]]\n",
      "[[trends, uropathogens, years, incidence, antibiotic resistance, extended, spectrum beta lactamases, Enterobacteriaceae, urine cultures, pediatric, patients, Study Design, Electronic medical records, children, admitted to, Poriya Medical Center, Israel, positive, urine cultures, reviewed, bacterial species, antibiotics, resistance, pathogen, Escherichia coli, Klebsiella, Enterococcus, Proteus, Statistically significant, gender-specific, ethnicity-specific differences, distribution, uropathogens, E. coli, females, males, Escherichia coli, ESBL-positive cultures, isolates, Klebsiella, Enterobacter spp., Morganella, Prevalence, ESBL-producing E. coli, increased, study, period, Increasing, prevalence, time, ceftriaxone, cefuroxime, amoxicillin/clavulanate, ampicillin, resistance, Gender, ethnic background, empiric, antibiotic therapy, urinary tract infections, children, continuous, increase, resistance, cefuroxime, amoxicillin/clavulanate, prescribing therapy, Israel, Ceftriaxone, gentamicin, antibiotics, inpatient, parenteral, treatment]]\n",
      "[[distribution, ESBL infections, Dammam Medical Complex, Eastern Province, Saudi Arabia, patient, demographics, wards, infection site, bacterial species, antibiotic resistance, gauged, hospital, staff, ESBLs, procedures, treat, infections, Hospital records, analysed, ESBL, samples, VITEK(R) 2 system, phenotypic, confirmation, disk diffusion test, HCWs, attitudes, knowledge, assessed, paper questionnaire, percentage, ESBL, isolates, Klebsiella pneumoniae(n=148, Escherichia coli(n=176, Proteus mirabilis(n=7, Morganella morganii(n=13, Enterobacter, Citrobacter freundii, tigecycline, susceptibility, P. mirabilis, M. morganii, isolates, resistant, K. pneumoniae, susceptibility, levels, E. coli, urine samples, Chi square=13.76, blood samples, resistance, K. pneumoniae, isolates, susceptibility, carbapenems, imipenem, meropenem, ertapenam, high, levels, uncertainty, healthcare workers, hospital policies, reporting, prescribing, ESBL-expressing infections, ESBL, variations, sample types, wards, antibiotic resistance, variability, staff training, communication procedures, infection prevention, control, ESBLs]]\n",
      "[[Cell culture liquid waste, antibiotic resistance genes, ARGs, microbial, community, recognition, potential, risks, human, health, resistance genes, intl1, detected, samples, Quantitative real-time PCR, intl1, detected, hospital group, bacterial, community, complex, diverse, sample, 16S rRNA, high-throughput sequencing, Morganella, Enterococcus, groups, Whole genome, shotgun sequencing, Morganella morganii, resistance genes, virulence factors, hospital group, extended-spectrum beta-lactamase, ESBL, genotypes, blaDHA-5, blaOXA-1, blaTEM-1, study, preliminary, ARGs, resistant, strains, people, attention, health, risks, potential, pathogens, waste]]\n",
      "[[Clinical, broth microdilution method, evaluate, in vitro, activities, plazomicin, comparator, antimicrobial agents, Gram-negative, Gram-positive bacterial, pathogens, patients, Canadian, hospitals, CANWARD Surveillance Study, Plazomicin, in vitro, activity, Enterobacteriaceae, MIC90, species, tested, Proteus mirabilis, Morganella morganii, aminoglycoside-nonsusceptible, extended-spectrum beta-lactamase, multidrug-resistant, MDR, isolates, Plazomicin, active, methicillin-susceptible, methicillin-resistant isolates, Staphylococcus aureus]]\n",
      "[[coexistence, extended-spectrum beta-lactamase, ESBL, plasmid, quinolone, resistance, PMQR, bacteria, animal, husbandry, humans, strains, screened, resistance, study, tested, prevalence, ESBL, PMQR, genes, bacteria, isolated, poultry, faeces, Faecal droppings, birds, farms, states, South Western Nigeria, Bacteria, isolated, samples, cefotaxime, plates, identified, MALDI-TOF, MIC, VITEK system, resistance genes, detected, PCR, strains, isolated, samples, strains, Klebsiella pneumonia, Morganella morganii, Leclercia adecarboxylata, Citrobacter freundii, species, resistant, gentamycin, trimethoprim/sulphamethaxole, tobramycin, piperacillin, cefotaxime, aztreonam, Morganella morganii, strains, susceptible, aztreonam, tested, strains, susceptible, imipenem, meropenem, amikacin, Leclercia adecarboxylata strains, resistant, ceftazidime, cefepime, fosfomycin, Morganella morganii, strains, resistant, fosfomycin, moxifloxacin, ciprofloxacin, tested, species, sensitive, ciprofloxacin, Morganella morganii, strains, resistant, ciprofloxacin, resistance, ciprofloxacin, ceftazidime, cefepime, tigercylin, colistin, fosfomycin, prevalence, SHV, TEM, CTX genes, isolates, ESBL, qnrA, gene, qnr B gene, qnrS gene, PMQR gene, Oqxb, qep gene, Klebsiella pneumoniae, ESBL, PMQR, genes, prevalence, extended, spectrum, beta-lactamase genes, strains, caution, beta lactam antibiotics, poultry, feeds, report, occurrence, extended, plasmid, quinolone, resistance genes, Morganella morganii, Leclercia adecarboxylata strains, isolated, poultry, faeces]]\n",
      "[[Surgical site infection, SSI, complication, colorectal surgery, associated with, increased, morbidity, hospital stay, Antimicrobial prophylaxis, reduce, risk, SSI, Extended-spectrum beta-lactamase, pathogens, prophylaxis, threat, patient care, colorectal surgery, study, characteristics, SSIs, colorectal surgery, prevalence, risk factors, clinical, relevance, ESBL infections, patients, tertiary center, patients, bowel resection operation, laparoscopy, laparotomy, laparoscopic-assisted colectomy, benign, malignant colorectal disease, retrospectively, prospective database, colorectal department, authors, tertiary center, patients, study, SSI, microorganisms, isolated, surgical sites, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, methicillin-resistant Staphylococcus aureus, Proteus mirabilis, Morganella morganii, Enterobacter cloacae, wound infections, ESBL-producing, pathogens, wound cultures, non-ESBL, microbes, wound infections, ESBL-producing, pathogens, resistant, antibiotic prophylaxis, antibiotic, usage, delay, postoperative, recovery, High-risk, patients, ESBL, colonization, preoperative, screening, protocol, cost, effectiveness, ESBL, screening program]]\n",
      "[[Omadacycline, aminomethylcycline, in vitro, activity, gram-negative pathogens, Omadacycline, comparators, Enterobacteriaceae, urinary tract infections, UTIs, global surveillance program, compared, results, isolates, surveillance, omadacycline, MIC50/90, Enterobacteriaceae, minus, Proteus, Providencia, Morganella spp., MIC50/90, E. coli, MIC50/90, MICs, Klebsiella spp, isolates, mug/mL., ESBL, screen-positive, SP, phenotype, E. coli, ESBL, SP, Klebsiella spp., MIC, values, mug/mL., Omadacycline, UTI-causing, Enterobacteriaceae, isolates, NA, EU, study, omadacycline, treat, UTIs, Enterobacteriaceae]]\n",
      "[[Mycobacterium abscessus complex, MABSC, environmental, organism, opportunistic pathogen, MABSC, pulmonary infections, people, cystic fibrosis, clinical, Resistance, data, macrolides, amikacin, MABSC, pulmonary disease, treatment, MABSC, resistance, macrolides, amikacin, 23S, 16S rRNA, gene mutations, Gap Statement, culture-based methods, MABSC, detection, antibiotic resistance, characterization, prolonged, treatment, clinical trials, Culture-independent molecular methods, limitation, real-time PCR assays, characterization, 23S, 16S rRNA, gene mutations, associated with, constitutive, resistance, MABSC.Methodology, real-time PCR assays, detect, 23S, 16S rRNA, gene mutations, rRNA genes, design, potential, cross-reactivity, primers, non-template bases, targeted, single-nucleotide, MABSC, assays, real-time PCR assay, MABSC, detection, respiratory samples, people, cystic fibrosis, results, molecular methods, gold, culture methods, 23S, 16S rRNA, gene sequencing, Results, real-time PCR MABSC, detection, assay, sensitivity, specificity, culture, results, real-time PCR resistance detection assays, concordant, cultured isolate sequencing, real-time PCR resistance detection assays, samples, resistant, susceptible, MABSC, culture-dependent methods, susceptible, MABSC, samples, molecular methods, results, health care providers, researchers, days, weeks, culture-based, antibiotic]]\n",
      "[[ABSTRACT, clinical results, problems, administration, rifampicin, ethambutol, clarithromycin, REC, treatment, Mycobacterium avium complex, MAC, hand, MAC).Participants, patients, hand MAC, resection, infected, lesion, REC, prescribed, months, patients, site, infection, clinical course, initiation, REC, adverse drug effects, ADEs, incidence, recurrence, evaluated, Sites, infection, flexor tenosynovium, patients, extensor tenosynovium, patient, flexor, extensor tenosynovium, patient, ADEs, REC, patients, visual disturbance, ethambutol, patients, liver function, abnormality, rifampicin, patients, fever, diarrhea, rifampicin, patient, patients, desensitization therapy, REC, reinstated, patients, causative drugs, discontinued, levofloxacin, quinolone, administered, Complete healing, patients, recurrence, patients, patients, recurrence, patient, REC, patient, REC therapy, modified, ADE.REC, clinical results, treatment, MAC, recurrences, completion, REC, alternative, drug, Optimal, duration, REC, drugs, identified, future]]\n",
      "[[Isoniazid, INH, anti-tuberculosis regimens, emergence, Mycobacterium tuberculosis, Mtb, resistant, strains, threat, control tuberculosis, TB, global level, Mutations, gene coding, catalase, KatG, resistance, level, INH, deletion, genomic region, katG gene, Mtb, clinical strain, isolated, Italy, patient, HIV infection, INH, preventive therapy, genotypically, characterized, Mtb strain, katG, deletion, high-level, resistance, INH, MIC, katG, deletion, impact, Mtb, fitness, detect, enhanced, susceptibility, H2O2, wild type, Mtb strains, impaired, growth, in vitro, infection, models, findings, Mtb, resistance, INH, fitness, pathogenic, potential]]\n",
      "[[Mycobacterium tuberculosis, morbidity, death, humans, worldwide, genetic variability, host, human, susceptibility, pathogen, finding, assess, association, genetic polymorphisms, cytokines, tuberculosis infection, cross-sectional study, January, whole blood, collected, extracted, genomic DNA, method, patterns, genetic polymorphism, amplification refractory method PCR, primers, PCR, electrophoresis, agarose gel, band, visualized, UV light, logistical regression model, assess, association, genetic polymorphisms, tubercular infection, association, explanatory, outcome, odds ratio, CI, calculated, statistically significant value, RESULT, study, frequency, TNF-alpha, -308 G allele, GG, OR, OR, IFN-gamma, allele, AA genotype, OR, OR, associated with, tuberculosis, incidence, correlation, IL-10, -1082 A, AA, allele, genotype, tuberculosis, patients, finding, genetic, variability, TNF-alpha, -308 A, IFN-gamma, alleles, host, genetic risk factors, associated with, tuberculosis, infection]]\n",
      "[[Eis-promoter mutations, reduced, Mycobacterium tuberculosis, kanamycin, susceptibility, GenoType MTBDRsl, assay, evaluating, region, isolates, eis-promoter, wildtype, isolates, mutations, kanamycin, resistance, eis-promoter, mutations, mutations, GenoType MTBDRsl, variants, reduced, susceptibility, data, reflex, phenotypic kanamycin, testing]]\n",
      "[[Pre-existing, resistant, pathogen, subpopulations, hetero-resistance, potential, risk factors, treatment failure, multi/extensively drug resistant, MDR/XDR, TB, Intra-patient, evolutionary, Mycobacterium tuberculosis complex, strains, treatment, outcomes, MethodsTo, Mtbc strains, escape therapy, analysed, isolates, genome sequencing, German, patient, Sequencing, data, phenotypic, drug susceptibility, patient's, factors, intra-patient, resistance, evolution, ResultsThe, patient, TB, episodes, resistances, drugs, XDR-TB, infection, isolate, patient's, TB, episode, fixed resistance, mutations, anti-TB drugs, isoniazid, rifampicin, streptomycin, pyrazinamide, prothionamide, para-aminosalicyclic acid, cycloserin/terizidone, years, dynamic, evolution, co-existing, heterogeneous, subpopulations, sequential, bacterial, isolates, emergence, drug-resistant, subpopulations, frequent, changes, treatment regimens, active compounds, evolutionary arms, race, sub-populations, fixation, XDR, variant, ConclusionOur, data, complex, intra-patient, microevolution, Mtbc, subpopulations, MDR/XDR-TB, treatment, effective, treatment regimens, detection, resistance, resistance, development, treatment failure]]\n",
      "[[effective, shorter-course therapies, tuberculosis, host-directed therapy, HDT, goal, HDT, modulate, host, infection, improving, immune defenses, reduce, duration, antibacterial therapy, amount, lung damage, innate, adaptive immune responses, intracellular, pathogens, autophagy, potential, target, HDT, tuberculosis, Mycobacterium tuberculosis, modulates, mammalian, target, rapamycin, mTOR, signaling, autophagy, pharmacologic, mTOR, inhibition, effective, HDT, mTOR, multiprotein complexes, mTOR complex-1, mTORC1, mTOR complex-2, mTORC2, Rapamycin, analogs, inhibit, mTORC1, mTOR kinase inhibitors, blocking, complexes, therapeutic, potential, effects, mTOR, inhibitors, rapamycin, orally, mTOR kinase domain inhibitor, CC214, blocks, mTORC1, mTORC2, adjunctive therapies, murine, TB, first-line regimen, RHZE, bedaquiline-pretomanid-linezolid (BPaL) regimen, mTOR, affected, lung, CFU, counts, weeks, treatment, BPaL, RHZE, CC214, BPaL, RHZE, associated with, relapses, C3HeB/FeJ, rapamycin, RHZE-treated mice, relapses, RHZE, CC214, mTOR kinase, inhibitors, effective, HDT, rapamycin, analogs, potential, duration, TB, treatment]]\n",
      "[[article, published information, systemic, infective, complications, tattoos, update, picture, literature, search, PubMed database, compared, search, year, restriction, Eligibility criteria, studies, systemic, case reports, case series, outbreak, investigations, reviews, systematic reviews, manuscripts, systemic infections, fatality, historical records, systemic tuberculosis, syphilis, viral, hepatitis, HIV, infections, study, period, sporadic, cases, Mycobacterium leprae, India, regional lymphadenopathy, associated with, skin lesions, non-tuberculosis mycobacteria, identified, Persistent fever, rigour, bacterial, episode, staphylococcal toxic shock syndrome, episodes, septic shock, associated with, cellulitis, necrotizing fasciitis, weeks, procedure, pyogenic bacteria, S. aureus, streptococcus, Identification, lung, systemic embolisms, absence, local symptoms, infective endocarditis, Bacterial bloodstream infections, subjects, fever, rigour, tattoos, local symptoms, causative organisms, documented, comparing, historical reports, NTM, organisms, lymphadenopathy, hygiene conditions, tattoo]]\n",
      "NaN\n",
      "[[man, admitted, hospital, fever, left chest pain, Computed tomography, multiple, lung nodules, narrowing, right bronchus intermedius, mediastinal lymphadenopathy, osteolytic lesion, Bronchoscopic findings, progression, multiple, polypoid, lesions, bronchial stenosis, biopsy, endobronchial lesions, non-necrotizing, granulomatous inflammation, tissue culture, Mycobacterium avium, anti-human immunodeficiency virus antibody, negative, anti-interferon-gamma (, IFN-gamma, autoantibodies, detected, patient, diagnosed, disseminated, nontuberculous mycobacterium infection, anti-IFN-gamma autoantibodies, Antimycobacterial therapy, effective, radiographic, findings, endobronchial lesions, resolved]]\n",
      "[[Objective, non-tuberculous mycobacteria, NTM, species, isolated, patient, co-isolation, trends, characteristics, co-isolation, multiple, NTM, species, data, multiple, NTM, isolation, patients, hospital, diagnosis, NTM, lung diseases, Mycobacterium avium complex, MAC, reviewed, medical records, evaluate, co-isolation, multiple, NTM, species, patients, non-MAC lung disease, NTM, species, M. gordonae, M. kansasii, M. abscessus, Non-MAC, NTM, lung disease, associated with, middle age, low body mass index, male, predominance, NTM, species, isolated, patients, clinical characteristics, associated with, multiple, NTM, species, isolation, female, predominance, never smokers, absence, cavity, lesions, lungs, co-isolation, rate, patients, M. gordonae isolation, M. furtuitum isolation, M. abscessus isolation, MAC, isolated, co-isolated, M. abscessus, M. szulgai, M. peregrinum, M. terrae, isolation, NTM, species, detected, Co-isolation, multiple, NTM, species, patients, non-MAC, NTM, lung diseases, co-isolation, multiple, NTM, species, NTM, species, characteristics, co-isolation]]\n",
      "[[knowledge, prevalence, diseases, non-tuberculous mycobacteria, NTM, Pakistan, absence, culture, identification, acid-fast bacilli, AFB, NTM, disease, tuberculosis, TB, nucleic acid amplification testing, Mycobacterium tuberculosis complex, MTBC, diagnostic accuracy, compared, smear microscopy, MTBC, mycobacteria, study, investigate, prevalence, NTM, patients, investigated, TB, NTM, disease, treatment, outcomes, tertiary care hospital, Pakistan, retrospective study, data, NTM, isolates, culture-positive, clinical samples, years, laboratory records, Information, clinical specimens, processed, AFB smear, results, AFB, positive, isolates, results, species, identification, MTBC, NTM, isolates, results, species, characterization, drug susceptibility testing, clinical data, patient, characteristics, treatment regimens, outcomes, patients, NTM, treated, Gulab Devi Hospital, Lahore, study, period, clinical specimens, mycobacterial, culture, positive, AFB, MTBC, NTM, NTM, isolated, pulmonary, extrapulmonary, specimens, NTM, speciation, isolates, M. avium complex, M. abscesses, patients, clinical records, patients, pulmonary disease, infected, M. avium complex, M. abscessus, patients, history, poor response, anti-TB treatment, patients, cured, months, treatment, M. abscessus infection, died, TB, endemic areas, NTM, misdiagnosed, pulmonary TB, anti-TB treatment, increased, morbidity, improved, diagnosis]]\n",
      "[[CONVERT study, treatment, amikacin, liposome, ALIS, guideline-based therapy, GBT, increased, culture, conversion, month, patients, treatment-refractory, Mycobacterium avium complex, MAC, lung disease, ALIS+GBT, GBT-alone, patients, culture, conversion, month, CONVERT, conversion, sustained, negative, months, treatment, negative, months, treatment, safety, signals, associated with, treatment, months, post-conversion, Adults, randomized, ALIS+GBT, GBT-alone, Patients, culture, conversion, month, therapy, months, off-treatment, observation, patients, randomized, ALIS+GBT (, intention-to-treat, conversion, sustained, months, treatment, patients, randomized, GBT-alone, ALIS+GBT, GBT-alone, patients, culture, conversion, month, converters, ALIS+GBT-treated arm, no converters, GBT-alone, sustained, conversion, P=.0017, Relapse, rates, months, treatment, ALIS+GBT, GBT-alone arm, adverse events, ALIS+GBT-treated, patients, dysphonia, cough, dyspnea, hemoptysis, months, treatment, refractory population, conversion, sustained, patients, treated with, ALIS+GBT, months, postconversion, treated with, GBT-alone, safety, signals, associated with, months, postconversion, treatment]]\n",
      "[[Opportunistic infections, OI, patients, acquired immunodeficiency syndrome, AIDS, Cryptococcus neoformans, Mycobacterium avium complex, MAC, infections, concurrent, infection, pathogens, uncommon, underreported, literature, Case description, case, Caucasian, Belgian, patient, low-grade, fever, headache, wasting syndrome, diagnosed, human immunodeficiency virus, AIDS, stage, HIV, viral load, viral, CD4 + T-cells, count, cells/microL., Diagnosis, disseminated, Cryptococcus neoformans infection, positive, positive, culture, Cryptococcus neoformans, blood, cerebrospinal fluid, Diagnosis, disseminated, Mycobacterium avium complex infection, positive, culture, biopsy, mediastinal lymph node, adequate, anti-retroviral therapy, ART, treatment, OIs, patient, recovered, clinical, evolution, knowledge, case, coexistence, OIs, post, ART, era, Clinicians, co-infections, high-income countries, patients, severe, immunodeficiency, Early detection, treatment, HIV, prevent, AIDS, complications, opportunistic infections, patients, diagnosed, AIDS.Abbreviations, ABC, abacavir, AIDS, acquired immunodeficiency syndrome, AFB, acid-fast bacilli, ART, antiretroviral therapy, CM, cryptococcal meningitis, CrAg, cryptococcal antigen, CSF, cerebrospinal fluid, CT, computed tomography, EACS, European AIDS Clinical Society, FTC, emtricitabine, HIC, high-income countries, HIV, human immunodeficiency virus, HIV-VL, HIV-viral, load, ICP, intracranial pressure, IRIS, immune reconstitution inflammatory syndrome, MAC, Mycobacterium avium complex, MRI, magnetic resonance imaging, MSM, man, sex, men, NR, normal range, OD, omne, die, OI, opportunistic infection, RAL, raltegravir, TAF, tenofovir alafenamide fumarate]]\n",
      "NaN\n",
      "[[Sarcoidosis, pathologically, characterized, formation, non-necrotizing epithelioid cell, granulomas, pathological, findings, patients, sarcoidosis, necrosis, report, patient, sarcoidosis, infectious disease, necrosis, lymph nodes, CASE PRESENTATION, Japanese, woman, hospital, dry cough, appetite loss, chest X-ray, computed tomography, enlarged, mediastinal, hilar lymph nodes, hepatosplenomegaly, Surgical biopsy, lymph nodes, diagnosis, Pathological findings, epithelioid cell, necrosis, infectious etiology, mycobacterial, fungal infections, pathological, findings, immunoglobulin A (, IgA, antibody, Mycobacterium avium complex, MAC, enlargement, lymph nodes, hepatosplenomegaly, disseminated, MAC, sarcoidosis, differential diagnosis, elevated, angiotensin-converting, enzyme, soluble, interleukin-2 receptor, uveitis, results, cultures, acid-fast bacilli, symptoms, cough, consumption, worsened, initiation, therapy, diagnosis, therapy, MAC, immunosuppressive therapy, corticosteroid, sarcoidosis, worsen, patient's, condition, MAC, infection, etiology, treatment, MAC, effective, acid-fast bacilli, cultured, liquid culture medium, diagnosis, sarcoidosis, clinical, pathological, findings, Prednisolone, administered, orally, patient's, symptoms, radiological, findings, improved, Sarcoidosis, pathological, findings, necrosis, cases, sarcoidosis, necrosis, lymph nodes, clinical, pathological, findings, discussion, pathologist, diagnosis]]\n",
      "[[Bovine tuberculosis, bTB, disease, cattle, humans, burden, bTB, countries, industrialized countries, reasons, discrepancy, bTB, control measures, testing, slaughter, infected, cattle, pasteurization, milk, countries, cost, bTB, countries, molecular typing studies, essential, transmission, dynamics, infection, sources, knowledge, circulating, strains, principal causative agent, Mycobacterium bovis, study, suite, molecular typing techniques, deletion analysis, spoligotyping, MIRU-VNTR, isolates, recovered, samples, routine, post-mortem, cattle, cold-storage, abattoir, Lilongwe, Malawi, isolates, European 1 M. bovis clonal complex, Spoligotyping, profiles, SB0131, predominant type, isolates, Spoligotypes, SB0273, SB0425, identified, isolates, MIRU-VNTR, differentiated, spoligotypes, genotypes, diversity, M. bovis, study area, infection, circulating, area, period, time, lack, effective, control measures, genetic similarities, isolates, Malawi, study, isolates, studies, Zambia, Mozambique, transmission, region, information, study, evidence, formulation, improved, bTB, control strategies]]\n",
      "[[Mycobacterium bovis, M. bovis, tuberculosis, mammals, public, worldwide, M. bovis, humans, domestic, wild ruminants, human-wildlife-livestock interface area, Zambia, information, primates, reservoir hosts, wild chacma, baboons, Papio ursinus, tuberculosis, human-wildlife interface area, Lochinvar National Park, Kafue Flats, Zambia, necropsy, lung tissue, associated lymph nodes, tuberculous-like lesions, adult, male, baboons, Mycobacterium culture, isolates, typed, Mycobacterium tuberculosis, complex-discrimination multiplex PCR assay, characterized, spoligotyping, 26-loci MIRU-VNTR, Mycobacteria, isolated, animals, identified, M. bovis, PCR, Spoligotyping, isolates, SB, spoligotype, humans, cattle, Kafue lechwe, antelopes, Kafue, Flats, ecosystem, MIRU-VNTR typing, baboon, isolates, clustered, cattle, Kafue lechwe, isolates, catchment area, intimates, cross species, transmission, M. bovis, Kafue Flats, ecosystem, interaction, baboons, humans, Zambia, results, potential, public health, concerns, conservation]]\n",
      "[[Mycobacterium bovis, M. bovis, disease, endangered, African wild dog, Lycaon pictus, endemic, bovine tuberculosis, bTB, Kruger National Park (KNP, information, M. bovis infection, dynamics, species, investigation, M. bovis, conservation, consequences, movement, restrictions, genetic management, study, investigate, mycobacterial, shedding, free-ranging, wild dogs, KNP, culturing, OS, bronchoalveolar lavage, BAL, samples, test, association, antemortem, culture, interferon gamma release assay, IGRA, results, OS, culture, BAL, results, Mycobacterial, culture, revealed, OS, samples, BAL, samples, M. bovis, culture-positive, wild dogs, M. bovis, respiratory secretions, contamination, ingestion, infected, prey, wild dogs, positive, OS, culture, results, test, outcomes, IGRA, culture, OS, BAL, wild dogs, IGRA, detectable, M. bovis, immune sensitization, wild dogs, culture-positive results, findings, intraspecies, transmission, M. bovis, wild dogs, risk, intraspecies, transmission, knowledge, assessing, risk, M. bovis, transmission, infected, wild dogs, uninfected, populations, translocations]]\n",
      "[[cross-sectional study, evaluate, pathogens, transmitted, non-close, contact, domestic-wild ruminants, interface, cattle, wild ruminants, red deer, Cervus elaphus, fallow deer, Dama dama, sampled, Donana National Park, DNP, south-western Spain, Mediterranean, ecosystem, interaction, network, ungulate, host, community, Pestiviruses, bovine, respiratory syncytial virus, BRSV, Bovine orthopneumovirus, bovine herpesvirus 1, BoHV-1, Bovine alphaherpesvirus 1, Mycobacterium tuberculosis complex, MTC, assessed, serological, microbiological, molecular techniques, seroprevalence, viruses, cattle, pestiviruses, BRSV, BoHV-1, virus-specific antibodies, wildlife, MTC, incidence, cattle, MTC, seroprevalence, wild ruminants, Mycobacterium bovis spoligotypes, SB1232, SB1230, SB1610, identified, cattle, red deer, fallow deer, serological, results, respiratory viruses, epidemiological cycles, cattle, Surveillance efforts, multi-host, epidemiological, scenarios, control strategies, pathogens]]\n",
      "[[study, assessed, performance, SD, Bioline MPT64 immunochromatographic test, identification, Mycobacterium tuberculosis complex, MTBC, Nigeria, mycobacterial, isolates, MTBC, M. tuberculosis, M. africanum, M. bovis, non-tuberculous mycobacteria, NTM, isolates, patients, attending, DOTS, Lagos, analyzed, isolates, Bactec, MGIT960, liquid media, identified, conventional method, MPT64 immunochromatographic test, Discrepant results, resolved, line probe assay, comorbid disease, rates, HIV, type 2 diabetes, conventional method, SD, Bioline MPT64, identified, MTBC, isolates, sensitivity, CI, shorter, days, days, conventional method, MTBC, line probe assay, M. tuberculosis, strains, test, NTM, specificity, CI, study, integration, SD, Bioline TB, MPT64 antigen test, diagnostic workflow, MTBC, case identification, Nigeria]]\n",
      "[[pathology, gastrointestinal tuberculosis, cows, Gross lesions, jejunum, ileum, cases, characterized, button-shaped ulcers, mucosa, overlying, Peyer's, patches, adjacent, mucosa, changes, pyloric region, abomasum, affected, intestinal, segments, granulomatous inflammation, effaced, lymphoid follicles, Peyer's, patches, transmurally, Transmural, granulomatous inflammation, abomasum, cow, Acid-fast bacilli, Ziehl-Neelsen method, lesions, immunolabelled, anti-Mycobacterium tuberculosis, complex antibody, M. tuberculosis, var, bovis, isolated, case, Disseminated tuberculosis, lung, lesions, cows, gastrointestinal lesions, secondary to, pulmonary infection]]\n",
      "[[H65, fusion protein, ESX-secreted antigens, Mycobacterium tuberculosis, Mycobacterium bovis, liposomal adjuvant, CAF01, protection, M. tuberculosis, infection, mice, study, evaluated, impact, BCG, H65 +, CAF01, immunization, M. bovis, infection, BCG-H65 + CAF01/ H65 + CAF01, prime-boost scheme, induced, protection, BCG, H65 +, CAF01, H65 antigen, liposomal adjuvant, improved, BCG-induced, immune protection, vaccine, bovine tuberculosis]]\n",
      "[[Caspases, inflammatory, apoptotic, category, Inflammatory caspases, participate, inflammasome activation, apoptotic caspases, apoptotic, activation, studies, apoptotic caspases, prevent, production, IFN-beta, apoptosis, virus infection, relationship, apoptotic caspases, IFN-beta, production, intracellular, bacterial infection, unclear, investigated, apoptotic caspases, IFN-beta, production, induced, Mycobacterium bovis, M. bovis) infection, M. bovis, intracellular, bacterium, Mycobacterium tuberculosis complex, M. bovis infection, tuberculosis, animals, human, beings, study, M. bovis infection, mitochondrial stress, leakage, cytochrome c, cytoplasm, activated, downstream, caspase-9, and-3, results, activation, apoptotic caspases, reduced, IFN-beta, production, M. bovis infection, vice, Confocal microscopy, analysis, apoptotic caspases, IFN-beta, production, decreasing, p-IRF3, nuclear translocation, findings, apoptotic caspases, regulate, production, IFN-beta, induced, intracellular, bacterial infection]]\n",
      "[[Bovine tuberculosis, bTB, zoonotic infection, targeting, livestock sector, countries, risk, humans, animal populations, prevalence, river buffaloes, emergent, countries, Pakistan, likeliness, human-livestock interfaces, extensively, lacking, effective, preventive measures, risk, spreading, infection, rate, river buffalo, Bubalus bubalis, host, Mycobacterium bovis, disease transmission, buffaloes, livestock species, study, potential, molecular biomarkers, Interferon-gamma gene, IFNg, identified, genomic screening, river buffaloes, genomic loci, river buffalo, novelty, genomic structure, phenomenal, animal, significance, natural, immunity, Mycobacterium, polymorphisms, identified, coding region, IFNg, SNPs, exonic region, transitions, conversion, purines, purines, SNPs, analyzed, Hardy Weinberg Equilibrium, gene diversity, protein structural conformation, Pathway analysis, tuberculosis, revealed, IFNg, inhibits, antigen-presenting cells, APC, JAK, STAT pathways, Network analysis, IFNg proteins, species, associations, immunity-related proteins, interleukins, tissue necrosis factors, receptors, interferons, polymorphic sites, novel-potentiated markers, selection, animals, superior, immune response, bTB, genomic sites, breeding, resistant, animal, herds, Mycobacterium infection]]\n",
      "[[Bovine tuberculosis, TB, chronic disease, Mycobacterium bovis, zoonotic pathogen, distribution, economic losses, milk, meat, producers, Chile, disease, dairy cattle, heterogeneous, distribution, Metropolitan Region, concentrates, highest, animal, prevalence, national control, eradication program, epidemiological context, vaccination, M. bovis Bacillus Calmette-Guerin (BCG, vaccine, disease prevention, control, study, assess, efficacy, impacts, productivity, fertility, vaccination, BCG Russia, strain, heifers, dairy farm, natural transmission, animals, vaccinated, subcutaneous route, equivalent, human, dose, BCG, control animals, saline, blood sampling, months, post, inoculation, infection status, IFNgamma, assay, DIVA, Differentiate Infected, Vaccinated, Animals, ESAT-6, CFP-10, Rv3615c, Efficacy, percentage, reduction, incidence, infection, vaccination, statistically significant, level, protection, adverse effects, fertility, production, effects, vaccination, milk, production, parameters, milk, yield, days, calving, BCG, group, unvaccinated, heifers, results, BCG, vaccination, heifers, natural transmission setting, sanitary, productive, benefits, implementation, TB, prevention, Chile]]\n",
      "[[Head-starting of, federally endangered, Houston toad, Anaxyrus houstonensis, release, egg strands, tadpoles, metamorphic juveniles, captivity, original, breeding, ponds, assessment, potential, threats, transmission, pathogens, captive, free-ranging toads, Illumina-based 16S rRNA, investigate, community structure, bacteria, skin lesions, captive, Houston toad, habitat, pond, samples, Proteobacteria, Actinobacteria, samples, Cyanobacteria, reads, tissue lesion, pond samples, diverse, Acidobacteria, Actinobacteria, Bacteriodetes, Chloroflexi, Cyanobacteria, Firmicutes, Planctomycetes, Proteobacteria, Verrucomicrobia, variation, samples, lesions, Actinobacteria, Mycobacteriaceae, sequence, identical, sequences, members, Mycobacterium chelonae-abscessus complex, pond samples, mycobacteria, small portion, actinobacteria, diversity, reads, Sequences, reads, pond samples, M. chelonae-abscessus complex, group, Mycobacterium marinum, Mycobacterium kansasii, Mycobacterium avium, group, Mycobacterium vaccae, Mycobacterium fortuitum, Mycobacterium poriferae, group, Mycobacterium elephantis, Mycobacterium celeriflavum, sequences, similarity, detected, reads, Mycobacterium holsaticum, Mycobacterium pallens, Mycobacterium obuense, Mycobacterium goodii, results, lesions, Houston toad, captivity, mycobacteria, case, presence, mycobacteria, captive, colony, pathogen, threat, wild populations, bacteria, natural pond, habitats, Houston toad]]\n",
      "[[OBJECTIVE, Skeletal muscle, size, predictor, prognosis, patients, respiratory diseases, Mycobacterium avium complex, research, impact, prognosis, patients, pulmonary tuberculosis, TB, study, assess, association, erector, spinae muscle, ESM, size, in-hospital mortality, patients, pulmonary TB, retrospectively, consecutive, patients, aged, years, admitted, hospital, bacteriologically, pulmonary TB, chest computed tomography, admission, cross-sectional area, ESM, ESMcsa, measured, lower margin, thoracic vertebra, single-slice CT scan, image, body surface area, BSA, patients, died, hospitalization, non-survivor, group, incidence, respiratory failure, comorbidities, lower hemoglobin, albumin, levels, performance status score, ESMcsa/BSA, Multivariate analysis, low, hemoglobin, albumin, levels, ESMcsa/BSA, body mass index, in-hospital mortality, age, comorbidities, ESM, size, associated with, in-hospital mortality, patients, pulmonary TB]]\n",
      "[[Mycobacterium leprae, Mycobacterium lepromatosis, gram-positive bacterial, pathogens, causative agents, leprosy, humans, world, elimination, leprosy, multidrug therapy, tools, drugs, prevent, emergence, resistant, strains, study, contribution, prediction, vaccine, targets, putative drugs, leprosy, reverse vaccinology, subtractive genomics, strains, Mycobacterium leprae, Mycobacterium lepromatosis, strains, comparison, Mycobacterium leprae, strain TN, reference genome, subtractive genomics approach, result, vaccine, targets, drug targets, Mycobacterium leprae, Mycobacterium lepromatosis, docking analysis, natural compounds, drug targets, bis-naphthoquinone compound, Diospyrin, indigenous, plant, Diospyros spp, binding, affinity, drug targets, therapeutic, target, leprosy]]\n",
      "[[Leprosy, chronic granulomatous infectious disease, Mycobacterium leprae, affecting, skin, peripheral nerves, clinical manifestations, leprosy, variable, skin diseases, histopathological, examination, early diagnosis, management, study, clinicohistopathological correlation, suspected, cases, Hansen's disease, Materials, Methods, retrospective study, skin biopsies, patients, clinically, diagnosed, lesion, leprosy, department, pathology, Demographic, clinical details, patients, hospital information system, Hematoxylin-eosin-, Fite-Faraco-stained, sections, evaluated, features, leprosy, Ridley-Jopling system, Sensitivity, specificity, concordance rates, male-to-female ratio, histopathological, clinical diagnoses, subclasses, borderline tuberculoid leprosy, BT, tuberculoid leprosy, TT, sensitivity, clinical diagnosis, indeterminate, histoid, neuritic types, specificity, BT, TT, neuritic leprosy, Clinical diagnosis, early, leprosy, lesions, difficulties, dermatologists, patient, clinicopathological forms, host, immune status, correlation, clinical, histopathological, bacteriological, features, diagnosis, classification, leprosy, Nerve, damage, irreversible, early detection, treatment, Grade 2 disabilities]]\n",
      "[[Leprosy, post-kala-azar dermal leishmaniasis, PKDL, co-endemic, tropical diseases, misdiagnosed, resemblance, clinical manifestations, test, differential diagnosis, leprosy, PKDL, endemic areas, report development, multiplex loop-mediated isothermal amplification, m-LAMP, assay, differential detection, Mycobacterium leprae, Leishmania donovani, real-time fluorometer, m-LAMP, assay, amplification, time, minutes, analytical sensitivity, L. donovani, M. leprae, Tm, M. leprae, L. donovani, differentiation, organisms, m-LAMP, assay, Diagnostic sensitivity, assay, evaluated, cases, leprosy, PKDL, tissue, slit aspirate samples, leprosy, PKDL, samples, study, positive, QPCR, loop-mediated isothermal amplification assays, diagnostic sensitivity, m-LAMP, assay, CI, detecting, PKDL, leprosy, CI, m-LAMP, assay, detect, M. leprae, L. donovani, patient, coinfected, leprosy, macular, PKDL, m-LAMP, assay, accurate, differential diagnosis, leprosy, PKDL, endemic areas]]\n",
      "[[OBJECTIVE, Leprosy, chronic infectious disease, Mycobacterium leprae, significant, health problem, parts, world, Early, accurate, diagnosis, disease, LAMP, protocols, detection, mycobacterial, species, primers, targeted, 16S rRNA, gyrB, insertion sequence genes, study, loop-mediated isothermal amplification, assay, leprosy, compared, quantitative PCR, q-PCR, conventional, PCR assays, techniques, sensitive, accurate, assays, conserved sequence RLEP, molecular target, LAMP, assay, rapid, accurate, results, clinical, skin tissue, samples, suspected, leprosy, leprosy, cases, target, pathogen, degrees, sensitive, PCR, simpler, faster, q-PCR, assay, LAMP, assay, potential, visual detection, methods, detecting, M. leprae, early diagnosis, treatment, prevention, infection, endemic areas]]\n",
      "[[Leprosy, negleted public health problem, Brazil, Early, adequate, treatment, leprosy, primary, health network, reduce, morbidity, sequelae, therapeutic management, leprosy, patients, primary healthy services, secondary specialized, analytical retrospective study, medical records, Notifiable Diseases Information System, Patients, diagnosed, leprosy, secondary, outpatient, clinic, Goias state, treatment, primary health services, Ministry of Health guidelines, Two-hundred, leprosy, patients, leprosy reactions, sequelae, suspected, recurrence, reinfection, therapeutic management, inadequate, adequate, inconclusive, multibacillary, patients, adequate, management, paucibacillary, patients, adequate, management, chi(2)=11.43, leprosy reactions, sequelae, management, inadequate, percentage, adequate, inadequate management, Goias health macroregions, chi(2)=7.23, freedom, data, incomplete, medical records, lack, patient, follow-up, study, equivocal, multibacillaryleprosy management, healthy, primary care, leprosy reactions, sequelae, Training, monitoring, medical staff, primary healthy services, reduce, morbidity, sequelae, leprosy]]\n",
      "[[Experts, negative, impact, coronavirus disease, cytokine storm syndrome, progression, leprosy-related disabilities, assessed, frequency, reactional states, patients, co-infected, Mycobacterium leprae, severe, acute respiratory syndrome, SARS, coronavirus, CoV, SARS-CoV-2, patients, COVID-19, epidemic, Brazil, analyzed, expressions, genes, encoding, interleukin (IL)-1beta, IL-6, IL-8, IL-10, IL-12A, IL-12B, tumor necrosis factor-alpha, peripheral blood mononuclear cells, leprosy, patients, controls, leprosy, patients, controls, diagnosed, COVID-19, Co-infection, associated with, increased, IL-6, IL-12B, expression, median, disability, leprosy/COVID-19, patients, difference, Patients, co-infected, M. leprae, SARS-CoV-2, proinflammatory state]]\n",
      "[[Hansen's disease, HD, leprosy, endemic, parts, world, multidrug therapy, MDT, curing, patients, long-term, treatment, identification, drug targets, Mycobacterium leprae, overview, in silico, in vitro studies, essentiality, M. leprae, proteins, reviewed, discussion, flux, gene expression, knockout articles, druggability techniques, validation, M. leprae, targets]]\n",
      "[[Mycobacterium leprae, M. leprae, etiological agent, leprosy, skin lesions, lepromatous leprosy, foamy, xanthomatous, histiocytes, parasitized, M. leprae, Lipids, nutrient, intracellular, survival, M. leprae, study, intracellular, lipid composition, mechanisms, changes, host, lipid metabolism, induced, M. leprae, infection, high-performance thin-layer chromatography, HPTLC, induction, triacylglycerol, TAG, production, human, THP-1 cells, M. leprae, infection, 14C, stearic acid, incorporation, host, TAG, M. leprae, TAG, accumulation, expression, host glycerol-3-phosphate acyltransferase 3, GPAT3, enzyme, de novo, TAG, synthesis, increased, M. leprae-infected cells, CRISPR/Cas9, genome, editing, GPAT3, THP-1 cells, GPAT3 KO, reduced, accumulation, TAG, M. leprae, infection, intracellular, mycobacterial, load, bacteria, viability, results, M. leprae, induces, host, GPAT3, expression, TAG, accumulation, macrophages, environment, intracellular, survival, bacilli]]\n",
      "[[published, single-nucleotide polymorphism rs2476601, PTPN22, protein tyrosine phosphatase non-receptor type 22]-C1858T, increased, sensibility, Mycobacterium tuberculosis, M. leprae, infection, results, inconclusive, degree, similarity, parameters, meta-analysis, systematically, correlation, PTPN22-C1858T, polymorphism, mycobacterial, infection, susceptibility, PTPN22-C1858T, carriers, autoimmune conditions, immunosuppressive therapy, M. tuberculosis, M. leprae, infection, systematic retrieval, studies, relevance, PTPN22-C1858T, polymorphism, susceptibility, M. tuberculosis, M. leprae, infection, Chinese National Knowledge Infrastructure, PubMed, Embase databases, Odds ratios, ORs, confidence intervals, CIs, effect size, case-control studies, tuberculosis, leprosy, genetic models, association, PTPN22-C1858T, polymorphism, tuberculosis's, susceptibility, T, OR, CI, PH, CT, CC, OR, CI, PH, TT+CT, CC, OR, CI, PH, increased, risk, leprosy, perceived, patients, PTPN22-C1858T polymorphism, T, OR, CI, PH, PTPN22-C1858T, polymorphism, susceptibility, infection, M. tuberculosis, Caucasians, Asians, increased, susceptibility, infection, M. leprae, results, M. leprae, quantity, studies, heterogeneity, well-designed studies, populations, conclusions]]\n",
      "[[Leprosy, chronic infectious disease, subgroups, therapeutic purposes, paucibacillary, PB, multibacillary, MB, host, immune responses, immunological, biomarkers, laboratorial strategy, follow-up, leprosy, household contacts, cross-sectional study, participants, patients, healthy controls, Peripheral blood mononuclear cells, PBMC, isolated, incubated, presence, Mycobacterium leprae bacilli, cells, surface, CD4(+), CD8(+), intracytoplasmic cytokine staining, IFN-gamma, IL-4, IL-10, Multiple comparisons, groups, ANOVA, Kruskal-Wallis, Student T, Mann-Whitney test, Comparative analysis, categorical variables, Chi-square, Functional, biomarker, analysis, global, biomarker index, cut-off edge, proportion, subjects, biomarker, levels, cytokine signature analysis, leprosy, patients, polyfunctional profile, T-cells, subsets, increased, frequency, IFN-gamma(+) T-cell, IL-10(+), IL-4(+, CD4(+) T-cells, health Controls, Venn diagram report, statistical analysis, parametric, non-parametric variance analysis, pairwise multiple comparisons, data normality distribution, polyfunctional profile, characterized, percentage, IFN-gamma(+), IL-10(+), IL-4(+, T-cell subsets, L(MB, cytokine functional profile, IL-10(+), IL-4(+) T-cells, contribution, IFN-gamma, CD4(+) T-cells, HHC(MB, enhanced, frequency, IFN-gamma(+) T-cells, HHC(PB, cytokine profile, IL-10, IL-4, data, L(PB), enhanced, percentage, IFN-gamma(+), IL-10(+), IL-4(+, L(MB, functional profile, IL-10(+), IL-4(+) T-cells, HHC(MB, enhanced, frequency, IFN-gamma(+) T-cells, HHC(PB), findings, immunological, features, associated with, leprosy, household contacts, data, evidence, biomarkers, immune response, diagnostic/prognostic, household contacts]]\n",
      "[[Murine, leprosy, chronic granulomatous disease, Mycobacterium lepraemurium, MLM, mice, rats, disease, development, cellular anergy, impedes, production, interferon gamma (, IFNgamma, tumor necrosis factor-alpha (TNFalpha, nitric oxide, NO, kill, microorganism, study, investigated, histone deacetylase inhibitors, HDACi, valproic acid, sodium butyrate, NaB, immunomodulator transfer factor, dialyzable leukocyte extracts, DLE, anergy, murine, leprosy, groups, Balb/c mice, intraperitoneally, inoculated, MLM, post, inoculation, treatment, group, no treatment, treated with, rifampicin-clofazimine, sodium valproate, VPA, NaB, DLE, animals, monitored, evidence, disease, days, euthanasia, spleens, removed, processed, histologic, bacteriologic, cytokine studies, disease, DLE, NaB, reduced, development, lesions, granuloma size, bacilli, VPA, effective, DLE, NaB, VPA, anergic condition, diverse, grades, expression, IFNgamma, TNFalpha, inducible, NO synthase, diverse, grades, Anergy, leprosy, murine, leprosy, disease progression, study, anergy, prevented, degree, DLE, immunomodulator, NaB, HDACi, VPA, effective, results, effects, DLE, NaB, ancillary treatment, leprosy]]\n",
      "[[study, taxonomic, status, species, genus, Mycobacterium, analysis, genomes, taxa, species, subspecies, genus, Mycobacterium, Average, Nucleotide Identity, Genome, Genome Distance, synonymous taxa, detected, subspecies, M. chelonae, M. chelonae subsp, bovis, M. chelonae subsp, gwanakae, subspecies, M. fortuitum, M. fortuitum subsp., fortuitum, M. fortuitum subsp., subspecies, M. avium, M. avium subsp., avium, M. avium subsp., M. avium subsp., paratuberculosis, M. avium subsp., couples, subspecies, M. intracellulare, M. intracellulare subsp, intracellulare/M. intracellulare subsp, paraintracellulare, M. intracellulare subsp, chimaera/M. intracellulare subsp., yongonense, species, M. austroafricanum, M. vanbaalenii, species, M. senegalense, M. conceptionense, species, M. talmoniae, M. eburneum, species, M. marinum, M. ulcerans, M. pseudoshottsii, species, subspecies, mycobacterium, M. lepraemurium, subspecies, M. avium, M. avium subsp., lepraemurium, nomenclature, priority, names, Code of nomenclature, prokaryotes, species, M. bouchedurhonense, M. marseillense, loss, standing, nomenclature, type strains, culture collections]]\n",
      "[[Nontuberculous mycobacteria, Mycobacterium avium complex, MAC, bacteria, opportunistic, pathogens, humans, result, studies, antibiotic treatment, taxonomy, MAC, intensifying, definition, MAC, taxonomical studies, clinical purposes, lacking, literature review, phylogenetic analyses, MAC, grouping, slow-growing mycobacteria, values, targets, M. avium ATCC 25291(T), Mycobacterium intracellulare ATCC 13950(T, sequence, identity, 16S rRNA gene, partial, 16S rRNA gene, hsp65, rpoB region, V. A >97.5 % value, concatenated analyses, 16S rRNA, hsp65, rpoB gene sequence, data, nucleotide, M. avium ATCC 25291(T), M. intracellulare ATCC 13950(T, whole genome sequencing, data, recommended, molecular definition, distances, MAC, M. avium, M. intracellulare, definition, complex, validly, published species, Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium chimaera, Mycobacterium colombiense, Mycobacterium arosiense, Mycobacterium vulneris, Mycobacterium bouchedurhonense, Mycobacterium timonense, Mycobacterium marseillense, Mycobacterium yongonense, Mycobacterium paraintracellulare, Mycobacterium lepraemurium]]\n",
      "[[Human, CD8(+) cytotoxic T lymphocytes, CTLs, antimicrobial defense, intracellular, pathogens, secretion, cytotoxic granule proteins, granzyme B, perforin, granulysin, CTLs, heterogeneous, expression, proteins, subset(s), antimicrobial activity, unclear, human leprosy, CTLs, coexpressing, cytotoxic molecules, increased, resistant, disease, interleukin-15, IL-15, naive, CD8(+) T cells, Langerhans cells, RNA sequencing analysis, identified, CTLs, express, gene signature, array, surface receptors, expressed, natural killer (NK) cells, CD8(+), CTLs, expressing, granzyme B, perforin, granulysin, activating, NK receptor, NKG2C, population, antimicrobial CTLs, T cell receptor, (TCR)-dependent, TCR-independent, release, cytotoxic granule proteins, antimicrobial activity]]\n",
      "[[5-month-old, male, European shorthair cat, ulcera, ted cutaneous nodules, entire body, serological, results, feline immunodeficiency virus, feline leukaemia virus, negative, detection, acid-proof bacilli, histological examination, skin biopsies, diagnosis, mycobacteriosis, skin, Polymerase chain reaction, presence, Mycobacteriumlepraemurium, surgical excision, cutaneous nodules, antibiotic therapy, Rifampicin, Clarithromycin, cat, cured, observation, year, therapy, relapse]]\n",
      "[[Murine leprosy, Mycobacterium lepraemurium, MLM, chronic disease, human, leprosy, disease, nervous system, investigated, effect, working memory, chronic infection, Balb/c mice, alterations, dorsal region, hippocampus, measured, peripheral, cytokines, days, post-infection, evaluate, working memory, T-maze, morphometric analysis, hippocampus, CA1, CA2, CA3, dentate gyrus, DG, measure, morphological, changes, neurochemical analysis, HPLC, results, days, post-infection, increase, bacillary, load, liver, spleen, associated to, increased, levels, IL-4, working memory deterioration, changes, hippocampal, morphology, degeneration, subregions, analyzed, decrease, neurotransmitter, levels, infection, MLM, infect, nervous system, findings, functional, immune system, central nervous system]]\n",
      "[[type I IFNs, pathogenesis, control, mycobacterial, infection, type I IFNs, exacerbated, M. tuberculosis, infection, Th1, conditions, natural, immune adjuvants, commercial, vaccines, IFN-alpha, Mycobacterium bovis Bacillus Calmette Guerin (BCG, vaccinated, mice, adult, mice, intradermal, M. lepraemurium infection, iNOS, intramuscular, IFN-alpha, Mycobacterium bovis Bacillus Calmette Guerin (BCG, vaccine, in vitro, human cell line, macrophages, PBMC, in vivo, aerosol mouse model, MTb, infection, development, anti-antimycobacterial Th1 type cytokines, IFN-gamma, IL-12, TNF-alpha, IL-17, IL1beta, bacterial load, reduction, logs, PBS, BCG vaccine, findings, experimental settings, interferon alpha, TH, cellular immune response, BCG-inducing, immunity, M. tuberculosis, infection]]\n",
      "[[Mycobacterium lepraemurium, causative agent, murine, leprosy, chronic, granulomatous disease, human leprosy, clinical manifestations, human, murine, leprosy, difficulty, bacilli, axenically, Mycobacterium leprae, M. lepraemurium, M. lepraemurium, Mycobacterium avium, study, genome, M. lepraemurium, sequenced, combination, PacBio, Illumina sequencing, Phylogenomic analyses, M. lepraemurium, species, M. avium complex, MAC, M. lepraemurium, genome, length, MAC, genomes, functional genes, pseudogenes, M. lepraemurium, genome, reduction, error-prone repair, DNA polymerase III alpha-subunit, nonfunctional, M. lepraemurium, pseudogene formation, accumulation, mutations, nonessential genes, M. lepraemurium, functionality, genes, influence, virulence, members, MAC.IMPORTANCEMycobacterium lepraemurium, evolving, genes, intracellular, lifestyle, host, niche, seldom, mycobacteria, free-living, M. lepraemurium, model, functions, genes, members, MAC, reduced, gene set, essentiality, genes, pathogenic, species, discovery, virulence factors, host-pathogen interactions, M. lepraemurium, in vitro, specific, conditions, difficulty, metabolic, (in)capabilities, M. lepraemurium, axenic media, genetic studies]]\n",
      "[[feline, description, disease, species, Candidatus, Mycobacterium lepraefelis', human, pathogens, Mycobacterium leprae, Mycobacterium lepromatosis, Cases, retrospectively, observational study, clinical, geographical, molecular microbiological data, cats, diagnosed, Candidatus 'M lepraefelis' infection, cases, feline, leprosy, scrutinised, cases, Victorian Infectious Diseases Reference Laboratory (VIDRL) records, veterinary pathology laboratories, veterinarians, cases, published studies, cats, diagnosed, Candidatus 'M lepraefelis' infection, cats, middle-aged, older, infected, male, predilection, Affected, cats, cutaneous lesions, cases, localised disease, Advanced cases, systemically unwell, cats, outdoor, access, histological, picture, lepromatous, patients, cases, tuberculoid disease, case, necropsy, lesions, liver, spleen, lungs, Treatment, cats, combination, oral, clarithromycin, rifampicin, Prognosis, recovery, variable, poor, Candidatus 'M lepraefelis', lepromatous, feline, leprosy, cases, systemic mycobacteriosis, disease, variable, clinical course, prognosis, cases, died, euthanased, infection, Multilocus sequence analysis, heterogeneous, picture, analysis, draft genome sequencing, taxonomy, epidemiology, organism, Prospective treatment trials, drug susceptibility testing, specialised systems, treatment, recommendations, Comparative aspects, comparative aspects, infection, feline leproid disease agents, subject, Candidatus ', Mycobacterium tarwinense', Mycobacterium lepraemurium, Candidatus 'M lepraefelis']]\n",
      "[[1,2,4-triazole derivatives, synthesized, assigned, anti-tuberculosis substances, molecular, crystal structures, model compounds, C1, C12, C13, X-ray analysis, X-ray, investigation, synthesis pathway, molecular structures, analyzed, 1,2,4-triazol-5-thione derivatives, conformational preferences, rotational degrees, 1,2,4-triazole ring substituents, characterized, lipophilicity, logP, electronic parameters, energy, orbitals, dipole moments, NBO, distribution, atoms, electrostatic potential, distribution, structures, calculated, AM1, DFT/B3LYP/6, level, in vitro test, M. tuberculosis H37Ra, M. phlei, M. smegmatis, M. timereck, results, antituberculosis, potential, compound C4, active, Mycobacterium H37Ra, MIC, Mycobaterium pheli, MIC, Mycobacerium timereck, Satisfactory, results, compounds C8, C11, C14, Myc, H37Ra, Myc, pheli, Myc, timereck, MIC, molecular docking studies, investigated, compounds, Mycobacterium tuberculosis, cytochrome P450 CYP121, enzyme, molecular, target, antimycobacterial activity]]\n",
      "[[non-tuberculous mycobacteria, NTM, infect, humans, animals, confounding, diagnosis, bovine tuberculosis, Official Mexican Standard, NOM-ZOO-031-1995), food safety, regulates, Mycobacterium bovis, cattle, NTM, species, study's, objective, isolate, NTM, condemned, bovine, lymph nodes, slaughterhouse, histological, lesions, bacteriological, microscopic findings, antemortem, tuberculin skin test, cattle, pooled, samples, lymph nodes, animal, cultured, Mycobacteria spp, histopathology, mycobacteria, isolated, condemned lymph nodes, isolates, NTM, bacteriological cultures, fungal, contamination, Granulomatous, pyogranulomatous, inflammation, NTM-positive, lymph nodes, species, NTM, associated with, granulomatous lymphadenitis, M. scrofulaceum, M. triviale, M. terrae, M. szulgai, pyogranulomatous, lesions, M. szulgai, M. kansasii, M. phlei, M. scrofulaceum, NTM, infections, false-positive, tuberculin test, cross immune reactivity, interference, postmortem, identification, M. bovis, cattle]]\n",
      "[[aspochracin-type cyclic tripeptides, sclerotiotides M-O, analogues, sclerotiotide L (4, sclerotiotide F, sclerotiotide B, ethyl acetate extract, fungus Aspergillus insulicola HDN151418, isolated, Antarctica, sponge, Spectroscopic, chemical approaches, structures, absolute, configuration, side chain, compound 4, Compounds 1, antimicrobial activity, pathogenic, strains, Bacillus cereus, Proteus species, Mycobacterium phlei, Bacillus subtilis, Vibrio parahemolyticus, Edwardsiella tarda, MRCNS, MRSA, MIC, values]]\n",
      "[[reformulation, Mycobacterium cell wall, fraction, immunotherapeutic, treat, sarcoids, horses, Sarcoids, equine, skin tumors, tumor type, location, treatment, surgical excision, curative, tumors, studies, sarcoid regression, injection, mycobacterial cell wall, immunotherapeutics, formulation, Mycobacterium phlei cell wall fraction immunostimulant, Immunocidin Equine, treat, cutaneous tumors, horses, Equids, skin tumors, diagnosed, sarcoids, study, Sarcoids, injected, visit, Immunocidin Equine, 2-week intervals, cases, cases, resolved, study, period, evaluation, time, follow-up, cases, improved, resolved, cases, discontinued, study, masses, case, masses, resolution, mass, tumor, months, treatment, case, follow-up, cases, mild, moderate, swelling, injection site, cases, discharge, injections, systemic, side effects, complications, study]]\n",
      "[[bacterial glycans, markers, detection, serological, identification, microorganisms, antigenic components, vaccines, gold, nanoparticles, carriers, glyco-epitopes, alternative, traditional, conjugation, proteins, synthetic polymers, study, evaluate, in vivo, glyco-gold nanoparticles, glyco-GNPs, terminal-branched hexaarabinofuranoside fragment, Ara6, arabinan domains, lipoarabinomannan, arabinogalactan, principal, polysaccharides, cell wall, Mycobacterium tuberculosis, causative agent, tuberculosis, antibodies, Ara6-GNPs, natural saccharides, cell surface, mycobacterial, strains, synthetic, glycosides, amino-functionalized spacer, aglycons, length, hydrophilicity, conjugated, spherical, nanoparticles, glyco-GNPs, immunization, rabbits, Dot assays, cross-reactions, antisera, hexaarabinofuranoside, 2-aminoethyl aglycon, preparation, glyco-GNPs, antisera, titers, antibodies, Mycobacteria, enzyme-linked immunosorbent assay, M. bovis, M. smegmatis cells, antigens, weak, response, M. phlei cells, interaction, E. coli cells, results, glyco-GNPs, agents, anti-mycobacterial antibodies]]\n",
      "[[CONTEXT, effective, bladder-sparing therapies, bacillus Calmette-Guerin (BCG)-unresponsive, non-muscle-invasive bladder cancer, NMIBC, lack, effective, agents, control, US, single-arm trials, patients, carcinoma in situ, CIS, CRR, duration of response, primary, endpoints, marketing applications, growth, clinical trials, space, consensus, clinically, CRR, CRR, recurrence-free rate, RFR, bladder-sparing agents, BCG, failure, clinical trial, results, ACQUISITION, systematic review, clinical trials, bladder-sparing therapeutics, NMIBC, intravesical BCG, PROSPERO, search, MEDLINE, EMBASE, Cochrane Library, studies, identified, bibliography, search, conference abstracts, systematic review, studies, treatment options, patients, analysis, Median, CRRs, treatment, CIS-containing tumors, mo, treatment, comparison, median, RFRs, papillary-only studies, mo, BCG-unresponsive population, CRRs, CIS-containing, patients, treated with, Mycobacterium phlei cell, wall-nucleic acid complex, median, disease-free rates, studies, progression-free rate, CIS-containing, studies, studies, papillary-only, recurrences, Toxicities, intravesical agents, mild, dose, toxicities, bladder-sparing therapies, efficacy, patients, NMIBC, BCG, study, reference, trial, results, BCG-unresponsive space, study, bladder-sparing therapies, efficacy, patients, non-muscle-invasive bladder cancer, bacillus Calmette-Guerin, BCG, results, clinical trial, results, salvage agents, treat, BCG-unresponsive bladder cancer]]\n",
      "[[report, vertebral osteomyelitis, pathogen, Mycobacterium phlei, Mycobacterium phlei, nontuberculous osteomyelitis, nonpathogenic, cases, human infection, Diagnosing infections, nontuberculous mycobacteria, NTM, difficult, delayed, microbiologic tests, inadequate, consensus guidelines, treatment, vertebral osteomyelitis, NTM, man, chronic back pain, bilateral, symptoms, status-post, lumbar fusion, deep infection, CT scan, incomplete, union, fusion, irrigation, debridement, tissue culture, biopsy, negative, cultures, completion, course, intravenous antibiotics, implant, removal, instrumentation, hospitalization, deep spinal fluid acid-fast bacilli culture, positive, weeks, identified, Mycobaterium phlei, empiric, 4-drug regimen, NTM, months, recurrence, infection, case, description, M. phlei osteomyelitis, spine, reminder, diagnosis, infectious etiologies, adequate, treatment]]\n",
      "[[polyketides, ketidocillinones A-C, extract, Antarctica, Penicillium sp. HDN151272, structures, spectroscopic data, NMR, HRESIMS, absolute, configuration, compound 3, ECD, calculation, Compounds 1, oxidized, quinone, exposed to, air, Ketidocillinones B and C, antibacterial activity, Pseudomonas aeurigenosa, Mycobacterium phlei, MRCNS, methicillin-resistant coagulase-negative staphylococci, MIC, values]]\n",
      "[[study, mycobacteria, Mycobacterium tuberculosis complex, MTC, mycobacteria, tuberculosis, MOTT, cord factor, p-nitro-alpha-acetyl-amino-beta-hydroxypropiophenone (, reanalysed, polymerase chain reaction-restriction fragment length polymorphism, identification, time, species, MOTT, identified, results, NAP, days, PCR-RFLP, results, day, species, identified, MTC, NAP, cord factor, PCR-RFLP method, species, MOTT, Mycobacterium species, evaluation, bands, observed, restriction, PCR, PCR-RFLP method, species, Mycobacterium intracellulare type I, species, Mycobacterium phlei, species, Mycobacterium kansasii, species, Mycobacterium fortuitum type I, species, Mycobacterium gordonae type I, species, Mycobacterium abscessus type I, species, Mycobacterium scrofulaceum, species, Mycobacterium szulgai type I, species, Mycobacterium avium type II, species, Mycobacterium terrae, results, cord factor, NAP, molecular method, time, mycobacteria, species, identification, accurate, result-giving method, PCR-RFLP, method, identification, mycobacteria, species, routine, procedures]]\n",
      "[[alkyl aromatics, penixylarins A-D, biogenetically, 1,3-dihydroxy-5-(12-hydroxyheptadecyl)benzene, 1,3-dihydroxy-5-(12-sulfoxyheptadecyl)benzene, isolated, Antarctic deep-sea-derived fungus, Penicillium crustosum, PRB-2, mangrove-derived fungus, Xylaria sp., HDN13, UPLC-MS, data, analysis, structural features, compounds, collaboration, fungi, compounds, Xylaria sp., HDN13, increased, quantities, cocultivation, Compounds 2, antibacterial activity, strains, compound 3, potential, antituberculosis, effects, MIC, Mycobacterium phlei]]\n",
      "[[Heterodimeric tryptophan-containing diketopiperazines, HTDKPs, bioactive, P450-mediated biocatalysis, structural, diversity, enzymes, insoluble, Escherichia coli, Streptomyces, validation, functions, Mycobacterium smegmatis, redox, partners, in vitro, comparing, efficiency, biocatalytic systems, P450s, in vivo, M. smegmatis, efficient, robust, cleaner, metabolites, background, E. coli, Streptomyces systems, M. smegmatis-based system, cyclodipeptide, HTDKPs, metabolites, efficient, system, HTDPKs, HTDKP-forming P450s, NasbB, NASS1868, compounds, neuroprotective properties, study, bioactive chemical scope, HTDKPs, excellent, biocatalysis, enzymes, Actinomycetes]]\n",
      "[[Mycobacterium tuberculosis, deadliest, pathogens, human history, unique, multilayered cell wall, bacterium, level, protection, attacks, host, immune system, primary structure, cell wall core, covalently, peptidoglycan, branched heteropolysaccharide, arabinogalactan, mycolic acids, enzymes, biosynthesis, components, characterized, cell wall, biogenesis, cytoplasmic, periplasmic, faces, plasma membrane, transport systems, translocating, metabolic, intermediates, compartments, characterized, M. Jackson, C. M. Stevens, M. Niederweis, Chem., CRISPR, interference methodology, Mycobacterium smegmatis, ATP-binding cassette, translocation, galactan precursors, plasma membrane, genetic, knockdown, transmembrane subunit of the transporter, results, severe, morphological, changes, accumulation, aberrantly long galactan precursor, similarities, structures, functions, O-antigen ABC transporters, gram-negative bacteria, C. Whitfield, model, coupled, synthesis, export, galactan polymer precursor, mycobacteria]]\n",
      "[[Complex II, succinate dehydrogenase, SQR, fumarate reductase, QFR, enzyme, Krebs cycle, oxidative phosphorylation, Mycobacterial, Sdh1, identified, respiratory complex II, type F, electron transfer, mechanism, cryoelectron microscopy, structure, Mycobacterium smegmatis, Sdh1, presence, absence, substrate, ubiquinone-1, resolution, Sdh1, subunits, water, soluble, SdhA, SdhB, membrane, SdhC., subunits, identified, quinone-binding site, Rieske-type, cluster, embedded, transmembrane region, mutant, ligands, Rieske-type, alanine, quinone, activity, Sdh1, structures, proposal, electron transfer pathway, substrate-binding, quinone-binding sites, features, Sdh1, Mycobacteria, structures, antituberculosis, drug discovery, target, complex]]\n",
      "[[Tuberculosis, pathogen, Mycobacterium tuberculosis, MTB, threat, global health, mechanisms, essential, MTB, genes, theoretical, drug exploitation, Gene mtsp17, essential, Mycobacterium genus, Mtsp17, structure, steroidogenic acute regulatory protein-related lipid transfer, START, family proteins, biological function, study, transcriptomes, Mycobacterium smegmatis, consequences, mtsp17 downregulation, gene expression, Suppression, mtsp17 gene, down-regulation, upregulation, protein-coding genes, Expression, desA1, gene, mycolic acid, synthesis, anti-SigF, MSMEG_0586, down-regulated, conditional, Mtsp17, knockout mutant, up-regulated, Mtsp17 over-expression strain, Trends, changes, Log2 fold change, conditional, Mtsp17, knockout strain, SigF, knockout strain, data, Mtsp17, activator, desA1, Mtsp17, regulates, SigF regulon, SigF, regulatory pathways, anti-SigF, MSMEG_0586, findings, Mtsp17, transcriptional regulation, molecular mechanisms, START, family proteins, node, regulatory network, mycobacteria]]\n",
      "[[Encapsulins, dye-decolorizing peroxidase (DyP)-type peroxidases, prokaryotes, cells, oxidative stress, interact, function, isolated, native, cargo-packaging, encapsulin, Mycobacterium smegmatis, high-resolution structure, cryogenic electron microscopy, cryo-EM, encapsulin, icosahedral shell, dodecameric DyP, cargo, dodecameric DyP, hexamers, axis, symmetry, stretches, interior, encapsulin, results, encapsulin shell, dodecameric DyP., potential, mechanism, removing, hydrogen peroxide, structural features, study, DyP, primary cargo protein, mycobacterial, encapsulins, potential, target, antituberculosis, drug discovery]]\n",
      "[[DNA gyrase, type II topoisomerase, negative, DNA, ATP, hydrolysis, effective, gyrase-targeted drugs, fluoroquinolones, FQs, gyrase, DNA-cleavage complex, transient, intermediate, supercoiling cycle, double-stranded DNA breaks, MfpA, protein, mycobacteria, gyrase, FQs, molecular mechanism, Mycobacterium smegmatis, MfpA, MsMfpA, inhibits, negative, supercoiling, M. smegmatis gyrase, Msgyrase, absence, FQs, presence, MsMfpA, decreases, FQ-induced, DNA cleavage, enzyme, drugs, MsMfpA, stimulates, ATPase, activity, Msgyrase, interacting, ATPase domain, MsGyrB47, X-ray crystallography, MsMfpA-MsGyrB47 complex, mutational analysis, MsMfpA, mimics, T, transported, DNA segment, data, molecular mechanism, MfpA, modulates, activity, gyrase, action, pentapeptide-repeat proteins]]\n",
      "[[HarryOW, Peeb, Mycobacterium smegmatis mc(2, Siphoviridae, temperate phages, base pairs, genome, length, HarryOW, A1 subcluster, Peeb, G1 subcluster, isolated, annotated, students, SUNY Old Westbury Science and Technology Entry Program]]\n",
      "[[Fluoroquinolones, FQs, antibiotics, treatment, drug-resistant tuberculosis, FQ-resistant, mutants, mutations, DNA gyrase, principal, resistance, pentapeptide proteins, low-level, FQ, resistance, Gram-negative bacteria, MfpA, pentapeptide repeat protein, mycobacterial chromosomes, adjacent, group, conserved genes, conservon, characterize, transcriptional regulation, mfpA gene, expression, ciprofloxacin, resistance, M. smegmatis, Reverse transcription PCR, mfpA gene, operon, conservon genes, transcriptional fusion, promoter, mfpEA, operon, promoter activity, growth conditions, expression, operon, increases, late growth, phases, pH, subinhibitory, concentrations, ciprofloxacin, cloning, mfpA gene, inducible vector, induced, expression, mfpA, increases, ciprofloxacin, Minimal, Inhibitory, Concentration, results, increased, expression, mfpA gene, mfpEA, operon, increases, ciprofloxacin, resistance, M. smegmatis]]\n",
      "[[Mannose-binding lectins, recognize, bind, complex, glycan, pathogens, potential, anti-viral, anti-bacterial agents, structure, lectin, archaeal, species, Mevo lectin, specificity, terminal, alpha1,2 linked manno-oligosaccharides, Mycobacterium tuberculosis, M. tuberculosis, mannosylated structures, lipoarabinomannan, ManLAM, surface, C-type lectins, entry, host cells, ManLAM, structure, mannose capping, terminal, recognition, innate immune cells, specificity, Mevo lectin, high-mannose type glycans, terminal, effect, M. tuberculosis, internalization, macrophages, ITC, studies, Mevo lectin, binding, manno-oligosaccharides, terminal, structures, affinity, ManLAM, binds, Mycobacterium smegmatis, M. smegmatis, MsmLAM, shorter, mannosyl, Crystal structure, Mevo lectin, complexed, Man7D1, revealed, multivalent, cross-linking, interaction, avidity-based high, affinity, ligands, manno-oligosaccharides, termini, Functional studies, M. tuberculosis, internalization, macrophage, impaired, binding, Mevo lectin, ManLAM, surface, M. tuberculosis, Selectivity, Mevo lectin, glycans, terminal, structures, compromise, internalization, M. tuberculosis, in vitro, potential, Mevo lectin, research tool, study, host-pathogen interactions]]\n",
      "[[Mycobacterium abscessus, opportunistic pathogen, human diseases, immunocompromised, patients, M. abscessus strains, rough morphotype, virulent, smooth morphotype, Morphotype switch, clinical infection, investigate, genes, colony, morphotype, switching, transposon mutagenesis, rough clinical strain, M. abscessus, morphotype switching mutant, smooth, mab_3083c::Tn, mutant, aggregative, ability, sliding motility, wild type strain, glycopeptidolipid, GPL, content, wild type, Complementation, mutant, functional, mab_3083c gene, morphotype, rough, mab_3083c, associated with, colony, morphology, M. abscessus, Bioinformatic analyses, mab_3083c, identity, amino acid sequence, well-characterized ribonuclease J, M. smegmatis, RNase JMsmeg), Complementation, mutant, RNase J gene, M. smegmatis, colony, morphology, smooth back, rough, results, Mab_3083c, homologue, RNase J, regulating, M. abscessus, colony, morphotype]]\n",
      "[[Comprehensive, drug susceptibility testing, DST, adequate, treatment regimens, patients, multidrug-resistant/rifampicin-resistant tuberculosis, MDR/RR-TB, investigated, next generation sequencing, NGS, analysis, Mycobacterium tuberculosis, complex, isolates, genes, drug resistance, design, effective, MDR/RR-TB, treatment regimens, NGS-based, genomic, DST, predictions, M. tuberculosis, complex, isolates, MDR/RR-TB, patients, admitted, TB, reference center, Germany, phenotypic, DST, results, Mycobacteria, MGIT, Standardized treatment algorithms, design, individualized, therapies, genomic, phenotypic, DST, results, discrepancies, evaluated, determination, minimum inhibitory drug concentrations, MIC, Sensititre MYCOTBI, UKMYC microtiter plates, patients, MDR/RR-TB, agreement, pairwise comparisons, genomic, phenotypic, DST, results, discordant, evaluated, presence, polymorphisms, drug resistance, predictions, drug susceptibility, phenotypically, MGIT, results, mutations, low, moderate, MIC, increase, drugs, combination therapies, genomic, DST, susceptible, pDST, NGS-based, genomic, DST, design, effective, MDR/RR-TB, treatment regimens]]\n",
      "[[second-line, drug resistance, multidrug resistant tuberculosis(MDR-TB), treatment, study, investigate, influence, microevolution, exogenous, reinfection, mixed-infection, second-line, drug resistance, two-year, MDR-TB, treatment, MDR-TB, patients, multi-centre prospective observational cohort study, years, treatment, completion, Whole genome sequencing, WGS, Mycobacterium tuberculosis, isolates, study, participants, treatment, study, microevolution, exogenous, reinfection, mixed-infection, development, second-line drug resistance, MDR-TB, patients, Mycobacterium tuberculosis, isolates, drug resistance, MDR-TB, treatment, criteria, drug-resistant, TB, WGS, data, isolates, patients, treatment, cases, second-line, drug resistance, exogenous, reinfection, drug resistance, microevolution, mixed-infections, drug-resistant, drug-susceptible, strains, multivariate analysis, TB, treatment[adjusted, confidence, disease, chest, type 2 diabetes mellitus, aHR4.00, risk factors, associated with, development, second-line, drug resistance, proportion, second-line, drug resistance, MDR-TB, treatment, exogenous, reinfection, urgency, infection control, health facilities, drug susceptibility testing, MDR-TB, treatment]]\n",
      "[[Conspectus\"Drug resistance, drugs, emergence, multi-drug resistance, accurate, diagnosis, regimens.\"Antimicrobial, resistance, AMR, health perils, century, global, increase, drug-resistant, strains, bacterial, pathogens, World Health Organization, WHO, priority, AMR, pathogens, Mycobacterium tuberculosis, Mtb, acid-fast bacillus, tuberculosis, TB, priority, pathogens, drug-resistant TB, DR-TB, deaths, AMR, years, funded collaborative efforts, researchers, academia, not-for-profit virtual, R&D, organizations, industry, continuous growth, TB, drug discovery, development, pipeline, accelerated, regulatory approval, bedaquiline, delamanid, treatment, DR-TB, availability, drug regimes, cure, rate, multi-drug-resistant TB, MDR-TB, XDR-TB, treatment regimens, regimens, administered, long duration, side effect profile, patient, adherence, acquisition, drug resistance, treatment failure, TB, drugs, novel, mechanism, actions, MoAs, regimens, drug resistance, TB, DR-TB, drugs, regimens, development, potential, treat, DR-TB, research, small molecule, targets, TB, global TB, drug discovery, development, pipeline, screening, small molecule, chemical libraries, phenotypic whole-cell, assays, hits, medicinal chemistry, optimization, deconvolution, MoA., identification, small molecule, chemotypes, active, Mtb, structure-activity relationships, SAR, MoA, chemical series, identified, whole-cell cross-screening, Mtb, MoA, deconvolution studies, pathway, lack, in vivo, efficacy, mouse model, TB, growth medium, phenotypic, screening, drug repositioning, DR-TB, section, preview, directions, inherent, drug pipeline, DR-TB]]\n",
      "[[Information, genetic, variability, drug resistant, isolates, Mycobacterium tuberculosis, transmission, dynamics, disease, TB, control strategies, multidrug-resistant, MDR, tuberculosis, cases, global burden, strains, expansion, development, drug-resistant, Mycobacterium tuberculosis, infections, characterized, India, study, investigate, genetic diversity, MDR, isolates, Mycobacterium tuberculosis, North India, Spacer oligonucleotide typing, spoligotyping, clinical, MDR, isolates, Mycobacterium tuberculosis, recovered, cases, pulmonary tuberculosis, North India, Spoligotyping, identified, spoligotype, patterns, Comparison, international, spoldb4 database, strains, strains, spoligotype, patterns, phylogeographic lineages, lineage 3, East African-Indian, predominant, lineage, lineage 2, East Asian, lineage 1, Indo-Oceanic, lineage 4, Euro American, CAS1_DEL, SITs, spoligotype, pattern, Beijing, SITs255, EAI3_IND, SITs, demographic, clinical characteristics, associated with, genotypic lineages, MDR-M.tuberculosis, isolates, recovered, pulmonary TB, patients, North India, study, genetic diversity, Mycobacterium tuberculosis, isolates, SIT141/CAS1_Del, SIT26/, Beijing, lineage, spoligotype, development, transmission, MDR-TB, North India, presence, spoligotype, patterns, MDR strains, epidemiological significance, strains, transmission, MDR-TB, community, robust, molecular tools]]\n",
      "[[study, rate, mutations, genes, first-line, antituberculous drugs, resistance, M. tuberculosis/canettii, isolated, Central Greece, study, period, rate, resistance, isoniazid, rifampicin, ethambutol, pyrazinamide, phenotypically resistant, isolates, isoniazid, ethambutol, pyrazinamide, rifampicin, susceptible, isolates, control group, tested, presence, mutations/alterations/polymorphisms, PCR, sequencing analysis, molecular typing, isolates, multispacer sequence typing, phenotypic resistance, mutations, detected, isolates, isoniazid, resistant, rifampicin, pyrazinamide, resistant, isoniazid-resistant strains, mutations, S315T, C-15T, isolates, E399, A162, W477STOP, S94A, G-48A, C-17T, L203, A196, S124, K367, novel, D74N, G691S, Ains-85, D171G, susceptible, strains, positive, mutation, pyrazinamide-resistant strains, mutations, S450L, S531L, L182W, uncommon, mutations, resistance, isoniazid, INH, diagnostic problem, routine, microbiological laboratory, commercial, methods, detection, mechanisms, resistance, S315T, C-15T, A-16G, T-8C, T-8A, detect, strains, regional, frequencies, mutations, associated with, resistance, first-line drugs, development, molecular-based diagnostic tests]]\n",
      "[[cure, TB, antituberculous, treatment, Mycobacterium tuberculosis, drug-susceptibility testing, DST, study, conventional, DST, Minsk, Belarus, TB, DR, high-burden country, extensive, geno-, phenotypic analyses, WHO TB, Supranational Reference Laboratory, Copenhagen, Denmark, TB/HIV, coinfected, patients, DST, results, treatment regimen, outcome, TB/HIV, coinfected, patients, Minsk, descriptive statistics, Results, results, Minsk, TB/HIV, patients, drug-sensitive TB, isoniazid monoresistant TB, multidrug-resistant, MDR, TB, preextensive drug-resistant, TB, drug-resistant, XDR, TB, first-line, drugs, rifampicin, isoniazid, DST, agreement, Minsk, Copenhagen, patients, second-line, anti-TB drugs, discrepancies, patients, disagreements, drug, patients, MDR-TB, Minsk, preXDR-TB, DST, results, Copenhagen, patients, anti-TB, treatment, rifampicin, isoniazid, pyrazinamide, ethambutol, patients, DST, average, DR-TB, patients, IQR, active drugs, months, IQR, treatment, adjustment, treatment duration, months, IQR, patients, DR-TB, treatment, months, patients, died, months, follow-up, concordance, rifampicin, isoniazid, DST, Minsk, Copenhagen laboratories, discrepancies, second-line drugs, patients, DR-TB, treatment, insufficient, relevant, adjustments, delayed, Minsk, Belarus, management, DR-TB, implementation, molecular DSTs, availability, second-line drugs, DR-TB, high-burden settings, individualized, treatment regimens, DST, patterns, patients, outcome, reduce, transmission, drug-resistant, Mycobacterium tuberculosis, strains]]\n",
      "[[Discordant, results, Mycobacterium tuberculosis, isolates, mutations, genotypic drug susceptibility testing, DST, gDST, phenotypic, DST, pDST, impact, RIF-resistant, RR, multidrug-resistant, TB, treatments, clinical guidelines, investigate, rpoB, mutations, M. tuberculosis, TB, treatment, outcomes, isolates, clinical RR, MDR-TB, cases, agar-based RIF, pDST, rpoB gene sequencing, MICs, isolates, rpoB, mutations, rpoB, mutations, identified, M. tuberculosis, isolates, phenotypic, RIF-, rifabutin, isolates, L533P, L511P, isolates, L511P, H526N, D516Y, L533P, mutations, MICs, isolates, H526L, MICs, cases, treatment outcomes, cases, died, case, cases, favorable outcomes, cases, treated with, standard-dose RIF-, RFB-containing, regimens, cases, treatment, statistically significant, active, inactive, fluoroquinolones, FQs, Odds ratio, confidence intervals, cases, rpoB, mutations, resources, sequencing, MIC testing, management, RR, MDR-TB, cases]]\n",
      "[[OBJECTIVE, study, evaluated, MICs, MBCs, ZnONPs, MgONPs, MgONPs-ZnONPs, H37Rv Mtb, MDR-Mtb, Mixture, magnesium oxide, nanoparticles, NPs, zinc oxide, MgONPs-ZnONPs, microplate alamar blue (MABA) assay, proportion method, evaluate, anti-tubercular activity, MDR-MTB, MTT test, MgONPs-ZnONPs, Vero, HepG2, cell lines, MIC, MgONPs, ZnONPs, H37Rv Mtb, MgONPs-ZnONPs, inhibit, Mtb, MIC, MgONPs, concentrations, MDR-Mtb, MIC, MgONPs/ZnONPs, concentrations, MDR-Mtb, MBC, ZnONPs, increased, concentrations, MDR-Mtb, Testing, MBCs, MgONPs/ZnONPs, concentrations, MDR-Mtb, IC50, MDR-TB, ZnONPs, MgONPs-ZnONPs, MgONPs-ZnONPs, toxic, Vero cell lines, ZnONPs, inhibit, Vero, HepG2, cell lines, ZnONPs, MgONPs-ZnONPs, bactericide, behavior, synergistic effects, MDR-TB]]\n",
      "[[OBJECTIVE, report, investigated, rates, coinfections, high-rik human papillomavirus, hrHPV, human, mycoplasmas, Mycoplasma hominis, M. genitalium, Ureaplasma urealyticum, U. parvum, cervical samples, asymptomatic, population, women, aged, years, screened, Papanicolaou, smears, cervical abnormalities, single-target, polymerase chain reaction, PCR, real-time PCR, rt-PCR, hrHPV, mycoplasmas, women, negative, intraepithelial lesions, malignancy cytology, NILM, abnormal, cytology, low-grade, LSIL, prevalence, hrHPV, mycoplasmas, U. parvum, bacteria, detected, Mycoplasma hominis, U. urealyticum, M. genitalium, detected, Women, positive, U. parvum, increased, risk, LSIL, OR, CI, co-infections, U. parvum, hrHPV, increased, risk, LSIL, OR, CI, associations, concentration, bacteria, results, hypothesis, mycoplasmas, cofactors, HPV-mediated, cervical carcinogenesis, populations.<br]]\n",
      "[[Natural killer (NK) cell therapy, treatment, malignancies, Osaki method, ex-vivo, autologous, NK cell, expansion, Japan, clinical trial, Shiraz University of Medical Sciences, collaboration, Japanese, group, preclinical setting study, evaluate, proliferative, efficacy, method, activation status, autologous, NK cells, contamination, cell product, Peripheral blood mononuclear cells, PBMCs, isolated, healthy, individuals, peripheral blood, transferred, culture, anti-CD52, anti-CD3, Interleukin (IL)-2, cells, cultured, days, incubator, cells, condition, passages, culture bags, procedures, cleanroom, associated facilities, activation, PBMCs, analyzed, phenotype, cytotoxic activity, flow cytometry, cytokine release, assay, results, NK, average, purity, NK cells, lymphocytes, cells, lytic, in-vitro, cytotoxic assay, expression, Natural killer group 2 member D, NKG2D, CD16, cell products, negative, HCV, HBV, HIV, mycoplasma, endotoxin, preclinical phase, activated, un-contaminated, NK cells, healthy, individuals, peripheral blood, method, clean cell, contamination, potential, NK cell therapy, clinical trials, infused, donors, phase I, clinical trial]]\n",
      "NaN\n",
      "[[porcine, respiratory disease, clinical condition, treatment-resistant respiratory disease, finishing, pigs, multifactorial, etiology, infectious, non-infectious factors, management, hygiene conditions, viral, bacterial, pathogens, development, course, PRDC, porcine reproductive, respiratory syndrome virus, PRRSV, porcine circovirus type 2, PCV2, influenza A virus, IAV, Mycoplasma, hyopneunoniae, pathogens, PRDC, clinical outcome, necropsy findings, involvement, pathogens, complex, nature, PRDC, impedes, diagnostic, preventive measures, affected, farms, review, pathomorphology, pathogenesis, inter-pathogen-interactions, practitioners, implementing, diagnostic, preventive measures]]\n",
      "[[Mycoplasma hyorhinis, mycoplasma, animals, swines, associated with, invasive infections, humans, human, case, mycotic infrarenal aortic aneurysm, M. hyorhinis, diagnosed, 16S rDNA sequencing, infrequent, case, micro-organism, culture negative, endovascular infections]]\n",
      "NaN\n",
      "[[Mycoplasma mycoides subsp., causative organism, Contagious Bovine Pleuropneumonia, CBPP, trans-boundary disease, endemic, Nigeria, financial loss, country's economy, study, isolate, confirm, presence, M. mycoides subsp., Mmm, cattle, South-Eastern states, Nigeria, Method, bovine, samples, pleural fluids, lung tissues, CBPP, abattoirs, South-eastern states, Nigeria, Anambra, Enugu, Imo, isolation, Mmm, cultural method, confirmation, polymerase chain reaction, PCR, samples, cultured, Pleuropneumonia, organism, protocols, samples, lungs, pleural fluid, positive, Mmm, PPLO agar, isolation, rate, isolates, PCR, PCR amplification, isolates, product, Mmm, isolates, Imo state, study, presence, Mmm, causative organism, CBPP, Southeast Nigeria, active, surveillance, vaccination protocol, region, control, prevention, disease]]\n",
      "[[Mycoplasma pneumoniae, Mp, human, community-acquired pneumonia, investigate, pathogenesis, infection, gerbils, intranasally, inoculated, Mp culture, animals, sterile mycoplasma broth, animals, euthanized, weeks, post infection, morphological, immunohistochemical study, animals, cellular populations, lung parenchyma, Polyclonal, monoclonal antibodies, detect, antigens, Mp, CD3, CD4, CD8, CD79, lymphocytes, cells, S100, major histocompatibility complex class II, MHC-II, antigens, progressive, infiltration, mononuclear cells, lamina propria, bronchi, bronchioles, hyperplasia, bronchus-associated lymphoid tissue, BALT, infected, animals, BALT, dendritic cells, immunopositive, S100, MHC-II, numerous, CD3, CD4, CD79, lymphocytes, immunohistochemical, T lymphocytes, CD4, CD79 cells, immune response, gerbils, Mp, experimental model, investigation, pathogenesis, Mp infection, development, therapeutic strategies]]\n",
      "[[smoking, infection, impact, pregnancy, group, identified, rodent, model, nicotine, increased, risk, fetal infection, gestation, GD, investigate, nicotine, doses, Pregnant Sprague-Dawley, rats, nicotine, infusion, low-, dose, nicotine, GD, intravenous inoculation, Mycoplasma pulmonis, MP, CFU, sterile broth, sham, GD, Uterus, fetuses, GD, MP, culture, histopathologic, evaluation, maternal, fetal, MIR, FIR, nicotine, MP, colonization, rates, decreased, MP-inoculated dams, fetuses, nicotine, Low-dose, nicotine, increased, MIR, FIR, sham-inoculated group, MP-inoculated group, reduced, RR, placental, colonization, RR, CI, MIR, FIR, nicotine, treatment, colonization, rates, FIR, suppressed, face, placental, amniotic fluid, colonization, nicotine, dose, decreased, risk, intrauterine infection, increased, MIR, FIR, nicotine, dose, inhibited, FIR, increased, risk, intrauterine infection, Nicotine, alterations, intrauterine, environment, dose-dependent]]\n",
      "[[detection, pathogens, associated with, respiratory disease, reptiles, viruses, bacteria, fungi, parasites, pathogens, disease processes, pathogens, prevalence, captive reptiles, serpentoviruses, pythons, mycoplasma, tortoises, reptiles, respiratory disease, secondary, gram-negative bacteria, Detection methods, pathogens, associated with, upper-, lower-respiratory disease]]\n",
      "[[Mycoplasmas, fastidious, microorganisms, characterised, metabolism, genome, evidence, mycoplasmas, biofilms, differences, metabolism, organisms, growth states, systematic, metabolomics, planktonic, biofilm, mycoplasmas, study, metabolomics, mycoplasmas, clinical importance, Mycoplasma pneumoniae, Mycoplasma fermentans, nuclear magnetic resonance spectroscopy, principle component analysis, Characterisation, metabolic, changes, generation, high-density metabolite, data, diffusion-ordered spectroscopy, size, structural, information, molecules, examination, discrimination, biofilms, planktonic states, metabolomic profiles, organisms, biofilm/planktonic differences, metabolite, composition, clinical, mycoplasmas, outcomes, baseline, changes, metabolism, observed, pathogens, growth states, organisms, exploiting, persisting, niches, survival, clinical setting]]\n",
      "[[etiology, prostate cancer, PCa, multiple, complex, chronic infections, microorganisms, illustration, case, infection, mollicutes, bacteria, urogenital mollicutes, incriminated, PCa, study, attempt, presence, mollicutes, PCR, biopsies, PCa, patients, evaluate, prevalence, Formalin-Fixed Paraffin-Embedded prostate tissues, patients, suffering, PCa, benign prostate hyperplasia, PCR amplification, targeting, species-specific genes, urogenital mollicutes, species, Mycoplasma genitalium, M. hominis, M. fermentans, Ureaplasma parvum, U. urealyticum, PCR products, sequenced, species, identification, significance, statistically assessed, Chi-square, Odds ratio tests, PCR amplification, results, M. genitalium, M. hominis, M. fermentans, tested, patients, Ureaplasma spp, detected, PCa, patients, Nucleotide sequencing, identified, ureaplasma species, individuals, U. parvum, U. urealyticum, co-infection, cases, Association, ureaplasma species, PCa, cases, statistically significant, risk factor, Ureaplasma spp, identified, patients, aged, prostatic, PSA, level, invasive, malignant prostate tumor, Gleason score, study, association, Ureaplasma spp, PCa, potential, involvement, condition, finding, investigation]]\n",
      "[[Context, Inflammation, mechanism, physiological, pathological rupture, fetal membranes, characterization, inflammasome-dependent, inflammation, processes, tissues, nucleotide-binding oligomerization domain (NOD)-like receptor, pyrin domain, protein 7, NLRP7, inflammasome, presence, NLRP7, inflammasome actors, NLRP7, apoptosis-associated speck-like protein, CARD domain, ASC, caspase-1, reverse transcriptase-polymerase chain reaction, RT-PCR, human, amnion, choriodecidua, trimesters, protein, concentrations, enzyme-linked immunosorbent assay, tissues, labor, presence, Mycoplasma salivarium, Mycoplasma fermentans, human, investigated, PCR, Human, AECs, treated, fibroblast-stimulating lipopeptide-1, FSL-1, M. salivarium-derived ligand, Transcripts, proteins, quantity, measured, RT-quantitative PCR, Western blotting, NLRP7, ASC, colocalization, immunofluorescence, Western blots, analysis, pro-caspase-1, gasdermin D, cleavage, NLRP7, ASC, caspase-1, transcripts, expressed, sheets, human, pregnancy stages, ASC, expression, increased, labor, M. salivarium, M. fermentans, detected, human, NLRP7, caspase-1, transcripts, NLRP7, ASC, pro-caspase-1 protein, levels, increased, FSL-1-treated AECs, NLRP7, inflammasome, assembled, nucleus, pro-caspase-1, gasdermin D, cleaved, mature, FSL-1, stimulation, mycoplasmas, M. salivarium, M. fermentans, identified, human, lipopeptide, M. salivarium, induce, NLRP7, inflammasome formation, AECs]]\n",
      "[[studies, association, Mycoplasma fermentans, M. fermentans, risk, human immunodeficiency virus 1, HIV-1, infection, results, inconsistent, study, systematically review, studies, M. fermentans, association, HIV-1, infection, findings, meta-analysis, Studies, inclusion criteria, PubMed, Embase, China, National Knowledge Infrastructure, WanFang Data, Chongqing, VIP, databases, identified, Cochran Q and I statistics, heterogeneity, pooled, OR, confidence intervals, CI, calculated, Forest plots, funnel plot, Begg test, Egger test, evaluate, publication, bias, source, heterogeneity, investigated, subgroup, sensitivity analyses, studies, HIV-1-positive, patients, controls, meta-analysis, results, M. fermentans, increase, risk, HIV-1, infection, humans, OR, Subgroup, analysis, risk, HIV-1, infection, associated with, M. fermentans, geographical distribution, Europe, United States, Asia, source, sample, blood samples, urine samples, detection method, polymerase chain reaction method, detection methods, source, controls, sexually transmitted, diseases, individuals, health, individuals, study, evidence, association, M. fermentans, HIV-1, infection, heterogeneity, studies, relationship, M. fermentans, HIV-1, infection]]\n",
      "[[Contamination, cell cultures, mycoplasmas, phenomenon, cell metabolism, spread, cell cultures, laboratory, early detection, fastest, methods, mycoplasma, detection, staining, mycoplasmas', DNA, DAPI, Hoechst dyes, method, low, signal, dyes, compared, nuclear DNA, reporter cell lines, cultivation, mycoplasmas, DAPI, Hoechst staining, study, tested, immunofluorescence assay, detection, mycoplasmas, method, enzymatic labeling, DNA polymerase I, modified, nucleotides, nicks, mycoplasmas' DNA, Modified nucleotides, mycoplasmas', DNA, visualized, immunofluorescence microscopy, mycoplasma strain, stain, nuclear DNA, stain, bacteria, sensitivity, labeling, DAPI, Hoechst dyes]]\n",
      "[[multidrug-resistant cells, overexpressed, drug-resistance transporters, collaterally sensitive, tiopronin, follow-up studies, sensitivity, tiopronin, study, infection, cells, human-specific strain, mycoplasma, results, mycoplasma infection, stored, samples, cells, in vitro studies]]\n",
      "[[Mollicutes, class, cell wall, lacking, bacteria, membrane, parasites, opportunistic bacteria, study, morphological, species, bacterial, Mollicutes, microcolonies, (MCs).Methodology, MCs, characterized, bacteriological, immunological methods, microscopy, Results, colonies, TCs, MCs, characterized, propeller-shaped, rod-like cells, packed, parallel rows, colonies, cultivated cultures, type strains, days, post-plating, Rod-like cells, visualized, scanning electron microscope, TCs, appearance, MCs, TCs, MCs, resistant, antibiotics, treatments, effective, TCs, MC, cultures, in vitro, treatment, Mycoplasma cultures, hyperimmune serum, antibiotics, argon, non-thermal, MCs, Mycoplasma hominis strain, characterized, species, MCs, tested, positive, PCR, M. hominis-specific primers, fluorescence, epifluorescence tests, Western blotting, camel-derived, nanobody aMh-FcG2a, MH3620 transporter protein, MCs, bacteriological tests, MC, cultures, isolated, clinical samples, serum, synovial liquid, urine, patients, flammatory, urogenital tract diseases, asthma, arthritis, MC, cultures, isolated, clinical samples, M. hominis, Mycoplasma pneumoniae, Mycoplasma fermentans, Mycoplasma spp., (n=5).Conclusion, MCs, infection, pathology, antibiotic resistance, studies, Mollicutes]]\n",
      "[[isolated, strain, human, mycoplasma, promotes, lymphomagenesis, SCID, mice, p53-dependent, mechanism, lymphomagenesis, uninfected, p53(-/-) SCID mice, mycoplasma infection, in vitro, reduces, p53, activity, Immunoprecipitation, p53, mycoplasma-infected cells, mycoplasma proteins, DnaK, Hsp70, chaperon family, DnaK, interact, proteins, mycoplasma, DnaK, reduces, activities, human proteins, cellular pathways, DNA-PK, PARP1, efficient, DNA repair, binds, USP10, p53 regulator, impairing, p53-dependent, anticancer functions, reduced, efficacy, anticancer drugs, p53, effect, mycoplasma, detected, early, infected, mice, low, copy numbers, mycoplasma, DnaK DNA sequences, primary, secondary tumors, hit-and-run/hide, mechanism, transformation, Uninfected, bystander cells, exogenous, DnaK, paracrine function, malignant transformation, cells, infected, mycoplasma, Phylogenetic amino acid analysis, bacteria, associated with, human cancers, DnaKs, consistent with, mechanism, cellular transformation, disruption, DNA-repair, mechanisms, p53, dysregulation, results, cancer-drug resistance, oncogenic, properties, bacteria, DnaK-mediated]]\n",
      "[[Mycoplasma fermentans-derived, diacylated lipoprotein, MALP404, human/mouse toll-like receptor, TLR, Short proteolytic products, macrophage-activating lipopeptide 2, MALP2, antitumor, immune-enhancing, adjuvants, chemically synthesized, MALP2, MALP2s, S-[2,3-bis(palmitoyloxy)propyl]-CGNNDE, MALP2, MALP2s, natural killer, cell activation, in vitro, poorly, induce, tumor regression, in vivo, mouse, models, loading, NK-sensitive tumors, identified, functional, mechanism, MALP2s, dendritic cell, cytotoxic T lymphocyte, tumor, eradication, CTL-sensitive tumor-implant models, EG7, B16-OVA, Programmed death ligand-1, PD-L1, blockade therapy, combination, MALP2s + ovalbumin, OVA, additive effect, tumor growth, suppression, MALP2s, increased, co-stimulators, CD80/86, CD40, MyD88-dependent, participation, toll-IL-1R homology domain-containing adaptor molecule-1, type I interferon signaling, DC, priming, MALP2s, OVA, augmented, proliferation, OVA-specific CTLs, spleen, tumor sites, Chemokines, cytolytic factors, upregulated, tumor, duration, reinvigoration, CTLs, spleen, tumors, MALP2s, OVA, antibody, alpha-PD-L1 Ab, monotherapy, tumors, MALP2s/OVA combination, alpha-PD-L1 Ab, monotherapy, MALP2s/tumor-associated antigens, alpha-PD-L1 Ab, therapeutic strategy, mouse models, patients, resistant, PD-1/PD-L1, blockade, DC-priming, adjuvants, Cytokine, toxicity, MALP2s, settled, chemical modification, studies]]\n",
      "[[Mycoplasma hyopneumoniae, M. hyo, agent, porcine, enzootic pneumonia, disease, economic losses, swine industry, Induction, apoptosis, porcine, alveolar macrophages, pathogenic, mechanism, M. hyo, Cholesterol, influence, cell, adherence, cell invasion, Mycoplasma gallisepticum, Mycoplasma fermentans, apoptosis, cholesterol, apoptotic, activity, M. hyo, study, positive, correlation, cholesterol, level, M. hyo infection, porcine, serum, lung tissue, Cholesterol, exacerbated, M. hyo-induced, apoptosis, porcine, alveolar macrophages, PAMs, dosage-dependent, associated with, increased, hydrogen peroxide, H2O2, nitric oxide, NO, production, up-regulated, TNF-alpha, mRNA, expression, activated, caspase-3, pathogenicity-enhancing effect of, cholesterol, increased, M. hyo, proliferation, up-regulation, M. hyo genes, DNA, protein synthesis, improved, M. hyo, adherence, PAMs, increased, mRNA, expression, adhesin genes, cholesterol, promotes, apoptotic, effect, M. hyo, stimulating, proliferation, enhancing, adherence, PAMs, study, cholesterol, PAM, M. hyo, interations]]\n",
      "[[OBJECTIVE, study, investigate, prevalence, sexually transmitted infections, STIs, colonizing, bacteria, urogenital symptoms, cross-sectional study, patients, visiting, STI, clinic, Umea University Hospital, symptoms, condom use, Samples, patients, male, female, analyzed, STIs, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, colonizing, bacteria, Mycoplasma hominis, Ureaplasma parvum, Ureaplasma urealyticum, Chlamydia trachomatis, prevalence, women, men, Neisseria gonorrhoeae, prevalence, women, men, Mycoplasma genitalium, women, men, Asymptomatic, men, women, distribution, patterns, microorganisms, urogenital symptoms, Neisseria gonorrhoeae-, Mycoplasma genitalium-infected, men, symptoms, men, urogenital symptoms, test-negative, women, urogenital symptoms, test-negative, study, complex, picture, multi-positive tests, urogenital symptoms, microorganisms, test-negative, symptomatic, patients, pathogens]]\n",
      "[[BACKGROUND, PURPOSE, Lactobacilli, vagina, pathogens, Cytokines, defense, infections, women, genital mycoplasmas, Mycoplasma genitalium, Ureaplasma urealyticum, associated with, infectious diseases, adults, infants, study, differences, cytokine profile, Lactobacillus species, dominance, study group, non-pregnant, pre-menopausal, women, genital, M. genitalium, U. urealyticum, colonization, control group, non-pregnant, pre-menopausal, women, genital, M. genitalium, U. urealyticum, colonization, real-time polymerase chain reaction, measure, Lactobacillus species, vaginal swab, Cytokine analysis, multiplex immunoassay techniques, Analysis, variance, cytokine profiles, patient groups, t-tests, cytokines, Categorical data analysis, patterns, Lactobacillus species, dominance, study group, Lactobacillus iners, predominant, Lactobacillus species, control group, Lactobacillus species, observed, study group, Vascular endothelial growth factor A, interleukin-8, interleukin-1beta, expressed, study group, interleukin-1 receptor antagonist, interleukin-10, interleukin-12, interferon-gamma, expressed, control group, Association matrices, cytokines, groups, negative, associations, control group, positive, associations, study group, Cytokine, levels, associations, patterns, Lactobacillus species, dominance, diverge, M. genitalium, U. urealyticum, colonization, non-pregnant, pre-menopausal, women]]\n",
      "[[Mycoplasma genitalium, urethritis, men, associated with, cervicitis, pelvic inflammatory disease, adverse obstetric outcomes, women, cross-sectional study, prevalence, M. genitalium infection, rate, macrolide, resistance, M. genitalium, isolates, patients, visiting, Dutch sexually transmitted infection, STI, clinics, evaluate, recommendations, Dutch guidelines, revised, risk factors, M. genitalium, identified, patients, M. genitalium, prevalence, rates, patients, men, sex, men, men, sex, women, women, Macrolide, resistance-associated mutations, detected, patients, infected, M. genitalium, Age, educational level, country, origin, sexual partners, HIV-positivity, infection, Neisseria gonorrhoeae, urethral symptoms, men, associated with, M. genitalium infection, prevalence, rates, macrolide, resistance, rates, M. genitalium, patients, visiting, STI, clinics]]\n",
      "[[Mycoplasma genitalium, MG, sexually transmitted infection, STI, rate, antimicrobial resistance, guidelines, screening, asymptomatic, men, sex, men, MSM, mathematical model, MG, transmission, impact, screening, incidence, prevalence, MG, MSM, attending, sexual health clinic, compartmental, MG, transmission, MSM, calibrated, data, Melbourne, Sexual Health center, resistance-guided therapy, treatment, effectiveness, model, stratified, men, symptom status, sexual risk behaviours, MG, macrolide, resistance, simulated, impact, endemic, MG, prevalence, incidence, screening, scenarios, screening, MSM, symptomatic, MSM, recommendation, symptomatic, high-risk, asymptomatic, MSM, MSM, base case analysis, treatment, effectiveness, resistance-guided therapy, impact, treatment, effectiveness, proportion, detected, MG, cured, screening, coverage, testing, rate, MG, prevalence, Findings, model, endemic, MG, prevalence, CI, situation, screening, symptomatic, MSM, base-case, increase, confidence intervals, CI, MSM, screening, decrease, CI, symptomatic, high-risk, asymptomatic, MSM, screening, CI, MSM, screening, coverage, MSM, screening, effect, decreasing, endemic, MG, incidence, evaluating, simultaneous, impact, treatment, effectiveness, screening, coverage, screening, MSM, reduce, prevalence, proportion, macrolide-resistant MG, treatment regimens, effectiveness, Interpretation, treatment options, screening, MG, MSM, group, symptomatic, MSM, reduce, prevalence, incidence, MG, screening, coverage, impact, lower, treatment, effectiveness, resistance-guided therapy, increasing, selection, macrolide, resistance, negative, consequences related, AMR, management, psychological, morbidity, infections, treatment]]\n",
      "[[Mycoplasma genitalium, agent, sexually transmitted infections, associated with, urethritis, cervicitis, pelvic inflammatory disease, increase, macrolide-resistant, M. genitalium, first-line, treatment, world, regions, increase, fluoroquinolone-resistance, second-line, treatment, knowledge, local, epidemiology, detecting, resistances, treatment, study, prevalence, macrolide, fluoroquinolone-resistant, Mycoplasma genitalium, University Hospital of Tours, real-time PCR technique, Sanger sequencing, prevalence, macrolide, resistance, population, FQ, resistance-conferring mutations, study, evaluated, performance, commercial kit S-DiaMGRes((R)) (Diagenode Diagnostics, Belgium, detection, 23S rRNA, mutations, resistance, macrolides]]\n",
      "NaN\n",
      "[[OBJECTIVE, study, incidence, sexually-transmitted infection, STI, agents, university students, Participants, Milwaukee, Wisconsin metropolitan area, student, encounters, university health clinics, consent, participants, eight-item demographic, behavioral questionnaire, specimen, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium RNA testing, C. trachomatis, M. genitalium, detection, rates, highest, C. trachomatis, symptomatic, infection, males, females, Female, M. genitalium, detection, rates, function, symptomatic, status, Students, African American, test positive, M. genitalium, races/ethnicities, M. genitalium, detection, genders, function, reported, condom, usage, Students, benefit, familiarity, STI, agents, behaviors, associated with, increased, risk, STI]]\n",
      "[[Infertility, social, economic world, Genital mycoplasmas, Mycoplasma hominis, M. genitalium, associated with, adverse effects, men&amp;rsquo;s, fertility, study, prevalence, M. hominis, M. genitalium, semen samples, thenortheast, Iran, thiscross-sectional study, semen samples, infertile, men, Mashhad, Khorasan Razavi province, northeast, Iran, M. hominis, M. genitalium, detected, cultivation, polymerase chain reaction, PCR, Multiplex PCR assays, colony, mycoplasma, Diene&amp;rsquo;s stain, arginine, hydrolysis, glucose, urea, utilization, evaluated, semen indices, analyzed, World Health Organization guidelines, semen analysis, color, volume, appearance, liquefaction, viscosity, concentration, pH, leukocyte concentration, progressive, motility, morphological, normality, motile, sperm, concentration, functional, sperm, concentration, sperm motility index, functional, sperm, gene, 16SrRNA, MGSO primers, target, Mycoplasma genus, PCR assay, Multiplex-PCR, primer, conserved regions, 16SrRNA gene, M. hominis, RNAH1&amp;amp, RNAH2, primers, Adhesion, Protein Gene, M. genitalium, MG1 &amp;amp;, MG2 primers).According, results,9, samples, PCR-positive, Mycoplasma spp, cases, isolated, cultivation, M. hominis, detected, samples, Multiplex PCR, evidence, M. genitalium, age scores, infertile, infected, men, years, study, statistical correlation, mycoplasma infection, abnormal, semen, parameters, heterogeneity, mycoplasma, prevalence, reports, geographic areas, sensitivity, identification method, condition, group, fertile/infertile, sample size, operator proficiency, results, studies, relationship, mycoplasma infection, abnormal, semen, parameters]]\n",
      "[[OBJECTIVE, study, evaluate, detection, sexually transmitted infections, patients, sterile pyuria, prospective study, Real-time multiplex, qPCR, consecutive, urine samples, data, sterile pyuria, STI, prevalence, patient, epidemiological, analyzed, positive, cases, Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis, co-infections, group, sexually transmitted infections, women, pregnant, study, effective, screening system, detection, sexually transmitted infections, laboratories, routine]]\n",
      "NaN\n",
      "[[Mycoplasma hominis, MH, opportunistic pathogen, funisitis, spontaneous abortion, low birth weight, laboratory methods, labor-intensive, laboratory instruments, Recombinase polymerase amplification, technology, significance, clinical application, commercial value, studies, RPA, detect, MH, study, MH, detection, assay, sensitive, POCT, clinic, Primers, MH 16SrRNA gene, gap gene, screened, probe, RPA-LFD, optimal, primer, confirmed, reaction, conditions, temperature, time, RPA, optimized, sensitivity, specificity, analysis, clinical specimens, efficiency, methods, optimal, reaction, conditions, minutes, degrees, sensitivity, RPA, MH, sensitive, PCR, non-target, pathogens, amplification products, no significant, RPA, cultivation, methods, clinical specimens, method, sensitive, detection, MH, RPA, large-scale screening, methods]]\n",
      "[[study, estimate, prevalence, antimicrobial susceptibility, Ureaplasma urealyticum, Mycoplasma hominis, comprehensive, teaching hospital, Shenyang, China, years, individuals, urogenital symptoms, mycoplasma testing, Detection, identification, antimicrobial susceptibility testing, Mycoplasma ID/AST kits, total infection, rate, genital mycoplasmas, cases, increase, years, positive, rates, detected, infections, infection, rate, females, males, positive, rate, infection, females, aged, years, age group, changes, observed, age groups, females, statistically significantly, positive, rates, U. urealyticum, M. hominis, co-infection, seasons, survey, U. urealyticum, isolates, resistant, ciprofloxacin, M. hominis, isolates, resistant, erythromycin, roxithromycin, azithromycin, clarithromycin, Josamycin, doxycycline, minocycline, effective, U. urealyticum, M. hominis, Results, study, rates, U. urealyticum, M. hominis infection, years, younger, age groups, screening, younger age cohorts, preventing, spread, pathogens, Monitoring, antimicrobial resistance, preventing, transmission, resistant, strains, infection, management, antibiotics]]\n",
      "[[Severe, acute respiratory syndrome, SARS-CoV-2, global, pandemic, Coronavirus disease, COVID-19, microbial, composition, respiratory tract, infected, tissues, pathogenic, contributions, degrees, disease severity, COVID-19, patients, unclear, January, sputum, nasal, throat swab, anal swab, feces, cohort, hospitalized, COVID-19, patients, mildly, severely, patients, Guangdong province, China, Total RNA, extracted, ultra-deep metatranscriptomic sequencing, combination, laboratory diagnostic assays, signatures, microbial, dysbiosis, severely ill, COVID-19, patients, antimicrobial therapy, Co-detection, human, human alphaherpesvirus 1, rhinovirus B, human orthopneumovirus, severely ill, patients, mildly, affected, patients, predominant, respiratory, microbial, taxa, severely ill, patients, Burkholderia cepacia complex, BCC, Staphylococcus epidermidis, Mycoplasma spp., M. hominis, M. orale, presence, bacterial taxa, clinical cultures, respiratory specimens, expectorated sputum, nasal secretions, severe, cases, secondary infection, B. cenocepacia, expressions, multiple, virulence genes, severely, patient, disease deterioration, death, month, ICU admission, findings, SARS-CoV-2-related, microbial, dysbiosis, antibiotic-resistant, respiratory microbes/pathogens, hospitalized, COVID-19, patients, disease severity, Detection, tracking strategies, prevent, spread, antimicrobial resistance, improve, treatment regimen, clinical outcomes, hospitalized, severely ill, COVID-19, patients]]\n",
      "NaN\n",
      "NaN\n",
      "[[study, genetic diversity, Trichomonas vaginalis, T. vaginalis, isolates, microsatellite, markers, Turkey, web-based microsatellite typing, MT, global, interpretation, data, endosymbiosis, Mycoplasma hominis, M. hominis, T. vaginalis virus, TVV, isolates, allele, sizes, locus, calculated, microsatellite, allele, profiles, population structure, Bayesian clustering method, website, collection, microsatellite, data, Presence, TVV, M. hominis, T. vaginalis, isolates, investigated, electrophoresis, PCR, vaginal samples, T. vaginalis, detected, analysis, structure, clustering algorithm, genetic groups, typing, isolates, microsatellites, microsatellite, clones, isolates, MT10, MT18, MT3, frequency, TVV, M. hominis, Presence, clones, T. vaginalis, isolates, microsatellite-based genotyping, efficient, clonal, distribution, T. vaginalis, isolates, studies, molecular epidemiology, T. vaginalis, Microsatellite, data, studies, deposited, website, frequency, endosymbionts, T. vaginalis, isolates, Turkey]]\n",
      "[[resolution, crystal structure, Mycoplasma Penetrans ferritin, ferroxidase center, inner surface, ferritin, four-helix, subunit, ferroxidase center, iron oxidation, activity, ferritin, Fe(2+), center, B-channels, normal, channels, findings, structural bases, iron oxidation, mechanism, ferritin, relationship, structure, function, ferritin]]\n",
      "[[structural organization, functionality, aminoacyl-tRNA synthetases, polypeptide, additions, core aminoacylation domain, domain, methionyl-tRNA synthetase, MetRS, intracellular, pathogen, Mycoplasma penetrans, Sequence analysis, N-terminal region, aminotransferase, aminotransferase domain, MpMetRS, methionine, alpha-keto acid analog, 2-keto-4-methylthiobutyrate (KMTB, methionine, cognate, tRNA(Met), MpMetRS aminoacylation domain, Genomic erosion, Mycoplasma species, impaired, host, metabolites, bifunctional MetRS, pathogen life cycle, neutral, reductive, evolution, Mycoplasma species]]\n",
      "NaN\n",
      "[[Extracts, sample, brown propolis, district, Itapara, Southern Brazil, solvents, increasing, polarity, extracts, analyzed, RPHPLC-DAD-ESI-MS/MS, evaluated, activity, Mycoplasma bovis, M. gallisepticum, M. genitalium, M. hominis, M. hyorinis, M. penetrans, M. pneumonieae, components, alecrim-do-campo, propolis, prenylated phenylpropanoids, caffeoyl-quinic acids, characterized, analyzed, extraccts, flavonols, polar extracts, anti-mycoplasma activity, MIC value, alcoholic, aqueous, extracts, MIC value, results, Itapara propolis, development, therapeutic drugs]]\n",
      "[[Nongonococcal urethritis, NGU, syndrome, etiology, cases, associations, urethral bacteria, NGU, men, sex, men, MSM, men, sex, women, MSW, Urine, NGU, cases, MSM, MSW, controls, MSM, MSW, attending, Seattle, STD, clinic, Cases, polymorphonuclear, leukocytes, Gram stain plus, symptoms, discharge, controls, PMNs, no symptoms, no discharge, NGU, idiopathic, Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis, adenovirus, herpes simplex virus, absent, urethral microbiota, characterized, 16S rRNA, gene sequencing, Compositional lasso analysis, associations, bacterial taxa, NGU, bacteria, targeted quantitative PCR, qPCR, NGU, cases, idiopathic, compositional lasso analysis, Haemophilus influenzae, HI, Mycoplasma penetrans, MP, targeted, qPCR, men, NGU, men, NGU, HI, MP, p</=0.001, stratified analyses, detection, HI, associated with, NGU, MSM, MSW, MP, associated with, NGU, MSM, Associations, stronger, men, idiopathic NGU, HI, MP, male urethritis, MP, detected, MSM, MSW, urethritis]]\n",
      "[[Mycoplasma sp., etiological agents, respiratory, sexually transmitted disease, Mycoplasma penetrans, species, Mycoplasma sp., detected, HIV-positive, patients, associated with, progression, HIV-associated disease, case report, M. penetrans, causative agent, severe, respiratory tract infection, HIV-negative, patient, CASE PRESENTATION, report, case, M. penetrans, bacteremia, HIV-negative, female, immunocompromised, solid organ transplant, patient, combined kidney, pancreas transplantation, admitted, hospital, anemic uterine bleeding, fever, degrees, admission, university hospital, latex, catheter, uterus, fatigue, dizziness, ongoing, vaginal bleeding, Laboratory examination, severe, anemia, microbiological examination, inconspicuous, culture negative, vaginal, cervical smears, negative, urine culture, Bacterial blood cultures, growth signal, microscopic examination, Gram staining, subcultures, agar, media, bacterial, pathogens, bacterial, malignancy, patient, metagenomic sequencing, blood culture, identified, M. penetrans, Metagenomic sequencing, M. penetrans, immunosuppressed, patient, culture-negative bacteremia, Clinicians, opportunistic, potential, M. penetrans, severe, infections, vulnerable, patient populations, limitations, culture, Gram staining, presence, fastidious, bacterial, pathogens, Mycoplasma spp.]]\n",
      "[[Arginine deiminase, ADI, arginine catabolizing, enzyme, anti-tumor agent, treatment, arginine, auxotrophic cancers, obstacles, clinical applications, review, clinical applications, ADI, brief history, limitations, clinical limitations, structure analysis, cloning, expression, protein engineering, applications, arginine deiminase, enzyme, review, patents, ADI, ADI, engineering, increase, efficacy, clinical application, intracellular, delivery, ADI, combination therapy, strategies, treatment, arginine, auxotrophic cancers, ADIs, optimum, features, sources, ADI, engineering, improve, clinical application, ADI]]\n",
      "[[prokaryotic DNA, C5-MTases, M.MpeI, M.SssI, specificity, eukaryotic, C5-MTases, 5'-CG, research tools, study, eukaryotic DNA, epigenetic regulation, improve, stability, solubility, fragments, MTases, genes, encoding, circularly permuted, CP, variants, M.MpeI, M.SssI, cloned, plasmid, vector, downstream, arabinose-inducible promoter, MTase activity, CP, variants, tested, digestion, plasmids, methylation-sensitive restriction enzymes, M.MpeI permutants, M.SssI permutants, detectable, MTase activity, partial, protection, plasmid, cpMTase gene, Permutants, cp58M.SssI, N-termini, conserved motifs II, III, activity, activity, cp62M.MpeI, activity, wild-type, M.MpeI., location, split sites, permutants, MTase activity, permutation sites, conserved motifs, MTase activity, permutants, measured, cell extracts, cases, wild-type, enzyme, proportion, circular permutation topologies, MTase activity, evidence, structural, plasticity, C5-MTases, computer search, REBASE, database, C5-MTases, CP, arrangement, natural circularly permuted, C5-MTases, permutation topology]]\n",
      "[[Intestinal neoplasms, zebrafish, Danio rerio, research facilities, tumours, older fish, small cell carcinomas, adenocarcinomas, Affected, fish, populations, subpopulations, preneoplastic, lesions, characterized, epithelial hyperplasia, inflammation, observations, tumours, diet, water quality, genetic background, infectious aetiology, transmission, experiments, exposure of, naive fish, affected, donor fish, cohabitation, exposure to, tank effluent water, Intestinal lesions, recipient fish, exposure groups, transmissions, recipient fish, moribund fish, prevalence, neoplasms, 16S rRNA, sequence, Mycoplasma penetrans, donors, exposed, recipients, unexposed control fish, presence, Mycoplasma sp., targeted PCR test, individual, dissected, intestines, faeces, tank faeces, Original donor, exposed fish, populations, positive, Mycoplasma, unexposed control fish, negative, study, infectious aetiology, transmissible tumours, zebrafish, agent, Mycoplasma species]]\n",
      "[[variation, Mycoplasma lipoproteins, genome rearrangements, genetic insertions, phenotypic, plasticity, evasion, host's, defence system, pathogenesis, genomes, human, Mycoplasma species, M. penetrans, HF-2, M. fermentans JER, M. genitalium G37, M. hominis PG21, metabolic, functions, core genes, assess, effects of, tandem repeats, phage-like genetic elements, prophages, virulence genes, results, comparative, in silico, genomic analysis, genes, core genomes, categories, nuclear metabolism, protein metabolism, energy generation, genomes, M. hominis PG21, M. fermentans JER, Tandem repeats, minisatellites, phage-like proteins, DNA gyrases/topoisomerases, Mycoplasma genomes, identified, coiled-coil structure, protein, M. penetrans, HF-2, Mem protein, M. fermentans, MFV1, Mycoplasma prophage, M. penetrans, HF-2, unannotated, genome, knowledge, Mycoplasma phages, prophages, detected, M. penetrans, study, complex, genetic factors, phenotypic, plasticity, virulence, Mycoplasma species, effective, arrangement, minimal, genomes]]\n",
      "[[Pseudomembranous laryngotracheobronchitis, life-threatening, infectious, airway obstruction, children, causative organisms, condition, bacterial superinfection, viral infection, case, pseudomembranous laryngotracheobronchitis, patient, human bocavirus 1, Mycoplasma pneumoniae, M. pneumoniae, child, admitted, hospital, cough, hoarseness, labored breathing, Computed tomography, chest, atelectasis, right middle lobe, lung, bronchostenosis, occlusion, Laryngeal edema, pseudomembrane formation, ulceration, trachea, bronchoscopy, Chronic inflammation, mucosa, local, acute, chronic inflammatory cell, hematoxylin-eosin staining, Human bocavirus 1, M. pneumoniae, detected, bronchoalveolar lavage fluid, next-generation sequencing, patient, positive, IgM antibodies, M. pneumoniae, Bronchoscopy, secretions, airway, azithromycin, ceftriaxone, methylprednisolone, budesonide inhalation, ambroxol, administered, treatment, patient's, condition, improved, days, admission, Clinicians, potential, involvement, human bocavirus 1, M. pneumoniae, pseudomembranous laryngotracheobronchitis, accurate, diagnosis, antibiotic administration, mortality, morbidity, rates]]\n",
      "[[Mycoplasma pneumoniae, community-acquired pneumonia, associated with, dermatological manifestations, mucosal, involvement, targetoid cutaneous, lesions, years, spectrum, erythema multiforme, authors, creation, syndrome, mycoplasma-induced rash, mucositis, syndrome, epidemiological, clinical, histological, features, drug-induced, Stevens-Johnson syndrome, toxic epidermal necrosis, erythema multiforme, patients, acute Mycoplasma pneumoniae, respiratory tract, severe, mucocutaneous, lesions, syndrome]]\n",
      "[[boy, emergency department, paediatric hospital, non-painful lesions, lips, inside, mouth, associated with, lip swelling, examination, oral mucosa, lips, blisters, yellowish, serofibrinous, content, lip oedema, eye examination, bilateral, Genitalia, skin lesions, day, clarithromycin, prescribed, atypical, pneumonia, Mycoplasma pneumoniae, patient, diagnosed, M. pneumoniae-associated mucositis, topical, treatment, fusidic acid, betamethasone, improvement, oral lesions]]\n",
      "[[secretory function, airway, epithelial cells, pathogenesis, Mycoplasma pneumoniae pneumonia, MPP, investigate, regulatory function, NKILA, nuclear factor-kappaB (NF-kappaB, interacting, long noncoding RNA, lncRNA, MPP, detected, NKILA, concentration, interleukin 8, IL-8, tumor necrosis factor-alpha, TNF-alpha, bronchoalveolar lavage fluid, children, MPP, NKILA, knocked down, epithelial cells, investigate, effect, secretory function, results, NKILA, downregulated, children, MPP, IL-8, TNF-alpha, levels, increased, Knockdown, NKILA, in vitro, promoted, inflammatory, effects, Mycoplasma pneumoniae, MP, epithelial A549, BEAS-2B cells, Knockdown, NKILA, inhibitor, kappaBalpha, IkappaBalpha, phosphorylation, degradation, NF-kappaB p65, nuclear translocation, RNA immunoprecipitation, NKILA, physically, bind, IkappaBalpha, MP-treated, A549 cells, data, attenuation, NKILA, enhances, effects, MP-stimulated secretory functions, epithelial cells, regulation, NF-kappaB signaling]]\n",
      "[[Factors, manifestations, associated with, Mycoplasma pneumoniae, unclear, investigated, Mp, genotypes, associated with, clinical outcomes, Mp, loads, genotypes, children, mucocutaneous disease, pneumonia, family members, upper respiratory tract infection, URTI, carriers, prospective cohort study, children, mucocutaneous disease, case series, Genotyping, macrolide, resistance, determination, P1 subtyping, multilocus variable-number tandem-repeat analysis, MLVA, multilocus sequence typing, MLST, Comparisons, pairwise Wilcoxon rank sum test, Fisher exact test, corrections, multiple testing, Mp, loads, patients, mucocutaneous disease, pneumonia, carriers, Macrolide, resistance, detected, patient, mucocutaneous disease, MLVA, correlated, P1, subtypes, MLST, MLVA, associated with, outcomes, mucocutaneous disease, pneumonia, URTI, carriage, identical, families, geographic, location, MLVA, patients, mucocutaneous disease, (P=0.02).Conclusions, results, Mp, genotypes, clinical outcomes]]\n",
      "[[coronavirus disease, COVID-19, epidemic, spread, incidence, children, study, evaluate, clinical characteristics, outcomes, children, infected, COVID-19, clinical work, study, retrospectively, reviewed, clinical characteristics, prognosis, children, diagnosed, COVID-19, infection, First People's Hospital, Jingzhou, cases, male, female, aged, months, days, years, asymptomatic, carrier, cases, mild type infection, symptoms, cough, fever, case, moderate, type, cases, serum white blood cell count, increased, case, decreased, case, liver transaminase, increased, case, lactate dehydrogenase, increased, cases, creatine kinase MB, CK-MB, increased, cases, C-reactive protein, elevated, cases, cases, mycoplasma pneumoniae, influenza B virus infection, chest computed tomography, CT, viral pneumonia, routine, antiviral, symptomatic, support therapy, median time, results, nucleic acid testing, pharyngeal swab, negative, days, days, median hospital stay, days, days, participants, cured, discharged, hospital, case, positive, nucleic acid testing, pharyngeal swab 1, month, discharged, anal swab, case, nucleic acid testing, positive 2, months, discharged, children, COVID-19, study, Jingzhou, infected, family clustering, laboratory examinations, Fever, cough, symptoms, cases, mild, prognoses]]\n",
      "[[researchers, microbiota, lower, infection, association, LRT, microbiome, refractory, M. pneumoniae pneumonia, RMPP, children, diagnosed, RMPP, non-refractory, M. pneumoniae pneumonia, NRMPP, characterized, structure, function, microbiota, bronchoalveolar lavage fluid, BALF, metagenomic, next generation sequencing, mNGS, Results, Bray-Curtis distance, samples, samples, RMPP, group, homogeneous, Shannon index, RMPP, group, NRMPP, group, Simpson index, degree, dominance, RMPP, group, dominant, taxon, abundance, Mycoplasma, RMPP, NRMPP, patients, proportions, taxonomic, distribution, M. pneumoniae, dominant, species, occupied, niches, RMPP, patients, genera, NRMPP, group, antibiotic resistance genes, ARGs, RMPP, group, abundance, macrolide antibiotics, macB, fluoroquinolone, antibiotic resistance genes, M. pneumoniae, genome, RMPP, patients, abundance, Streptococcus pneumoniae, correlation, increased, hospitalization, days, abundance, Streptococcus pneumoniae, negative, correlation, hospitalization, days, NRMPP, patients, microbiota, LRT, children, RMPP, homogeneous, NRMPP, group, abundance, macrolide, resistance gene, M. pneumoniae, genome, M. pneumoniae, dominant, RMPP, patients, Prolonged, hospitalization, days, associated with, abundance, M. pneumoniae, NRMPP, patients, pathogens, abundance, Streptococcus pneumoniae, RMPP, patients]]\n",
      "[[Mycoplasma pneumoniae, pathogen, community-acquired pneumonia, humans, rates, antibiotic resistance, vaccination, method, control, dissemination, M. pneumoniae, recombinant carboxyl terminus, immunodominant antigen, negative, effects, poor stability, lower, purity, study, T-B epitopes, P1C protein, bioinformatics, analysis, assessed, efficacy, peptide, vaccination, BALB/c mice, subcutaneously, inoculated, T-B epitope, infected, M. pneumoniae, respiratory tract, results, T-B epitope, P1C protein, P1C103, P1C155-169, P1C224, induced, antigen-specific serum antibody, responses, cellular immune responses, levels, serum IgG, IgA antibodies, Th1-biased, IFN-gamma, IL-2, cytokines, Immunization, T-B epitope peptides, reduced, M. pneumoniae, burden, degree, inflammation, mice, levels, IFN-gamma, TNF-alpha, supernatants, lung homogenates, observably, reduced, PBS, group, findings, T-B epitopes, P1C103, P1C155-169, P1C224, P1C protein, induce, humoral, cellular immune responses, protection, M. pneumoniae, pulmonary infection, design, potential, multiepitope, vaccines, prevent, host, infection, M. pneumoniae]]\n",
      "[[Neisseria meningitidis, bacterial meningitidis, worldwide, Children, years, adolescents, affected, invasive, strains, surrounded, polysaccharide capsule, N. meningitidis serogroups, differentiated, A, B, X, Y, infections, humans, Mono-, vaccines, meningococcal infections, licensed, clinical development, overview, approaches, meningococcal, vaccines]]\n",
      "[[Penicillin, ciprofloxacin, invasive, IMD, management, prevention, IMD, cases, ciprofloxacin-resistant Neisseria meningitidis, ROB-1 beta-lactamase gene, blaROB-1, mutated DNA gyrase gene, gyrA, USA, meningococcal genomes, US, population-based surveillance, IMD, cases, strains, blaROB-1, gyrA-mediated resistance, Antimicrobial resistance, phenotypically, US, isolate, genomes, isolate, genomes, blaROB-1, Interspecies, ciprofloxacin, resistance, assessed, gyrA, Neisseria species, ciprofloxacin-resistant, isolates, identified, serogroup Y, sequence type, clonal complex, CC, blaROB-1, T91I-containing gyrA allele, penicillin-resistant, US, isolates, wild-type, gyrA, isolates, isolates, countries, blaROB-1-containing US, isolates, Hispanic, individuals, ciprofloxacin-resistant, isolates, gyrA, T91 mutations, identified, Ciprofloxacin-resistant isolates, CCs, gyrA, alleles, identical, alleles, N. lactamica, N. gonorrhoeae, IMD, cases, resistant, antimicrobial resistance, patterns, USA, dual-resistance, acquisition, ciprofloxacin, resistance, beta-lactamase-containing N. meningitidis, antimicrobial resistance, surveillance, resistance, changes, spread]]\n",
      "[[Neisseria meningitidis, N. meningitidis, urogenital infections, meningococcal urethritis, Thailand, Thai, male, sexual health clinic, dysuria, urethral discharge, oral, insertive anal intercourse, N. meningitidis, serogroup C, cultured, urethral discharge specimen, patient, treated, standard treatment, gonococcal urethritis, case, reports, meningococcal urethritis, sexual contact]]\n",
      "[[systematic reviews, benefits, harms, screening, compared, screening, alternative, Chlamydia trachomatis, CT, Neisseria gonorrhoeae, NG, non-pregnant, sexually active, individuals, patients, relevant, outcomes, Findings, recommendations, Canadian Task Force on Preventive Health Care, databases, trial registries, conference proceedings, reference lists, English, French literature, Screening, study selection, risk, bias, assessments, reviewers, consensus, decisions, Data extraction, reviewer, accuracy, completeness, Meta-analysis, appropriate, GRADE, rate, certainty, evidence, Task Force, content, experts, thresholds, effect sizes, interpretation, findings, studies, benefits, harms, screening, patient, preferences, Universal screening, CT, general populations, years, age, population-based, opportunistic approaches, low, screening, female's, risk, pelvic inflammatory disease, PID, RCTs, n=141,362, ectopic pregnancy, RCT, n=15,459, CT transmission, RCTs, benefits, reducing, PID, screening rates, increased, trials, reducing, CT, NG, transmission, intensely, screening, high-prevalence, female, populations, trials, NNS, Evidence, infertility, females, CT, screening, transmission, NG, males, sexes, screening, CT, NG, evidence, cervicitis, chronic pelvic pain, infertility, males, CT, screening, clinical outcomes, NG, screening, screening, diagnosis, CT, small-to-moderate number, people, experience, degree, harm, feelings, stigmatization, anxiety, infertility, risk, individuals, affected, screening-eligible population, Screening, general anxiety, self-esteem, relationship, break-up, Evidence, transmission, studies, comparing, home, clinic, screening, studies, patient, preferences, consequences, CT, NG infections, duration, health state, experiences, infertility, chronic pelvic pain, PID, ectopic pregnancy, cervicitis, patients, potential, benefits, harms, screening, survey, qualitative studies, risks, reproductive health, transmission, transient, psychosocial, harms, evidence, screening, CT, NG, low, certainty, benefits, harms, Indirectness, comparison, groups, screening, outcome, ascertainment, outreach settings, uncertainty, Patient, preferences, potential, benefits, screening, harms, evidence, screening strategies, intervals, age, stop screening, screening, males, females, clinical outcomes, research, areas, informative, evidence, review, information, factors, equity, acceptability, implementation, cost/resources, feasibility, recommendations, Task Force, International Prospective Register of Systematic Reviews, PROSPERO, registration]]\n",
      "[[inadequacies, syndromic management, genital ulceration, inflammation, Rwanda National Guidelines, sexually transmitted infection, STI, syndromic management, local prevalence, correlates, STI, etiologies, component World Health Organization guidelines, stress, locally relevant, algorithms, Radio announcements, pharmacists, symptomatic, patients, free, STI, services, Kigali, Clients, services, sexual partners, symptomatic, friends, Demographic, behavioral risk factor, medical history, symptom data, Genital exams, trained research nurses, physicians, phlebotomy, HIV, plasma, vaginal pool, swab, microscopy, wet preparation, diagnose, Trichomonas vaginalis, TV, bacterial vaginosis, BV, vaginal, Candida albicans, VCA, GeneXpert testing, Neisseria gonorrhoeae, NG, Chlamydia trachomatis, CT, factors, associated with, diagnosis, NG, CT, men, women, factors, associated with, TV, BV, VCA, women, genital ulcer, RPR, results, HIV, status, gender, circumcision, men, men, visits, positive, CT, positive, NG, women, visits, positive, CT, positive, NG, multivariate analyses, factors, associated with, CT, men, younger age, responding, radio advertisements, days, suspected, exposure, dysuria, Factors, associated with, NG, men, higher, education, full-time employment, days, suspected, exposure, genital ulcer, urethral discharge, physical exam, Factors, associated with, CT, women, younger age, days, symptoms, Factors, associated with, NG, women, younger age, lower education, lack, full-time employment, condoms, never, hormonal, non-hormonal contraception, genital ulcer, itching, symptoms, days, HIV+, status, BV, endocervical discharge, speculum exam, negative, vaginal wet mount, VCA, multivariate analyses, associated with, BV, RPR+, associated with, TV, month, pregnant, genital itching, discharge, HIV, RPR negative, associated with, VCA, Genital ulcers, positive, RPR, associated with, HIV+, lack, circumcision, men, HIV+, women, RPR+, HIV+, men, women, ulcers, herpetic, syphilitic, compared, HIV-, counterparts, Syndromic management, guidelines, Rwanda, improved, prevalence, infections, study, symptomatic, men, women, representative, care, government, health centers, Inclusion, demographic, risk factor, measures, predictive, STI, non-STI dysbioses, increase, diagnostic accuracy]]\n",
      "[[Antimicrobial-resistant, AMR, Neisseria gonorrhoeae, threat, public health, strains, resistant, last-line antibiotics, empiric therapy, gonorrhoea, ceftriaxone, azithromycin, spread, internationally, Whole genome sequencing, WGS, data, AMR, clones, transmission, networks, development, point-of-care tests, antimicrobial susceptibility, novel, antimicrobials, vaccines, analysis, genomic, epidemiological, data, public, surveillance, public, genomic epidemiology, N. gonorrhoeae, Pathogenwatch, https://pathogen.watch/ngonorrhoeae, international, advisory group, experts, epidemiology, public health, genetics, genomics, N. gonorrhoeae, current, analytics, platform, implement, compatibility, MLST, NG-MAST, NG-STAR typing schemes, library, genetic, AMR, determinants, genotypic, prediction, resistance, antibiotics, collection, N. gonorrhoeae, genome sequences, public archives, quality-checked, assembled, public, metadata, contextualization, AMR, prediction, genome, data, specificity values, azithromycin, ciprofloxacin, ceftriaxone, sensitivity, values, benzylpenicillin, tetracycline, case study, Pathogenwatch, collection, N. gonorrhoeae, public genomes, global, expansion, azithromycin-resistant lineage, mosaic mtr, years, power, Pathogenwatch, evaluate, genomic epidemiology, questions, public health, N. gonorrhoeae, Pathogenwatch, bioinformatic pipelines, expert, opinion, public, health agencies, departments, expertise, bioinformatics, lower-resourced settings, internet connection, computational, infrastructure, advisory group, assess, public, field, gonorrhoea, gonococcal, AMR, modified, analytic methods]]\n",
      "[[mismatch repair system, MMR, stability, genetic information, DNA replication, organisms, Mismatch repair, recognition, non-canonical nucleotide pair, MutS protein, formation, complex, MutS, MutL. Eukaryotic, bacterial, MutL, homologs, function, endonucleases, single-strand, daughter strand, DNA, activating, repair process, functioning, protein, ATPase, DNA binding functions, MutL protein, pathogenic, Neisseria gonorrhoeae, NgoMutL, endonuclease activity, kinetic, parameters, ATP, hydrolysis, NgoMutL protein, interactions, single-, double-stranded DNA fragments, lengths, NgoMutL, complexes, DNA fragments, nucleotides, modified, 2-pyridyldisulfide group, linkers, lengths, NgoMutL conjugates, DNA, results, Cys residues, wild-type protein, distance, duplex, efficiency, affinity modification, Cys residues, NgoMutL, reactive DNAs, decrease, presence, ATP, non-hydrolyzable analog, ZnCl2, reaction mixture, Cys residues, C-terminal domain, NgoMutL, coordination, metal ions, active center, protein, interaction, DNA, information, reconstruction, stages, MMR, prokaryotes, gamma-proteobacteria, search, targets, drugs, N. gonorrhoeae]]\n",
      "[[Carbohydrate-binding antibodies, diverse, human, health, Endogenous, carbohydrate-binding antibodies, bacterial, fungal, microbial, carbohydrates, prevent, systemic infections, microbiome, homeostasis, Anti-glycan antibodies, beneficial, detrimental effects, alloantibodies, ABO, blood group, carbohydrates, reduce, spread, infectious diseases, limitations, blood transfusions, Antibodies, self-glycans, autoimmune diseases, Guillain-Barre syndrome, endogenous, antibodies, natural processes, vaccines, induce, anti-glycan antibodies, primary, mechanism, protection, vaccines, impact, human, health, pneumococcus, Haemophilus influeanza type b, Neisseria meningitidis, Monoclonal antibodies, targeting, pathogen, associated or, tumor, TACAs, clinically, diagnostic, therapeutic purposes, review, applications, anti-carbohydrate antibodies]]\n",
      "[[incidence, invasive, meningococcal disease, serogroup C, MenC, decreased, Portugal, introduction, conjugate vaccine, MCC, free, market, National Immunisation Plan, potential, antibody response, literature, vaccination schemes, country, Neisseria meningitidis serogroup C, circulate, Portuguese population, increased, risk, infection, absence, national data, evaluated, seroprotection, level, Portuguese population, MenC, fraction, population, booster, dose, MCC, vaccine, serum, bactericidal antibody, levels, MenC, sample, population, aged, years, National Serological Survey, individuals, studied, MenC., geometric mean titre, proportion, seroprotected, low, children, aged, years, dose, vaccine, months, age, vaccination strategy, proportion, seroprotected, adolescent, young adults, years, age, vaccination, catch-up, campaign, years, age, protection, rates, vaccine, administered, adolescence, fraction, population, seroprotected, effect, antibody response, Portuguese population, risk, infection, results, vaccination, booster, dose, MCC, vaccine, adolescence]]\n",
      "[[Acute abdominal, manifestation, meningococcal infection, uncommon, hyperinvasive isolates, meningococci, patients, infected, meningococcal strain, Europe, abdominal pain, report, laboratory, fatal, case, healthy, adult, male, acute abdominal pain, hours, masking Neisseria meningitidis, N. meningitidis) infection, National Reference Center for meningococci, blood, man, post-mortem, identified, N. meningitidis serogroup C, real time polymerase chain reaction, PCR, massivelly-parallel sequencing, MPS, isolated, pathogen, confirmation, investigation]]\n",
      "[[Nonulosonic acids, NulOs, group, nine-carbon monosaccharides, functions, nature, N-acetylneuraminic acid, Neu5Ac, NulO., membrane, surface, human cells, central molecule, process, self-recognition, SIGLECS receptors, pathogenic, escape, immune system, sialylation, host cell membrane, Neu5Ac production, bacteria, enzyme, NeuB., bacteria, NulOs, pseudaminic, legionaminic acids, NeuB homologues, PseI, LegI, Opisthokonta eukaryotes, biosynthesis, Neu5Ac, enzyme NanS., study, data, sequences, NulOs synthases, investigate, distribution, domains, life, relationship, pathogenic bacteria, KEGG database, NeuB sequences, NeuB sequences, KEGG, orthology, database, environmental bacteria, sequences, pathogenic bacteria, higher, conservation, prevalence, domain, SAF, HMM, profile, NulO synthase sequences, UniProt, Phylogenetic analysis, sequences, synthases, groups, lifestyle, bacteria, environmental, intermediate, pathogenic, NeuB, groups, LegI, PseI, groups II, III, PseI, evolutionary process, NeuB., methodology, sialic acid synthase sequences, Archaea, Eukarya, large-scale, phylogenetic analysis, Archaea sequences, spread, tree, eukaryotic, grouped, branch, group II, bacterial, NanS sequences, grouped, eukaryotic branch, analysis, conserved residues, synthases, Archaea, Eukarya, mutation, catalytic residues, E134D change, Neisseria meningitidis reference sequence, conservation, NeuB, pathogenic bacteria, NanS, eukaryotes, NeuB, environmental bacteria, NanS, eukaryotes, large-scale analysis, perspectives, evolution, NulOs synthases, presence, universal ancestor]]\n",
      "[[Splenectomy, distal pancreatectomy, DP, optimal, cytoreduction, advanced ovarian cancer, AOC, tumors, splenic hilum, capsule, spleen, tumor-free margins, splenectomy, gastro-splenic ligament, short gastric vessels, dissected, splenocolic ligament, splenic flexure, colon, transected, peritoneal, attachments, splenorenal, splenophrenic ligaments, mobilize, spleen, splenic artery, vein, identified, ligated, separately, DP, bloc resection, tumors, linear cutting stapler, tail, pancreas, suture, reinforcement, prolene, cut section, pancreas, postoperative, pancreatic fistula, POPF, Immunization, polyvalent pneumococcal vaccine, splenectomy, post-splenectomy infection, OPSI, Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, POPF, splenectomy, DP, drainage, monitoring, administration, board spectrum antibiotics, grade A, B POPF, criteria, International Study Group, Pancreatic Fistula, ISGPF, grade C POPF, aggressive management, mouth, parenteral nutrition, somatostatin, analogs, reoperation, deteriorating, signs, sepsis, organ dysfunction, pancreatic tail, reduce, hospitalization, risk, POPF, minimal, impact, DP, success, rate, optimal, cytoreduction]]\n",
      "[[Complete deficiency, alternative pathway, AP, complement factors, homozygous, mutations, risk factor, invasive, bacterial infections, heterozygous mutations, siblings, heterozygous, NM_001928.3(CFD):c.125C, p.(Ser42*), mutation, complement factor D, history, recurrent, bacterial infections, effect, heterozygous, fD deficiency, AP, complement activity, effect, fD, levels, complement activation, AP, activity, complement C3 binding, bacterial, surface, Neisseria meningitidis, Nm, Streptococcus pneumoniae, Sp, non-typeable Haemophilus influenzae, NTHi, complement-mediated killing, Nm, NTHi, measured, effect, vaccination, complement C3 binding, bacterial, surface, killing, Nm, Reconstitution, fD-deficient serum, fD, increased, AP, activity, dose- and time-dependent way, Reconstitution, patient serum, fD, complement C3 binding, Sp, Nm, NTHi, complement-mediated killing, Nm, NTHi, Vaccination, increased, complement C3 binding, killing, Nm, fD, reconstitution, fD serum levels, reduced, speed, complement activation, results, diminished, bacterial, killing, consistent with, recurrent, bacterial infections, patients, antibodies, induced, vaccination, overcome, diminished, bacterial, killing, capacity, patients, fD, levels]]\n",
      "[[Gorakhpur division, Gorakhpur, neighboring, districts, Deoria, Kushinagar, Maharajganj, Uttar Pradesh, India, witnessing, seasonal, outbreaks, acute encephalitis syndrome, AES, children, decades, Investigations, Japanese encephalitis, aetiology, AES, introduction, JE, vaccination, control strategies, incidence, JE, region, declined, outbreaks, acute febrile illness, neurological manifestations, investigations, Orientia tsutsugamushi, aetiology, AES, outbreaks, region, review, clinical, epidemiological, animal, entomological investigations, AES, O. tsutsugamushi, Gorakhpur region, Surveillance, acute febrile illness, children, peripheral, health facilities, scrub typhus, aetiology, febrile illness, monsoon, post-monsoon, months, Population-based serosurveys, endemicity, scrub typhus, Entomological studies, natural infection, O. tsutsugamushi, small, animal, hosts, vector mites, Children, infection, exposure, outdoor, environment, playing, visiting fields, defecating, open fields, children, scrub, progress, CNS, manifestations, early administration, appropriate, antibiotics, preventing, progression, AFI, scrub typhus, AES, investigations, multi-disciplinary team, transmission, dynamics, scrub typhus, Gorakhpur division, control]]\n",
      "[[Scrub typhus, tropical disease, people, antibiotic therapy, delayed, mis-, late diagnosis, case fatality rate, increase, Scrub typhus, obligate, intracellular, bacterium, Orientia tsutsugamushi, phagocytes, endothelial cells, in vivo, diverse, tissue culture cell, in vitro, O. tsutsugamushi, replicate, cytoplasm, eukaryotic, immune defense, mechanisms, transcription factor, NF-kappaB, initiator, proinflammatory, antimicrobial responses, inhibitory proteins, p105, IkappaBalpha, sequester, NF-kappaB, p50:p65 heterodimer, cytoplasm, Canonical activation, NF-kappaB, TNFalpha, IKKbeta-mediated serine, phosphorylation, IkappaBalpha, p105, degradation, NF-kappaB nuclear, translocation, portion, p105, p50, O. tsutsugamushi, impairs, NF-kappaB, translocation, nucleus, FINDINGS, Western blot, densitometry, quantitative, O. tsutsugamushi, infected, host cells, pathogen's, inhibit, NF-kappaB, modulation, p105, p105, levels, elevated, O. tsutsugamushi, infected, HeLa, RF/6A cells, increase, p50, O. tsutsugamushi-stimulated, increase, p105, bacterial, dose- and, protein synthesis-dependent, level, host cell, TNFalpha-induced, phosphorylation, p105 serine, unhindered, infected, cells, p105 levels, elevated, NF-kappaB p65, cytoplasm, O. tsutsugamushi, stabilizes, p105, inhibit, canonical NF-kappaB pathway, host, immunity, infection]]\n",
      "[[Scrub typhus, acute febrile disease, transmitted, bites, mite, larvae, chigger, infected, Orientia tsutsugamushi, Arrhythmias, ischaemic, changes, QT, prolongation, ECG abnormalities, patient, angina, sinus bradycardia, ST, elevation, inferior, T wave inversion, lateral, coronary angiography, normal, evaluation, diagnosis, scrub typhus infection, doxycycline therapy, ECG, normal, Afebrile scrub typhus infection, cardiac manifestation, scenario]]\n",
      "[[Orientia tsutsugamushi, causative agent, scrub typhus vectored, larval stages, trombiculid mites, chiggers, tropical regions, Southeast Asia, chiggers, mammals, positive scrub, locality, Kelantan, Malaysia, screened, presence, O. tsutsugamushi, chiggers, grouped, pools, extraction, DNA, screening, O. tsutsugamushi, nucleotide sequence, TSA, gene, nested polymerase chain reaction, species, on-host chiggers, identified, Leptotrombidium deliense, dominant, Ascoshoengastia sp., pathogen, detected, pools, L. deliense, recovered, Rattus rattus, Tupaia sp., TSA, gene sequence analysis, O. tsutsugamushi, harboured, chiggers, high similarity, Findings, study, scrub typhus infections, parts, Malaysia, local reports, study, observation, O. tsutsugamushi, DNA sequences, chiggers, positive scrub, localities, distribution, prevalence, zoonotic pathogen]]\n",
      "[[Scrub typhus, fatal, zoonotic disease, Orientia tsutsugamushi, disease, systemic vasculitis, lymphadenopathy, headache, myalgia, eschar, studies, strain, resistant, medical treatment, identified, Thailand, development, drugs, scrub typhus, molecular mechanism, progression, scrub typhus, disease-related, genetic factors, mechanisms, associated with, progression, scrub typhus, genome-wide association study, GWAS, scrub, typhus-infected, patients, scrub, typhus-related signaling pathway, molecular interaction search tool, MIST, PANTHER, scrub, SNPs, PRMT6, PLGLB2, DTWD2, BATF, JDP2, ONECUT1, WDR72, KLK, MAP3K7, TGFBR2, genes, GWAS, genes, protein-protein interactions, genes, scrub typhus, identified, signaling pathways, associated with, genes, genes, signaling pathways, signaling pathway, associated genes, gonadotropin-releasing hormone receptor pathway, TGF-beta signaling pathway, apoptosis, signaling pathway, knowledge, report, GWAS, scrub typhus]]\n",
      "[[Scrub typhus, arthropod-borne bacterium, Orientia tsutsugamushi, endemic, infectious disease, Asia-Pacific area, study, investigate, seroprevalence, scrub typhus, associated risk, protective factors, forestry workers, risk group, scrub typhus, National Park Offices, South Korea, nationwide, cross-sectional serosurvey, National Park Office forestry workers, NPOFWs, South Korea, offices, structured questionnaire, data, general characteristics, work activities, hygiene-related factors, potential, risk factors, Serum samples, NPOFWs, tested, indirect, immunofluorescence assay, detect, O. tsutsugamushi immunoglobulin (Ig) G, M antibodies, NPOFWs, cross-sectional study, seroprevalence, /=1:256, IgG, IgM, multivariate logistic analysis, duration, national parks, years, odds ratio, OR, confidence interval, CI, dry field farming, OR, CI, associated with, risk, scrub typhus infection, risk, scrub typhus infection, NPOFWs, working clothes daily, OR, CI, study, scrub typhus, disease, NPOFWs, South Korea, Work hygiene, working clothes, daily, NPOFWs, precautions, diminish, rate, scrub typhus infection, NPOFWs, dry field farming]]\n",
      "[[Scrub typhus, Orientia tsutsugamushi, obligate, intracellular, gram-negative bacterium, hemorrhagic fever, renal syndrome, HFRS, hantaviruses, natural-focus infectious diseases, Shandong Province, China, diseases, clinical manifestations, disease stages, epidemic, seasons, difficulties, physicians, study, investigate, misdiagnosis, scrub typhus, HFRS, patients, Shandong Province, Serum samples, clinically, HFRS, patients, Shandong Province, analyzed, enzyme-linked immunosorbent assay, ELISA, antibodies, hantavirus, Orientia tsutsugamushi, ELISA, clinically, HFRS, patients, IgM antibody, positive, hantavirus, O. tsutsugamushi, hantavirus IgM antibody, positive, patients, IgM antibody, positive, O. tsutsugamushi, hantavirus IgM antibody, negative, sera, sera, positive, O. tsutsugamushi, scrub typhus, patients, misdiagnosed, HFRS, co-infection, scrub typhus, HFRS, China, treatments, scrub typhus, HFRS, physicians, scrub typhus, HFRS, administering, anti-rickettsia antibiotics, treatment, HFRS]]\n",
      "[[Pasteurella multocida, pneumonic pasteurellosis, small ruminants, prevalence, investigated, pneumonic, lungs, sheep, goats, genotypes, isolates, capsular, lipopolysaccharide, LPS, typing, virulotyping, detection, virulence-associated genes, P. multocida, isolated, sheep lungs, goat, lungs, D, capsular types, L3, L6, LPS, genotypes, detected, L6 genotype, prevalent, sheep, goat, isolates, virulence profiles, VP, detected, non-toxigenic, toxigenic, correlated, capsular-LPS, genotype, isolates, VP, LPS, capsular, genotype, isolate, VP1, diversity, VP, toxigenic, non-toxigenic, isolates, toxigenic, VPs, diversity, capsular-LPS, genotypes, toxigenic, VPs, genotypes D, VP2, VP3, abundance, toxigenic, isolates, sheep, goat, isolates, expansion, virulent, lineage, associated with, pneumonic pasteurellosis, small ruminants, genotypes, sheep, isolates, non-toxigenic VP1:A:L6, toxigenic VP3:A:L3, genotypes, prevalent, goat, isolates, toxigenic VP2:D:L3, non-toxigenic VP1:A:L6, VP4:A:L6, genotypes, toxigenic, non-toxigenic genotypes, epidemiologically, pneumonic pasteurellosis, small ruminants]]\n",
      "[[Respiratory disorders, rabbits, Rabbits, obligate, nasal breathers, rhinitis, severe, respiratory distress, patient collapse, Causes, dyspnea, primary origin, secondary, diseases, affecting, organs, respiratory embarrassment, respiratory system, healthy, anemia, cardiac disease, Diagnosis, radiography, ultrasonography, endoscopy, computed tomography, pathogen, isolation, diagnosis, completed, treatment options, owner, article, anatomy, respiratory tract, diagnostics, therapy, respiratory disorders, rabbits]]\n",
      "[[Pasteurella multocida, bacterial pathogen, infect, hosts, humans, companion, animals, livestock, wildlife, study, bioinformatic approaches, genomic diversity, P. multocida, isolates, epidemiological, associations, host factors, genotypes, Isolates, study, hosts, poultry, cattle, swine, rabbits, rodents, humans, continents, Multi-locus sequence typing, identified, sequence types, In-silico methodology, capsular, serogroup, validated, genome sequences, capsular serogroups A, B, D, F, Whole genome, phylogeny, core single nucleotide variants, SNVs, host, capsular, serogroup, specificity, isolates, bovine, sources, SNVs, srlB gene, identified, P. multocida subsp., genomes, mutations, subspecies, associations, capsular, serogroup, virulence factors, capsular serogroup A, OmpH1, OmpH3, PlpE, PfhB1, capsular, HgbA, PtfA, capsular serogroup F, PtfA, PlpP., mobile genetic elements, identified, ICEPmu1, ICEhin1056, IncQ1 plasmids, antimicrobial resistance-encoding genes, analyses, isolates, turkeys, fowl, cholera, outbreaks, strains, P. multocida, circulating, outbreak, virulent, clone, study, extensive, genomic diversity, P. multocida, epidemiological context, genotyping schemes, isolates, tools, P. multocida, molecular typing]]\n",
      "[[bacterial microorganisms, associated with, canine, keratomalacia, review, antimicrobial, sensitivity, evaluate, clinical outcomes, results, microbial, culture, Retrospective analysis, clinical records, dogs, diagnosed, melting corneal ulcer, referral hospital, Hertfordshire, UK, melting corneal ulcers, sampled, dogs, bacterial, isolate, Pseudomonas aeruginosa, beta-hemolytic Streptococcus, Melting corneal ulcers, cultured, coagulase-positive Staphylococcus, coliform bacteria, Pasteurella multocida, Enterococcus, Streptococcus viridans, numbers, analyzed, Multiple cultures, identified, cases, cultures, bacterial growth, susceptibility, fluoroquinolones, beta-hemolytic Streptococci, no significant, ulcer, severity, presentation, cultured bacteria, eyes, surgical grafting, medical treatment, cases, progression, corneal melting, medical +/-, surgical treatment, enucleation, enucleated eyes, Pseudomonas aeruginosa, isolates, beta-hemolytic, Streptococcus-associated ulcers, healed, bacterial species, associated with, canine, keratomalacia, Pseudomonas aeruginosa, beta-hemolytic Streptococcus, variation, antibacterial sensitivity, species, bacterial culture, sensitivity, dogs, keratomalacia, Melting corneal ulcers, associated with, Pseudomonas infection, globe loss, melting corneal ulcers, associated with, cultures]]\n",
      "[[Bacteriophages, evolution, bacteria, emergence, pathogenic, strains, horizontal, transfer, virulence genes, Pasteurella multocida, disease syndromes, domesticated, animal, species, influence, bacteriophages, disease, pathogenesis, species, Temperate bacteriophage, diversity, assessed, P. multocida, isolates, avian, bovine, ovine, porcine, origin, Induction, phage, particles, mitomycin, identified, diverse, morphological, Siphoviridae, Myoviridae, family-types, isolates, Phage, morphological, identified, isolates, bacterial, host, multiple, prophages, DNA, isolated, bacteriophages, recovered, P. multocida, isolates, characterization, restriction endonuclease, analysis, identified, RE, Phage, identical, RE, identified, strains, phage, RE, isolates, acquisition, host, induced, phage, particles, plaque, assay, phage, lysates, signs of, infection, indicator, strains, isolates, phage, lysates, infection, groups, phylogenetically, ovine, porcine, strains, possessed, toxA gene, Pasteurella multocida, Siphoviridae-, Myoviridae-type bacteriophages, evolution, virulence, pathogen]]\n",
      "[[antibiotic residues, pathogenic resistance, drug, poultry, antibiotics, feed, natural, effective, synthetic antibiotic, study, investigate, immune response, Nigella sativa, Curcuma longa, broilers, biological stress, Pasteurella multocida, one-day-old, chicks, groups, Groups, control negative, control positive, control groups, simple diet, natural, infection, group 2, day, dose, Groups 3A, 3B, seed powder, Nigella sativa, groups 4A, 4B, C. longa, powdered form, group 5A, 5B, C. longa, N. sativa 2, feed, day, groups, 4B, 5B, P. multocida, haemagglutination, inhibition, titter, Newcastle Disease virus, NDV, feed conversion ratio, mortality, gross, histopathology, results, study, hemagglutination, inhibition, titers, NDV, treated, groups, titers, 3A, 5A, treated, Groups, feed, conversion, N. sativa + C. longa, treated, 5A, 3A, nontreated groups, gross, histopathological, changes, severe, control positive, changes, treated, groups, natural, black cumin, N. sativa, turmeric, C. longa, immune enhancer, broilers, P. multocida]]\n",
      "[[Influenza D virus, IDV, single-stranded negative-sense ribonucleic acid, Delta influenza virus, genus, Orthomyxoviridae, family, Cattle, natural, reservoir, IDV, infection, associated with, mild-to-moderate respiratory clinical signs, cough, nasal discharge, dyspnoea, PRINCIPAL, FINDINGS, investigate, IDV, bovine, respiratory disease, period, nasal, naso-pharyngeal swabs, Canadian, cattle, respiratory signs, cough, dyspnoea, tested, (RT-)qPCR, IDV, bovine, viral, bovine herpesvirus 1, bovine, viral diarrhoea virus, bovine, respiratory syncytial virus, bovine parainfluenza virus 3, bovine coronavirus, bacterial, Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Mycoplasma bovis, respiratory pathogens, whole-genome sequencing, phylogenetic analyses, IDV-positive, samples, prevalence, IDV RT-qPCR, animal, level, estimated, confidence interval, Positive, IDV, associated with, (RT-)qPCR-positive, results, bovine, respiratory syncytial virus, Mycoplasma bovis, phylogenetic analyses, segments, clade D/660, reassortment, clades, D/660, D/OK, samples, SIGNIFICANCE, influenza D virus, pathogens, bovine, respiratory disease, Canadian, dairy cattle, Whole-genome sequencing, evidence, reassortment, clades, D/660, D/OK, information, surveillance, IDV, cattle, production]]\n",
      "[[OBJECTIVE, Pleurisy, pigs, economic impacts, production stage, slaughter, study, micro-organisms, lungs, pleurisy, batches, pigs, abattoir, Queensland Australia, Samples, lung, trachea/bronchus, lymph nodes, maximum, pleurisy, affected, pigs, batches, pigs, Queensland farms, PROCEDURE, Pleurisy-affected lung areas, cultured, bacteriological methods, bacteria, quantified, plate scores, tracheal, bronchial swabs, apical lobe fluid, tested, Mycoplasma hyopneumoniae, DNA, superior, tracheobronchial, lymph nodes, tested, porcine circovirus type 2 DNA, polymerase chain reaction, PCR, bacteria, PCR, sequencing, Typing, bacterial, isolates, pathogens, M. hyopneumoniae, Streptococcus suis, Porcine Circovirus type 2, batches, bacteria, Actinobacillus species, batches, Pasteurella multocida, batches, Mycoplasma flocculare, batches, Actinobacillus pleuropneumoniae, batches, Mycoplasma hyorhinis, batches, Bisgaard Taxon 10, batch, Glaesserella parasuis, batch, Streptococcus, minor, batch, Streptococcus porcinus, batch, batches, bacterial species, percentage, batches, infected, S. suis, M. hyopneumoniae, PCV2, clustering, batch, pathogens, presence, secondary, pathogens, synergy, organisms, pleurisy]]\n",
      "[[Pasteurella multocida, zoonotic, pathogen, multiple diseases, animals, humans, Test, immunogenic proteins, vaccine, development, disease control, study, immunogenic proteins, P. multocida, 2-DE MALDI-TOF MS, immune serum, proteins, trimethylamine-N-oxide reductase, TorA, translation elongation factor, Ts, phosphoglyceromutase, PGAM, peroxiredoxin PrX., proteins, TorA, Prx, PGAM, expressed, E. coli, Western-blotting assays, recombinant, TorA, Prx, PGAM, infectious, sera, P. multocida serogroups A, B, D, Immunization, rTorA, rPrx, rPGAM, induced, levels, antibodies, IFN-gamma, IL-4, IL-10, mice, Protective efficacy, tests, vaccination, rTorA, rPrx, rPGAM, tested, mice, P. multocida field, isolate, results, study, proteins, tested, vaccine, P. multocida, infections]]\n",
      "[[foreskin, site, heterosexual, acquisition, HIV-1, uncircumcised, men, men, HIV-negative, unprotected, vaginal intercourse, HIV-positive, partners, infected, exposures, foreskin microbiome, diverse, group, anaerobic bacteria, HIV, acquisition, anaerobes, coassociate, species, increase, HIV, risk, innocent, bystanders, anaerobic, bacterial species, Peptostreptococcus anaerobius, Prevotella bivia, Prevotella disiens, Dialister propionicifaciens, Dialister micraerophilus, genetic near neighbor, Dialister succinatiphilus, increased, cytokine, production, HIV-susceptible, CD4+ T cells, inner foreskin, associated with, HIV, acquisition, penile, microbiome, increases, host, susceptibility, HIV, species, potential, targets, microbiome-based prevention strategies]]\n",
      "[[Aberrant, microbiota, composition, disease development, anatomical sites, Microbiota, changes, reaction, viral infections, human papillomavirus, HPV, investigated, female, reproductive tract, HPV infection, male, health, reducing, semen, quality, fertility, study, investigate, HPV DNA, associated with, detectable, changes, semen, bacterial, composition, diversity, study, stored, semen, samples, fertile, healthy, men, Finnish, years, DNA, semen, PCR template preparation kit, HPV, genotyped, Luminex-based Multimetrix(R) assay, Microbiota, analyzed, V3-V4 region, 16S rDNA gene, sequencing, Illumina MiSeq platform, statistical analyses, Calypso software version, HPV DNA, detected, semen samples, HPV status, semen, impact, alpha-diversity, estimations, Chao1, Shannon indices, ss-diversity, HPV-positive, semen samples, differences, taxonomic, composition, bacterial microbiota, abundances, Moraxellaceae, Streptococcus, Peptostreptococcus, HPV-negative, semen, HPV infection, associated with, bacterial, composition, semen, impact, male, health, changes, HPV infection, bacterial microbiota, increases, susceptibility, HPV infection, research, viral-bacterial interactions, male reproductive system]]\n",
      "[[Necrotizing fasciitis, life-threatening, skin, soft tissue infection, associated with, morbidity, mortality, adult, patients, infection, type 1 infection, mixed microflora, Streptococci, Enterobacteriacae, Bacteroides sp., Peptostreptococcus sp., patients, surgery, diabetic, patients, type 2, monomicrobial, group A, Streptococci, pathogens, Vibrio vulnificus, Gram-negative rod, infections, humans-gastroenteritis, primary infection, vascular bed, wound infections, infecting, wound, V vulnificus, life-threatening, condition-necrotizing fasciitis, rare, case, necrotizing fasciitis, insect bite, exposure to, seawater, propagation, infectious complication, region, right lower limb, necessity, amputation, demarcated, necroses, secondary, soft tissue infection, multiresistant, strain, Acinetobacter baumannii, chemical necrectomy, benzoic acid-a, application, condition, chemical necrectomy, selectivity, vital parts, limb, salvaged, minimum blood loss, antimicrobial effect, benzoic acid, decolonization, necrosis, wound bed preparation, defect, closure, split-thickness skin grafts, patient, healed, complications, normal life]]\n",
      "NaN\n",
      "[[Colorectal cancer, cancer-related deaths, worldwide, human, microbiome, active area, research, initiation, progression, treatment, colorectal cancer, studies, alterations, carriage, bacteria, gut microbiome, colorectal cancer, patients, bacterium, cases, alterations, species, carriages, cause, outcome, cancer formation, unclear, changes, bacterial, cancer-associated gut microbiome, analyses, whole-genome shotgun sequenced, healthy, late-stage, colorectal cancer, subjects, taxonomic, functional, structural, changes, human, microbiome, Bacterial, association, data, bacterial, healthy, colorectal cancer, gut, microbiomes, cancer-associated ecosystem, bacterial species, associations, species, taxonomically, modules, potential, changes, tumor-associated ecosystem, Bacterial, samples, increase, species, diversity, cancer-associated gut microbiome, elevated, abundance, species, oral microbiome, Fusobacterium nucleatum, Peptostreptococcus stomatis, Gemella morbillorum, Parvimonas micra, Differential, community functional, capabilities, elevation, functions, virulence factors, peptide degradation, reduction, functions, amino-acid biosynthesis, colorectal cancer, gut microbiome, whole-genome shotgun sequenced fecal samples, cohort, late-stage, colorectal cancer, healthy subjects, taxonomic, functional, structural, alterations, colorectal cancer, gut microbiome, analyses, cancer-associated ecosystem, bacterial, native, microbiota, oral bacteria, associations, relevant, tumor progression]]\n",
      "[[salivary microbiota, patients, progressive, histological stages, gastric carcinogenesis, microbial, markers, detecting, gastric cancer, patients, grouped, superficial gastritis, SG, atrophic gastritis, AG, gastric cancer, GC, histology, 16S rRNA, gene sequencing, salivary microbiota, profile, random forest model, gastric, histological, salivary, microbiota, compositions, salivary, microbiota, patients, GC, comparing, SG, AG, enrichment, proinflammatory taxa, Corynebacterium, Streptococcus, decreased, oral bacteria, GC, patients, Haemophilus, Neisseria, Parvimonas, Peptostreptococcus, Porphyromonas, Prevotella, Haemophilus, Neisseria, reduce, nitrite, accumulation, carcinogenic, N-nitroso compounds, GC, accurately, patients, AG, SG, AUC, random forest model, salivary, microbiota, profiles, taxa, Streptophyta, Streptococcus, potential, diagnostic biomarkers, GC, changes, salivary, microbiota, functions, detected, histological types, upregulation, isoleucine, valine, level, amino acids, gastric tumor, tissues, studies, bacteria, oral cavity, gastric cancer, diagnostic, biomarkers, GC, evaluation, clinical cohorts, potential, mechanisms, salivary microbiota, pathogenesis, GC, accumulation, proinflammatory bacteria, decline, carcinogenic, N-nitroso compounds]]\n",
      "[[cancer treatment failures, tumour microbiota, microbiota, manipulation, treatment, efficacy, antibiotics, bacterial growth, dysbiotic, effects, microbiome, failure, penetrate, biofilms, decreased, efficacy, antimicrobial resistance, bacteria, Bacteriophages, targeting, oncobacteria, abundance, increased, tumour tissue, microbiomes, Fusobacterium, Streptococcus, Peptostreptococcus, Prevotella, Parvimonas, Treponema species, tumour tissue, microbiomes, cancers, cancer growth, immunity, release, proinflammatory cytokines, interacting, cancer cells, stimulate, proliferation, Lytic bacteriophages, oncobacteria, isolated, characterised, testing, therapies, review, oncobacteria, abundance, intra-tumour microbiome, increased, potential, bacteriophages, micro-organisms, cancer therapies, capacity, bacteriophages, modulate, immunity, kill, bacteria, tumour microbiome, negate, effects, oncobacteria]]\n",
      "[[Ulcerative colitis, UC, inflammatory disease, colon, rectum, evidence, influence, microbiota, development, disease, studies, intestinal microbiota, pathogenesis, UC, incomplete, ulcerative colitis, data, microbiological composition, intestines, patients, ulcerative colitis, Russia, study, microbiological composition, intestines, patients, ulcerative colitis, healthy, individuals, changes, bacteria, genera, species, patients, UC, compared, control group, sequencing, IonTorrent PGM system, data analysis, study, increase, genus, Haemophilus, Olsenella, Prevotella, Cedecea, Peptostreptococcus, Faecalibacterium, Lachnospira, Negativibacillus, Butyrivibrio, species, Bacteroides coprocola, Phascolarctobacterium succinatutens, Dialister succinatiphilus, Sutterella wadsworthensis, Faecalibacterium prausnitzii, patients, ulcerative colitis, patients, ulcerative colitis, decrease, genus, Fusicatenibacter, Butyricimonas, Lactococcus, Eisenbergiella, Coprobacter, Cutibacterium, Falsochrobactrum, Brevundimonas, Yersinia, Leuconostoc, species, Fusicatenibacter saccharivorans, confirmation, data, literary sources, studies, UC, taxa, Negativibacillus spp., Falsochrobactrum spp, human, stool samples, data, research, microbiome, changes, development, UC, people, populations]]\n",
      "[[Porphyromonas gingivalis/lipopolysaccharide, inflammatory diseases, TNF-alpha-mediated, transcription factors, data, TNFAIP1, TNF-alpha, induced, protein 1, TNF-alpha, TNFAIP1, TNF-alpha-dependent pathway, biological function, TNFAIP1, examined, TNFAIP1, TNF-alpha, genes, TNF-alpha, upregulated, peaks, upregulation, apoptotic genes, Bad, Bcl-x, Caspase 3, Catalase, Claspin, Cytochromic, Ho-1/HMOX1/HSP32, MCI-1, time course, TNFAIP1-treated cells, findings, studies, regulation, TNFAIP1, intervention, inflammatory disease]]\n",
      "[[OBJECTIVE, efficacy, gel, propolis, extract, nanovitamin C, nanovitamin E, adjuvant, mechanical debridement, treatment, peri-implant mucositis, PM, Propolis, anti-inflammatory, antibacterial effect, peri-implant health, randomized, double-blind study, patients, implant, PM, Participants, professional prophylaxis, test, control gel, toothpaste, times/day, month, Clinical, microbiological, parameters, evaluated, PM, resolution, absence, bleeding, probing, BOP, Data, analysed, Mann-Whitney U, Wilcoxon signed-rank, chi-square tests, patients, group, treatment, test, patients, PM, resolution, control group, reductions, plaque, BOP, probing, depths, test, compared, control group, reduction, Tannerella forsythia, statistically greater, test, control group, follow-up, Porphyromonas gingivalis, statistically reduced, test group, baseline, follow-up, Test gel, clinically, PM, antimicrobial effect, month, comparison, control group, long-term, clinical trials, results]]\n",
      "[[Periostin, periodontal tissue, integrity, homeostasis, associated with, periodontitis, periodontitis healing, study, investigate, temporal, spatial, expression, Periostin, Wnt5a/CaMKII, periodontitis, Wnt5a, regulates, Periostin, CaMKII signaling pathway, PDLCs, inflammatory environment, experimental periodontitis, mice, temporal, spatial, expression, Wnt5a, CaMKII, Periostin, early periodontitis, Wnt5a, CaMKII, Periostin, expression, regulation, mechanism, PDLCs, Porphyromonas gingivalis, Lipopolysaccharide, P.g, LPS, induced, inflammatory condition, periodontitis, development, Wnt5a, CaMKII, Periostin, increased, periodontal ligament, increased, gingiva, day, periodontitis, homeostasis, periodontal ligament tissue, Wnt5a, CaMKII, Periostin, decreased, increased, PDLCs, induced, P.g, LPS, Wnt5a, total CaMKII protein, pCaMKII, Periostin, blocked, CaMKII inhibitor, KN93, conclusions, early periodontitis, Wnt5a/CaMKII, Periostin, periodontal homeostasis, Wnt5a, up-regulate, Periostin, CaMKII pathway, inflammation, pathogenesis, periodontitis, therapeutic strategies]]\n",
      "[[Periodontitis, chronic infectious-inflammatory disease, associated with, systemic diseases, Visfatin, adipokine-enzyme, locally, human periodontal ligament cells, hPDLCs, human, fibroblasts, hGFs, upregulate, proinflammatory cytokines, matrix metalloproteinases, MMPs, cells, effects, visfatin, healthy, inflammatory, human, periodontal cells, molecular mechanisms, unclear, study, visfatin, expression, elevated, inflamed, human, Pg, LPS-treated, hPDLCs, recombinant visfatin, upregulated, expression, proinflammatory cytokines, TNF-alpha, IL-1beta, IL-6, prodegradative factors, EMPPRIN, MMP1, MMP3, MMP13, hPDLCs, levels, proinflammatory, prodegradative cytokines, increased, visfatin-overexpressing, hPDLCs, decreased, visfatin-silencing, inflammatory, iGFs, treated with, Pg, LPS, absence, Pg, LPS, visfatin, silencing, expression, factors, iGFs, overexpression, visfatin, upregulated, MMPs, factors, hPDLCs, NF-kappaB pathway, activation, increased, phosphorylation, p65, visfatin-overexpressing, hPDLCs, BAY11, inhibitor, NF-kappaB, upregulation, proinflammatory, prodegradative factors, induced, visfatin, overexpression, study, visfatin, regulates, Pg, LPS-induced, proinflammatory/prodegradative effects, healthy, inflammatory periodontal cells, NF-kappaB pathway, findings, visfatin, development, periodontitis, biomarker, therapeutic, target, periodontitis, management]]\n",
      "[[study, evaluate, periodontal disease, oral, biofilm, children, adolescents, cleft lip, palate, CLP, individuals, aged, years, CLP, CLP, evaluated, plaque, PI, gingival bleeding index, BI, clinical attachment level, CAL, probing pocket depth, PPD, Gingivitis, periodontitis, diagnosed, Samples, subgingival, biofilm, genomic DNA, oral, microbial, Aggregatibacter actinomycetemcomitans, Tannerela forsythia, Porphyromonas gingivalis, Streptococcus oralis, identified, quantified, qPCR, Taqman primers, probes, PI, BI, CAL, PPD, statistically higher, CLP, group, Gingivitis, mild periodontitis, percent, CLP, control groups, permanent, dentition, group, evaluated, occurrence, mild periodontitis, CLP, group, level, A. actinomycetemcomitans, P. gingivalis, T. forsythia, statistically higher, subgingival, biofilm, CLP, group, presence, cleft lip, palate negatively, oral hygiene, levels, periodontopathogens, oral, biofilm, clinical, microbiological results, early assessment, young people, cleft lip, palate, permanent dentition, prevent, periodontal disease]]\n",
      "[[Porphyromonas gingivalis fimbrillin, IV, factors, periodontitis, associated with, systemic diseases, detect, fimA type II, IV genes, rapidly, loop-mediated isothermal amplification, LAMP, method, specificity, DNA, P. gingivalis, strain, amplified, type II-specific primers, W83 strain, amplified, type IV-specific primers, Pathogens, Streptococcus sobrinus, S. mutans, Candida species, lack, type II and IV genes, detected, LAMP, reaction, bacterial cells, purified, DNA, LAMP, reaction, LAMP, reaction, sensitive, type II, type IV genes, detected, DNA molecules, bacterial, suspensions, HW24D1, W83 strains, type II, type IV genes, detected, bacterial cells, type II, type IV genes, dental plaques, P. gingivalis-positive, patients, LAMP, method, person, positive, type II gene, type IV gene, positive, cases, identified, type II, type IV genes, detected, simultaneously, multiplex amplification, primer, fimA type II, type IV, visible light, method, detect, P. gingivalis, fimA type II, IV genes, LAMP]]\n",
      "[[early, osseointegration, long-term, survival rate, implants, multifunctional, titanium, promotes, osteogenesis, antibacterial properties, Incorporation, bioactive trace elements, magnesium ions, method, osseointegration, titanium, Phytic acid, chelating, multivalent, cations, surface, modification, phytic acid, antibacterial, potential, improve, osteogenic, antibacterial properties, phytic acid-magnesium, titanium, phytic acid, cross-linker molecule, changes, surface, characterization, scanning electron microscopy, atomic force microscopy, X-ray photoelectron spectroscopy, PA-Mg, covalently bond, Ti, surface, thickness, PA-Mg, layer, improved, hydrophilic, protein, adsorption, Ti-PA-Mg, controlled, magnesium, release, Ti-PA-Mg, Human bone mesenchymal stem cells, adhesion, proliferation, osteogenic, differentiation, Ti-PA-Mg, samples, biocompatibility, osteoinductivity, Ti-PA-Mg, antibacterial, properties, porphyromonas gingivalis, Ti, PA-Mg, layer, Ti, surface, improved, osteogenic, antibacterial properties, dental implantation]]\n",
      "[[Early infection, peri-implantitis, implant, restoration, reasons, dental implant failure, Implant-associated infections, biofilm formation, study, co-incorporated zinc- (, Zn-, strontium- (Sr-, nanorod, coating, sandblasted, acid-etched, SLA, titanium, SLA-Zn/Sr, fabricated, hydrothermal synthesis, promoting, osteogenesis, inhibiting, biofilm formation, nanorod-like particles, SLA-Zn/Sr, Zn, Sr, well-crystallized, ZnTiO3, SrTiO3, phases, SLA-Zn/Sr, enhanced, corrosion, resistance, titanium, SLA-Zn/Sr, promoted, cellular, adhesion, proliferation, osteogenic, differentiation, rBMSCs, in vitro, inhibiting, adhesion, Staphylococcus aureus, Porphyromonas gingivalis, down-regulating, icaA, gene expression, surface, reduced, secretion, polysaccharide intercellular adhesion, reduced, SLActive, suppress, S. aureus, biofilm formation, chemical modification, titanium, multifunctional implant material, development, Zn/Sr co-doping, coating, material, properties, osteogenic, effect, antibacterial ability, titanium, simultaneously, enhanced, potential, dental implantation, future]]\n",
      "[[Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR, bacterial defense, mechanism, bacteriophages, parts, CRISPR, Cas genes, spacer acquisition, adaptation, module, Cas1, Cas2, proteins, inserts, spacers, CRISPR, array, CRISPR-Cas system, Proteus mirabilis, P. mirabilis, isolates, CRISPR loci, genomic, contents, P. mirabilis, isolates, locus, CRISPR, arrays, array, leader sequences, type I-E CRISPR-Cas system, isolates, source, spacers, identified, phages, prophages, CRISPR spacer origin, PAM, sequence, 5'-AAG-3' nucleotide stretch, spacers, CRISPR, arrays, P. mirabilis, isolates, integration, bacteriophageal, source, spacers, study, findings, area, P-mirabilis CRISPR-Cas system, analyzed, genome, P. mirabilis, isolates, Class I, CRISR-Cas systems, dominant, I-E., CRISPR, elements, regulatory role, motif, size, analyzed, genome, CRISPR-Cas system, transcription facilitator, targeting, Rho element]]\n",
      "[[Urinary tract infections, hospital admissions, Accurate, diagnosis, increasing, morbidity, mortality, antimicrobial resistance, evaluated, polymerase chain reaction test, Acuitas AMR Gene Panel, Acuitas Lighthouse Software, detection, uropathogens, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Enterococcus faecalis, antibiotic resistance genes, urine, prediction, phenotypic, resistance, semiquantitative detection, uropathogens, urine culture, urine, accuracy, genotypic, prediction, antibiotic resistance, E. coli, K. pneumoniae, P. mirabilis]]\n",
      "[[Nanoparticles, biological, pharmaceutical, industrial, applications, Green synthesis, nanoparticles, cost, effective, method, nanoparticle synthesis, Pseudomonas strains, isolated, rhizosphere, soil, samples, Cell free, supernatants, isolates, production, silver, nanoparticles, isolates, SMS13, SMS100, SMS124, nanoparticle producers, Amplification, DNA sequencing, 16srRNA gene, identified, strains, Pseudomonas aeruginosa, Scanning electron microscopy, particles, ranges, diameter, elemental, composition, silver, surface plasmon resonance, maximum, absorbance, nanoparticles, antibacterial activity, synthesized, nanoparticles, assessed, spot assay, Cell Free Supernatants, CFS, isolates, clinical, isolates, Salmonella typhi, Shigella dysentriae, Klebsiella pneumoniae, P. aeruginosa, Proteus mirabilis, Streptococcus epidermidis, Nanoparticles, suspension, isolates, antibacterial activity, screened, isolates, biological activity, CFS, strains]]\n",
      "[[emergence, transmission, antimicrobial resistance genes, threat, public health, plasmid-encoding RND, efflux, pump, TMexCD1-TOprJ1, Klebsiella pneumoniae, reduce, sensitivity, multiple, antimicrobials, identified, pandrug-resistant, Proteus mirabilis, isolate, novel, tmexCD3-toprJ3 gene cluster, SXT/R391, ICE, study, knowledge, transfer, mechanism, tmexCD1-toprJ1-like gene clusters, P. mirabilis, genomic epidemiology, investigations]]\n",
      "[[Objective, detect, frequency, pathogenic bacteria, zoonotic, ducks, dropping, environment, farmworkers, contact with, susceptibility, pattern, isolated, bacteria, antimicrobial drugs, efficiency, disinfectants, CID, Durak((R, hydrogen peroxide, H2O2, nano zinc oxide, ZnO, NPs, hydrogen peroxide, nano zinc oxide, H2O2/ZnO, NPs, composites, isolated, bacteria, evaluated, Materials, Methods, samples, duck, pens, fecal droppings, environmental samples, hands, pen workers, isolation, identification, bacterial strains, microbiological procedures, antibiotic, bacterial, isolates, disk diffusion assay, ZnO, NPs, H2O2/ZnO, NPs, characterized, Fourier-transform infrared spectrum, high-resolution transmission electron microscopy, efficacy, disinfectants, nanocomposites, enteropathogenic bacteria, broth macro-dilution method, results, prevalence, pathogenic bacteria, duck, pens, isolation, rate, detected, duck, fecal droppings, Escherichia coli, isolated, pathogen, Pseudomonas aeruginosa, Proteus mirabilis, Salmonella species, Multidrug resistance, MDR, detected, bacterial, isolates, efficiency, CID, Durak((R, disinfectants, bacterial, isolates, susceptible, exposure time, effectiveness, H2O2, enteropathogenic bacteria, concentration, sensitivity, Salmonella spp, Durak((R), duck, fecal droppings, primary source, bacterial, isolates, MDR, isolates, susceptible, CID, Durak((R, disinfectants, exposure time, concentration, 1:100, H2O2/ZnO, NPs, composite, lethal effect, testing, strains, exposure, biosecurity guidelines, mitigate, prevent, transmission, zoonotic, pathogens, farm, environment, duck, droppings]]\n",
      "[[male, mixed breed dog, wounds, epidermis, dermis, fascia, dorsum, thoracolumbar region, lumbosacral area, Lesions, dorsum, thorax, affecting, regions, necrotic, crepitating foci, shaving, histopathological, bacterial culture, polymicrobial necrotizing fasciitis, NF, diagnosed, Bruker MALDI Biotyper identification technique, Macrococcus caseolyticus, Proteus mirabilis, Escherichia coli, identified, bacteria, simultaneously, NF, dog, authors, microbes, associated with, NF, humans, animals]]\n",
      "[[Naja atra, venomous, Taiwan, bite, snake, wound necrosis, necrotizing, soft tissue infection, microbial, culture-based techniques, potential, human, pathogens, antibiotics, ineffective, management, wound infection, evaluated, 16S Sanger sequencing, next-generation sequencing, NGS, bacterial species, oropharynx, N. atra, microbial, VITEK 2 system, isolated, species, snakebite, wounds, 16S Sanger sequencing, bacterial clones, agar plates, bacterial species, oropharynx, N. atra, Morganella morganii, Proteus vulgaris, Proteus mirabilis, infected, bite, wound, NGS, 16S metagenomics, bacterial species, oropharynx, N. atra, bacterial species, identified, 16S Sanger sequencing, identified, NGS, 16S metagenomics, bacterial microbiota, oropharynx, N. atra, NGS, 16S, metagenomics, microbial, culture-based techniques, Stenotrophomonas maltophilia, Acinetobacter baumannii, Proteus penneri, identified, NGS, 16S metagenomics, bacterial microbiota, native, oropharynx, N. atra, bite, wound, therapeutic, empiric, antibiotic selection, N. atra bites]]\n",
      "[[OBJECTIVES, Malodors, soiled, cat litter, frustration, cat owners, absorbent, litters, claims, odor control, Technologies, effective, litter, odor control, evaluated, effectiveness, litter, formulation, 1-monochlorodimethylhydantoin (MCDMH)-modified, clinoptilolite, zeolite, MCDMH-Z, control, odors, 3-mercapto-3-methylbutanol (3M3MB, ammonia, principal products, enzymatic, breakdown, felinine, urea, efficacy, MCDMH-Z, odor control, MB, solid-phase microextraction, gas chromatography mass spectrometry analysis, colorimetric analysis, sensory panel, Enzyme inhibition, colorimetric coupled assay, ammonia, antimicrobial, properties, measured, reduction, colony-forming units, CFUs, MB, susceptible, modification, MCDMH-Z granules, Headspace, litter, MCDMH-Z, MB, levels, detected, products, Urease activity, decreased, incubation, MCDMH-Z, Cat litter F, inhibition, inhibition, ammonia, MCDMH-Z, reduced, CFUs, Proteus vulgaris, log reduction values, mins, amount, time, reduction, commercial products, tested, odor control, MCDMH-Z granules, sensory panel scoring, litters, Samples, litter products, effect, malodor, inhibition, urease, antimicrobial activity, MCDMH-Z granules, effective, test, categories, Control, odors, potential, cat owner satisfaction, beneficially, cat behaviors, pheromonally, sulfurous, metabolites, deposited, litter]]\n",
      "NaN\n",
      "[[Proteus vulgaris, foodborne, opportunistic pathogen, environmentally, clinically, appropriate, antibiotics, therapeutic effects, emergence, spread, drug-resistant, strains, study, P. vulgaris, strain, P3M, isolated, Penaeus vannamei, Tianjin, China, genome, P3M, sequenced, information, genes, metabolic pathways, physiological functions, antibiotic resistance genes, ARGs, genome, determination, inhibitory, concentrations, P3M, multidrug-resistant, MDR, bacterium, resistance, antibiotics, categories, Determination, fractional inhibitory concentration index, combination, ciprofloxacin, tetracycline, synergistic, antimicrobial activity, Bioinformatics, phylogenetic analyses, detected, presence, two-component systems, multidrug resistance, mobile genetic elements, horizontal, ARGs, P3M, P. vulgaris, strains, clinicians, infection control teams, worldwide, relevance, human, life, knowledge, isolation, characterization, foodborne, MDR, P. vulgaris, strain, study, theoretical, selection, clinical, antibiotics]]\n",
      "[[scenario, development, eco-friendly, multifunctional, low, cost, high, efficiency, center of focus, study, synthesis, magnesium oxide, MgO, chitosan-modified, magnesium oxide, CMgO, nanoparticles, NPs, green precipitation process, process, leaves extract, Plumbago zeylanica L, nucleating agent, MgO, CMgO, NPs, face-centered cubic structures, XRD studies, Morphologically, FESEM, TEM, images, MgO, CMgO, NPs, spherical, average, particle size, ~40+/-2, EDX spectra, elemental, compositions, nanoparticles, FTIR spectra, Mg-O stretching, frequency, MgO, CMgO, NPs, photoluminescence, spectra, MgO, CMgO, NPs, revealed, oxygen vacancies, active, radicals, biocidal activities, toxicity, effects, nanoparticles, cell viability, antibacterial, anticancer, measured, MCF-7 cell line, gram-negative bacteria, antibacterial activities, nanoparticles, Klebsiella pneumoniae, Escherichia coli, Shigella dysenteriae, Pseudomonas aeruginosa, Proteus vulgaris, Vibrio cholerae bacteria, MgO, CMgO, NPs, tested, breast cancer cell line, MCF-7, MTT assay, CMgO, NPs, anticancer, properties, MgO, NPs, CMgO, NPs, amount, cytotoxicity, bacterial, cancer cells, MgO, NPs, Toxicity studies, fibroblast L929 cells, CMgO, NPs, healthy cells, MgO, NPs, results, biopolymer, chitosan-modified, MgO, NPs, healthcare, industrial, applications, human, health conditions]]\n",
      "[[OBJECTIVE, study, experiment, morphological, features, infected, skin wounds, manifestation, acne vulgaris, severe, gel, carbon dioxide, extract, hops, Materials, methods, experimental study, male, WAG, rats, months, age, animals, groups, Group, intact, animals, Group, animals, hair epilation, dorsal surface, body, area, small es, Cyrillicm2, application, placebo gel, area, Group, animals, epilated, dorsal surface, body, area, small es, Cyrillicm2, gel, carbon dioxide, extract, hops, Group, rats, epilated, dorsal surface, body, area, small es, Cyrillicm2, simulated, thermal, damage, Group, rats, epilated, dorsal surface, body, area, small es, Cyrillicm2, simulated, thermal, damage, placebo gel, wound surface, Group, rats, measures, group, application, gel, carbon dioxide, extract, hops, wound surface, group, rats, epilated, dorsal surface, body, area, small es, Cyrillicm2, thermal damage, skin, soft tissues, simulated, wound surface, strains, Staphylococcus aureus, Streptococcus pyogenes, Proteus vulgaris, Propionibacterium acnes, Escherichia coli, Pseudomonas aeruginosa, Malassezia slooffiae, Malassezia pachydermatis, Candida albicans, Candida parapsilosis, groups, rats, measures, group, placebo gel, surface, infection, wound, group, group 9, gel, carbon dioxide extract, hops, material, study, skin, soft tissues, histological, histochemical, morphometric, statistical methods, Results, experimentally, gel, carbon dioxide, extract, hops, activates, separation processes, horny masses, surface, epidermis, cleaning, pores, skin, stimulating, proliferative activity, epidermis, marginal sections, wound, surface, regenerate, activating, processes, cleansing, wound, necrotic tissue, activating, growth, maturation, granulation tissue, transformation, connective tissue, anti-inflammatory, bactericidal, antimycotic, effects, normalizing, skin microbiocenosis, complex, morphological, gel, carbon dioxide, extract, hops, effective, drug, treatment, severe, acne vulgaris, characterized, development, deep, infected, wound defects]]\n",
      "[[Proteus species, human infections, infections, cause, study, detect, species, Proteus, PCR, RFLP, antibiotic resistance, pattern, cross-sectional study, Department of Microbiology of Dhaka Medical College, Dhaka, Bangladesh, wound swab, pus, urine, blood samples, tested, bacterial, pathogens, Proteus spp, identified, differentiated, biochemical test, PCR, RFLP, Antibiotic susceptibility, disc-diffusion technique, Fourty Proteus spp, isolated, culture positive samples, prevalence, Proteus infections, Proteus mirabilis, Proteus vulgaris, culture, biochemical test, PCR, RFLP, results, methods, biochemical tests, PCR, RFLP, 16S rRNA, digested, HaeIII, revealed, P. mirabilis, bands, bp, P. vulgaris, bands, proportion, P. mirabilis, P. vulgaris, proportion, Proteus spp, isolated, wound swab, pus, urine samples, proportion, Proteus spp, multidrug resistant, extensively drug resistant, Fosfomycin, sensitive, drug, imipenem, study, antibiotic resistance, pattern, Proteus spp, level, resistance, antimicrobial agents, PCR, RFLP, method, differentiate, species, Proteus, treat]]\n",
      "[[Novel, tri-phase, CuO-MgO-ZnO, nanocomposite, co-precipitation technique, investigated, physical properties, characterization techniques, XRD, FTIR, Raman, IV, UV-vis, PL, SEM, application, grown, CuO-MgO-ZnO, nanocomposite, degradation, dyes, sunlight, antibacterial activity, bacteria, XRD, diffraction, peaks, CuO, monoclinic, MgO, cubic, ZnO, hexagonal, CuO, phase, MgO, ZnO, optical energy, nanocomposite, efficient, catalyst, sunlight, Raman, FTIR spectra, formation, nanocomposite, SEM, images, agglomerated, rod-shaped, morphology, EDX, results, atomic percentage, element, Cu>Zn>Mg, PL, results, presence, intrinsic defects, photocatalytic activity, methylene blue, MB, methyl orange (MO, rhodamine-B, RhB, cresol red, CR, P-nitroaniline, excellent, degradation, efficiencies, dye, concentration, dye, concentration, sunlight, illumination, degradation, generation, superoxide, hydroxyl radicals, recyclability test, reusability, catalyst, 5th cycle, antibacterial activity, Escherichia coli, Klebsiella pneumoniae, Proteus Vulgaris, Staphylococcus aureus, Pseudomonas aeruginosa bacteria, zone, inhibition]]\n",
      "[[Bioremediation, microbial, consortia, individual, species, natural environments, Biodegradation, dicarboximide fungicides, brunisolic soil, bacterial, cocultures, Providencia stuartii JD, Brevundimonas naejangsanensis J3, cocultures, degraded, dimethachlon, iprodione, procymidone, liquid culture, efficiency, strains, JD, J3, cocultures, dimethachlon, iprodione, procymidone, cocultures, immobilized, charcoal-alginate-chitosan carrier, free, cocultures, degradability, stability, reusability, brunisolic soils, treated, immobilized, cocultures, a.i./ha dimethachlon, iprodione, procymidone, degraded, half-lifes, immobilized, cocultures, free cocultures, natural dissipation, study, strains, JD, J3, synergetic degradation, bioremediation, dicarboximide fungicide, contamination]]\n",
      "[[study, investigate, effect, oropharyngeal aspiration, ventilator-associated pneumonia, VAP, incidence, patient, randomized controlled experimental study, anesthesiology, reanimation, intensive care unit, ICU, patients, experimental group, oropharyngeal aspiration, surgical, position change, Patients, control group, oropharyngeal aspiration, age, patients, years, mean, median, duration of stay, ICU, days, mean, median, duration, mechanical ventilation, days, patients, VAP, duration, VAP, development, days, rate, VAP, development, mechanical ventilator, days, experimental group, patients, VAP, control group, patients, VAP, VAP, rate, control group, mechanical ventilator, VAP, rate, experimental group, mechanical ventilator, VAP agents, multidrug resistant, Distribution, isolated, microorganisms, Acinetobacter baumannii, Pseudomonas aeruginosa, Corynebacterium striatum, Staphylococcus aureus, Providencia stuartii, Serratia marcescens, Stenotrophomonas maltophilia, Aspergillus flavus, study, oropharyngeal aspiration, patient, prevented, development, VAP]]\n",
      "[[aac(6')-Ib-cr, bla KPC genes, spreading, Enterobacteriaceae, species, Providencia stuartii, countries, world, genes, investigated, P. stuartii, isolates, public hospital, Recife, Pernambuco, Brazil, PCR, sequencing, aac(6')-Ib-cr gene, detected, resistant, isolates, bla KPC gene, presence, genes, P. stuartii, drug-resistant, isolates, resistance, species, increasing, therapeutic options]]\n",
      "[[mass spectrometry-based methods, antimicrobial sensitivity testing, years, alternative, testing systems, cost-, time-efficiency, study, LC-MS/MS-based, antibiotic, hydrolysis, assay, antimicrobial resistance, AMR, Gram-negative bacteria, Materials, Methods, species, Gram-negative bacilli, Klebsiella pneumoniae, Escherichia coli, Providencia stuartii, Acinetobacter baumannii, tested, antibiotics, classes, ampicillin, meropenem, imipenem, ceftazidime, ceftriaxone, cefepime, Bacterial suspensions, species, incubated, antibiotics, antibiotic, incubation, measured, LC-MS/MS, results, measurements, E. coli, strain, sensitive, antibiotics, expressed, percentage, hydrolyzed, antibiotic, bacteria, identification, susceptibility testing, LC-MS/MS assay, commercial, antimicrobial, organism, resistant/sensitive, antibiotic, time, LC-MS/MS-based hydrolysis test, shorter, susceptibility testing, platforms, sensitive, strain, results, interpretation, simultaneous, multiple, antibiotics, protocol, robustness, multiplexing, methods, antibiotic sensitivity testing, research, routine, assimilation, method, strains, intermediate resistance]]\n",
      "[[bacterial genus, Providencia, Gram-negative, opportunistic, pathogens, isolated, environments, organisms, humans, animals, Providencia alcalifaciens, Providencia rettgeri, Providencia stuartii, clinical, isolates, species, pathogenicity, antibiotic resistance, environmental, adaptation, Genomes, isolates, genus, Providencia, investigated, genetic diversity, virulence factors, antibiotic resistance genes, environmental, adaptation, study, pan-genome, genus, Providencia, gene families, Species, genus, Providencia, functional, constraints, core genes, accessory genes, unique, genes, maximum-likelihood phylogeny reconstructed, concatenated single-copy core genes, Providencia, isolates, distant groups, Comprehensive, systematic, distributions, virulence genes, homologous, virulence genes, genus, Proteus, diversity, pathogenicity, Providencia alcalifaciens, Providencia rettgeri, Providencia stuartii, multidrug resistance, MDR, phenotypes, isolates, Providencia rettgeri, Providencia stuartii, resistance genes, integrons, Providencia rettgeri, Providencia stuartii, genes, material, transport, energy metabolism, diverse, environments, study, genetic diversity, functional, features, genus, Providencia, genetic mechanisms, diversity, pathogenicity, antibiotic resistance, environmental, adaptation, members, genus]]\n",
      "[[Multidrug-resistant, MDR, bacteria, morbidity, mortality, study, investigate, in vitro, antibacterial activities, crude methanol extract, constituents, isolated, Column Chromatography, CC, Cassia sieberiana bark, CSB, MDR, Gram-negative bacteria, mechanisms, action, active, antibacterial activity, tested samples, extract, fractions, compounds, isolated, CC, structures, (1)H, (13)C Nuclear magnetic resonance, presence, absence, efflux, pumps inhibitor, phenylalanine-arginine beta-naphthylamide, PAbetaN, evaluated, micro-dilution method, effects, active, evaluated, cell growth, kinetic, bacterial, H(+)-ATPase proton pumps, Phytochemical composition, crude extract, distribution, secondary, metabolites, presence, polyphenols, tannins, steroids, triterpenes, flavonoids, alkaloids, saponins, absence, anthocyanins, anthraquinones, tested, samples, antibacterial activities, inhibitory, concentrations, MICs, Crude extract, CS, fraction, inhibitory spectra, inhibiting, bacteria, Enterobacter aerogenes, EA27 strain, Fraction, bactericidal effects, bacteria, crude extract, CS, sub-fraction, CSc2, bacteriostatic effects, Compounds 1, spectaline, iso-6-cassine, inhibited, growth, Escherichia coli, ATCC8739, AG102, Klebsiella pneumoniae, Enterobacter aerogenes, EA27, Providencia stuartii ATCC29916, Pseudomonas aeruginosa PA01, Escherichia coli, ATCC8739, Klebsiella pneumoniae, ATCC11296, KP55, Providencia stuartii ATCC29916, Pseudomonas aeruginosa PA01, PA124, bacteria, MICs, mug/mL., presence, PAbetaN, activities, crude extract CS, fraction, CAc, sub-fraction, CSc2, increased, bacteria, strains, MICs, decreased, Sub-fraction, inhibited, H(+)-ATPase proton pumps, growth, kinetic, Escherichia coli, ATCC8739, results, C. sieberiana, treatment, bacterial infections]]\n",
      "[[Bacterial, AR, primary, public, Saudi National Action Plan, SNAP, AR, effectiveness, plan, evaluated, rates, AR, extended-spectrum beta-lactamase, ESBL, positivity, multi-drug resistance, MDR, gram-negative bacteria, private Saudi hospital, retrospective study, patients, diagnosis, gram-negative bacterial infection, Identification, bacterial strains, VITEK 2, ID-GNB cards, AR, ESBL, MDR, AST-No, cards, manufacturer, Cards, VITEK 2 system, examination, isolated, gram-negative bacteria, isolated, organism, Escherichia coli, strains, Providencia stuartii, strains, clinical, isolates, ESBL-positive, 851/4760, MDR, Escherichia coli, isolated, ESBL, activity, MDR, 772/1328, isolates, rates, ESBL, MDR, bacteria, Salmonella species, increased, resistance, antibiotics, findings, rates, AR, ESBL, MDR, reduced, time, SNAP, effective, AR, risk]]\n",
      "[[investigate, clinical, drug resistance, characteristics, Providencia stuartii infections, Huainan region, Anhui, clinical selection, antimicrobial agents, single-center retrospective analysis, patients, P. stuartii infection, Huainan, period, hospital department, patients, treated, drug susceptibility, characteristics, P. stuartii, isolates, patients, lung, site, infection, intensive care unit, hospital department, Extended spectrum, expression, isolates, P. stuartii, isolates, drug resistance, extensive, drug resistance, P. stuartii, isolates, sensitive, cefepime, imipenem, beta-lactam antibiotics, isolates, resistant, antibiotics, patients, infected, drug-resistant, isolates, died, Drug resistance, increasing, P. stuartii, antimicrobial agent, imipenem, effective, treatment, P. stuartii infections, Fluoroquinolones, aminoglycosides, fourth-generation cephalosporins, options, antibiotic therapy]]\n",
      "[[years, infections, drug-resistant, microbes, impacted, health care system, infections, carbapenem-resistant, CR, Gram-negative bacilli, increased, CR-Gram-negative bacilli, carbapenemases, NDM-1, Enterobacterales, NDM-1, Providencia stuartii, Morganellaceae, family, environment, nosocomial infections, genomic analysis, NDM-1-, P. stuartii, strains, recovered, patient, carbapenem, resistant, strains, recovered, hospital, genomic analysis, resistance genes, beta-lactams, blaOXA-1, blaTEM-1, blaNDM-1, aminoglycosides, aphA6, aac(3)-IId, aac(2')-Ia, sulfonamides, sul1, chloramphenicol, catB3, catA3, rifampicin, bleomycin, ble, tetracycline, mobile genetic elements, insertion sequences, plasmids, sequences, P. stuartii, genomes, spread, carbapenem-resistant, isolates, clinical, public health, detection, CR, isolates, problem]]\n",
      "[[Providencia stuartii, opportunistic pathogen, Enterobacteriales, draft, genome sequence, New Delhi metallo-beta-lactamase, Providencia stuartii, isolated, emergency, patient, private clinic, Lima, Peru]]\n",
      "[[Macrophages, polarization, infection control, Llipopolysaccharide, LPS, host, innate immune, LPS, structure, Pseudomonas aeruginosa, modifies, adaptation, pathogen, biofilm-related chronic infection, Gap statement, studies, LPS, induced, polarization, human, mouse macrophages, results, lipid A, structure, LPS, biofilm-forming, Pseudomonas aeruginosa, PAO1, modified, study, investigate, effect, pathway, LPS, biofilm-forming, PAO1, human, murine, macrophage, polarization, Methodology, LPS, isolated, biofilm-forming, planktonic, PAO1, quantified, LPS, PMA-differentiated, human, THP-1 cells, Raw264.7 murine, macrophage cells, expression, iNOS, Arg-1, IL4, TNF-alpha, CCL3, CCL22, analysed, cell lines, expression, TICAM-1, MyD88, human, THP-1 macrophages, quantified, Western blot, PAO1, infected, macrophages, polarization states, intracellular, bacterial growth, macrophages, evaluated, Results, LPS, biofilm-forming, PAO1, induced, hyperinflammatory responses, THP-1, Raw264.7 macrophages, LPS, planktonic, PAO1, responses, up-regulation, MyD88, Intracellular, growth, PAO1, increased, THP-1 macrophages, polarized, LPS, biofilm-forming, PAO1, decreased, THP-1, Raw264.7 macrophages, polarized, LPS, planktonic, PAO1.Conclusion, in vitro study, LPS, biofilm-forming, PAO1, M1, polarization, human, murine, macrophage cell lines, LPS, planktonic, PAO1]]\n",
      "[[infectious foot ulcers, lower-limb amputation, action, early detection, sufficient, treatment, diabetic foot infection, DFI, study, investigating, bacterial, epidemiology, antimicrobial resistance, AMR, patterns, DFIs, Iran, systematic search, PubMed, Embase, Web of Science, Scopus, Google Scholar, Scientific Information Database, articles, proportion, bacteria, isolated, Iranian, DFI, samples, Quality, assessed, Joanna Briggs Institute tool, pooled, estimate, proportion, confidence interval, CI, calculated, random effect method, studies, eligible, bacterial, isolates, patients, predominant, isolates, recovered, DFIs, Staphylococcus aureus, proportion, CI, CI, methicillin-resistant S. aureus, MRSA, Gram-negative strains, Escherichia coli, proportion, CI, Pseudomonas aeruginosa, CI, pooled, estimates, resistance, cotrimoxazole, ciprofloxacin, S. aureus, CI, E coli, isolates, CI, study, AMR, level, Iran, clinicians, bacterial resistance, patterns, antibiotic regimens]]\n",
      "[[Infections, drug-resistant bacteria, human, health, global public health, discover, antimicrobial agents, multidrug-resistant bacteria, study, synthesized, membrane-active bakuchiol derivatives, biomimicking, structure, function, cationic antibacterial peptides, compound, antibacterial activity, Gram-positive bacteria, concentration, MIC, Gram-negative bacteria, MIC, weak, hemolytic activity, low, cytotoxicity, Compound, bactericidal, properties, bacterial resistance, compound, in vivo, antibacterial, efficacy, Staphylococcus aureus, Pseudomonas aeruginosa, murine, corneal infection, models, design, effective, solution, antibiotic crisis]]\n",
      "[[semisyntheses, polymyxin, analogues, 2-Thr, modifications, structure-activity, SAR, total-synthetic strategies, replacements, 2-Thr, semisynthetic approaches, esterification, 2-Thr, esterification, results, in vitro, antibacterial assays, SAR, analysis, replacement, amino acids, hydrophobic side chains, activity, Pseudomonas aeruginosa, effects, Gram-negative bacteria, aminoacetyl esterification, antibacterial activity, compound, activity, strains, lower, toxicity, HK-2 cell line, SAR, polymyxin, development, novel, polymyxin derivatives]]\n",
      "[[Whole-genome sequence, Pseudomonas sp., Kongsfjorden, Arctic fjord, investigated, molecular machinery, microbial, association, survival, polar fjord, genome size, Kongs-67, Antarctic P. pelagia, CL-AP6, genome, encodes, chemotaxis response regulator proteins, chemoreceptors, methyl-accepting chemotaxis proteins, flagellar system proteins, FliCDEFGOPMN, FlhABF, FlgBCDEFGHIJKL, MotAB proteins, cellular interactions, dynamic, fjord, proportion, genes, biofilm formation, pgaABCD operon, signal transduction protein, categories, EnvZ/OmpR, CpxA/CpxR, PhoR/PhoB, PhoQ, biofilm formation, Kongs-67, response, availability, signalling-metabolites, genome, Kongs-67, encoded, HemBCD, CbiA, CobABNSTOQCDP, BtuBFR proteins, cobalamin, biosynthesis, transport, proteins, siderophore-mediated iron channelling, PchR, Fur protein, FpvA, microbial, association, genomes, Arctic strain, Kongs-67, Antarctic strain, CL-AP6, retainment, core genes, polar, Pseudomonas strains, evolutionary, adaptation, survival, polar fjord, study, knowledge, genetics, polar, Pseudomonas member, biosynthetic potentials, Pseudomonas sp. Kongs-67, investigation, functional aspects, molecular adaptations, polar marine]]\n",
      "[[effective, antimicrobial agents, modes, action, emergence, drug-resistant bacteria, ruthenium complexes, functionalized, benzothiophene, [Ru(phen)2(BTPIP)](ClO4)2, Ru(II)-1, [Ru(dmp)2(BTPIP)](ClO4)2 (Ru(II)-2, [Ru(dmb)2(BTPIP)](ClO4)2, Ru(II)-3, phen, 1,10-phenanthroline, synthesized, antimicrobial activities, in vitro, assessed, MIC, Ru(II)-1, Ru(II)-2, Ru(II)-3, complexes, antibacterial activity, Staphylococcus aureus, Pseudomonas aeruginosa, active, Ru(II)-3 complex, biofilms, tested, complex, Ru(II)-3, antibacterial adjuvant, checkerboard, data, Ru(II)-3, synergism, aminoglycoside antibiotics, synergetic effect, inhibition, regulatory function, SaCcpA., in vivo, bacterial infection, treatment studies, murine, skin infection, model, skin irritation test, results, ruthenium complexes, functionalized, benzothiophene, antimicrobial activity, Staphylococcus aureus]]\n",
      "[[glycoside hydrolase, PslG, attacks, degrades, dominant, Psl polysaccharide, exopolymeric substance, EPS, Pseudomonas aeruginosa, biofilms, therapy, potentiate, effect, antibiotics, coadministration, antibiotic, potential, susceptibility, PslG, proteolysis, effective, delivery system, liposomes, lipid liquid, LCNPs, PslG, tobramycin, potential, formulation, PslG, proteolysis, enzyme's, release, presence, bacteria, improve, antimicrobial, in vitro, in vivo, Caenorhabditis elegans infection, model, LCNPs, effective, formulation, PslG, tobramycin, enzyme, proteolysis, triggered, sustained, release, PslG, improved, antimicrobial effect, increased, survival, C. elegans, infected, P. aeruginosa, Digestible, LCNPs, triggering, enzyme's, release, presence, bacteria, nondigestible, LCNPs, LCNPs, PslG, proteolysis, potentiate, antimicrobial activity, combination, tobramycin, C. elegans, antimicrobial, efficacy, tobramycin-LCNPs, PslG + tobramycin-LCNPs, reduction, bacteria, compared, unformulated, combination, Herewith, LCNPs, protective delivery system, biofilm, enzymes, antibiotics, infection-directed therapy, improved, performance]]\n",
      "[[Plant, responses, pathogen, attacks, temperature stress, HTS, nature, signaling components, plants, responses, signaling, intermediates, reverse-genetics approaches, mechanism, trade-offs, pepper, Capsicum annuum, growth, immunity, thermotolerance, NAC-type transcription factor, CaNAC2c, induced, HTS, Ralstonia solanacearum infection, RSI, CaNAC2c, inhibited, pepper growth, promoted, immunity, RSI, activating, jasmonate-mediated, immunity, H2O2, accumulation, HTS, responses, activating, Heat shock factor A5, transcription, blocking, H2O2, accumulation, CaNAC2c, physically, CaHSP70, CaNAC029, HTS, CaNAC2c-CaHSP70 interaction, nucleus, CaNAC2c, degradation, activation, thermotolerance, increasing, CaNAC2c binding, transcriptional activation, target, promoters, CaNAC2c, induce, immunity-related genes, HTS, degradation, CaNAC029, 26S proteasome, RSI, CaNAC2c, CaNAC029, nucleus, activated, jasmonate-mediated, immunity, prevented, activating, thermotolerance-related genes, non-stressed plants, CaNAC2c, nucleus, interaction, CaHSP70, activate, immunity, thermotolerance, results, pepper growth, immunity, thermotolerance, coordinately, CaNAC2c, inducible, expression, differential, interaction, CaHSP70, CaNAC029]]\n",
      "[[Multiprotein bridging factor 1, MBF1, transcription coactivator, pathogens, regulatory mechanisms, MBF1, resistance, bacterial wilt, StMBF1c, potato resistance, Ralstonia solanacearum infection, characterized, qRT-PCR, StMBF1c, SA, MJ, ABA, expression, StMBF1c gene, induced, R. solanacearum, upregulated, expression, early, middle stages, bacterial wilt, co-expression, analysis, disease-resistant, marker genes, gain-of-function, loss-of-function assays, StMBF1c, associated with, defence priming, Overexpression, silencing, MBF1c, plants, resistance, sensitivity, R. solanacearum, inducing, reducing, NPR, PR, genes, SA, signal pathway, Yeast two-hybrid, Y2H, bimolecular fluorescence complementation, BiFC, experiment, results, interaction, StMBF1c, StTPS5, ABA, potato, StTPS5, resistance, StMBF1c, activated, participate, potato bacterial wilt, resistance, EPI, PTI]]\n",
      "[[Airborne, microorganisms, waste, environments, active, complex, compared, diversity, structure, airborne bacteria, waste-associated environments, study, airborne, bacterial, community, electronic waste, waste transfer station, culture-dependent, culture-independent methods, isolates, airborne sites, residential area, electronic industrial park, office area, near, electronic waste, waste transfer station, Southern China, morning, afternoon, evening, isolates, isolated, air, novel, species, Sanger sequencing, Bacterial, communities, waste-associated bioaerosols, Proteobacteria, Bacteroidetes, Abundant, genera, Paracaedibacteraceae, uncultured EF667926, Ralstonia, Chroococcidiopsis, Chitinophagaceae, uncultured FN428761, Sphingobium, Heliimonas, species, genera, uncultured, approximately, community structure, airborne, bacterial, diversity, sampling sites, results, waste-associated environments, bacterial, diversity, studies, environments, bacterial, community]]\n",
      "[[Ralstonia solanacearum, bacterial wilt disease, solanaceous crops, Identification, avirulence type III secreted, effectors, disease resistance proteins, host, plant, species, resistance, crops, study, R. solanacearum effector, RipJ, functions, avirulence, determinant, Solanum pimpinellifolium LA2093, avirulence, shortlisted, effector repertoire, comparison, avirulent Pe_9, virulent, Pe_1 strain, Infection assays, transgenic, Pe_1 strain, avirulence effector, Pe_9, RipJ, bacterial wilt, resistance, S. pimpinellifolium LA2093, identified, RipJ, natural, variants, induce, bacterial wilt, resistance, S. pimpinellifolium LA2093, RipJ, YopJ, family, acetyltransferases, sequence analysis, presence, amino acid residues, acetyltransferase catalytic triad, effector-triggered immunity, RipJ, auto-acetylate, lysine residues, study, reports, identification, R. solanacearum avirulence protein, triggers, bacterial wilt, resistance, tomato, discovery, RipJ, avirulence protein, development, bacterial, tomato, varieties, future]]\n",
      "[[plant pathogen, Ralstonia solanacearum, plant, resources, intensely, proliferate, xylem, vessels, plant wilting, automatic phenotyping, tissue/xylem, quantitative, metabolomics, infected, tomato plants, dynamics, bacterial wilt, acquisition, physiological, parameters, transpiration, growth, Measurements, tipping point, bacterial wilt, dynamics, tipping point, bacterial density, plant, physiology, induces, death, metabolic, physiological signatures, infection, drought stress, changes, Quantitative, dynamics, xylem, content, glutamine, asparagine, primary resources, R. solanacearum, colonization, abundant, production, putrescine, infection, process, correlated, planta, bacterial, Dynamic profiling, xylem, metabolites, glutamine, substrate, R. solanacearum, triple mutant strain, metabolize glucose, sucrose, fructose, reduced, planta growth, pathogenicity]]\n",
      "[[Bacterial wilt, Ralstonia solanacearum species, complex, soil-borne disease, plant species, peanut, yield, quality, losses, measures, bacterial wilt, lack, research, pathogenic, mechanism, bacterial wilt, complete, genome, toxic, Ralstonia solanacearum, species, strain, Rs-P.362200, peanut, pathogen, genome, encoding, genes, average, G + C, content, coding genes, type III effector proteins, pseudogenes, Phylogenetic analysis, strains, Rs-P.362200, genetic distance, geographic origins, phylotypes, host, species, associated with, complexity, strain, distribution, numbers, effectors, virulence factors, changed, strains, genomic analysis, families, genes, strain, compared, pathogenic, strains, analysis, genes, homologous genes, gene ID, encoding, virulence protein, RipP1, associated with, host, Rs-P.362200 strain, bacteria, pathogenicity, islands, prophages, genes, effectors, genes, effectors, mechanism, horizontal gene transfer, pathogenicity, evaluation, hosts, HA4, Rs-P.362200 strains, genes, genomes, genomic islands, prophages, HA4, genome, Rs-P.36220, bacterial wilt, pathogens, genome sequence analysis, peanut, bacterial wilt, pathogen, enhanced, information, R. solanacearum, genome, research, theoretical, research, interaction, Ralstonia solanacearum, peanut]]\n",
      "[[Nicotinamide adenine dinucleotide phosphate, dehydrogenases, catalyze, chemical reactions, applications, cofactor, NAD(P)H, engineered, thermotolerant phosphite dehydrogenase, Ralstonia sp. 4506, RsPtxD, cofactor, specificity, efficient, robust, NADPH regeneration system, amino acid residues, Cys174-Pro178, C-terminus, beta7-strand, Rossmann-fold domain, RsPtxD, site-directed mutagenesis, mutants, increased, preference, NADP, catalytic, efficiency, mutant, RsPtxDHARRA, NADP, highest, phosphite dehydrogenases, RsPtxDHARRA, mutant, thermostability, degrees, tolerance, organic solvents, bound, NADP, applicability, RsPtxDHARRA, NADPH regeneration system, reaction, chiral, conversion, 3-dehydroshikimate, shikimic acid, thermophilic shikimate dehydrogenase, Thermus thermophilus HB8, degrees, parent, RsPtxD, enzyme, RsPtxDHARRA, mutant, alternative, NADPH regeneration system, applications]]\n",
      "[[Soil, microbiome, manipulation, pesticides, improving, soils, pathogen infestation, natural, suppressiveness, simulated, soil, fumigation, investigated, application, bio-organic, organic, amendments, reshapes, taxonomic, functional, potential, soil, microbiome, suppress, pathogens, Ralstonia solanacearum, Fusarium oxysporum, tomato, monocultures, organic, amendment, shifts, bacterial, fungal, community, composition, suppressiveness, Fumigation, decreased, F. oxysporum, induced, drastic changes, soil, microbiome, disease, suppressive, soil, microbiome, application, organic, amendment, affected, bacterial, fungal, communities, reassembled, indirect, effects, efficient, disease control rate, control, diseases, pathogens]]\n",
      "[[Rickettsia felis, obligate, intracellular, bacterium, infecting, ticks, fleas, lice, arthropods, bacterium, Transitional Group, evidence, R. felis, mutualistic, relationship, eukaryote organisms, scientific, R. felis, moths, Lepidoptera, association, work reports, identification, bacteria, R. felis, Phereoeca sp., polymerase chain reaction, assay, gltA, ompA, ompB, genes, nucleotide sequences, identity, Rickettsia felis sequences, genus-level, identification, moth larvae, morphological, taxonomic, keys, PCR analysis, cytochrome oxidase I, nucleotide sequenced, similarity, species, Phereoeca praecox, sequences, deposited, databases, species, Phereoeca sp., results, R. felis, organism, blood-feeding behavior, Lepidoptera, booklice, Psocoptera, investigation, pathogenic, mutualistic, association, moths]]\n",
      "[[Rickettsia amblyommatis, spotted fever, group, Rickettsia, infects, Amblyomma americanum, Lone Star ticks, transmission, offspring, mammals, geographic, A. americanum, southeastern, United States, tick, surveys, identified, progressive, northward, invasion, A. americanum, increased, patients, febrile illnesses, etiology, tick bite, northeastern, United States, serological, evidence, patients, infected, R. amblyommatis, virulence, potential, R. amblyommatis, bioinformatic analysis, genome sequences, R. amblyommatis, identified, presence, multiple, putative virulence genes, products, spotted fever, pathogenesis, pathogenic, spotted fever rickettsiae, R. amblyommatis, intracellularly, cytoplasm, tissue culture cells, R. amblyommatis, defective, attachment, microvascular, endothelial cells, attachment, defect, slow growth, R. amblyommatis, intravenous, dose-dependent, morbidity, mortality, C3H mice, results, clinical, evidence, R. amblyommatis, mild disease, manifestation, patients]]\n",
      "[[Undifferentiated febrile illness, medical problem, world, low-, middle-income countries, Scientific, clinical investigations, undifferentiated febrile illness, rickettsial diseases, Kazakhstan, lacking, study, investigation, antibodies, spotted fever group, SFG, typhus group, rickettsiae, patients, undifferentiated febrile illness, southern region, Kazakhstan, Almaty, Kyzylorda oblasts, hospitals, oblasts, presence, IgM, IgG antibodies, typhus, group, IgG antibodies, spotted fever group rickettsiae, ELISA, Patient's, questionnaires, statistically analyzed, inpatients, Almaty, Kyzylorda (N = 4) hospitals, research, ELISA, results, patients, oblasts, IgG antibodies, SFG rickettsiae, patients, acute infection, tick-borne rickettsiosis, TG rickettsiae, R. typhi, infection, detected, febrile, patients, acute infection, patients, oblasts, data, SFG, TG, rickettsioses, Kazakhstan, Kazakh physicians, diseases, investigated, oblasts, occurrence, diseases, suspected, day-to-day, clinical practice, identification, rickettsial, pathogens, implementation, modern laboratory methods, diagnostics, rickettsioses, Kazakhstan]]\n",
      "[[case, Rickettsia sibirica subspecies sibirica, BJ-90, infection, China, metagenomic analysis, eschar biopsy, specimen, nested PCR, Seroprevalence, spotted fever group, Rickettsia, local population, report, threat, rickettsioses, public health, Qinghai-Tibet Plateau]]\n",
      "[[Birds, hosts, maintenance, spread, ticks, worldwide, species, Amblyomma, rickettsial agents, members, spotted fever group, SFG, survey, diversity, tick, rickettsial agents, infecting, ticks, wild birds, Atlantic rainforest, state, Bahia, Brazil, birds, families, species, specimens, parasitized, immature ticks, larvae, nymphs, species, level, species, genus, Amblyomma, Amblyomma longirostre, Amblyomma nodosum, Amblyomma varium, Amblyomma parkeri, Amblyomma coelebs, Amblyomma calcaratum, Amplification, PCR, sequencing, rickettsial genes, gltA, ompA, detected, presence, Rickettsia DNA, ticks, Rickettsia amblyommatis, agent, detected, larvae, nymphs, A. longirostre, nymph, A. varium, similarity]]\n",
      "[[Rickettsia species, identified, ticks, fleas, sheep keds, Melophagus ovinus, bats, Pipistrellus pipistrellus, tick-bitten, patient, Xinjiang, XUAR, northwestern China, molecularly, rickettsial agents, red fox, Vulpes vulpes, marbled polecat, Vormela peregusna, ticks, red foxes, marbled polecat, ticks, sampled, counties, city, XUAR, heart, liver, spleen, lung, kidney, carnivores, dissected, DNA extraction, Hard ticks, morphologically, molecularly, samples, presence, rickettsiae, genetic markers, gltA, ompA, sca1, adult, ticks, nymphs, Ixodes canisuga, Ixodes kaiseri, Haemaphysalis erinacei, Dermacentor marginatus, red foxes, Ha., erinacei ticks, marbled polecat, Analysis, cytochrome c oxidase subunit I, gene sequences, nucleotides, I. canisuga, I. kaiseri, Ha., erinacei, northwestern China, Europe, Rickettsia raoultii, detected, red foxes, Candidatus Rickettsia barbariae, red fox, Rickettsia sibirica, red fox, marbled polecat, R. raoultii, tick, species, I. canisuga, D. marginatus, knowledge, I. canisuga, red foxes, China, DNA, R. sibirica, R. raoultii, detected, organs, red foxes, R. sibirica, organs, marbled polecat, molecular evidence, presence, R. raoultii, I. canisuga, findings, tick-borne, pathogens, wildlife species, associated ticks, China]]\n",
      "[[knowledge, Rickettsia felis infection, humans, sporadic, case reports, retrospective, seroepidemiological survey, R. felis infection, febrile, patients, visiting, medical center, Taipei, METHODOLOGY/PRINCIPAL, FINDINGS, patients, suspected, rickettsioses, fever, FUO, negative, scrub typhus, murine typhus, Q fever, retrospectively, serum samples, presence, antibodies, R. felis, Rickettsia japonica, Rickettsia typhi, microimmunofluorescence, MIF, assay, Serological, evidence, Rickettsia exposure, patients, patients, antibodies, R. felis, infection, increase, IgG, titer, acute, convalescent, sera, clinical presentations, patients, fever, skin rash, lymphadenopathy, severe, conditions, pancytopenia, hepatomegaly, elevated, life-threatening, acute respiratory distress syndrome, patients, died, doxycycline, negative, scrub typhus, Q fever, murine typhus, Rickettsia felis, flea-borne, pathogen, Taiwan, infection, life-threatening, prospective studies, prevalence, R. felis, patients, FUO, clinical manifestations]]\n",
      "[[rodent-murine ectoparasite-human model, plague, transmission, historical, plague, pandemics, Europe, analysis, genomes, Yersinia pestis, transmitted, rat, fleas, Present, rodent-murine ectoparasite-human model, plague, transmission, historical, plague, pandemics, Europe, Review, data, Y pestis, transmission, human, lice, context, genomic evolution, co-transmission, epidemic, pathogens, human history, plague, transmission, Experimental models, efficiency, human, lice, plague vectors, infected, faeces, Y pestis, louse-borne disease, Borrelia recurrentis, Rickettsia prowazekii, Bartonella quintana, Studies, louse-borne, outbreaks, pathogens, cases, co-transmission, Y pestis, B quintana, louse-borne bacterium, B recurrentis, circulating, northern Europe, plague, pandemic, data, historical, pandemics, multiple bacteria, human, lice, interhuman, transmission, plague, pathogen, co-transmission, epidemics, plague, pandemics]]\n",
      "[[Depicting, epidemics, DNA-based, detection, pathogens, pathogens, well-preserved, DNA sequences, paleoserology, antibodies, mini line-blot format, positive, negative, Mini line blot assay, skim milk, negative control, Staphylococcus aureus, positive control, antigens, lice-borne, pathogens, Rickettsia prowazekii, Borrelia recurrentis, Bartonella quintana, Yersinia pestis, Paleoserums, rehydrated, dental pulp, recovered, buried, individuals, Mini line blots, naked eye, quantified, scanner, software, Paleoserology, indirect, detection, lice-borne, pathogens, skeletons, exhumed, suspected, military burial site, Auxi-le-Chateau, exhumed, burial site, Saint-Mont, detection, pathogens, quantitative real-time PCR, Auxi-le-Chateau, paleoserology, paleoserums, positives, B. recurrentis, positive, B. quintana, Saint-Mont, paleoserology, paleoserums, pathogens, Antibodies, R. prowazekii, pestis, detected, seroprevalence, military burial site, Auxi-le-Chateau, civil burial site, Saint-Mont, Real-time PCR, detection, B. quintana, positive, Saint-Mont, Auxi-le-Chateau, B. recurrentis, detected, Paleoserology, outbreak, relapsing, B. recurrentis fever, military garrison, real-time PCR, Paleoserology, investigating, epidemics, DNA sequence-based approaches]]\n",
      "[[authors, methodological approach, study, IgM/IgG, Rickettsia prowazekii, sera, estimation, avidity index, IgG., data, authors, conclusions, epidemic, outbreak, Russia]]\n",
      "[[Pediculus humanus, ecotypes, body, head lice, obligate, bloodsucking, parasite, human, hosts, years, information, human, migration, Pediculosis, head lice, year, world, pathogenic bacteria, associated with, body lice, detected, Gabon, pediculosis, widespread, data, genetic diversity, head lice, bacteria, study, investigate, phylogeny, head lice, Gabon, bacteria, molecular tools, head lice, women, Franceville, genetic diversity, lice, cytochrome b gene, screened, DNA, Bartonella quintana, Borrelia spp., Acinetobacter spp., Yersinia pestis, Rickettsia spp., R. prowazekii, Anaplasma spp., C. burnetii, real time, standard PCR, sequencing, lice, Clade A, Clade C, Clade E., phylogenetic analysis, head lice, variable, positions, haplotypes, novel, Bacterial, screening, presence, Borrelia spp., DNA, head lice, Clade A, infesting, individual, Borrelia, B. theileri, GenBank, MN621894, Acinetobacter spp., DNA, detected, screened, lice, A. baumannii, Acinetobacter nosocomialis, A. pittii, knowledge, study, investigate, genetic diversity, head lice, Gabon, Clade C, clade, Gabon, Clade A, global distribution, detection, Borrelia spp., DNA, lice, potential, circulation, bacteria, Gabon]]\n",
      "[[habitable, intracellular, niche, pathogenic, bacteria, secrete, effectors, target, intracellular, trafficking, modulate, phosphoinositide, PI, metabolism, Murine typhus, obligate, intracellular, bacterium Rickettsia typhi, severe, disease, humans, mechanisms, R. typhi effector molecules, internalization, induced, phagocytosis, phagosomal, escape, cytosol, intracellular, growth, bacteria, ill-defined, molecule, Risk1, phosphatidylinositol 3-kinase, PI3K, secreted, effector, bacterial, class I, Inactivation, Risk1, PI3K, reduced, phosphorylation, phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 3,4,5-trisphosphate, host, host, colonization, R. typhi, infection, Risk1, targets, Rab5-EEA1-phosphatidylinositol 3-phosphate, signaling, bacterial, phagosomal, escape, R. typhi, ubiquitination, induces, host, autophagy, maturation, autolysosomes, intracellular, growth, enzymatically active, Risk1, binds, Beclin-1 core complex, R. typhi-induced, data, Risk1, dual class I, class III PI3K activities, host, PI, metabolism, intracellular, trafficking, intracellular, growth, R. typhi, Rickettsia species, Gram-negative obligate, intracellular, bacteria, infect, eukaryotes, vertebrates, human body louse-borne Rickettsia prowazekii, flea-borne Rickettsia typhi, humankind, reemerge, vaccines, effectiveness, antibiotics, late, infection, lethality, rates, mechanisms, Rickettsia pathogenicity, detail, effector, Risk1, secreted, phosphatidylinositol 3-kinase, PI3K, dual class I, class III activities, Risk1, host, colonization, vacuolar phosphatidylinositol 3-phosphate generation, modulates, endosomal, trafficking, arrest, autophagosomal, maturation, Risk1, R. typhi growth, phosphoinositide metabolism, intracellular, trafficking]]\n",
      "[[evidence, presence, bacterial, pathogens, clothes lice, homeless, individuals, Marseille, France, period, lice, individuals, molecular analysis, low, prevalence, Bartonella quintana, DNA carriage, positive, Rickettsia sp., Rickettsia prowazekii, Borrelia sp., Anaplasma sp., Yersinia Pestis, Coxiella burnetii, comparison, studies, reduction, rate, B. quintana, DNA positivity, prevalence, Acinetobacter species, DNA carriage, A. baumannii, increase, time, detected, Acinetobacter ursingii, DNA, clothes lice, Genotypic, characterization, antimicrobial susceptibility testing, A. baumannii, isolates, clothes lice, assess, A. baumannii, strains, lice, human infections, mechanisms, resistance, antibiotics]]\n",
      "[[Homeless people, exposed to, unhygienic environments, animals, arthropods, transmit, zoonotic infections, human, pathogens, prevalence, antibodies, vector-borne, zoonotic, pathogens, homeless adults, Marseille, period, sera, samples, homeless adults, living, shelters, Antibodies, Bartonella quintana, Bartonella henselae, Borrelia recurrentis, Coxiella burnetii, Francisella tularensis, 1:100, Rickettsia akari, Rickettsia conorii, Rickettsia felis, Rickettsia prowazekii, Rickettsia typhi, microimmunofluorescence, MIF, MIF-positive, serum, cross-adsorption, cross-reacting antigens, immunoblotting, Positive, sera, Western blot, qPCR, prevalence, seroreactivity, pathogen, phase II C. burnetii, B. quintana, R. conorii, R. prowazekii, R. typhi, B. recurrentis, F. tularensis, DNA, pathogens, detected, comparison, studies, period, decrease, seroprevalence, vector-borne, zoonotic infections]]\n",
      "[[Typhus, group rickettsioses, TGRs, vector-borne diseases, murine typhus, Rickettsia typhi, epidemic typhus, R. prowazekii, public, interventions, decreases, incidence, contemporary, TGR, prevalence, disease, notifiable, administrative, data, population, trends, TGR, medical encounters, analysed, data, IBM(R) MarketScan(R, Databases, persons, inpatient, outpatient visits, International Classification of Diseases, Ninth, Clinical Modification, epidemiologic, associated with, incident, diagnosis, identified, patients, diagnosed, TGR, Patients, states, female, median, age, years, years, Epidemic typhus, TGRs, murine typhus, TGR, patients, diagnosed, outpatient setting, hospitalized patients, murine, diagnosis, TGRs, diagnosed, diseases, patients, diagnosed, epidemic, murine, R. prowazekii, transmission, body louse, flying, exposure, Patients, geographic regions, diagnosed, murine, epidemic, ranges, diseases, epidemiologic, misalignment, insurance, data, historic, TGRs, data, alternative, data, sources, national surveillance, data]]\n",
      "[[Acyl carrier proteins, ACPs, kingdoms, life, fatty acid, polyketide biosynthesis, eukaryotes, ACPs, fatty acid synthase, flexible, tethers, lipid chain, active sites, FAS, type II synthesis systems, bacteria, plastids, proteins, monomers, processes, donor, synthesis, products, endotoxins, acyl chains, lipid A, lipoic acid FAS, quorum sensing, signaling molecules, bioluminescence, activation, toxins, essential, diverse, nature, functions, ACP, target, antimicrobial drug discovery, structure, dynamics, evolution, ACPs, human, pathogens, Borrelia burgdorferi, Brucella melitensis, Rickettsia prowazekii, discovery, inhibitors, ACP, function, pathogenic bacteria]]\n",
      "[[analyses, bacterial, mitochondrion-like ancestry, giant viruses, Megavirales sensu latu, amoeban, mitochondrial gene, arrangements, homologs, megaviral genomes, ancestral synteny, decreases, genome size, megaviral families, Poxviridae, study, analyses, Phycodnaviridae, polyphyletic group, giant viruses, infecting, Haplophyta, Stramenopiles, algae, syntenies, algal, mitogene, arrangements, chloroplast, genomes, Rickettsia prowazekii, positive controls, Mitogene, alignment, qualities, Rickettsia, viral genomes, Mitogenome synteny, viruses, Rickettsia, alignments, qualities, algae, syntenies, cohosted chloroplast, virus, mitochondrion, higher, gene, coevolution, cohosted genomes, coregulations, organelle, metabolisms, algae, viral mitogenome, mimicry, organelle-committed, synteny, human, mitochondria, pathogenic, endocellular, ancestry, bacteria/mitochondrion-like, genomic ancestors, Phycodnaviridae, mitochondrion-bacteria, split, ulterior, gene arrangements, cohosted genomes]]\n",
      "[[Ticks, vectors, disease-causing, pathogens, threat, animals, people, Dogs, cats, tick, infestation, transport, infected, ticks, domestic, environments, people, Pet owners, increased, risk, ticks, pets, tickborne diseases, study, detect, presence, pathogens, potential, public health, ticks, removed, cats, dogs, Tuscany, Italy, collected ticks, screened, presence, protozoan, Theileria species, Babesia species, bacterial, Rickettsia species, Anaplasma species, Ehrlichia species, Chlamydia species, Bartonella species, Coxiella burnetii, pathogens, PCR, PCR, sequencing analysis, ticks, PCR-positive, presence, Rickettsia helvetica, DNA, ticks, PCR-positive, Bartonella henselae DNA, ticks, PCR-positive, Chlamydia psittaci, Chlamydia abortus DNA, examined, ticks, PCR-positive, Theileria, species, Babesia species, Anaplasma species, Ehrlichia canis, Coxiella burnetii, DNA, results, preliminary study, monitoring, companion, animals, indicators, evaluate, health status, owners, Preventive measures, spread, zoonotic, pathogens, companion, animals, people, home environment]]\n",
      "[[Amblyomma sculptum, human-biting tick, Brazil, vector, Rickettsia rickettsii, agent, Brazilian spotted fever, seasonal, dynamics, A. sculptum, urban area, Cerrado, biome, midwestern Brazil, human rickettsiosis, endemic, Ticks, sites, campus, Federal University of Goias, collections, dragging, flagging, visual, search, ticks, Amblyomma spp., larvae, nymphs, adults, A. sculptum, nymph, adults, Amblyomma dubitatum, larvae, nymphs, peaked, Adults, data, A. sculptum, year, urban area, Cerrado, biome, midwestern Brazil, nymphs, period, cases, rickettsiosis, Goias, relationship, seasonal, dynamics, tick stage, rickettsiosis, transmission, state]]\n",
      "[[data, Rickettsia species, detected, ticks, wild animals, 16S rRNA, gltA, ompA., Rickettsia DNA, ticks, EZ, BioCloud libraries, reads, identified, Rickettsia aeschlimannii, Illumina BaseSpace, reads, Rickettsia rickettsii, group, Rickettsia bellii, group, Rickettsia, gltA, ompA gene-specific primers, R. aeschlimannii, detection, Rickettsia amblyommatis, Amblyomma auricularium, Amblyomma geayi, Amblyomma mixtum, Amblyomma pacae, R. bellii, Amblyomma dissimile, Candidatus Rickettsia colombianensi, A. dissimile, Rickettsia spp, R. raoultii, A. geayi, Rickettsia tamurae, A. dissimile, Rickettsia endosymbionts, Ixodes, Ixodes affinis, databases, 16S rRNA, Neotropical Rickettsia, species, primers, 16S rRNA, accurate, interpretations, identifications, findings, increase, Rickettsia species, detected, Panama, isolates, Rickettsia, area]]\n",
      "[[Brazilian spotted fever, BSF, tick-borne disease, Rickettsia rickettsii, Horses, primary hosts, vector, Amblyomma sculptum, efficient, sentinels, circulation, Rickettsia, study, detect, antibodies, R. rickettsii antigens, horses, non-endemic area, north-central region, Bahia state, Brazil, Blood samples, ticks, horses, municipalities, Senhor, Antonio, Pindobacu, Campo Formoso, sera, tested, indirect, immunofluorescence assay, detect, anti-Rickettsia antibodies, horses, R. rickettsii antigens, Ticks, horses, A. sculptum, Dermacentor nitens, non-endemic area, seropositive, animals, identified, study, circulation, rickettsial agents, region, serological survey, agent, horses, north-central region, Bahia, studies, epidemiology, BSF, locations]]\n",
      "[[Rhipicephalus sanguineus, species, complex, ticks, vector disease, Feeding, dogs, members, complex, feed, incidentally, humans, transmitting disease agents, Rickettsia rickettsii, R. conorii, Ehrlichia species, genetic Rh, sanguineus lineages, North America, temperate, tropical lineages, discrete, locations, overlap, parts, California, Arizona, sanguineus, Europe, aggressive, humans, hot weather, increasing, risk, pathogen, transmission, humans, study, assess, impact, hot weather, humans, dog, hosts, tropical, temperate lineage Rh, sanguineus, individuals, Ticks, two-choice olfactometer, migrated, dog, human, trials, room, high, temperature, degrees C, tropical lineage, adults, humans, compared, room, temperature, temperate lineage, adults, reduction, preference, dogs, increase, preference, humans, nymphs, host, degrees, room, temperature, lineages, results, risk, disease transmission, humans, increased, periods, hot weather, lineage, hot weather, events, associated with, climatic change, frequent, rickettsial disease, outbreaks]]\n",
      "[[cases, Rocky Mountain spotted fever, patients, Kinkantu, Ngabe-Bugle indigenous comarca, Panama, isolated, Rickettsia rickettsii, cell culture, intraperitoneal, inoculation, guinea, pigs, tissues, deceased, patient, results, Rocky Mountain spotted fever, region]]\n",
      "[[authors, cases, neuroretinitis, Rickettsia rickettsii infection, Observations, male, months, vision loss, female, weeks, eye pain, vision loss, Examination, patients, neuroretinitis, characterized, optic disc, swelling, macular, exudates, serological analysis, positive, Rickettsia rickettsii, patients, treatment, oral doxycycline, prednisone, potential, neuroretinitis, permanent, presence, acute vision loss, optic disc edema, macular, exudates, evaluation, Rickettsial disease, endemic areas, absence, systemic symptoms, history, tick bite]]\n",
      "[[Amblyomma sculptum, tick, medical, veterinary, Brazil, vector, Rickettsia rickettsii, disease, humans, presence, ticks, residence, peri-urban area, Atlantic Forest region, Brazil, dogs, lived, A. sculptum, adults, walking, cemented pillar, porch, house, sheltering, pillar's crevices, dogs, Rhipicephalus sanguineus sensu lato ticks, dogs, circulated, forest regions, A. sculptum, residence, dogs, carriers, Brazilian spotted fever, BSF, tick, vectors, human, habitation, Strategies, prevention, control, BSF, hypothesis, ticks, infected, R. rickettsii, human, dwellings, peri-urban areas]]\n",
      "[[Rickettsia, sources, tick-borne diseases, humans, worldwide, North America, species, spotted fever, group, Rickettsia, associated with, disease, humans, Rickettsia rickettsii, causative agent, Rocky Mountain spotted fever, Rickettsia parkeri, R. parkeri rickettsiosis, lab, non-endothelial, parasitism, pathogenic, SFG Rickettsia, Rickettsia conorii, THP-1-derived, macrophages, hypothesized, growth, rickettsial, pathogenesis, mammalian, hosts, multiple, human, pathogenic, Rickettsia, R. rickettsii, R. parkeri, Rickettsia africae, Rickettsiaakari, target, endothelial cells, PMA-differentiated, THP-1 cells, Rickettsia bellii, Rickettsia species, associated with, disease, humans, R. rickettsii strain Iowa, avirulent, derivative, pathogenic, R. rickettsii, invade, cell types, proliferate, endothelial cells, analysis, revealed, studies, R. conorii, pathogenic, Rickettsia species, grow, cytosol, THP-1-derived, macrophages, localization, markers, lysosomal compartments, LAMP-2, cathepsin D. R. bellii, hand, co-localization, lysosomal compartments, findings, pathogenic, rickettsial species, niche, macrophage-like cells, factor, disease, mammals, findings, analysis, growth, mammalian, phagocytic cells, pathogenic, potential, isolated, identified, Rickettsia species]]\n",
      "[[cases, human rickettsiosis, fatal, annually, US-Mexico transboundary region, undercount, cases, Rickettsia rickettsii, agent, Rocky Mountain spotted fever, Rickettsia pathogens, North America, multiple-host, surveillance, domestic, synanthropic, sylvatic mammals, ectoparasites, investigate, ecology, Rickettsia species, region, mammals, dogs, wild carnivores, lagomorphs, rodents, sampled, fleas, ticks, species, detected, Rickettsia spp., DNA, blood sample, coyote, Canis latrans, ear tissues, rodents, ectoparasites, Rickettsia-positive fleas, Echidnophaga gallinacea, Pulex simulans, ticks, Rhipicephalus sanguineus s.l, Ixodes pacificus, DNA sequence, alignment, gltA, ompB, regions, genetic variants, Rickettsia spp., variants, clustered, clades, zoonotic species, R. felis, R. massiliae, R. parkeri, R. rickettsii, R. typhi, organisms, pathogenic, R. asembonensis, Candidatus Rickettsia tarasevichiae, coyote, infected, R. rickettsii, zoonotic, rickettsial agents, study area, wild canids, host, RMSF, host, Rh, sanguineus s.l, ticks, spread infection, ticks, human rickettsiosis, cases, R. rickettsii, Rickettsia species, study, multiple-host, vector, eco-epidemiological studies, Health approach, disease, RMSF-epidemic region]]\n",
      "[[OBJECTIVE, case, abducens nerve palsy, retinal, involvement, rickettsia typhi infection, case report, documented, multimodal imaging, woman, history, high-grade fever, diagnosed, typhoid fever, treated with, fluoroquinolone, history of diplopia, headaches, best-corrected visual acuity, eyes, Ocular motility, examination, left lateral gaze restriction, Lancaster test, presence, left abducens palsy, Fundus, examination, optic disc, swelling, eyes, associated with, superotemporal retinal hemorrhage, retinal hemorrhage, nasal periphery, left eye, Magnetic resonance imaging, MRI, brain, orbits, no abnormalities, diagnosis, rickettsial disease, suspected, serologic test, Richettsia Typhi, positive, patient, treated with, doxycycline, days, recovery, left lateral rectus motility, resolution, optic disc swelling, retinal hemorrhages, retinal infiltrate, Rickettsial disease, differential diagnosis, abducens nerve palsy, patient, fever, endemic area, Fundus, examination, early diagnosis, rickettsial treatment]]\n",
      "[[studies, presence, murine typhus, Greece, retrospective, investigation, clinical, epidemiological, patients, diagnosed, murine typhus, Greece, METHODOLOGY/PRINCIPAL, FINDINGS, serum samples, hospitalized patients, outpatients, Greece, suspected, murine, infection, tested, immunofluorescence assay, Rickettsia typhi, Immunofluorescence positive samples, tested, qPCR, targeting, R. typhi, Clinical, epidemiological, retrospectively, patients, murine typhus, tested, patients, patients, geographic regions, Greece, diagnosed, murine typhus, sign, symptom, fever, headache, rash, fever, headache, rash, patients, illness, Severe, infections, complications, acute renal failure, septic shock, cases, May-October, peaked, September, patients, infected, Athens, recalled, activity, weeks, symptoms onset, swimming, beach, insect bite, sunbathing, CONCLUSIONS/SIGNIFICANCE, results, reemergence, murine typhus, Greece, awareness, difficult-to-recognize undifferentiated febrile illness]]\n",
      "[[Murine typhus, flea-borne disease, worldwide, distribution, reemergence, United States of America, data, presentation, treatment, outcomes, pregnant population, cases, murine, pregnancy, review, literature, cases, comprehensive, search, PubMed database, published articles, articles, criteria, symptomatic, pregnant murine typhus, infection, patients, identified, Patients, prolonged, duration, fevers, presentation, headache, elevated, hepatic transaminases, diagnosis, serology, Treatment, pregnancy outcome, favorable, Murine typhus, pregnancy-related pathologies, large-scale studies, murine, pregnancy]]\n",
      "[[Next generation sequencing, NGS, technology, epidemiological, surveillance studies, amplicon-based, NGS, species, Rickettsia, arthropod, hosts, entomological surveillance, screened, samples, rodents, ectoparasites, rodents, domestic mammals, dog, cat, cattle, Thailand, Rickettsia, citrate synthase gene, amplified, Rickettsia, species, Cytochrome Oxidase subunit I, COI, subunit II, target, genes, ectoparasite, identification, target, gene amplicons, pooled, library, preparation, sequenced, Illumina MiSeq platform, percentage, Rickettsia DNA, fleas, domestic animals, dogs, samples, ticks, domestic animals, rodent fleas, rodent, tissue, positive, Rickettisia DNA, NGS, characterization, Rickettsia, host, Rickettsia asembonensis, bacteria, positive fleas, dogs, Candidatus Rickettsia senegalensis, detected, Rickettsia positive dog fleas, Sequence analysis, COI, COII, revealed, fleas, dogs, Ctenocephalides felis orientis, Rickettsia species, detected, NGS, Rickettsia heilongjiangensis, Haemaphysalis hystricis ticks, Rickettsia typhi, rodent, tissue, study, NGS, high-throughput sequencing, species, characterization/identification, bacteria, ectoparasite, entomological, surveillance, rickettsiae, percentage, C. f. orientis, positive, R. asembonensis, findings, risk, tick-borne Spotted, Fever, rickettsiosis, flea-borne murine typhus, transmission, Tak, Phangnga, provinces, Thailand]]\n",
      "[[Bloodstream infections, morbidity, mortality, clinical suspicion, infections, blood cultures, negative, investigated, blood cultures, negative, days, incubation, presence, bacterial, pathogens, specific, Rickettsia spp., Leptospira spp., 16S rRNA PCR, samples, positive, bacterial DNA, incidence, dengue, patient serum, samples, positive, Rickettsia spp, Rickettsia typhi, 16S rRNA PCR, positives, Escherichia coli, Klebsiella pneumoniae, identified, samples, Leptospira, species, detected, Molecular investigation, negative, blood cultures, potential, pathogens, routine, culture, Patient management, influenced, patients, bacterial, organism, identified, patients, outcome, findings, study, cost-benefit, routine, implementation, timing, PCR, organisms, Rickettsia, Leptospira, pathogens, rural Asia]]\n",
      "[[Salmonella Enteritidis, intracellular, foodborne, pathogen, mechanisms, poultry, intestinal, physiology, infect, gut, Short chain fatty acid butyrate, microbiota, metabolic activities, gut homeostasis, interaction, S. Enteritidis infection, butyrate, host, intestinal, knowledge, chicken macrophages, HTC cells, infected, S. Enteritidis, treated with, sodium butyrate, proteomic analysis, growth curve assay, sub-inhibitory, concentration, SIC, concentration, bacterial growth, control, sodium butyrate, S. Enteritidis, HTC cells, infected, S. Enteritidis, presence, absence, SIC, sodium butyrate, proteins, extracted, analyzed, tandem mass spectrometry, results, SIC, S. Enteritidis-infected, upregulated, macrophage proteins, ATP, synthesis, oxidative phosphorylation, ATP synthase subunit alpha, ATP5A1, ATP synthase subunit, mitochondrial, ATP5PD, cellular apoptosis, Cytochrome-c, CYC, sodium butyrate, influenced, S. Enteritidis-infected, cells, reducing, expression, macrophage proteins, actin, cytoskeletal rearrangements, WD repeat-containing protein-1, WDR1, Alpha actinin-1, ACTN1, Vinculin (VCL, Protein disulfide isomerase, P4HB, intracellular, S. Enteritidis growth, replication, V-type proton ATPase catalytic subunit A (ATPV1A, sodium butyrate, increased, expression, infected, HTC cell protein, bacterial, killing, Vimentin, VIM, sodium butyrate, modulates, expression, HTC cell, essential, S. Enteritidis invasion]]\n",
      "[[study, frequency, seeds, samples, contaminated, Salmonella spp, local, markets, black pepper, Salmonella spp, detected, analyzed, sesame, samples, serotypes, identified, S. Montevideo, S. Stanleyville e S. Tilene, efficacy, gamma irradiation, inactivate, Salmonella Montevideo, black pepper, sesame, irradiated, evaluated, reduce, CFU/g, reduce, log, CFU/g, samples, black pepper, sesame, statistically significant, black pepper, sesame]]\n",
      "[[self-assembled-micelle inhibitory, RNA-targeting amphiregulin, SAMiRNA-AREG, small-interfering RNA, siRNA, nanoparticle, treatment, pulmonary fibrosis, investigated, potential, genotoxicity, SAMiRNA-AREG, guidelines, published, Organization, Economic Cooperation, Development, bacterial reverse mutation assay, Ames test, SAMiRNA-AREG, induce, mutations, Salmonella typhimurium TA100, TA1535, TA98, TA1537, Escherichia coli, concentrations, metabolic, activation, SAMiRNA-AREG, concentrations, induce, chromosomal aberrations, cultured Chinese hamster, metabolic, activation, in vivo, mouse, bone marrow micronucleus assay, SAMiRNA-AREG, concentrations, body weight, proportions, polychromatic erythrocytes, erythrocytes, increase, micronucleated, ICR mice, results, SAMiRNA-AREG, genotoxicity, mutagenesis, clastogenesis, experimental conditions, results, safety, SAMiRNA-AREG, potential, therapeutic agent, pharmaceutical development]]\n",
      "[[outbreaks, Salmonella, Escherichia coli, fresh, United States, transfer, foodborne, pathogens, animal, feeding, operations, fresh, risk, study, vegetation barrier, VB, sustainable farms, prevent, transmission, Salmonella, E. coli, fresh, fields, VB, dairy farm, poultry, farm, nearby, field, Fresh, romaine lettuce, tomato, animal, feces, environmental, air, soil, barrier, samples, months, replicates, soil, fresh, samples, plots, animal, locations, processed, Salmonella, E. coli, Air, vegetative strip, sampled, intervals, Multiple, colonies, positive, sample, positive, Salmonella, E. coli, isolates, soil, air, fecal samples, Salmonella, E. coli, isolates, fresh, samples, Salmonella, isolates, fecal, samples, dairy pasture, Data analysis, VB, effective, tool, reducing, transmission, E. coli, Salmonella, animal farms, fresh, fields, phenotypic, genotypic testing, fecal samples, animal farms, source, pathogen, contamination, environment, soil, wind, setup, farm, proximity, service roads, plot placement, contamination, fresh, study, effective, bioremediation, prevention control, measures, conjunction, VBs, pathogen transmission]]\n",
      "[[Foodborne diseases, pathogenic bacteria, Salmonella enteritidis, intestinal, imbalance, microbial, toxins, gastrointestinal tract, induce, symptoms, diarrhea, Coffee, active ingredients, antioxidants, anti-inflammatory agent, pro-inflammatory, cytokine, body, study, interaction, Lampung's robusta, coffee, tissue damage, chickens, infected, S. enteritidis, study, first-day-old, brown layer, chickens, treatment groups, negative, healthy, normal, chickens, positive control group, chickens, infected, S. enteritidis bacteria, concentration, 10(8) CFU/ml, Groups T1, T2, T3, coffee extract, doses, BW, low dose, BW, moderate dose, BW, high dose, infected, S. enteritidis bacteria, concentration, 10(8) CFU/ml, coffee extract, bacteria, orally, feeding tube, volume, chick, extract, days, day, day, bacteria, days, day, chickens, necropsied, malondialdehyde, MDA, level, analyzed, one-way analysis of variance test, GLM procedure, tissue histopath, analyzed, qualitative study, ileal, damage, results, MDA, levels, decreased, treatment groups T1, T2, T3, positive control, improvements, ileum, histopathology, group T1, T2, normal, regular, intestinal, epithelium, arrangement, ileum, long intestinal villi, decreased, leukocytes, Green coffee robusta, potential, increase, antioxidants, reduce, inflammation, small intestine, chickens, infected, S. enteritidis]]\n",
      "[[Salmonella enterica, foodborne, bacterial disease, Retail meat, source, human, salmonellosis, S. enterica, isolates, retail meat, sources, China, lacking, S. enterica strains, isolated, retail meat, districts, Beijing, China, time points, Comparative genomics, investigate, genetic diversity, virulence, antimicrobial resistance gene, ARG, profiles, isolates, serotype, S. Enteritidis, isolates, time points, year, Laboratory retesting, accuracy, serotyping, results, Salmonella, In Silico Typing Resource (SISTR, pangenome, S. enterica, isolates, genes, core genome, genes, Salmonella phage, sal3, Gifsy-2, prevalence, diversity, accessory genes, functions, IncFII(S, IncX1, IncFIB(S) plasmid, replicons, isolates, sources, horizontally, virulence gene, virulence genes, associated with, type III secretion systems, isolates, chicken, ARGs, isolates, beta-lactamases, bla, CTX, M, bla, CTX, M, bla, CTX, M, retail, meats, emergence, qnrE1, bla, CTX, M, potential, increase, prevalence, retail, meats, prohibition, colistin, China, isolates, positive, colistin, resistance genes, mcr-1.1, mcr-9, evolution, genomic features, S. enterica, isolates, retail, meats, Beijing, China, diverse, ARGs, isolates, clinical threat]]\n",
      "[[Microencapsulated phage, dry powder, protection, phage, particles, harsh, conditions, improving, efficacy, controlling, Salmonella, study, wall materials, phage, encapsulation, ratios, whey protein, isolate, WPI, trehalose, freeze-drying, Combination, WPI/trehalose, ratio, optimal, formulation, encapsulation, efficiency, Fourier transform infrared spectroscopy analysis, H-bonding, mixture system, glass transition, temperature, degrees, phage, survivability, exposure to, pH, Phages, non-encapsulated form, survive, pH, microencapsulated, phage, effectiveness, decreasing, S. Enteritidis, S. Typhimurium, CFU/ml, degrees, serovars, Phage powder, study, Salmonella control, application, stability, temperatures, pH., encapsulated, phage, food applications, interfered, physiological acidic, alkaline, pH, foods, environments, phages]]\n",
      "[[Pleuropulmonary, Samonella infections, rare, associated with, mortality, case, empyema, Salmonella, male, patient, uncontrolled, hematological disease, patient, history, fever, productive cough, purulent sputum, dyspnea, pleuritic pain, localized, right hemithorax, nausea, vomiting, diarrhea, No history of, smoking, respiratory diseases, Chest imaging, right loculated pleural effusion, adjacent, parenchymal, Blood test, anemia, leukocytosis, elevated C-reactive protein, chest tube, drainage, purulent fluid, empiric, antibiotic therapy, ceftriaxone, clindamycin, Pleural fluid, blood cultures, positive, Salmonella serotype Enteritidis, stool cultures, negative, slow improvement, clindamycin, suspended, ciprofloxacin, patient, clinical, laboratory improvement, weeks, antibiotic therapy, negative, blood cultures, imaging, improvement, patient, discharged, case, positive, outcome, unusual, infection, mortality, non-typhoid, Salmonella]]\n",
      "[[beta-Acids, natural, antibacterial, antioxidant ingredients, supercritical, CO2 hop, extract, study, beta-acids/chitosan complex, films, casting method, Complex, films, characterized, scanning electron microscopy, SEM, atomic force microscope, AFM, Fourier transform infrared spectroscopy, FTIR, X-ray diffraction analysis, XRD, Structure analysis, beta-acids, chitosan matrix, Mechanical tests, tensile strength, films, increase, beta-acids, content, chitosan-based films, UV, capability, release, beta-acids, film, Fickian diffusion, complex, films, inhibited, growth, food-borne, pathogens, Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Salmonella enteritidis, Listeria monocytogenes, study, composite, film, alternative, active packaging]]\n",
      "[[United States, shell, eggs, processed, USDA Agricultural Marketing Service, shell, sanitizing rinse, chlorine, equivalent, washing process, study, concentration, peroxyacetic acid, PAA, chlorine, Cl, reducing, target, organisms, conditions, shell, eggs, isolates, Salmonella spp., Enteritidis, Braenderup, Typhimurium, Enterobacter cloacae, inocula, Sanitizing treatments, negative control, deionized water, Cl, PAA, concentrations, isolates, tested, chlorine, cultural organisms, shell, surface, peracetic acid, cultural organisms, compared, untreated control average, Salmonella Typhimurium, resistant, shell, sanitizer, treatments, Peroxyacetic acid, concentrations, reductions, microbial, populations, PAA, concentration, increased, Culturing, prevalence, viable, injured, organisms, PAA, eggs, positive, Salmonella spp., E. cloacae, culturable, enrichment, inoculated, eggs, sanitizer, treatment, results, study, PAA, chlorine, reducing, egg surface, microorganisms, PAA, incidence, viable, culturable, Salmonella spp, shell, surface, E. cloacae, viable, culturable, organism, recovery, sanitizing treatments, indicator, organism, processing, facility, sanitation procedures]]\n",
      "[[Salmonella spp, agents, foodborne disease, virulence genes, pathogenic, mechanisms, micro-organism, whole-genome sequencing, WGS, pathogens, lower-cost, genotyping tool, gene analysis, possibilities, study, in silico, investigation, virulence genes, plasmidial, bacteriophage genes, Brazilian strains, public, Salmonella genomes, frequency analysis, sequenced serovars, temporal analysis, decades, NCBI sequence reads archive, SRA, database, Salmonella, public, whole-genome sequences, strains, isolated, Brazil, genomes, Salmonella, in silico, Typing, SISTR, quality control, serovars, prevalent, S. Enteritidis, S. Typhimurium, S. Dublin, S. Heidelberg, S. Heidelberg, virulence, Yersinia High Pathogenicity Island, HPI, rare, Salmonella, Brazil, genes, mgtC, csgC, ssaI, ssaS, genomes, prevalence, frequent, genes, astA, iucBCD, tptC, shdA, frequency, plasmids, bacteriophages, virulence genes, decreasing, decades, phage gene, grvA, increased, period, study, Salmonella virulence, distribution, Brazil, bioinformatics, tools, in vivo, in vitro studies, method, investigation, surveillance, Salmonella virulence, genes, mgtC, csgC, ssaI, ssaS, targets, PCR, identification, Salmonella, Brazil, frequency, genomes]]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[inexpensive, standardized paper chromogenic array, PCA, machine learning, pathogens, Listeria monocytogenes, Salmonella Enteritidis, Escherichia coli, O157:H7, multiple, pathogens, multiple, monocultures, presence, background, microflora, food, Cantaloupe, commodity, significant, volatile organic compound, VOC, emission, diverse, populations, background, microflora, model food, PCA, fabricated, microarray, photolithography, paper microfluidics, chromogenic dye spots, infused, taped, VOCs, emitted, pathogens, dye spots, color, changes, pattern shifts, digitized, DeltaR/DeltaG/DeltaB database, advanced, deep feedforward, neural, learning rate scheduler, L2 regularization, connections, training, DeltaR/DeltaG/DeltaB database, network, excellent, performance, pathogens, monocultures, multiple, monocultures, cocktail culture, signal, cantaloupe, accuracy, ambient, refrigerated, conditions, combination, speed, reliability, portability, low, cost, nondestructive, potential, culture-free pathogen, detection, identification, food, food commodities, complex microflora]]\n",
      "[[Salmonella, food-borne, Gram-negative pathogen, serotypes, Pullorum disease, Salmonella Pullorum, poultry, industry, studies, epidemiological, characteristics, Salmonella infections, antibiotic, poultry, Salmonella infections, chicken, flocks, fed, antibiotic-free, diets, investigated, compared, Salmonella infections, Chinese, native, breeders, fed, antibiotic-free, diets, Luhua, Langya, Qingjiaoma, chickens, breeder, Bairi chicken, dead, embryos, results, Salmonella, serotypes, detected, isolates, S. Pullorum, S. Enteritidis, Coinfection, serotypes, Salmonella, Bairi chicken, sequence type, ST, S. Pullorum, ST92, ST2151, ST11, S. Enteritidis, Salmonella, isolates, breeder, flocks, fed, antibiotic-free, diets, phenotypic, heterogeneity, drug resistance spectrum, isolates, chicken, breeds, Luhua, Langya, Qingjiaoma, fed, antibiotic-free, diets, resistant, antibiotic, erythromycin, rate, resistance, antibiotic, conventional, Bairi chicken, isolates, multidrug-resistance rate, Salmonella, isolates, layer, flocks, fed, antibiotic-free, diets, chickens, fed, diets, rate, resistance, erythromycin, streptomycin, breeder, flocks, fed, antibiotic-free, diets, resistance, antibiotics, spread, antibiotic-free, feeding, poultry, farms, findings, study, supplement, epidemiological, data, salmonellosis, characteristics, Salmonella, chicken, flocks, antibiotic]]\n",
      "[[Salmonellosis, food-borne disease, resistance, Salmonella spp, years, prevalence, multidrug-resistant, Salmonella spp, problem, phage therapy, study, isolate, bacteriophages, specific, Salmonella enterica serovar, Paratyphi B, S. enterica serovar, Typhimurium, isolated, sources, chicken meat, beef, eggshells, antibiotic resistance, profiles, bacteria, phenotypic, genotypic methods, prevalence, extended-spectrum beta-lactamase genes, polymerase chain reaction, isolated, Salmonella strains, resistant, tetracycline, resistant, azithromycin, isolates, beef, resistant, nalidixic acid, extended-spectrum beta-lactamase genes, isolates, blaSHV, blaTEM, blaCTX, bacteriophages, isolated, characterized, host, Salmonella Paratyphi B, S. enterica serovar Paratyphi A, S. enterica, vB_StyS-sam phage, Salmonella Typhimurium, S. enterica serovar Enteritidis, characteristics, isolated, phages, control, foodstuff contaminations, phage therapy, infected, animals]]\n",
      "[[Salmonella, animal, human, pathogen, Salmonellosis, associated with, consumption, contaminated, poultry, study, estimate, prevalence, Salmonella, poultry, farms, genetic relationship, samples, broiler farms, cloacal, feed, water, environmental, farm, samples, microbiological isolation, Molecular, confirmation, Salmonella, isolates, amplification, invA gene, discrimination, d-tartrate-fermenting Salmonella, isolates, multiplex PCR, analysed, pulsed-field gel electrophoresis, PFGE, survey questionnaire, potential, risk factors, Salmonella, presence, broiler farms, prevalence, Salmonella, farm, level, Salmonella, isolates, serotyped, S. Paratyphi B, isolates, d-tartrate-fermenting, dT+, PFGE, clusters, Salmonella, isolate, S. Paratyphi B, poultry chain, Tolima region, identification, source, control, dissemination]]\n",
      "[[Enteric fever, global, Salmonella enterica serovars Typhi, Paratyphi A., study, novel, bivalent oral vaccine, serovars, genetically engineering, attenuated, S. Typhi, ZH9 strain, safety, record, clinical trials, S. Paratyphi A, immunogenic elements, flagellin H, lipopolysaccharide, LPS, O:2, native, S. Typhi, fliC gene, encoding, flagellin, homologous, fliC gene, S. Paratyphi A, Xer-cise technology, S. Typhi rfbE gene, encoding, tyvelose epimerase, spacer sequence, sustained, expression, O:2, LPS, prevent, conversion, O:9, tyvelose epimerase activity, strain, ZH9PA, genetic changes, growth, kinetics, parental, ZH9 strain, formulation, ZH9, ZH9PA, strains, bivalent vaccine, targets, S. Typhi, S. Paratyphi A antigens, global, enteric, fever, prophylaxis, vaccine, tested, Phase I clinical trial]]\n",
      "[[Enteric fever, EF, Salmonella enterica serovars Typhi, S. Typhi, Paratyphi, S. Paratyphi, significant, health problems, countries, Ethiopia, study, prevalence, antimicrobial resistance, S. Typhi, S. Paratyphi, EF, suspected, patients, Felege-Hiwot, Bahir Dar, Ethiopia, Hospital, cross-sectional study, March-to-May, patients, Data, questionnaires, face-to-face interview, venous blood, stool specimens, collected, bacteriological technique, Antimicrobial susceptibility test, AST, disc diffusion method, Logistic regression, factors, associated with, EF infection, study, EF, prevalence, S. Typhi, S. Typhi, S. Paratyphi, isolates, sensitive, cephalosporins, resistance, chloramphenicol, tetracycline, isolates, multidrug resistance, MDR, water, drinking, AOR, CI, EF history, AOR, CI, associated with, EF infection, bacterial, prevalence, MDR, isolates, health professionals, AST, antibiotics, EF, patient, management]]\n",
      "[[study, investigate, frequency, antibiotic resistance, patterns, Salmonella species, isolated, infectious diarrhea, samples, pediatric, patients, central Iran, study, analyzed, stool specimens, cultured, XLD, MacConkey agar, GN, Polymerase chain reaction, assay, Salmonella genus, antibiotic resistance, profiles, frequency, quinolone, integron genes, samples, infectious diarrhea, cases, Salmonella spp, culture methods, samples, positive, PCR, results, S. serovar Paratyphi B and C, S. Typhi, antibiotic resistance, rates, nalidixic acid, tetracycline, isolates, resistant, cotrimoxazole, ampicillin, chloramphenicol, plasmid-mediated quinolone resistance, PMQR, determinants, qnrS, qnrA, qnrB, positive, isolates, Class 1, integrons, identified, isolates, rates, quinolone, resistant, low, frequency, MDR, Salmonella spp, isolates, identified, central Iran, findings, parts, Asia, spread, resistant, strains, antimicrobial resistance, Salmonella spp, isolates, constant, surveillance, empiric, antibiotic therapy]]\n",
      "[[conjugate vaccines, typhoid fever, World Health Organization, deployment, vaccine, paratyphoid, multidrug resistance, chronic carriage, elimination, enteric fever, development, in vitro, human, models, advances, enteric, fever, pathogenesis, review, advances, mechanisms, host restriction, intestinal invasion, interactions, innate immunity, chronic carriage, knowledge, vaccines, antimicrobials]]\n",
      "[[cases, enteric fever, annually, England, Wales, imported, infections, Clinical management, enteric fever, emergence, ESBL-producing strains, XDR, Salmonella Typhi, Sindh, Pakistan, strains, S. Typhi, Salmonella Paratyphi, isolated, cases, symptoms, enteric fever, England, Wales, characterized, WGS, Antibiotic susceptibility testing, agar dilution method, ESBL, strains, cases, enteric fever, S. Typhi, S. Paratyphi A, imported, Pakistan, Iraq, Bangladesh, India, Ages, years, children, female, duration, hospital stay, days, ESBL, phenotype, presence, blaCTX-M-15, S. Typhi, S. Paratyphi A, blaCTX-M-55, S. Typhi, IncY plasmid, blaCTX-M-15, qnr, detected, strains, Pakistan, IncY plasmid, absent, strains, evidence, gene cassette, insertion, chromosome, integration points, Chromosomal, integration, blaCTX-M-15, XDR, Sindh, strains, maintenance, resistance, absence, antibiotic selection pressure, Empirical treatment, cases, complicated, enteric, Pakistan, carbapenem]]\n",
      "[[poultry, industry, Colombia, changes, measures, chicken, processing, sanitary, operations, control pathogens, prevalence, in-plant, microbial, data, processing value chains, research, study, microbial, profiles, antimicrobial resistance, Salmonella, isolates, plants, samples, processing sites, Prevalence, Salmonella spp, levels, Enterobacteriaceae, assessed, whole-genome sequencing, isolated, strains, genotypically, prevalence, Salmonella spp, establishment, plant A, B, C., levels, Enterobacteriaceae, chicken, rinsates, plant A, B, C. Significant, reductions, identified, counts, post-chilling, rinsate samples, increased, levels, chicken, parts, Salmonella spp., clusters, predominant, ST32, ST28, serotypes Infantis, Paratyphi B, identified, processing plants, abundance, antimicrobial resistance genes]]\n",
      "[[Diseases, typhoidal, non-typhoidal, Salmonella, threat, countries, clinical symptoms, serological tests, Salmonella enterica serovar Paratyphi A, S. enterica serovar Paratyphi A, serovar Typhi, S. enterica serovar Typhi, study, quadruplex real-time polymerase chain reaction, assay, internal amplification control, IAC, simultaneously, differentiate, S. enterica serovar Paratyphi A, serovar Typhi, detect, Salmonella serovars, salmonellosis, humans, assay, evaluated, salmonellae, non-salmonellae strains, specificity, species, differentiation, Inclusion, IAC, efficiency, assay, evaluation, blind test, spiked stool, blood, food specimens, detection, PCR, efficiency, targets, S. enterica serovar Paratyphi A, blood, assay, clinical specimens, detect, causative agents, gastrointestinal infections, identified, salmonellosis, patients, diarrhoea, patients, quadruplex real-time PCR, study, enhance, detection, differentiation, salmonellae, assay, stools, blood, food, performance, simulation tests, field evaluation]]\n",
      "[[Enteric fever, systemic disease, fever, abdominal pain, dissemination, Salmonella Typhi, Salmonella Paratyphi, Enteric fever, organ systems, liver, gastrointestinal tract, kidney, brain, Neurological manifestations, patients, meningitis, Gullian-Barre syndrome, neuritis, neuro-psychiatric symptoms, Spastic quadriparesis, complication]]\n",
      "[[antimicrobial resistance, AMR, public, Pakistan, data, trends, resistance, pathogenic bacteria, studies, long-term, trends, AMR, study, long-term, AMR, trends, national level, Pakistan, report, results, comprehensive, analysis, resistance, pathogens, isolated, blood, cerebrospinal fluid, CSF, Susceptibility, data, local laboratory, collection, Pakistan, Resistance, proportions, antimicrobials, calculated, pathogen, period, years, Acinetobacter species, resistance, rates, tested, antimicrobials, increase, carbapenem, resistance, results, presence, third, cephalosporins, resistance, Salmonella enterica serovar Typhi, Pakistan, AMR, invasive, pathogens, decreasing, resistance, trends, Staphylococcus aureus, antimicrobials, pathogens, isolated, blood, CSF, increase, resistance, antimicrobials]]\n",
      "[[Salmonella Typhi, human-restricted, bacterial, typhoid fever, life-threatening, systemic infection, S. Typhi, pathogenesis, survive, human, macrophages, macrophages, animals, mice, macrophages, systemic, S. Typhi infection, mechanisms, macrophages, control, growth, S. Typhi, mechanisms, bacterium's, adaptation, human, host, identification, genes, controlling, growth, S. Typhi, macrophages, experimental conditions, loss-of function, shRNA, screens, primary, macrophages, infection, fluorescent-labeled, S. Typhi, infected, cells, sorted, intensity, fluorescence, intracellular, fluorescent bacteria, shRNAs, fluorescent population, next-generation sequencing, targeting, mouse, Rab GTPases, Rab32, S. Typhi, mouse macrophages, screen, Rab1b controls, S. Typhi growth, mouse macrophages, report, Rab GTPase, Rab32, S. Typhi, host-restriction, methodology, genome-wide screening, mechanisms, controlling, growth, S. Typhi, intracellular, pathogens, primary immune cells]]\n",
      "[[Rapid, reliable, sensitive, detection, pathogenic bacteria, magnetically assisted, Raman scattering, immunoassay, sensitive, detection, bacteria, universal approach, free antibody, staphylococcus proteins, tags orientation recognition, SERS, biosensor, functional, nanomaterials, aptamer-conjugated, Fe3O4@Au, magnetic nanoparticles, MNPs, magnetic SERS, pathogen, enrichment, PA, Au@DTNB@PA, universal probe, target, bacteria, quantitative detection, target, bacteria, free antibody, target, bacteria, Fc fragment, PA-SERS, tags, Fe3O4@Au/bacteria/SERS, bacteria, species, Staphylococcus, limits, LODs, assay, pathogens, Escherichia coli, E. coli, Listeria monocytogenes, L. mono, Salmonella typhimurium, S. typhi, real food samples, universal method, rapid, robust, potential, food safety, monitoring, infectious diseases, diagnosis]]\n",
      "[[Salmonella Typhi, ST, rod-shaped gram-negative bacterium, infects, humans, contaminated food, water, Humans, reservoirs, bacteria, Infection, fever, abdominal pain, diarrhea, complications, intestinal perforation, hepatosplenomegaly, renal injury, Acute kidney injury, AKI, ST, bacteria, gastrointestinal (GI) infections, pathophysiology, AKI, ST, infection, mechanisms, rhabdomyolysis, case, resistant, ST, infection, AKI, rhabdomyolysis, extensive, literature reviews, ST, bacteremia, cases, AKI, secondary to, rhabdomyolysis]]\n",
      "[[quantification, pathogens, unprocessed, samples, severe, inhibition, nucleic acid amplification, nanoporous polyethylene glycol, hydrogel, self-cleaning capacity, amplification, nucleic acid, complex matrices, human, animal blood, milky tea, humic acid, surfactants, sample, pretreatment, DNA extraction, isothermal amplification, hydrogel, inhibitors, assay, adsorbed, removed, nanostructured, polymers, nucleic acid amplification, bright dots, bacteria, counting, loop-mediated isothermal amplifications, LAMP, inside, hydrogel, level, resistance, inhibition, complex, matrices, anti-inhibition, mechanism, investigated, Digital, quantification, Escherichia coli, Salmonella typhi, Listeria monocytogenes, whole blood, specificity, low, detection, bacterium, Visual, counting, naked eye, LED flashlight, hydrogel, potential, on-site, complex, crude, unprocessed, samples, clinical, food, agricultural, environmental fields]]\n",
      "NaN\n",
      "NaN\n",
      "[[individuals, pet, creatures, cats, dogs, rats, care, boost, populace, advanced culture, interaction, family pets, individuals, ideal, conditions, bacterial transmission, antimicrobial agents, animal, husbandry, studies, bacteria, confrontation, Staphylococcus intermedius, Escherichia coli, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, multidrug-resistant, Salmonella typhi, zoonotic, transmission, review, attention, household pets, dogs, antimicrobial resistance, food animals, evidences, food animals, nation-wide, hub, food animals, antimicrobial, policy, small, animal, veterinary exercise, chance, transmission, antimicrobial resistance, humans' statistics, pet, animals, Transmission, organisms, pathogenic, staphylococci, pets, owners, veterinary staff, pets, reservoirs, bacteria, impact, antimicrobials, human medicine, statistics, levels, carriage, microorganism, pets, risk factors, associated with, switch, microorganism, human, beings, contact, infected, pets, hygiene measures, veterinary practice]]\n",
      "[[global, enteric disease, antimicrobial treatment, effective, eradication programs, increased, glycoconjugate, vaccines, carbohydrate-based membrane, pathogen, characterisation, physico-chemical, immunological tests, vaccine, characterisation, consistency, potency, safety, stability, relevant, World Health Organization, Pharmacopoeia, guidelines, Variable requirements, analytical methods, conjugate structure, carrier protein, nature, size, O-acetyl, content, polysaccharide, investigated, stability-indicating method, measures, saccharide, Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide, detergent precipitation, depolymerisation, HPAEC-PAD, quantitation, design, glycoconjugates, improvements, solubility, structural conformation, stability, immunogenicity, antigens, spectrum, vaccines, validation experiments, effective, methods, glycoconjugate analysis, uniformity, protocols, complex, vaccines, overview, current, analytical approaches, characterisation, vaccines, Salmonella Typhi, Shigella species, study, development, glycoconjugate vaccines, prevention, enteric diseases]]\n",
      "[[serovar Typhimurium, [5],12:i:1,2, isolated, serovar, case, salmonellosis, pigs, Europe, monophasic, variant, [5],12:i:-, Salmonella, outbreaks, humans, samples, years, pig, farms, Northern Italy, Samples, material, sources, fecal samples, rectal swabs, gut, content, organs, Salmonella, isolated, samples, isolates, typed, Salmonella Typhimurium, ST, monophasic, MST, time, increase, isolation, MST, ST, strains, isolated, animals, weaning stage, growing, fattening, period, clinical cases, young, pigs, weaning, study, presence, ST, MST, pig, farms, isolated, serotypes, years, ST, MST, MST, competitive, ST, antigenicity, pathogenicity, infection, stealthier, recognize, control]]\n",
      "[[development, rapid, sensitive, methods, bacterial, pathogens, food poisoning, Nucleic acid amplification tests, NAATs, culture-free detection, bacterial, pathogens, labor intensive, time consuming, culture-based detection methods, sample preparation methods, realization, rapid, sensitive, NAATs, problem, sample preparation method, bacterial, enrichment, DNA extraction, engineered, magnetic nanoparticles, MNPs, physicochemical probe, tryptamine, single-tube sample preparation, sample loss, tryptamine-functionalized, MNPs, Indole@MNPs, hydrophobicity, indole side chain, zeta potential, decrease, pH., physicochemical characteristics, Indole@MNPs, adsorb, bacterial, pathogens, sample, enrichment, DNA binding, release, weak, electrostatic interactions, pH control, detected, Salmonella enterica serovar Typhimurium, bacterial food, concentration, milk, samples, quantitative PCR, method, sensitive, detection, Salmonella typhimurium, nontyphoidal, salmonella, detection, food safety]]\n",
      "[[Foodborne, pathogens, microbial, antibiotic resistance, researchers, natural compounds, alternative, antimicrobials, study, chemical profile, antimicrobial, mutagenic activities, Elletaria cardamomum essential oil, investigated, GC-MS analysis, identified, bioactive components, alpha-terpinyl acetate, 1,8-cineole, linalool acetate, sabinene, concentrations, essential oil's, content, antimicrobial activity, inhibitory, concentration, green cardamom, essential oil, Escherichia coli, O157:H7, Pseudomonas aeruginosa ATCC 14213, Green cardamom, essential oil, concentrations, v/v, biofilm formation, Escherichia coli, O157:H7, concentrations, inhibited, Salmonella Typhimurium, JSG, biofilm, mutagenicity assay, green cardamom, essential oil, mutagenic activity, tested, strains, study's, findings, green cardamom, bioactive compounds, organic, antimicrobials, effective, controlling, biofilm formation, Gram-negative pathogens, compounds, food industry, bakery, dairy, meat, food products, chemical preservatives, antimicrobials, shelf, life, improving, antimicrobial status, time, imparting, pleasant, aroma, consumers]]\n",
      "[[U.S. FDA Food Safety Modernization Act, Preventive Controls, Human Food Rule, effective, environmental, EM, program, EM, harborage sites, microorganisms, processing equipment, effectiveness, sanitation programs, prevent, transmission, foodborne, pathogens, study, commercially-available polyurethane foam, PUF, cellulose, EM, tools, efficacy, release, foodborne, pathogens, sponge matrices, study, compare, EM, tools, release, microorganisms, recovery, eluent, EM, performance, decreasing, inoculum, concentrations, assess, impact, operators, processing, EM, samples, bacteria, Listeria monocytogenes, Salmonella Typhimurium, human, norovirus, surrogate, Tulane virus, TV, decreasing, inoculum, levels, elution techniques, mechanical stomacher, manually, operator, operators, Data, EM, material, composition, impacted, release, microorganisms, PUF, TV, CELL EM tool, decreasing, inoculum, levels, release, microorganisms, EM, matrices, no significant difference, machine stomacher, manual, elution, human, operator, operators, study, characterization, EM, tools, identified, study, improve, effectiveness, EM, programs]]\n",
      "[[in vitro, genotoxicity, compounds, functional ingredients, docosahexaenoic acid, DHA, rutin, alpha-tocopherol, assessed, miniaturized, version, Ames test, Salmonella typhimurium TA97a, TA98, TA100, TA102, TA1535 strains, principles, OECD, in vitro, micronucleus test, TK6 cells, OECD, European Food Safety Authority, in vitro, genotoxicity, assessment, food, feed, in vitro, enzyme-modified comet assay, S9-/S9+), hOGG, EndoIII, hAAG, premutagenic, lesions, TK6 cells, Rutin, equivocal response, in vitro, micronucleus test, Salmonella typhimurium, inductor, Ames test, DHA, equivocal, in vitro, micronucleus test, DHA, rutin, interact, DNA, chromosomal, level, rutin, frameshift mutations, genotoxicity, cells, treated with, alpha-tocopherol, evidence, genotoxicity, compounds, studies, consequences, functional ingredients, human, health]]\n",
      "[[Salmonella, zoonotic pathogen, attention, transmission, household pets, humans, investigated, epidemic, distribution, dog, Salmonella, pet, hospitals, breeding, Xuzhou, Jiangsu Province, China, multilocus sequence typing, MLST, clustered regularly interspaced short palindromic repeats, CRISPRs, subtype, Salmonella, isolates, samples, pet, hospitals, breeding, dog, samples, cat samples, S. Kentucky, serotype, S. Typhimurium, S. Indiana, widespread, sequence type, ST, patterns, MLST, ST198, proportion, isolates, CRISPRs analysis, Kentucky CRISPR types, KCTs, ST198, spacers, CRISPR1, CRISPR2, polymorphic, Salmonella genes, samples, sources, analysis, serotypes, pet, hosts, area, analysis, CRISPR genes, recognition, serotype, positive, effect, traceability, Salmonella, prevention, treatment, salmonellosis]]\n",
      "[[emergence, bacterial, pathogens, agriculture, food safety, Salmonella Typhimurium, foodborne illness, worldwide, pigs, zoonotic, reservoir, phylogenetically, variants, U288, ST34, UK, pigs, time, risk, food safety, genomic epidemiology, ST34, S. Typhimurium infections, people, U288 less, U288 clade, AMR, genes, indels, virulence, plasmid, pU288-1, accumulation, loss-of-function polymorphisms, coding sequences, U288 replicates, slowly, sensitive, desiccation, ST34, isolates, pathogenicity, murine, model, colitis, pigs, U288 infection, disseminated, lymph nodes, ST34, recovered, intestinal, contents, data, consistent with, evolution, S. Typhimurium, adaptation, pigs, reduced, zoonotic, potential]]\n",
      "[[cluster, Achromobacter xylosoxidans, multidrug-resistant aquaphilic bacterium, identified, long-term-care facility, residents, Pseudomonas aeruginosa, Serratia marcescens, clinical specimens, investigation, water-associated species, identified, P. aerguniosa, S. marcesens, contamination, facility, Sequencing analysis, P. aeruginosa, clinical, isolate, Findings, measures, prevent, transmission, water-associated, multidrug-resistant bacteria, long-term-care facilities]]\n",
      "[[insecticides, microbial, origin, biocontrol agents, control pests, study, metabolite, extracted, purified, Serratia marcescens, KH-001, identified, prodigiosin, molecule weight, primary, aim, evaluate, effects, prodigiosin, Diaphorina citri Kuwayama, Hemiptera, Liviidae, laboratory, field, Toxicity, purified, prodigiosin, nymphs, increased, increasing, temperature, degrees, laboratory experiment, results, inhibition, effects, purified, prodigiosin, LC50, oviposition, egg hatch, D. citri, degrees, adults, fed, citrus leaves, treated with, LC20, LC50, purified, prodigiosin, degrees, excreted, honeydew, controls, moderate, antifeedant, activity, prodigiosin, results, field experiment, prodigiosin, emulsifiable, concentrate, control efficacy, concentrations, July, October, data, prodigiosin, effective, compound, control, D. citri, temperature, conditions, product, citrus orchards]]\n",
      "[[cases, neonatal, endophthalmitis, poor prognosis, primary evisceration, Observations, 27-weeks', gestation neonate, Pseudomonas aeruginosa, endophthalmitis, complicated, globe rupture, 34-weeks', gestation neonate, Serratia marcescens endophthalmitis, patients, poor prognosis, primary, evisceration, long-term, cosmetic outcomes, years, months, Importance, Primary evisceration, neonates, endophthalmitis, poor prognosis, long-term, cosmesis]]\n",
      "[[Serratia marcescens, SCQ1, red-pigmented bacterium, isolated, silkworm larva, septicemia, Pigment-deficient spontaneous mutants, S. marcescens, SCQ1, incubated, stable, laboratory conditions, long time, complete, genome sequence, SCQ1, resequenced genomes, spontaneous, pigment, mutants]]\n",
      "[[Serratia marcescens, red, membrane-associated pigment prodigiosin, positive, prodigiosin, ATP, production, population, negative, high-rate, low, study, growth rate, growth phase modulation, chemostat, culture, prodigiosin, high density, stationary, Cellular levels, prodigiosin, positively, associated with, cellular levels, ATP, high-density growth, artificial, pigment, induction, phase, increased, cellular ATP, peak high density ATP, cell, early, stationary phase, population growth, prodigiosin, levels, high, ATP, declined, late stationary phase, ATP, cell, positively, associated with, prodigiosin, cell, declined, growth, results, correlational, evidence, multiple, effects, prodigiosin, pigment, ATP, production, growth cycle, data, formulation, working model, oscillating, relationships, cellular levels, ATP, prodigiosin, batch, culture]]\n",
      "[[Serratiopeptidase, proteolytic enzyme, anti-inflammatory, analgesic drug, work reports, thermoactive serratiopeptidase, Serratia marcescens, AD-W2, soil, isolate, North-Western Himalayan region, India, extracellular metalloprotease, purified, activity, purification, molecular mass, metalloprotease, SDS-PAGE, purified serratiopeptidase, optimum, activity, pH, temperature, degrees, C, stability, pH, temperature, range, Critical, temperature, degrees, thermoactivity, purified serratiopeptidase, kinetic studies, purified serratiopeptidase, Vmax, Km, casein, purified serratiopeptidase, S. marcescens, AD-W2, serralysin, Serratia marcescens ATCC 21074/E-15, catalytic domain, Zn, coordinated, histidine residues, His192, His196, His202, glutamate, Glu193, tyrosine, purified protein, serralysin]]\n",
      "[[occurrence, multidrug-resistant, Serratia marcescens, strains, public, report, cases, carbapenem-resistant, S. marcescens infections, clinical outcomes, molecular description, antibiotic resistance, determinants, genomic level, bacterial, identification, VITEK 2, MALDI-TOF, inhibitory, concentrations, antimicrobials, Clinical, tigecycline, Etest strips, Preliminary, screening, presence, carbapenemases, ertapenem, hydrolysis, MALDI-TOF MS, Whole-genome sequencing, genes, virulence, antimicrobial resistance, report, cases, S. marcescens, resistant, antibiotics, genome, description, genes, resistance, virulence, cases, infection, multidrug-resistant organisms, complexity, treatment, results, evaluate, isolates, long-term, hospital stay, optimal, quality, clinical care, patient, outcomes]]\n",
      "[[Serratia marcescens, time, infect, vascular access catheters, bona, source, hospital outbreaks, adverse, patient, outcomes, unique, case, severe, recurrent, Serratia infection, persistent, bacteria, blood, haematogenous, dissemination, development, abscesses, degree, literature, infections, eradicate, virulence, mechanisms, deep seeding, microorganism, Serratia infections, multifaceted approach, identification, therapeutics, surveillance, literature, reviewed, report]]\n",
      "[[AGL, lectin, Amaranthus gangeticus, seeds, isolated, ion-exchange, gel filtration chromatography, AGL, neutral sugar, inhibited, N-acetyl-D-galactosamine, Hemagglutination, activity, lectin, maximum, pH, temperatures, degrees, lost, activity, treated with, urea, EDTA, LC50 value, AGL, mild, toxicity, Artemia, nauplii, inhibited, growth, pathogenic bacteria, Shigella boydii, Shigella dysenteriae, Staphylococcus aureus, treated, lost, antibacterial activity, treatment, AGL, inhibit, growth, Escherichia coli, mitogenic growth, AGL, inhibited, biofilm formation, Escherichia coli, concentrations, inhibition, proliferation, Ehrlich ascites carcinoma cells, treated with, doses, AGL, AGL, inhibited, in vivo, growth, EAC cells, mice, doses, alteration, expression, apoptosis, genes, Fas, NF-kB, MAPK]]\n",
      "[[Shiga toxins, Stxs, bacterial, toxins, virulence factors, toxigenic, Shigella dysenteriae, enterohemorrhagic Escherichia coli, EHEC, toxins, glycosphingolipid globotriaosylceramide, Gb3/CD77, receptor, inhibit, protein synthesis, cells, cleaving, 28S ribosomal RNA, life-threatening, complications, hemolytic uremic syndrome, HUS, associated with, severe, cases, EHEC, infection, acute kidney injury, children, threat, Stxs, exacerbated, lack, toxin inhibitors, effective, treatment, HUS, Stx, structure, subtypes, in vitro, in vivo, models, Gb3, expression, HUS, studies, CRISPR-Cas9-mediated genome-wide screens, host, Stx action, progress, engineering, Stx, components, biomedical applications]]\n",
      "[[synthesis, characterization, Al(III)(mu-OH)M(II, Zn, Cu, complexes, unsymmetrical ligand, H2L{2-[[(2-hydroxybenzyl)(2-pyridylmethyl)]aminomethyl]-6-bis(pyridylmethyl)amino methyl}-4-methylphenol, complexes, characterized, elemental analysis, X-ray crystallography, IR spectroscopy, mass spectrometry, potentiometric titration, complex 2, characterized, electronic spectroscopy, studies, hydrolysis, model, substrate, bis(2,4-dinitrophenyl)phosphate, Michaelis-Menten behavior, active, pH, antimicrobial effect, compounds, bacterial strains, Staphylococcus aureus, Pseudomonas aeuruginosa, Shigella sonnei, Shigella dysenteriae, complexes, inhibition, bacterial growth, superior, sulfapyridine, inferior, tetracycline, dark, cytotoxicity, photocytotoxicity, UV-A light, complexes, chronic myelogenous leukemia cell line, investigated, Complexes, cytotoxic activity, K562 cells, increase, irradiation, UV-A light, Complex 2, effective, correlation, cytotoxicity, intracellular, concentration, intracellular, copper, concentration, inhibit, cell growth]]\n",
      "[[study, food-grade nanoemulsion, tarragon, NEO, investigate, antioxidant, antimicrobial, properties, Oil, water NEO, blending, tarragon, EO, TEO, water, surfactants, antioxidant, antimicrobial activities, evaluated, components, TEO, estragole, beta-cis-ocimene, beta-trans-ocimene, l-limonene, NEO, droplet, diameter, zeta potential, Results, free radical DPPH, scavenging activity, hydrogen donating, capacity, nanoemulsion, TEO, concentration, inhibitory activity, DPPH, ferric reducing potential, TEO, NEO, NEO, antibacterial, Staphylococcus aureus, Listeria monocytogenes, Shigella dysenteriae, results, NEO, higher, antioxidant, antimicrobial activity, compared, free, TEO]]\n",
      "[[Synthesiomyia nudiseta (van der Wulp, synanthropic muscid, tropical, subtropical zones, world, larvae, species, secondary agent, myiasis, necrophagous habits, forensic entomology, indicator, post-mortem interval, Adults, vectors, etiological agents, Escherichia coli, Shigella dysenteriae, environmental conditions, dispersal, capacity, Europe, predatory habits, larval stage, difficulty, goal, update, knowledge, species, review, identification, geographical distribution, biology, species, investigations, fly]]\n",
      "[[cases, diarrhoeal disease, year, children, age, years, dying, diarrhoea, people, UK, year, diagnosis, appropriate, treatment, infection control, measures, Public Health Wales, England Microbiology Division test, bacterial, pathogens, Escherichia coli O157, VTEC, Shigella dysenteriae, Salmonella spp, Campylobacter spp, Clostridioides difficile, poor success, rate, identification, pathogens, patient, risk, untreated infections, study, effective, tools, positive, outcome, diagnosis, diarrhoeal infection, study, analysed, samples, abundant, species, Shigella sonnei, genus, Bacteroides, Campylobacter spp, abundance, Clostridium difficile 3%, Salmonella spp, abundance, genus, level, Flemish, Gut project, diarrhoea samples, Shigella, Campylobacter, project, Shigella spp., Escherichia, threshold, Escherichia, healthy, unhealthy, community, DMBiome model, integrate, threshold, Shigella spp., Public Health laboratory, pathogens, enteropathogens, positive, outcome, samples, diagnosed, diarrhoea infections]]\n",
      "[[Shigella dysenteriae, agents, bacillary dysentery, illnesses, morbidity, worldwide, Shiga toxin, Stx, encoded, defective, prophage, virulence factor, S. dysenteriae type 1, strains, genome sequence, SD1 strain, HNCMB, isolated, compare, sequenced, SD1 genomes, assess, diversity, Stx-prophages, SD1 strains, genome, HNCMB 20080, chromosome sized, CDSs, plasmids, genomic analysis, degree, uniformity, SD1 genomes, structure, Stx prophage regions, subgroups, PT-I, PT-II, PT-I strains, members, sequence type, ST, ST260, PT-II, strain, Sd1617, ST, untypeable, data, reports, Stx1, prophage, induced, HNCMB 20080, cumulative, data, stx-harboring phages, STEC, SD1 isolates]]\n",
      "[[Pseudomonas aeruginosa, opportunistic pathogen, iron, survival, virulence, P. aeruginosa, iron, heme, non-redundant, heme assimilation system, Pseudomonas heme, Heme, transported, Phu system, sequestered, cytoplasmic protein, PhuS, transfer, heme, iron-regulated heme oxygenase HemO., PhuS homolog, ShuS, Shigella dysenteriae, bind, DNA, function, heme status, PhuS, regulating, heme flux, HemO, functions, DNA binding protein, combination, CHIP-PCR, EMSA, fluorescence anisotropy, holo-PhuS, binds, upstream, tandem iron-responsive sRNAs prrF1,F2, studies, PrrF, sRNAs, iron, proteins, iron starvation, conditions, heme-dependent, read, prrF1, terminator, yields, PrrH, transcript, qPCR analysis, P. aeruginosa, WT, DeltaphuS, strains, loss, PhuS, abrogates, heme-dependent regulation, PrrF, PrrH, levels, data, PhuS, extracellular, heme metabolism, functions, transcriptional regulator, PrrF, PrrH, levels, response, heme, dual function, PhuS, extracellular, heme, utilization, PrrF/PrrH sRNA, regulatory network, P. aeruginosa, adaptation, virulence, host]]\n",
      "[[Shigellosis, diarrheal disease, Shigella flexneri, Shigella sonnei, Infection, self-limiting, medium-term, serotype-specific, immunity, clearance, cases, men, sex, men, (MSM)-associated shigellosis, Shigella, serotype, individuals, days, persistent, carriage, reinfection, serotype, investigate, accessory genome, dynamics, MSM-associated, S. flexneri, S. sonnei, isolates, serially sampled, individual, patients, days, adaptation, pathogens, infection, pairs, associated with, persistent, infection/carriage, single nucleotide polymorphism, distance, variation, accessory genome, content, pairs, associated with, reinfection, SNP, distance, antimicrobial resistance, acquisition, Shigella carriage, gain, extended-spectrum beta-lactamase gene, carriage, chromosomal structural, variations, rearrangements, chronic, reinfection, associated), S. flexneri 3a, isolates, MSM-associated, sublineage, variations, regions, isolate, pairs, insertion sequence elements, functional profile, study, variation, accessory genome, dynamics, structural, Shigella, persistent, infection/carriage, genome, biobanked isolate, pathogen, S. flexneri 3a, Shigella spp, Gram-negative bacteria, etiological agent, shigellosis, diarrheal illness, children, age, low-income countries, high-income countries, shigellosis, sexually transmissible disease, men, sex, men, prolonged, recurrent infection, shigellae, serotype, belief, Shigella infection, short lived, early, study, evolution, pathogen, course, infection, transmission, scenario, genomic changes, course, individual, infection, Shigella, functional profile, variable, genomic regions, findings, relevance, Enterobacteriaceae]]\n",
      "[[OBJECTIVE, study, investigate, genetic relatedness, antimicrobial resistance, Shigella species, isolated, food, stool samples, cross sectional study method, Shigella spp., isolated, food, clinical samples, culture-based, biochemical, serological methods, Antimicrobial susceptibility, genetic relatedness, isolates, evaluated, disk diffusion, RAPD-PCR methods, prevalence, Shigella spp, food, stool samples, food isolates, Sh, sonnei, Shigella stool, isolates, Sh, sonnei, food isolates, resistant, tetracycline, clinical, isolates, resistant, imipenem, amikacin, azithromycin, food, clinical, isolates, MDR, Dendrogram, RAPD-PCR, isolates, food, stool samples, categorized, group, genetic relatedness, MDR, Shigella, isolates, food, clinical samples, foods, vehicles, transmission, MDR, Shigella, human, acute diseases, Survey, MDR, Shigella, food, clinical samples, implemented]]\n",
      "[[data, antimicrobial effects, cinnamon essential oils, EO, multidrug-resistant, MDR, Shigella species, study, evaluate, antibacterial activities, Cinnamomum zeylanicum, EO, clinical, MDR, Shigella isolates, MDR, Shigella, isolates, S. flexneri, S. sonnei, S. boydii, isolates, phenotypic, molecular methods, MDR, phenotypes, resistant, antibiotic, disc diffusion, C. zeylanicum, EO, analyzed, gas chromatography/mass spectrometry, GC/MS, MIC, cinnamon EO, evaluated, microtiter broth dilution, Shigella, isolates, resistant, antibiotics, resistotype, pattern, detected, S. sonnei, S. boydii, S. flexneri, isolates, GC/MS, cinnamaldehyde, ingredient, C. zeylanycum, EO, susceptible, strain, C. zeylanycum, EO, S. boydii, MIC, S. flexneri, MIC, S. sonnei, MIC, ranges, MIC, MBC, values, cinnamon EO, Shigella spp, antibacterial effects, cinnamon EO, study, increase, plant compounds, treat, infections, MDR, Shigella isolates]]\n",
      "[[complete, genome sequence, selenate, Shigella sonnei, SE6, isolated, stream, sediment, industrial, Jeonju, South Korea, genome sequence, G+C content, genes, coding sequences, rRNA genes, tRNA genes]]\n",
      "[[Foodborne diseases, pathogenic bacteria, threats, food safety, facile, effective, recognition methodology, pathogens, food, automatic approach, detection, in vivo, volatile, metabolites, emitted, foodborne, pathogens, coupling, solid phase microextraction, SPME, technique, comprehensive, two-dimensional gas chromatography quadrupole time-of-flight mass spectrometry, GC, GC-QTOFMS, polymer, composite, SPME, probe, high-coverage, microbial, metabolites, sensitive, extraction, untargeted, metabolites, result, in vivo, metabolites, investigated, pathogens, detected, identified, volatile metabolites, Shigella sonnei, Escherichia coli, Salmonella typhimurium, Vibrio parahaemolyticus, Staphylococcus aureus, Multivariate statistical analyses, analysis, metabolic, data, separation, responsive, metabolic, features, microbial systems, foodstuffs, contaminated, microorganisms, growth, potential, volatile, markers, pathogen, food samples, consistent with, strain, incubated, medium, study, promotes, application, SPME, technology, microbial, metabolomics, development, approaches, foodborne, pathogens, recognition]]\n",
      "[[Shigellosis, endemic, middle-income countries, episodes, diarrhea, deaths, annually, associated with, children, characteristics, antimicrobial resistance, profiles, Shigella species, recovered, Colombia, isolates, laboratories, Colombian, departments, serotyped, antiserum, antimicrobial resistance, minimal, inhibitory, concentrations, antibiotics, Kirby-Bauer tests, Clinical, recommendations, analyzed, isolates, Shigella spp, stools, children, years, age, species, S. sonnei, S. flexneri, resistance, rate, tetracycline, trimethoprim-sulfamethoxazole, ampicillin, isolates, resistant, chloramphenicol, amoxicillin/clavulanic acid, cefotaxime, ceftazidime, gentamicin, ciprofloxacin, S. sonnei, resistance profile, trimethoprim-sulfamethoxazole, S. flexneri, antibiotic profiles, multidrug resistance, Colombia, children, years, affected, Shigella species, findings, funders, public, health officials, evidence, decisions, protection, prevention measures, antimicrobial resistance, characteristics, study, dissemination, isolated, species, S. sonnei, S. flexneri]]\n",
      "[[Conventional disease, surveillance, shigellosis, country settings, serotyping, low-resolution, molecular typing, evolutionary history, genus, collection, Shigella whole, organisms, isolated, continental, Thailand, Vietnam, Laos, Cambodia, decades, evolution, S. flexneri, S. sonnei, S. sonnei, S. flexneri serotype, genetically, diverse, populations, Southeast Asia, Intranational, regional, dissemination, propagation, species, region, data, epidemiology, S. sonnei, S. flexneri, serotypes, frequent, clonal replacement, susceptibility, patterns, contemporaneous, antimicrobials, adaptation, antimicrobial pressure, evolutionary, Shigella, Southeast Asia]]\n",
      "[[Arabian flora, bioactive compounds, study, investigated, aromatic plant, species, sources, antimicrobial agents, pathogenic, microorganisms, microorganisms, outbreaks, infectious disease, mass gatherings, pilgrimages, season, Saudi Arabia, essential oils, aromatic plant, hydrodistilled, flowering, Lavandula pubescens Decne, Pulicaria incisa subsp, candolleana, E.Gamal-Eldin, leaves, stems, ripe, unripe, Juniperus procera Hochst, Ex Endl, analyzed, gas chromatography-mass spectrometry, GC-MS, constituents, L. pubescens, carvacrol, methyl carvacrol, beta-bisabolene, P. incisa subsp, Candolleana, essential oil, linalool, chrysanthenone, eugenol, cis-chrysanthenol, components, J. procera, essential oil, alpha-pinene, delta-3-carene, essential oils, tested, American Type Culture Collection (ATCC) strains, Gram-positive, Gram-negative bacteria, agar diffusion assay, effective, essential oil, L. pubescens, sensitive, strains, Acinetobacter baumannii, Salmonella typhimurium, Shigella sonnei, Enterococcus faecalis, Staphylococcus epidermidis, Carvacrol, L. pubescens, tested, strains, vancomycin, amikacin, ciprofloxacin, Minimum Inhibitory Concentration, MIC, Minimum Bactericidal Concentration, MBC, assays, L. pubescens, essential oil, carvacrol, Gram-negative strains, susceptible, Gram-positive ones]]\n",
      "[[DNA gyrase, topoisomerase IV, topo IV, inhibitors, antibacterial drug classes, antibacterial pipeline, representative, quinoline-1,3,4-oxadiazole, quinoline-1,2,4-triazole hybrids, tested, DNA gyrase, topoisomerase IV, Escherichia coli, Staphylococcus aureus, compounds 4c, 4e, 4f, IC50, E. coli, DNA gyrase, novobiocin, IC50, activities, 4c, 4e, 4f, DNA gyrase, S. aureus, E. coli gyrase, Compound 4e, IC50, values, E. coli topo IV, S. aureus topo IV, novobiocin, IC50, Antibacterial activity, Gram-positive, Gram-negative, strains, compounds, superior, antibacterial activity, ciprofloxacin, bacterial strain, active compounds, study, cytotoxic effect, cell, molecular docking analysis, investigate, binding mode, interactions, active compounds, active site, DNA gyrase, topoisomerase IV, topo IV, enzymes]]\n",
      "[[Host-microbe interactions, orchestrate, skin homeostasis, dysregulation, chronic, inflammatory, atopic dermatitis, psoriasis, Staphylococcus cohnii, skin commensal, beneficially, inhibiting, skin inflammation, Tmem79(-/-), spontaneously, interleukin-17, T-cell-driven, skin inflammation, Comparative skin microbiome, analysis, disease activity index, associated with, S. cohnii, Inoculation, S. cohnii, strains, isolated, mouse, human, skin microbiota, prevents, ameliorates, dermatitis, Tmem79(-/-), mice, affecting, pathobiont, burden, S. cohnii, colonization, activation, host, glucocorticoid-related pathways, induction, anti-inflammatory genes, skin, effective, suppressing, inflammation, diverse, pathobiont-independent dermatitis, models, chemically, induced, immune-driven models, S. cohnii, strains, potential, effective, live, biotherapeutics, skin inflammation]]\n",
      "[[Cationic glycopolymers, structures, poly(ionic liquid)s, PILs, synthesized, quaternization, reaction, poly(4-vinyl pyridine, halogen-functionalized d-mannose, tetraphenylethylene units, postpolymerization, modification, PILs, aggregation-induced emission effect, carbohydrate-protein recognition, lectins, concanavalin A., interactions, cationic glycopolymers, microorganisms, Gram-positive Staphylococcus aureus, Gram-negative, Escherichia coli, killing, imaging, detection, bacteria, sugar-containing PILs, hemolysis, rate, presence, saccharide units, potential, application, field, biomaterials]]\n",
      "[[Chirality, phenomenon, biological systems, biomolecules, biological components, species, chiral, recognize, enantiomer, increasing, research, nanomaterials, biomedical purposes, chirality, nanoparticles, cellular level, chiral, cysteine functionalization, mesoporous silica, nanoparticles, interaction, U87 MG, human, glioblastoma cell, healthy, human, GM08680, methicillin-resistant S. aureus bacteria, research, advancement, nano-biotechnology]]\n",
      "[[compare, effects, mannans, Konjac glucomannan, KGM, guar gum, GG, locust bean gum, LBG, obesity, obesity-related, metabolic disorders, mice, fed, high-fat diet, HFD, investigate, potential, modulation, gut microbiota, week, study, C57BL/6J mice, fed, HFD, mannan, supplementation, results, KGM, GG, LBG, HFD, reduced, body weight gain, adipose, accumulation, attenuated, liver injury, antagonized, glycolipid metabolism, inflammation-related, parameters, HFD-fed mice, degrees, LBG, supplement, dose, reduced, LBG, impacts, weight control, lipid metabolism, 16S rRNA, gene sequencing, gut microbiota, mannans, structures, supplement, doses, affected, structure, gut microbiota, extent, abundance, OTUs, OTUs, genera, Muribaculum, Staphylococcus, group, Christensenella, correlation, obesity, obesity-related, metabolic disorders, host, mannans, potential, alternative, dietary supplements, functional foods, prevent, obesity, obesity-related, metabolic disorders, induced, HFD, effects of, dose, time, functions, mannans, associated with, regulate, gut microbiota]]\n",
      "[[increase, deaths, infections, multidrug-resistant bacteria, cancer diseases, molecules, biological activity, Actinobacteria, potential, source, compounds, microorganisms, diversity, clinically, antibiotics, Endophytes, biomes, Pantanal, wetland, world, source, molecules, Hymenachne amplexicaulis, native, plants, Pantanal, endophytic, community, plant, weed, countries, adapt, compete, native, plants, evidence, endophytic, community, H. amplexicaulis, competitiveness, therapeutic, potential, study, isolated, identified, partial sequence, 16S rDNA, H. amplexicaulis, endophytic, actinobacteria, isolates, genera, Streptomyces, Microbispora, Leifsonia, Verrucosispora, root fragments, susceptibility, isolates, classes, antibiotics, evaluated, isolates, resistance, antibiotics Nalidixic Acid, Ampicillin, Chloramphenicol, Oxacillin, Rifampicin, antibacterial, antitumor, methanolic extracts, fermentation, SG, culture medium, degrees, days, extract, S. albidoflavus, isolate, activity, Gram-negative bacterium, Acinetobacter baumanii, clinical, pathogen, difficulty, active compounds, isolate, investigated, identification, active compounds, mode, action, results, extract, isolates, Streptomyces albidoflavus, CMRP4852, Verrucosispora sp., CMRP4860, antibacterial effect, Methicilin-resistant Staphylococcus aureus, MRSA, MIC, Vancomycin-resistant Enterococcus, VRE, MIC, extracts, Extracts, endophytes, cytotoxicity, murine, B16-F10 melanoma cells, CMRP4852, extract, affected, density, normal cells, results, crude extract, isolate, CMRP4860, Verrucosispora sp., cytotoxicity, reduced, cell density, tumor cells, analysis, scale-up fermentation, CMRP4860, fractions, tested, bacteria, tumor cells, fractions, investigation, results, study, endophytic, community, H. amplexicaulis, actinobacteria, secondary, metabolites, antibacterial, cytotoxic, properties, biomes, Brazilian, Pantanal]]\n",
      "[[increase, antimicrobial resistance, treatment, Staphylococcus aureus, S. aureus, infection, critically ill, patients, Silver, nanoparticles, bactericidal agents, effective, vancomycin, resistant, S. aureus, VRSA, study, bactericidal efficacy, silver, nanoparticles, VRSA, blood, sputum samples, isolated, intensive care, patients, Methicillin resistant, S. aureus, MRSA, isolates, identified, samples, incidence, VRSA, isolates, isolates, isolates, sputum, blood samples, incidence, incidence, Vancomycin, intermediate, S. aureus, VISA, isolates, inhibitory, isolates, VRSA, isolates, inhibitory, detected, isolates, findings, study, silver, nanoparticles, effective, treatment, VRSA]]\n",
      "[[in vitro study, standard, antiseptics, skin, environmental, disrupt, metabolic activity, measure, viability, multidrug-resistant gram-negative bacteria, methicillin-resistant Staphylococcus aureus, MRSA, vancomycin-resistant Enterococcus, isolates, native, biofilms, clinical, isolates, multidrug-resistant bacteria, testing, chlorhexidine gluconate, octenidine, polyhexanide, chloroxylenol, concentrations, Metabolic, inhibition, biofilm, clinical, isolate, analysed, biofilm viability assay, Chlorhexidine gluconate, octenidine, efficacy, biofilms, tested, microorganisms, efficacies, MRSA, antiseptics, efficacy, biofilms, Pseudomonas aeruginosa, Chlorhexidine gluconate, octenidine, level, bacterial, metabolic, inhibition, statistically equivalent, Polyhexanide, effective, chloroxylenol, inferior, chlorhexidine gluconate, octenidine, tested, organisms]]\n",
      "[[Antimicrobial resistance, AR, problem, search, adequate, effective, antibiotic therapy, multi-resistant bacteria, methicillin-resistant Staphylococcus aureus, MRSA, vancomycin-resistant Enterococci, VRE, Clostridium difficile, Daptomycin, treatment, infections, Gram-positive bacteria, time, patients, clinical conditions, pharmacokinetic, PK, adequate, plasma, concentrations, review, data, therapeutic drug monitoring, TDM, method, hospitalized, patients, daptomycin, impact, therapeutic success, suppression, bacterial resistance, control, side effects, strategies, antibiotics, performance, therapeutic drug monitoring, TDM, TDM, dose, adjustment, clinical outcome, patients, measuring, plasma, concentrations, administered, drug, concentration, dosages]]\n",
      "[[Phaeanthus ophthalmicus, Roxb, P. ebracteolatus, Philippine, medicinal plant, evergreen shrub, lowland, forests, Luzon, islands, Filipinos, treat, bacterial conjunctivitis, ulcer, wound infections, investigations, cyclooxygenase-2, COX-2, functions, immune-linked factor, infectious sensitivities, bacterial, pathogens, triggering, pro-inflammatory, immune-associated reactions, investigated, antimicrobial, COX, inhibitory, extracts, tetrahydrobisbenzylisoquinoline alkaloids, P. ophthalmicus, in vitro, in silico, ethnomedicinal, dichloromethane-methanol, DCM-MeOH, crude extract, alkaloid, extracts, antibacterial activities, drug-resistant, bacterial strains, methicillin-resistance, Staphylococcus aureus, MRSA, vancomycin-resistant Enterococcus, VRE, Klebsiella pneumoniae, CRE, Pseudomonas aeruginosa, MBL, (+)-tetrandrine, (+)-limacusine (2, biologically, tetrahydrobisbenzylisoquinoline, purification, tetrahydrobisbenzylisoquinoline alkaloids 1, antibacterial activity, inhibition, Gram-negative bacteria, MbetaL-Pseudomonas aeruginosa, Klebsiella pneumoniae, CRE, alkaloid, limacusine, inhibition, ovine, COX-2, in vitro, results, molecular docking, molecular dynamics simulation, experiments, alkaloid 2, affinity, catalytic sites, Gram-negative, bacterial, P. aeruginosa elastase, K. pneumoniae KPC-2 carbapenemase, enzymes, infectivity, mechanisms, ovine, COX-2, study, ethnomedicinal use, Philippine, P. ophthalmicus, plant-based adjuvant, treat, bacterial conjunctivitis, infections, antibacterial activities, COX-2, inhibition, limacusine, biologically active, P. ophthalmicus, drugs, COX-2, inhibitory, properties, celecoxib, antibacterial activity, tetrahydrobisbenzyl, alkaloids, pharmaceutical inspirations, treatments, bacterial/inflammation-related infections]]\n",
      "[[Methicillin-resistant S. aureus, MRSA, antimicrobial resistance, global, endangering, prevalence, molecular characterization, virulence genes, antimicrobial resistance, patterns, strains, isolated, beef burger, hot dog, sandwiches, vended, Mansoura city, Egypt, sandwiches, tested, contaminated, coagulase-positive, S. aureus, CFU/g, Genes, encoding, mecA, alpha-hemolysin, staphylococcal enterotoxins, toxic shock syndrome toxin-1, detected, strains, isolated, coagulase-positive strains, MRSA, strains, vancomycin-resistant S. aureus, VRSA, resistant, antimicrobials, tested, isolates, resistant, antimicrobials, tested, multi-drug resistant, MDR, antimicrobial resistance, MAR, isolates, resistant, Kanamycin, Nalidixic acid, Cefotaxime, Sulphamethoxazole-Trimethoprim, Penicillin G, Tetracycline, Cephalothin, potential, hazard, MDR-, MRSA-, VRSA-contaminated sandwiches, indication, presence, hygienic measures, standards, food handler's, personal hygiene, prevent, transmission, pathogens, consumers]]\n",
      "[[Multidrug-resistant organisms, MDROs, public, Single-centre, interventions, fail, long term, patients, transferred, institutions, economic integration, borders, transnational approach, targeting, regions, plan, interventions, differences, diagnostic, infection prevention, control, IPC, measures, MDROs, systematically, assessed, diagnostic, IPC, measures, detection, control, MDROs, tertiary academic care centres, Freiburg, Strasbourg, Basel, Data, standardised data collection, sheet, filled, centre, Uncertainties, contact, telephone, email, data supplier, Internal validity, researchers, filling, survey, centres, culture-based, nucleic acid amplification-based approach, detection, MDROs, vancomycin-resistant Enterococci, VRE, methicillin-resistant Staphylococcus aureus, MRSA, extended-spectrum beta-lactamase-producing Enterobacteriaceae, ESBL, carbapenemase-producing, carbapenem-resistant Gram-negatives, IPC, measures, centres, High-risk, patients, screened, MDROs, intensive care unit, admission, centres, French centre, screening, patients, admitted, ICU, VRE, MRSA, ESBL, Patients, colonised/infected, MRSA, quinolone-resistant ESBL, Klebsiella spp., CPGN/CRGN, isolated, patients, colonised/infected, VRE, ESBL, isolated, German centre, French, Swiss centres, German centre, isolation, measures, control VRE, quinolone-susceptible, ESBL, French centre, intercepting, MDRO, transmission, outside, German, Swiss centres, endemic, MDRO, transmission, findings, IPC, measures, borders]]\n",
      "[[Objective, study, assessed, prevalence, MRSA, ESBL, VRE, students, dental schools, Europe, hand, tongue, nostrils, students, treated, patients, study group, treat, patients, control group, sampled, incubation, TSB, subculturing, presence, oxacillin, positive cultures, identified, Staphylococcus aureus, Mannitol salt agar, agglutination tests, presence, MRSA, PCR, species, SSCmec genes, ESBL, VRE, isolated, CHROMagar, antibiotic sensitivity tests, students, study, students, treated, patients, controls, students, positive, multi-drug resistant bacterium, MDRB, students, positive, MRSA, ESBL, VRE, statistically significant, students, treated, patients, control group, MDRB, study centres, MRSA, carriage, Italian, student, population, antibiotics, year, sampling, associated with, presence, MDRB, OR, Confidence Interval, risk, MDRB, carriage, sequential, transmission, MDRB, dental health care, students, patients]]\n",
      "[[Methicillin-resistant staphylococci, threats, human, health, novel, antimicrobials, Natural, AMPs, antibiotics, cationic alpha-helical antimicrobial peptides, Lausporin-1, Lausporin-2, venom gland, scorpion L. australasiae, cDNA library, Biochemical analyses, Lausporin-1, Lausporin-2, cationic alpha-helical amphipathic molecules, Antimicrobial assays, peptides, antibacterial activities, species, antibiotic-resistant staphylococci, active, methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus capitis, inhibitory, concentrations, peptides, induce, dose-dependent, plasma membrane, disruptions, bacteria, knowledge, scorpion L. australasiae venom-derived, AMPs, potential, Lausporin-1, Lausporin-2, development, novel, drugs, methicillin-resistant staphylococci]]\n",
      "[[distribution, antimicrobial resistance, AMR, risk factors, associated with, multidrug-resistant, MDR, methicillin-resistant staphylococci, MRS, isolated, cats, admitted to, veterinary clinics, decrease, risk, MDR, MRS, transmission, humans, cats, study, investigate, diversity, Staphylococcus spp, anatomical, locations, healthy, diseased, cats, occurrence, MDR, MRS spp, risk factors, associated with, colonization, cats, swabs, anus, skin, ear canal, conjunctival sac, nares, cat, healthy, diseased, admitted, veterinary clinic, Eastern Province, Saudi Arabia, January, December, sample collection, cat owners, questionnaire, information, cat, demographics, health status, management, antimicrobial, usage, Staphylococcus isolates, healthy, diseased, cats, coagulase-positive staphylococci, CoPS, coagulase-negative staphylococci, CoNS, Staphylococcus spp, identified, Staphylococcus aureus, Staphylococcus pseudintermedius, Staphylococcus felis, Staphylococcus capitis, Staphylococcus saprophyticus, Staphylococcus isolates, resistant, penicillin, ciprofloxacin, isolate, resistant, clindamycin, Staphylococcus spp., S. aureus, S. pseudintermedius, isolates, MDR, resistance, antibiotic classes, Staphylococcus spp., methicillin-resistant S. aureus, S. pseudintermedius, mecA gene, Risk factor analysis, cats, history, antibiotic therapy, indoors, child, visit, veterinary clinic, treatment, risk, MDR, MRS, colonization, MDR, MRS, healthy, diseased, cats, Saudi Arabia, effective, antimicrobial, stewardship, program, studies, Health approach, investigate, cats, vectors, AMR, transmission, humans]]\n",
      "[[Biofilm, characteristics, Microbacterium lacticum D84, M. lacticum, Staphylococcus capitis subsp., S. capitis, polytetrafluoroethylene, AISI-304 stainless steel, late-stage, biofilm formation, investigated, M. lacticum, biofilm structure, S. capitis, mature, biofilms, amorphous matrix, extracellular, polymeric substances, EPSs, late-stage, biofilm formation, S. capitis, growth behavior, biofilm structure, correlations, roughness, parameters, S. capitis, surface, coverage, gammas, S. capitis, surface, coverage, M. lacticum, unaffected, biofilm, characteristics, M. lacticum, model, biofilm research, biofilm formation, bacteria, bacterial, adhesion, interfaces, reduce, biofilm formation, food industry]]\n",
      "[[information, staphylococcal populations, teatcups, milking, parlours, sheep, goat farms, objectives, populations, staphylococci, teatcups, milking, parlours, sheep, goat farms, field investigations, Greece, findings, anti-staphylococcal mastitis, vaccinations, farms, investigations, cross-sectional, sheep, goat farms, Greece, longitudinal, sheep farms, samplings, lactation, study, swab samples, teatcups, upper, staphylococcal, recovery, identification, assessment, biofilm-formation, contaminated teatcups, sheep, goat, farms, Staphylococci, recovered, upper, teatcups, teatcups, identification, staphylococcal, isolates, Staphylococcus aureus, Staphylococcus equorum, Staphylococcus lentus, Staphylococcus capitis, isolates, biofilm-forming, proportion, contaminated teatcups, farms, vaccination, anti-staphylococcal mastitis, vaccination, mastitis, biofilm-forming, staphylococcal strains, farms, vaccination, longitudinal study, contaminated teatcups, identified, sampling, occasions, staphylococci, upper part, species, cross-sectional study, isolates, biofilm-forming, farms, vaccination, mastitis, biofilm-forming, staphylococcal strains, proportion, contaminated teatcups, farms, vaccination, proportions, contaminated teatcups, sampling, occasions, staphylococci, recovered, teatcups, milking, parlours, sheep, goat farms, biofilm-forming, isolates, Reduced, staphylococcal, farms, anti-staphylococcal vaccination, effect, reduced, excretion, staphylococci, milk, vaccinated, animals]]\n",
      "[[Coagulase-negative staphylococci, Staphylococcus aureus, colonize, niches, mammals, compete, space, nutrients, coagulase-negative staphylococcus, Staphylococcus chromogenes, ATCC43764, synthesizes, secretes, 6-thioguanine, 6-TG, purine analog, suppresses, S. aureus, growth, inhibiting, de novo, purine biosynthesis, 6-TG, biosynthetic gene cluster, S. chromogenes, coagulase-negative staphylococci, S. epidermidis, S. pseudintermedius, S. capitis, Recombinant, S. aureus, strains, operon, 6-TG, subcutaneous, co-infections, mice, virulent, S. aureus, USA300, host, necrotic, prophylactically, 6-TG, reduces, necrotic, mice, infected, USA300, effect, abrogation, toxin, production, RNAseq, analyses, 6-TG, downregulates, expression, genes, coding, purine biosynthesis, accessory gene regulator, agr, ribosomal proteins, S. aureus, explanation, effect, toxin, production]]\n",
      "[[terrestrial, life, martian, environment, planetary protection, measures, space, exploration, microbial, survival, potential, Mars-like conditions, fungal, bacterial samples, NASA, scientific balloon flight, middle stratosphere, altitude, radiation levels, values, equatorial Mars, Fungal spores, Aspergillus niger, bacterial cells, Salinisphaera shabanensis, Staphylococcus capitis subsp., capitis, Buttiauxella sp. MASE-IM-9, MARSBOx, Microbes, Atmosphere, Radiation, Survival, Biological Outcomes Experiment, payload, filled, artificial martian atmosphere, pressure, mission profile, dried, microorganisms, UV-VIS radiation, UV, dose, shielded, radiation, stratospheric, exposure, samples, assayed, survival, metabolic, changes, Spores, fungus, A. niger, cells, Gram-(-) bacterium, S. shabanensis, resistant, reduction, Exposed Buttiauxella sp. MASE-IM-9, inactivated, UV, exposure, S. capitis subsp., UV, reduction, results, variation, survival, phenotypes, spacecraft, microorganisms, hypothesis, pigmented, fungi, resistant, martian, surface, spacecraft, missions]]\n",
      "[[skin microbiota, atopic dermatitis, AD, patients, characterized, increased, Staphylococcus aureus, colonization, disease symptoms, reduced, bacterial, diversity, Skin, bacterial, communities, AD, patients, family, genus, levels, species-level, characterization, study, investigated, bacteria, Staphylococcus genus, targeted sequencing, tuf gene, genus-specific primers, staphylococcal, communities, lesional, non-lesional, skin, AD, patients, AD, patients, healthy controls, absolute, abundance, bacteria, site, staphylococcal, community, bacterial alpha, diversity, bacterial, densities, lesional, non-lesional, skin, AD, severity, associated with, changes, staphylococcal, composition, Increased, S. aureus, Staphylococcus capitis, Staphylococcus lugdunensis, abundances, correlated, increased, severity, Staphylococcus hominis, abundance, negatively, correlated, severity, S. hominis, abundance, reduced, AD, skin, compared, healthy, skin, staphylococcal species, skin health]]\n",
      "[[study, bacterial profiling, bacterial profiles, head lice, Orang Asli, communities, head lice, Orang Asli, community volunteers, surface, head lice, genomic DNA extraction, next generation sequencing, 16S rRNA, Illumina MiSeq platform, female, male, head lice, identified, Pediculus humanus capitis, NGS sequencing reads, bacterial taxa sequences, Symbiotic bacteria, reads, Arsenophonus, Rhodococcus sequences, abundant, genera, female, male, samples, female, head lice, microbial, diversity, pathogenic, bacterial species, sequences, methicillin-resistant Staphylococcus aureus, Streptobacillus moniliformis, Haemophilus influenzae, Bordetella pertussis, Acinetobacter baumannii, 16S rRNA, genome sequencing, rare, pathogenic, bacterial species, head lice, Orang Asli, socio-economic practices, community, forest foraging, hunting, transmission, zoonotic, bacterial, pathogens, head lice, head lice, vectors, transmission, pathogenic bacteria, study, diverse, microbial, community, head lice's, gut, Orang Asli, detection, multiple, rare, pathogenic bacteria, severe, infections]]\n",
      "[[evaluate, proficiency, microbiology, laboratories, Spain, antimicrobial susceptibility testing, AST, Staphylococcus spp., Staphylococcus spp, resistance, mechanisms, Staphylococcus aureus, CC-01/mecA, CC-02/mecC, CC-03/BORSA, CC-04/MLSBi, CC-06/blaZ, CC-07/linezolid resistant, cfr, Staphylococcus epidermidis, CC-05/linezolid resistant, 23S rRNA mutation, Staphylococcus capitis, non-susceptible, laboratories, report, AST system, antimicrobial, MICs, breakpoints, CLSI, EUCAST, clinical category, Minor, errors, mEs, MEs, VMEs, MIC, discrepancies, AST method, gradient diffusion, antimicrobial agent, daptomycin, oxacillin, isolate, CC-07/cfr, error, rates, AST method, gradient, diffusion, VMEs, EUCAST, CLSI, breakpoint, EUCAST, CLSI, error type, EUCAST, CLSI, MEs, EUCAST, CLSI, VMEs, EUCAST, CLSI, antimicrobial agent, VMEs, linezolid, oxacillin, EUCAST, MEs, fosfomycin, tobramycin, gentamicin, EUCAST, mEs, amikacin, EUCAST, Clinical microbiology laboratories, susceptibility, Staphylococcus spp, antimicrobial agents, false-resistant results, discrepancies, errors, associated with, gradient, EUCAST, breakpoints, antimicrobials, aminoglycosides, MEs, fosfomycin, aminoglycosides, oxacillin, VMEs, linezolid, oxacillin]]\n",
      "[[retrospective-observational analytical study, evaluate, epidemiology, catheter-related bloodstream infections, CRBSI, adult, patients, hospitalized, intensive care unit, ICU, Hospital Aleman of Buenos Aires, Argentina, study, period, incidence, CRBSI, cases, catheter, days, occurrence, CRBSI, associated with, clinical, stay, ICU, stay, patients, CRBSI, median, days, days, CRBSI-associated mortality, statistically higher, OR, Gram-positive bacteria, microorganisms, Staphylococcus epidermidis, frequent, isolates, microorganisms, surveyed, multi-resistant germs, permanence, catheter, risk factor, CRBSI, OR, multivariate analysis, analysis, risk, infection, anatomical site, insertion, catheter, ward, procedure, ICU, operating room/external ward, skill, medical practitioner, ultrasound, vascular accesses, CRBSIs, frequent, complication, department, relevant, clinical, consequences, epidemiology, problems, service, programming interventions, public, health problems]]\n",
      "NaN\n",
      "[[Appendiceal, neurofibromas, experimental, observational, data, evidence-based diagnosis, treatment, case, woman, NF1, aqueductal stenosis, resultant, hydrocephalus, ventriculoperitoneal shunt, VPS, emergency department, abdominal pain, abnormalities, right hemiabdomen, cross-section imaging, Staphylococcus epidermidis growth, distal portion, VPS, treated with, intravenous antibiotics, VPS, removal, improvement, appendectomy, pathologic, evidence, NF, appendectomy, malignancy, symptoms, preventing, malignant transformation, case, appendiceal, neurofibromas, differential diagnoses, abdominal pain, patients, NF1]]\n",
      "[[Periprosthetic shoulder infection, PSI, complication, reverse shoulder arthroplasty, RSA, scientific data, management, PSI, optimal, strategy, clinical outcome, unclear, Guidelines, Infectious Diseases Society of America, management, periprosthetic joint infection, data, patients, hip, knee arthroplasty, study, evaluate, guidelines, patients, PSI, RSA, functional outcome, surgical intervention, assessed, RSA, database, retrospectively, reviewed, infections, primary, revised, RSAs, diagnosed, Data, age, sex, indication, RSA, causative pathogen, surgical, antimicrobial, treatment, functional outcome, recurrence, patients, PSI, identified, Surgical treatment, debridement, implant retention, DAIR, 1-stage revision, revision, multiple stage revisions, stages, resection arthroplasty, causative pathogens, Staphylococcus epidermidis, Cutibacterium acnes, patients, diagnosed, recurrence, treated with, DAIR, approach, median, follow-up, months, months, PSI, low-virulent, pathogens, diagnosed, delay, chronic infection, time of surgery, results, treating, patients, chronic, PSI, DAIR, recurrence, rate, implant exchange, 2-stage, functional, implant retention, patients, chronic, PSI, treated with, implant exchange, research, surgical strategy, 2-stage exchange, outcome]]\n",
      "[[Embp protein, Staphylococcus epidermidis, inhibits, hemagglutination, H1N1 influenza virus, protects, birds, viral respiratory infection, species, Coagulase-negative Staphylococcus, CoNS, respiratory cavity, nostrils, non-epidermidis, CoNS, animals, function, S. epidermidis, Non-epidermidis, CoNS, isolates, poultry, sheep, goat, pig, dairy cow, nostrils, Haemagglutination inhibition, activity, assayed, bacteria-free supernatants, non-epidermidis, CoNS, Newcastle disease virus, NDV, bovine parainfluenza virus type 3, BPIV, strains, bacteria-free supernatants, HI, activity, NDV, BPIV-3, Staphylococcus xylosus, supernatants, poultry, isolate, sheep, isolates, goat, isolate, dairy cow, isolates, frequency, HI, activity, NDV, BPIV-3, Staphylococcus sp. supernatants, goat, isolate, dairy cow, isolates, Staphylococcus equorum, Staphylococcus chromogens, Staphylococcus gallinarum, supernatants, isolation, poultry, pig, poultry, isolates, homologous gene, embp gene, S. epidermidis, associated with, HI, activity, viruses, Pulsed-field gel electrophoresis, S. xylosus, isolates, clones, origin, isolation, HI, activity, results, non-epidermidis, CoNS, supernatants, animals, origins, HI, NDV, BPIV-3, S. epidermidis, function]]\n",
      "[[Human, skin, microorganisms, microbiota, bacteria, viruses, yeasts, fungi, archaea, skin microbiota, constant, contact, environment, eubiotic state, application, cosmetic products, balance, skin microbiota, effect, factors, residual, activity, preservatives, skin, effect, preservatives, cosmetic products, Propionibacterium acnes, Staphylococcus epidermidis, Staphylococcus aureus, in vitro, 3D skin models, culture-dependent methods, effect, Histone deacetylase 3, HDAC3, investigated, tested, combinations, restoring, dysbiosis, inhibiting, C. acnes, S. aureus, simultaneously, inhibiting, growth, S. epidermidis, combinations, topical products, skin, scalp, eubiosis, microbiota, tested, increase, HDAC3, expression, data, preservatives, skin, resident, microflora, dynamics, preservatives, dosage, cosmetic formulations, homeostasis, skin microbiota]]\n",
      "[[study, evaluate, presence, bacterial, contamination, biometric identification devices, public hospital, species, bacteria, contamination, assess, bacterial, recovery, disinfectants, isopropyl alcohol chlorhexidine, Design, trial, Public hospital, tertiary referral center, Participants, biometric identification devices, hospital, Collection, microbiological samples, fingerprint reading surface, biometric devices, solution, time periods, isopropyl alcohol chlorhexidine, bacterial species, samples, Staphylococcus epidermidis, samples, S aureus, samples, S epidermidis, samples, disinfecting, samples, disinfected, isopropyl alcohol chlorhexidine, S aureus, samples, bacterial growth, devices, disinfection, alcohol, devices, disinfection, isopropyl alcohol chlorhexidine, decrease, frequency, species, isolated, disinfection, solutions, isopropyl alcohol chlorhexidine, effective, biometric identification devices, hospital, products, cleaning, bacteria, commensal, skin microorganisms, pathogenic bacteria, immunocompetent, individuals, methicillin-resistant S aureus]]\n",
      "[[Biofilms, difficulties, treatment, infectious diseases, properties, escape, antibiotic effect, antiphagocytic effects, infectious diseases, associated with, biofilm-forming bacteria, Staphylococcus aureus, Staphylococcus epidermidis, agents, hospital infections, infections, biofilm-related, problem, infectious, isolates, biofilm, MBEK, values, biofilm forms, minimum, inhibition, MIC, values, planktonic forms, doses, antibiotics, treatment, infections, increase, antibiotic resistance, N-acetylcysteine, NAC, molecule, effective, biofilm, disrupting, mature, biofilms, reducing, adhesion, bacteria, surfaces, study, biofilm-forming, abilities, ampicillin, vancomycin, MIC, values, presence, NAC, molecules, change, MBEK, values, antibiotics, presence, NAC molecule, change, expression, levels, genes, biofilm formation, presence, NAC molecule, S.aureus, S.epidermidis, isolates, isolated, clinical specimens, Trakya University Health Research, study, microplate crystal violet method, biofilm formation, staphylococci, Broth microdilution, checkerboard method, change, presence, NAC molecule, MIC, MBEC, values, ampicillin, vancomycin, effect, NAC, expression, intercellular binding proteins A and D, icaA, icaD, Staphylococcus regulatory protein A, genes, genes, biofilm formation, staphylococci, quantitative real-time Polymerase Chain Reaction, Student-t test, compare, control, experimental groups, concentrations, detected, synergy, additive effect, limit value, significance, study, NAC molecule, ampicillin, vancomycin, combination, MIC, values, staphylococcus isolates, staphylococcal, biofilm MBEK, values, expression, levels, icaA, icaD, sarA, effective, biofilm formation, staphylococci, decreased, result, study, NAC molecule, alternative, drug therapy, treatment, NAC molecule, microorganisms, antimicrobial agents, results, study, studies, subject]]\n",
      "[[study, trends, distribution, drug resistance, pathogenic bacteria, isolated, patients, treated, burn ward, investigated, AIM, effective, clinical strategies, techniques, prevention, treatment, bacterial infections, burn, patients, Clinical samples, positive bacteria, patients, burn ward, Beijing, Jishuitan Hospital, China, samples, retrospectively analyzed, distribution, pathogenic bacteria, trends, changes, bacterial, drug resistance, period, assessed, Drug resistance, pathogenic bacteria, analyzed, Samples, patients, collected, analyzed, strains, pathogenic bacteria, isolated, hospital, bacteria, strains, isolated, burn wounds, isolated, blood, patients, Gram-positive bacteria, Gram-negative bacteria, fungi, pathogens, Staphylococcus aureus, Pseudomonas aeruginosa, Staphylococcus epidermidis, pathogens, isolated, patients, patients, treated, burn ward, hospital, Staphylococcus aureus, Pseudomonas aeruginosa, clinical, pathogens, bacterial infections, detection, monitoring, intensity, growth, pathogenic bacteria, clinical, patients, tests, drug sensitivity, burn, recovery, guidelines, application, antibiotics, drugs, collection, correct, standard culture, bacterial specimens, improve, efficiency, bacterial infection, detection, Effective, monitoring, clinical treatment, patients, reduce, rate, infection, effects of, drug resistance, patients, burn centers]]\n",
      "[[complications, surgical therapy, ankle fractures, wound infection, study, evaluate, postoperative function, risk factors, associated with, postoperative, wound infection, patients, open reduction, internal fixation, ankle fracture, multicenter study, patients, diagnosed, closed ankle fracture, treated, surgical therapy, institutions, patients, men, women, mean, SD, age, years, mean body mass index, BMI, SD, subjects, patients, self-termination, treatment, discharge, open fracture, distal tibia shaft fracture, pilon fracture, risk factors, wound infection, age, sex, BMI, fracture type, injury, energy, histories, smoking, diabetes, arteriosclerosis, heart failure, myocardial infarction, logistic regression analysis, investigate, risk factors, wound infection, items, explanatory variables, presence, absence, wound infection, response, variable, Wound infection, surgery, closed ankle fracture, patients, causative organism, methicillin-susceptible Staphylococcus aureus, MSSA, patients, methicillin-resistant S. aureus, MRSA, patients, Finegoldia magna, patient, S. haemolyticus, patient, patients, causative organisms, detected, culture, causative organisms, univariate analysis, sex, smoking, fracture type, heart failure, Logistic regression analysis, smoking, type of fracture, trimalleolar fracture, explanatory factors, infection, odds ratio, rate, postoperative, wound infection, closed ankle fracture, Staphylococcus, frequent, causative, organism, surgeon, attention infection, surgery, patients, trimalleolar fracture, smoking habits]]\n",
      "[[Methicillin-resistant Staphylococcus aureus, MRSA, non-aureus staphylococci, MRNAS, infections, animals, mastitis, livestock, humans, study, compare, staphylococcal chromosome cassette mec (SCCmec, MRSA, MRNAS, isolated, animal, species, humans, countries, S. aureus, non-aureus staphylococci, Chrom MRSA ID((R)) agar, phenotypically resistant, cefoxitin, tested, positive, PCR, mecA gene, MRSA, MRNAS, isolated, Belgium, cows, livestock-associated, MRS, humans, community-acquired, MRS, Japan, dogs, cats, SCCmec cassettes, multiplex PCR, MRSA, MRNAS, WGS, MRSA, SCCmec types IV, V, frequent, Belgian, LA-MRS, CA-MRS, SCCmec type II, identified, Japanese, MRSA, isolate, bovine, S. haemolyticus, SCCmec, identified, results, prevalence, SCCmec types IV, V, LA-MRS, CA-MRS, Belgium, public, hazard, former, absence, SCCmec, MRNAS]]\n",
      "[[Linezolid, treat, infections, multidrug-resistant, Gram-positive cocci, linezolid-resistant S. aureus, LRSA, coagulase-negative staphylococci, CoNS, strains, isolates, linezolid, resistance genes, laryngological, patients, characterized, antimicrobial resistance, patterns, molecular methods, spa typing, MLST, SCCmec typing, detection, virulence genes, ica, operon, expression, analysis, antimicrobial resistance, determinants, isolates, multidrug resistant, resistance, methicillin, S. aureus, strain, ST-398/t4474/SCCmec IVe, adhesin, hemolysin genes, ica, operon, S. haemolyticus, strain, ST-42/mecA-positive, hemolysin genes, Linezolid, resistance, S. aureus, strain, associated with, mutations, ribosomal proteins L3, L4, S. haemolyticus, resistance, associated with, presence, cfr gene, S. aureus, optrA, poxtA genes, identified, case, staphylococci, linezolid, patients, chronic sinusitis, Poland, S. aureus, CoNS, etiological factors, laryngological infections, monitoring, infections, combined, surveillance, infection prevention programs, decrease, linezolid-resistant staphylococcal strains]]\n",
      "[[prosthetic joint infections, PJIs, identification, causative microorganisms, adapt, optimize, treatment, microbiological diagnosis, PJIs, bacteria, biofilm, prosthetic material, dithiothreitol, DTT, treatment, prosthesis, release, bacteria, biofilm, improve, microbiological diagnosis, study, evaluated, commercial, device, DTT, MicroDTTect system, Heraeus, Hanau, Germany, diagnosis, low-grade, chronic, PJIs, conventional, culture, periprosthetic tissue, PPT, samples, patients, surgery procedure, removal, prosthetic material, suspicion, low-grade, PJI, pre-operative, microbiological documentation, Bacteriological results, fluid, prosthesis, treatment, MicroDTTect system, results, conventional, culture, PPT, samples, bacteria, PJIs, recovered, culture, PPT, samples, detected, MicroDTTect device, patient, bacterial, isolate, Staphylococcus haemolyticus, suspected, polymicrobial, PJI, DTT, treatment, positivity, cultures, reduced, MicroDTTect system, case, Cutibacterium acnes infection, bacterial contaminants, MicroDTTect system, PPT, samples, study, DTT, treatment, prosthetic component, MicroDTTect device, microbiological diagnosis, low-grade, PJIs]]\n",
      "[[compact CRISPR/Cas9 system, gRNA, promoter, expression, AAV, therapeutic, applications, SauriCas9, activity, NNGG, PAM, specificity, moderate, Cas9, orthologs, Staphylococcus lugdunensis, Cas9, SlugCas9, Staphylococcus lutrae, Cas9, SlutrCas9, Staphylococcus haemolyticus, Cas9, ShaCas9, mammalian, genome, editing, Cas9, orthologs, SlugCas9, NNGG, PAM, activity, SaCas9, SlugCas9-SaCas9 chimeric nuclease, specificity, high activity, engineered, SlugCas9, mutations, high-fidelity variant, high, specificity, on-target, editing, efficiency, study, minimal, Cas9, tools, research, clinical applications]]\n",
      "[[Coagulase-negative staphylococci, CoNS, recovered, ecological niches, genetic relatedness, isolates, study, genome sequencing, compare, mecA, positive, mecA, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, isolates, recovered, hand-touched, surfaces, East, data, isolates, European Nucleotide Archive, ENA, research groups, isolates, associated with, hospital settings, patients, healthy, humans, livestock, pets, plants, natural, public environments, core, accessory phylogenetic analyses, mecA(+, S. epidermidis, S. haemolyticus, isolates, recovered, general public settings, genetically, isolates, recovered, bloodstream, urinary tract, eye infections, S. epidermidis, isolates, recovered, study, genetically, isolates, livestock/livestock housing, S. haemolyticus, isolates, genetically, isolates, recovered, dog, kefir, fermented cow milk, drink, MecA, S. hominis, isolates, genetically, isolates, recovered, clinical samples, genetically, isolates, recovered, mosquitoes, air samples, residential areas, kefir, species, genetic relatedness, isolates, recovered, healthy, humans, results, CoNS, isolates, study, genetic, similarities, lineages, mecA(+, S. epidermidis, S. haemolyticus, isolates, general public settings, study, risk, public health]]\n",
      "[[study, occurrence, methicillin-resistant (MR) non-aureus staphylococci, NAS, German, dairy farms, Farms, detection, methicillin-resistant Staphylococcus aureus, MRSA, diagnostic investigations, Bacterial culture, presumptive, MR-NAS, method, MRSA, detection, Quarter milk samples, QMS, tank milk, swab samples, young, stock, environmental samples, bacterial culture, Methicillin-resistant NAS, detected, study farms, MR-NAS positive test, rate, QMS, tank milk, nasal swabs, milk-fed calves, postweaning calves, nasal swabs, prefresh, heifers, environment, MR-NAS, detected, dust, samples, dairy farms, teat, liners, suckers, automatic calf, feeders, geometric mean somatic cell count, QMS, affected, MR-NAS, compared, QMS, MR-NAS species, identified, Staph, sciuri, Staph, Staph, fleurettii, Staph, epidermidis, Staph, haemolyticus, species, NAS, isolates, identified, reduced, cefoxitin, susceptibility, mecA, mecC, genes, farms, mobile genetic elements, detected, MR-NAS, MRSA, resistance genes, transferred, NAS, Staph, aureus, farms]]\n",
      "[[study, anti-diarrheal, probiotic, pigs, antibiotic alternatives, livestock, intestinal, pathogens, Escherichia coli, O157, H7, Staphylococcus aureus ATCC 6538, Listeria monocytogenes ATCC 19115, Salmonella Typhimurium ATCC 14028, Shigella boydii ATCC 9207, Staphylococcus haemolyticus, ZSY2, indicator bacteria, Lactobacillus animalis, isolated, pig, feces, extensive, higher, antibacterial activity, indicator, pathogens, tested, strains, pZL8a, tolerance, low, pH, bile salts, high-level, adhesion, Caco-2, cells, susceptibility, reference strain, Lactobacillus rhamnosus GG, LGG, observed, control, supplement, improved, level, immunoglobulin G (, IgG, immunoglobulin M, IgM, interleukin-2, IL-2, mouse serum, L. animalis pZL8a, potential, probiotic, research, reduce, application, antibiotics, animal production]]\n",
      "[[Coagulase-negative staphylococci, CoNS, associated with, nosocomial infections, immunocompromised, invasive medical devices, concern, clinical, multidrug-resistant, CoNS, uMgungundlovu District, KwaZulu-Natal Province, South Africa, pathogens, presumptive, CoNS, blood cultures, Culture, biochemical tests, Staphaurex Latex Agglutination Test, identification, CoNS, isolates, confirmation, speciation, VITEK 2 system, Susceptibilities, isolates, antibiotics, Kirby-Bauer disk diffusion method, multiple, antibiotic resistance, MAR, indices, isolates, polymerase chain reaction, PCR, mecA gene, methicillin, resistance, CoNS, isolates, CoNS, VITEK 2 system, isolates, methicillin-resistant, phenotypic, cefoxitin, mecA, positive, Staphylococcus epidermidis, S. hominis ssp., hominis, S. haemolyticus, CoNS, species, Isolates, resistance, penicillin, erythromycin, azithromycin, susceptibilities, linezolid, gentamicin, tigecycline, Multidrug resistance, MDR, isolates, MAR index, calculation, isolates, MAR index, Isolates, highest, MAR, indices, neonatal, intensive care unit, MDR antibiograms, observed, prevalence, methicillin resistance, multidrug resistance, species, CoNS, surveillance, pathogen, contaminant, microbial, cultures]]\n",
      "[[Background, Urinary tract infection, UTI, infection, people, ages, antibiotics, susceptibility, bacterial agents, improve, empirical, antibacterial, prescription, multi-drug resistant, MDR, bacteria, Materials, Methods, retrospective observational study, patients, UTI, hospital, center, Al-Basrah Governorate, south, Iraq, Bacterial, isolates, urine samples, bacteria, investigated, automated, VITEK(R) 2 compact system, causative bacteria, antibiotics, susceptibility, Escherichia coli, Klebsiella pneumoniae, frequent, Gram-negative, isolates, Staphylococcus haemolyticus, Enterococcus faecalis, frequent, Gram-positive isolates, Fosfomycin, tigecycline, colistin, meropenem, imipenem, amikacin, nitrofurantoin, susceptibility, rates, Gram-negative isolates, Nitrofurantoin, tigecycline, daptomycin, teicoplanin, vancomycin, linezolid, Gram-positive isolates, causative, isolates, Gram-negative, isolates, E. coli, K. pneumoniae, resistance, rates, antibiotics, penicillin/beta-lactamase, piperacillin/tazobactam, ceftazidime cefepime, ciprofloxacin, levofloxacin, trimethoprim/sulfamethoxazole, treatment, UTI]]\n",
      "[[Antimicrobial resistance, ecosystems, wildlife, investigated, presence, methicillin-resistant, susceptible, staphylococci, colony-born, wild vervet monkeys, Chlorocebus sabaeus, isolation, PCR, MALDI-TOF, whole-genome sequencing, methicillin-resistant, susceptible, Staphylococcus spp, isolated, vervet monkeys, characterized, methicillin-resistant staphylococci, nasal samples, Strains, MALDI-TOF analysis, Staphylococcus cohnii, isolated, species, species, isolated, PCR analysis, strains, mecA, positive, whole-genome sequencing, WGS, methicillin-resistant strains, S. epidermidis, S. cohnii, S. arlettae, S. hominis, S. cohnii, strains, strains, identified, MALDI-TOF, genetically, characterized, S. cohnii, S. warneri, resistance genes, mobile genetic elements, blaZ, tet(K), msr(A), cat, fosB, dfrG, erm(C), mph(C, str, identified, strains, Phylogenetic analysis, S. cohnii, strains, SNPs, clusters, associated with, colony born, wild, singleton, S. cohnii, isolated, group, clustered, S. cohnii, strains, NCBI, study, presence, AMR, mobile genetic elements, colony-born, wild vervet, monkeys, prevalence, S. cohnii, nasal flora, monkeys, investigation]]\n",
      "[[case, woman, non-exertional hyperthermia, NEHT, excessive, anticholinergic, effects, psychiatric medications, patient, non-air-conditioned room, outside, temperature, degrees, mental status, hypotension, oral, temperature, degrees, C. Drug-drug, interactions, home medications, depression, bipolar disorder, seizures, amitriptyline, cyclobenzaprine, benztropine, topiramate, clonazepam, trazodone, suspected, Blood cultures, Staphylococcus hominis, patient, baseline, supportive care, intensive care unit, treated, Staph hominis, bacteraemia, course, vancomycin, recovery, lack, neurological, findings, severe, NEHT, bacteraemia, presenting, symptoms, patient's, multiple, anticholinergic medications, increased, susceptibility, NEHT, inhibited, sweating, patient's, natural, cooling, mechanism]]\n",
      "[[Microbes, foodstuffs, foodborne, illnesses, microbial hazards, foods, sale, tools, foodborne illness, outbreaks, study, microbial hazards, food samples, retail, shops, sale points, MALDI-TOF MS, Food samples, stores, supermarkets, Delta cities, Tanta, Kutour, Kafr-Elzayat, Benha, Analysis, samples, fish, meat, dairy products, bacterial species, isolates, E. coli, Enterobacter spp., E. cloacae, predominant, Citrobacter spp, C. braakii, predominant, Klebsiella spp., K. pneumoniae, predominant, Proteus mirabilis, Morganella morganii, Staphylococcus hominis, Serratia marcescens, Pseudomonas aeruginosa, Salmonella typhimurium, Enterococcus faecalis, detected, Foodstuffs, contaminated, production, processing, storage, transport, Identification, human, pathogens, foodstuffs, alarming, public health, Identification, microbiological hazards, foods, MALDI-TOF MS, efficient, foodborne, pathogens]]\n",
      "[[microbiological, infectious endophthalmitis, isolated, years, retrospective review, medical records, eyes, clinically, diagnosed, infectious endophthalmitis, subjects, Jeju Island, baseline, characteristics, subjects, investigated, culture examination, isolated, pathogens, analyzed, microbiological, features, regions, geographical conditions, eyes, causative microorganisms, identified, eyes, Bacteria, cases, fungi, cases, exogenous, Staphylococcus species, Staphylococcus aureus, S. epidermidis, S. hominis, pathogens, cases, Achromobacter xylosoxidans, causative pathogen, cases, Moraxella species, cases, frequent, endogenous, origin, Klebsiella pneumoniae, cases, subjects, groups, treatment, results, analyzed, predisposing factors, visual outcomes, presence, diabetes mellitus, initial, visual acuity, predisposing factors, visual outcomes, causative microorganisms, endogenous, endophthalmitis, Jeju Island, isolated, exogenous, microorganisms, studies, inland areas, high, incidence, atypical, clinical features, Achromobacter xylosoxidans, Moraxella, exogenous, endophthalmitis, reflective, climatic features, Jeju Island, high humidity, temperature, causative microorganisms, exogenous, endophthalmitis, causative microorganisms, exogenous, endophthalmitis, clinical manifestations, region]]\n",
      "[[Burn injury, global, people, die, annually, burn injury, cases, low-, middle-income countries, Indonesia, complications, burns, mortality, sepsis, threats, risk, multi organ dysfunction syndrome, study, descriptive-retrospective method, medical records, severe, burn injury, patients, data, age, etiology, outcome, antibiotic resistance, pathogens, sepsis, medical records, severe, burn injury, sepsis, sepsis, cases, age, category, years, cases, fire-related burns, Blood, burn, wound culture, recovered, patients, contamination, gram-positive bacteria, Staphylococcus hominis, Contamination, blood, burn, wound culture, deceased, patients, gram-negative bacteria, Pseudomonas Aeruginosa, chance, severe, burn, patients, septic, conditions, patients, infected, gram-negative bacteria, Pseudomonas aeruginosa, culprit, septic, burn-related death]]\n",
      "[[Staphylococcus lugdunensis, coagulase-negative, Staphylococcus, pathogen, significant, infections, body sites, bone, joints, case, Caucasian, elderly, male, recurrent, lumbar osteomyelitis, S. lugdunensis, history, chronic low back pain, chronic kidney failure, hemodialysis, history, immunosuppression, fever, leukocytosis, erythrocyte, sedimentation, rate, elevated, blood cultures, periphery, hemodialysis, access, tunneled catheter, positive, S. lugdunensis, diagnosis, bone biopsy, culture, bacteremia, cleared, dialysis catheter, patient, weeks, antibiotic therapy, osteomyelitis]]\n",
      "[[BACKGROUND/PURPOSE, Staphylococcus lugdunensis, Gram-positive coagulase-negative bacterium, pathogenic, species, evaluate, cefoxitin, CDD, oxacillin agar dilution, OAD, mecA PCR, oxacillin-resistant, S. lugdunensis, ORSL, isolates, Multilocus sequence typing, analysis, clonality, S. lugdunensis, isolates, isolated, CDD, OAD, mecA PCR, oxacillin-resistant, S. lugdunensis, ORSL, MLST, results, sequence type, ST, S. lugdunensis, isolates, ST6, ST3, ST27, ST4, CDD, OAD, isolates, ORSL, ST3, CDD-susceptible, S. lugdunensis, OSSL, isolates, MIC, values, oxacillin, mecA PCR, results, OAD-resistant, S. lugdunensis, OAD-susceptible, ST27, S. lugdunensis, mecA gene, OAD, gold, evaluate, performance, CDD, mecA PCR, ORSL, sensitivity, specificity, accuracy, CCD, ORSL, detection, sensitivity, specificity, accuracy, mecA PCR, ORSL, results, OAD, higher, accuracy, ORSL, detection, compared, CDD, mecA PCR]]\n",
      "[[joint aspiration, benchmark, diagnosing, periprosthetic joint infections, PJI, results, bacteria, culture, patient, concurrent, antibiotic therapy, cases, joint, aspirations, results, BJI, InoPlex, Diaxonhit, multiplex ELISA, Enzyme Linked Immunosorbent Assay, measures, immune response, presence, IgG, bacterial species, families, Staphylococcus, antigens, epidermidis, aureus, lugdunensis, Streptococcus B, antigens, Cutibacterium acnes, antigens, assay, peripherally collected blood, published studies, assay, microbiological diagnosis, cases, suspected, chronic, PJI, retrospective study, French tertiary care center, sensitivity, specificity, BJI, InoPlex, positive, PPV, negative predictive value, NPV, diagnostic errors, HYPOTHESIS, BJI, InoPlex, sensitivity/specificity, PPV/NPV, BJI, InoPlex, patients, scenarios, microbiological diagnosis, antibiotic therapy, aspirations, negative, cultures, history of infection, clinical, evidence, PJI, hip arthroplasty, knee arthroplasty, cases, results, BJI, InoPlex test, MusculoSkeletal Infection Society, MSIS, criteria, joint infection, bacterial species, test, sensitivity, BJI, InoPlex, diagnosing, chronic, PJI, MSIS, criteria, specificity, PPV, NPV, minimally invasive, rapid, results, BJI, InoPlex, effective, diagnosis, chronic, PJI, complex, microbiological, study, test, situations, patients, results, studies, performance, cost, algorithm, treating, patients, suspected, PJI, biomarkers, spectrum, bacterial strains, chronic, PJI, Knowledge, infectious agent, increases, diagnostic value, monitor, outcome, PJI, studies, diagnostic study]]\n",
      "[[PURPOSE, knee arthroscopy, irrigation fluid, surgical site, accumulates, sterile reservoir, fluid, collections, suture material, arthroscopic, surgical processes, bacterial, contamination, time, surgery, unclear, study, contamination, rate, influence, postoperative infection, study, patients, reconstruction, anterior cruciate ligament, ACL, meniscal surgery, patients, ACL reconstruction, meniscus repair, samples, irrigation fluid, reservoir, sterile drape, surgery, evaluated, suture material, ACL graft, meniscus repair, bacterial, contamination, Samples, microbiological analysis, incubation time, days, patients, outpatient department, weeks, months, postoperatively, examined, clinical signs, infection, statistical correlation, advanced, surgery, positive, microbiological, findings, fluid, Suture, fixation, material, contamination, rate, cases, contamination, rate, infection, follow-up, examinations, Staphylococcus lugdunensis, bacterial, contamination, fluid, increases, contact, fluid, reservoirs, IV]]\n",
      "[[Epidermal inclusion cysts, EIC, cysts, underneath, skin, Inflamed, EICs, signs, symptoms, pain, erythema, mimicking, cutaneous abscess, studies, lesions, culture negative, rate, culture positivity, mild inflamed, epidermal, empiric, antibiotics, retrospective chart review, cases, inflamed, EIC, mild, analyzed, department, dermatology, Mount Sinai, cultures, inflamed, cysts, bacterial growth, growth, normal flora, growth, aerobic bacteria, methicillin-resistant Staphylococcus aureus, Staphylococcus lugdunensis, methicillin-sensitive Staphylococcus aureus, growth, anaerobic bacteria, Finegoldia magna, Peptostreptococcus, Cutibacterium acnes, presenting, Review, prescribed, treatment regimens, antibiotic medication, prevalence, negative, culture, cases, mild inflamed, EIC, lacking, cultured, pathogenic bacteria, incision, drainage, culture, therapy, therapeutic, uncomplicated, inflamed, EIC, lesions, prescription, antibiotics, minimized]]\n",
      "[[characterisation, non-aureus staphylococci, NAS, isolates, sheep, humans, Sardinia, Italy, identified, species, level, gap gene polymerase chain reaction, PCR, restriction fragment length polymorphism analysis, AluI. Isolates, phenotypically, disc diffusion method, genotypically, PCR, resistance, antimicrobial agents, cationic antiseptic agents, ovine, isolates, Staphylococcus epidermidis, S. chromogenes, S. haemolyticus, S. simulans, S. caprae, prevalent, species, human, isolates, S. haemolyticus, S. epidermidis, predominant, S. lugdunensis, S. hominis, ovine, isolates, resistance genes, tested, resistance genes, antibiotic, resistance, rates, ovine, isolates, tetracycline, penicillin, resistant, methicillin, multidrug resistance, MDR, positive, antiseptic resistance, smr gene, human, isolates, resistant, antimicrobials, MDR, penicillin-resistant, isolates, blaZ gene, mec gene, Staphylococcal Chromosomal Cassette, type V, type III, type I, type II, erythromycin-resistant, isolates, efflux, msrA gene, methylase ermC gene, genes, tetracycline-resistant, efflux, tetK, gene, qacA/B, smr genes, detected, human, NAS, results, species, distribution, antimicrobial resistance, ovine, human-derived, NAS]]\n",
      "[[Transient global amnesia, TGA, disease, characterized, sudden onset, anterograde amnesia, improves, hours, woman, disruption, memory, day, fever, heart murmur, diagnosed, infective endocarditis, Staphylococcus lugdunensis, coagulase-negative staphylococcus, Septic embolizations, spleen, kidney, CT scan, patient, aortic valve replacement, susceptibility-weighted imaging, dotted low intensity area, right hippocampus, etiology, TGA, hippocampal disorder, rare, case, TGA, hippocampal infarction, septic embolism, infective endocarditis]]\n",
      "[[Clinical data, topical probiotics, dermatological diseases, atopic dermatitis, acne, psoriasis, data, live lactobacilli, axillary malodor, study, application, topical, oil-based cream, live, Lactobacilli, decrease, malodor-producing bacteria, axilla, healthy subjects, AIMS, effects, topical cream, live lactobacilli, malodor-producing bacteria, axilla, healthy subjects, adult, volunteers, males, females, consent, Axillary skin swabs, days, application, topical cream, live, Lactobacillus pentosus KCA1, Bacterial DNA, V4 region, 16S rRNA, amplified, sequenced, pair-end configuration, Illumina MiSeq platform, Microbial, taxonomy, species, level, Greengenes database, Linear discriminant analysis, LDA, LEfSe, biologically, statistically significant, abundance, Actinobacteria, decreased, Firmicutes, increased, female, participants, males, Actinobacteria, decreased, Firmicutes, increased, Corynebacterium, decreased, Lactobacillus, increased, males, females, reduction, Staphylococcus species, associated with, malodor, Staphylococcus hominis, Staphylococcus hemolyticus, Staphylococcus lugdunensis, Bacterial functional, Pyridoxal protein, dependent, enzymes, biotransformation, malodor, precursor, volatile thioalcohols, down-regulated, Lactobacillus pentosus KCA1 cream, decrease, abundance, odor-producing, Corynebacterium species, female, male, subjects, species, associated with, malodor, Corynebacterium striatum, Corynebacterium jeikeium, Corynebacterium tuberculostearicum, Staphylococcus hominis, decreased, males]]\n",
      "[[study, development, drug-resistant bacteria, isolated, acute uncomplicated cystitis, AUC, evaluate, methodology, survey, clinical data, female, patients, years, age, diagnosed, AUC, Patient, information, age, menopausal status, results, bacteriological examination, collected, analyzed, bacterial, identification, antimicrobial susceptibility testing, extended-spectrum beta-lactamase, ESBL, detection, cases, Escherichia coli, E. coli, isolated, bacterial species, proportions, fluoroquinolone-resistant E. coli, QREC, ESBL-producing E. coli, isolates, E. coli, isolates, proportion, Staphylococcus saprophyticus, S. saprophyticus, premenopausal, women, drug susceptibility, E. coli, isolates, Eastern Japan, susceptibility, cefazolin, cefotiam, cefpodoxime, lower, susceptibility, levofloxacin, postmenopausal, women, ESBL-producing, E. coli, isolates, susceptibility, tazobactam-piperacillin, cefmetazole, carbapenems, aminoglycosides, fosfomycin, S. saprophyticus, susceptibility, beta-lactams, carbapenems, proportions, QREC, ESBL-producing E. coli, trends, lower, susceptibility, LVFX, postmenopausal, women, observed, surveillance, clinical data, inexpensively, survey, bacterial strains]]\n",
      "[[study, investigated, effect, solar drying, storability, physiochemical, antioxidant, capacities, dried tomatoes, Sliced fruit, dried, solar tunnel dryer, stored, ambient, temperature, days, Solar drying, treatments, reduced, bacterial, mold, load, Staphylococcus aureus, S. saprophyticus, Escherichia coli, samples, Solar drying, treatment, reduced, water activity, dried, tomato's, level, storage, period, days, Storage, dried, tomato, slices, decrease, color, vitamin C, content, increased, carotenoid, lycopene, phenolic compound, content, antioxidant activity, principle component analysis, PCA, solar drying, tomato, slices, physicochemical properties, antioxidant capacity, storage, days, solar drying, process, tomato, slices, storage, physicochemical characteristics, shelf, life, months, potential, application, low-tech, solar, food industry, effective, post-harvest, preservative method, seasonal, vegetable, fruit, countries]]\n",
      "[[comparative analysis, quality, nutrient media, Baird-Parker dry agar base, Vogel-Johnson dry agar Base, foreign, analogues, results, clinical trials, tested, biological, parameters, sensitivity, growth rate, differentiating, inhibiting, properties, evaluation, statistical reliability, results, trials, clinical samples, evaluated, parallel studies, matches, results, studies, performers, clinical samples, laboratory, testing laboratory center, research, hospital, no.164, period, clinical trials, analyzed, cultures, potential, pathogens, isolated, culturing, test, control media, S. aureus, S. epidermidis-6, S. saprophyticus, Lecithinase activity, medium, Baird-Parker dry agar Base, mannitol fermentation, medium, Vogel-Johnson dry agar Base, preliminary, phenotypic test, isolation, differentiation, clinical, isolates, S. aureus, S. epidermidis, S. saprophyticus]]\n",
      "[[primary, experiment, dissimilarity, single, multiple, exposures, electrotherapeutic modalities, development, Gram-positive, Gram negative, spectrum, Material, methods, Bacterial strains, study, Gram-negative bacteria, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonae, Gram-positive bacteria, Staphylococcus aureus, Staphylococcus saprophyticus, Streptococcus pyogenes, Fluence, Low level laser therapy, LLLT, microwave, MWD, dosage, 100-Watt, duration, magnetic field therapy, MT, duration, intensity, Measures, analysis, variances, RANOVA, within-subject effects, detect, global significant, experiments, within-subjects, groups, F value, significant, variation, groups, pre, post exposures, variation, exposure, multiple, exposures, experimental sample's, pre-post, groups, Scanning, Transmission electron microscopy, images, damage, bacterial cells, surface, Gram negative, Gram positive spectrums, study, exposure with, LLLT, emphatic effect, exposure, MWD, MT]]\n",
      "[[Staphylococcus saprophyticus, primary, community-acquired, urinary tract infections, UTIs, young, women, S. saprophyticus, colonizes, humans, animals, features, molecular epidemiology, phylogenomic analysis, S. saprophyticus, isolates, human, UTIs, isolates, human, UTIs, pig-processing chain, region, epidemiologic, genomic, evidence, meat-production chain, source, S. saprophyticus, human, UTIs, human, microbiota, origin, Pathogenic, S. saprophyticus, lineages, genetic features, locally disseminated, Pangenome-wide approaches, association, pathogenicity, antimicrobial resistance, phages, platelet binding proteins, increased, recombination, rate, study, origin, transmission, population structure, pathogenic, S. saprophyticus, virulence factors]]\n",
      "[[meat products, beef kargyong, pork kargyong, satchu, khyopeh, food items, Himalayan state, Sikkim, India, study, assess, microbiological safety, traditional, meat products, potential, spoilage, pathogenic bacteria, detecting, enterotoxins, screening, antibiotic susceptibility, patterns, pH, moisture, contents, meat products, microbial, loads, aerobic bacteria, Staphylococcus, Bacillus, coliform, 16S rRNA, gene sequencing, bacterial species, isolated, meat products, Staphylococcus piscifermentans, Citrobacter freundii, Enterococcus faecalis, Salmonella enterica, Staphylococcus aureus, Citrobacter werkmanii, Klebsiella pneumoniae, Macrococcus caseolyticus, Klebsiella aerogenes, Staphylococcus saprophyticus, Pseudocitrobacter anthropi, Citrobacter europaeus, Shigella sonnei, Escherichia fergusonii, Klebsiella grimontii, Burkholderia cepacia, Bacillus cereus, enzyme-linked immunosorbent assay, ELISA, Salmonella spp, enterotoxins, B. cereus, Staphylococcus, tested, samples, PCR method, detect, virulence genes, B. cereus, Salmonella, isolates, Virulence gene, sea, detected, S. piscifermentans, BSLST44, S. piscifermentans, BULST54, isolated, beef kargyong, S. aureus, PSST53, isolated, pork kargyong, enterotoxins, detected, khyopeh, samples, antibiotic sensitivity test, bacterial strains, susceptible, gentamicin, cotrimoxazole, norfloxacin, trimethoprim, Gram-positive bacteria, sensitivity, clindamycin, erythromycin, resistance, pattern, oxacillin, penicillin, ampicillin]]\n",
      "[[Staphylococcus saprophyticus, frequent, community-acquired, causative agent, acute urinary tract infection, UTI, strains, S. saprophyticus, biofilms, increasing, virulence, biofilms, antibiotic resistance, exacerbated, study, study, biofilm formation, structure, antibiotic resistance, S. saprophyticus, UTIs, women, Ahvaz, Iran, S. saprophyticus, isolates, UTIs, Antibiotic resistance, pattern, biofilm production, structure, phenotypic methods, S. saprophyticus, isolates, resistant, erythromycin, isolates, sensitive, linezolid, vancomycin, S. saprophyticus, multidrug resistant, S. saprophyticus, isolates, mecA gene, Biofilm formation, S. saprophyticus, isolates, polysaccharide matrix, data, rates, antibiotic resistance, capability, biofilm formation, S. saprophyticus, isolates, emergence, antibiotic resistance, management, UTIs, public health, findings, study, improve, treatment plans, UTIs, increased, awareness, mechanisms, biofilm formation, development, drug resistance, UTIs, controlled, treated]]\n",
      "[[OBJECTIVE, study, investigate, antimicrobial susceptibility pattern, biofilm production, presence, biofilm genes, S. maltophilia, clinical, isolates, clinical, isolates, S. maltophilia, patients, hospitals, Susceptibility, antibiotics, investigated, disc diffusion method, guidelines, Clinical, CLSI, crystal violet staining method, capability, biofilm formation, genes, associated with, biofilm production, investigated, PCR-sequencing techniques, isolates, resistant, doripenem, imipenem, meropenem, Minocycline, trimethoprim/sulfamethoxazole, levofloxacin, susceptibility, results, crystal violet staining assay, isolates, biofilm, isolates, weak, moderate, biofilm producers, Biofilm genes, rpfF, spgM, rmlA, prevalence, prescribing, antibiotics, implementation, infection control protocols, prevent, infection, development, antimicrobial resistance, Combination strategies, antibiotics, anti-biofilm agents, biofilm-associated infections]]\n",
      "NaN\n",
      "[[Polycyclic Aromatic Hydrocarbons, PAHs, toxic, recalcitrant, pollutants, environment, study, assessed, capacity, isolated, soil, microbial, consortium, OMC, biodegrade, PAHs, OMC, biodegradation, naphthalene, acenaphthylene, acenaphthene, fluorene, phenanthrene, solution, anthracene, fluoranthene, PAHs, measure, phenanthrene, PHE, mineralization, OMC, strains, isolated, OMC, identified, PCR amplification, gene 16S ribosomal RNA, Stenotrophomonas maltophilia, CPHE1, PAH, degrader, mineralize, PHE, biodegrade, solution, OMC, PHE, degradation, mineralization, metabolites, identified, PHE, degradation, detection, genes, PAH, RHDalpha, nahAc, OMC, consortium, degradation, salicylic, phthalic acid, PAH, RHDalpha, PHE, biodegradation, DNA, S. maltophilia, CPHE1, ecotoxicology study, PHE, bioremediation, inoculating, S. maltophilia, CPHE1, days, decreased, solution, toxicity]]\n",
      "[[emergence, drug-resistant bacteria, problem, Bacterial, dipeptidyl peptidases, DPP7s, DPP11s, family-S46 peptidases, enzymes, bacterial growth, mammals, inhibitors, peptidases, potential, antibiotics, molecular mechanisms, specificity, S1 subsite, S46 peptidases, preference, S2, subsite, peptidases, study, structural, biochemical analyses, DPP7, Stenotrophomonas maltophilia, SmDPP7, SmDPP7, preference, accommodation, hydrophobic amino acids, S2, subsite, exception, asparagine, hydrophilic, amino acid, Structural analyses, SmDPP7, revealed, preference, asparagine, hydrogen bonding, network, S2, subsite, residues, S2, subsite, S46 peptidases, S1 subsite, findings, development, universal inhibitor, S46 peptidases]]\n",
      "[[woman, nasal stuffiness, progressive, headache, reduced, visual acuity, weeks, endoscopic endonasal transsphenoidal approach, EETA, pituitary spindle cell oncocytoma, months, admission, Magnetic resonance imaging, MRI, intrasellar, cystic lesion, suprasellar, extension, EETA, tumor, removal, histological, findings, inflammatory infiltration, pituitary abscess, Microscopy, mites, fungal hyphae, Cultures, abscess, Staphylococcus hyicus, Stenotrophomonas maltophilia, Aspergillus sp., patient, antibiotic, treatment, resolved, clinical symptoms, cleared, MRI, findings]]\n",
      "[[multidrug-resistant pathogen, Stenotrophomonas maltophilia, multiple, intrinsic, resistances, carbapenem, resistance, companion, animals, antimicrobial susceptibility, sequence types, STs, S. maltophilia, isolation, rate, investigated, antimicrobial, susceptibilities, multilocus sequence types, MLSTs, S. maltophilia, strains, isolated, dogs, cats, Japan, Prevalence, resistance, detected, imipenem, aztreonam, piperacillin, trimethoprim-sulfamethoxazole, ceftazidime, Rates, resistances, chloramphenicol, minocycline, levofloxacin, low, MLST, analysis, strains, STs, STs, STs, Phylogenetic analysis, MLSTs, categorization, isolates, genogroup, genogroup, human, isolates, Multinational surveillance, significance, antimicrobial-resistant, S. maltophilia, isolates, companion, animals]]\n",
      "[[Stenotrophomonas maltophilia, S. maltophilia, aerobic, non-fermentative, Gram-negative, multidrug resistant, organism, microorganism, causative agent, nosocomial infections, neonatal, intensive care unit, cases, causative microorganism, early-onset, neonatal, sepsis, EONS, cases, EONS, S. maltophilia, reviewed, EONS, S. maltophilia]]\n",
      "[[honey bee, crop, pollinator, model, insect, social behavior, disease transmission, development, ectoparasitic Varroa destructor mite, threats, honey bee, industry, Varroa toxic protein, VTP, saliva, Varroa mites, toxicity, Apis, cerana, deformed, wing virus, elevation, Apis mellifera, immune response, hemolymph microbiota, honey bee, species, injection, recombinant VTP, study, A. cerana, A. mellifera, worker larvae, injected, recombinant VTP, expressions, honey bee, immune genes, defensin, domeless, time points, qRT-PCR, hemolymph, microbial, community, analyzed, culture-dependent method, recombinant, VTP, injection, mortality rates, A. cerana, larvae, A. mellifera, larvae, VTP, VTP, injection, induced, upregulation, defensin gene, expression, A. mellifera, larvae, levels, abaecin, domeless, mRNAs, response, A. cerana, larvae, compared, control, injection, Phosphate buffer, saline, PBS, injection, upregulated, expression, levels, abaecin, defensin, domeless, A. mellifera, A. cerana, larvae, bacterial species, Enterococcus faecalis, Staphylococcus cohnii, Bacillus cereus, isolated, hemolymph, A. cerana, larvae, VTP, injection, PBS, injections, bacterial species, Stenotrophomonas maltophilia, Staphylococcus aureus, isolated, A. mellifera, larvae, VTP, bacterial, colonies, detected, larval, hemolymph, honey bee, species, treated, injection, control, abaecin, defensin, domeless genes, hemolymph microbiota, VTP, VTP, injection, induce, growth, bacterial species, hemolymph, injected, larvae, A. mellifera, A. cerana, cues, interactions, honey bee, VTP, hemolymph bacteria]]\n",
      "[[PURPOSE, Inhibitory, effects, planktonic, sessile, bacterial cells, Streptococcus mutans, investigated, study, MIC, MBC, TF/EGCG/CHX, S. mutans UA159, biofilms, treated with, agents, proliferative activity, viability, bacterial cells, detected, SPSS, software package, statistical analysis, TF, inhibit, planktonic cells, S. mutans UA159, MIC, MBC, bacterial cells, S. mutans UA159, biofilms, treated with, TF, concentrations, higher, proliferative activity, viability, biofilms, TF, suppressed, proliferative activity, viability, S. mutans, biofilms, theoretical, clinic, applications, TF]]\n",
      "[[Objective, study, investigate, antibacterial, antibiofilm activity, medicinal plants, oral bacteria, Materials, Methods, Salvia officinalis, Lippie citriodora, Mentha piperita, Echinacea purpurea, Matricaria chamomilla, Isolates, oral cavity, microbiological, molecular methods, inhibitory, concentration, bactericidal, concentration, Broth microdilution method, anti-biofilm activity, essential oils, extracts, investigated, Broth dilution method, Toxicity, herbal mixture, assayed, Wistar rats, treated with, intradermal injection, Wound healing, properties, herbal mixture, infected, wounds, rats, investigated, Anti-biofilm activity, investigated, tooth surfaces, Bacterial structure, changes, structure study, light microscopy, Transmission electron microscopy, lowest, MIC, MBC, plant mixtures, Streptococcus pyogenes, values, Eikenella corrodens, essential oils, S.officinalis, L.citriodora, M.piperita, E.purpurea, M.chamomilla extracts, biofilms, bacteria, herbal mixture, heal, wound skin, rats, days, control, teeth, biofilm, results, light, electron microscopy, bacterial structure, exposed to, herbal mixture, deformed, essential oils, S.officinalis, L.citriodora, M.piperita, effects, inhibition, oral bacteria, biofilm formation]]\n",
      "[[Candida albicans, Ca, opportunistic, pathogenic fungus, oral cavity, oral, interacting, bacteria, Streptococcus mutans, Sm, characteristics, Ca, adhesion, acidogenicity, aciduric, nature, collagenolytic proteinases, latent, cariogenic, potential, review, research, progress, detectable, rate, Ca, caries, cariogenic, potential, interaction, Sm, oral bacteria, pathogenesis, dental caries, therapeutic, preventive strategies, dental caries]]\n",
      "NaN\n",
      "[[Impaired, respiratory, swallow function, patients, intensive care, unit-acquired deconditioning, associated with, tissue loss, uncommon, prolonged, rehabilitation, AIM, study, effect, combined, inspiratory, expiratory respiratory muscle strength training, RMST, respiratory, swallow function, critical care, patients, deconditioning, tissue loss, male, patient, body surface area burns, case 2, man, group, streptococcus myositis, quadruple amputation, prolonged, intensive care, mechanical ventilation, routine, intensive pulmonary, swallow rehabilitation, trial, chronic aspiration, poor secretion, clearance, weeks, injury, RMST, EMST150, expiratory, Threshold, IMT, baseline, treatment, data, peak expiratory flow, PEF, anthropometry, measures, aspiration, risk, Penetration-Aspiration Scale, PAS, pharyngeal clearance, Yale Pharyngeal Residue Scale, secretions, New Zealand Secretion Scale, NZSS, functional diet, Functional Oral Intake Scale, FOIS, endoscopy, RESULTS/DISCUSSION, baseline, PEF, score, age-height norm, PEF, score, case 2, severe, expiratory compromise, energy requirements, baseline, swallowing scores, PAS, Yale, NZSS, FOIS, dysphagia, week, RMST, swallow function, improved, oral intake, tracheostomy, decannulation, weeks, dysphagia, resolution, FOIS, PAS, NZSS, PEF, predicted, patients, RMST, discharge, acute facility, PEF, predicted, RMST, swallow, pulmonary rehabilitation, cases, clinically, deliver, Controlled validation trials]]\n",
      "[[T-antigen activation, red blood cell, RBC, membrane cryptantigen, exposure, bacterial enzymes, uncommon, condition, underrecognized, hemolysis, plasma, plasma-containing, anti-T antibody, healthy, blood donors, experts, extent, severity, clinical hemolysis, PROCEDURE, retrospectively, identified, patients, positive, polyagglutination, Arachis hypogea, Glycine max, lectins, records, patients, reviewed, clinical symptoms, laboratory evidence, hemolysis, transfusion, clinical outcomes, patients, identified, diagnosis, anemic, thrombocytopenia, Severe, Streptococcus pneumoniae infection, patients, died, patients, laboratory, evidence, hemolysis, Peripheral blood smear, findings, patients, RBC, agglutination, changes, hemolysis, spherocytes, schistocytes, RBC, morphology, patients, plasma, platelet transfusions, discharge, T-antigen activation, rare, entity, patients, diagnosed, hospital, hemolytic anemia, severe, pneumococcal infection, Hemoglobin, decreased, plasma, platelet transfusions, patients, assessed, transfusions, treatment, RBCs, hemoglobin levels]]\n",
      "[[Streptococcus halichoeri, species, pyogenic streptococci, zoonotic infection, humans, S. halichoeri, indigenous, seals, reports, human, S. halichoeri infection, published, S. halichoeri, small, white, nonhemolytic, colonies, catalase-positive, routine, blood agar, isolates, coagulase-negative staphylococci, S. halichoeri tests, positive, Lancefield group B antigen, S. agalactiae, identified, matrix-assisted laser desorption/ionization time, flight mass spectrometry, partial, 16S rRNA sequencing, cases, S. halichoeri bone, joint infections, patients, United States, health conditions, microbiologic, characteristics, S. halichoeri, organism, skin commensal]]\n",
      "[[COVID-19, pandemic, academic, communities, online, learning, networking, engaging, research, increased, interaction, engagement, streptococcal research, community, COVID-19, shutdown, Virtual Streptococcal Seminar Series, Virtual Streptococcal Trainee Symposium, advertised, e-mail, social media, outlets, seminar, weekly, Thursdays, Eastern Daylight Time, monthly, seminars, trainee, symposium, days, study, analyzed, seminar, attendance, data, online recording accesses, seminars, community, engagement, independent, speaker gender, career stage, geographic location, organism, average, live attendees, recording accesses, seminar, report, attendance, speaker statistics, Virtual Streptococcal Trainee Symposium, hosted, trainees, continents, Streptococcus pneumoniae, Streptococcus agalactiae, Streptococcus pyogenes, Streptococcus suis, oral streptococci, Enterococcus faecalis, Virtual Streptococcal Trainee Symposium, live attendees, session, attendees, continents, event, online platforms, in-person conferences, seminar, symposium, streptococcal research, community, forum, scientific, COVID-19, crisis]]\n",
      "[[Streptococcus agalactiae, group B streptococcus, GBS, pathogen, severe, neonatal infections, sepsis, pneumonia, meningitis, Neonatal, GBS, meningitis, neurological prognosis, mortality rate, GBS disease, late-onset, onset age, days, birth, preventive strategy, late-onset, GBS, case, female, infant, LOGBS meningitis, recovered, septic shock, exchange transfusions, ExTs, severe, neurological sequela, born, gestational age, weeks, caesarian section, oligohydramnios, fever, days, birth, GBS, detected, cerebrospinal fluid, CSF, blood, vaginal, breast-milk cultures, mother, patient, treated with, intravenous antibiotic administration, pulseless, ventricular tachycardia, asystole, heart rate, cardiopulmonary resuscitation, ExTs, recovered, septic shock, Cytokine-profile analysis, serum, CSF, levels, pro-inflammatory, anti-inflammatory cytokines, elevated, ExTs, serum, levels, cytokines, decreased, ExTs, effective, life, patient, neurological prognosis, neonatal, GBS, meningitis, fatality, sequela rates, preventive strategy]]\n",
      "[[Streptococcosis, bacterial disease, Nile tilapia, Streptococcus agalactiae infection, development, resistant, strains, Nile tilapia, sustainable approach, disease, study, controlled disease, full-sib, families, quantify, characterize, potential, genomic selection, survival, S. agalactiae infection, Nile tilapia, genomic model, optimal, density, single nucleotide polymorphisms, SNPs, trait, fish, family, fish, intraperitoneally, injected, fish, cohabitants, challenge test, Mortalities, days, quality control, genotypes, SNPs, phenotypes, dead, alive, cohabitant fish, Genetic parameters, genomic selection models, genomic best linear unbiased prediction, GBLUP, BayesB, BayesC, BayesR, BayesS, pedigree-based model, PBLUP, pedigree-based analysis, deep 17-generation pedigree, Prediction, accuracy, bias, evaluated, replicates, cross-validation, genomic models, analyzed, subsets, SNPs, densities, effect, pruning, SNP, density, predictive, accuracy, Moderate, estimates, heritabilities, models, pedigree-based model, GBLUP, SNPs, increased, prediction, accuracy, Bayesian genomic selection model, SNP, density, increased, prediction, accuracy, SNPs, non-zero effects, BayesB, BayesC, BayesS models, marker, marker, locations, results, potential, genomic selection, survival, S. agalactiae infection, Nile tilapia, PBLUP, GBLUP, models, Bayesian genomic models, boost, prediction, accuracy]]\n",
      "[[Streptococcus agalactiae, bacterial pathogen, causative agent, diseases, neonatal, sepsis, meningitis, infections, pregnant women, non-pregnant, adults, antibiotic, treatments, symptoms, emergence, transmission, multidrug-resistant strains, effective, immunotherapy, Effector T helper (Th, cells, subpopulation, helper CD4(+) T lymphocytes, expressing, interleukin (IL)-17A, host defenses, pathogens, bacteria, viruses, S. agalactiae infection, induce, differentiation, CD4(+) T cells, Th17, cells, IL-17A, effective, S. agalactiae infections, unclear, study, analyzed, responses, CD4(+) T cells, defensive effects, S. agalactiae infection, results, S. agalactiae infection, induce, formation, Th1 cells, expressing, interferon, (IFN)-gamma, differentiation, mouse splenic, CD4(+) T cells, Th17, cells, express, IL-17A, bacterial, load, S. agalactiae, increased, decreased, organs, antibody, neutralization, IL-17A, experiments, results, IL-17A, host, S. agalactiae, S. agalactiae, results, effective, methods, regulate, expression, IL-17A, effective, prevention, treatment, S. agalactiae infection]]\n",
      "[[strains, Streptococcus agalactiae, invasive infections, neonates, encode, II-A, system, S. agalactiae, strains, hypervirulent Sequence Type 17, ST17, spacers, CRISPR locus, lineages, functional, CRISPR-Cas system, deletion, ST17 cas, promoter region, evaluated, impact, transcription, cas genes, functionalities, CRISPR-Cas system, Cas9, interference, functional, CRISPR-Cas system, ST17 strains, spacers, absence, promoter sequence, srn036, small RNA, antisense tracrRNA, ST17, CRISPR-Cas, adaptation, interference activities]]\n",
      "[[bacteremia, level, administration, antibiotics, blood collection, recovery, bacterial, pathogens, pediatric, blood cultures, BacT/Alert, Virtuo, Bactec FX BC systems, techniques, diagnose, bacteremia, pediatric, patients, pediatric, low, intermediate, bacteremia, level, evaluate, BacT/Alert PF Plus, Bactec Peds Plus, resin-based inactivation, antibiotic-bacterium combinations, BacT/Alert PF, Plus bottles, Bactec Peds Plus bottles, organisms, grow, exposed to, antibiotics, BacT/Alert PF Plus, Bactec Peds Plus, effective, piperacillin/tazobactam, Pseudomonas aeruginosa, oxacillin, methicillin-susceptible Staphylococcus aureus, growth, effectiveness, apparent, ceftriaxone, Escherichia coli, Streptococcus agalactiae, Streptococcus pneumoniae, cefepime, E. coli, growth, relevant, vancomycin, methicillin-resistant S. aureus, Streptococcus pneumoniae, BacT/Alert PF Plus bottles, Bactec Peds Plus bottles, findings, potentiality, resin-containing bottles, diagnosis, bacteremia, pediatric, patients, antimicrobial therapy, evaluated, BC, systems, simulated, bacteremia, level]]\n",
      "[[Objective, research, isolate, virulence, Streptococcus agalactiae, group B Streptococcus, GBS, isolated, popped eye disease, Tilapia, Vietnamese Koi, V. Koi) fishes, Materials, Methods, fish, samples, Tilapia, V. Koi, affected, ponds, districts, Bangladesh, Isolation, bacterium, culture media, Nutrient broth, Plate count agar, Tryptic Soy Agar, Blood agar, identification, biochemical tests, conventional, API, Strep kit, polymerase chain reaction, PCR, primers, 16S rRNA, S. agalactiae, Antibiotic susceptibility, bacteria, antibiotics disc, Tetracycline, Oxytetracycline, Chlortetracycline, Streptomycin, Ciprofloxacin, Gentamicin, Neomycin, Virulence, isolated, S. agalactiae, infecting, healthy, Tilapia, V. Koi fishes, experimental infection, Isolated bacteria, Gram-positive paired, cocci, beta-hemolytic, non-motile, Findings, biochemical, serological tests, isolated, bacterium, Group B, Lancefield, classification, PCR, result, bacteria, S. agalactiae, bacterial, isolates, resistance, antibiotics, study, isolated, GBS, virulent, mortality, Tilapia, V. Koi fishes, experimental infection, days, post-infection, findings, study, isolated, GBS, Tilapia, V. Koi fishes, virulent, multidrug-resistance, properties]]\n",
      "[[pH, drop, hindgut, horse, lactic acid-producing bacteria, abundant, horse's, feeding, carbohydrate, drop, pH, hindgut, acidosis, laminitis, Lactic acid-producing bacteria, Streptococcus equinus, Mitsuokella jalaludinii, L-lactate, D-lactate, Early detection, increased, levels, bacteria, horse, horse's diet, hindgut, acidosis, laminitis, 16s ribosomal ribonucleic acid, identified, modified, target, single stranded deoxyribonucleic acid, DNA, bacteria, modified, Binding, capture probe, target, single stranded deoxyribonucleic acid, ssDNA, solution, gel electrophoresis, probes, target, single stranded DNA, hybridization, Streptococcus equinus capture probe 1, SECP1, Streptococcus equinus, SET1, gel electrophoresis, Adsorptive stripping voltammetry, study, binding, thiol, SECP1, gold, glass substrates, studies, binding signal, thiol, SECP1, hybridization, SET1, gold, working electrode, Cyclic voltammetry, electrochemical impedance spectroscopy, binding, thiol, SECP1, gold, working electrode, hybridization, thiol, SECP1, target, gold, electrode, surface, modified, capture probe layer, hybridization, thiol, ssDNA probe, target, DNA, electrochemical biosensor, potential, detection, non-synthetic, target, equine, hindgut, acidosis]]\n",
      "[[Bacteria, genus, Streptococcus, animal, infections, humans, clinicians, emergence, species, development, human diseases, increasing, frequency, isolation, streptococci, S. suis, S. dysgalactiae, S. iniae, S. equi, people, Isolation, Streptococcus bovis/Streptococcus equinus complex bacteria, streptococcal species, review, properties, virulence factors, thrive, environments, potential, bacteria, changes, genome, settlement, hosts, Information, clinical cases, streptococcus species, groups, Bovis, Pyogenic, Suis, antibiotic resistance, profiles, bacteria, resistance, beta-lactams, review, classification, clinical characteristics, antibiotic resistance, groups, species, streptococci, animal, pathogens]]\n",
      "[[inactivation, capabilities, pathogen, inactivation, PI, platelet components, PC, Mirasol, Intercept, investigated, determination, absence, bacteria, shelf, life, testing, contents, PC, enrichment, culture, terminal sterility, pool-and-split method, treated units, untreated control, inoculum, concentration, PC, bags, inoculated, bacterial, concentrations, concentration, tested, published data, manufacturer, Dependent, results, concentrations, tested, increased, decreased, inactivation, capability, system, Bacterial count, post-spiking, treatment, spiking, treatment, day, Enrichment, culture, treatment, treatment, shelf, life, inactivation, capabilities, CFU/ml, Intercept, Mirasol, PC, shelf, Staphylococcus aureus, Staphylococcus epidermidis >/=10(6), Klebsiella pneumoniae, Streptococcus bovis, Escherichia coli, Streptococcus pneumoniae, Streptococcus mitis, Listeria monocytogenes, Streptococcus dysgalactiae, Serratia marcescens, Pseudomonas aeruginosa, Mirasol, Bacillus cereus < 10(2), Mirasol, inactivation, capability, Intercept, Mirasol, Inactivation, capability, sterility, measure, evaluate, PI, system, bacteria, logarithmic reduction, assessed, treatment, plate count, PI, alternative, bacterial, screening, treatment, inactivation, capabilities, system]]\n",
      "[[effect, association, non-protein nitrogen, yeast, bacterial, probiotics, ruminal microbiome, beef cattle, pasture, evaluated, experiment, randomized design, treatments, replications, treatments, group, animals, pasture, low, LS, groups, days, concentrate, body weight, supplements, association, additives, urea, U, slow-release, U+SRN, yeast, Saccharomyces cerevisiae, U+SRN+Y, bacterial probiotics, live strains, bacteria, U+SRN+Y+BP, supplements, salinomycin, virginiamycin, slaughtering, animals, samples, ruminal content, quantify, groups, fibrolytic bacteria, Ruminococcus albus, Fibrobacter succinogenes, non-fibrolytic, Prevotella ruminicola, Selenomonas ruminantium, Streptococcus bovis, Archaea, ciliate protozoa, qPCR technique, abundance, F. succinogenes, LS, animals, supplement, U+SRN+Y, treatments, Supplementation, reduced, abundance, S. bovis, LS, inclusion, yeast, increased, abundance, fibrolytic bacteria, animals, supplement, U+SRN+Y+BP, LS, non-fibrolytic bacteria, 3.07x10(9, yeasts, sources, non-protein nitrogen, high-concentrate diets, beef cattle, stimulates, growth, fibrolytic bacteria, reduction, digestive disorders, metabolic diseases, animals, diets, concentrate, pasture, intensive termination systems]]\n",
      "[[investigated, effect, diets, organic, zinc, medicinal herbs, ruminal, microbial, fermentation, histopathology, lambs, lambs, groups, unsupplemented, animals, Control, animals, supplemented, organic, zinc, Zn, Zn/kg, diet, animals, dry medicinal herbs, Herbs, dry matter, (DM)/d, animals, supplemented, zinc, herbs, Zn+Herbs, lamb, basal diet, meadow hay, barley, herbs Fumaria officinalis L., FO, Malva sylvestris L., MS, Artemisia absinthium L., AA, Matricaria chamomilla L., MC, proportions, lambs, slaughtered, ruminal, contents, parameters, fermentation, in vitro, in vivo, quantify, microbes, molecular, microscopic methods, Samples, fresh, ruminal tissue, histopathological, evaluation, Quantitative analyses, bioactive compounds, FO, MS, AA, MC, identified, DM, phenolic acids, DM flavonoids, alkaloid, content, FO, DM, diets, affected, levels, total gas, methane, n-butyrate, in vitro, quantification, real-time PCR, lambs, Zn, Zn+Herbs groups, Control group, abundances, Ruminococcus albus, R. flavefaciens, Streptococcus bovis, Butyrivibrio proteoclasticus, Zn, group, Morphological, observation, infiltration, inflammatory cells, lamina propria, rumen, Zn+Herbs group, effect, organic, zinc, herbal mixture, parameters, ruminal fermentation, in vitro, in vivo, ruminal microbiota, lambs, zinc-supplemented, diets, Long-term, supplementation, diet, zinc, medicinal herbs, negatively, health, ruminal epithelium, lambs]]\n",
      "[[OBJECTIVE, case, patient, synchronous diagnosis, colorectal cancer, CRC, endocarditis, S. gallolyticus subsp., pasteuranus, S. Bovis, evidence, condition, CRC, pathophysiologic, significance, clinical case, review, literature, association, infections, S. Bovis, group, CRC, microbiota, species, occurrence, CRC, case, evidence, association, species, S. Bovis, group, CRC, evidence, bacteria, CRC, genomic, mechanism, conclusions, CRC, neoplasms, endocarditis, species, S. bovis, group, association, case, infection, subspecies, diagnostic, completion, colonoscopy, increased, reports/series, original, articles, evaluation, gut microbiota, patients, CRC, association, bacteria, CRC, causative, sporadic, causative, mechanism, bacteria, initiating, promoting, CRC]]\n",
      "[[findings, microbiome, impact, development, lung cancer, effects, inflammation, dysbiosis, genome damage, study, compare, sputum microbiome, lung cancer, LC, patients, chromosomal aberration, CA, micronuclei, MN, frequency, peripheral blood lymphocytes, study, taxonomic, composition, sputum microbiome, men, untreated, LC, control subjects, CA, MN, frequency, centromere FISH analysis, Results, increase, CA, MN, frequencies, LC, patients, control subjects, frequency, centromeric positive, MN, LC, patients, aneuploidy, increase, Streptococcus, Bacillus, Gemella, Haemophilus, LC, patients, control subjects, bacterial genera, reduced, decrease, beta diversity, microbiome, LC, patients, CA, frequency, LC, patients, associated with, increased, presence, genera, Bacteroides, Lachnoanaerobaculum, Porphiromonas, Mycoplasma, Fusobacterium, sputum, decrease, genus, Granulicatella, application, false discovery rate, FDR, significance, decrease, MN, frequency, LC, patients, associated with, increase, Megasphaera, genera, Selenonomas bovis, beta diversity, microbiome, LC, control subjects, association, sputum microbiome, composition, genome, damage, LC, patients, detected, studies, etiological connection, airway, microbiome, LC]]\n",
      "[[S. bovis/S. equinus complex, SBSEC, lactic acid-producing bacteria, causative agent, associated with, acute rumen, lactic acidosis, intensive ruminants, information, characteristics, diversity, SBSEC, Korea, emergence, antimicrobial resistance, AMR, investigated, diversity, SBSEC, domestic ruminants, verified, presence, antimicrobial resistance genes, ARGs, antimicrobials, phenotypic resistance, SBSEC, isolates, SBSEC members, S. equinus, S. lutetiensis, identified, phylogenetic analyses, comparisons, overall, genome, relatedness, potential, plasticity, diversity, AMR, rates, SBSEC, erythromycin, clindamycin, tetracycline, SBSEC, isolates, clinical origin, investigation, ARGs, antimicrobials, tetracycline, resistance, SBSECs, correlated, presence, tet(M)-possessing Tn916-like transposon, correlation, presence, ARGs, phenotypic resistance, erythromycin, clindamycin, animals, SBSEC, isolates, study, potential, intraspecies, biodiversity, ruminant-origin, SBSEC, status, antimicrobial resistance, bacteria, Korean livestock, industry]]\n",
      "[[Bacteriocins, natural, antimicrobial peptides, bacteria, kill, competitors, opportunistic pathogen, Streptococcus gallolyticus subsp., gallolyticus, commensal, enterococci, murine, microbiota, tumoral conditions, production, two-peptide bacteriocin, gallocin, genes, regulatory control, gallocin, S. gallolyticus subsp, encode, histidine kinase/response regulator, BlpH/BlpR, secreted, peptide, GSP, gallocin-stimulating peptide, BlpS, BlpR, 243-amino-acid, phospho-receiver domain, LytTR, BlpS, protein, LytTR domain, results, secreted, peptide, GSP, activates, two-component system, BlpH/BlpR, induce, gallocin, transcription, genome-wide transcriptome analysis, regulatory system, GSP-BlpH/BlpR, bacteriocin, production, BlpR, BlpS, repress, gene transcription, promoter regions, BlpR, BlpS. Electrophoretic mobility shift assays, EMSA, footprint assays, binding, BlpS, BlpR, promoter regions, dose-dependent, conserved sequence, Gallocin, expression, controlled, S. gallolyticus subsp, quorum sensing, antagonistic activity, LytTR-containing proteins, Competition experiments, gut microbiota, medium, CO2, intestinal, gallocin, functional, vivo-like conditions, Streptococcus gallolyticus subsp, gallolyticus, Streptococcus bovis biotype I, opportunistic pathogen, septicemia, endocarditis, elderly, associated with, asymptomatic, colonic neoplasia, studies, S. gallolyticus subsp., gallolyticus, driver, passenger, colorectal cancer, S. gallolyticus subsp, bacteriocin, gallocin, colonization, colon, tumoral conditions, commensal members, murine, microbiota, Enterococcus faecalis, identified, characterized, four-component system, regulates, gallocin, production, Gallocin, gene transcription, activated, secreted, peptide pheromone, GSP, two-component signal transduction system, transmembrane histidine kinase receptor, BlpH, cytosolic response regulator, BlpR, DNA-binding protein, BlpS, repress, genes, transcription, BlpR., gallocin, regulation, prevent, S. gallolyticus subsp., gallolyticus colon, colonization, tumoral conditions]]\n",
      "[[Microorganisms, quorum sensing, detect, small signaling molecules, control access, nutrients, space, competitive, polymicrobial, niches, bacterial processes, QS-regulated, examples, traits, natural, production, antimicrobial peptides, bacteriocins, Streptococcus genus, competence, bacteriocins, antimicrobial peptides, potential, treatment, infections, multiple-resistant, pathogens, severe, public health, transduction, two-component system controls, competence, streptococci, ComD/E, controls, competence, Mitis, Anginosus groups, ComR/S, function, Bovis, Mutans, Salivarius, Pyogenic, groups, cell-to-cell communication, bacteriocin, production, Streptococcus groups, controlled, paralog, ComD/E system, relationships, pheromone, signals, induction pathways, bacteriocin, review, signaling, induction, bacteriocin, biosynthesis, QS regulation, streptococci, information, design, methods, development, production, antimicrobial peptides, analysis, applications, bacteriocins, safety, quality, human, health benefits]]\n",
      "[[study, assessed, oral, mucosal, irritation, potential, antimicrobial chemotherapy, hydrogen peroxide, H2O2, photolysis, laser device, output power, hamsters, cheek, pouches, male, Syrian hamsters, treatment, pure water, PW, H2O2, laser irradiation, PW, laser irradiation, H2O2, laser irradiation, PW, laser irradiation, H2O2, diameter, irradiation area, calculated, irradiances, optical power, densities, laser lights, cheek, pouches, animals, laser irradiation, H2O2, treatment, intervals, Macroscopic, histological, changes, evaluated, treatment, in vitro, bactericidal activity, treatment, periodontal pathogens, evaluated, laser irradiation, H2O2, moderate, severe, oral, irritation, treatment, mild, irritation, H2O2, photolysis, decrease, bacterial counts, findings, H2O2, photolysis, kill, periodontal pathogens, acceptable, laser device, laser, prevention, oral, irritation]]\n",
      "[[diketo esters, bioisosteres, synthesized, antibacterial agents, targeting, methionine amino peptidases, MetAPs, biochemical, purified, MetAPs, Streptococcus pneumoniae, SpMetAP1a, Mycobacterium tuberculosis, MtMetAP1c, Enterococcus faecalis, EfMetAP1a, human, HsMetAP1b, compounds 3a, 4a, 5a, inhibition, tested, MetAPs, 100muM, concentration, Compounds 4a, 5a, antibacterial potential, MIC values, S. pneumoniae, E. faecalis, Escherichia coli, S. pneumoniae, E. coli, 5a, inhibited, growth, multidrug resistant, E. coli, strains, conc, cytotoxic effect, healthy, CHO, cells, Growth, inhibition, bacterial growth, treated with, conc, 5a, TEM, analysis, vital damage, bacterial cells, 5a, MIC conc, inhibition, biofilm formation, bacterial cells, treated with, MIC conc, visualized, SEM, micrographs, alteration, hemocyte, density, Galleria mellonella, larvae, in vivo model, antimicrobial studies, non-toxic, conc]]\n",
      "[[Antimicrobial chemotherapy, ultraviolet-A, UVA, irradiation, polyphenol solution, adjunctive treatment, dental caries, safety, treatment, evaluated, study, assess, influence, treatment, oral mucosa, hamsters, wounded, skin, rats, oral, hamsters, cheek pouch, everted, treated, UVA, irradiation, water, caffeic acid, grape seed extract, light-emitting diode, irradiance, treatment, Macroscopic, histological, evaluations, treatment, effects of, treatment, healing, process, skin wounds, rats, Full-thickness, skin wounds, rats, treated, wound area, assessed, daily, results, treatment, induced, oral, mucosal, irritation, irradiation, influence, wound healing, process, oral, mucosal, irritation, potential, treatment, sessions, minimal, mild, moderate, histological analysis, findings, duration, treatment, UVA, irradiation, polyphenols, oral cavity, clinical, efficacy, antimicrobial effects, irritation, potential]]\n",
      "[[Genetic engineering, cell lines, model organisms, CRISPR/Cas9 system, cell lines, labor intensive, time consuming, mutant, clones, difficulties, isolating, mutated clones, sophisticated genotyping, study, fluorescent protein reporter, isolation, maximal, diversity, mutant cells, spectrally, fluorescent proteins, DsRed2, ECFP, reporters, CRISPR/Cas9, targeting, one-cell-one-well sorting, mutant cells, ultra-high, efficiency, CRISPR/Cas9 system, dual reporters, DNA fragment deletion, loci, cleavage, monoclonal mutant cells, PCR, speed, genome, genotyping, loss, function mutations, CRISPR/Cas9, genome editing, loss, function mutant, clones, month, transfection]]\n",
      "[[smokeless tobacco products, STPs, health problems, oral microbiota, oral, systemic, disruption, oral, microbial, periodontal disease, health problems, impact, smokeless tobacco, oral microbiota, in vivo, high-throughput sequencing, oral microbiota, Syrian, Golden hamster cheek, pouches, hamsters, groups, treated with, STP Grizzly snuff, weeks, weeks, treatment, bacterial, genomic DNA, oral swabs, sampled, cheek pouches, hamsters, oral, bacterial, communities, hamster groups, characterized, sequencing, hypervariable regions V1-V2, V4, 16S rRNA, Illumina MiSeq platform, phyla, classes, orders, families, genera, identified, sequence reads, cheek pouch, samples, bacterial, diversity, taxonomic, abundances, treatment groups, non-treated, hamsters, Bacterial, diversity, decreased, weeks, exposure to 2.5mg, increased, exposure to 250mg, STP, Treatment, STP, increased, Firmicutes, increased, Cyanobacteria, TM7, decreased, Bacteroidetes, Fusobacteria, control group, genus, level, weeks, administration, STP, increased, Granulicatella, Streptococcus, Oribacterium, Anaerococcus, Acidaminococcus, Actinomyces, Eubacterium, Negativicoccus, Staphylococcus, decreased, Bacteroides, Buleidia, Dialister, Leptotrichia, decreased, Arcanobacterium, control group, animal model, evaluating, effects, STP, oral microbiota, metagenomic sequencing, results, shift, oral microbiota, response, STP, exposure, Syrian, Golden hamster, findings, smokeless tobacco, oral microbiota]]\n",
      "[[fluorescence microscopy, electron cryo-tomography, spatial localization, tagged, macromolecular assemblies, structural features, cellular environment, localization, scale, integration, imaging, modalities, accurate, alignment procedures, marker-free method, images, light, cryo-light fluorescence microscopy, electron cryo-microscopy, sample, features, holes, carbon, film, accuracy, method, prediction errors, hole center coordinates]]\n",
      "[[nuclease-deactivated variant, CRISPR-Cas9 proteins, dCas9, fused, heterologous, transactivation, RNA, repressor, gene expression, mammalian cells, system, long-term, presence, stable, dCas9 effector, draw-back, repressed, activated, target, gene expression states, static environment, synthetic regulatory circuits, cell, issue, toolkit, degradable, stabilisable, orthologous, dCas9, Cpf1, options, multidimensional control, functional activities, combinations, orthogonal, drug-tunable artificial transcription factors]]\n",
      "[[Streptococcus thermophilus YIT 2001, ST-1, lactic acid, bacterial strain, inhibitory, effects, oxidation, low-density lipoprotein (, LDL, development, aortic fatty lesions, animal model, lower, serum, levels, malondialdehyde-modified LDL, oxidative modification, product, LDL, clinical trial, study, intracellular, active component, ST-1, associated with, anti-oxidative activity, LDL oxidation, High-performance liquid chromatography-electrospray ionisation mass spectrometry analysis, fractionation, cellular extract, reversed-phase chromatography, active fraction, reduced, glutathione, GSH, GSH, anti-oxidative activity, dose-dependent, activity, thiol derivatisation, ST-1, anti-oxidative activity, LDL oxidation, level, intracellular, GSH, strains, S. thermophilus, anti-oxidative activity, ST-1, thiol derivatisation, decreased, strains, poor, intracellular, GSH, thiol components, anti-oxidative activity, LDL oxidation, hyperlipidaemic, hamsters, fed, GSH, ST-1, cells, GSH, cells, findings, intracellular, GSH, ST-1, effects, anti-oxidative activity, LDL oxidation, excess, oxidative stress, blood]]\n",
      "[[glycosaminoglycans, bacterial, cellular invasion, xylosyltransferase-deficient mutants, Chinese hamster ovary, cells, clustered regularly interspaced short palindromic repeat (CRISPR, CRISPR-associated gene 9, CRISPR-cas9, targeting, mutants, pgsA745 cell line, CHO, xylosyltransferase mutant, chemical mutagenesis, Bacterial invasion, pgsA745 cells, group B Streptococcus, GBS, group, Streptococcus, Staphylococcus aureus, reduced, invasion, wild-type cells, CRISPR-cas9, mutants, resistant, GBS, Invasion, pgsA745 cells, transfection, xylosyltransferase, mutation, multiple bacteria, pgsA745 cells, Whole-genome sequencing, transcriptome sequencing, RNA-Seq, deletion, gene, encoding, laminin subunit alpha2, Lama2, domain L4a, Silencing, Lama2, isoform, wild-type cells, bacterial invasion, transfection, human, LAMA2, cDNA, invasion, pgsA745 cells, exogenous, laminin-alpha2beta1gamma1/laminin-alpha2beta2gamma1, increased, bacterial invasion, CHO cells, human, alveolar, human, brain microvascular, endothelial cells, L4a domain, laminin alpha2, cellular invasion, bacterial, pathogens, Pathogenic bacteria, penetrate, host, cellular barriers, attachment, extracellular matrix molecules, proteoglycans, laminins, collagens, invasion, epithelial, endothelial cells, cellular invasion, human, pathogens, group, Streptococcus, group, Streptococcus, Staphylococcus aureus, domain, laminin alpha2 subunit, finding, molecular, pathogenesis, bacteria, development, antimicrobial drugs]]\n",
      "[[Adults, Opisthorchis viverrini, biliary system, inflammation, bile ducts, cholangitis, hepatobiliary disease, HBD, cholangiocarcinoma, O. viverrini, infection, bacterial, community, bile ducts, liver, investigate, chronic O. viverrini infection, months, bacterial, genomic DNA, livers, hamsters, worms, investigated, culture techniques, PCR, Helicobacter spp., high-throughput next-generation sequencing, targeting, V3-V4, hypervariable regions, prokaryotic, 16S rRNA gene, DNA sequence reads, filtering, Metagenomic analyses, assigned, operational, OTUs, OTUs, bacteria, phyla, genera, chronic O. viverrini-infected, group, bacterial, diversity, increased, controls, Sequences, Fusobacterium spp, Streptococcus luteciae, Escherichia coli, Bifidobacterium spp., Helicobacter pylori, sequences, identified, liver, chronic O. viverrini, infections, normal liver, H. pylori, PCR, antibody, bacterial antigen, metagenomics, data, identities, bacteria, cultured, enrichment, chronic, O. viverrini, infection, changes, liver microbiome, promotes, Helicobacter spp., growth, synergy, O. viverrini, liver microbiome, immune, response-mediated hepatobiliary diseases]]\n",
      "[[prevalence, poxtA, clinical, linezolid-resistant enterococci, LRE, France, genetic supports, environments, LRE, clinical, isolates, National Reference Centre, Enterococci, French hospitals, LRE, isolates, screened, linezolid, cfr-like, optrA, poxtA, real-time PCR, phenotypically, characterized, collection, poxtA-positive isolates, Enterococcus faecium, Enterococcus faecalis, WGS, hybrid assembly, short-read, Illumina MiSeq, long-read, MinION, approaches, Transferability, poxtA, filter-mating experiments, LRE, National Reference Centre, Enterococci, period, poxtA-positive, E. faecium, isolates, characterized, WGS, epidemiologically, core genome analysis, STs, E. faecium, isolates, poxtA gene, plasmid, IS1216E transposase genes, isolates, fexB, tet(M, tet(L, poxtA-harbouring, plasmids, hybrid assembly, plasmid, transfer, poxtA, cases, poxtA/optrA-positive isolates, genes, plasmids, poxtA gene, circulating, clinical enterococci, France, E. faecium, poxtA-carrying plasmids, co-carried, resistance genes, phenicols, tetracyclines, co-selected, veterinary]]\n",
      "[[CoMiniGut in vitro, model, mimicking, small intestine, piglets, evaluate, probiotic, strains, potential, preventive measure, development, diarrhea, weaned, pigs, in vitro system, piglet, digesta, inoculated, pathogenic, enterotoxigenic, Escherichia coli F4, ETEC, short-chain fatty acid profile, gut microbiota, composition, assessed, probiotic, strains, evaluated, Enterococcus faecium, CHCC, Lactobacillus rhamnosus, CHCC, Bifidobacterium breve, CHCC, Faecalibacterium prausnitzii, CHCC, short chain fatty acid profile, enumeration, Enterobacteriaceae, ETEC, lactic acid bacteria, variation, inoculating material, pathogen, probiotic, treatment, Probiotic, administration, influenced, microbiota, composition, In vitro, models, mimicking, small intestine, piglets, investigating, mode, action, probiotics, learnings, study, experimental setup, incubation time, inoculating material, care, results, evaluate, potential, probiotics, prevent, diarrhea, ETEC, weaned, pigs]]\n",
      "[[OBJECTIVE, molecular characterization, antibacterial activity, oral antibiotics, copper nanoparticles, Cu-NPs, endodontic strains, isolated, persistent, infections, Root canal samples, teeth, patients, persistent, endodontic infections, isolated, strains, biochemical tests, 16S rDNA sequencing, Genotyping, molecular methods, antibacterial activity, antibiotics, copper, nanostructures, MIC, MBC, values, time-kill, kinetics, assay, evaluated, Nonparametric tests, Kruskal-Wallis ANOVA, isolated, strains, identified, isolates, Enterococcus faecalis, grouped, clusters, isolates, clones, clarithromycin-resistant, erythromycin, Pseudomonas putida, clusters, Pseudomonas spp., clonal, resistant, tested, antibiotics, tetracycline, strains, Cutibacterium acnes, clonal, resistant, metronidazole, lowest, MIC, MBC, values, Cu-NPs, Time-kill, kinetics, Cu-NPs, decrease, tested, species, C. acnes, study, health care-associated infections, endodontic strains, species, isolated, patient, polyclonal, Pseudomonas spp, clone, patients, E. faecalis, C. acnes, strains, susceptible, low, Cu-NP, concentrations, Pseudomonas spp., strains, resistant, Assessing, susceptibility, clinical strains, antimicrobial compounds, clinical outcome, results, Cu-NPs, alternative, endodontic treatment, selection, resistant, strains]]\n",
      "[[genus, Streptococcus, bacterial, colonizes, mucosal, surfaces, vertebrates, disease etiologies, diverse, body sites, respiratory, digestive, reproductive tracts, modes, treating, infections, increasing, antibiotic resistance, escalated, Streptococcus mutans, opportunistic pathogen, agent, dental caries, systemic diseases, endocarditis, regulates, virulence, competes, oral niche, priority, pathogens, S. mutans, bona, short hydrophobic peptide, (SHP)/Rgg, quorum-sensing system, regulates, biosynthetic, radical-SAM, S-adenosyl-l-methionine, RaS, enzyme, ribosomally synthesized, posttranslationally modified peptide, RiPP, pairing, SHP/Rgg, regulatory systems, RaS, biosynthetic operons, streptococci, locus, S. mutans, Streptococcus ferus, oral streptococcus, isolated, wild rats, identified, RaS-RiPP product, operon, structure, combination, analytical methods, RiPPs, tryglysin A, B, unusual, Trp-Gly-Lys, linkage, tryglysins, inhibit, growth, streptococci, Gram-positive bacteria, Enterococcus faecalis, Lactococcus lactis, tryglysin, S. mutans, oral niche, inhibiting, growth, species, streptococci, Bacteria, interact, compete, community, organisms, natural environment, Streptococcus mutans, organism, oral microbiota, S. mutans, quorum-sensing system, regulate, production, posttranslationally, inhibiting, growth, streptococcal species, inhibitory, properties, peptide, S. ferus, peptides, interspecies, competition, oral niche]]\n",
      "[[alpha-pregnane-type steroidal alkaloids, hookerianamides L(1), M(2), O(4), N-formylchonemorphine, isolated, acid-base extraction, dichloromethane extract, Sarcococca hookeriana, structures, compounds, spectroscopic techniques, comparison, literature, data, compounds, antileishmanial, antibacterial properties, Compounds 1, standard, pentamidine, IC, leishmanicidal activity, inhibitory, concentration, compounds, Bacillus subtilis, Streptococcus, minor, Streptococcus ferus, standard, ampicillin]]\n",
      "[[AIM, study, culture-based media, chairside cultural assays, mutans streptococci, MS, cultures, saliva, samples, pure, cultures, culture-based media, mitis-salivarius bacitracin, agar, bacterial, recovery, trypticase-yeast extract-cysteine sucrose-bacitracin, modified medium, Ritz (HLR-S, species, MS, Streptococcus ferus, MSB, medium, Chairside cultural tests, disparity, tests, bacteria, cultures, glass adherence assay, Mucount, S. ferus, detected, Streptococcus criceti, dipslide assay, Cariescreen SM, plastic adherence assay, Dentocult SM, Strip mutans, frequency, isolation, strains, bacteria, MS, saliva, samples, frequency, isolation, MS, HLR-S, TYCSB, glass adherence assay, frequency, isolation, MSB, medium, dip-slide, plastic adherence assays, decreased, Recovery scores, culture methods, studied, HLR-S, medium, glass adherence assay, Growth, recovery, profiles, bacterial, saliva, samples, MS, media, SIGNIFICANCE, IMPACT, Caution, results, studies, cultural methods, MS, enumeration]]\n",
      "[[strain, viridans group, streptococci, isolated, human blood sample, species, Streptococcus sanguinis, group, biochemical, characteristics, Phylogenetic analysis, 16S rRNA, gene sequence, comparisons, clustered, strain, Streptococcus ferus, mutans group, phylogenetic analysis, rpoB, sodA gene sequence, comparisons, S. sanguinis, group, isolate, 16S rRNA, gene sequence, similarity, S. ferus, S. sanguinis, taxon, Streptococcus massiliensis sp. nov., type strain]]\n",
      "[[Phenotypic, phylogenetic studies, Gram-positive staining, catalase-negative, alpha-hemolytic, Streptococcus-like organisms, recovered, teeth, horses, SDS PAGE, analysis, whole-cell proteins, comparative, 16S rRNA, gene sequencing, strains, species, genus, Streptococcus, Phylogenetic analysis, 16S rRNA, gene sequences, organisms, sub-line, Streptococcus genus, affinity, Streptococcus mutans, Streptococcus ferus, organisms, Sequence divergence values, streptococcal species, organisms, equine, sources, novel, species, phenotypic, distinctiveness, bacterium, molecular chemical, molecular genetic evidence, species, Streptococcus devriesei sp. nov., type strain, Streptococcus devriesei, CCUG 47155T (= CIP 107809T]]\n",
      "[[Mutans streptococci, isolated, dental plaque, carious, lesions, bacteria, identified, conventional methods, biochemical, serologic tests, isolation, colonies, mitis-salivarius agar, inconsistent, species-specific polymerase chain reaction, PCR, Streptococcus mutans, Streptococcus sobrinus, case, identification, classification, species, group, mutans streptococci, species, identification, species-specific PCR, inefficient, development, preparation, primers, species, study, restriction fragment length polymorphism analysis, PCR-amplified, 16S ribosomal RNA genes, 16S rRNA genes, PCR-RFLP, identification, species, group, mutans streptococci, amplified, 16S rRNA, gene sequences, genomic DNA samples, PCR, universal primers, digested, PCR products, restriction endonucleases, HpaII, HaeIII, HpaII, RFLP, patterns, strains, patterns, S. sobrinus, Streptococcus downei, Streptococcus ferus, RFLP, patterns, HaeIII, species, RFLP, patterns, 16S rRNA, gene sequences, GenBank database, actual, RFLP, patterns, study, 16S rRNA, comparisons, oral mutans streptococci, identification, sequencing, large-scale studies, small laboratories, 16S rRNA genes, PCR-RFLP, HpaII, HaeIII, alternative method, identification, mutans streptococci, large-scale studies, cariogenicity, mutans streptococci]]\n",
      "[[Streptococcus ferus, mutans-like streptococcus, isolated, wild rats, fed, sugar cane, Taxonomically, species, Gram-positive coccal, isolated, tonsils, nasal conchae, piglets, S. ferus, 16S rDNA sequencing, tRNA-intergenic spacer length polymorphism analysis, tDNA-PCR, whole-cell protein profiling, SDS-PAGE, G+C content, determination, extensive, biochemical testing, tests, type strain, S. ferus, rat, results, tests, emended species, description]]\n",
      "[[Streptococcus ferus, isolated, rats, mutans group, streptococci, phenotypic criteria, phylogenetic position, investigated, relationship, organism, streptococcal groups, DNA-DNA hybridization, partial sequencing, 16S rDNA, sodA gene, S. ferus, streptococci, evidence, inclusion, streptococcal groups]]\n",
      "[[Oligonucleotide primers, comparison, dextranase gene, Streptococcus sobrinus, S. mutans, primers, amplified, 1610-bp long DNA fragment, dex gene, PCR, pair, primers, S. sobrinus, members, mutans streptococci, S. mutans, S. downei, S. cricetus, S. rattus, S. macacae, S. ferus, PCR products, gram-positive oral bacteria, strains, species, cocci, strains, species, rods, gram-negative oral bacteria, strains, species, cocci, strains, species, rods, negative, results, PCR, PCR procedure, detect, purified, chromosomal DNA, cfu, S. sobrinus, clinical, isolates, S. sobrinus, positive, dex PCR, laboratory, S. mutans-specific PCR, dexA PCR, method, primers, portion, dextranase gene, S. mutans Ingbritt, Primers, dex, dexA PCR methods, detected, species, mutans streptococci, species, species-specific amplicons, lengths, application, PCR method, human, dental plaque, prevalence, S. sobrinus, oral cavities, results, PCR method, detection, identification, human, cariogenic bacteria, S. sobrinus, S. mutans]]\n",
      "[[pSSU1, isolated, Streptococcus suis serotype 2 strain, DAT1, sequence, pSSU1, bp, ORFs, ORF1, ORF2, encode, proteins, homologous, CopG, RepB, pMV158 family, ORF5, encodes, protein, homologous, pMV158, ORF4, encodes, protein, homologous, orf3, pVA380-1 of S. ferus, function, ORF3, ORF6, protein sequences, plasmid, ORF1, CopG protein, multiples, nucleotides, double-strand origin, DSO, rolling circle replication, RCR, mechanism, ORF5, Mob protein, potential, hairpin loop, single-strand origin, SSO, RCR, mechanism, sequence, leader region, Rep mRNA, homologous, countertranscribed RNA, ctRNA, pLS1, 5-amino acid conserved sequence, Rep, Rep proteins, pMV158 family plasmids, observations, plasmid, replicates, rolling circle, mechanism]]\n",
      "[[isolation, bacteria, degrading, milk oligosaccharides, suckling infant, rats, bacteria, isolated, serially, diluted, intestinal, contents, infant, rats, incubated, enrichment, medium, 3'-sialyllactose, 3'-SL, isolation, strains, streaked agar plates, selection, strains, thin-layer chromatography, genomic, phenotypic analyses, strains, Enterococcus gallinarum, strains, degrading, 3'-SL, 6'-SL, type strain, E. gallinarum, reference, study, high-performance anion-exchange chromatography, pulsed, amperometric detection, strain AH4, degraded, 3'-SL, equimolar, amount, lactose, equimolar, amount, sialic acid, anaerobic, incubation, findings, enterococci, rat, milk, oligosaccharides, cross-feed, degradants, members, concomitant, bacteria, gut, infant, rat]]\n",
      "[[Peritonitis, complication, peritoneal dialysis, Peritonitis, associated with, increased, mortality risk, gram-positive, gram-negative bacteria, fungal, viral infections, peritoneal fluid, sample, cell count, differential, gram stain, culture, empiric, antibiotic therapy, case, peritoneal, dialysis-related peritonitis, Enterococcus gallinarum, case, medical literature, patient, vancomycin, cefepime, deteriorate, peritoneal, cultures, E. gallinarum, sensitivities, patient, treated with, daptomycin, cefazolin, resolved, peritonitis]]\n",
      "[[Musculoskeletal infections, Enterococcus gallinarum, rare, multi-drug resistance, attention, scientific community, case, immunocompetent, Caucasian, female, multifocal joint infection, agent, Shoulder arthrocentesis, blood cultures, vancomycin-resistant agent, symptomatic, patient, surgical debridement, weeks, antibiotherapy, ampicillin, IV, clinical, laboratory findings, improved, treatment, years, follow-up, patient, recurrence]]\n",
      "[[Enterococcus gallinarum, gram positive, facultatively, mammalian, intestinal, tracts, pathogenic, humans, draft, data, Enterococcus gallinarum strain, isolated, human, clinical sample, sequenced, Illumina HiSeq 4000 system, genome, strain, 3,730,000bp, G+C content, de novo, assembly, genome, contigs, 208,509bp, Maximum Likelihood phylogenetic analysis, 16S rRNA, data, clustered, EGR748, E. gallinarum, strains, data, capacity, enterococcal species, causal agents, nosocomial blood-stream infections, genome, dataset, DDBJ/ENA/GenBank, accession]]\n",
      "[[OBJECTIVE, study, genome, linezolid-intermediate, Enterococcus gallinarum, strain, EG81, swine origin, China, Whole genome, EG81, sequenced, Illumina MiSeq platform, Nanopore PromethION platform, assembled, Canu v1.5, NCBI, Prokaryotic Genome Annotation Pipeline, PGAP, annotate, genome, EG81, Antimicrobial resistance genes, CGE, ResFinder, genome, EG81, plasmids, pEG81, pEG81, coding sequences, RNA genes, PGAP, oxazolidinone-phenicol resistance gene, optrA, chromosome, plasmid, pEG81, associated with, Tn554, Tn558, EG81, vanC1XY (, vancomycin, resistance, fexA, phenicol, dfrG, trimethoprim, aadD, ant(6)-Ia, ant(9)-Ia, aminoglycoside, erm(A), erm(B), macrolide, tet(L), tet(M), tetracycline, report, oxazolidinone-phenicol gene, E. gallinarum, resistant, vancomycin, threat, public health, genome sequence, E. gallinarum, EG81, information, dissemination, optrA, vancomycin-resistant enterococci]]\n",
      "[[gut microbiota, dysbiosis, autism, etiology, neurodevelopmental disorders, NDD, knowledge, study, evaluate, gut microbiota, diversity, composition, children, Republic, Serbia, diagnosed, NDD, healthy, children, results, increased, incidence, bacteria, Clostridium species, NDD, patient, group, Control group, Desulfotomaculum guttoideum, Intestinibacter bartlettii, Romboutsia ilealis, hand, diversity, commensal bacteria, NDD, group, patients, Enterococcus faecalis, Enterococcus gallinarum, Streptococcus pasteurianus, Lactobacillus rhamnosus, Bifidobacteria sp., detected, patients, absent, NDD, patients, butyrate-producing bacteria, Faecalibacterium prausnitzii, Butyricicoccus pullicaecorum, Eubacterium rectale, frequent, NDD, patient group, levels, fecal, short chain fatty acids, SCFAs, SCFA, levels, NDD, patients, Control group, positive, correlation, rDNA, amplicons, universal primers, level, propionic acid, levels, SCFAs, butyric acid, Control group, correlation, lost, NDD, patient group, NDD, patients, microbiota, microbiota, healthy, children, presence, SCFA-producing bacteria, range-weighted richness index, microbial, diversity, NDD, patient group, study, intestinal microbiota, NDD, patients, microbiota, healthy, children, early, life microbiome, impact, GI, disturbances, behavioral problems, patients, spectrum, NDD]]\n",
      "[[Enterococcus gallinarum, casseliflavus, vancomycin, resistance, pathogens, characterized, pediatric, patients, prevalence, enterococcal species, immunocompromised, patients, pediatric, institution, impact, patient care, antibiotic, stewardship, infection control]]\n",
      "[[study, investigate, molecular characteristics, genetic relatedness, cases, vancomycin-resistant enterococci, VRE, Tripoli Medical Center, Libya, VRE, isolates, clinical sites, years, vanA-type, vanB-type vancomycin-resistant, Enterococcus faecium, isolates, vanC1-type Enterococcus gallinarum, E. faecium, isolates, genome sequencing, Core genome multilocus sequence typing, sequence clusters, SCs, isolates, hospital wards, VRE, isolates, isolated, early, patients, medical intensive care unit, grouped, SC1, MLST, ST, vanB, cgMLST alleles, SC2, special care, baby unit, neonatal, intensive care unit, pediatric surgery ward, oncology ward, SC3, antenatal ward, ST80 vanA-VRE, SC3, isolate, alleles, compared, SC2, SC2, isolates, alleles, Comparison, database, E. faecium, strains, isolates, clustered, hospital clade A1, combination, Resfinder, mlplasmid, analysis, identified, presence, resistance genes, plasmid, genetic elements, SCs, study documents, isolates, outbreaks, VRE, Libyan health care system, surveillance, molecular typing methods, spread, multidrug-resistant bacteria, Libyan health care system]]\n",
      "[[Organic acid, contents, acidified, fermented fish, silages, gibel carp, Caracius gibelio, klunzinger's ponyfish, Equulites klunzingeri, fishes, fish processing residues, by-products, studied, silages, wet, spray-dried, raw-materials, weeks, room, temperature, lactic acid bacteria, LAB, Enterococcus gallinarum, Lactobacillus brevis, Lactobacillus plantarum, Pediococcus acidilactici, Streptococcus spp, fermented, fish-based silages, acidified, silage, formic acid, v/v, Lactic, propionic acids, dominant, organic acids, succinic acid, fermented silages, acidified, silage, lactic, formic acids, organic, sample, fermented, fish-based silages, LAB strains, unfolded, propionic acid, gibel carp, silage, organic, sample, Spray-dried fermented, silages, organic acid, content, wet silages, Propionic acid, accumulation, levels, gibel carp, silage, fermented, L. plantarum, propionic, sample, research, capability, lactic acid bacteria, strains, organic, acids-especially lactic, acetic, propionic, acids-during, fermentation, fish-based silages, food safety, quality, production, organic acids, wet, spray-dried, fish-based silages, suitableness, animal, feed]]\n",
      "[[immunocompetent, male, patient, emergency department, lumbar pain, days, lumbar torsion, neurologically, intact, systemic, lumbar MRI, spinal epidural abscess, L3-L4, L5-S1, levels, patient, early, occurrence, neurological deficit, abscess, cultures, Streptococcus mitis infection, patient, recovery, surgical decompression, washout with, samples, cultures, targeted, antibiotic therapy, weeks]]\n",
      "[[OBJECTIVE, effect, antimicrobial photodynamic therapy, A-PDT, oral, biofilm, early, colonizing, microorganisms, photosensitizer methylene blue, beta-cyclodextrin, nanoparticles, red light sources laser, LED, groups, triplicate, C, negative control, NaCl, CX, positive control, chlorhexidine, Photosensitizer/Nanoparticle, L (Laser, LED, light-emitting diode), LP, Laser + Photosensitizer/Nanoparticle, LEDP, LED, Photosensitizer/Nanoparticle, multispecies, biofilm, ofS. gordonii, S. oralis, S. mitis, S. sanguinis, microplates, BHI, supplemented, sucrose, irradiations, laser, LED, microbial, reduction, assessed, biofilm microorganisms, selective culture media, treatments, Data normality, assessed, Shapiro-Wilk test, results, Kruskal-Wallis analysis, Dunn's test, significance level, groups, LP, LEDP, biofilm microorganism, counts, negative control group, positive control group, CX, A-PDT, encapsulated, beta-cyclodextrin methylene blue, irradiated, Laser, LED, effective, microbial, reduction, multispecies, biofilm, early, colonizing, microorganisms]]\n",
      "[[study, report, anatomical, functional, results, surgical management, cases, endophthalmitis, day, intravitreal, Patients, signs, endophthalmitis, aflibercept injections, eyes, day, retrospectively evaluated, data, visual acuity, optical coherence tomography, OCT, months, follow-up, treatment, results, microbiological cultures, cases, positive, bacterial, Streptococcus mitis, patients, vitrectomy, combined, phacoemulsification, eyes, pseudophakic, vancomycin, infusion, silicone oil tamponade, systemic antibiotics, administered, intravenously, best-corrected visual acuity, BCVA, treatment, finger, counting, light perception, cases, eyes, disruption, inner retinal layers, stabilization, retina, changes, wet, AMD, retinal, anatomy, patients, affected, Streptococcus, mitis-induced endophthalmitis, baseline, vision, therapy]]\n",
      "[[Objective, Systematic review, association, oral, microorganisms, corrosion, intra-oral metallic, Design, PubMed, Scopus, Web of Science, keyword combinations, microbes, oral, corrosion, microbes, dental, corrosion, microorganisms, oral, corrosion, microorganisms, dental, corrosion, articles, selection criteria, Lactobacillus reuteri, Streptococcus mutans, Streptococcus sanguis, Streptococcus mitis, Streptococcus sobrinus, Streptococcus salivarius, sulfate-reducing bacteria, sulfate oxidizing bacteria, Veilonella, Actinomyces, Candida albicans, potential, association, corrosion, intraoral, metallic, alloys, stainless steel, titanium, nickel, cobalt-chromium, neodymium-iron-boron magnets, zirconia, amalgam, copper aluminum, metal, alloys, studies, association, oral, microorganisms, intra-oral metallic alloys-based, dental appliances, studies, review, in-vitro, simulation, intra-oral condition]]\n",
      "[[evaluate, cetrimide, combined, photodynamic therapy, reduce, S. mutans, burden, carious, lesions, permanent, sectioned, coronal dentin, exposed, cariogenic, brain-heart infusion, BHI, supplemented, S. mutans ATCC 25175, Specimens, incubated, anaerobic, jars, degrees, days, BHI, days, specimens, groups, C, control, no treatment, CHX, application, chlorhexidine, CT, application, cetrimide, application, cetrimide, methylene blue dye, aPDT, antimicrobial photodynamic therapy, energy 4J, spot size, energy density, application, experimental solution, methylene blue dye, cetrimide, aPDT, aPDT, Carious, tissue, specimen, applications, decimal dilutions, solution, seeded, mitis-salivarius-bacitracin agar, Plates, incubated, anaerobic, jars, degrees, Analysis of variance, ANOVA, post hoc Tukey's test, compare, S. mutans, counts, reductions, S. mutans, application, CT+aPDT (0.30 (0.97, ES+aPDT (, Cetrimide, methylene blue dye, mixture, photosensitizing agent, aPDT, reduce, S. mutans, burden, dentinal caries]]\n",
      "[[Bacterial, contamination, dental implant surgery, Macrophages, polarisation, bacterial, colonisation, tissue, integration, bacterially contaminated, dental implants, study, investigated, macrophages, stimulating, tissue, coverage, overgrowth, contaminating, oral bacteria, polished, titanium, Ti-P, acid-etched zirconium dioxide, ZrO2-MA, dental implant materials, co-culture, models, phagocytosis, rates, Streptococcus mitis, Staphylococcus aureus, contaminating, dental implant, surface, influence, contaminating, bacteria, osteoblasts, U2OS, macrophage, polarisation, S. aureus, phagocytized, S. mitis, smooth, Ti-P, surfaces, Contaminating, S. mitis, polarisation, macrophages, Ym1-expressing-phenotype, smooth Ti-P, ZrO2-MA, phenotypes, tri-cultures, U2OS-cells, smooth Ti-P, percentage, macrophages, non-Ym1-expressing, fighting, M1-like, phenotype, Ti-P, surfaces, contaminating, bacteria, ZrO2-MA, surfaces, macrophages, and-repair, phenotype, Ti-P, surfaces, Surface, coverage, smooth, bacterially contaminated, Ti-P, surfaces, U2OS-cells, stimulated, fighting, M1-like macrophages, ZrO2-MA, surfaces, Comprehensive, guidelines, development, infection-resistant, dental implant materials, bacteria, tissue, immune cells, guidelines, results, clinical application, Ti-P, ZrO2-MA]]\n",
      "[[genus, Streptococcus, pathogens, human, animal, microbiota, Advances, molecular genetics, taxonomic approaches, phylogenomic studies, species, severe, impact, human, health, economic losses, agriculture, infectivity, pathogens, cell-surface components, secreted, virulence factors, Bacteria, multifaceted, adaptation, host, environment, biofilm formation, survival, professional, phagocytes, host, immune response, review, virulence, mechanism, zoonotic, potential, Streptococcus species, pyogenic, S. agalactiae, S. pyogenes, mitis groups, S. pneumoniae]]\n",
      "[[Context, Hydroxyapatite, regenerate, mineralized layer, dentin, combination, enzymes, lysozyme, lactoferrin, lactoperoxidase, antimicrobial, properties, oral pathogens, evaluate, combination, hydroxyapatite, lysozyme, lactoferrin, lactoperoxidase, treatment, dentinal caries, measuring, Streptococcus mutans, Design, Laboratory study, experimental groups, Methods, Material, Carious, lesions, permanent, treated with, combination, hydroxyapatite, enzymes, lysozyme, lactoferrin, lactoperoxidase, Carious dentin, collected, homogenized, vortex shaker, homogenization, decimal dilutions, aliquots, dilution, seeded, surface, mitis salivarius bacitracin, MSB, medium, plates, incubated, anaerobic jars, incubation, bacterial count, S. mutans, counts, month, months, treatment, Statistical Analysis, Descriptive, statistical analysis, Kruskal-Wallis test, supplemented, Student-Newman-Keuls test, reduction, S. mutans, counts, sealing, combination, hydroxyapatite, lysozyme, lactoferrin, lactoperoxidase, counts, month, months, combination, hydroxyapatite, lysozyme, lactoferrin, lactoperoxidase, alternative, S. mutans, control, dentinal caries]]\n",
      "[[Streptococcus pneumoniae, identification, biochemical tests, susceptibility, pneumococci, optochin, solubility, bile-salt solution, slowness, difficulty, interpretation, bile solubility test, disuse, assess, effectiveness, optochin, susceptibility test, pneumococcal, identification, clinical practice, viridans group, streptococci, isolated, respiratory samples, analyzed, optochin, susceptibility test, colony, culture, optochin, susceptible, optochin, resistant, analyzed, bile solubility test, discrepancy, tests, isolate, optochin, susceptible, bile, insoluble, optochin, resistant, bile, soluble, optochin, susceptibility test, inoculum, McFarland standard, Species, sequencing, lytA, recA genes, discrepancies, optochin test, optochin test, isolates, discrepancies, optochin-resistant, isolates, gene sequencing, S. pneumoniae, optochin-susceptible bile-nonsoluble isolates, Streptococcus mitis, Streptococcus pseudopneumoniae, optochin test, viridans group, streptococci, clinical, isolates, optochin, susceptible, optochin, resistant, strains, group, optochin, susceptible, viridans, identified, optochin, resistant, group, identified, technique, S. pneumoniae, viridans group, streptococci, clinical setting, testing, identification]]\n",
      "[[Oral tissues, homeostatic, exposure, potential, inflammatory agents, resident, microbiota, balancing, inflammation, regulatory mechanisms, anti-inflammatory, commensal bacteria, levels, anti-inflammatory, commensal bacteria, resident, populations, homeostatic, Hypothesis/Gap Statement, incidence, immunosuppressive streptococci, oral cavity, proportion, organisms, mechanisms, host-microbe homeostasis, development, probiotics, prebiotics, maintenance, oral health, incidence, potential, modes, action, immunosuppressive capacity, resident, oral streptococci, Methodology, Supragingival, plaque, healthy, participants, supragingival, subgingival, plaque, gingivitis, streptococci, sample, co-cultured, epithelial cells+/-flagellin, LL-37, CXCL8, secretion, detected, ELISA, induction, cytotoxicity, human, epithelial cells, lactate dehydrogenase, release, NFkappaB-activation, reporter cell line, Bacterial, identification, partial, 16S rRNA, gene sequencing, next-generation sequencing, Results, CXCL8, secretion, inhibited, isolates, Immunosuppressive isolates, detected, supragingival, plaque, healthy, gingivitis, samples, subgingival, gingivitis, plaque, samples, Streptococcus mitis/oralis, immunosuppressive, isolates, inhibited, NFkappaB, activation, immunosuppressive, mechanism, strain, specific, ultra-violet light-labile factors, bacterial, viability, species, streptococci, isolated, plaque, suppressed, epithelial cell, CXCL8, secretion, inhibition, NFkappaB., phenomenon, oral, host-microbe homeostasis]]\n",
      "[[investigate, effect, abiotic stresses, nitrogen, sulfur (S), combination, S + 6 g/l N]), axenic, culture, Nostoc linckia, production, secondary, metabolites, induce, biological activities, Growth rate, measured, dry weight, DW, optical density (OD)550, phytochemical compounds, defense enzymes, antioxidant activity, 2,2-diphenyl-1-picrylhydrazyl, DPPH, 2,2'-azino-bis(ethylbenzthiazoline-6-sulfonic acid, ABTS(.+, radical assays, crude extracts, methylene chloride, methanol, evaluated, antioxidant activity, extracts, biological activities, anticancer, antimicrobial, antiviral activities, results, supplementation, external, nitrogen source, sodium nitrate, increase, phycobiliprotein, content, nitrogen depletion, quantities, phenolic, flavonoid, content, effects, biological activities, Nostoc linckia, S, effective, extract, increase, antioxidant activity, DPPH, ABTS assays, anticancer activity, HCT 116 cell line, IC50, extract, antibacterial, potency, inhibition, Staphylococcus aureus, Streptococcus mutans, antiviral activity, H5N1 virus, percentage, inhibition, concentration, cytotoxicity, GC-MS analysis, presence, bioactive compounds, biological activities, results, bioactive compounds, variable, biological, potencies]]\n",
      "[[Probiotics, non-pathogenic, microorganisms, administered, health, host, group, probiotic, microorganisms, bacteria, lactic acid, genera, Lactobacillus, Bifidobacterium, LAB, lactic acid bacteria, groups, yeast, Saccharomyces boulardii, Probiotics, Candida spp, oral infection, colonization, Lactobacillus limits, progression, chronic periodontitis, inhibiting, secretory activity, Th17, lymphocytes, pathogenesis, disease, excessive, cytokine response, adverse changes, periodontal tissues, meta-analysis, results, studies, clinical evaluation, effectiveness, probiotics, treatment, gingivitis, probiotics, improved, condition, gums, course, therapeutic process, probiotics, orthodontic treatment, reduces, bacteria, Streptococcus mutans, group, patient's, saliva, inhibits, expression, inflammatory mediators, excessive, immune response, mechanisms, action, probiotics, elimination, inhibition, growth, pathogenic, microorganisms, competition, receptor sites, secretion, metabolites, antibacterial activity, stimulation, specific, non-specific, immune responses, activating, T lymphocytes, stimulating, production, cytokines, pro-health bacteria, oral diseases]]\n",
      "[[OBJECTIVE, release, bisphenol-A, BPA, dental materials, study, quantify, BPA, impurity, BPA-based, non-BPA-based monomers, evaluate, monomers, BPA, salivary, bacterial, chemical, BPA, monomer, TEGDMA, UDMA, mUDMA, BisGMA, BisEMA-3, -6, -10, -30, BisPMA, EBPADMA, urethane, BADGE, BisDMA, monomers, immersed, human, saliva, adults, Streptococcus mutans, acidic, HCl, alkaline, NaOH, control media, amount, BPA, quantified, specific, sensitive, UPLC-MS/MS method, derivatization, BPA, pyridine-3-sulfonyl chloride, monomers, BisGMA, BisEMA-3, BPA, impurities, synthesis process, BPA, concentrations, increased, monomers, BisGMA, BisEMA-3, BisEMA-6, BisEMA-10, BisPMA, BADGE, saliva, S. mutans, degradation, amount, monomer, BPA, BisPMA, BADGE, degraded, BPA, alkaline, conditions, conversion, rate, monomers, BPA, Impurities, degradation, BPA-based, monomers, release, BPA, resin-based dental materials, detected, BPA, monomer impurity, small, manufacturers, dental materials, reduce, BPA, content, monomers, highest, purity, BPA-free materials, investigate, non-BPA, monomers, dental resin-based materials]]\n",
      "[[OBJECTIVE, Zinc, antimicrobial, cariogenic bacteria, effective, anti-plaque agent, study, investigated, efficacy, zinc oxide, nanoparticles, ZnO-NP, varnish, inhibit, S. mutans, biofilm, acid production, antioxidant, potential, cytotoxicity, Green synthesized, ZnO-NP, characterized, ultraviolet-visible spectroscopy, x-ray diffraction spectroscopy, transmission electron microscopy, Secondary, metabolites, assessed, fourier transform infrared spectroscopy, Anti-oxidant, potential, 2,2-diphenyl-2-picrylhydrazyl hydrate, DDPH, assay, cytotoxicity, synthesized, nanoparticles, evaluated, human, Hep G2, human embryonic kidney 293, HEK-293T) cell lines, Synthesized, ZnO-NP, antimicrobial, properties, S. mutans, inhibitory, bactericidal concentrations, ZnO-NP, concentration, zone, inhibition, ZnO-NP, ampicillin, ZnO-NP, varnish, inhibited, S. mutans, biofilms, reduced, acid production, baseline, antioxidant capacity, dose, dependent, Biocompatibility, ZnO-NP, varnish, evaluated, Hep G2, HEK-293, T cell lines, concentration, ZnO-NP, cytotoxicity, Hep G2 cells, non-cytotoxic, HEK-293, T cells, limits, study, ZnO-NP, varnish, effective, inhibiting, S. mutans, potential, effective, anticaries agent]]\n",
      "[[Dental caries, associated with, acid-producing bacteria, Streptococcus mutans, primary, etiological agents, Bacterial, accumulation, dental demineralization, destruction, bonding, longevity, composite, study, investigated, remineralization, effectiveness, adhesive, nanoparticles, amorphous, NACP, oral, biofilm environment, enamel, immersed, demineralization, solution, artificial, carious, lesion, Streptococcus mutans, biofilm, samples, demineralization, brain heart infusion broth, sucrose, BHIS, remineralization, artificial saliva, AS, days, daily, pH, BHIS, incubation, lactic acid production, colony-forming unit, content, calcium, Ca, phosphate, biofilm, evaluated, remineralization, effectiveness, enamel, analyzed, X-ray diffraction, XRD, surface microhardness testing, transverse microradiography, TMR, scanning electron microscopy, SEM, NACP, adhesive, abundant, Ca, acid neutralization, reduced, lactic acid, production, lowered, CFU count, Enamel, treated with, NACP, adhesive, remineralization, effectiveness, remineralization, TMR, microhardness, recovery, cross sections, mineral deposits, NACP, group, NACP, adhesive, performance, remineralizing, initial, enamel, lesion, cariogenic, biofilm, NACP, adhesive, protection, bonding, interface, prevention, secondary caries, longevity, prolonging, restoration]]\n",
      "[[study, characterized, oropharyngeal, anorectal, isolates, Neisseria spp, cohort, men, sex, men, pathogenic Neisseria, N. meningitidis, nonpathogenic Neisseria, N. subflava, N. mucosa, N. oralis, proportion, strains, panel, resistant, azithromycin, ceftriaxone, Whole genome sequencing, WGS, strains, mutations, reduced, susceptibility, azithromycin, ceftriaxone, N. gonorrhoeae, presence, absence, mutations, level, resistance, azithromycin, nonpathogenic, isolates, screening, antimicrobial resistance, AMR, genes, ribosomal protection protein, Msr(D, azithromycin, resistant, nonpathogenic strains, integration site, Streptococcus pneumoniae, associated with, level, resistance, azithromycin, bacterial species, AMR, resistance, mechanism, azithromycin, nonpathogenic Neisseria, public health, transmitted, pathogenic, Neisseria, study, WGS-based, surveillance, nonpathogenic Neisseria]]\n",
      "[[Excessive, biofilm formation, surfaces, oral cavity, severe, infection, development, periodontitis, peri-implantitis, Mechanical, biofilm, removal, adjuvant antiseptics, prevention, pathogenic, biofilm formation, antibacterial effect, oral care, REPHA-OS((R, medicinal plant, essential oils, oral, pathogens, agar plates, study, effectiveness, product, medical, oral, biofilm development, in vitro, oral, multispecies, biofilm, Streptococcus oralis, Actinomyces naeslundii, Veillonella dispar, Porphyromonas gingivalis, antibacterial effect, REPHA-OS((R, concentrations, planktonic bacteria, biofilm formation, mature, biofilms, quantified, metabolic activity, live/dead fluorescence staining, three-dimensional confocal laser-scanning microscopy, effects, species, distribution, biofilm, assessed, quantitative real-time PCR, REPHA-OS((R, statistically significant, antimicrobial effects, stages, biofilm development, inhibitory, concentration, detected, planktonic bacteria, biofilm formation, concentration, kill, bacteria, mature, biofilms, influence, biofilm matrix, species, distribution, observed, effect, herbal ingredients, ethanol, antibacterial effect, REPHA-OS((R, stages, oral, biofilm development, application, alternative, adjuvant, oral care therapies]]\n",
      "[[correlation, oral bacteria, dental implants, failure, effect, mechanism, bacteria, dental implants, unclear, study, genes, gene clusters, human, fibroblasts, HGF, cells, response, Streptococcus oralis, biofilm, weighted gene, co-expression, network analysis, WGCNA, differential genes, analysis, gene expression matrix, Gene Expression Omnibus, database, genes, module, associated with, S. oralis infection, DEGs, S. oralis, biofilm, DEGs, correlation, S. oralis injury, immune pathways, tumor necrosis factor, TNF, signaling pathway, genes, genes, IL6, JUN, FOS, CSF2, HBEGF, EDN1, CCL2, MYC, NGF, SOCS3, CXCL1, CXCL2, hub genes, associated with, S. oralis infection, JUN, IL6, FOS, MYC, CCL2, fraction, macrophage M0 cells, increased, biofilm treatment, compared, control, expression, FOS, MYC, correlated, macrophage M0 cells, findings, inflammation, changes, transcript, level, HGF, response, S. oralis]]\n",
      "[[Periodontitis, tooth loss, chronic inflammation, severe, systemic, risks, Adjunctive, mechanical treatment, periodontitis, antibiotics, probiotic bacteria, study, inhibitory, effect, probiotic, Streptococcus salivarius subsp., salivarius strains, M18, K12, Streptococcus oralis subsp., Lactobacillus reuteri ATCC, PTA, anaerobic, periodontal bacteria, Aggregatibacter actinomycetemcomitans, tested, studies, quantified, inverse, effect, pathogens, probiotic growth, Probiotics, periodontal pathogens, co-incubated, anaerobically, autoclaved, saliva, brain heart infusion broth, genome, pathogens, probiotics, measured, quantitative real-time PCR, Mixtures, streptococcal probiotics, synergistic, additive, antagonistic effects, inhibitor, periodontal pathogens, L. reuteri ATCC, PTA, effect, coenzyme B12-, glycerol-dependent, modulated, L. reuteri strain DSM 17938, absence, glycerol, pathogen-inhibitory effect, growth spurt, streptococci, tested, S. salivarius, constant, inhibitory, potential, pathogens, K12, S. dentisani 7746, inhibitory, effects, P. intermedia, A. actinomycetemcomitans, mixtures, streptococcal probiotics, inhibit, growth, pathogens, or-in, case, A. actinomycetemcomitans-, strains, P. gingivalis, F. nucleatum, inhibited, cultures, S. salivarius K12, S. salivarius M18, Testing, growth, S. salivarius M18, enhanced, incubated, periodontal pathogens, probiotics, S. oralis subsp., influenced, pathogens, inhibited, presence, streptococcal probiotics, natural, persistence, potential, probiotic, treatment, activity, synergistic, strains, application, oral prebiotics, essential supplements, conditions]]\n",
      "[[Antibiotic acyldepsipeptides, ADEPs, deregulate, ClpP, proteolytic core, bacterial, Clp protease, inhibiting, native, functions, activating, uncontrolled, proteolysis, nonnative substrates, ADEP-activated, ClpP, target, polypeptide, protein substrates, bacterial cell, proteins, susceptible, Bacillus subtilis, cell division protein FtsZ, sensitive, degradation, ADEP-activated, ClpP, inhibitory, ADEP, concentrations, FtsZ, bacterial protein, degraded, in vitro, bacterial cells, molecular reason, degradation, ADEP-activated, ClpP, absence, Clp-ATPase, unfolding, degradation, N-terminal domain, FtsZ, prevented, stabilization, FtsZ, nucleotide binding, elevated, antibiotic, concentrations, C terminus, FtsZ, targeted, degradation, N terminus, results, target, structures, ClpP, ADEP, level, present, data, Clp-ATPase-independent protein unfolding, ClpP, core, bacterial, Clp protease, protein fold, FtsZ, flexible, anticipated, Acyldepsipeptide, ADEP, antibiotics, kill, multidrug-resistant, Gram-positive pathogens, vancomycin-resistant enterococcus, penicillin-resistant Streptococcus pneumoniae, PRSP, methicillin-resistant Staphylococcus aureus, MRSA, antibacterial activity, ADEP, mechanism, action, deregulation, bacterial protease, ClpP, bacterial, self-digestion, data, mode, ADEP, action, molecular explanation, bacterial, phenotypes, low, ADEP, concentrations, ClpP, absence, unfoldase, energy-consuming system, activated, small molecule, antibiotic, ADEP, unfolding, cell division protein]]\n",
      "[[Delafloxacin, fluoroquinolone, activity, Gram-positive, Gram-negative, atypical, pathogens, methicillin-resistant Staphylococcus aureus, MRSA, microbiological, results, phase 3, clinical trial, adults, community-acquired pneumonia, CAP, comparing, delafloxacin, intravenously, orally, moxifloxacin, orally, day, QD, Patients, continents, Europe, South America, Asia, microbiological intent-to-treat, MITT, population, patients, patients, bacterial pathogen, identified, diagnostic methods, culture, serology, PCR, urinary antigen tests, baseline, MIC90, values, delafloxacin, activity, moxifloxacin, Gram-positive, fastidious, Gram-negative pathogens, Delafloxacin, activity, resistant, phenotypes, Streptococcus pneumoniae, macrolide-, multiple-drug resistant, Haemophilus species, beta-lactamase, macrolide, nonsusceptible, S. aureus, MRSA, methicillin-susceptible S. aureus, MSSA, microbiological success, rates, S. pneumoniae, penicillin-resistant, S. pneumoniae, PRSP, S. aureus, MRSA, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Moraxella catarrhalis, Haemophilus influenzae, Haemophilus parainfluenzae, Mycoplasma pneumoniae, Legionella pneumophila, Chlamydia pneumoniae, correlation, MICs, outcomes, proportion, favorable outcomes, delafloxacin, baseline, MIC, values, Delafloxacin, treatment, monotherapy, CAP, adults, broad-spectrum coverage, MRSA, activity]]\n",
      "[[PURPOSE, study, evaluate, efficacy, educational intervention, reducing, oral third-generation cephalosporins, prevalence, resistant, bacteria, clinical outcomes, before-after study, compare, data, year, intervention, Japanese, university hospital, Educational intervention, lectures, medical staff, oral antibiotics, educational meetings, medical department, primary outcome, oral third-generation cephalosporins, inpatients, measured, monthly, median, days, therapy, DOTs, patient, days, Secondary outcomes, oral, antibiotic, inpatients, outpatients, proportion, beta-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae, BLNAR, penicillin-resistant Streptococcus pneumoniae, PRSP, extended-spectrum beta-lactamase, Escherichia coli, ESBLEC, incidence, hospital-acquired, Clostridioides difficile, HA-CDI, hospital mortality, oral third-generation cephalosporins, inpatients, decreased, intervention, DOTs, interquartile range, outpatients, decreased, fluoroquinolones, macrolides, increase, intervention, proportion, BLNAR, PRSP, ESBLEC, study, period, incidence, HA-CDI, decreased, hospital mortality, intervention, Educational intervention, effective, reducing, oral third-generation cephalosporins, increasing, broad-spectrum antibiotics, worsening, clinical outcome, prevalence, resistant, bacteria, study, period]]\n",
      "[[kill-curve activity, tedizolid, linezolid, clinically relevant, free, plasma, lung, concentrations, methicillin-resistant Staphylococcus aureus, MRSA, penicillin-resistant Streptococcus pneumoniae, PRSP, isolated, Chinese, patients, Tedizolid, in vitro, potency, linezolid, staphylococci, streptococci, enterococci species, tedizolid minimum, MIC, linezolid, MIC, kill-curve experiments, growth, MRSA, inhibited, tedizolid, concentration, MIC, MIC, linezolid, concentration, MIC, MIC, PRSP, tedizolid, concentration, MIC, bacteriostatic, bactericidal effect, higher, concentrations, Results, linezolid, proportion, organisms, results, potency, tedizolid, clinical strains, Gram-positive pathogens, linezolid, Chinese, patients]]\n",
      "[[China, multidrug-resistant bacteria, threat, public health, Antimicrobial resistance, effectiveness, medicines, antibacterial drugs, treat, drug-resistant, bacteria, Eravacycline, tigecycline, clinical, antibiotics, tested, reference broth micro-dilution method, strains, collected, teaching hospitals, China, isolates, Enterobacteriaceae, non-fermentative, Staphylococcus spp., Enterococcus, fastidious organisms, strains, study, drug resistance, characteristics, China, Drug resistant bacteria, ESBL, carbapenemases, KPC-2, NDM-1, colistin, resistance, mcr-1, tigecycline, study, methicillin-resistant Staphylococcus aureus, MRSA, vancomycin-resistant enterococci, VRE, beta-lactamase positive Haemophilus influenzae, penicillin, resistant, Streptococcus pneumoniae, PRSP, Eravacycline, efficacy, strains, tested, organisms, ESBLs, carbapenemases, mcr-1 gene, tigecycline, antibiotics, tested, MIC, values, eravacycline, carbapenemase, Enterobacteriaceae, OXA-23-producing A. baumannii, MIC, values, antibiotics, MRSA, VRE, beta-lactamase positive Haemophilus influenza, PRSP, sensitive, eravacycline, strain, tested, strains, tested, MICs, eravacycline, MICs, tigecycline, Eravacycline, antibacterial activity, clinically, antibiotic-resistant, pathogens, MIC, distribution, eravacycline, tigecycline, drug, effective, medications]]\n",
      "[[period, Streptococcus pneumoniae strains, Haemophilus influenzae strains, Moraxella catarrhalis, strains, isolated, clinical specimens, pediatric infections, national 16 institutions, susceptibilities, antibiotics, capsular, serotype, S. pneumoniae, capsular b type, beta-lactamase, capability, H. influenzae, beta-lactamase production, capability, M. catarrhalis, measured, S. pneumoniae, results, strains, PSSP, PISP, PRSP, susceptibilities, TBPM, GRNX, oral antibiotics, PAPM, injectable, antibiotics, lowest value, MIC90, mug/mL., frequent, distribution, S. pneumoniae, serotypes, 15B, 19A, 35B, Serotype strains, 13-valent pneumococcal, PCV13, strains, H. influenzae, results, BLNAS, strains, BLNAI, strains, BLNAR, strains, beta-lactamase, strains, susceptibilities, quinolones, lowest, outcome, oral antibiotics, MIC90, CTRX, TAZ/PIPC, TAZ4, fixed, injectable, antibiotics, MIC, mug/mL., detection, capsular type b strains, M. catarrhalis, isolates, beta-lactamase, strains, susceptibilities, TBPM, CPFX, TFLX, GRNX, oral antibiotics, TAZ/PIPC, TAZ4, fixed, PAPM, MEPM, DRPM, injectable, antibiotics, lowest, outcome, MIC, mug/mL.]]\n",
      "[[Antimicrobial activity, tigecycline, comparator agents, assessedin vitroagainst, isolates, source, blood samples, Tigecycline Evaluation, Surveillance Trial, TEST, broth microdilution methods, inhibitory, MIC, blood-borne, isolates, guildlines, Clinical, CLSI, Antimicrobial susceptibility, breakpoints, CLSI, guidelines, standards, susceptibility, comparator agents, tigecycline breakpoints, US, FDA, Results, Enterobacteriaceae, isolates, Escherichia coli, Klebsiella pneumoniae, Enterobacter, susceptible, amikacin, meropenem, tigecycline, Meropenem, resistance, isolates, Extended-spectrum beta-lactamase, ESBL, K.pneumoniaeisolates, MIC90, tigecycline, Acinetobacter baumannii, proportion, susceptible, A.baumanniiisolates, minocycline, P.aeruginose, isolates, susceptible, antibiotics, Staphylococcus aureusisolates, susceptible, tigecycline, proportion, methicillin-resistant S.aureus, MRSA, S.aureusisolates, worldwide, Asia, North America, Latin America, Vancomycin-resistant, VR, isolates, ofEnterococcus faecalis, VR.E.faecalis, Enterococcus faecium(VR.E.faecium), VR.E.faeciumwere, North America, Latin America, isolates, Production, penicillin-resistant Streptococcus pneumoniae(PRSP, S. pneumoniae, isolates, PRSP, proportion, Asia, Africa, Latin America, study, tigecycline, antibiotic, active, blood-borne, pathogens, global, antimicrobial resistance, Africa, Asia, Latin America, Europe, North America]]\n",
      "[[Japanese, Welfare, Japanese, Nosocomial Infection Surveillance, nationwide, epidemiological, information, data, clinically, bacteria, hospitals, treated, protocol, analyzed, JANIS, office, Nationwide, individual, hospital, data, hospitals, monthly, yearly, study, local, antimicrobial resistance, clinically, bacteria, Kawasaki City, JANIS, data, hospitals, Kawasaki City, surveillance, data, hospital monthly, JANIS, Kawasaki City, compared, nationwide, data, Kawasaki City, data, nationwide, data, resistant, bacteria, decreased, years, examined, incidence, methicillin-resistant Staphylococcus aureus, MRSA, S. aureus, Kawasaki City, Japan, incidence, penicillin-resistant Streptococcus pneumoniae, PRSP, S. pneumoniae, Kawasaki City, incidence, MRSA, PRSP, nationwide, incidences, continuous, local, national surveillance, monitoring, antimicrobial resistance, clinical, isolates, JANIS database, epidemiology, nosocomial infections, Japanese, hospitals]]\n",
      "[[study, investigate, amino acid motifs, PBPs, Streptococcus pneumoniae, isolates, invasive diseases, pediatric, patients, Casablanca, Morocco, penicillin-susceptible, PSSP, penicillin-intermediate, PISP, penicillin-resistant, S. pneumoniae, PRSP, PCR-RFLP, DNA sequencing, pbp1a, genes, motifs, PBP1a, PBP2b, PBP2x, PSSP, strains, Substitution, PBP1a, conserved motifs, PRSP, isolates, six/five, PISP, Analysis, PBP2b, PISP, strains, PRSP, substitutions, Substitution, PBP2x, motifs, PISP, strains, PRSP, substitutions, motifs, genotypes, analysis, pbp1a, pbp2b, pbp2x, penicillin-nonsusceptible, S. pneumoniae, isolated, Casablanca, amino acid substitutions, worldwide, pneumococci, low, level, resistance, b-lactams]]\n",
      "[[Novel, 7-[(3 aS,7 aS)-3 a-aminohexahydropyrano[3,4- c]pyrrol-2(3 H)-yl]-6-fluoro-1-[(1 R,2 S)-2- fluorocyclopropyl]-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 5, DS21412020, synthesized, antibacterial drugs, treatment, respiratory tract infections, Compound, trans-fused pyranose ring, pyrrolidine moiety, C-7 position, quinolone, scaffold, in vitro, antibacterial activity, respiratory pathogens, quinolone-resistant, methicillin-resistant Staphylococcus aureus, QR-, MRSA, quinolone-resistant, Escherichia coli, QR-, E. coli, compound 5, in vivo, activity, experimental, murine, pneumonia, model, penicillin-resistant Streptococcus pneumoniae, PRSP, favorable profiles, preliminary, toxicological, nonclinical, pharmacokinetic studies, reduced, lipophilicity, basicity, compound 5, synthesized, carba-type compound 4, reduction, human ether-a-go-go, hERG, gene channel, inhibition, potential, QT interval]]\n",
      "[[Necrotizing, soft tissue infections, NSTIs, characterized, extensive, soft tissue, destruction, systemic, toxicity, sepsis, septic shock, clinical characteristics, microbiological results, laboratory data, therapies, outcome, patients, NSTIs, admitted, intensive care unit, ICU, monocentric observational study, patients, admitted, ICU, university hospital, demographic characteristics, comorbidities, clinical features, microbiology, laboratory results, organ dysfunctions, therapies, outcome, retrospectively analyzed, patients, males, age, SD, type II, monomicrobial, NSTI, patients, isolated, pathogen, Streptococcus pyogenes, patients, Septic shock, diagnosed, patients, organ dysfunctions, circulatory, renal, patients, mean value, SD, serum lactate, admission, ICU, median, SOFA, SAPS II, IQR, IQR, ICU, mortality rate, SOFA, serum lactate, prognostic value, ICU outcome, OR, OR, cut-off value, serum lactate, positively, mortality, sensitivity, specificity, NSTIs, risk, septic shock, multiple organ dysfunction syndrome, associated with, mortality, study, serum lactate, admission, ICU, correlated, mortality, easy-to-measure parameter, decision-making process, prognosis, continuation, care]]\n",
      "[[healthy, Mexico, massive hemoptysis, fevers, chills, cavitary lesions, right upper lobe, lung, suspicious, tuberculosis, patient, treated with, vancomycin, ceftriaxone, azithromycin, isolation, suspected, tuberculosis, Sputum AFB stains, negative, blood cultures, Group, Streptococcus, GAS, Antibiotics, ampicillin-sulbactam, patient, clinical improvement, Strep A pyogenes, rare, cavitary hemorrhagic pneumonia, associated with, mortality, Clinical suspicion, early diagnosis, patient]]\n",
      "[[pathogenic, emm1 Streptococcus pyogenes, strains, secrete, multidomain Streptococcal inhibitor of complement, SIC, binds, inactivates, components, innate immune response, vaccine-induced antibodies, SIC, invasive, S. pyogenes infection, Immunisation, SIC, mice, systemic, bacterial, dissemination, intranasal, intramuscular, infection, emm1, S. pyogenes, Vaccine-induced rabbit anti-SIC antibodies, human anti-SIC antibodies, bacterial, clearance, ex vivo, whole-blood assay, SIC, vaccination, mice, rabbits, antibody, recognition, domains, SIC, human anti-SIC, proline-rich region, SIC, model, natural infection, S. pyogenes, non-protective antibodies, proline-rich region, SIC, vaccination, SIC, development, protective antibodies, SIC, domains]]\n",
      "[[extensive, knowledge, CRISPR-Cas9, molecular mechanisms, protein engineering, effective, method, improving, CRISPR-Cas9, traits, natural forms, protein evolution method, selection, catalytically, enhanced, CRISPR-Cas9, variants, CECas9, targeting, protospacer, toxic gene, effectiveness, method, characterized, Type II-C, Cas9, Acidothermus cellulolyticus, AceCas9, enzyme, kinetics, improvement, in vitro, catalytic, efficiency, AceCECas9, Streptococcus pyogenes, Cas9, SpyCas9, improvement, SpyCECas9-facilitated homology, repair-based gene, insertion, human colon cancer]]\n",
      "[[delivery, biopharmaceuticals, oral mucosa, potential, applications, antimicrobial peptides, treat, resistant infections, growth factors, tissue regeneration, alternative, injections, systemic delivery, formulations, targeting, site, non-specific, control, dose, electrospun, dual-layer, mucoadhesive, investigated, protein delivery, oral mucosa, Lysozyme, model, antimicrobial protein, poly(vinylpyrrolidone)/Eudragit RS100, polymer, nanofibers, electrospinning, ethanol/water mixture, fibrous membranes, released, protein, clinically, rate, cumulative, Dual fluorescent fibre labelling, confocal microscopy, homogeneity, lysozyme, polymer, distribution, encapsulation, efficiency, preservation, enzyme activity, released, lysozyme, inhibited, growth, oral bacterium, Streptococcus ratti, evidence, retention, biological activity, potential, application, treating, preventing, oral infections, protective poly(caprolactone, backing layer, promote, unidirectional, delivery, loss, enzyme activity, dual-layer, long residence times, in vitro test, adhesive, properties, maintained, study, drug delivery system, potential, delivery, therapeutic proteins, oral mucosa]]\n",
      "[[report, complete, genome sequence, Streptococcus ratti strain JH145, Streptococcus ratti, cariogenic species, mutans streptococcus, isolated, rat, human teeth, strain JH145, strain BHT-2, oral health, cariogenic, lactic acid, biofilm production]]\n",
      "[[Lactococcus lactis subsp., BGBU1, bacteriocin, lactolisterin, BU, antimicrobial activity, species, Gram-positive bacteria, food spoilage, foodborne, pathogens, Listeria monocytogenes, Staphylococcus aureus, Bacillus spp., streptococci, Lactolisterin, BU, cell surface, BGBU1, 2-propanol, purified, homogeneity, C18 solid-phase extraction, reversed-phase high-performance liquid chromatography, molecular mass, purified, lactolisterin, BU, 5,160.94 Da, internal fragment, AVSWAWQH, N-terminal sequencing, low-level, similarity, antimicrobial peptides, Curing, transformation, experiments, presence, bacteriocin operon, plasmid, pBU6, strain, BGBU1, Analysis, bacteriocin operon, leaderless, bacteriocin, amino acids, similarity, bacteriocin BHT-B, Streptococcus ratti, bacteriocin, analogy, aureocin, Lactolisterin, BU, broad-spectrum leaderless, bacteriocin, L. lactis subsp., BGBU1, antimicrobial activity, food spoilage, foodborne, pathogens, Listeria monocytogenes, Staphylococcus aureus, Bacillus spp., streptococci, Lactolisterin, BU, similarity, aureocin-like bacteriocins, bacteria, operon, synthesis, plasmid, pBU6, strain, BGBU1, horizontal transfer, producers]]\n",
      "[[AIM, evaluate, adjunctive effects, Streptococcus oralis, KJ3, Streptococcus uberis KJ2, Streptococcus rattus JH145, probiotic tablet, scaling, root planing, SRP, periodontitis, patients, double-blind, placebo-controlled clinical trial, root planing, patients, placebo, probiotic, tablet, day, weeks, pocket probing depth, primary outcome measure, bleeding, probing, attachment, levels, measured, baseline, weeks, baseline, weeks, microbiological sampling, plaque, gingival indices, primary, secondary outcome, improved, evaluation, groups, no significant, inter-group, detected, time point, sites, plaque, probiotic, group, control group, evaluation, 12-week time point, salivary, Prevotella intermedia, counts, probiotic, group, No differences, detected, comparing, adjunctive use, placebo, investigated, streptococci, probiotic tablet, SRP]]\n",
      "[[AIM, IRB, clinical trial, effect, probiotic, supplements, Caries, Risk, CRT-, results, oral microflora, caries, risk children, subjects, years, caries, risk assessment, CAMBRA, moderate, high, caries, evaluated, analysis, salivary, levels, pathogenic bacteria, mutans streptococci, Lactobacilli, subjects, randomizing, software, assigned, diferent, Groups, Group, PerioBalance, Lactobacilli, lozenges, days, Group B, EvoraKids, Streptococcus uberis KJ2, Streptococcus oralis, KJ3, Streptococcus rattus, JH1, probiotics, chewable, tablets, days, Salivary samples, incubated, hours, colony, counting, ranking, Follow up testing, CRT, days, statistically significant, diference, CRT, results, pre, post, probiotics, PerioBalance, SM, results, Lactobacilli, results, EvoraKids SMresults t=, Lactobacilli, results, CRT, values, caries, children, probiotic, study's, results, conclusions, EvoraKids, PerioBalance, affected, CRT, results, decreasing, S. mutans, lactobacilli, salivary, samples]]\n",
      "[[Gram-positive, catalase-negative, coccoid, isolates, donkey oral cavities, clonal groups, characterized, phenotypic, phylogenetic studies, results, biochemical tests, organisms, identified, streptococcal species, 16S rRNA, gene sequencing studies, organisms, members, genus, Streptococcus, isolates, Streptococcus ursoris, similarity, 16S rRNA, Streptococcus ratti, similarity, heat-shock protein gene, groEL, isolates, Streptococcus criceti, similarities, 16S rRNA, groEL genes, phylogenetic, phenotypic, evidence, isolates, clonal groups, novel, species, genus, Streptococcus, names, organisms, Streptococcus orisasini sp. nov., type strain NUM 1801(T), JCM 17942(T), DSM 25193(T, Streptococcus dentasini sp. nov., type strain NUM 1808(T, JCM 17943(T, DSM 25137(T)]]\n",
      "[[rapid, species-specific detection, identification, Streptococcus ratti, polymerase chain reaction, PCR primer, S. ratti, nucleotide sequence, dextranase gene, dex, S. ratti, ATCC19645(T, primer, detected, S. ratti, mutans streptococci, strains, species, PCR procedure, detecting, genomic DNA, S. ratti, ATCC19645, Streptococcus, Streptococcus, Streptococcus downei-, Streptococcus, dex PCR methods, primer, portion, dex gene, species, primer, pairs, S. ratti, study, differentiated, species, mutans streptococci, species-specific amplicons, lengths, results, PCR method, detection, identification, S. ratti, primer, pairs, dex PCR, species-specific detection, discrimination, species, mutans streptococci]]\n",
      "[[Gram-positive, catalase-negative, coccus-shaped organisms, isolated, oral cavities, bears, isolates, identified, streptococcal species, results, biochemical tests, 16S rRNA, gene sequencing studies, organisms, members, genus, Streptococcus, species, genus, phylogenetic, isolates, Streptococcus ratti ATCC 19645(T), DNA-DNA hybridization, analysis, isolates, DNA-DNA, relatedness, type strain, S. ratti, Colonies, strains, mitis salivarius agar, extracellular polysaccharide-producing, colony, morphology, phenotypic, phylogenetic, evidence, novel, isolates, genus, Streptococcus, Streptococcus ursoris sp. nov., type strain, S. ursoris, NUM]]\n",
      "[[Kinetic, mutans streptococci, patients, hexadecane, Sigma, patients, high, dental caries, risk, Group, dmft + DMFT, active caries, low, dental caries, risk, Group B, dmft + DMFT, active caries, bacteria, Group, bacteria, Group B, typed, De La Higuera's procedure, API, strip, patients, Group, S. mutans, hydrophobic/4, non-hydrophobic, S. sobrinus, non-hydrophobic, S. rattus, hydrophobic, patients, Group B, Streptococcus mutans, non-hydrophobic/1 hydrophobic, Streptococcus sobrinus, non-hydrophobic/ 1 hydrophobic, Streptococcus rattus, hydrophobic, Patients, high, dental caries, risk, prevalence, hydrophobic bacteria, patients, low, dental caries, risk, typed, S. rattus, hydrophobic]]\n",
      "NaN\n",
      "[[Streptococcus sobrinus, etiologic, dental caries, tooth decay, humans, knowledge, S. sobrinus, organism's, oral health, S. sobrinus, natural, streptococci, regulate, growth, virulence, quorum sensing, natural, competence, genetic manipulation, S. sobrinus, knowledge, pathogenicity, strains, S. sobrinus, ComRS, competence system, S. sobrinus, mutans group, streptococci, S. sobrinus, ComRS system, competence pathways, salivarius, group, ComRS systems, S. sobrinus pathway, copies, transcriptional regulator, ComR, peptide pheromone, XIP, aromatic amino acids, Synthetic, XIP, transformation, S. sobrinus, plasmid, linear DNA, genetic tractability, ComR, homologs, induced, competence, suppress, competence, Exogenous, XIP, increases, expression, bacteriocin gene, antimicrobial response, inhibits, growth, S. mutans, strains, S. sobrinus, cheaters, XIP, recombination, event, nonresponsive strain, function, ComRS pathway, gene, XIP, S. sobrinus, ComRS pathway, tools, pathogen, lens, evolution, ecological, cheaters]]\n",
      "[[Cytocompatible, bioactive surface, treatments, antibacterial, properties, osseointegrated dental implants, bacteria-related peri-implantitis, family, mesoporous, coatings, zirconia, ZrO2, microstructure, doped, gallium, Ga, antibacterial, pro-osseo-integrative, properties, ZrO2, films, sol-gel synthesis, Pluronic F127, templating agent, Ga, doping, gallium nitrate hydrate, Chemical, characterization, XPS, GDOES, effective, incorporation, Ga., coatings, morphological, structural analysis, TEM, SAED, effective, stabilization, mesoporous structure, tetragonal, ZrO2, phase, Specimens, cytocompatibility, gingival fibroblast, osteoblasts, progenitors, cultivated, coatings, metabolic activity, morphology, controls, polystyrene, Ga, reduced, metabolic activity, oral, pathogens, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, comparison, untreated, zirconia, Ga ions, metabolism, oral, commensal, Streptococcus salivarius, anti-pathogens, activity, coatings, cells, bacterial infection, co-culture, cells, bacteria, environment, presence, Ga, reduction, bacteria, viability, time, cells proliferation, coatings, antibacterial, cytocompatibility, properties, improvement, implantable devices, field, implant dentistry]]\n",
      "[[study, potential, lactic acid, probiotics, antimicrobially, pathogens, food-poisoning, microorganisms-was, evaluated, activity, bacterial, pathogens, study, plaster/bandage, application, inhibitory substances, probiotics, diseased, skin, Streptococcus salivarius, strains, Lactobacillus plantarum, tested, production, antimicrobials, bacteriocin-like substances, active, Gram-positive, Gram-negative pathogens, methods, membrane test, probiotics, antimicrobials, diffusible, membranes, Target, organisms, Cutibacterium acnes, Staphylococcus aureus, Pseudomonas aeruginosa, L. plantarum 8P-A3 strain, bacteria, skin disorders, Lactobacillales, active, potential, skin pathogens, tested, probiotics, enclosed, polymer, membranes-one tight, permeable, products, vacuum drying, reactivated, months, storage, reactivated pads, probiotics, antibacterial activity, agar, plates, pathogens, tested, probiotic, pads, topically, treatment, skin disorders, antibiotic, treatment, adjunctive therapy]]\n",
      "[[AIM, ex vivo, study, evaluate, Er, Cr, YSGG laser, effectiveness, decontamination, endodontic, biofilm, human teeth, freshly, tooth, species, endodontic, Enterococcus faecalis, Streptococcus salivarius, Porphyromonas gingivalis, Prevotella intermedia, experimental groups, group 1, teeth, biofilm-forming technique, groups, teeth, group, irradiated, Er;Cr, YSGG laser settings, groups, teeth, group, irrigated, solutions, laser irradiated, settings, group, teeth, control group, treated, NaOCl, irrigation, observations, group 2, specimens, ripeness, biofilm, presence, Enterococcus faecalis, Streptococcus salivarius, chains, group, thermal edge, effects, optic fiber, canal walls, group, specimens, observation, average, cleaning, root canal walls, canal walls, group, samples, apical, debris, smear layer, centre, cracks, melting dentin, radicular wall, experimental conditions, study, Er, Cr, YSGG laser, canals, decontamination, NaOCl, irrigation]]\n",
      "[[Morbidity, mortality, infectious diseases, rank, human, illnesses, pathogenic, mechanisms, unclear, misuse, antibiotics, emergence, drug-resistant, strains, Infectious diseases, spread, pathogens, mutate, threats, human, health, increasing, high-throughput screening, pathogen genomes, research, data mining, visualization analysis, studies, infectious disease prevention, control, framework, infectious pathogens, Fusobacterium, Streptococcus, Neisseria, Streptococcus salivarius, functions, genome annotation, phylogeny analysis, core genome, analysis, structure, genomes, prediction, virulence, genes/factors, pathogenic, mechanisms, prediction, resistance, genes/factors, signaling pathways, experiments, angles, phylogeny, macro perspective, structure, genomes, micro perspective, virulence, drug-resistance, prediction perspective, framework, evidence, identification, pathogens, prevention, control, infectious diseases, strains, clinical, scientific research, genome, framework, data mining, technology, accommodation, depth, pathogens, molecular level, research]]\n",
      "[[Dental caries, acid-related disease, anti-caries agents, bacteriostatic effect, neutral environment, target, acid-resistant, microorganisms, caries, acidic milieus, in vitro, antibacterial activities, bedaquiline, oral pathogens, acidic milieus, Streptococcus mutans, Streptococcus sanguinis, Streptococcus salivarius, mono-/multiple suspension, biofilm, MIC, IC50, bedaquiline, S. mutans, broth microdilution method, Bedaquiline, inhibitory activity, pH, time points, planktonic, biofilm, effect, production, lactic acid, extracellular polysaccharide, pH, S. mutans, biofilm, cytotoxicity, effects, activity, H(+)-ATPase enzyme, S. mutans, pH, BHI, IC50, MIC, bedaquiline, inhibited, proliferation, biofilm generation, S. mutans, Mix, dose-dependent, neutral environment, lactic acid, production, polysaccharide, production, pH, reduced, incorporation, bedaquiline, pH, environment, inhibitory effect, H(+)-ATPase enzyme, S. mutans, non-toxic effect, periodontal ligament stem cells, Bedaquiline, efficient, inhibiting, proliferation, biofilm generation, S. mutans, oral pathogens, acidic environment, targeting, property, non-cytotoxicity, promote, clinical, potential, preventing, caries, investigation, action sites, drug modification]]\n",
      "[[OBJECTIVE, study, assess, antimicrobial activity, ursolic acid, UA, multi-species, biofilms, Streptococcus mutans, Streptococcus sanguinis, Streptococcus gordonii, measure, biocompatibility, Crystal violet staining, CFU, counting, CCK-8, assays, scanning electron microscopy, SEM, investigate, effect, UA, multi-species, biofilms, UA's, effect, exopolysaccharides, EPS, production, measured, confocal laser scanning microscopy, CLSM, anthrone-sulfuric acid method, Fluorescent in situ hybridization, FISH, visualize, quantify, microbial, composition, multi-species, biofilms, Quantitative real-time PCR, qRT-PCR, measure, expression, virulence genes, S. mutans, S. sanguinis, S. gordonii, UA, treatment, CCK-8, assays, evaluate, cytotoxicity, human, HOKs, human, HGEs, results, UA, antimicrobial activity, oral streptococci, UA, reduced, EPS, synthesis, oral streptococci, suppressed, gtf genes, expression, UA, reduced, proportion, S. mutans, multi-species, biofilms, UA, low, cytotoxicity, HOKs, HGEs, UA, antibiofilm activity, oral, potential, dental caries, treatment]]\n",
      "[[Behcet disease, BD, chronic systemic inflammatory disorder, aetiology, study, orientation, T cell, subpopulations, pediatric, BD, regulatory T lymphocytes, imbalance, T cell, subpopulations, analyzed, flow cytometry, peripheral blood, pediatric, patients, acute, aBD, remitting, rBD, BD, healthy controls, HC, Tregs, CD4+CD25hiCD127-/loFoxp3+), activated, Tregs, GITR, LAP, CTLA-4, HLA-DR, expression, CD4+, CD8+ T cells, interferon-g, Th1, Tc1, interleukin (IL)-17, Th17, Tc17, polyclonal, OKT3/IL-2, antigenic, Streptococcus sanguis KTH-1 peptides, HSP-60, stimulation, numerated, Th17, Tc17, frequency, mitogenic stimulation, increased, aBD, rBD, patients, HC, Th17, frequency, antigenic stimulation, patients, HC, percentage, Tregs, activated, Tregs, patients, HC, Tregs, removed, antigen-driven differentiation, Th1, Th17, BD, HC, CD4+T cells, bias, Th17, polarization, acute, remitting, BD, children, increase, Tregs, patients, Tregs, CD4+T, Th1, Th17, cells, pediatric, BD, Tregs, Th17, orientation, helper T cell response]]\n",
      "[[study, evaluate, effect, copper oxide, CuO, titanium dioxide, TiO2, nanoparticles, antimicrobial activity, thermocycled polymethyl methacrylate, PMMA, denture base material, strains, yeast, bacteria, species, Material, Methods, in vitro study, disk-shaped, specimens, heat-cured, PMMA, prepared, groups, CuO, CuO, TiO2, TiO2, nanoparticles, control group, nanoparticle, specimens, thermocycled, antimicrobial activity, assessed, strains, yeast, Candida albicans, C. dubliniensis, oral bacteria, species, Streptococcus mutans, S. sobrinus, S. salivarius, S. sanguis, Data, analyzed, ANOVA, Tukey's post hoc tests, alpha, concentrations, CuO, TiO2, nanoparticles, antimicrobial activity, S. salivarius, S. sanguis, C. dubliniensis, compared, control group, CuO, control group, S. mutans, TiO2, groups, control group, S. mutans, C. albicans, TiO2, nanoparticle, antimicrobial activity, compared, control group, concentrations, CuO, TiO2, effective, antimicrobial agents, S. salivarius, S. sanguis, C. dubliniensis, concentration, CuO, effective, S. mutans, TiO2, effective, C. albicans, TiO2, efficient, antimicrobial activity]]\n",
      "[[High-throughput sequencing, window, structural, functional profiling, microbial, communities, portion, microbial, communities, scale, solution, problem, studies, viability, assessments, propidium monoazide, PMA, treatment, downstream, molecular profiling, qPCR, sequencing, studies, moderate, success, communities, systematic evaluations, technique, PMA-seq, PMA, treatment, 16S rRNA, gene amplicon sequencing, viability assessment, synthetic, microbial, communities, PMA-seq, synthetic, viable/heat-killed, Escherichia coli, Streptococcus sanguinis, complex, communities, computer screens, computer mice, soil, human, saliva, E. coli, spike-in controls, PMA-seq, quantify, viability, variability, amplicon sequencing, performance, affected, community properties, biomass, sample types, compositional diversity, technique, environmental swabs, Boston subway system, taxa, PMA, treatment, microorganisms, PMA-responsive, microbes, results, PMA-based studies, PMA, responsiveness, microbes, ecosystems, environments, studies, study, comprehensive, evaluation, PMA-seq, quantitative, potential, synthetic, complex, microbial, communities, technique, effective, semi-quantitative purposes, synthetic, communities, qualitative assessments, complex, community samples, Video abstract]]\n",
      "[[Untreated, dental caries, disease, Development, caries, associated with, intake, sugar, microorganisms, sugar, acidic environment, results, mineral loss, fluoride, associated with, decline, caries, preventing, caries, increase, pH, dental plaque, years, arginine, streptococci, arginine deiminase system, ADS, metabolizes free arginine, In vivo, incidence, caries, inversely, correlated, ADS, activity, saliva, dental plaque, ADS, active, Streptococcus gordonii, S. sanguinis, absent, S. sobrinus, S. mutans, presence, L-arginine, S. gordonii, S. sanguinis, S. mutans, S. sobrinus, synthesize, metabolite, citrulline, increase, pH, environment, multispecies, biofilms, ADS-positive, ADS-negative streptococci, supplementation, arginine, suppressed, growth, ADS-negative, ADS-positive streptococci, increase, pH, environment, Evaluating, influence, daily, manual, removal, biofilm, in vitro, brushing, commercial toothpaste, fluoride, arginine, surface microhardness, compared, toothpaste, fluoride, studies, clinically, investigated, effect, arginine-containing dentifrice, decrease, DMFS]]\n",
      "[[Pulmonary arteriovenous malformation, vascular anomaly, complications, paradoxical embolization, stroke, brain abscess, case, brain abscess, associated with, pulmonary arteriovenous malformation]]\n",
      "[[Evidence, bacterial, proteomes, functional roles, activities, diverse, mechanisms, unclear, study, amyloid-forming truncated protein C123, Streptococcus mutans, S. mutans, biological functions, microbial, proliferation, biofilm formation, investigated, mechanism, hexapeptides, simulated, synthesized, amyloid-forming hexapeptides, AFhPs, efficient, broad-spectrum, antibiofilm activity, Gram-positive bacteria, S. mutans, Streptococcus sanguis, Staphylococcus aureus, Gram-negative bacteria, Escherichia coli, fungus, Candida albicans, aggregating, rigid, amyloid fibres, agglutinating, microbes, non-amyloid-forming hexapeptides, AFhPs, kill, microbes, cytotoxicity, AFhPs, antibiofilm activity, source, microbial cell wall, carbohydrates, peptidoglycan, PGN, lipoteichoic acid, LTA, glucan, zymosan A, AFhP binding, triggered significant, AFhP fibrillation, amyloid fibres, agglutinated, lipid membrane model, large, unilamellar vesicles, LUVs, LUVs, AFhP fibrillation, lipid membranes, AFhP, antibiofilm activities, potential, AFhPs, antibiofilm agents]]\n",
      "[[in vitro study, evaluate, surface, properties, severely, fluorotic enamel, adhesion, Streptococcus mutans, Streptococcus sanguinis, enamel, relationship, dental fluorosis, dental caries, microbiology, perspective, surface, properties, severely, fluorotic, surface microhardness test, scanning electron microscopy, SEM, atomic force microscopy, S. mutans, single-species biofilms, S. mutans, S. sanguinis, dual-species, biofilms, cultured, fluorotic enamel, surface, morphology, biofilms, volume, bacteria, expolysaccharides, EPS, bacteria, tested, SEM, confocal laser scanning microscopy, colony-forming units, CFU, counting, Fluorotic enamel, microhardness, surface, roughness, sound enamel, structure defects, pores, pits, biofilm thickness, volume, bacteria, EPS, CFU, counts, bacteria, single-species, dual-species, biofilms, fluorotic enamel, sound enamel, volume, bacteria, EPS, dual-species, biofilms, single-species biofilms, surface, roughness, structure, defects, teeth, moderate, severe, dental fluorosis, adhesion, S. mutans, S. sanguinis, increased, adhesion, S. mutans, increase, susceptibility, dental caries, S. sanguinis, designer bacteria, reduce, cariogenicity, biofilms, fluorotic enamel, surface]]\n",
      "[[beta-Glycyrrhetinic acid, BGA, natural, antibacterial agent, studies, BGA, antibacterial effects, bacteria, study, evaluated, effects, BGA, regulation, supragingival, plaque, bacteria, MICs, BGA, oral bacteria, measured, minimum, concentrations, inhibition, biofilm formation, Streptococcus mutans, Streptococcus sobrinus, insoluble, glucan, synthesis, abilities, MICs, biofilm formation, bacteria, MIC, inhibition, effects, BGA, coaggregation, Porphyromonas gingivalis, Streptococcus gordonii, evaluated, BGA, inhibited, coaggregation, bacteria, incubation, inhibition, effects, BGA, human, supragingival, plaque, bacteria, evaluated, Human, supragingival, plaque, samples, healthy donors, inhibition, effects, BGA, biofilm formation, plaque, bacteria, evaluated, samples, biofilm formation, attenuated, BGA, colony forming units, biofilms, attenuated, BGA, inhibits, growth, biofilm formation, bacteria, effect, supragingival, plaque, bacteria, BGA, natural agent, prevents, outbreak, progression, periodontal disease, suppresses, growth, biofilm formation, bacteria, coaggregation, P. gingivalis, plaque, bacteria]]\n",
      "[[study, evaluated, Bifidobacterium, Lactobacillus species, associated with, streptococci, increase, insoluble, extracellular polysaccharide, EPS, production, caries, lesion, progression, Bovine enamel, surface, SH, groups, S. mutans, Bifidobacterium, Lactobacillus, S. mutans, S. sobrinus, Bifidobacterium, Lactobacillus species, blocks, bacterial, associations, days, quantity, EPS, biofilms, caries, lesion, colorimetric, cross-sectional enamel hardness, data, one-way analysis of variance, Bonferroni test, S. mutans, B. animalis, B. dentium, quantity, EPS, S. mutans + B. animalis, KHN, S. mutans + S. sobrinus, B. longum, induced, EPS, KHN, values, associations, B. animalis, B. longum, streptococci, EPS, production, caries, lesion, progression]]\n",
      "[[probiotic bacteria, inhibitory effects, oral pathogens, Lactobacillus spp, probiotics, difficulties, laboratory cultivation, experimentation, oral microorganisms, studies, Lactobacillus spp, isolated, oral cavity, oral, pathogens, study, evaluate, biosafety, inhibitory, effects, Lactobacillus fermentum OK, oral, biotherapeutic probiotic, oral pathogens, L. fermentum OK, evaluated, microbial, genetic characteristics, dilution, L. fermentum OK, culture supernatant, inhibition, growth, S. mutans, L. fermentum OK, inhibitory, effects, growth, Fusobacterium nucleatum, Porphyromonas gingivalis, Streptococcus gordonii, Streptococcus sanguinis, proliferation, L. fermentum OK, co-cultured, oral bacteria, retarded, L. fermentum OK, hydrogen peroxide, aggregate, Streptococcus sobrinus, S. gordonii, S. mutans, S. sanguinis, P. gingivalis, reduce, S. mutans, artificial dental, in vitro, cell adhesion, capacity, L. fermentum OK, oral epithelial cell line, cells, cell, cell adhesion, F. nucleatum, S. mutans, decreased, protection, displacement assays, L. fermentum OK, evaluated, safety, ammonia production, biogenic, hemolytic property, mucin degradation testing, antibiotic susceptibility, whole genome sequencing, WGS, study, L. fermentum OK, bioactive lactobacterial food ingredient, starter culture, probiotic, microorganism, human]]\n",
      "[[antimicrobial, antimicrobial photodynamic therapy, aPDT, visible light plus, water-filtered infrared-A irradiation, natural compounds, photosensitizers, PSs, study, information, antimicrobial effects, aPDT, mother juices, cariogenic, Streptococcus pathogens, planktonic, eradication, potential, human, volunteers, Mother juices, pomegranate, bilberry, chokeberry, concentrations, PSs, unweighted, irradiance, minutes, Planktonic cultures, Streptococcus mutans, Streptococcus sobrinus, saliva, volunteers, treated with, aPDT, S. mutans, S. sobrinus, killed, aPDT, pomegranate juice, chokeberry juice, bilberry juice, strains, Concentrations, pomegranate, chokeberry, bilberry, eradicated, mixed bacteria, saliva samples, pilot study, pomegranate, mother, juice, berry, juices, multicomponent, PS, killing, pathogenic, oral bacteria, aPDT]]\n",
      "[[inhibitory, antibiofilm effects, Thymus vulgaris, EOTv, Hyptis spicigera, EOHs, cariogenic, microorganisms, evaluated, methods, chemical, characterization, EOTv, gas chromatography/mass spectrometry, Streptococcus mutans, Streptococcus gordonii, Streptococcus sanguinis, Streptococcus mitis, Streptococcus sobrinus, Lactobacillus acidophilus, Actinomyces naeslundii, agar diffusion assays, determination, minimal, inhibitory, minimal, bactericide, concentrations, streptococci, lactobacilli, clinical, isolates, tested, effects of, essential oil, microbial, biofilm formation, microcosm, biofilm, human, saliva, essential oils, inhibitory, effects, cariogenic species, reduced, bacterial, adherence, dental enamel, Essential oils, disrupt, microcosm, biofilms, Thymus vulgaris, Hyptis spicigera, potential, development, formulations, control, cariogenic, biofilms]]\n",
      "[[Biofilm formation, biomaterials, health area, Antimicrobial substances, nanomaterials, problem, nanostructured, silver, vanadate, decorated, silver nanoparticles, dental porcelains, IPS, Inline, concentrations, evaluate, surface, characteristics, SEM/EDS, antimicrobial activity, Streptococcus mutans, Streptococcus sobrinus, Aggregatibacter actinomycetemcomitans, Pseudomonas aeruginosa, silver, vanadium, V(4+)/V(5+), ions, release, mechanical properties, microhardness, roughness, fracture toughness, incorporation, porcelain's components, reduced, S. mutans, S. sobrinus, A. actinomycetemcomitans, viability, increased, fracture, toughness, IPS, Inline, roughness, groups, microhardness, group, groups, IPS, Inline, released, Ag(+), released, V(4+)/V(5+), incorporation, dental porcelains, antimicrobial activity, S. mutans, S. sobrinus, A. actinomycetemcomitans, preventing, biofilm formation, release, vanadium, silver ions, adequate, mechanical behavior, observed, incorporation, P. aeruginosa, viability, increased, surface, roughness, dental porcelains]]\n",
      "[[study, evaluate, effect, dried, distillers, grains, solubles, DDGS, red-osier dogwood, extract, in vitro, fermentation, characteristics, nutrient, disappearance, microbial, profiles, rumen, experiment, randomized design, factorial arrangement, treatments, replicates, treatment, basal diet, barley silage, dry-rolled barley, grain, vitamin, mineral supplement, dry matter, DM, DDGS, diet, basal diet, wheat, DDGS, portion, barley, grain, supplemented, ROD, extract, DM, experimental period, days, adaptation, days, data, sample collection, substitution, wheat, DDGS, barley, grain, gas production, disappearances, DM, organic matter, crude protein, total volatile fatty acid, VFA, production, microbial, production, barley, grain, wheat DDGS, increased, fermenter, pH, molar, proportion, branched-chain VFA, fermentation, pattern, acetate, production, increased, disappearance, neutral detergent fiber, NDF, decreased, methane, CH4, production, basal barley diet, ROD, extract, increased, acetate, propionate, ratio, reduced, disappearance, starch, no effect, variables, No effects, ROD, DDGS, diet, observed, operational, OTUs, Shannon diversity index, microbial, community, variation, treatments, Taxonomic analysis, no effect, ROD, extract, abundance, bacteria, phylum, level, basal diet, DDGS, diet, genus, level, microbial, community, affected, DDGS, ROD, extract, Prevotella, Fibrobacter, abundant, genera, basal diet, Treponema, abundant, genus, ROD, extract, results, substitution, wheat, DDGS, barley grain, enteric, CH4, emissions, reduced, starch, fermentability, increased, NDF, disappearance, ROD, extract, reduced, risk, rumen, acidosis, improvement, utilization, fiber, cattle-fed, high-grain diet]]\n",
      "[[Syphilis, transmission, increasing, Treponema pallidum, transmitted, sexually, person, person, unclear, frequency, T pallidum, shedding, asymptomatic, stage, infection, shedding, frequent, men, sex, men, MSM, affected, syphilis, prospective, cross-sectional study, MSM, Melbourne, Sexual Health Centre, Melbourne, VIC, Australia, Men, eligible, aged, years, older, sex, men, months, laboratory, primary, secondary, early latent, syphilis, consistent with, Australian, definitions, Primary, secondary, syphilis, lesions, swabbed, non-lesion samples, oral rinse, oral cavity swab, anal canal swab, urine, semen, Samples, tested, T pallidum, PCR assays, targeting, polA, lesion, non-lesion samples, non-lesion samples, gene targets, primary outcome, proportion, men, T pallidum, detected, asymptomatic, sites-namely, mouth, anus, urethra, semen, FINDINGS, MSM, screened, inclusion, serologically, early syphilis, study, primary syphilis, secondary syphilis, early, syphilis, T pallidum DNA, detected, CI, men, oral rinse, oral lesion swab, oral lesions, Oral T pallidum, detection, frequent, secondary syphilis, compared, stages, disease, men, plasma, higher, compared, titres, T pallidum, detected, anal canal swab, anal lesion swab, CI, men, samples, anal, lesion, T pallidum, detected, urine samples, men, semen samples, men, samples, men, secondary syphilis, T pallidum, detected, site, detection, sites, men, primary syphilis, T pallidum, detected, site, detection, sites, men, early latent, syphilis, T pallidum, detected, site, T pallidum, detected, sites, Unrecognised, oral, anal, shedding, T pallidum, MSM, early syphilis, secondary syphilis, secondary syphilis, infectious stage, detection, treatment, syphilis, prevent, progression, secondary stage, improve, syphilis, control, research, contribution, shedding, T pallidum, non-lesion sites, transmission, syphilis, FUNDING, Australian, National Health and Medical Research Council]]\n",
      "[[sub-Saharan Africa, SSA, men, healthcare programs, sports, gambling, SSA, male, engagement, health programs, point-of-care, HIV, syphilis testing, men, gambling centers, Uganda, assessed, HIV, risky, sexual behavior, men, HIV-positive, syphilis, Risky, sexual behavior, condomless, sex, partner(s), HIV, status, multiple, sexual partners, engaging, transactional sex, illicit drugs, nonalcohol consumers, moderate, users, hazardous, consumption patterns, months, follow-up, incidence, rate, syphilis, CI, men, men, SSA, prevalence, syphilis, risky, sexual behavior, reduce, risk, HIV, acquisition]]\n",
      "[[Papua, PNG, rates, sexually transmitted infections, STIs, reducing, incidence, Syphilis, Interventions, Elimination, model, impact, cost, alternative, syphilis, intervention, scale-up, scenarios, SITE, dynamical model, syphilis, transmission, adults, years, Individuals, groups, sexual behaviour, stages, infection, model, PNG, data, routine, surveillance, bio-behavioural, surveys, research studies, program records, syphilis, prevalence, risk behaviours, intervention, coverage, service delivery unit, costs, Scenarios, interventions, clinical treatment, contact tracing, syphilis, screening, condom promotion, incidence, cost, infection, averted, Increasing, treatment, coverage, symptomatic, primary/secondary-stage, syphilis, cases, reduced, estimated, incidence, scenario, constant, coverage, levels, contact tracing, contacts, symptomatic, person, treated, reduced, incidence, Increasing, screening, coverage, percentage, level, reduced, incidence, target, population, Scaling-up clinical, symptom-driven treatment, contact tracing, lowest, cost, infection, averted, condom promotion, periodic, screening, female, sex workers, men, sex, men, PNG, reduce, syphilis, burden, clinical treatment, contact tracing, behavioural, interventions, SITE, tool, countries, national, STI, programming, resource allocation]]\n",
      "[[Ducks, genetic background, adiposity, phenotypes, gut microbiota, host, physiological development, metabolism, fat deposition, association, gut microbiota, lipogenic, phenotype, ducks, study, investigated, cecal microbiota, adult, Muscovy ducks, correlation, cecal microbiota, fat, phenotypes, Muscovy ducks, population, Muscovy ducks, record, abdominal fat weight, collect, cecal, contents, slaughtered, defeathered, cecal, contents, DNA isolation, 16S rRNA, gene sequencing, results, sorted, percentage, abdominal fat, high, low, groups, results, cecum, Muscovy ducks, Bacteroidetes, Firmicutes, Fusobacteria, predominant, phyla, Bacteroides, Oscillospiraceae_uncultured, Parabacteroides, Bacteroidales_norank, dominant, genera, Abdominal fat weight, percentage, abdominal fat, R, lipogenic, phenotypes, ducks, alpha-diversities, high, low, groups, random forest analysis, genera, Treponema, Ruminococcus_torques_group, associated with, fat deposition, Muscovy ducks, abundances, Treponema, Ruminococcus_torques_group, negative, positive, association, abdominal fat weight, Ducks, level, Treponema, percentage, abdominal fat, percentage, abdominal fat, ducks, Ruminococcus_torques_group, abundance, ducks, low, Ruminococcus_torques_group, abundance, findings, data, cecal microbiota, Muscovy ducks, theoretical, fat, deposition, modulating, gut microbiota, duck, industry]]\n",
      "[[termite, microbiome, lignocellulose, microorganisms, study, intestinal, microbiota, Argentinian, termite, species, feeding habits, Microcerotermes strunckii, hardwood, Nasutitermes corniger, softwood, Termes riograndensis, soil, organic matter/grass, Cornitermes cumulans, grass, deep sequencing, amplified, 16S rRNA, ITS genes, taxonomic, gut community structure, comparison, analysis, microbiomes, termite, species, diets, bacterial, Spirochaetes, dominant, guts, M. strunckii, N. corniger, C. cumulans, Firmicutes, T. riograndensis, gut microbiome, bacterial, Treponema, Spirochaetes, dominant, termite, species, T. riograndensis, sequenced samples, comparison, prokaryotic, alpha-diversity, soil/grass feeders, wood feeders, beta-diversity, prokaryotes, fungi, wood-feeders, soil-, grass-feeders, grouped, Ascomycota, Basidiomycota, fungal, phyla, identified, gut samples, lack, reference sequences, public databases, microbial, diversity, termites, feeding, sources, evidence, diet, factors, host, taxonomy, influences, microbial, community, termite, gut]]\n",
      "[[Syphilis, sexual transmitted disease, Treponema pallidum, underdiagnosed, underreported, acute hepatitis, years, cases, primary, secondary syphilis, increasing, men, sex, men, Clinical manifestations, syphilis, diverse, earning, imitator, organ, hepatic, involvement, rare, stage, disease, case, immunocompetent, male, cholestatic hepatitis, diffuse erythematous rash, palmo-plantar affection, patient, primary syphilis, aetiologic study, diagnosed, syphilitic hepatitis, treated with, intramuscular, Benzathine benzylpenicillin, disappearance, rash, normalization, liver enzymes, months, aetiology, patients, elevation, liver enzymes, cholestatic, enzymes, epidemiologic context, unsafe, sexual exposure]]\n",
      "[[clinical picture, mowed, meadow, pattern, tongue, sexually active man, sex, men, painful, lesions, Plaques, prairie, fauchee, context, discovery, HIV, serology, diagnosis, secondary syphilis, positive, serology, nontreponemal RPR test title, positive, Treponema pallidum PCR, tpp47 gene, tongue swab, lesions, penicillin, treatment]]\n",
      "[[Syphilis, sexually transmitted, systemic, inflammatory disease, spirochaete, Treponema pallidum, natural history, untreated syphilis, progresses, stages, primary, secondary, latent, tertiary syphilis, Ocular, involvement, stage, syphilis, eye, affected, syphilitic posterior placoid chorioretinitis, diverse, manifestations, ocular syphilis, features, clinical diagnosis, ocular syphilis, differential diagnosis, ocular infectious, inflammatory, presentations, uveitis, presentations, high-risk, sexual history, illicit drug use history, treatment failure, history of, syphilis, diagnostic workup, ocular syphilis, presumptive diagnosis, ocular syphilis, serological testing, treponemal, nontreponemal tests, patients, ocular syphilis, cerebrospinal fluids, tested, co-existence, neurosyphilis, blood, human immunodeficiency virus, co-infection, United States, ocular syphilis, treatment guidelines, neurosyphilis, parenteral, aqueous, crystalline, penicillin G, drug, diagnosis, appropriate, treatment, ocular syphilis, curable, delayed diagnosis, ocular syphilis, long-term, visual impairment, Delayed diagnosis, diverse, presentations, mimicking, ocular diseases, failure, clinician, serological testing, resurgence, ocular syphilis, clinicians, manifestation, diagnosis, treatment, ocular syphilis]]\n",
      "[[Infectious agents, pathogenesis, vascular disease, complications, review, relevant, information, infections, vascular disease, pathophysiological, mechanisms, review, issue, infections, vascular disease, Medline, Scopus, ScienceDirect database, infectious agents, herpesviruses, parvovirus B19, hepatitis viruses, human immunodeficiency virus, acute respiratory syndrome, coronavirus 2, treponema pallidum, mycobacterium tuberculosis, pseudomonas aeruginosa, staphylococcus aureus, candida albicans, vascular disease, Infectious agents, vessel's, homeostasis, functionality, arterial, venous side, pathophysiological, mechanisms, dysregulation, vasomotor function, thromboembolic, complications, initiation, progression, atherosclerosis, alteration, perivascular, adipose tissue, inflammatory cells, molecules]]\n",
      "[[Malignant syphilis, MS, manifestation, secondary syphilis, immunocompromised, individuals, coinfected, human immunodeficiency virus, HIV, reports, MS, immunocompetent, individuals, characteristics, individuals, MS, associated risk factors, review, case reports, published, published case reports, cases, HIV-positive, individuals, CD4 counts, cases, HIV-negative, individuals, comorbidities, diabetes mellitus, alcoholism, drug abuse, psoriasis, hepatitis, frequent, manifestation, MS, ulceronodular cutaneous lesions, central adherent crust, affected, face, trunk, limbs, MS, immune status, dermatologists, general practitioners, early diagnosis, treatment, reducing, morbidity]]\n",
      "[[Congenital syphilis, placental, transmission, mother, fetus, Treponema pallidum, congenital syphilis, preventable, treatment, rate, infections, United States, US, increased, year, increasing, pace, California, CA, research, congenital syphilis, individual, psychosocial, behavioral factors, maternal, vulnerability, syphilis, study, evaluate, structural, prenatal care, access, utilization, congenital syphilis, prevention, Kern County, CA, Transcripts, interviews, prenatal care providers, focus group, discussions, pregnant, postpartum persons, thematic analysis, Structural barriers, pregnant, postpartum persons, prenatal care, access, utilization, burdens, poverty, stigma, substance use, pregnancy, citizenship, status, lack, healthcare, coverage, low, sexual health, gender, Structural barriers, prenatal care providers, congenital syphilis, guidance, clinical management, syphilis, pregnancy, decay, public health, infrastructure, inadequate, patients, social comorbidities, response, congenital syphilis, prevention, examination, complex, context, social determinants, health, persons, diagnosed, syphilis, live]]\n",
      "[[periodontitis, atherosclerosis, inflammatory, mechanisms, bacteria, associated with, periodontal lesions, influence, initiation, propagation, atherosclerotic, lesion, study, detect, presence, periodontal pathogens, atheromatous, plaques, patients, coronary artery disease, Subgingival, atherosclerotic, plaque, samples, patients, scheduled, CABG, angioplasty, nested PCR, detection, pathogens, plaque, samples, Porphyromonas gingivalis, Tanarella forsythia, Treponema denticola, detected, atherosclerotic, plaque, samples, patients, atherosclerotic plaques, tested, positive, pathogens, chronic periodontitis]]\n",
      "[[Porphyromonas gingivalis, pathogen, microbiota, associated with, periodontitis, study, association, salivary, counts, red-complex bacteria, clinical periodontal status, Japanese, population, subjects, general dental clinic, Japan, study, Stimulated, saliva, periodontal bacteria, measured, real-time polymerase chain reaction, Probing pocket depth, PPD, bleeding, probing, BOP, subject's, proximal, level, BCL, dental radiographs, measured, P. gingivalis, associated with, percentage, PPD, sites, BOP, positive, percentage, BCL, sites, detection, P. gingivalis, Treponema denticola, Tannerella forsythia, rate, positive, clinical, parameters, P. gingivalis, detected, group, P. gingivalis, rate, positive, clinical, parameters, red-complex bacteria, amount, P. gingivalis, association, severity, periodontal condition, co-occurrence, P. gingivalis, T. denticola, T. forsythia, heightened, progression, periodontitis]]\n",
      "[[Papillomatous digital dermatitis, PDD, polymicrobial infection, lameness, dairy cattle, Culture-independent analysis, Treponema phagedenis, lesions, pathogenesis, PDD, tissue penetration pathway, examined, study, investigated, T. phagedenis, strains, isolated, PDD, proteolytic, enzyme(s), disruption, epithelial cell barrier, translocate, polarized, human, NHEK, in vitro, strains, T. phagedenis, isolated, lesions, proteolytic activity, modified skim milk agar, human, strain, T. denticola, control, activity, integrity, tight junctions, measurement, transepithelial, TER, TER, values, inoculation, T. phagedenis, examined, experimental period, apical, basolateral, translocation, T. phagedenis, microscopy, Treponema-specific PCR, translocation, T. phagedenis, accelerated, co-inoculation, live, T. denticola, heat-killed organisms, tight junction ZO-1 protein, inoculation, T. phagedenis, organism, NHEK cells, florescence microscope, results, T. phagedenis, strains, translocate, transcellular route, in vitro, invasion, accelerated, bacteria, T. denticola, proteolytic activity]]\n",
      "[[Treponema denticola, Td, gram-negative anaerobic bacterium, occurrence, development, periodontal disease, proportion, mature, plaque, colonizer, subgingival, plaque, biofilm, Td, complex, interactions, concurrent, colonists, symbiotic, relationship, synergistic, antagonistic effects, regulation, quorum sensing molecules, Adhesin, coaggregation, surface molecules, interaction, interactions, gene expression, metabolism, virulence, metabolism, changes, up-, down-regulation, multiple, enzymes, amino acid metabolism, reviews, researches, interaction, Td, microorganisms, subgingival plaque]]\n",
      "[[BACKGROUND, Local, systemic IgG antibodies, oral bacteria, periodontitis, observations, impact, intrinsic factors, serum IgG, subclass antibodies, commensal, pathogenic, oral bacteria, variations, immune protection, disease susceptibility, periodontitis, Subjects, healthy, gingivitis, periodontitis, categorized, mild, moderate, severe, periodontitis, Demographic stratification, sex, age, race/ethnicity, smoking, obesity, Whole formalin-fixed bacteria, antigens, detect, serum, immunoglobulin (Ig)G subclass antibody, levels, ELISA, variations, IgG, subclasses, periodontitis, health, gingivitis, bacteria, oral pathogens, Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Treponema denticola, IgG1, IgG2, IgG4, increased, Pg, subclass levels, distribution, disease severity, individual, subclass responses, Pg, population, females, elevated, antibody, elevated, IgG2, amounts/proportions, older group, subjects, elevated, antibody, oral bacteria, lacking, subclass pattern, IgG2, antibody, Aa, Pg, increased, smokers, Multiple IgG, subclass antibody, levels, oral pathogens, decreased, obese, subset, population, investigation, patterns, IgG, subclass antibody, responses, oral bacteria, effects of, disease, level, subclass, distribution, antibody, array, oral bacteria, subclass antibody, profiles, IgG2, levels, antibody, P. gingivalis, sex, age, disease severity, race/ethnicity, smoking, obesity, pathogens, commensal bacteria]]\n",
      "[[Fixed, prosthodontic, periodontal tissues, vice, periodontium, influence, longevity, esthetic, appearance, dental restorations, investigation, bacterial, periodontal pathogens, periodontal, parameters, patients, dental fixed prosthesis, degrees, periodontal tissue loss, photoactivation therapy, PDT, adjunctive, scaling, root planing, study, subjects, scaling, root planing, SRP, subjects, sites, SRP, chlorhexidine, rinsing, subjects, sites, SRP, PDT, subjects, sites, Periodontal, parameters, plaque index, bleeding, probing, probing depth, clinical attachment loss, bacterial, periodontal pathogens, Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, patient, baseline, months, PDT, improvements, clinical, microbiological load, month, results, months, chlorhexidine, rinsing, SRP, severe, periodontitis, cases, Photoactivation therapy, adjunctive periodontal, therapeutic method, efficient, periodontal, improvements, clinical, microbiological, parameters, patients, fixed dental prosthesis, severe, periodontitis, cases]]\n",
      "[[Methionine sulfoxide reductase, Msr, family, enzymes, reduces, oxidized methionine, survival, bacteria, oxidative stress conditions, MsrA, MsrB, fusion protein form, MsrAB, pathogenic bacteria, Helicobacter pylori, Hp, Streptococcus pneumoniae, Treponema denticola, fused, enzyme, molecular level, crystal structure, HpMsrAB(C44S/C318S, linker region, Hpiloop, domains, interacted, HpMsrA, HpMsrB, domain, salt bridges, E193-K107, D197-R103, K200-D339), acetate molecules, active site pocket, sp(2) planar electron density map, crystal structure, conserved residues, fusion, MsrABs, pathogen, Biochemical, kinetic analyses, Hpiloop, increase, catalytic, efficiency, HpMsrAB, salt bridge mutants, D193A, E199A, entrance, tailgate, Hpiloop, linker region, MsrAB, structural stability, catalytic, efficiency, MsrAB, fused form]]\n",
      "[[Accumulation, amyloid-beta, Abeta, brain, central component, pathology, Alzheimer's disease, volume, evidence, associations, periodontal pathogens, Porphyromonas gingivalis, P. gingivalis, Treponema denticola, T. denticola, AD, effect, mechanisms, T. denticola, accumulation, Abeta, unclear, study, T. denticola, brain, nerve cells, intra-, extracellular, Abeta1, Abeta1, accumulation, hippocampus, C57BL/6 mice, activating, beta-secretase, gamma-secretase, inhibitor, beta-secretase, DAPT, inhibitor, secretase, inhibit, effect, T. denticola, Abeta, accumulation, N2a neuronal cells, T. denticola, increases, expression, Abeta1, Abeta1, regulation, beta-site amyloid precursor protein cleaving enzyme-1, presenilin 1]]\n",
      "[[OBJECTIVE, investigate, prevalence, endodontic pathogens, association, clinical features, apical periodontitis, study population, patients, Khartoum Dental teaching Hospital, Sudan, endodontic treatment, Samples, single-rooted teeth, carious, traumatised teeth, clinical, radiographic, evidence, apical periodontitis, endodontic pathogens, Porphyromonas endodontalis, Fusobacterium nucleatum, Treponema denticola, quantified, real time polymerase chain reaction, qPCR, prevalence, species, identified, low detection, threshold, bacteria, threshold, bacteria, patients, age, yrs, SD, analysis, bacterium, low, threshold, F. nucleatum, T. denticola, low, threshold, P. endodontalis, threshold, association with, symptoms, low, detection, threshold, threshold, P. endodontalis, associated with, swelling, odds ratio, OR, species, apical periodontitis, caries, low, detection, threshold, T. denticola, F. nucleatum, P. endodontalis, prevalence, F. nucleatum, T. denticola, P. endodontalis, apical periodontitis, associated with, caries, bacterial, associated with, pain, presence, P. endodontalis, levels, associated with, swelling]]\n",
      "[[study, evaluate, feasibility, diagnosing, periodontitis, identification, bacterial species, mouth-rinse samples, Patients, dental examinations, Department of Periodontology, Veterans Health Service Medical Center, healthy, periodontitis, groups, bacteria, bacteria, real-time polymerase chain reaction, mouth-rinse samples, groups, evaluated, logistic regression, sex, age, smoking history, prevalence, healthy, periodontitis, group, Aggregatibacter actinomycetemcomitans, Treponema denticola, Prevotella nigrescens, Levels, Treponema denticola, Prevotella nigrescens, Streptococcus mitis, associated with, severe, periodontitis, feasibility, periopathogenic bacteria, mouth-rinse samples, patients, periodontitis, periopathogenic bacteria, studies, assess, potential, oral-rinsing solutions, oral infection, risk, oral hygiene, complementary method, periodontal disease, diagnosis]]\n",
      "[[bacterial, synthetic biology, genome transplantation, mycoplasmas, small genome, competent, foreign, genome, uptake, study, Escherichia coli, strains, programmed, 1-megabase (Mb) chromosomes, 3-Mb chromosome, strain, split-chromosome, original, replication, oriC, partitioning, oriC, locus, F plasmid, ori, locus, Vibrio tubiashii, tripartite-genome cells, maintained, rod-shaped form, grew, parent, genetic engineering, proportion, 1-Mb chromosomes, purified, covalently closed supercoiled molecules, alkaline lysis, method, anion exchange columns, third chromosomes, electroporated, competent, cells, split-chromosome, chromosome, origin region, exchangeable, conjugation, tripartite-genome strains, selection, markers, E. coli-based technology, potential, synthetic biology, synthetic genomics]]\n",
      "[[AIMS, in silico, analysis, CRISPRcas loci, Tenacibaculum maritimum, evaluated, spoligotyping, subtyping method, genotyped, uncharacterized, Turkish, isolates, European, sea bass, MLST, Spoligotyping, primers, amplification, sequencing, CRISPR-arrays, T. maritimum, isolates, completed/draft genomes, NCBI database, analysed, MLST, Turkish, isolates, 7-gene, T. maritimum, genomes, complete, defective, CRISPRcas locus, amino acid substitutions, encoded, Cas9 proteins, spacer identification, host, bacteriophage, P2559Y, Vibrio phage nt-1, T. maritimum, recurrent infection, isolates, Tenacibaculum phage, PTm5, isolates, CRISPRcas locus, spoligotypes, sequence, MLST, MLST, T. maritimum, isolates, Turkey, sequence, ST3, ST40, ST41, isolates, Spain, Malta, France, evaluated, spoligotyping, discriminatory power, MLST, SIGNIFICANCE, IMPACT, Spoligotyping, potential, subtyping, T. maritimum, isolates]]\n",
      "[[polymeric immunoglobulin receptor, pIgR, transports, secretory, immunoglobulins, mucosal, epithelial cells, secretions, mucosal, surface, defenses, regulation, mechanism, pIgR, expression, teleost fish, study, dynamic, changes, flounder, Paralichthys olivaceus, pIgR, fpIgR, pro-inflammatory, cytokine, tumor necrosis factor-alpha, TNF-alpha, mRNA, expression, mucosal tissues, post, inactivated, Vibrio anguillarum, immunization, increased, production, TNF-alpha, increased, expression, fpIgR., cytokine, TNF-alpha, fpIgR, expression, natural, fpIgR, expressed, flounder gill, FG cells, incubated, concentrations, recombinant, TNF-alpha, time, results, expressions, fpIgR, upregulated, gene, protein levels, dose-dependent, free secretory component, SC, secreted, fpIgR, culture supernatant, FG cells, treated with, TNF-alpha, phosphoinositide 3-kinase, PI3K) inhibitor, wortmannin, nuclear factor kappa-B, inhibitor, Bay11, mixtures, TNF-alpha, wortmannin, Bay11, fpIgR protein, mRNA, SC, secretion, decreased, Bay11, 7082-treated, cells, compared, untreated control, cotreatment, wortmannin, Bay11, TNF-alpha, lower, expression, treatment, TNF-alpha, inhibition, PI3K, NF-kappaB, blocked, TNF-alpha, increase, cellular fpIgR, SC, levels, gene expressions, PI3K, NF-kappaB, upregulated, increase, decrease, TNF-alpha, treatment, FG cells, expression, PI3K, mRNA, inhibited, wortmannin, Bay11, expression, NF-kappaB, mRNA, suppressed, Bay11, wortmannin, inhibition, PI3K, NF-kappaB, influence, results, TNF-alpha, transcriptionally, upregulate, fpIgR, expression, SC, production, TNF-alpha-induced, pIgR, expression, complex, mechanisms, PI3K, NF-kappaB signaling pathways, pro-inflammatory, cytokine, TNF-alpha, regulator, pIgR, expression, regulation, mechanism, pIgR, expression, teleost fish]]\n",
      "[[Adrenocorticotropic hormone, ACTH, bioactive peptide, family, melanocortins, pro-opiomelanocortin, POMC, research, functions, ACTH, immune system, teleosts, DNA, cDNA, POMC, ayu, Plecoglossus altivelis, PaPOMC-A, PaPOMC-B., transcripts, tissues, expression, immune tissues, experimental infection, Vibrio anguillarum, PaACTH-A, suppressed, phagocytosis, monocytes/macrophages, MO/Mcapital EF, Cyrillic, isoforms, PaACTH, increased, bactericidal capacity, MO/Mcapital EF, Cyrillic, PaACTH-A, increased, anti-inflammatory, cytokine, expression, decreased, pro-inflammatory, cytokine, expression, MO/Mcapital EF, Cyrillic, PaACTH-B, treatment, PaACTH-A, treatment, improved, survival rate, reduced, bacterial, load, V. anguillarum-infected ayu, interleukin (IL)-10, results, PaACTH isoforms, effects, host defense, bacterial infection]]\n",
      "[[PURPOSE, Pinna nobilis, fan mussel, endemic, bivalve molluscs, Mediterranean, mass mortality events, mussels, years, study, mass mortalities, Haplosporidium, pinnae, spreading, Mediterranean, years, Canakkale Strait, entrance, Marmara, Black Sea, Field observations, sampling, histopathological, biochemical, genetic, microbiological analyses, analyses, H. pinnae infection, spread, natural beds, P. nobilis, severe, tissue damage, oxidative stress, phylogenetic analyses, parasite, spread, Mediterranean, results, vibriosis, Vibrio coralliilyticus, Vibrio tubiashii, Vibrio mediterranei, Vibrio hispanicus, H. pinnae, infected, individuals, death, spread, H. pinnae, Sea, Marmara, Black Sea, mass deaths, co-infection, H. pinnae, geographically, marine pathogen, infect, P. nobilis, populations]]\n",
      "[[Burns, trauma, Burns, problem, morbidity, mortality, Burn, wound infection, complication, increasing, fatality rate, burn, patients, study, case, polymicrobial burn, wound infection, V mimicus, male, transferred, hospital, inpatient, burn unit, traumatic, burn injuries, firework explosion accident, patient, surgical treatment, antibiotics, improvement, rare, case study, V mimicus, human, pathogen]]\n",
      "[[quorum-sensing (QS) system, phages, hosts, phage, lysis-lysogeny decision, Vibrio cholerae, QS system, LuxR-type receptor VqmA, VqmAVc, autoinducer molecule 3,5-dimethylpyrazin-2-ol (DPO, VqmA, homolog, encoded, vibriophage VP882, VqmAPhage, host, QS system, binding, host-produced, DPO, cognate promoter, Pqtip, induce, phage, lysogeny-to-lysis transition, VqmAVc, influence, VqmAPhage-induced pathway, asymmetry regulation, study, crystal structure, VqmAPhage-DPO complex, mechanism, DPO recognition, VqmA, homologs, non-classical palindrome sequence, Pqtip, VqmAPhage, VqmAVc, sequence, interval, vqmR, promoter, VqmAVc, DBD regions, VqmAPhage dimer, architecture, VqmAVc, conformation, bind, target, promoter, longer interval, findings, structural, biochemical, DBD-dependent, DNA recognition, promoter regions, phage, lysogeny-to-lysis, phage, Vibrio cholerae infection]]\n",
      "[[Type VI secretion system, T6SS, Gram-negative, bacterial, species, inter-bacterial competition, years, effectors, T6SS, identified, bacterial species, involvement, inter-bacterial interactions, defence mechanisms, T6SS, attack, prey bacteria, Escherichia coli, assessed, susceptibility, T6SS-mediated killing, Vibrio cholerae, TheT6SS-mediated, bacterial, absence, presence, protease inhibitors, mutant, E. coli, strains, Expression levels, proteins, monitored, SDS-PAGE, immunoblot analyses, T6SS-mediated killing, E. coli, V. cholerae, blocked, serine protease inhibitor, Pefabloc, E. coli, lacking, periplasmic protease inhibitor, Ecotin, susceptibility, killing, V. cholerae, Mutations, affecting, E. coli, stability, increased, susceptibility, killing, V. cholerae, E. coli, lacking, maltodextrin porin protein, LamB, reduced, susceptibility, killing, V. cholerae, E. coli, induced, levels, LamB, reduced, survival, inter-bacterial competition, study, proteins, E. coli, intrinsic protease inhibitor, Ecotin, outer membrane, LamB, influenced, E. coli, susceptibility, T6SS-mediated killing, V. cholerae, findings, target, modulate, expression, changes, inter-bacterial competition, in vivo, gastrointestinal microbiome]]\n",
      "[[Vibrio cholerae, severe, diarrheal disease, cholera, Clinical disease, oral, cholera, vaccines, antibody, responses, associated with, protection, Immunity, lipopolysaccharide, (LPS)-specific antibodies, targeting, O-antigen, properties, protective mechanism, relevant, antibodies, early, B cell, cholera, cohort, Bangladeshi, patients, characterized, human, MAbs, isolated, induced, plasmablasts, antibodies, study, expressed, IgG1, backbone, isotype, impact, affinity, immunoglobulin isotype, subclass, functional, properties, MAbs, low-, high-affinity antibodies, isotype, subclass immunoglobulin backbones, characterized, impact, changes, binding, vibriocidal, agglutination, motility, inhibition, activity, high-affinity antibodies, O-antigen, isotype, low-affinity antibodies, avidity, differences, binding, properties, variants, low-affinity, MAbs, agglutination, motility, inhibition, properties, potently, binding antibodies, MAb, binds, O-antigen, function, pentameric IgM, dimeric, IgA, monomeric IgA, IgG, counterparts, inhibiting, motility, F(ab, versions, antibodies, LPS, cross-linking, motility, inhibition, Immunity, severe, diarrheal disease, cholera, lipopolysaccharide, (LPS)-specific antibodies, properties, protective mechanisms, relevant, antibodies, engineered, low, high-affinity, LPS-specific antibodies, immunoglobulin backbones, assess, impact, affinity, immunoglobulin isotype, subclass, binding, vibriocidal, agglutination, motility, inhibition, functional, properties, affinity, functional, potency, variants, low-affinity, MAbs, agglutination, motility, inhibition, properties, potently, binding antibodies, antibody, binds, sterically, function, pentameric IgM, dimeric, IgA, monomeric IgA, IgG, counterparts, inhibiting, motility, F(ab, versions, antibodies, LPS, cross-linking, motility, inhibition]]\n",
      "[[ICP2, virulent bacteriophage, phage, preys, Vibrio cholerae, ICP2, isolated, cholera, patient, stool samples, stools, ICP2-resistant, isogenic, V. cholerae, strains, missense mutations, trimeric, OmpU, ICP2 receptor, study, ICP2, proteins, interactions, OmpU, ICP2, host-range mutants, infant, rabbits, infected, wild type, OmpU, mutant, strains, ICP2, host-range mutants, infect, OmpU, mutant, strains, missense mutations, putative tail fiber gene, gp25, putative adhesin gp23, site-specific mutagenesis, double mutations, gp25, host-range mutant, phenotype, mutation, gp23, robust, plaque, formation, OmpU, mutants, Mutations, gp23, insufficient, host-range mutant, phenotype, ICP2, host-range mutants, plaque, wild type, V. cholerae cells, strength, binding, host-range mutants, V. cholerae, correlated, plaque, morphology, mutations, gp25, gp23, molecular interactions, receptor, ICP2, host-range mutants, two-step process, gp25 mutations, host-range, level, phage, adsorption, selection, gp23 mutations, increase, productive, OmpU, alleles, near, wild type, efficiencies, adsorption, phage, multiplication, ImportanceConcern, multidrug-resistant, bacterial, pathogens, Vibrio cholerae, phage, biology, potential, phage therapy, ICP2, genetically, virulent, phage, isolated, cholera, patient, stool samples, phages, prophylactic cocktail, effective, animal models, infection, protein receptor, OmpU, study, ICP2, tail, fiber, receptor binding protein, ICP2, phage-resistant, OmpU, mutants, co-evolutionary arms, race, fitness, costs, ICP2, V. cholerae]]\n",
      "[[Oral, cholera, vaccination, cholera, responses, young children, low, short duration, correlates, protection, cholera, target, Vibrio cholerae, O-specific polysaccharide, anti-OSP, vibriocidal responses, cholera, conjugate vaccine, induces, anti-OSP, immune responses, memory B-cell, responses, cholera, conjugate vaccine, boost, immune responses, oral, cholera, vaccination, immunized, mice, oral, cholera, vaccine, Inaba, CVD 103-HgR, buffer, placebo, day, parenteral, immunizations, days, cholera, conjugate vaccine, OSP, recombinant tetanus, PBS/placebo, responses, mice, immunized, oral vaccine, intramuscular, cholera, conjugate vaccine, mice, combination, vaccination, vibriocidal, IgM, OSP-specific serum, OSP-specific IgM memory B-cell, responses, vaccination, oral, cholera, vaccination, parenteral, cholera, conjugate vaccine, boosting, results, increased, immune responses, associated with, protection, cholera, results, evaluated, humans]]\n",
      "[[Vibrio parahaemolyticus, foodborne, pathogen, biofilm formation, colonization, persistence, foods, stresses, environmental variation, antibiotic, exposure, proteins, biofilm formation, identity, function, study, hypothetical protein, VP0610, negatively, regulates, biofilm formation, Vibrio parahaemolyticus, loss, vp0610, pleiotropic, phenotypes, promoting, biofilm formation, increased, insoluble, exopolysaccharide, production, swimming motility, decreased, soluble, exopolysaccharide, production, decreased, bis-(3'-5')-cyclic, production, Pull-down assays, VP0610, interact, proteins, Hfq, VP0710, VP0793, CyaA, participate, biofilm formation, deleting, vp0610, enhanced, expression, genes, biofilm component, flaE, sugar phosphotransferase system, PTS, vp0710, vp0793, high-density regulator, quorum sensing, opaR, reducing, expression, bis-(3'-5')-cyclic dimeric guanosine monophosphate degradation protein, CdgC, biofilm formation, results, vp0610, integral member, biofilm, V. parahaemolyticus, functions, repressor, biofilm formation]]\n",
      "[[study, evaluated, occurrence, distribution, pathogenic, V. parahaemolyticus, oyster, culture, environments, Taiwan, V. parahaemolyticus, oysters, seawater, sediment, quantified, MPN, method, combined, qualitative polymerase chain reaction, PCR, V. parahaemolyticus, presence, absence, tlh gene, pathogenic, V. parahaemolyticus, detection, tdh, trh gene, results, V. parahaemolyticus, detected, samples, concentrations, V. parahaemolyticus, oysters, seawater, sediment, MPN/g, MPN/g, variations, abundance, V. parahaemolyticus, associated with, sea, SST, Findings, study, improve, accuracy, risk assessment model, V. parahaemolyticus, oysters, Taiwan]]\n",
      "[[Vibrio parahaemolyticus, type III secretion system 1, T3SS1, virulence factor, effectors, host, eukaryotic cytoplasm, studies, infection, mechanism, limited, function, vscF, gene, vscF, deletion mutant, DeltavscF, complementation strain, CDeltavscF., Compared, wild-type POR-1, CDeltavscF, cytotoxic, adherent, apoptotic, abilities, DeltavscF, HeLa cells, infected, HeLa cells, mutant strain, reduced, translocation, rates, VP1683, VP1686, effectors, wild-type, complementation strains, BLAST, search, vscF, homologous, MixH needle protein, Shigella flexneri, vscF, gene, encodes, needle protein, T3SS1, V. parahaemolyticus, translocation assays, translocated, HeLa, eukaryotic cytoplasm, T3SS1, secretion assays, VPA0226, secreted, supernatant, T3SS1, T3SS1 effectors, data, vscF, V. parahaemolyticus T3SS1, VPA0226, secreted, host, T3SS1, study, T3SS1, infection, mechanism]]\n",
      "[[study, detection, Vibrio parahaemolyticus, oysters, tryptic soy agar, TSA, supplemented, NaCl, oxgall, sodium citrate, pH, Vibrio spp, indicators, food-borne, isolates, streaked, modified media, incubation, degrees, indicators, isolates, grow, TSA, NaCl, oxgall, sodium citrate, TSAOSS1, pH, V. parahaemolyticus, culturable, TSAOSS1, quantify, V. parahaemolyticus, oysters, thiosulphate citrate bile salts sucrose, V. parahaemolyticus, white-yellowish, round, edge-pointed colony, TSAOSS1, TSAOSS1, TCBS, alternative, detection, V. parahaemolyticus, seafoods, natural reservoirs, online version]]\n",
      "[[Programmed cell death, PCD, essential process, immune system's, development, homeostasis, remotion, infected, unnecessary cells, PCD's, molecular mechanisms, non-inflammatory, pro-inflammatory, Hemocytes, cellular immunity, bivalve mollusks, infectious microorganisms, toxins, impair, hemocytes, functions, knowledge, PCD, cells, study, evaluate, in vitro, marine toxins, induce, PCD, hemocytes, bivalve mollusk, Crassostrea gigas, degrees, C. Hemocytes, incubated, marine toxins, non-proteinaceous, toxins, microalgae, saxitoxin, STX, gonyautoxins 2, GTX2/3, okadaic, acid/dynophysistoxin-1, OA/DTX-1, brevetoxins 2, PbTx-2,-3, brevetoxin 2, PbTx-2, proteinaceous extracts, bacteria, Vibrio parahaemolyticus, Vp, V. campbellii, Vc, apoptosis, inducers, staurosporine, STP, camptothecin, CPT, STP, CPT, STX, GTX, hemocyte, mortality, characterized, apoptosis, hallmarks, phosphatidylserine, translocation, outer leaflet, cell membrane, exacerbated, chromatin condensation, DNA oligonucleosomal fragments, variation, gene expression, levels, apoptotic caspases 2, PbTx-2,-3, apoptosis, features, apoptotic, DNA oligonucleosomal fragments, PbTx-2, OA/DTX-1, proteinaceous extracts, bacteria, Vp, Vc, induced, degree, cell death, gene expression, pro-inflammatory initiator, caspase-1, process, pyroptosis-like PCD, Hemocytes, PCD, simultaneously, marine toxins, PCD's, signaling pathways, C. gigas, hemocytes, toxin's, nature, structurally, functionally]]\n",
      "[[Vibrio parahaemolyticus cells transit, free, swimming, surface, lifestyles, swarming, colonies, three-dimensional, biofilms, transitions, sensory modules, regulatory networks, messenger cyclic, c-di-GMP, uncharacterized, c-di-GMP phosphodiesterase, VP1881, V. parahaemolyticus, modulating, c-di-GMP, pool, product, VP1881, promotes, expression, levels, c-di-GMP, low, phosphodiesterase, catalytically inactive, behavior, c-di-GMP receptors, Trigger, phosphodiesterases, product, VP1881, TpdA, Trigger phosphodiesterase A., absence, tpdA, negative, effect, swimming motility, overexpression, IPTG, inducible, promoter, positive, effect, swimming, swarming motility, negative, effect, biofilm formation, Changes, TpdA, abundance, expression, polar, lateral flagellar genes, biofilm, gene, results, autoactivation, native, promoter, c-di-GMP, responses, swarming, biofilm formation, V. parahaemolyticus, observation, dynamics, social behaviors, phosphodiesterases, PDEs, controlling, heterogeneity, biofilm-matrix composition, characteristics, relevant, integrity, functionality, biofilms, natural environments, Trigger, PDEs, sequence, signaling proteins, literature, identification, PDE, V. parahaemolyticus, evidence, autoactivation, progression, swarming motility, biofilm formation, multicellular behaviors, survival, dissemination, environmental pathogen]]\n",
      "[[Acute hepatopancreatic necrosis disease, AHPND, shrimp, bacterial disease, Vibrio species, severity, impact, disease, aquaculture, worldwide, prophylactic, application, probiotics, potential, probiotics, detrimental, AHNPD, evaluated, effect, ILI, strain, Vibrio sp. bacterium, efficient, shrimp, probiotic, metabarcoding, 16S rRNA gene, gastrointestinal microbiota, shrimp, AHPND-causing V. parahaemolyticus, gastrointestinal microbiome, shrimp, healthy, infected, organisms, working, AHPND-causing Vibrio pathogens, Vibrio-related bacteria, probiotics, potential, risk, probiotic, strain, pathogenic, evaluated, ILI, strain, plasmid, pV-AHPND, horizontal transfer, disease, shrimp, Conjugation assays, frequency, colonies, pv-AHPND, shrimp, mortality, transconjugant, colonies, ILI, strain, healthy shrimp, sequenced, genome, ILI, strain, AHPND, Vibrio isolates, phylogenetic, phylogenomics analyses, ILI, strain, Vibrio diabolicus, study, probiotics, normal, gastrointestinal shrimp, microbiome, AHPND-infected shrimp, ILI, probiotic, pathogenic, bacterial populations, host's, gastrointestinal tract, stimulate, shrimp's, survival, identification, probiotic, bacterial, species, effective, host's, colonization, promote, animal, health, prevent, disease, study, probiotic bacteria, controlling, pathogenic, bacteria, shrimp gastrointestinal tract, complex, dynamics, shrimp, changes, microbiota, application, probiotics, problems, pathogens, mortality-rate, shrimp farming, world, Abstract]]\n",
      "[[Vibrio parahaemolyticus, marine, estuarine, environments, isolated, aquatic products, food-borne, pathogens, typing methods, serotyping, infectious disease specialists, infection control agencies, detection, epidemiological, investigation, pathogen, serotypes, K, serotypes, untypeable strains, isolated, routine, detection, O, K antigens, identified, characterized, serotyping survey, Shandong province, China, clinical, V. parahaemolyticus strains, untypeable K antigen, strains, study, K, serotypes, V. parahaemolyticus, genetic analysis, K antigen gene cluster, serological tests, production, antisera, strains, K untypeable 2, antigens, group, O, K combinations, O3:KUT2, O11:KUT2, characterized, K serotype, genomic analysis, Shandong KUT2, strains, virulence profiles, identical, K serotype, partners, Zhejiang province, Chinese coastal province, strains, regions, clustered, linage, ancestor, isolate, SD2016062, phylogenetically, strains, associated with, local, gastroenteritis, outbreaks, toxin, patterns, potential, sporadic, disease, local pandemics, sero-specific PCR assay, targeting, K, serotypes, V. parahaemolyticus spectrum, clinical, epidemiological purposes, identified, characterized, strains, V. parahaemolyticus, technique, tracking, diversity, strains, food-borne pathogen]]\n",
      "[[Pathogens, sub-lethal, acidic, increase, virulence, survival ability, lethal, conditions, aquaculture, industry, feed acidifiers, increase, growth, aquatic animals, study, effects of, acidic condition, virulence, survival, pathogens, aquaculture, study, investigated, survival, Vibrio parahaemolyticus, lethal, pH, bacteria, sub-lethal, pH, results, strain, increased, survival, lethal, pH, inorganic, HCl, organic, RNA-sequencing, RNA-seq, results, genes, expressed, sub-lethal, pH, cadC, cadBA, acid tolerance response, ATR, genes, outer membrane, heat-shock proteins, phosphotransferase system, flagella system, Quantitative real-time polymerase chain reaction, qRT-PCR, cadC, cadBA, upregulated, sub-lethal, acidic, CadC protein, regulate, expression, cadBA, modulate, ATR, V. parahaemolyticus, RNA-seq, data, genes, CadC-dependent way, genes, CadC-independent way, expressed, regulation, ATR, motility, cytotoxicity, sub-lethal, wild type, WT, increased, compared, unadapted, strain, results, dietary acidifiers, increase, virulence, survival, V. parahaemolyticus, aquaculture]]\n",
      "[[Failure, cell, regulate, number, intracellular, positioning, flagella, detrimental effects, cells, swimming, ability, flagellation, pattern, numerous, bacteria, NTPases, FlhF, FlhG., FlhG controls, flagella, FlhF, coordinates, position, flagella, human, pathogen, Vibrio parahaemolyticus, positioned, old cell pole, spatiotemporal, localization, FlhF, FlhG, V. parahaemolyticus, effect, swimming motility, Absence, FlhF, FlhG, defect, swimming, ability, absence, flagella, DeltaflhF mutant, aberrant, flagellated, phenotype, DeltaflhG., proteins, localized, cell pole, cell cycle-dependent, patterns, localization, cell cycle, FlhF, localization, polarly flagellated bacteria, Localization, FlhG, dependent, cell pole-determinant, HubP, polar localization, FlhF, HubP, independent, localization, FlhF, FlhG, interdependent, intracellular, localization, recruitment, cell pole, absence, HubP, FlhF, FlhG, non-polar foci, cytoplasm, cell, secondary, cell, recruitment, cell poles]]\n",
      "[[Vibrio vulnificus, motile, gram-negative, halophilic, aquatic bacterium, estuarine, microbiome, warm coastal waters, Infection, pathogen, consumption, contaminated, seafood, exposure to, contaminated, seawater, Vibrio vulnificus, mortality rate, United States, seafood-related deaths, United States, Vibrio vulnificus, diseases, gastroenteritis, cellulitis, necrotizing fasciitis, sepsis, Gastroenteritis, self-limited, septicemia, fatal, Gastroenteritis, septicemia, ingestion, contaminated shellfish, wound infections, necrotizing fasciitis, exposure to, contaminated, seawater, handling, contaminated, seafood, Septicemia, presentation, V vulnificus, fatalities, bacteria, Prompt, diagnosis, treatment, prevent, mortality, V vulnificus, differential, patient, bullae, cellulitis, history, raw, seafood, consumption, exposure to, brackish water, diagnosis, necrotizing fasciitis, sepsis, death]]\n",
      "[[Vibrio vulnificus, foodborne, pathogenic bacterium, contaminates, seafood, Rapid, accurate, technologies, on-site, detection, effective, control, spreading, Conventional detection methods, polymerase chain reaction, (PCR)-based, qPCR-based approaches, limitations, on-site, scenarios, loop-mediated isothermal amplification, technology, on-site, detection, study, recombinase polymerase amplification, detection method, V. vulnificus, lateral flow strip, LFS, visualized signal, method, targeted, empV gene, encoding, extracellular metalloproteinase, detection, low, temperature, C. It, specificity, excellent, sensitivity, copies, genome, colony forming unit, CFU, reaction, spiked food samples, enrichment, method, tolerated, unpurified, templates, sample boiling, convenience, procedure, RPA-LFS, method, clinical samples, accurate, detection, results, bioassay, quantitative PCR, RPA-LFS, combined method, on-site, detection, V. vulnificus]]\n",
      "[[Dysbiosis, coral, microbiomes, results, biotic, environmental, interactions, reef fishes, vectors, opportunistic microbes, deposition, fecal material, elevated, sea, effects, coral, microbiomes, growth, virulence, opportunists, pathogens, host, immunity, health, interactions, biotic, abiotic factors, evaluated, factorial experiment, investigate, effects, fecal pellet, deposition, surgeonfish, Ctenochaetus striatus, elevated, sea, microbiomes, associated with, reef-building coral, Porites lobata, results, temperature, exposure of, P. lobata, C. striatus, feces, increased, alpha, diversity, dispersion, shift, microbial, community, composition, microbial, dysbiosis, elevated, temperature, changes, alpha, beta diversity, increasing, abundant, taxa, corals, feces, thermal stress, experiment, opportunistic, microbial, lineages, taxa, potential, coral, pathogens, Vibrio vulnificus, Photobacterium rosenbergii, taxa, absent, controls, surgeonfish, feces, temperature, regimes, mechanisms, microbial, transmission, enrichment, fish, feces, corals, impact, coral, microbiomes, fish, feces, higher, temperatures, inhibit, wound healing, corals, tissue, recovery, site, feces, deposition, degrees, compared, degrees, tissue, recovery, associated with, abundance, bacterial lineages, surgeonfish, feces, Rhodobacteraceae, Bdellovibrionaceae, Crocinitomicaceae, findings, fish, feces, interact, elevated, sea, surface, temperatures, microbial, opportunism, enhance, dysbiosis, susceptibility, P. lobata, frequency, duration, thermal stress, events, increase, coral, microbiomes, biotic stressors, deposition, fish, feces, affected, coral, health, resilience]]\n",
      "[[Biofilm formation, Vibrio vulnificus, adherence, flagellated cells, surfaces, flagellum-driven motility, biofilm maturation, matured, biofilms, cells, flagellated, swim, biofilms, consequence, regulations, flagellar components, expression, biofilm, life-cycle, study, flagellins', production, biofilm stage-specific, activities, protease, DegQ, chaperone FlaJ., flagellin subunits, V. vulnificus filament, FlaC, affinities, hook-associated proteins, maturating, flagellum, susceptibility, DegQ, presence, methionine residues, DegQ-sensitive domains, ND1, CD0, differential regulation, DegQ, FlaJ controls, cytoplasmic stability, flagellins, motility-dependent, stage-specific development, biofilms]]\n",
      "[[Vibrio species, water environments, water, outbreaks, risk, human, animal, health, worldwide, presumptive, isolates, recovered, rivers, Southwest, Nigeria, Vibrio species, genus, polymerase chain reaction techniques, antibiotic susceptibility testing, antibiotics, prevalence, Vibrio species, V. parahaemolyticus, V. vulnificus, V. mimicus, V. harveyi, V. cholerae, Antibiotic resistance, Vibrio species, doxycycline, erythromycin, tetracycline, rifampicin, sulfamethoxazole, susceptibility, meropenem, cephalothin, norfloxacin, ciprofloxacin, amikacin, gentamicin, trimethoprim/sulfamethoxazole, species, Vibrio mimicus, expressed, resistance, streptomycin, chloramphenicol, V. vulnificus, V. cholerae, resistance, cephalothin, resistance, ampicillin, amoxicillin, V. cholerae, V. mimicus, Indexes, multiple, antibiotic resistances, MARI, Vibrio species, highest, MAR, isolate, V. vulnificus, study, prevalence, Vibrio species, rivers, elevated, resistance, first-line, antibiotics, antimicrobial, usage, study, communities, freshwater, resources, investigated, domestic, industrial, recreational, treatment, reservoirs, antibiotic-resistant, Vibrio species, environment]]\n",
      "[[Antimicrobial, multidrug-resistant bacteria, problem, worldwide, surveillance, antibiotic-resistant bacteria, assessment, dissemination, routes, essential, migratory, birds, environments, Vibrio strains, sedentary species, increased, risk, contacts, environment, habitats, transit, nest, strains, migratory, birds, multidrug resistance, oral, rectal swabs, wild birds, locations, Danube Delta, Malic, Sfantu-Gheorghe, Letea Forest, processed, standardized selective media, V. cholerae, strains, serology, molecular methods, susceptibility, evaluated, prevalence, Vibrio species, host species, habitat, location, interpreted, isolated, Vibrio species, Vibrio cholerae, V. fluvialis, V. alginolyticus, V. mimicus, V. vulnificus, V. parahaemolyticus, V. metschnikovii, prevalent, Vibrio spp, isolates, resistant, antimicrobials, multidrug resistance, phenotype, penicillins, aminoglycosides, macrolides, results, study, Vibrio strains, migratory, sedentary, birds, hypothesis, increased, pathogenicity, Vibrio spp., strains, isolated, wild migratory, sedentary, birds, increased, multiple, antibiotic resistance]]\n",
      "[[Vibrio vulnificus, V. vulnificus, Gram-negative bacterium, living, warm, salty water, marine bacterium, hemolysin, VVH, gastroenteritis, septicemia, people, contact, seawater, seafood, V. vulnificus, Timely, diagnosis, disease surveillance, quick, sensitive, method, detection, Vibrio vulnificus, real time recombinase polymerase amplification, real time RPA, primers, exo probe, vvhA gene sequence, GenBank, Target, DNA, amplified, labeled, fluorophore, degrees, method, specificity, Vibrio vulnificus, cross-reaction, bacteria, sensitivity, method, reaction, DNA, copies, standard plasmid, detection, LOD, target, level, detected, time, estimated, copies, probit, results, replicates, concentration, quantitative analysis, real time RPA, polynomial regression, study, results, correlation coefficients, model, quantitative analysis, real time RPA, routine, linear regression model, contaminated, plasma, Vibrio vulnificus, detected, real time RPA, concentration, CFU per reaction, real time RPA method, study, potential, detecting, Vibrio vulnificus, research laboratory, disease diagnosis]]\n",
      "[[distribution, qnr genes, plasmids, presence, chromosomes, aquatic bacteria, Vibrio vulnificus, suspected, sources, origin, development, synthetic quinolones, native, function, expression, qnrVv, V. vulnificus, induced, cold shock, investigate, qnrVv, cspA, gene, cold shock protein, double mutant, qnrVv, cspA, V. vulnificus ATCC 17562 to, evaluate, response, environmental conditions, stresses, exposure to, DNA, qnrVv, resistance, ciprofloxacin, levofloxacin, mitomycin C, cold shock response, V. vulnificus, DeltaqnrVv, DeltacspA, mutants, growth, treated with, bile salts, degrees, degrees C, cold shock, bile salts, media, effect, higher, double mutant, transition, V. vulnificus, ingested, gastrointestinal tract, released, natural environment, Cold shock, bile salts, induced, expression, cspA, DNA gyrase, topoisomerase IV genes, induction, DeltaqnrVv mutant, qnrVv gene, response, DNA damage, nucleic acid, secondary structure]]\n",
      "[[Vibrio vulnificus, opportunistic pathogen, food-borne illnesses, ingestion, contaminated, seafood, strain, V. vulnificus FORC_016, isolated, patient's, blood sample, South Korea, genome, circular DNA chromosomes, chromosome I, G + C, contents, ORFs, tRNA genes, rRNA genes, chromosome II, GC, content, ORFs, tRNA genes, rRNA genes, chromosome I, super integron, SI, ORFs, associated with, functions, antibiotic resistance, pathogenicity, Pan-genome analysis, V. vulnificus, core genome, virulence factors, accessory genome regions, SI region, genes, cell wall, biosynthesis, generation, host cell, capsule, resistance, environmental stresses, RNA-Seq analysis, samples, contact, crab, conditions, expressions, amino acid/peptide, carbohydrate transport, utilization, down-regulated, expressions, cell division, growth-related genes, up-regulated, crab, nutrition reservoir, propagation, V. vulnificus, consumption, contaminated, V. vulnificus, humans, biocontrol, V. vulnificus, safety, seafood, consumption]]\n",
      "[[dengue fever, DF, healthcare systems, societies, public health officials, resources, budgets, optimization, CO, limitations, conventional, health economic analyses, optimal, allocation, resources, interventions, constraints, dynamic transmission, dengue, cases, Thailand, steady state, CO, optimal, combination, interventions, release, Wolbachia-infected mosquitoes, paediatric, vaccination, constraints, budget, cost, estimates, current, dengue, cases, disability-adjusted life years, DALYs, lost, Epidemiological, cost, effectiveness, data, national data, research literature, horizon, years, Scenario analyses, disease management, intervention, costs, budget, constraints, vaccine, efficacy, optimization time, budget, constraints, optimal, coverage, interventions, dengue, incidence, Wolbachia, paediatric, vaccination, coverages, Wolbachia, paediatric, vaccination, upper bound, Wolbachia, paediatric, vaccination, budget, ceilings, Scenario analyses, situations, costs, Wolbachia, paediatric, vaccination, increases, costs, interventions, correlation, coverage, decreases, control strategies, examination, investment, dengue, control, identification, optimal, interventions, implement, public, outcomes, fixed, budget, constraints, CO, model, dengue, cases, DALYs, lost, constraints, estimated, budgets, vector control, absence, vaccination, Wolbachia, model, estimates, optimal, coverage, dengue, dengue, burden, lowest, budget]]\n",
      "[[dengue, transmission, model, SIR(S)-SI type, sex-structured, mosquito, populations, wild mosquitoes, males, females, Wolbachia-free, infected, wMel, wMelPop strain, Wolbachia, epidemiological model, outcomes, Wolbachia, dengue, outcome, Wolbachia, dengue, dynamic, optimization, design, optimal, programs, Wolbachia-carrying male, female mosquitoes, discussion, drawbacks, Wolbachia strains, wMelPop, wMel, dengue, prevention, control, wMel, strain, population replacement, Wolbachia, persistence, wild mosquito, requiters, releases, wMelPop strain, results, dengue infections, human, population]]\n",
      "[[mosquitoes, interaction, gut microbiota, immune system, pathogens, insects, transmit, humans, animals, development, control strategies, reducing, burden, severe, diseases, malaria, dengue, fever, microorganisms, mosquito microbiota, investigated, traits, biology, host, insect, survival, development, reproduction, microorganisms, modulate, immune response, mosquito, females, vector, competence, review, current, knowledge, field, complex, interaction, intestinal microbiota, mosquito females, defenses, gut, humoral level, knowledge, issues, development, novel, targeted strategies, control, mosquito-borne diseases, paratransgenesis, relationship, Wolbachia, mosquito, hosts, knowledge, microbiota-immune system, insect, vectors]]\n",
      "[[Wolbachia, maternally inherited, obligate, endosymbiont, induce, spectrum, effects, host, mutualism, reproductive parasitism, genomic level, recombination, strains, transposable elements, horizontal, strains, host, species, Wolbachia, invasive cherry fruit fly, Rhagoletis cingulata, Europe, North America, years, native, cherry, pest, R. cerasi, distribution, horizontal, Wolbachia strains, species, transmission, dynamics, comparative genome study, strain, native, United States, invasive, European populations, R. cingulata, wCer2, European, R. cerasi, multilocus sequence genotyping, MLST, genes, source, wCer2, R. cerasi, wCin2, R. cingulata, genomic, horizontal transfer, hypothesis, origin, wCer2, MLST, markers, substantial sequence, loci, wCer2, wCin2, structural rearrangements, differences, prophage, repetitive element, gene content, cytoplasmic, genes, study, whole-genome sequencing, MLST, markers, Wolbachia strains, evolutionary, dynamics]]\n",
      "[[Wolbachia, intracellular, endosymbionts, arthropods, interactions, Wolbachia, arthropods, fruit fly, Drosophila, melanogaster, model, insect, Wolbachia-host interactions, native, wMel, strain, D. melanogaster, isolated, titres, wMel, antibiotics-treated, fruit, flies, interactions, injected, wMel, density, gradient, recipient, host, trans-generational transmission, results, trans-generational, transmission, rates, wMel, titres, wMel, fluctuating, generations, titres, wMel, fluctuating, trans-generational, positive, correlation, transmission, rate, titre, wMel, Reciprocal, crossings, wMel-transinfected, uninfected, wMel, induce, cytoplasmic incompatibility, CI, titres, intensity, CI, correlated, titre, wMel, Quantitative PCR analysis, immune genes, Drsl5, Spn38F, transcriptional response, wMel, transfection, negative, correlation, titre, wMel, generations, RNA, interference-mediated, knockdown, Drsl5, Spn38F, drastic, increase, titre, wMel, combination, study, trans-generational transmission, wMel, modulated, density, immune genes, regulation, Wolbachia density]]\n",
      "[[Wolbachia infection, host, reproduction, development, mechanism, effects, Wolbachia, host, development, developmental duration, body weight, instars, Wolbachia-positive, Wolbachia-negative, spiders, Hylyphantes graminicola, detected, expression, levels, insulin-related genes, ecdysone-related genes, reverse transcription qPCR, RT-qPCR, Results, developmental duration, W(+), compared, W(-) spiders, W(+) spiders, W(-) spiders, instars, no significant, body weight, maturity, expression, levels, insulin-like growth factor-2 mRNA-binding protein-1, insulin-degrading enzyme, ecdysone-inducible protein-1 genes, down-regulated, W(+), compared, W(-) spiders, expression, levels, insulin-like growth factor-binding protein-1, insulin-like peptide receptor, insulin receptor, insulin-like, ecdysone-induced protein-2, ecdysone receptor genes, up-regulated, W(+) spiders, results, Wolbachia, influence, host, development, affecting, insulin, ecdysone signaling pathways]]\n",
      "[[Reduced, activity, insulin/IGF, signalling, network, increases, health, ageing, multiple, species, Diverse, tissue-specific, mechanisms, health improvement, tissue-specific transcriptional, proteomic profiling, long-lived, Drosophila, dilp2, mutants, tissue-specific regulation, transcripts, proteins, expression, changes, post-transcriptionally, fat body, mutants, infected, endosymbiotic bacteria, Wolbachia pipientis, increases, lifespan, Bioinformatic analysis, co-translational ER, targeting, secreted, membrane-associated proteins, increased, DNA damage/repair response proteins, age-related DNA damage, genome instability, fat body, mutant, overexpression, minichromosome, protein subunit, lifespan, Proteins, carbohydrate metabolism, expression, mutant intestine, gut-specific, overexpression, lysosomal mannosidase, increased, autophagy, gut homeostasis, lifespan, processes, ageing-related decline, organisms]]\n",
      "[[Filarial infections, individuals, disabilities, treatment options, mass drug, successes, Administration, doxycycline, anti-Wolbachia agent, clinical effectiveness, limitations, long treatment, durations, contraindications, in silico, drug repurposing approach, screening, library, FDA-approved, medications, filarial endosymbiont, Wolbachia, target, enzyme, catalyzes, heme biosynthesis, Wolbachia, inhibit, heme, synthesis, filarial worm, heme, macrofilaricidal, effect, molecular docking, molecular simulations, binding energy calculations, identification, paritaprevir, nilotinib, anti-Wolbachia agents, binding, affinities, catalytic pocket, natural, substrate, drugs, structural, potential, bind, active site, wolbachia, Acid Synthase, paritaprevir, nilotinib, experimental validations, anti-Wolbachia agents]]\n",
      "[[development, metagenomic techniques, microbial, community structure, bed bugs, Cimex lectularius, information, constituents, bacterial, communities, associated with, tropical bed bugs, Cimex hemipterus, lacking, study, bacteria, communities, blood-fed, starved, tropical bed bugs, analysed, characterized, v3-v4 hypervariable region, 16S rRNA, gene region, MiSeq Illumina sequencing, samples, Proteobacteria, microbial, community, alpha-proteobacterium Wolbachia, gamma-proteobacterium, Dickeya chrysanthemi, Pseudomonas, dominant, OTUs, genus, level, dominant, OTUs, bacterial, communities, blood-fed, starved, bed bugs, bacterial genera, bacteria, load, starved, bed bugs, blood-fed, bed bugs]]\n",
      "[[investigated, cluster, Yersinia enterocolitica, cases, affecting, youth, summer, camp, nearby, community, northeastern Pennsylvania, telephone interviews, camp owners, community members, pasteurized milk, small dairy, on-site, pasteurization, Dairy A, exposure, site visits, camp, Dairy A, milk, samples, Samples, cultured, enterocolitica, Clinical, nonclinical, isolates, molecular subtyping, case finding, telephone interviews, community cases, cohort study, adult, camp, staff, administering, online questionnaire, identified, enterocolitica, cases, Consumption, Dairy A milk, Dairy A milk, Dairy A, shipped, gallons, pasteurized milk, weekly, shipments, camp, mid-July, Dairy A milk, exposure, identified, camp, community, enterocolitica, isolated, Dairy A, unpasteurized milk, samples, clinical, isolates, camp members, clinical, isolates, community members, isolates, unpasteurized milk, whole-genome sequencing, risk, yersinosis, camp staff, Dairy A milk, risk, confidence interval, Dairy A, sold, pasteurized, milk, pasteurized milk, outbreak, source, governmental agencies, small, dairies, on-site, pasteurization, outbreak]]\n",
      "[[Rodents, benefit, increased, precipitation, dry habitats, years, precipitation, improve, forage, water, balance, Yersinia pestis, plague, flea-borne, pathogen, mammals, western, North America, negative, impact, species, rodents, years, above-average precipitation, absence, plague, mitigation, negative, effects, plague, wet years, effects, increased, moisture, Montana, Utah, USA, plague, enzootically, investigated, influence, precipitation, finite rates, annual, population change, species, prairie dogs, Cynomys spp., plots, treated with, deltamethrin dust, non-treated, plots, paired comparisons, interaction, precipitation, treatment, reduced, plague vector, prairie dog, visual counts, increase, increasing, precipitation, Simultaneously, negative, relationship, counts, precipitation, paired plots, plague, plague, transformed, reversed, effect, increased, precipitation, years, prairie dogs, years, historic times, invasion, plague, scenario, ecosystems, conservation, western, North America]]\n",
      "NaN\n",
      "[[Objective, investigate, reciprocal regulation, Fur, RyhB, homologs, Yersinia pestis, RyhBs, biofilm formation, Regulatory relationships, assessed, combination, colony, morphology, assay, primer extension, electrophoretic mobility shift assay, DNase I footprinting, Fur, promoter-proximal DNA regions, ryhB1, ryhB2, repress, transcription, RyhB1, RyhB2, repressed, expression, Fur, post-transcriptional, level, RyhB1, RyhB2, pestis, biofilm exopolysaccharide, EPS, production, expression, hmsHFRS, hmsT., Fur, RyhB, homologs, negative, reciprocal regulation, RyhB, homologs, positive, regulatory effect, biofilm formation, pestis]]\n",
      "[[Streptomycin, effective, antibiotics, treatment, plague, investigate, streptomycin, resistance, Y. pestis, China, streptomycin, susceptibility, pestis strains, China, in vitro, inhibitory, MIC, screened, streptomycin, resistance-associated genes, strA, strB, PCR method, clinical, pestis, isolate, S19960127, high-level, resistance, streptomycin, MIC, strain, biovar antiqua, isolated, pneumonic plague, outbreak, Tibet Autonomous Region, China, Marmota himalayana, Qinghai-Tibet Plateau plague, streptomycin, resistance, conjugative plasmids, genome sequencing, allelic replacement, rpsL gene, ribosomal protein S12, mutation, substitution, amino-acid 43, K43R, high-level resistance, streptomycin, strain S19960127, consistent with, mutation, streptomycin-resistant, Mycobacterium tuberculosis, strains, Streptomycin, first-line, treatment, plague, countries, emergence, streptomycin, resistance, pestis, public, streptomycin, susceptibility, monitoring, Y. pestis, isolates, plasmid-mediated resistance, ribosomal protein S12 gene, rpsL, mutation, treatment failure, suspected, antibiotic resistance]]\n",
      "[[sequencing technologies, assembly, multi-chromosome genomes, Vibrionaceae, plasmids, combination, Oxford Nanopore MinION long reads, short Illumina reads, sequenced, closed, curated, genomes, strains, Photobacterium damselae subsp., isolated, Australia, genome sequences, P. damselae subsp., isolated, Oceania, knowledge, Southern hemisphere, investigated, phylogenetic, relationships, Australian, overseas, isolates, Australian, P. damselae subsp., Asian, American strains, European, investigated, mobilome, evidence, host, specialization process, progressive, adaptive evolution, fish, P. damselae subsp., transposable elements, chromosome 2, plasmids, potential, virulence, determinants, P. damselae subsp., chorismate mutase gene, retained, co-localized, AIP56, apoptogenic toxin-encoding gene, pPHDP10, plasmid, transfer-messenger RNA gene, ssrA, chromosome, homologous, critical-to-virulence determinant, Yersinia pseudotuberculosis, study, knowledge, closed, manually curated, P. damselae subsp., fish, pathogen, evolution]]\n",
      "[[Yersinia ruckeri, pathogen, enteric, redmouth disease, salmonid species, fish, rainbow trout, Oncorhynchus mykiss, transcriptomic profiling, spleen samples, rainbow trout, post-Y. ruckeri infection, RNA-seq, immunological, responses, DEGs, up-, down-regulated, assessment, DEGs, associated with, immune system, CCR9, CXCL11, IL-1beta, CARD9, IFN, TNF, CASP8, NF-kappaB, NOD1, TLR8alpha2, HSP90, MAPK11, genes, associated with, immunological, KEGG pathways, Cytokine-cytokine receptor, interaction, Toll-like receptor signaling, RIG-I-like receptor signaling, NOD-like receptor signaling, MAPK signaling pathways, expression, DEGs, qRT-PCR, approach, immunological, importance, findings, preliminary, molecular mechanism, immune responses, rainbow trout, ruckeri infection, base, studies, host-pathogen interactions, rainbow trout]]\n",
      "[[Yersinia pestis, causative agent, plague, western, United States, rodent, populations, epizootics, susceptible, species, black-tailed prairie dogs, Cynomys ludovicianus, pestis, long-term, environment, epizootics, multiple, mechanisms, enzootic transmission cycle, pestis, involvement, epizootic, hosts, persistence, Y. pestis, epizootic, host, populations, mortality, populations, live-trapped, collected fleas, black-tailed, dogs, mammal, species, sites, black-tailed, prairie, dogs, tested, fleas, presence, Y. pestis, pestis, detected, fleas, detected, fleas, multiple sites, epizootic, reduced, black-tailed, prairie dog, populations, affected, colonies, Temporal, spatial patterns, pestis, occurrence, fleas, genotyping, pestis, infected, fleas, pestis, sources, study area, dispersed, sites, pestis, black-tailed, prairie dog, colonies, epizootic activity, colonies, enzootic, hosts, evidence, deer mice, Peromyscus maniculatus, hosts, pestis, enzootic, hosts, black-tailed, dogs]]\n",
      "[[Antibiotic, bacteria, global, antimicrobials, injectisome type III secretion system, T3SS, Gram-negative bacteria, virulence, absent, non-pathogenic bacteria, antimicrobial, target, synthetic cyclic peptomers, natural product phepropeptin D, inhibit, protein secretion, Yersinia Ysc, Pseudomonas aeruginosa, Psc T3SSs, inhibit, bacterial growth, identification, isomer, IC50, parental compound, inhibited, Yersinia Ysa, Salmonella SPI-1, T3SSs, cyclic, peptomer, efficacy, evolutionarily distant injectisome T3SSs, inhibited, intracellular, growth, Chlamydia trachomatis, HeLa cells, T3SS, inhibit, Twin arginine, translocation, impact, T3SS gene, injectisome, flagellar T3SSs, evolutionarily, structurally, cyclic, peptomer, inhibit, secretion, substrates, Salmonella flagellar, T3SS, cyclic peptomers, target, injestisome T3SS, reduced, T3SS needles, detected, surface, pseudotuberculosis, detected, microscopy, data, cyclic peptomers, inhibit, injectisome T3SS, Gram-negative bacteria, T3SS, assembly]]\n",
      "NaN\n",
      "[[Infectious diarrhea, hematopoietic cell transplantation, HCT, morbidity, mortality, HCT, recipients, experience, diarrhea, post-transplantation, period, infectious pathogens, detected, diarrheal, episodes, patients, colonized, gastrointestinal (GI), pathogens, transplantation, colonization, diarrheal illness, HCT, recipients, colonized, GI, pathogens, HCT, degree, pre-HCT colonization, post-transplantation, infectious diarrheal illness, prospective cohort study, allogeneic, autologous, HCT, recipients, January, Stool samples, week, HCT, samples, evaluated, presence, diarrheal, pathogens, BioFire FilmArray GI panel, frequency, participants, colonized, pathogen, factors, associated with, colonization, pretransplantation, colonization, post-transplantation, diarrheal infections, colonizing, pathogen, colonization, associated with, increased, days, post-transplantation, diarrhea, transplant, hospitalization, asymptomatic, patients, allogeneic, autologous, stool specimen, HCT, GI, pathogen, detected, detected, organisms, Clostridioides difficile, Yersinia enterocolitica, enteropathogenic Escherichia coli, EPEC, norovirus, Female, sex, C. difficile, infection, associated with, C. difficile, colonization, non-Hodgkin lymphoma, associated with, colonized, diarrheal, pathogen, C. difficile, patients, pretransplantation, C. difficile, colonization, clinical, C. difficile, infection, post-transplantation, patients, colonized, EPEC, enteroaggregative E. coli, post-transplantation infections, colonizing, pathogen, Pretransplantation, C. difficile, colonization, associated with, increased, duration, post-transplantation diarrhea, patients, pretransplantation Yersinia enterocolitica, colonization, post-transplantation, infection, Patients, admitted, HCT, colonized, diverse, GI, pathogens, Colonization, C. difficile, colonization, diarrheagenic, E. coli, associated with, post-transplantation, diarrheal infections, organisms, clinical significance, colonization, GI, pathogens]]\n",
      "[[Yersinia enterocolitica, zoonosis, andwild, boars, transmission, wild boar, population, increase, haspushed, urbanized areas, human-wildlife interface, spread, infectious diseases, wildlife, domestic animals, humans, serotype, antimicrobial resistance, presence, pathogenicity genes, Yersinia enterocolitica, isolated, species, analyzed, liver, wild boars, hunted, Liguria region, isolated, serotyped, positive samples, pathogenicity, presence, virulence genes, isolated, ystB, ymoA, ail, ystA, evaluated, susceptibility, antimicrobic agents, Ampicillin, Chloramphenicol, Enrofloxacin, Gentamicin, Kanamycin, Trimethoprim-Sulfamethoxazole, Sulfisoxazole, Ceftiofur, Tetracycline, antibiotic resistance, analyzed, increase, wild boars, reserve, diseases, humans, antibiotic resistance, public health]]\n",
      "[[study, conditions, pharmacological activity, medicinal plants, development, phytomedicine, study, optimal, conditions, antibacterial activity, extracts, Harungana madagascariensis, leaves, bark, roots, harvested, Douala, Littoral Region, Cameroon, day, early, morning, midday, afternoon, dried, room, temperature, fine powder, powder, macerated, methanol, boiled, distilled water, palm wine, extracts, evaluated, antibacterial activity, broth microdilution method, clinical, bacterial strains, results, extraction, yield, bark, palm wine, decoction, methanol bark, active, solvents, activity, extract, strains, tested, MIC, moderate, strains, tested, activity, noon extract, strains, moderate, strains, activity, extract, strains, moderate, strains, extract, harvested, inhibited, growth, strains, tested, MIC, Staphylococcus aureus, Escherichia coli, Citrobacter freundii, Serratia marcescens, Salmonella enterica serovar typhi, Yersinia enterocolitica, harvesting time, study, bark, H. madagascariensis, antibacterial agent, harvested, extracted, methanol]]\n",
      "[[Necklace orchids, Coelogyninae, Epidendroideae, medicine practices, centuries, studies, orchid species, traditional, practices, antimicrobial, anti-inflammatory, anti-oxidant activity, experimental, medicinal properties, species, investigated, ethno-botanically, phylogenetic context, study, group, wild orchids, EBDCS, Economic Botany Data Collection Standards) organ, targeted, biological response methods, medicinal use, necklace orchids, books, journals, published, orchids, Coelogyne cristata, Coelogyne fimbriata, cultivated, indoors, outdoors, antimicrobial, properties, extracts, leaves, pseudobulbs, tested, selection, human, pathogens, molecular phylogeny, Coelogyninae, nuclear ribosomal ITS, plastid matK DNA sequences, species, reconstructed, Maximum Likelihood, ML, RAxML, Maximum Parsimony (, MP, PAUP, Bayesian Inference, MrBayes, Bioprospecting, comparison, EBDCS, biological response, R, scripts, Ethanolic extracts, leaves, C. fimbriata, inhibited, growth, Bacillus cereus, Staphylococcus aureus, Yersinia enterocolitica, antimicrobial, properties, extracts, Leaf extracts, antimicrobial, properties, plants, cultivated outdoors, indoors, differences, statistically significant, hot nodes, potency, antimicrobial activities, detected, EBDCS, organ, hot nodes, detected, biological response, biological response, effective, tool, finding, hot nodes, clades, species, medicinal]]\n",
      "[[bacterial, pathogens, type III secretion system, T3SS, host cells, Protein secretion, T3SS, injectisome, activated, contact, host cell, unclear, premature secretion, infection, report, gastrointestinal pathogens, Yersinia enterocolitica, Shigella flexneri, cytosolic injectisome components, released, proximal, injectisome, pH, preventing, protein secretion, acidic environments, stomach, Yersinia enterocolitica, low, pH, detected, periplasm, partial, dissociation, inner membrane injectisome component, SctD, dissociation, cytosolic, T3SS, components, effect, restoration, neutral, pH, fast activation, T3SS, native, target, host, findings, cytosolic components, adaptive regulatory interface, regulates, T3SS, activity, response, environmental conditions]]\n",
      "[[Pathogenic Yersinia, enterocolitica, causative agent, Yersiniosis, outbreaks, numerous, countries, world, diarrhea, vomiting, animals, humans, instrument-free, nucleic acid visualization method, RPA-SYBR Green I, recombinase polymerase amplification, RPA, fluorescent dye SYBR Green I, detection, adhesion gene, pathogenic, enterocolitica, optimization, conditions, primer, concentration, detection, pathogenic, enterocolitica, DNA extraction, observation, results, isothermal temperature, C. RPA-SYBR Green I, cross-reactivity, bacteria, detection, CFU/muL, sensitivity, conventional PCR, method, PCR, identified, spiked, samples, meat, samples, stored, refrigerated, consistency, methods, RPA-SYBR Green I, visual, detection, assay, pathogenic, enterocolitica]]\n",
      "[[Isolation, pathogens, Yersinia enterocolitica, Yersinia pseudotuberculosis, foods, slow, day, cold, protocols, results, results, alternative, method, culture, non-selective medium, identification, colonies, elastic light scatter, analysis, prototype database, ELS, profiles, Yersinia species, bacterial genera, pork mince, compare, profiles, colonies, enrichment, cultures, pork mince, samples, seeded, strains, Y. enterocolitica, pseudotuberculosis, presumptive, identification, ELS, computerised, visual analyses, colonies, experiments, target, species, partial, 16S rDNA sequencing, seeded, cultures, method, recovered, Yersinia strains, results, modified, ELS, detection, foodborne, pathogenic, yersiniae]]\n",
      "[[Plague, vector-borne, infectious disease, history, humankind, natural, plague, foci, Caucasus, territory, Russian Federation, Azerbaijan, Armenia, Georgia, whole-genome sequencing, Y. pestis, strains, isolated, natural foci, Caucasus, Transcaucasia, data, whole-genome SNP, analysis, Bayesian phylogeny methods, evolutionary-phylogeographic analysis, modern population, plague, pathogen, phylogenetic, relationships, Y. pestis, strains, Caucasus, strains, countries, genomes, evolutionary, phylogenetic reconstruction, species, whole-genome SNP, analysis, genomes, isolates, sequenced, study, genomes, GenBank database, Analysis, core genome, SNPs, differentiation, strains, evolutionary, pestis strains, genetic lineages, 2.MED1, Y. pestis, strains, isolated, territory, East, Caucasian, high-mountain, Transcaucasian, high-mountain, Priaraksinsky low-mountain plague, foci, genetic lineages, whole-genome SNP, analysis, strains, modern population structure, plague, pathogen, strains, isolated, natural foci, Caucasus, Transcaucasia, structure, global population, Y. pestis, retrospective, evolutionary-phylogeographic analysis, population, pathogen, time frame, divergence, genetic lineages, Y. pestis, paths, historical, spread, plague, pathogen]]\n",
      "[[Members, flea family Pulicidae, studies, significance, diseases, vectors, medical, veterinary, cosmopolitan, distribution, variation, morphological, features, species, identification, management, Xenopsylla brasiliensis, Baker, plague vector, study, genetic tools, species, identification, DNA barcoding approach, flea, specimens, native, host, Namaqua rock, mouse, Micaelamys namaquensis, South Africa, morphologically, measurements, morphological, characteristics, barcodes, mitochondrial cytochrome c oxidase subunit I, X. brasiliensis, comparing, data, COI sequences, Rwandan, X. brasiliensis, sequences, regions, relationship, X. brasiliensis, populations, haplotype, nucleotide, diversity, South African, specimens, human-assisted spread, differences, habitat, host, species, sampled, study, future]]\n",
      "[[variable response, wild mice, Yersinia pestis infection, causative agent, plague, speculation, ecology, lethal disease, Researchers, pestis, nature, methods, disease, assessed, efficacy, tool, sylvatic plague vaccine, SPV, wild-caught northern grasshopper mice, Onychomys leucogaster, Sonoran deer mice, Peromyscus maniculatus sonoriensis, animals, subcutaneous, pestis, colony forming units, white mouse, lethal dose, vaccine-treated, control groups, results, SPV, distribution, adult, mice, plague infection, field settings, corroborate, heterogeneous response, pestis infection, mice]]\n",
      "[[intestinal, host-microbe interface, transmembrane mucin, MUC1, function, physical barrier, receptor, bacteria, MUC1, epithelial cell, morphology, receptor function, bacterial, pathogens, integrins, infect, eukaryotic cells, MUC1, influences, interaction, bacteria, integrins, Escherichia coli, expressing, invasin, Yersinia pseudotuberculosis, E. coli inv, assess, effects, MUC1, beta1 integrin, bacterial invasion, results, expression, MUC1, physical barrier, enhances, E. coli, uptake, Enzymatic, removal, MUC1, extracellular domain, ED, secreted, protease, C1 esterase inhibitor, StcE, pathogenic, Escherichia coli, effect, E. coli inv invasion, expression, truncated, MUC1, cytoplasmic tail, CT, reduced, bacterial entry, Substitution, tyrosine residues, MUC1, CT, reduced, bacterial, uptake, deletion, C-terminal half, cytoplasmic tail, minor, effect, regulatory role, tyrosine phosphorylation, N-terminal region, MUC1, CT, integrin-mediated uptake process, StcE, removal, ED, MUC1-DeltaCT cells, reversed, block, bacterial invasion, findings, MUC1, beta1-integrin-mediated bacterial invasion, action, glycosylated, membrane-juxtaposed, Bacteria, membrane receptor integrins, cellular invasion, binding, bacterial, adhesins, extracellular matrix, components, MUC1, transmembrane glycoprotein, expressed, epithelial cells, defensive, receptor functions, host-microbe interface, integrin clustering, investigated, epithelial, MUC1, beta1, integrin-mediated bacterial invasion, MUC1, barrier, bacterial entry, beta1 integrins, process, action, MUC1, O-glycosylated, extracellular domain, cytoplasmic tail, findings, dimension, complexity, bacterial, mechanisms, functions, MUC1, domains, host-microbe interface]]\n",
      "[[Yersinia, pseudotuberculosis, pathogen, humans, animals, infect, livestock, pets, wild animals, years, reports, isolation, pseudotuberculosis, zoo animals, birds, mammals, infection, lethal, cases, deceased, mammals, species, Zoo Wuppertal, Germany, pseudotuberculosis, infection, information, properties, pseudotuberculosis, zoo animals, characterized, isolates, infected, species, members, biotype 1, serotypes, sequence types, STs, cgMLST types, Pulsed-Field Gel Electrophoresis, PFGE, analysis, whole-genome sequencing, WGS, isolates, discriminated, virulence genes, mobile genetic elements, virulence, pYV, serotypes, isolates, HPI, detected, serotypes, O:1a, O:1b, O:13, isolates, O:2a, O:2b, content, plasmids, prophages, isolates, data, deceased, mammals, infected, isolates, zoo animals]]\n",
      "[[LcrF, master regulator, positively, regulates, Ysc type III secretion system, T3SS, Yersinia, similarity, DNA-binding domain, T3SS master regulator, ExsA, Pseudomonas aeruginosa, features, bioinformatics analysis, LcrF-binding site, target, promoters, experimentally, characterized, binding motif, adenine-rich LcrF-binding region, lcrG, promoter sequence, regulatory, target, LcrF, information, binding region, cloned, synthetized, promoter, mutations, region, 5'-AAAAA-n5-GnCT-3' sequence, LcrF, regulation, motif, noncanonical promoter, -35, -10 elements, putative binding motif, promoters, T3SS, operons, genes, LcrF. Transcriptome analysis, LcrF, activates, T3SS genes, Yersinia, data, LcrF, T3SS activator, requirement, transcriptional regulation]]\n",
      "[[Yersinia bacteriophages fPS-2, fPS-65, fPS-90, isolated, pig, stools, long contractile tails, elongated heads, genus, Tequatroviruses, Caudovirales, phages, host, ranges, Yersinia pseudotuberculosis, species, One-step growth curve, experiments, phages, latent, periods, burst sizes, virions, infected, cell, phage, genomes, circularly permuted dsDNA, bp, size, G + C, content, predicted, genes, phage, genomes, identical, phage T4, phage receptors, genome sequencing, spontaneous, phage-resistant mutants, phage-resistant strains, mutations, ompF, galU, hldD, hldE genes, OmpF, porin, genes, lipopolysaccharide, LPS, biosynthetic enzymes, ompF, galU, hldE, mutants, wild-type genes, host, recognition, long tail fiber tip protein Gp38, T-even phages, Salmonella phage, distal]]\n",
      "[[Yersinia pseudotuberculosis, enteric, bacterium, yersiniosis, humans, Yersinia pseudotuberculosis, detection, methods, sample, pretreatment, live/dead cells, reports, phage-based, electrochemical biosensor, rapid, detection, Yersinia pseudotuberculosis, conductive, poly(indole-5-carboxylic acid, reduced, graphene oxide, gold, nanoparticles, surface, modification, electrode, redox, response, consecutive, cycles, cyclic voltammetry, bacteriophages, isolated, hospital sewage, water, immobilized, modified, electrodes, Au-NH2 bond, gold, nanoparticles, phages, biosensor, fabricated, nanomaterials, phages, detect, Yersinia pseudotuberculosis, detection, detection, CFU, assay, time, biosensor, detect, live, Yersinia pseudotuberculosis, responding, phage-non-host, bacteria, dead Yersinia pseudotuberculosis cells, results, biosensor, rapid, detection, Yersinia pseudotuberculosis, food, water, clinical samples]]\n",
      "[[February, increase, mortality, colony, captive, Seba's, short-tailed bats, Carollia perspicillata, animals, cohabited, nocturnal, animal, species, dome, private zoo, Switzerland, Gross, histological analysis, animals, necropsy, period, necrosuppurative pneumonia, hepatitis, splenitis, enterocolitis, endometritis, abundant, intralesional, colonies, Gram-negative rods, Yersinia, pseudotuberculosis, serotype, O:1, biotype, sequence type, ST90, isolated, affected, organs, animals, diagnosis, colony, animals, culled, gross, histopathological, bacterial culture, Yersinia spp., lung, liver, spleen, animals, gravid, female, tested, positive, pseudotuberculosis, absence, clinical symptoms, histopathological, lesions, PCR analysis, bacterial, isolates, virulence factors, revealed, presence, ail gene, isolate, positive, virF, yadA plasmid, genes, findings, Carollia perspicillata, susceptible, lethal yersiniosis, reservoir, pseudotuberculosis, Culling, population, spread, infection, colony, no infections, detected, cohabitant, nocturnal, animals, caretakers, zoonotic, risk, case, low]]\n",
      "[[Penicillin-resistant viridans group streptococci, VGS, infections, issue, infectious diseases, case, mitral valve infective endocarditis, penicillin-resistant VGS, inhibitory, concentration, treated with, daptomycin, clinical, efficacy, daptomycin, alternative, treatment, resistant, VGS, endocarditis]]\n",
      "[[supposition, usage, fibrin, leukocytes, platelets, A-PRF, ulcerative osteomyelitis, diabetic foot, rehabilitation, critical illness, investigation, focus, normalize, platelet-rich fibrin, PRF, patients, osteomyelitis not amputated, second-generation platelet concentrate, regeneration, enabler, researchers, A-PRF membranes, patients, diabetics, osteomyelitis, cutaneous injury, months, membranes, combination, supernatant fluid, stress, skin lesion, bone, surgical debridement, advancement, lesions, period, time, analyzed, subjects, probe-to-bone positive assay, magnetic resonance imaging, cortico-periosteal coagulation, foci, cortico-spongeous osteolysis, contiguous, lesion, Gram-positive bacteria, identified, procedures, cases, Gram, Cocci, Staphylococcus aureus, beta-hemolytic Streptococci, Streptococcus viridans, Gram-negative bacteria, Pseudomonas, Proteus, Enterobacter, Candida albicans, active, cases, blood count, differences, cutaneous lesions, cured, subjects, treated, patient, years, evidence, infection, recurrence, results, subjects, PRF, membranes, therapeutic, problematic disease, clinical approach, potential, promote, healing, diabetic, skin lesions, osteomyelitis]]\n",
      "[[American Heart Association published, evidence-based guidelines, antibiotic prophylaxis, prevent, viridans group, streptococcal, VGS, infective endocarditis, IE, cardiac patients, invasive procedures, guidelines, conditions, antibiotic prophylaxis, recommended, categories, risk, adverse outcome, update, interval, evidence, acceptance, impact, recommendations, VGS, IE, revisions, evidence, writing group, experts, prevention, treatment, infective endocarditis, members, American Dental Association, Infectious Diseases Society of America, American Academy of Pediatrics, American Heart Association, MEDLINE database, searches, English language, articles, compliance, recommendations, guidelines, frequency, morbidity, mortality, VGS, IE, publication, guidelines, awareness, guidelines, variable, compliance, recommendations, evidence, VGS, IE, frequency, morbidity, mortality, increased, review, evidence, VGS, IE, prevention guidelines, VGS, IE, prophylaxis, categories, patients, risk, adverse outcome, oral, dental care, Randomized controlled studies, antibiotic prophylaxis, VGS, IE, recommendations]]\n",
      "[[Infective endocarditis, children, severe, consequences, risk factor, paediatric, infective endocarditis, congenital heart defects, causative organisms, Staphylococcus aureus, viridans group, streptococci, spectrum, symptoms, children, difficulty, diagnosis, infective endocarditis, Infective endocarditis, children, modified Duke criteria, blood cultures, effective, microbiological test, pathogen, identification, blood culture-negative, infective endocarditis, serology testing, IgG, titres, effective, diagnosis, Imaging techniques, echocardiograms, computed tomography, positron emission tomography, Biomarkers, diagnosis, C-reactive protein, literature, interleukin-15, C-C motif chemokine ligand, risk, prediction, American Heart Association (AHA, European Society of Cardiology (ESC) guidelines, differences, infective endocarditis, children, Medical intervention, antimicrobial, treatment, surgical interventions, repair, replacement, cardiac valves, Quality of life, improve, surgical intervention, decades, clinical practice, outcomes, patients, infective endocarditis, investigative, high risk, cohort, diagnostic techniques, Duke's criteria, paediatric, infective endocarditis, diagnosis, management, guidelines, paediatric, infective endocarditis, long-term, outcomes, patients, medical, surgical intervention, quality of life, paediatric, patients, medical, surgical intervention]]\n",
      "[[Aerococcus spp, Gram-positive, catalase-, oxidase-negative, microaerophilic, nonmotile bacteria, species, associated with, human infections, arthritis, bacteremia, endocarditis, meningitis, bacteria, streptococci species, treated, contaminant, Patients, Methodology, retrospective, observational cohort study, patients, Aerococcus spp, isolates, blood samples, categorical data, counts, proportions, continuous, data, median, interquartile ranges, Aerococcus spp, isolates, study, period, years, Aerococcus urinae, isolated, Aerococcus viridans, Aerococcus spp., speciated, median, age, years, males, females, frequent, presentations, fever, mentation, patients, predisposing, comorbidity, urinary tract system, recurrent, urinary tract infection, urinary incontinence, indwelling catheter, renal stones, benign, prostatic hyperplasia, cystoscopy, median, white blood cell, median hemoglobin, median platelet count, median blood urea, nitrogen, median creatinine, urinary tract, source, bacteremia, imaging, findings, cases, positive, urine culture, Aerococcus spp., cases, instrumentation history, case, rest, bacteremia, Endocarditis, suspected, patients, Transthoracic echocardiography/transesophageal echocardiography, TEE, cases, aortic valves, mitral valve, pacemaker, case, septic emboli, right frontal stroke, TEE, normal, Doppler study, deep venous thrombosis, Blood cultures, positive, polymicrobial growth, coagulase-negative staphylococci, Enterococcus faecalis, Diphtheroids spp., Proteus mirabilis, cases, intensive care unit, vasopressor support, patients, treated, days, cases, infective endocarditis, IE, median hospital stay, duration, days, fatalities, patients, Old age, urologic conditions, risk factors, Aerococcus spp., infection, diagnostic technology, increase, detection, Aerococcus spp.-related infections, occurrence, Aerococcus spp, human infections, resultant, lack, randomized control trials, degree, clinical uncertainty, management, Aerococcus spp., IE]]\n",
      "[[evaluate, effects, antimicrobial peptide, de novo, structure, morphology, composition, cariogenic, biofilm, cariogenic, biofilm consis-ted, cariogenic, Streptococcus mutans, S. mutans, commensal bacteria, Streptococcus sanguinis, S. sanguinis, Streptococcus gordonii, S. gordonii, biofilm, treated, GH12, untreated, biofilm, control, Changes, morphology, structure, three-species, biofilm, evaluated, crystal violet, scanning electron microscopy, SEM, fluorescent in situ hybridization, FISH, S. mutans, biofilm, cultured, colony-forming units, biomass, density, cariogenic, biofilm, treated, GH12, decreased, compared, control, S. mutans, decreased, gradually, undetectable, S. gordonii, S. sanguinis, increased, predominant, biofilm, GH12, reduce, S. mutans, cariogenic, biofilm, destroys, integrity, biofilm, remove]]\n",
      "[[Core microbes, development, caries, microbial disorders, goal, detect, core microbes, associated with, microbiota, imbalance, early childhood, caries, ECC, caries-free children, high-caries, DMFT, children, aged, years, diagnostic criteria, caries, WHO, 16S rRNA, samples, plaque, saliva, amplified, PCR, PCR products, sequenced, Illumina Miseq platform, sequencing results, analyzed, professional software, composition, structure, saliva microorganisms, statistically significant, groups, abundance, Streptococcus mutans, Wilcoxon rank-sum test, No significant difference, groups, species, functional genes, S. mutans, pathogens, core microbes, occurrence, development, early childhood, caries]]\n",
      "[[epidemiology, early-onset, sepsis, EOS, time, Longitudinal surveillance, causative pathogens, antibiotic susceptibility, patterns, antibiotic therapy, optimal, therapy, strategies, incidence, culture-confirmed, EOS, causative pathogens, antibiotic susceptibility, patterns, antibiotic therapy, period, Retrospective population-based study, single-center neonatal, intensive care unit, Stavanger University Hospital, Norway, population, South-West Norway, period, live born infants, infants, culture-confirmed, EOS, Gram positive, Gram-negative bacteria, EOS-attributable, mortality, pathogens, incidences, Group B streptococcus, GBS, Escherichia coli 0.11/1,000, viridans group streptococci, VGS, GBS, pathogen, infants, gestational age, GA, weeks, preterm infants, GA, weeks, incidence, E. coli, infection, GBS, infection, bacterial, pathogens, EOS, infants, VGS, incidence, EOS, study, period, decline, EOS, year, CI, incidences, GBS, E. coli, study, period, empirical, antibiotic regimen, EOS, cases, combination, benzylpenicillin, ampicillin, aminoglycoside, cases, broad-spectrum antibiotic, substituted, regimen, EOS, cases, pathogens, nonsusceptible, empirical, antibiotic regimen, E. coli, isolates, susceptible, aminoglycosides, GBS, causative, pathogens, EOS, E. coli, dominated, infants, GA, weeks, incidence, EOS, study, period, empiric regimen, benzylpenicillin, gentamicin, coverage, EOS]]\n",
      "[[Bacillus thuringiensis Cry proteins, parasporins, cell proliferation, inhibition, human cancer, in vitro, protease, activation, peptides, Cry11Bb, protoxin, B. thuringiensis subsp., medellin, evaluated, investigate, membrane, permeabilization, cytolytic activities, red blood cells, cancer cell lines A549, MCF-7, Caco-2, peptides, permeabilized, red blood cells, membrane, potential-dependent, maximal, inhibitory, concentration, cancer cells, time, peptides, concentration, hemolysis, percentage, peptides, BTM-P1, BTM-P4, lowest, IC50, values, MCF-7 cell line, peptides, evaluated, Fluorescence microscopy, AnnexinV-FLUOS staining, MCF-7 cell, peptide BTM-P1, apoptosis, Real time PCR analysis, increased, transcription, p53, MCF-7 cells, pro-apoptotic effect, peptide BTM-P1, study, cytolytic activity, polycationic peptides, Cry11Bb, protoxin, pro-apoptotic, mechanism, potential-dependent membrane, permeabilization, studies, peptides, cytolytic, cancer cell lines, solid tumors]]\n",
      "[[Deciphering, molecular mechanisms, insect, resistance, Cry toxins, Bacillus thuringiensis, Bt, utilization, Bt biopesticides, transgenic Bt crops, MAPK-mediated, reduced, expression, PxABCB1 gene, associated with, Bt Cry1Ac, resistance, diamondback moth, Plutella xylostella, transcriptional regulation, mechanism, PxABCB1, promoter, Cry1Ac-susceptible, Cry1Ac-resistant, P. xylostella, strains, cloned, analyzed, Jun binding site, JBS, dual-luciferase reporter assay, yeast one-hybrid assay, Y1H, transcription factor, PxJun, repressed, PxABCB1, expression, interacting, JBS, expression, levels, PxJun, increased, midguts, resistant, strains, compared, susceptible, strain, Silencing, PxJun, expression, PxABCB1, expression, Cry1Ac, susceptibility, resistant, NIL-R, strain, silencing, PxMAP4K4, expression, decreased, PxJun, expression, increased, PxABCB1, expression, results, MAPK-activated PxJun, suppresses, PxABCB1, expression, Cry1Ac, resistance, P. xylostella, transcriptional regulation, midgut, Cry receptor genes, molecular, insect, resistance, Bt Cry toxins, ImportanceThe, transcriptional regulation, mechanisms, reduced, expression, Bt toxin receptor genes, Bt-resistant, insects, study, transcription factor, PxJun, activated, MAPK signaling pathway, PxABCB1, expression, Cry1Ac, resistance, P. xylostella, results, transcriptional regulation, mechanisms, midgut, Cry receptor genes, molecular, insect, resistance, Bt Cry, toxins, knowledge, study, identified, transcription factor, transcriptional regulation, mechanisms, midgut, Cry receptor genes, Bt-resistant, insects]]\n",
      "[[Ascaris, Parascaris, parasites, family Ascarididae, intestinal-dwelling, nematodes, infecting, classes, vertebrates, Parasitic nematode, drug resistance, veterinary medicine, drug recalcitrance, human medicine, increasing, worldwide, therapeutic classes, horizon, parasites, zoonotic, Ascaris, humans, pigs, vice, development, therapies, family, parasites, human, livestock, health, tested, therapeutic, paraprobiotic, dead, probiotic, expresses, Bacillus thuringiensis Cry5B protein, anthelmintic, properties, zoonotic Ascaris, Parascaris spp, paraprobiotic, IBaCC, intoxicated, A. suum, larvae, in vitro, effective, in vivo, intestinal, A. suum infections, mouse model, parasite, Fermentation, scaled, treat, pigs, horses, Single dose, Cry5B, IBaCC, cleared, A. suum infections, pigs, Cry5B, IBaCC, fecal, Parascaris-infected foals, zero, parity, potential, superiority, efficacy, anthelmintics, parasite, Cry5B, IBaCC, paraprobiotic, targeting, Ascarididae, effective, scalable, stable, human, veterinary medicine, regions, world]]\n",
      "[[parameter, bioprocesses, biomass, quantity, culture, behavior, concerns, conditions, operation, bioreactor, biomass, production, operation, conditions, measurement, biomass, on-line, effect, bioreactor, operating condition, variations, model, parameters, impedance spectroscopy, biomass, monitoring, model, parameters, analyzed, capacitance, resistance, alpha, alpha, conductivity delta, critical frequency, model, parameters, fitting, data, impedance measurements, circuit model, Cole-Cole conductivity model, effect, operating conditions, medium, no cells, percentage, change, model, parameter, operating conditions, percentage, change, percentage, model, parameters, fermentation, Bacillus thuringiensis, cellular model, Equivalent, circuit, parameters, affected, variation, pH, temperature, aeration, Cole-Cole parameters, affected, variation, agitation, aeration, temperature, pH., variation, operating conditions, test interval, fermentation, changes, monitoring, parameters, change, properties, biomass]]\n",
      "[[Aedes aegypti, Lao People's, Democratic Republic, PDR, primary vector, arboviral diseases, Chemical insecticides, mosquito-borne diseases, development, insecticide, resistance, insecticide, resistance, mosquito, populations, Lao PDR, mechanisms, vector, phenotypic, haplotypic profiles, insecticide, resistance, populations, Ae., central Lao PDR, Ae., sites, Lao PDR, susceptibility, temephos, deltamethrin, permethrin, Bacillus thuringiensis israelensis, Bti, tested, larval bioassays, Synergistic tests, evaluate, activity, insecticide-metabolizing enzymes, larvae, Deltamethrin-resistant, Deltamethrin-susceptible larvae, genotyped, knockdown, resistance, kdr, mutations, associations, genotype, resistance, Ae., central Lao PDR, resistant, mortality, organophosphates, pyrethroids, bio-insecticide Bti, effective, larvae, resistance, mechanisms, Ae., larvae, populations, pyrethroid, resistance, Kdr mutations, associated with, deltamethrin resistance, Ae., Xaythany population, synergist assays, piperonyl butoxide, cytochrome P450 monooxygenases, resistance, Khounkham, Thakhek, populations, study, information, design, implementation, insecticide-based vector, management, Ae., central Lao PDR, Ae., central Lao PDR, susceptible, Bti, resistant, temephos, diagnostic dose, insecticides, vector control, temephos, larvicides, Bti, pyriproxyfen, pyrethroid, resistance, mechanisms, Ae., increase, success, dengue, control, Lao PDR]]\n",
      "[[Insecticides, agriculture, human disease, decrease, nuisance, biting, insects, potential, environmental, impacts, toxicity, nontarget organisms, reviewed, data, effects of, insecticides, toxins, Bacillus thuringiensis var., Bti, Bacillus thuringiensis var., Btk, amphibians, peer-reviewed publications, Bti, variable, conclusions, observable effects, evidence, acute, toxicity, concentrations, controversies, investigation]]\n",
      "[[conclusions, European Food Safety Authority, EFSA, peer, review, initial, risk assessments, competent, authorities, rapporteur Member State, Denmark, co-rapporteur Member State, Netherlands, pesticide active, Bacillus thuringiensis subsp., kurstaki strain, EG2348, considerations, inclusion, substance, Annex IV of Regulation, EC, peer review, Commission Implementing Regulation, EU, Commission Implementing Regulation, EU, conclusions, evaluation, Bacillus thuringiensis kurstaki strain, EG2348, insecticide, pome fruits, field use, solanaceous fruiting vegetables, permanent, greenhouse, walk-in tunnel, ornamentals, field, permanent, greenhouse, walk-in tunnel, end points, regulatory risk assessment, information, regulatory framework, Concerns, identified]]\n",
      "[[novel, chitosanase gene, PbCsn8, cloned, Paenibacillus barengoltzii, highest, identity, glycoside hydrolase, chitosanase, Bacillus thuringiensis JAM-GG01, gene, heterologously, expressed, Bacillus subtilis, extracellular protein, chitosanase, yield, high-cell density fermentation, 5-L fermentor, recombinant chitosanase, PbCsn8, homogeneity, biochemically characterized, PbCsn8, active, pH, degrees, stable, pH, degrees, C. PbCsn8, bifunctional enzyme, chitosanase, glucanase activities, specificity, chitosan, barley beta-glucan, lichenan, hydrolyzed, chitosan, release, chitooligosaccharides, COSs, degree, polymerization, DP, hydrolyzed, barley beta-glucan, glucooligosaccharides, DP, PbCsn8, COS, production, highest, COS, yield, GH family 8, chitosanase, P. barengoltzii, yield, hydrolysis, properties, PbCsn8, industrial, application]]\n",
      "[[conclusions, EFSA, peer, review, initial, risk assessments, competent, authorities, rapporteur Member State, Denmark, co-rapporteur Member State, Netherlands, pesticide active, Bacillus thuringiensis subsp., kurstaki strain, considerations, inclusion, substance, Annex IV of Regulation, EC, peer review, Commission Implementing Regulation, EU, Commission Implementing Regulation, EU, conclusions, evaluation, Bacillus thuringiensis subsp., kurstaki strain, PB, insecticide, stone, fruit, ornamentals, field uses, tomato, field, permanent, greenhouse, walk-in tunnel, end points, regulatory risk assessment, information, regulatory framework, Concerns, identified]]\n",
      "[[Non-native pests, crop, damage, Drosophila suzukii, invaded, North America, Europe, global production, soft, thin-skinned fruits, severe, losses, control, dipteran, pesticides, negative, impact, environment, human, health, alternative, bio-insecticides, Bacillus thuringiensis, entomopathogenic nematodes, Steinernema carpocapsae, biological control agents, effectiveness, D. suzukii, limits, environmental, methodological, physiological factors, tested, concentrations, B. thuringiensis, S. carpocapsae, evaluate, efficacy, D. suzukii, larvae, administered, combination, agar traps, combined trials, nematodes, bacteria, assessed, larvae, lethality, assays, efficacy, combined administration, time-shifted, concurrent, data, relevant, decrease, time, kill, larvae, maximum, mortality rate, highest, concentrations, B. thuringiensis, IJs, S. carpocapsae, concurrent, trials, study, laboratory tests, controlled conditions, field studies, control, D. suzukii]]\n",
      "[[effects, concomitant, infection, COVID-19, Burkholderia cepacia, Bc, CF, case, years, woman, CF, colonized, Bc, SARS-CoV2, positive, hospital, week, acute respiratory failure, chest imaging, interstitial, involvement, multiple, thickenings, treated with, antibiotics, dexamethasone, remdesivir, heparin, gradual improvement, discharge, day, SARS-CoV-2, Bc, potential, interactions, contribution, therapies, favourable outcome, unclear, SARS-CoV2, Bc pulmonary, chronic, Bc infection, development, COVID-19, aggressive, CF, hypothesis, cases, Bc colonization, risk factor, severe, COVID-19, expression, CF]]\n",
      "NaN\n",
      "[[environment, iron levels, intracellular, iron concentrations, bacterial survival, iron levels, low, bacteria, Burkholderia cepacia, group, secrete, chemically diverse, siderophores, Fe(3+), synthesis, siderophores, ornibactin, pyochelin, iron concentration, dependent, regulator protein Fur, study, Nonribosomal Peptide Synthetase (NRPS) cluster, strain R456, Burkholderia seminalis, B. cepacia, group, NRPS cluster, production, siderophore, ornibactin, pyochelin, production, signaling pathway, targeting, global iron regulating effector, Fur, regulates, siderophore, production, NRPS cluster, cell motility, biofilm formation, dependent, iron concentration, bacteria, data, NRPS, regulates, siderophore iron metabolism, bacteria, horizontal gene transfer, algae]]\n",
      "[[Marine aerosols, organic, surface, coating, fatty acids, component, surface, activity, enzyme species, abundantly, seawater, marine aerosols, perspective, marine, aerosol, simulation, investigate, effect, Burkholderia cepacia lipase, surface, properties, stearic acid, SA, monolayer, air-water interface, surface-sensitive techniques, Langmuir, trough, Infrared reflection-absorption spectroscopy, IRRAS, findings, stearic acid, film, significant, expansion, lipase, concentration, incorporation, lipase, surface pressure-area, IRRAS spectra, reduced, intensities, ordering, methylene stretching, stearic acid, low, surface, density, disordered packing, enzyme, concentration, increases, concentration, lipase, Ias/Is values, water subphase, artificial, seawater, subphase, gauche conformations, SA, SA, films, lipase incorporation, pH, subphase, environment, decrease, pH, reaction, acidic gases, aerosol, aging, results, expansion, SA, monolayer, acidic environment, pH, hydrophobic, interaction, disorder, SA, monolayer, coexistence, fatty acids, enzymes, marine environment, study, surface organization, behavior, organic-coated marine aerosols, knowledge, lipid-enzyme interfacial interactions, atmosphere]]\n",
      "[[Trimeric Autotransporter Adhesins, TAA, Gram-negative bacteria, virulence, case, Burkholderia cepacia complex, Bcc, group, bacteria, infections, patients, cystic fibrosis, bacteria, TAAs, virulence factors, bind, host protein receptors, carbohydrate ligands, Blocking, contacts, inhibit, Bcc infections, study, antibody, TAA, BCAM2418, epidemic strain, Burkholderia cenocepacia K56-2, adhesin, host, glycan structures, recognition, targets, neutralisation, BCAM2418, reduction, adhesion, bacteria, bronchial cells, mucins, in vivo studies, anti-BCAM2418 antibody, inhibitory, infection, Galleria mellonella, glycan, arrays, host, epitopes, TAA, BCAM2418, binding, histo-blood group A, alpha-(1,2)-linked Fuc-containing structures, Lewis structures, GM1, gangliosides, glycan microarrays, specificities, Burkholderia species, intensely, binding carbohydrates]]\n",
      "[[cystic fibrosis, CF, patients, lung transplantation, chronically, infected, Gram-negative opportunistic, pathogens, chronic infections, CF, patients, impact, lung-function, decline, survival, transplantation, rate, timing, re-colonization, transplantation, impact, survival, stratification, bacteria, single-center retrospective analysis, consecutive, CF, patients, lung transplantation, Copenhagen Lung Transplant program, patients, re-transplantation, time, CF, diagnosis, patients, monthly, sputum cultures, transplantation, CF-patients, bronchoscopy, bronchoalveolar lavage, weeks, months, transplantation, sputum samples, relevant, culture results, transplantation, stored, colonization, frequent, bacteria, Pseudomonas aeruginosa, PA, Stenotrophomonas maltophilia, SM, Achromobacter xylosoxidans, AX, Burkholderia cepacia complex, BCC, Pulsed-field gel electrophoresis, PFGE, clonality, bacterial, isolates, lung transplantation, re-colonization, time, transplantation, positive, culture, species, culture, data, analyses, median, cultures, transplantation, colonization-free, days, positive, transplantation, years, patients, re-colonized, PA, SM, AX, BCC, No difference, survival, patients, colonized, years, colonized, Re-colonization, bacteria, lower airways, median, days, transplantation, cohort, patient cohort, survival, re-colonization, bacterial species]]\n",
      "[[accurate, identification, bacterial species, clinical diagnostics, Species, identification, potential, adaptation, empiric, antibiotic, treatments, resistance, Matrix assisted Laser Desorption Ionization Time, Flight mass spectrometry, MALDI-TOF MS, method, bacterial species, identification, species, identification, incomplete, databases, relatedness, species, spectral quality, clinically, bacterial, isolates, species, MALDI-TOF MS, measured, isolates, analytical conditions, MALDI-TOF MS systems, spectral features, associated with, species, identification, databases, features, systematically, spectra, sample preparation, protocols, quantities, bacterial, colony, bacterial, colony, age, identified, ribosomal marker, peaks, detected, median, ribosomal marker, peaks, intensity, detected, peaks, measurement, precision, reproducibility, peaks, spectral quality, formic acid, measuring, bacterial, colonies, young age, MALDI-TOF MS device, increase, mass spectral quality, spectral quality, bacterial taxa, optimal, measurement, conditions, taxon, identified, quality, measures, MALDI-TOF MS, spectral quality, routine settings, Phylogenetic marker, peaks, reproducibly, detected, increased, resolution, species, Enterobacter cloacae complex, Burkholderia cepacia complex, viridans streptococci]]\n",
      "[[atypical, presentations, herpetic infection, immunocompetent, individuals, extensive, chronic, verrucous, appearances, immunocompromised, host, case, genital herpes, manifesting, painless, chronic non-healing genital ulcers, exuberant, granulation tissue, immunocompetent, man, morphology, ulcers, donovanosis, knowledge, presentation, genital herpes, immunocompetent, individual]]\n",
      "[[Donovanosis, chronic indolent, sexually, granulomatous ulceration, genito-inguinal region, Calymmatobacterium granulomatis, antibiotics, years, condition, genital ulcers, HIV infection, episode, genital donovanosis, complicated, squamous cell carcinoma, middle aged, female, rarity, clinical]]\n",
      "[[Granuloma inguinale, GI, chronic, progressive, mildly contagious disease, venereal origin, characterized, granulomatous ulceration, genitalia, neighboring, sites, spontaneous healing, Klebsiella, male, fissured, foul smelling, fungating growth, prepuce, phimosis, squamous cell carcinoma, SCC, lymphadenopathy, painless papulonodular, pseudoepitheliomatous hyperplasia, infiltration, dermis, acanthosis, vacuolated macrophages, GI, histopathological, features, SCC, Patient, treated, cotrimoxazole, day, days, case, GI, mimicking, SCC, penis, diagnosed, histopathology, treated with, excision, medical therapy, cotrimoxazole]]\n",
      "[[man, ulcerovegetative, lesions, anogenital region, month, presentation, patient, history, travel, African countries, ulcerovegetative, lesions, patient, suspected, granuloma inguinale, GI, Calymmatobacterium granulomatis, examination, scrapings, base, ulcerovegetative lesion, histological examination, cutaneous metastasis, mucinous adenocarcinoma, rectum, diagnosis, GI, eliminated, patient, history, rectal cancer, travelled, African countries, diagnosis, GI]]\n",
      "[[Haemophilus ducreyi, Klebsiella, sexually transmitted, bacteria, characteristic, ulceration, external genitals, chancroid, granuloma inguinale, ulcers, endemic, countries, granuloma inguinale, geographic, hot spots.\"H. ducreyi, genus, Haemophilus, family Pasteurellacae, phylogenetic position, multiple, bacterium, econiche, specialized, nutrient, acquisitions, defenses, immune system, virulence factors, increase, attachment, fitness, persistence, genital tissue, analysis, K. granulomatis, phylogeny, degree, identity, Klebsiella species, K. granulomatis comb, difficulty, bacterium, artificial media, characteristics, studies, bacterial, genetics, pathogenesis, evolution, K. granulomatis]]\n",
      "[[authors, images, clinical forms, granuloma inguinale, donovanosis, males, females, Donovanosis, sexually transmitted disease, endemic, tropical, subtropical regions, world, microscopic images, direct smear, presence, Donovan bodies, mononuclear cells, identified, Giemsa stain, histological, findings, rod-shaped Donovan bodies, mononuclear histiocyte]]\n",
      "[[Donovanosis, rare, sexually transmitted, infection, sporadic, cases, Papua, South Africa, India, Brazil, Australia, causative organism, Calymmatobacterium granulomatis, proposal, organism, Klebsiella granulomatis, incubation, period, days, genital papules, ulcers, increase, size, lesions, described, ulcerogranulomatous, hypertrophic, necrotic, sclerotic, diagnosis, microscopic, identification, Donovan bodies, stained, tissue, smears, polymerase chain reaction, methods, recommended, treatment, azithromycin, weekly, healing]]\n",
      "[[Donovanosis, progressive, granulomatous ulcerative disease, Klebsiella, disease, years, complications, male, patient, aged, years, HIV-2, infection, department, STD, painful, ulceration, genital region, months, duration, absence, penis, Tissue smear, ulcer, histopathological, examination, histiocytes, intracellular, Donovan bodies, Pund cell, diagnosis, donovanosis, auto-amputation, penis, HIV-2 infection, streptomycin, doxycycline, amoxycillin, effective, HIV-2 infections, HIV-1, infections, aspects, donovanosis, HIV-2, infected, case, complications, CD4 count, severity, long standing, nature, negligence, patient, immunodeficiency]]\n",
      "NaN\n",
      "[[Chlamydia pneumoniae, Cp, obligate, intracellular, human, respiratory pathogen, lung infection, asthma, pathogenesis, population, risk, treatable, Cp infection, asthma, author, un-reviewed, cross sectional, prospective controlled studies, Cp, biomarkers, chronic asthma, children, adults, Qualitative, quantitative, estimates, population, risk, biomarkers, IgG, IgA, IgE, FINDINGS, long-term, prospective population-based studies, Cp infection, asthma, identified, case-control studies, associations, Cp, biomarkers, chronic asthma, Heterogeneity, results, age group, pediatric, adult, asthma, severity, severe/uncontrolled, moderate/partly controlled, mild/controlled), antibody isotype, IgG, IgA, IgE, qualitative, results, meta-analyses, population, risks, Cp-specific IgG, IgA, children, confidence interval, adults, nul, small population, risks, Cp-specific IgG, IgA, population, risk, C. pneumoniae-specific IgE, children, adults, combined, studies, asthma, severity, categories, Cp, biomarkers, positively, associated with, asthma, severity, C. pneumoniae-specific IgE, associated with, asthma, asthma, severity, mechanism, chronic, Cp infection, asthma, individuals, asthma, Infection, biomarkers, macrolide, treatment trials, severe, uncontrolled, asthma]]\n",
      "[[Chlamydia psittaci, etiological agent, chlamydiosis, birds, transmitted, humans, severe, systemic disease, C. psittaci, infects, hosts, strains, isolated, birds, mammals, reduced, infectious, zoonotic, potential, Comparative analysis, chlamydial genomes, coding sequences, polymorphic membrane proteins, Pmps, Pmps, characterized, adhesins, C. trachomatis, C. pneumoniae, immunoreactive proteins, Chlamydia species, Pmps, associated with, tissue, tropism, pathogenicity, C. psittaci, Pmps, infectious, potential, host, tropism, avian, mammalian, C. psittaci, strains, dependent, differences, Pmp, repertoires, study, experimentally, virulence, avian, mammalian, strains, testing, survival rate, infected, embryonated eggs, chlamydiae, dissemination, embryos, investigated, involvement, Pmps, host, tropism, Analysis, pmp sequences, C. psittaci, strains, degree, variation, correlation, host, tropism, identified, comparison, Pmp, expression, profiles, strains, Pmps, G group, expressed, avian, mammalian, strains, investigate, functions, Pmps, recombinantly, avian, mammalian, strain, adhesion, abilities, relevance, infection, C. psittaci, strains, avian, mammalian cells, tested, identified, Pmp22D, Pmp8G, OmcB, adhesins, infection, C. psittaci, strains, Pmp17G, player, host, adaptation, bind, influence, infection, avian cells, impact, infection, mammalian cells, data, hypothesis, Pmp, repertoires, combination, host factors, host, tropism, C. psittaci, strains]]\n",
      "[[Chlamydia pneumoniae, Cp, Mycoplasma pneumoniae, bacteria, atypical, pathogens, pneumonia, exacerbate, conditions, asthma, chronic obstructive pulmonary disease, Australian, Capital Territory, information, seasonal patterns, positive infections, testing, gap, control strategies, seasonal patterns, immunoassay, results, patients, Canberra Hospital, Australia, tested, Cp, Myco, Pathology data, patients, analysed, time series, decomposition, time series regression, proportion, positive, Cp infections, autumn, lowest, winter, proportion, positive, Myco infections, December, January, summer, lowest, winter, testing, pathogen, winter, low, summer, Models, long-term, trend, variable, month, data, null models, infections, seasonal patterns, testing, proportion, positive infections, findings, preventative, measures, infections, seasonal testing, practices, accurate, picture, temporal, changes, infections]]\n",
      "[[evidence, infectious agents, viruses, bacteria, parasites, development, Alzheimer's disease, AD, primary suspects, herpes viruses, spirochetal bacteria, Chlamydia pneumoniae, Porphyromonas gingivalis, mycobacteria, toxoplasma, parasites, antimicrobial, antiviral agents, treat, AD, interventions, evidence, clinical trials, drugs, federally approved, treatments, delay, halt, reverse, AD]]\n",
      "[[associations, inhaled corticosteroid, ICS, pulmonary infections, Chlamydia pneumoniae, C. pneumoniae, asthma, exacerbations, data, ICS, effects, C. pneumoniae infections, investigated, fluticasone propionate, FP, budesonide, BUD, C. pneumoniae, in vitro, in vivo, mechanisms, anti-chlamydial outcomes, qPCR, detect, C. pneumoniae, growth, infected, FP-treated, BUD-treated, A549 cells, FP, BUD, administered, inhalation, C. pneumoniae-infected mice, recoverable, C. pneumoniae, indirect, immunofluorescence, Expression levels, interferon, (IFN)-gamma, IFN-gamma, inducible, chemokines, assessed, qPCR, measured, protein, concentrations, IFN-gamma, cytokines, participate, anti-chlamydial response, ELISA, FP, treatment, suppressed, Chlamydia growth, A549 cells, mice, levels, IFN-gamma, gene expression, FP-treated, mice, untreated, BUD-treated mice, IFN-gamma, anti-chlamydial protein, MIG/CXCL9, values, FP, inhalation, FP, BUD, suppressed, C. pneumoniae, growth, in vitro, in vivo, enhanced, IFN-gamma, responses]]\n",
      "[[Early detection, family Chlamydiaceae, pathogens, rapid, sufficient, management, atypical, pneumonia, GENECUBE, TOYOBO, automated, gene analyzer, amplifying, detecting, target, DNAs, study, PCR assay, quenching probe, PCR-QC, assay, Chlamydia pneumoniae, CPN, Chlamydia psittaci, CPS, PCR-QC, assay, simultaneously, detect, DNA fragments, melting temperatures, frozen, samples, patients, respiratory tract infection, PCR-QC, assay, cell culture method, gold, Kappa index, agreement, PCR-QC, assay, culture method, confidential interval, CI, sensitivity, specificity, PCR-QC, assay, CI, CI, samples, positive, CPN, CPS, method, PCR TaqMan assay, results, PCR-QC, assay, PCR-QC, assay, GENECUBE, shortened, detection, CPN, CPS, PCR TaqMan assays, PCR-QC, GENECUBE, CPN, CPS, pathogens, clinical laboratory, improve, management, atypical, pneumonia]]\n",
      "[[OBJECTIVE, Epicardial fat thickness, EFT, chlamydia infection, cardiovascular risk factors, coronary artery disease, CAD, evaluate, effect, coexistence, EFT, chlamydia infection, presence, severity, CAD, patients, stable angina pectoris, SAP, study, patients, SAP, CAD, group, control group, presence, Chlamydia pneumoniae-IgG, CP-IgG, EFT, left ventricular ejection fraction, LVEF, groups, CP-IgG, LVEF, EFT, predictors, CAD, CP-IgG, OR=1.559, LVEF, OR=0.798, EFT, OR=3.175, statistically significant, interaction, detected, CP-IgG, EFT, predicting, presence, CAD, positive, correlation, EFT, Gensini score, interaction, CP-Ig, EFT, CAD, development, interaction, CP-IgG, EFT, inflammatory process]]\n",
      "[[Chlamydia pneumoniae, C. pneumoniae, obligate, intracellular, bacterial pathogen, investigated, potential, developmental, factor, pathologies, C. pneumoniae, infects, respiratory tract, associated with, extrarespiratory manifestations, case, young, patient, acute acalculous cholecystitis, AAC, acute pericarditis, chlamydia pneumoniae infection, hematogenous, lymphogenous, routes, systemic, dissemination, Chlamydia pneumoniae infection]]\n",
      "[[Chlamydiae, obligate, intracellular, pathogens, secreted, effector proteins, intracellular, niche, issue, Journal of Bacteriology, screen, C. pneumoniae effectors, C. trachomatis, proteins, translocated, infection, Yanatori, genetic approaches, C. trachomatis, characterize, virulence factors, Chlamydia species]]\n",
      "[[Chlamydia psittaci, infection, zoonotic infectious disease, inhaled, lungs, secretions, poultry, pathogenic bacteria, respiratory specimens, serological antibody testing, slow, false-negative rate, Metagenomic next-generation sequencing, mNGS, diagnosis, retrospectively, clinical characteristics, C. psittaci, pneumonia, patients, diagnosed, mNGS, literature review, clinical characteristics, patients, C. psittaci, pneumonia, C. psittaci, pneumonia, patients, mNGS, aged, years, males, patients, history, contact, avian, poultry, patients, fever, degrees, cough, hypodynamia, hypoxemia, dyspnea, admission, patients, invasive ventilator support, extracorporeal membrane oxygenation, Inflammatory index, levels, admission, follow-up, normal values, Doxycycline, moxifloxacin, combination therapy, patients, patients, improved, discharged, patient, died, organ failures, disseminated, intravascular coagulation, articles, C. psittaci, pneumonia, patients, patients, publications, mNGS, patients, treated with, tetracycline, quinolone, outcomes, mNGS, diagnosis, increase, detection, rate, diagnosis, time, C. psittaci, pneumonia, case-control studies, confirm]]\n",
      "[[Chlamydia, gram-negative, microorganism, human, animals, study, systematic review, meta-analysis, Chlamydia infection, swine, China, PubMed, ScienceDirect, Chinese Web of knowledge, CNKI, VIP Chinese journal database, Wanfang database, publications, prevalence, Chlamydia, China, sampling, year, subgroup, prevalence, highest, southern China, prevalence, prevalence, northern China, difference, significant, provincial, level, Hubei, rate, Boars, higher, prevalence, prevalence, Chlamydia, detection, pigs, reproductive disorders, reproductive disorders, age groups, finishing, pigs, highest, prevalence, prevalence, large-scale farmed, pigs, subgroup, feeding methods, prevalence, farms, survey, prevalence, spring, methods, highest, prevalence, enzyme-linked immunosorbent assay, ELISA, indirect, hemagglutination, assay, prevalence, Chlamydia psittaci, prevalence, Chlamydia abortus, analyzed, impact, climate factor, rainfall, temperature, humidity, probability, pigs, suffering, disease, results, Chlamydia, pigs, China, detection, Chlamydia, semen, breeding, pigs, pigs, reproductive disorders, environment, large-scale, pig, farms, infection, Chlamydia, pigs]]\n",
      "NaN\n",
      "[[Psittacosis, zoonotic disease, Chlamydia psittaci, C. psittaci, risk, animal, industry, human, health, Lack, commercial, effective, vaccines, C. psittaci, infection, Polymorphic outer membrane protein Gs, PmpGs, diverse, C. psittaci, C. psittaci, infection, study, pmp20G gene, cloned, pET-28a vector, plasmid, Escherichia coli Rossetta, DE3, denaturation, renaturation, recombinant Pmp20G-N, SDS-PAGE, Western-blot, Pmp20G-N, coating antigen, indirect, ELISA, assay, specificity, sensitivity, Pmp20G-N ELISA, MOMP-ELISA, sensitivity, specificity, concordance, MOMP-ELISA, Pmp20G-N ELISA, assay, Pmp20G-N ELISA, potential, diagnostic antigen, detection, C. psittaci, antibody, studies, differentiating, C. psittaci, Chlamydia spp., C.psittaci-specific serovars, Pmp20G-N ELISA]]\n",
      "[[AIMS, frequency, Chlamydia psittaci infection, shedding, dynamics, C. psittaci, C. psittaci, genotype, diversity, waterfowl, resident, rehabilitation facility, mallards, wild, Conjunctival-choanal-cloacal swabs, healthy, captive, wild mallards, Anas platyrhynchos, paradise shelducks, Tadorna variegata, housed, waterfowl, breeding, rehabilitation facility, Wellington, NZ, wild mallards, Palmerston North (n=50), Southland, DNA, swabs, analysed, quantitative PCR, qPCR, high-resolution melt curve, analysis, targeting, ompA gene, C. psittaci, captive, waterfowl, mallards, paradise shelducks, positive, C. psittaci, wild mallards, wild mallards, paradise shelducks, C. psittaci, genotype, captive, wild mallards, genotypes, C, mixed infection, genotypes, Captive, wild mallards, paradise shelducks, shedding, 5x10(4, 1x10(5, 4x10(5, copies, C. psittaci, DNA, swab, wild mallards, shedding, DNA, qPCR-HRM analysis, proportion, wild mallards, infected, C. psittaci, birds, shedding, bacterial DNA, proportion, sampled, ducks, infected, amount, bacterial, shedding, birds, wildlife, rehabilitation facility, C. psittaci, genotype, mallards, paradise shelducks, genotype, detection, C. psittaci, genotype, co-infection, genotype A, C, ducks, results, mallards, reservoir, C. psittaci, zoonotic, risk, people, duck, hunting, wildlife care, recreational duck, feeding, Mallards, transmission, risk, native, birds, captive facilities, conservation, management, endangered, native, birds]]\n",
      "[[estimated, diagnosed, patients, marginal zone lymphoma, MZL, US, mature, non-Hodgkin lymphomas, NHL, data, US, SEER-18, program, age-standardized, incidence, MZL, person-years, MZL, cases, splenic MZL, SMZL, nodal MZL, NMZL, extranodal MZL, EMZL, mucusa-associated lymphoid tissue, MALT, Incidence rates, men, SMZL, NMZL, EMZL, increased, age, MZL, subtypes, incidence, MZL, non-Hispanic whites, Hispanics, races, non-Hispanic blacks, Asian/Pacific islanders, incidence, MZL, increased, year, US, increases, countries, relative survival rate, MZL, US, racial/ethnic groups, sex, survival rates, increasing, US, countries, Established, risk factors, MZL, MZL, subtypes, family history, NHL, genetic loci, HLA region, Helicobacter pylori infection, gastric MALT lymphoma, autoimmune diseases, Sjogren syndrome, systemic lupus erythematosus, Hashimoto thyroiditis, evidence, Chlamydia psittaci, ocular adnexal, MALT lymphoma, Borrelia burgdorferi, cutaneous MZL, hepatitis C virus, human immunodeficiency virus, solid organ transplantation, risk factors, study, infections, autoimmune conditions, trichloroethylene, exposure, occupations, hair dye, cigarette smoking, sun exposure, protective, alcohol use, protective, MZL, model, antigen-driven malignancy, epidemiologic risk factors, tissue-specific factors, host, immune response, impact, chronic inflammation, immunosuppression, lymphomagenesis, prevention]]\n",
      "[[patient, dyspnea, painful, ulcers, multi-organ failure, positive, PCR testing, Chlamydia psittaci, history, diagnosis, clinicians, dyspnea, multi-organ failure, psittacosis]]\n",
      "[[Chlamydia, psittaci, causative agent, avian, chlamydiosis, human, psittacosis, study, single-nucleotide polymorphisms, SNPs, genome sequences, C. psittaci, strains, identified, lineages, host-related, PCR/high-resolution melting, assay, screen, phylogenetically informative, SNPs, identified, C. psittaci, lineages, PCR-HRM, method, strains, isolates, PCR-HRM, clustering, consistent with, genotyping, data, ompA, MLST, analysis, method, C. psittaci-positive samples, animal, human, cases, PCR-HRM, typing, results, human, samples, genotypes, ducks, pigeons, source, human, exposure, poorly, Mat116-like genotype, genotyping method, sequencing, identification, source, infection]]\n",
      "[[Ehrlichia spp, tick-borne, pathogens, animals, Brazil, Ehrlichia canis, species, infecting, dogs, Ehrlichia minasensis, identified, ehrlichial agent, infects, cattle, Brazil, study, dogs, infected, E. minasensis, investigate, sera, dogs, Pantanal region, retrospectively analyzed, presence, antibodies, E. canis, E. minasensis, Canine, sera, screened, isolates, E. canis, indirect, IFA, antibodies, endpoint, titers, E. canis-specific antibodies, IFA, positive, sera, analyzed, ELISA, E. canis-specific peptides, TRP19, TRP36, detected, E. canis antibodies, dog, sera, samples, detectable, antibodies, E. canis, IFA, negative, E. canis peptide, ELISA, sera, tested, E. minasensis IFA, Cuiaba strain, antigen, positive, titers, sera, antibody, titers, E. minasensis, E. canis, dogs, infected, E. minasensis, results, study, ehrlichial agents, infect, dogs, Brazil, Ehrlichia spp, Brazilian dogs, dogs, tick, species, investigation, serologic, evidence, E. minasensis infection, dogs, Brazil]]\n",
      "[[Hemophagocytic lymphohistiocytosis, HLH, multi-organ failure, release, multiple, cytokines, widespread, inflammation, patient, multiple myeloma, maintenance, chemotherapy, anti-CD38, monoclonal antibody, daratumumab, autologous stem cell transplant, ASCT, fatal, HLH, secondary to, Ehrlichiosis]]\n",
      "[[diagnostic performance, routine electrophoresis, agarose gel electrophoresis, AGE, capillary zone electrophoresis, CZE, species-specific immunofixation, IF, detection, immunoglobulin paraproteins, M-proteins, diagnosis, secretory myeloma-related disorders, sMRD, improved, Available canine, IF, targets, IgG-FC, IgA, IgM, light chain, LC, IgG4, free, LC, fLC, review, features, associated with, presence, M-proteins, canine, serum, samples, features, inaccurate, M-proteins, improve, diagnostic performance, routine, electrophoresis, IF, detection, M-proteins, Features, AGE, CZE, routine, IF, IgG4, IF, fLC, IF, canine, serum, study, evaluated, multivariate logistic regression, factors, associated with, presence, M-proteins, Cases, negative, positive, M-proteins, reviewed, features, increase, diagnostic performance, SPE, IF, M-protein detection, presence, hypogammaglobulinemia, peak taller, albumin, associated with, M-protein, concentrations, globulin concentrations, peaks, albumin, associated with, M-protein, Free LC, sMRD, cases, diagnosed, SPE, routine, IF, Cases, infectious, inflammatory etiologies, polyclonal gammopathy, gamma-globulin, restrictions, false-positive results, SPE, combined, IF, results, features, identified, study, estimated, sensitivity, specificity, criteria, study, increase, diagnostic performance, electrophoretic evaluation, M-proteins]]\n",
      "[[effects of, respiratory inhibitors, quinone analogues, artificial substrates, membrane-bound electron transport system, fastidious, Eikenella corrodens, O2-limited, NADH, respiration, isolated, membrane particles, inhibited, rotenone, dicoumarol, quinacrine, flavone, capsaicin, response, succinate, oxidation, presence, thenoyltrifluoroacetone, N, N'-dicyclohexylcarbodiimide, NADH, respiration, resistant, site II inhibitors, cyanide, percentage, electrons, transported, O2, bc1 complex, Succinate, respiration, sensitive, myxothiazol, antimycin A, 2-heptyl-4-hydroxyquinoline-N-oxide, HQNO, Juglone, plumbagin, menadione, reactivity, NADH dehydrogenase, membrane particles, oxidase activities, ascorbate-TCHQ, tetrachlorohydroquinone, TCHQ, NADH-TMPD (N,N, N',N'-tetramethyl-p-phenylenediamine, minor, activity, ascorbate-DCPIP, NADH-DCPIP, substrates NADH-DCPIP, NADH-TMPD, TCHQ, electron donors, cyanide-sensitive cbb' cytochrome c oxidase, presence, dissimilatory, nitrate reductase, aerobic, respiratory system, E. corrodens ATCC 23834, results, complexes I, II, resistance, inhibitors, oxidation, NADH, stimulated, juglone, plumbagin, menadione, sensitivity, KCN, substrates, TCHQ, NADH-DCPIP, NADH-TMPD]]\n",
      "[[case, patient, morbid history, brain abscess, secondary to, endocarditis, Eikenella corrodens, diagnosis, detecting, microorganism, universal polymerase chain reaction, fluid, brain collection, Trans-esophageal echocardiogram study, vegetations, mitral valve, External ventricular shunt, placement, emptying, abscess, brain ventricles, secondary hydrocephalus, days, effective, antibiotic, treatment, evolution, resolution, infection, images, echocardiogram, Follow-up, months, ventricule-peritoneal drainage valve dysfunction, infection]]\n",
      "[[Severe, periodontal disease, worldwide, affecting, population, ages, years, etiological, epidemiology, Peru, studies, prevalence, periodontal disease, general population, Periodontitis, oral diseases, associated with, oral microbiota, associated with, socioeconomic state, study, etiology, resistance, bacteria, identified, group, Peruvian, patients, periodontal disease, subgingival, plaque, samples, patients, severe, periodontitis, Bacterial, identification, culture, PCR amplification, DNA sequencing, evaluated, antibiotic susceptibility, disk diffusion method, Variable, diversity, oral microbiota, identified, patients, bacterial genus, Streptococcus spp., Rothia spp., Actinomyces spp., Eikenella spp., species, Rothia dentocariosa, antimicrobial susceptibility assay, species, tested, isolates, evaluated, Actinomyces naeslundii, resistant, penicillin, tetracycline, Eikenella corrodens, resistant, dicloxacillin, Rothia dentocariosa, resistant, amoxicillin, clavulanic acid, metronidazole, susceptible, trimethoprim-sulfamethoxazole, periodontal bacterium, study, Rothia dentocariosa, antimicrobial therapy, improve, treatment, outcomes, patients, periodontal disease, antibiotic resistance]]\n",
      "[[HACEK, Haemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, Kingella spp., group organisms, infective endocarditis, cases, Cardiobacterium spp., HACEK, microorganism, genus, Cardiobacterium valvarum, C. valvarum, organism, cases, C. valvarum, infection, English-language literature, cases, infective endocarditis, patients, valvular disease, C. valvarum, infections, spreading, bone, case, man, history, aortic dissection, aortic endograft replacement, back pain, radiographic, evidence, infected, aortic endograft, vertebral osteomyelitis, discitis, epidural phlegmon, Blood cultures, C. valvarum, causative organism, patient, treated with, ceftriaxone, surgical intervention, deferred, patient's, complex, anatomy, septic cerebral emboli, cerebrovascular, accident, case report, C. valvarum, rare, HACEK, group, microorganism, high-risk, patients, evidence, subacute infection, disseminated disease, C. valvarum, infective endocarditis, extra-cardiac manifestations, case, endograft, involvement, osteomyelitis, rare, circumstances]]\n",
      "[[case, male, tissue necrosis, necrotizing fasciitis, right upper extremity, puncture injury, black locust tree, Robinia pseudoacacia, Blood, intraoperative, wound cultures, Streptococcus constellatus, Eikenella corrodens, infection, treatment, IV antibiotics, fasciotomy, multiple, debridements, defect, negative, wound therapy, Integra, Dermal Regeneration, Plainsboro Township, NJ, split-thickness skin grafts, uncommon, plastic surgeons, tissue necrosis, associated with, robin toxalbumin, cases, black locust tree, Robin toxalbumin, cellular death, inhibiting, protein synthesis, patient, toxalbumin, black locust tree fragment, extensive, tissue necrosis, nidus, necrotizing fasciitis]]\n",
      "[[Infective endocarditis, Acinetobacter, baumannii, rare, severe, complication, ill, hospitalized patients, invasive procedures, associated with, increased, mortality rate, endocarditis, HACEK, group, Haemophilus species, Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella kingae, gram-negative bacteria, case, woman, diagnosed, infective endocarditis, A. baumannii, days, admission, intensive unit care, ICU, diagnosis, blood cultures, transthoracic echocardiography, mobile vegetation, mitral valve, aggressive, therapeutic regimens, outcomes, poor, patient, died, report, severe, nature, A. baumannii, infections, associated with, prolonged, hospital stay, increased, morbidity, mortality, medical costs]]\n",
      "[[PURPOSE, study, investigate, efficacy, validity, subgingival, bacterial, retraction cord, evaluate, sampling method, changes, periodontal conditions, periodontal therapy, clinical examinations, subjects, healthy group, periodontitis, group, Clinical measurements, subjects, periodontal probing depth, PD, bleeding, probing, BOP, clinical attachment loss, CAL, plaque, Saliva, gingival crevicular fluid, GCF, subgingival, bacterial, sampled, months, periodontal therapy, salivary, subgingival, bacterial, analyzed, reverse-transcription polymerase chain reaction, quantify, periodontal pathogens, Aggregatibacter actinomycetemcomitans, Aa, Porphyromonas gingivalis, Pg, Tannerella forsythus, Tf, Treponema denticola, Td, Prevotella intermedia, Pi, Fusobacterium nucleatum, Fn, Pavimonas micra, Pm, Campylobacter rectus, Cr, Prevotella nigrescens, Pn, Eikenella corrodens, Ec, Eubacterium nodatum, Non-surgical periodontal therapy, decreases, PD, CAL, BOP, months, species, Pg, Tf, Pi, Pm, abundant, samples, periodontitis, group, healthy group, periodontal therapy, Cr, bacterium, statistically significant, decrease, saliva, statistically significant, decreases, Cr, Pg, Pn, GCF, Salivary, subgingival, bacterial, gingival retraction cord, equivalent, accuracy, periodontitis, GCF, changes, bacterial, abundance, periodontal therapy, sensitively, saliva]]\n",
      "[[Periodontitis, chronic inflammatory disease, interactions, periodontal bacteria, homeostasis, host, investigate, performance, reliability, machine learning, models, predicting, severity, chronic periodontitis, Mouthwash samples, subjects, healthy controls, generalized chronic periodontitis, patients, genomic DNA, isolated, copy numbers, pathogens, measured, multiplex qPCR, pathogens, Porphyromonas gingivalis, Pg, Tannerella forsythia, Tf, Treponema denticola, Td, Prevotella intermedia, Pi, Fusobacterium nucleatum, Fn, Campylobacter rectus, Cr, Aggregatibacter actinomycetemcomitans, Aa, Peptostreptococcus anaerobius, Pa, Eikenella corrodens, Ec, species, accuracy, optimal, combination, input features, algorithm, severity, periodontitis, machine learning techniques, accuracy, models, healthy, moderate, severe, periodontitis, M-S, average, accuracy, models, AUC, sensitivity, specificity, diagnostic odds ratio, red complex, pathogens, models, chronic periodontitis, patients, healthy controls, accuracy, AUC, sensitivity, specificity, diagnostic odds ratio, accuracy, reduced, models, reliability, predicting, severity, chronic periodontitis, samples, results, well-designed combination, salivary bacteria, biomarker, periodontally healthy, group, chronic periodontitis, group]]\n",
      "[[study, investigate, changes, saliva, concentration, inflammatory marker, MRP-8/14, presence, periodontitis-associated bacteria, patients, mixed dentition, treated with, rigid acrylic, bonded maxillary expander, patients, mixed dentition, treated with, bonded, palatal expander, longitudinal study, Saliva samples, therapy, weeks, months, therapy, sample, levels, MRP-8/14, ELISA, presence, bacteria, detected, PCR, DNA-DNA hybridization, Salivary, concentration, MRP-8/14, amount, Tannerella forsythia, Treponema denticola, Eikenella corrodens, increased, treatment, bonded maxillary expander, changes, transient, maximal, levels, MRP-8/14, periodontitis-associated, pathogens, months, therapy, Therapy, bonded maxillary results, MRP-8/14, levels, increased, prevalence, periodontitis-associated bacteria, T. forsythia, T. denticola, E. corrodens, results, detection, salivary, MRP-8/14, levels, oral, children, fixed orthodontic treatment, data, treatment, bonded maxillary expander, influence, oral health status, oral health, therapy]]\n",
      "NaN\n",
      "[[beta-defensin, components, innate immune system, vertebrates, evidence, antimicrobial, antibiofilm, immunomodulatory activities, mammals, beta-defensins, vertebrate species, crocodylians, study, crocodylian, variants, Alligator mississippiensis, Crocodylus porosus, synthesis, characterization, charge, hydrophobicity, values, Linear peptides, synthesized, folded, purified, evaluated, antimicrobial, antibiofilm activities, bacterial, pathogens, Salmonella enterica serovar Typhimurium, Staphylococcus aureus, Enterobacter cloacae, Acinetobacter baumannii, Am23SK variant, SCRFSGGYCIWNWERCRSGHFLVALCPFRKRCCK, A. mississippiensis, activity, planktonic cells, bacterial biofilms, human beta-defensin 3 under, experimental conditions, cytotoxicity, mammalian cells, immunomodulatory effects, in vitro, suppressing, production, proinflammatory mediators, stimulated, human, bronchial epithelial cells, results, activity, landscape, crocodylian, reptilian beta-defensin]]\n",
      "[[adaptation, mechanism, wild type, WT, resistant type, aerobic, Enterobacter cloacae strain, HNR, short-term, ZnO, nanoparticle, NP, stresses, investigated, results, Re, nitrite reductase, NIR, nitrate reductase, NR, activities, increment, reactive oxygen species, ROS, WT, ZnO, NP, stresses, affinity constant, KA, WT, Zn(2+), Re, Re, repulsive, Zn(2+), ZnO, NPs, Transcriptomic analysis, up-regulation, nitrogen metabolism, Re, NIR, NR, activities, enhancement, purine metabolism, lowered, intracellular, ROS, increment, up-regulation, cationic antimicrobial peptide, resistance, KA, Re, Zn(2+), findings, adaptation, mechanism, aerobic, denitrifying, bacteria, ZnO, NPs]]\n",
      "[[Colistin, antimicrobial, treat, infections, multi-drug resistant, Gram-negative rods, MDRGNR, emergence, colistin, resistance, mobile genetic elements, mcr genes, threat, management, MDRGNR, infections, study, assess, presence, mcr genes, collection, colistin-resistant, commensal, Escherichia coli, isolated, healthy, pigs, cattle, poultry, Belgium, isolates, mcr gene, mcr-1, collection, replicons, associated with, mcr genes, IncHI2/IncHI2A, associated with, mcr-1, IncX4, mcr-1, mcr-2, ColE10 with, mcr-4, multiple, mcr genes, isolate, triple, occurrence, mcr-1, -3, study, isolates, multi-drug resistant, replicons, sequence types, E. coli, isolates, study, presence, reservoir, mobile resistant genes, colistin, mcr-1, mcr-5, years, commensal, gut flora, pigs, cattle, poultry]]\n",
      "[[Shiga toxin, AB5 toxin, Shigella species, toxins, Shiga toxin-producing, Escherichia coli, STEC, Infection, Shigella, bloody diarrhea, fatal, hemolytic uremic syndrome, HUS, effective, toxin, inhibitor, comparing, classes, carbohydrate-based inhibitors, glycodendrimers, glycopolymers, oligosaccharides, enhancement, potency, multivalent, inhibitors, divalent, tetravalent, compounds, inhibiting, millimolar, micromolar, polymeric inhibitor, galabiose, nanomolar, inhibition, Alginate, chitosan oligosaccharides, inhibit, Shiga toxin, prophylactic drug, shigella, outbreaks]]\n",
      "[[plasmid-mediated colistin-resistance gene, mcr-1, countries, public health, studies, spread, Escherichia coli, mcr-1 gene, community, hospital settings, colistin-resistant, E. coli, mcr-1, community, healthcare-acquired infections, colonization, identified, complexity, hospitals, Sao Paulo, Brazil, colistin-resistant, isolates, screened, mcr genes, PCR, strains, Whole Genome Sequencing, conjugation, experiment, strains, sequence types, ST744, ST131, ST69, ST48, ST354, ST57, ST10, resistance profiles, Transference, mcr-1, conjugation, E. coli, strain C600, isolates, mcr-1 gene, plasmid, IncX4, IncI2, isolates, ESBL-encoding genes, blaCTX-M-2, report, genetically, E. coli, isolates, STs, mcr-1 gene, associated to, community, healthcare-acquired infections, colonization, patients, hospitals, Sao Paulo, findings, potential, spread, plasmid-mediated colistin-resistance mechanism, E. coli, strains, Brazil]]\n",
      "[[study, finite-time stabilization, asymptotic stabilization, probability, Markovian jump Boolean control networks, MJBCNs, sampled-data state feedback controls, SDSFCs, semi-tensor product, STP, augmented, variable, vector, switching signal, state, MJBCN, SDSFC, sequence, states, augmented, variable, sampling, instants, Markov property, convergences, switching signal, augmented, variable, sufficient, criteria, finite-time stabilization, asymptotic stabilization, MJBCNs, SDSFCs, stabilization, feedback, matrices, SDSFCs, results, apoptosis, network, model, lactose operon, Escherichia Coli]]\n",
      "[[Antimicrobial resistance, AMR, spreads, pathogenic, commensal bacteria, reservoir, resistance genes, study, investigate, AMR, patterns, presence, mobilized, colistin, resistance, commensal, Escherichia coli, circulating, chickens, farm, environments, street foods, human, patients, Materials, Methods, cross-sectional survey, isolates, samples, tested, AMR, profiles, antimicrobials, MIC, phenotypically, colistin-resistant, isolates, screened, mcr genes, sequencing, mcr-1 gene, multidrug-resistant, MDR, isolates, E. coli, strains, isolated, polymerase chain reaction, Antimicrobial susceptibility testing, confidence interval, CI, isolates, MDR, CI, isolates, resistance, colistin, MIC, values, colistin, isolates, human, patients, colistin-resistant, isolates, sources, isolation, mcr-1 gene, abundance, commensal, MDR, E. coli, strains, acquisition, mcr-1 gene, chickens, farm, environments, Bangladesh]]\n",
      "[[Neurologic manifestations, associated with, Covid-19, stroke, acute cerebrovascular events, cardiovascular risk factors, associated with, age, young adults, medical, cardiovascular history, stroke, Covid-19, stroke, mechanisms, inflammatory storm, hypercoagulability, vasculitis, pediatric, stroke, cases, associated with, Covid-19, cardioembolic, mechanism, focal cerebral arteriopathy, case, adolescent, febrile meningism, stupor, Clinical, biological, radiological, features, diagnosis, Lemierre syndrome, LS, Fusobacterium necrophorum infection, sphenoid sinusitis, meningitis, intracranial vasculitis, patient, concurrent, SARS-CoV-2 infection, medical, surgical, antimicrobial, treatment, stroke, prevention, venous thrombosis, prevention, severe, cerebrovascular, complications, Venous thrombosis, stroke, extension, intracranial vasculitis, death, F. necrophorum, SARS-CoV-2, inflammation, coagulation, activate, endothelial cells, coinfection, potentiated, aggravated, course, LS, potentiation, SARS-CoV-2, vascular, thrombotic effects, bacterial infection, underreported, cerebrovascular injury, mechanism, Covid-19, patients, findings, mechanisms, stroke, disease, SARS-CoV-2 pandemic, sanitary, measures, lockdown, fear, attend, medical facilities, delayed diagnosis, influenced, outcomes, case, clinical assessment, limits, telemedicine, acute, diagnosis]]\n",
      "[[Lemierre's syndrome, illness, characterized, internal jugular vein thrombophlebitis, infectious agents, Fusobacterium necrophorum, bacteria, oropharynx, gastrointestinal tract, pylephlebitis, condition, development, hepatic abscesses, manifestation, disease, abdominal variant, Lemierre's syndrome, Patients, gastrointestinal malignancies, surgeries, susceptible, abdominal variant, Lemierre's syndrome, Timely, diagnosis, life-threatening, complications, abdominal variant, Lemierre's syndrome, Diffusion-weighted magnetic resonance imaging, MRI, disease, liver metastasis, patients, malignancies, Radiologists, clinicians, condition, prevent, misdiagnosis, prompt, treatment, lifesaving]]\n",
      "[[Fusobacterium necrophorum, tonsillar flora, studies, Europe, US, carriage, transiently, adolescence, young adulthood, Africa, cross-sectional study, tonsillar carriage, F. necrophorum, investigate, geographical differences, tonsillar, carriage, rates, F. necrophorum, healthy participants, aged, years, Sweden, Zambia, investigate, age, distribution, tonsillar carriage, Zambia, Specimens, tonsillar swabs, analyzed, real-time PCR, F. necrophorum, participants, aged, years, tonsillar carriage, Sweden, Zambia, Zambian, participants, aged, years, tonsillar, carriage, rare, rate, tonsillar carriage, participants, aged, years, Sweden, interpretation, tonsillar, findings, patients, pharyngotonsillitis, geographical difference, tonsillar carriage, identified, Zambia]]\n",
      "[[case, healthy, immunocompetent, male, Lemierre's Syndrome, headache, sore throat, pyrexia, Initial, blood tests, inflammatory, markers, electrolyte abnormalities, Blood cultured, Fusobacterium necrophorum, respiratory distress, imaging, lung abscess, empyema, septic emboli, surgical drainage, prolonged, course, antibiotics, case, rare, life-threatening, condition, Lemierre's Syndrome, prompt, recognition, early, antibiotic therapy]]\n",
      "[[Liver abscesses, feedlot cattle, polymicrobial infections, Culture-based studies, Fusobacterium necrophorum, causative agent, bacterial species, isolated, incidence, liver abscesses, variable, factors, cattle, Holstein, steers, beef, production, incidence, crossbred, feedlot cattle, Tylosin, antimicrobial, additive, reduce, incidence, liver abscesses, study, 16S ribosomal RNA amplicon sequence, bacterial, purulent material, liver abscesses, crossbred cattle, Holstein steers, fed, finishing diet, tylosin, DNA, extracted, V3, V4 regions, 16S rRNA gene, amplified, sequenced, analyzed, minimum, mean, maximum sequence reads, sample, liver abscess, samples, Sequence analyses, phyla, families, genera, amplicon sequence, variants, ASV, treatment groups, dominant, phyla, identified, Fusobacteria, total reads, Proteobacteria, genera, identified, genera, Gram negative, Gram positive, genera, total reads, abundance, Fusobacterium, Pseudomonas, Bacteroides, abundance, expressed, total reads, phyla, family, genera, treatment groups, Generic richness, evenness, Shannon-Weiner, Simpson's diversity indices, groups, UniFrac distance matrices, data, ASV, variance, samples, treatment group, Co-occurrence, network analysis, genus, level, association, Fusobacterium, genera, isolated, liver abscesses, culture-independent method, identified, bacterial, composition, liver abscesses, Gram negative, Fusobacterium, dominant, genus, Pseudomonas, bacterial, crossbred, Holstein, steers, fed, finishing, diets, tylosin]]\n",
      "[[case, female, orbital cellulitis, meningeal, involvement, secondary to, severe, paranasal sinusitis, positive blood culture, Fusobacterium necrophorum, patient, recovered, course, systemic antibiotics, functional, endoscopic sinus surgery, Fusobacterium, rare, entity, cases, literature, reviewed, review, Fusobacterium necrophorum, aggressive pathogen, orbital cellulitis, affected, patients, aggressive, workup, Lemierre's syndrome, complication, Fusobacterium necrophorum infection, transthoracic echocardiogram, chest radiograph, upper extremities, venous duplex, magnetic resonance venography]]\n",
      "[[Fusobacterium necrophorum, cause, endocarditis, case, F. necrophorum endocarditis, liver abscesses, woman, case, monomicrobial, F. necrophorum endocarditis, patient, years, reviewed, cases, case, review, anaerobic bacteria, Gram-negative anaerobic bacilli, F. necrophorum, differential diagnosis, infective endocarditis, patients, organic heart disease]]\n",
      "[[study, immunodominant, outer membrane proteins, OMPs, Fusobacterium necrophorum, sheep, severe, foot-rot, OMP, profile, ovine, strains, F. necrophorum, analyzed, OMP, profile, frequent, lktA, variant, JKS-F3, F. necrophorum, associated with, severe, ovine, foot-rot, lesion score, immunodominant, OMPs, Electrophoretic separations, extracted, OMPs, spots, two-dimensional electrophoretic gels, immunoreactive, size, identified, western blotting, hyperimmune, sera, rabbits, immunogenic, OMPs, analyzed, Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, MALDI-ToF/MS, OMPs, lktA, variant, JKS-F3, F. necrophorum, protein sequence, coverage, scores, outer membrane protein, F. necrophorum strain H05, porin, properties, pore-forming proteins, anaerobic, Gram-negative bacteria, immunogenic, OMPs, pathogenic, organism, ovine foot-rot, effective, control strategy, development, OMP-based, foot-rot, sheep, goats]]\n",
      "[[Lemierre's syndrome, oropharyngeal infection, complicated, septic thrombophlebitis, internal jugular vein, bacteremia, septic emboli, immunocompetent, individuals, physician, Andre Lemierre, male, institution, sore throat, difficulty swallowing, left-sided ear pain, nausea, vomiting, subjective fevers, general malaise, right-sided rib pain, anorexia, Complete blood cell count, metabolic panels, severe, thrombocytopenia, mild, anemia, acute kidney injury, hyperbilirubinemia, Blood cultures, Fusobacterium necrophorum, Ultrasound, computed tomography scan, neck, thrombosis, left internal jugular vein, ADAMTS13, activity, decreased, diagnosis, thrombotic thrombocytopenic purpura]]\n",
      "[[Fusobacterium necrophorum, Gram-negative anaerobe, etiologic agent, liver abscesses, beef cattle, bacterium, microbial, community, rumen, liver, portal, circulation, abscesses, severity, liver abscesses, mild, small abscesses, severe, medium, abscesses, Leukotoxin, secreted, protein, virulence factor, infection, leukotoxin, production, strains, F. necrophorum, isolated, mild, severe, liver abscesses, slaughtered, cattle, quantification, leukotoxin, assays, measure, cytotoxicity, protein antigen, concentration, strains, mild, severe, abscesses, study, Cell-free supernatants, cultures, anaerobic broth, incubations, leukotoxic activity, quantified, measuring, cytotoxicity, release, lactic dehydrogenase, bovine, lymphocyte cells, BL3, treated with, culture supernatant, Leukotoxin protein, concentration, quantified, ELISA, assay, leukotoxin-specific monoclonal antibody, antibody, leukotoxin activity, concentration, variable, strains, severity, liver abscesses, leukotoxic, activity, incubation time, leukotoxin protein, concentration, higher, incubation, Strains, severe, liver abscesses, leukotoxic activity, higher, protein, concentration, strains, mild, culture supernatants, strains, correlation coefficients, leukotoxic activity, leukotoxin, concentration, strains, isolated, severe, liver abscesses, leukotoxic activities, leukotoxin protein, concentrations, strains, isolated, mild, liver abscesses]]\n",
      "[[Microbiota, colorectal cancer, initiation, development, E. coli, polyketide synthase, synthetize, bacterial toxin, colibactin, Nougayrede, group, E. coli, positive, pks genes, colorectal cancer, biopsies, prevalence, effect, pks positive bacteria, risk factor, colorectal cancer, development, pks gene cluster, E. coli, sequence, identity, K. pneumoniae, function, regulation, K. pneumoniae, virulence factors, capsules, siderophores, iron-scavenging systems, adhesins, endotoxins, pks cluster, colibactin, hypervirulence, K. pneumoniae, Acquisition, pks locus, associated with, K. pneumoniae, colonisation, mucosal invasion, Colibactin, increases, likelihood, complications, bacterial infections, development, meningitis, tumorigenesis, K. pneumoniae, gut colonizer, pks positive, K. pneumoniae, GIT, investigated, CRC-distinctive microbiota, early stages, cancer development, microbiome analysis, discover, early stages, cancer, effectiveness, anticancer therapy, pks positive, K. pneumoniae, potential, biomarker, tumour, prevalence, anticancer therapy, response]]\n",
      "NaN\n",
      "[[targets, treatment, Leishmaniasis, dihydrofolate reductase, DHFR, target, folate, metabolic pathway, study, pharmacoinformatics approaches, quantum chemistry methods, molecular docking, molecular dynamics simulations, Leishmania donovani DHFR, LdDHFR, inhibitors, design, LdDHFR, inhibitors, virtual combinatorial library, head groups, scaffolds, linkers, tail, groups, scaffolds, library, design, proton affinity, PA, quantum chemical methods, H-bond interaction, negatively, LdDHFR, active site, molecular docking-based virtual screening, screen, library, Selectivity, hits, LdDHFR, re-docking, human, HsDHFR, hits, molecular dynamics, MD, simulations, selectivity, stability, LdDHFR, hits, favorable, LdDHFR, comparison, HsDHFR.Communicated, Ramaswamy H. Sarma]]\n",
      "[[development, molecules, treatment, leishmaniasis, parasitic disease, anti-leishmanial, therapeutics, drug toxicity, resistance, pyrrolo[1,2-b]isoquinoline core, palladium-catalyzed Heck-initiated cascade reactions, synthesis, C-10 substituted derivatives, in vitro, leishmanicidal activity, visceral, L. donovani, cutaneous, L. amazonensis) leishmaniasis, evaluated, activity, 10-arylmethyl substituted pyrroloisoquinolines, 2ad, IC50, muM, SI, 2bb, IC50, SI, drug, reference, miltefosine, L. amazonensis, in vitro, promastigote, assays, active compound, in vitro, amastigote assays, IC50, SI, compounds, low, cytotoxicity, CC50, J774 cells, tested, dose, Perturbation Theory Machine Learning, algorithm, simultaneously, biological activity, parameters, IC50, Ki, Leishmania species, target, specificity, sensitivity, training, validation, model, reduce, time, assay, costs, material, human, resources, drug discovery process]]\n",
      "[[RATIONALE, REVIEW, systematic review, literature, investigate, efficacy, safety, pentamidine, isethionate, treatment, human, visceral, tegumentary leishmaniasis, KEY FINDINGS, papers, evaluated, studies, data, cases, leishmaniasis, patients, tegumentary leishmaniasis, visceral leishmaniasis, studies, New World cutaneous leishmaniasis, visceral leishmaniasis, Leishmania donovani, time, data, Old World cutaneous leishmaniasis, mucosal leishmaniasis, visceral leishmaniasis, L. infantum, Pooled, cure, rate, tegumentary leishmaniasis, randomized trial, observational studies, case report, case series, Pooled, cure, rate, visceral leishmaniasis, randomized trial, observational studies, case report, case series, cure, rate, recurrent, refractory, cases, visceral leishmaniasis, safety, treated, subjects, information, relevant, side effects, cases, arrhythmia, cases, fatal, ventricular fibrillation, cases, irreversible diabetes, cases, muscular aseptic abscess, intramuscular, administration, CONCLUSIONS/RECOMMENDATIONS, Pentamidine isethionate, associated with, cure, rate, Severe, irreversible, adverse effect, rare, drug, treatment, human leishmaniasis, first-line, failed, patients, drugs, context, travellers, migrants, cases, drug, combination]]\n",
      "[[Visceral Leishmaniasis, tropical disease, increasing, incidences, drug resistance, search, drug, target, chemotherapeutic intervention, Potassium channels, family, membrane proteins, homeostasis, perturbation, cell survival, target, calcium-activated potassium channel, Leishmania donovani, LdKCa, ion-channel, protein, sequence, similarity, Trypanosoma cruzi, putative potassium channels, cloned, expressed, histidine tag, MALDI, potassium channel, Homology model, LdKCa, I-TASSER, transmembrane protein, localized, plasma membrane, DeepLoc tool, In silico, analyses, protein, small conductance, Point mutation, conserved signature domain, TXGYGD, protein function, heat map analysis, LdKCa, model, amino acids, S207, T208, M236, ligand-binding sites, sequence, HSLRGRSARVIQLAWRLRKARKVGPHAPSLKQKVYTLVLSWLLT, scoring B-cell epitope, scoring T-cell epitope, RLYSVIVYL, study, antigenicity, features, leishmanial calcium-activated potassium channels]]\n",
      "[[Leishmaniasis, debilitating disease, clinical manifestations, self-healing ulcers, life-threatening, visceral pathologies, protozoan, parasites, Leishmania genus, professional vacuolar, pathogens, transmitted, infected, sand flies, mammalian, hosts, metacyclic promastigotes, internalized, phagocyte populations, monocytes, myeloid cells, migrate, infection sites, evidence, recruitment, cells, parasite, burden, establishment, chronic disease, Leishmania-inflammatory monocyte, interactions, early stages, host infection, investigated, assess, impact, Leishmania donovani, metacyclic promastigotes, antimicrobial responses, cells, data, inflammatory, monocytes, colonized, L. donovani metacyclic promastigotes, infection, Escherichia coli, cleared, internalization, metacyclic promastigotes, inhibited, superoxide, production, parasitophorous vacuole, PV, mechanism, exclusion, NADPH oxidase subunits gp91, phox, p47, phox, PV membrane, phagosomes, zymosan particles, vacuoles, parasites, acidify, poorly, parasite, surface, coat virulence, glycolipid lipophosphoglycan, LPG, inhibition, PV, acidification, impairment, NADPH oxidase, assembly, LPG, GP63, observations, permissiveness, inflammatory, monocytes, L. donovani, parasite, impair, microbicidal, properties, phagosomes]]\n",
      "[[Leishmaniasis, transmissible disease, Leishmania protozoa, Spain, endemic, visceral, cutaneous leishmaniasis, autochthonous, aetiological agent, Leishmania infantum, world, L. donovani complex, associated with, visceral symptoms, species, Leishmania, Viannia subgenera, affecting, human, tegumentary forms, imported, cases, associated with, globalization, study, aetiological, evolution, human, tegumentary leishmaniasis, region, Spain, Catalonia, Leishmania strains, isolated, analysed, MLEE, gene sequencing, hsp70, rpoIILS, fh, ITS2, MALDI-TOF, analytical methods, compared, results, increase, leishmaniasis, decades, imported, cases, cases, L. infantum, L. major, L. tropica, L. braziliensis, L. guyanensis, L. panamensis, identified, combination, molecular, enzymatic methods, identification, strain types, AC, Strain, diversity, L. (Viannia, L. major types, geo-temporal, data, autochthonous, cases, type C, prevailed, period, Minor types, short time interval, techniques, identical, identification, species, level, MALDI-TOF, rpoIILS, identification, tools, clinical practice, tandem, hsp70-ITS2, MLEE, epidemiological field]]\n",
      "[[Human, VL, life-threatening disease, protozoan, parasites, Leishmania donovani complex, Atypical, cases, leishmaniasis, HIV, coinfection, documented, case reports, associated with, gastrointestinal tract, kidney, skin, involvement, VL, cases, atypical, localizations, east Africa, diagnosed, treated, Leishmaniasis, Research, Gondar, Ethiopia, case, HIV-infected, patient, scrotal, penile, involvement, Leishmania, parasites, detected, spleen, scrotum, case, immunocompetent, individual with, esophageal, laryngeal, pharyngeal, involvement, facial lesions, Leishmania, parasites, detected, spleen, skin, esophageal biopsies, evidence, atypical, presentation, patients, HIV, status, high index, suspicion, VL, clinicians, working, endemic areas, Ethiopia]]\n",
      "[[Leishmania infantum, protozoan, parasite, vector, infectious disease, humans, visceral leishmaniasis, VL, pathology, L. donovani, impacts, health, people, worldwide, treated with, anti-parasitic drugs, poor treatment regimens, severe, side effects, cost, emergence, resistant, parasites, anti-Leishmania activity, (-)-Epigallocatechin 3-O-gallate, EGCG, flavonoid, green tea, leaves, mechanism, action, EGCG, Leishmania, leishmanicidal, action, EGCG, goal, EGCG, inhibits, L. infantum promastigote, proliferation, concentration-dependent, leishmanicidal effect, EGCG, associated with, mitochondria, depolarization, decreased, concentration, intracellular, ATP, increased, concentration, intracellular, H2O2, leishmanicidal effect, elevated, H2O2, levels, induced, EGCG, PEG-catalase, flavonoid, kills, L. infantum promastigotes, intracellular, redox, balance, in silico, in vitro, evidence, EGCG, binds, trypanothione reductase, TR, central enzyme, redox, homeostasis, Leishmania, competitive, inhibitor, trypanothione, substrate]]\n",
      "[[intracellular, protozoan, parasites, Leishmania genus, Leishmaniases, vector, diseases, clinical manifestations, Leishmania (L.) donovani, visceral leishmaniasis, kala azar, severe, diseases, biological cycle, Leishmania, parasites, developmental, metacyclogenesis, differentiation, metacyclic promastigotes, MPs, amastigotes, Metacyclogenesis, phlebotomine, sandfly, host's, midgut, procyclic, promastigotes, non-dividing, infective, MPs, injected, skin, mammalian, hosts, phagocytosed, macrophages, MPs, modified, phagolysosomes, intracellular, amastigotes, developmental transitions, changes, cell size, shape, reformatting, flagellum, membrane, cytoskeleton remodeling, phosphoinositide, PI, signaling, metabolism, central roles, study, reports, LDBPK_220120.1 gene, L. donovani ortholog, LmjF.22.0250, encodes, phosphatase, Atypical, ALPs, enzyme family, expression, LDBPK_220120.1 gene, L. donovani promastigotes, axenic, amastigotes, in vitro, Dual Specificity, P-Tyr, monophosphorylated, PI(3)P, PI(4)P, PI phosphatase, LdTyrPIP_22, Leishmaniad onovani, Tyrosine PI Phosphatase, gene locus, chromosome 22, immunofluorescence confocal microscopy, localized, LdTyrPIP_22, intracellular, cell body, L. donovani promastigotes, amastigotes, flagellum, temperature, pH, degrees, degrees, pH, induced, recruitment, LdTyrPIP_22 epitopes, flagellar pocket, redistribution, nucleus, results, role(s), P-Tyr/PI phosphatase, regulation, processes, initiated, upregulated, shift, developmental transition, MPs, amastigotes, mammalian, host, macrophages]]\n",
      "[[Leptospira, bacteria, leptospirosis, transmitted, water, soil, mud, contaminated, urine, infected, animals, associated with, urban environment, Leptospires, circulate, rural, wild environments, study, investigate, small, mammals, leptospirosis, epidemiology, western, Amazon, Brazil, animals, species, orders, Didelphimorphia, Rodentia, Blood, kidney, urine samples, collected, Microscopic Agglutination Test, MAT, lipL32 PCR, secY sequencing, culturing, MAT, reactive, sera, bacterial, isolate, PCR, positive, samples, species, samples, genetically, characterized, identified, L. interrogans, L. noguchii, L. santarosai, statistical, association, prevalence, infection, Leptospira spp, mammals, carrier/hosts species, orders, study area, forest, strata, results, prevalence, pathogenic, Leptospira spp, rodent, marsupial, species, report, evidence, Leptospira spp., Brazilian Western, Amazon]]\n",
      "[[Brazil, leptospires, isolated, cattle, Amazon, epidemiology, disease, region, unclear, study, Leptospira, isolates, urine, cattle, raised, Brazilian, Amazon, Leptospira infection, cattle, region, study, serologically, molecularly, isolates, laboratory assays, microscopic agglutination test, MAT, polyclonal antisera, Leptospira spp, serogrouping, isolates, DNA sequencing, secY, multiple locus, MLVA, isolates, species, L. borgpetersenii, L. kirschneri, L. santarosai, L. noguchii, L. interrogans, serogrouping, serogroups, detected, frequency, Sejroe serogroup, MLVA, L. borgpetersenii, isolates, profile, serovar Hardjo, isolates, diversity, patterns, strains, characterized, Brazilian, Amazon, leptospires, circulating, cattle, revealed, infections, area, strains, characterized, frequency, Sejroe serogroup, serovar Hardjo, regions, Brazil]]\n",
      "[[Leptospirosis, zoonosis, Spain, leptospirosis, reports, people, animals, increased, Cats, infected, Leptospira, chronic carriers, study, serological antibody, prevalence, Leptospira sp., blood DNA, shedding, DNA, pathogenic, Leptospira species, urine, cats, Spain, Microagglutination tests, MAT, blood, urine TaqMan real-time polymerase chain reaction, PCR, Leptospira antibodies, detected, cats, positive, results, confidence interval, CI, Titers, 1:320, serovars Ballum, Bataviae, Bratislava, Cynopteri, Grippotyphosa Mandemakers, Pomona, Proechimys, serovar, Cynopteri, Blood samples, cats, amplified, Leptospira DNA, CI, Urine samples, cats, amplified, Leptospira DNA, CI, free-roaming, cats, Spain, pathogenic, Leptospira DNA, urine, source, human infection, Serovars, cats, Spain, detected, presence, species, pathogenic leptospires, country, L. borgpetersenii, L. interrogans, L. kirschneri, L. noguchii]]\n",
      "[[Pathogenic, Leptospira species, livestock, human, health, zoonotic infections, strains, L. interrogans, L. borgpetersenii, L. noguchii, isolated, infected, cattle, Uruguay, whole-genome sequences, strains]]\n",
      "[[Leptospirosis, complex, dynamic, epidemiology, Bovine leptospirosis, infectious disease, impairing, reproductive, efficiency, infections, Leptospira interrogans, L. santarosai, L. borgpetersenii, cattle, presence, L. noguchii, animals, study, serological, MAT, molecular characterization, rrs, secY gene sequencing, multilocus sequence typing, MLST, pulsed-field gel electrophoresis, PFGE, L. noguchii strains, slaughtered, cows, Intraspecific, genetic diversity, evaluated, haplotype, networks, hosts, geographical localizations, Strains, characterized, serogroups Australis, Autumnalis, Panama, molecular characterization, heterogeneity, strains, STs, STs, novel, alleles, pulsotypes, clonal complexes, Phylogenetic trees, secY, locus, concatenated, MLST loci, clusters, sequences, study, relationship, geographical origin, secY, phylogenetic clusters, secY, phylogenetic clusters, serogroups, Molecular diversity, indexes, variability, intraspecific, variation, observed, differences, virulence, pathogenicity, antigenicity, adaptability, strains, haplotype, networks, circulation, genotypes, humans, animals, zoonotic, potential, study, relevant, data, study, leptospirosis, Health context, human, animal, environmental health]]\n",
      "[[Leptospirosis, bacterial zoonosis, Health approaches, Small mammals, maintenance, reservoirs, pathogens, nature, leptospires, study, infection, leptospires, small mammals, Atlantic forest, biome, evaluate, potential, carriers, spirochetes, small, mammals, Rodentia, Didelphimorphia, genera, species, Blood, kidney samples, animals, PCR, targeted, lipL32 gene, renal tissues, Species, identification, samples, sequencing, rrs gene, animals, lipL32, PCR-positive, pathogenic, Leptospira species, L. interrogans, L. borgpetersenii, L. santarosai, L. noguchii, identified, study, small, mammals, carriers, leptospires, Atlantic, Forest, source, pathogenic, Leptospira spp infection, humans, domestic animals]]\n",
      "[[study, seroprevalence, correlates, Leptospira IgG, antibodies, backyard pigs, northern Mexican state, Durango, cross-sectional study, backyard, pigs, Anti-Leptospira IgG antibodies, detected, microscopic agglutination assay, MAT, Leptospira antigens, antibodies, Leptospira, Leptospira serovars, examined, pigs, Seropositive, pigs, properties, surveyed, serovar, Leptospira interrogans Pomona, Leptospira noguchii Lousiana, Leptospira santarosai Tarassovi, L. interrogans Bataviae, Leptospira biflexa, L. interrogans Hebdomadis, L. interrogans Pyrogenes, L. interrogans Djasiman, Leptospira borgpetersenii Ballum, L. noguchii Panama, L. interrogans Canicola, L. borgpetersenii Mini, Logistic regression, seropositivity, associated with, low, sea, altitude, odds ratio, OR, confidence interval, CI, report, Leptospira, exposure, backyard, pigs, Mexico, association, Leptospira, exposure, pigs, altitude, Backyard pigs, high-risk group, Leptospira, exposure]]\n",
      "[[seropositive, percentage, determinants, Leptospira, exposure, domestic, donkeys, slaughter, State, Durango, Mexico, donkeys, gathering, premises, Sera, donkeys, analyzed, Leptospira IgG, antibodies, microscopic agglutination assay, Leptospira antigens, association, Leptospira, seropositivity, characteristics, donkeys, assessed, bivariate, multivariate analyses, Antibodies, Leptospira, Leptospira serovars, examined, donkeys, Seropositive, donkeys, regions, municipalities, premises, examined, serovar, L. interrogans Icterohaemorrhagiae, L. interrogans Sejroe, L. interrogans Canicola, L. kirschneri Grippotyphosa, L. borgpetersenii Ballum, L. biflexa Semaranga, L. noguchii Panama, Leptospira, seropositivity, associated with, gathering premises, OR, CI, municipalities, OR, CI, results, seropositive, percentage, Leptospira infection, donkeys, Mexico]]\n",
      "[[Leptospirosis, zoonosis, distribution, causative agents, spirochete bacteria, Leptospira genus, diversity, serovars, identity, effective, diagnosis, vaccination, mammalian, species, Leptospira, cattle, acute, calves, chronic disease, adult, animals, abortions, South America, Uruguay, beef, dairy export, sources, national income, bovine, health, food safety, bovine-related dissemination, leptospirosis, humans, limited, information, identity, Leptospira species, serovars, infecting, cattle, Uruguay, South American, subcontinent, multicentric 3-year study, isolation, characterization, strains, Leptospira spp, infected, cattle, serologic, molecular typing, identified, isolates, L. interrogans serogroup Pomona serovar Kennewicki, strains, L. interrogans serogroup Canicola serovar Canicola, strain, L. borgpetersenii serogroup Sejroe serovar Hardjo, strains, L. noguchii, strains, phenotypic, genetic variability, serogroups, serogrouping, antisera, cattle, sampled, field, shedding, pathogenic, Leptospira, urine, threat, public health, L. interrogans serovars, isolated, cattle, identical, genetic signatures, human, isolates, leptospirosis, patients, local, Leptospira strains, diagnostic tools, leptospirosis, epidemiology, South America, strains, components, bacterin, vaccines, pathogenic, Leptospira strains, circulating, measure, reduce, risk, human, leptospirosis]]\n",
      "[[weeks, isolation, people, commencing, treatment, pulmonary tuberculosis, TB, evidence, clearance, infectious, tuberculous mycobacteria, sputum, World Health, Organization-commissioned review, investigated, sputum, sterilisation, dynamics, TB, treatment, FINDINGS, analysis, systematic literature, searches, OvidSP MEDLINE, Embase, Global Health, EBSCO CINAHL Plus, studies, data, TB, infectiousness, studies, randomised controlled trials, RCTs, drug-susceptible TB, articles, patients, effective, treatment, culture-confirmed, drug-susceptible pulmonary TB, outcome, sputum, bacteriological, conversion, proportion, patients, time point, measure, conversion, assessed, smear, culture, study, design, participants, Record sifting, data extraction, duplicate, Random, meta-analyses, narrative summary, results, systematic search, data, infectiousness, humans, experimental animals, PubMed, studies, evidence, duration, infectiousness-including studies, cough dynamics, human tuberculin skin test, conversion, bactericidal activity, TB, treatments-was, review, literature, search, request, editors, studies, published, censor, small studies, outcome measures, identified, data, findings, review, meta-analyses, records, RCTs, cohort studies, studies, data, Africa, Asia, South America, North America, Europe, studies, data, multiple, continents, estimates, smear, conversion, patients, weeks, CI, patients, months, treatment, CI, baseline, smear-positive, patients, solid culture, conversion, weeks, CI, increasing, months, CI, time points, liquid culture, conversion, CI, CI, heterogeneity, interrogation, data, heterogeneity, lack, disaggregation, results, factors, HIV, status, baseline, presence, absence, lung cavitation, systematic review, patients, culture positive, weeks, TB, treatment, individuals, infectious, interval, Culture positivity, component, infectiousness, reduced, aerosol, TB, treatment, initiation, Studies, findings, data, cough dynamics, perspective, potential, transmission, Mycobacterium tuberculosis, individuals, treatment, Systematic review, registration, PROSPERO]]\n",
      "[[Mycoplasma synoviae, MS, Mycoplasma gallisepticum, MG, strains, isolated, degrees, temperature-sensitive strains, ts+, identified, random amplification, polymorphic DNA, inhibitory, concentrations, MIC100, calculated, isolated, strains, broiler, breeders, laying, hens, vaccinated, ts+, MS-H, ts+ MG, TS-11, vaccines, Mexico, lots, hens, MS, isolates, MG, isolates, analyzed, random amplification, polymorphic DNA, matched, DNA, patterns, MS-H, MG-F, strains, isolated, MS, MG, strains, sensitive, tiamulin, tylosin, intermediate sensitivity, resistance, lincomycin, florfenicol, erythromycin, enrofloxacin, curcumin, MS, MG, strains, sensitive, antibiotics, MIC100, MG, strains, sensitive, MS strains, MS, isolated, mycoplasma, Mexican, poultry, production, MS, vaccine, ts+, MS-H, reverse, thermosensitivity, virulence, MS, sensitive, tiamulin, tylosin, MG]]\n",
      "NaN\n",
      "NaN\n",
      "[[Mycoplasma pneumoniae, community-acquired pneumonia, CAP, Information, prevalence, M. pneumoniae, pediatric, patients, CAP, Mexico, study, detect, M. pneumoniae, hospitalized, pediatric, patients, CAP, Patients, methods, descriptive study, tertiary-level pediatric reference center, respiratory samples, patients, years, age, diagnosed, CAP, M. pneumoniae, detected, real-time polymerase chain reaction, PCR, targeting, p1, CARDS, genes, Complete blood cell count, measurement, C-reactive protein, detection, IgM, IgG, Clinical, epidemiological, radiological, data, patients, analyzed, M. pneumoniae, detected, real-time PCR, samples, cases, spring, season, patients, M. pneumoniae, disease, renal disease, autoimmune disease, primary immunodeficiencies, association, M. pneumoniae, CAP, Children, years, age, cases, Fever, cough, frequent, symptoms, IgM, IgG, positive, patients, chest X-ray, patients, multifocal, alveolar infiltrates, pattern, complications, mortality, study, report, Mexico, M. pneumoniae, causal agent, CAP, tertiary care, pediatric hospital, real-time PCR, serology, M. pneumoniae, cases, frequent, children, years, age, clinical presentation, patients, diseases]]\n",
      "[[investigation, human embryonic stem cells, HESC, decreasing, derivation, lines, diminished, preeminence, HESC lines, research, universal, applicability, results, genetic under-representation, derivation, male, karyotype, Mexican population, HESC line, Amicqui-2, female, karyotype, embryos, pluripotent, requirements, normal karyotype, detection, pluripotency-associated, markers, mycoplasma test, teratoma, formation, model, diseases, population]]\n",
      "[[hemotropic mycoplasma, hemoplasma, Mycoplasma wenyonii, animal, pathogen, bovine, cattle, health, draft, genome sequence, hemoplasma, M. wenyonii, strain, INIFAP02, cattle, Mexico]]\n",
      "[[Androctonus australis, ubiquitous, scorpion species, desert, arid lands, North Africa, India, ecological, social impact, bacterial, community, associated to, species, composition, gut, gonads, venom gland, 16S rRNA, gene culture-independent, revealed, taxonomic groups, Firmicutes, Betaproteobacteria, Gammaproteobacteria, Flavobacteria, Actinobacteria, Cyanobacteria, dominance, Mollicutes, phylotypes, digestive tract, gonads, Mollicutes, Spiroplasma, phylotypes, DGGE bands, clones, Mycoplasma cluster, clones, 16S rRNA, identities, Mollicutes, detected, Mexican scorpions, Centruroides limpidus, Vaejovis smithi, scorpion-associated Mollicutes, lineage, distant ancestor, Mycoplasma hominis, host, specificity, apparent, phylogenetic, divergence, co-evolution, symbionts, scorpion, hosts, ecological point, association, host, fitness, dormancy, molt, periods]]\n",
      "[[diversity, bacteria, Southwestern Gulf of Mexico, study, perspective, presence, bacterial, pathogens, ecosystem, metagenomic, data, Mexican, research group, Gulf, genera, bacteria, annotated, pathogens, detected, water, sediment, marine, samples, native, pathogenic, genera, Burkolderia, Halomonas, Pseudomonas, Shewanella, Vibrio, genera, public health, detected, Borrelia, Ehrlichia, Leptospira, Mycobacterium, Mycoplasma, Salmonella, Staphylococcus, Streptococcus, Treponema, metagenomics, studies, environment, potential, influences, natural, anthropogenic, ecological factors, diversity, pathogenic bacteria, reviewed, taxonomic, annotation, bacterial, biodiversity, Southwestern Gulf of Mexico, tool, public health, infectious diseases, associated with, exposure to, marine water, ingestion, fish, shellfish, predicting, preventing, waterborne disease, outbreaks]]\n",
      "[[OBJECTIVE, prevalence, genital, Mycoplasma spp, women, systemic lupus erythematosus, SLE, factors, associated with, infection, cross-sectional study, patients, SLE, healthy, women, attended, hospital, Puebla, Mexico, participants, aged, years, older, sexually active, structured interview, assessed, sociodemographic, obstetric, gynecologic, clinical characteristics, Disease activity, evaluated, Mexican SLE Disease Activity Index, Polymerase chain reaction, detect, presence, Mycoplasma spp, genital samples, Ureaplasma urealyticum, genital, mycoplasma, detected, patients, SLE, healthy, women, Patients, SLE, increased, odds, infection, odds ratio, confidence interval, patients, SLE, multiparity, U. urealyticum infection, women, SLE, genital infection, U. urealyticum, association, infection, multiparity, women, SLE]]\n",
      "[[Cervical cancer, development, associated with, persistent, human papillomavirus, infections, HPV infection, cervical cancer, contribution, sexually transmitted infections, STIs, factor, cervical lesion-progression, study, estimate, prevalence, STIs, associated with, HPV-positivity, cervical samples, patients, annual, routine, gynecological exams, prevalence, STIs, frequent, infection, Ureaplasma spp (UP, Gardnerella vaginalis, GV, alpha-HPV, Chlamydia trachomatis, CT, Mycoplasma genitalium, MG, prevalence, rate, multiple, non-HPV infections, age-range, papillomavirus infection, age-range, cervical samples, HPV16, genotype, genotypes, HPV18, detected, study population, genotypes, samples, abnormal cytology, Papillomavirus infection, oncogenic, associated with, GV, associated with, non-HPV pathogens, variables, correlated, cytological diagnosis, low-grade, squamous intraepithelial lesion, LSIL, GV, multiple, non-HPV infections, high-risk, HPV positivity, Epidemiological, data, study, molecular detection, sexually transmitted, pathogens, screening programs, women, risk, cervical lesions]]\n",
      "[[Chronic Fatigue Syndrome/Myalgic Encephalomyelitis, CFS/ME, severe, multisystemic disease, characterized, immunological abnormalities, dysfunction, energy metabolism, correlations, dysbiosis, pathological condition, research, composition, intestinal, oral microbiota, CFS/ME, patients, healthy controls, fecal, metabolomic profile, subgroup, CFS/ME, patients, healthy controls, fecal, salivary, bacterial, composition, CFS/ME, patients, investigated, Illumina sequencing, 16S rRNA, gene amplicons, metabolomic analysis, UHPLC-MS, fecal microbiota, CFS/ME, patients, reduction, Lachnospiraceae, Anaerostipes, increased, abundance, genera, Bacteroides, Phascolarctobacterium, non-CFS/ME groups, oral microbiota, CFS/ME, patients, increase, Rothia dentocariosa, fecal, metabolomic profile, CFS/ME, patients, levels, glutamic acid, argininosuccinic acid, decrease, alpha-tocopherol, microbial, signatures, dysbiosis, intestinal, microbiota, CFS/ME, patients, studies, microbial, composition, changes, cause, CFS/ME, secondary symptoms]]\n",
      "[[case, subacute, bacterial endocarditis, mycotic brain aneurysm, Rothia dentocariosa, untreated, dental caries, R.dentocariosa, rare, endocarditis, incidence, aneurysmal, haemorrhagic, complications, patients, intracranial aneurysms, systemic infection, mycotic aneurysms, Dental habits, dental care, patients, infectious symptoms]]\n",
      "[[Rothia sp., Gram-positive bacteria, Actinobacteria, physiological, cases, Rothia aeria, Rothia dentocariosa, infective endocarditis, IE, biofilm, potential, Rothia, endocarditis, Specimen, cases, Rothia endocarditis, cardiac surgery, patients, mitral valve IE, Rothia aeria, case, IE, prosthetic pulmonary valve, Rothia dentocariosa, Fluorescence in situ hybridization, FISH, visualization, microorganisms, heart valve tissues, combination, PCR, sequencing, FISHseq, heart valve specimens, mature, biofilms, bacteria, FISHseq, Rothia aeria, Rothia dentocariosa, FISH, in situ, biofilms, microorganisms, phenotypes, ex vivo, cases, treated, heart valve surgery, antibiotic therapy, beta-lactam antibiotics, biofilm, potential, Rothia sp., awareness, Rothia aeria, Rothia dentocariosa, rare, relevant, pathogens, infective endocarditis, raised, biofilm-effective antibiotics, Rothia IE]]\n",
      "[[endogenous, microbiome, healthy, individuals, oral cavities, diverse, bacterial species, Imbalance, oral, gut microbiome, composition, gene expression, hematological, cancers, oral, profiles, patients, blood cancers, BC, group, patients, oral samples, healthy control subjects, HC group, subjects, oral samples, Saliva samples, swabs, buccal mucosa, supragingival, plaque, tongue, blood cancer, patients, healthy controls, Next-generation sequencing, 16S-rRNA gene V3-V4 region, abundance, bacterial taxa, genus, species, levels, oral, microbiome, beta-diversity, multivariate permutational analysis of variance, PERMANOVA, Linear discriminant analysis, LDA, analysis, bacterial taxa, pairwise comparisons, PATRICv3.6.7, online tool, potential, pathogenicity, BC, group, oral, microbiome, beta-diversities, BC, HC, groups, reduced, alpha-diversity, BC, group, LEfSe analysis, significant, LDA scores, Actinomyces, Rothia spp., BC, group, HC group, In silico, analysis, PATRICv3.6.7, groups, bacteria, traits, antibiotic resistance, oral pathogen, virulence, BC, group, BC, patients, antibiotics, weeks, oral, Actinomyces genus, BC, group, administration, antibiotics, Rothia dentocariosa, detected, BC, patients, antibiotics, antibiotics, investigation, interactions, oral species, host, immune system, clinically, associations, hematological cancers]]\n",
      "[[male, patient, history of heart valve replacement surgery, aortic valve stenosis, family history of heart disease, emergency room, complaints, headache, fever, back pain, general malaise, Multiple blood samples, patient's, hospitalization, cultured, Rothia dentocariosa, patient, daily, intravenous ceftriaxone, vancomycin, weeks, patient's, condition, deteriorated, symptoms, persistent, inflammatory, markers, elevated, fever, consistent with, R. dentocariosa infection, patient's, clinical progression, cerebrovascular, accident, thrombectomy, symptomatic, relief, valve replacement, R. dentocariosa, mouth, flora, pathogenic, case, severe, complications, bacterium, rare, cases, deadly, complications, R. dentocariosa, standard, treatment, bacterium, clinical knowledge, R. dentocariosa]]\n",
      "[[effect, xylitol tablets, XPT, XT, red propolis, salivary, parameters, dental biofilm, acceptability, adolescents, evaluated, randomized crossover clinical trial, Healthy volunteers, XPT, XT, groups, washout period, consumption, tablets/dayfor, days, increase, salivary, parameters, tablet, consumption, XPT, XT, results, microorganisms, XT, controlling, Streptococcus spp., Rothia dentocariosa, Streptococcus salivarius, frequent, biofilm, saliva, XPT, XT, acceptability, purchase, intention, XT, propolis, properties, XT, studies testing, protocols, follow-up, XT controlled, Streptococcus spp, biofilms, potential, clinical application]]\n",
      "[[decades, resistant, microbial, rate, increased, infections, biofilm-producing strains, complex, treatments, increased, mortality, compared, infectious diseases, biofilms, factor, chronic infections, drug tolerance, treatment, biofilm-causing, bacterial infections, future, antimicrobial agents, scientific, study, biologically active compounds, plant-related extracts, antimicrobial, properties, evaluate, antibiofilm activity, study, assess, antibiofilm activity, polyphenolic, extracts, myrtle, leaf, pomegranate peel, oral, pathogens, dental plaque, polymicrobial, biofilm model, in vitro, antibiofilm, properties, myrtle, pomegranate extracts, binary combination, inhibiting, biofilm formation, polyphenolic, extracts, single-species, multispecies, biofilms, Streptococcus mutans, Streptococcus oralis, Streptococcus mitis, Rothia dentocariosa, oral, isolates, natural, sources, compounds, biofilm-related infections]]\n",
      "[[OBJECTIVE, epidemiological, clinical, microbiological, therapeutic features, outcomes, Rothia infective endocarditis, RIE, extracardiac infections, ECRI, systematic literature review, published cases, RIE, ECRI, inclusion, personal case report, cases, RIE, cases, ECRI, ECRI, patients, RIE, patients, males, intravenous drug users, IVDU, immunocompetent, infected, R. dentocariosa, median, age, years, rate, orodental abnormalities, six-month, mortality, microbiological documentation, RIE, treated with, beta-lactam antibiotic, duration, weeks, surgery, cases, RIE, rare, secondary, dental portal, entry, cutaneous, inoculation, IVDU, prognosis, favorable]]\n",
      "[[study, evaluated, influence, periodontal therapy, microbiological profile, individuals, Grade C Molar-Incisor Pattern Periodontitis, C/MIP, African-American, participants, ages, diagnosed, C/MIP, Patients, mouth, mechanical debridement, systemic antibiotics, metronidazole, amoxicillin, tid, days, Subgingival samples, diseased, healthy site, individual, treatment, months, therapy, sites, Samples, 16S rRNA, gene based-microarray, Treatment, effective, reducing, clinical, parameters, disease, Aggregatibacter actinomycetemcomitans, A.a, species, associated with, diseased sites, species, associated with, diseased sites, Treponema lecithinolyticum, Tannerella forsythia, Species, associated with, healthy sites, Rothia dentocariosa/mucilaginosa, Eubacterium yurii, Parvimonas micra, Veillonella spp., Selenomonas spp., Streptococcus spp, treatment, effective, reducing, A.a, pathogens, health-associated species, changes, maintained, months, Treatment, A.a, microbial, healthy-site profile, Clinicaltrials.gov registration]]\n",
      "[[development, inhibitive, assay, copper, molybdenum-reducing enzyme assay, enzyme, assayed, 12-molybdophosphoric acid, pH, electron acceptor substrate, NADH, electron donor, substrate, enzyme, yellowish solution, deep blue solution, assay, copper, inhibit, molybdenum-reducing enzyme, molybdate-reducing Serratia sp. Strain DRY5, heavy metals, tested, inhibit, enzyme, model, high regression coefficient, measure, copper, inhibition, one-phase binding, calculated, IC50, concentration, inhibition, regression coefficient, LC50, EC50, IC50, data, copper, toxicity, tests, IC50, copper, study, immobilized, urease, bromelain, Rainbow trout, R. meliloti, Baker's Yeast dehydrogenase activity, Spirillum volutans, P. fluorescens, Aeromonas hydrophilia, synthetic, sludge, IC50, Ulva pertusa, papain assays, Daphnia, magna, Microtox assays]]\n",
      "[[obligately organotrophic, facultatively microaerophilic spirillum, strain, D-427(T), isolated, sulfidic, sludge, municipal, wastewater-treatment plant, Cells, Gram-negative, large, motile, bipolar tufts, flagella, mucous sheaths, Coccoid cells, Strain, pH, degrees, presence, gas phase, organism, oxidase, catalase activity, isolate, chemo-organotrophically, organic acids, substrates, DNA, G+C content, T(m, Phylogenetic analysis, 16S rRNA, gene sequence, D-427(T), genus, Spirillum, class Betaproteobacteria, 16S rRNA, gene sequence, similarity, strain, D-427(T), Spirillum volutans ATCC 19554(T), type strain, species, genus, level, DNA-DNA hybridization, phenotypic, properties, strain, D-427(T), Spirillum volutans, strain, S. volutans, culture collection, authors, species, phenotypic, genotypic, data, type, species, genus, Spirillum, scientific study, type strain, lost, strain, D-427(T), species, genus, Spirillum, Spirillum winogradskyi sp. nov., type strain D-427(T), DSM 12756(T), VKM B-2518(T, Judicial Commission place, Spirillum volutans, names, type strain, neotype, years, publication, description, genus, Spirillum]]\n",
      "[[New microaerophilic, sulfur-oxidizing spirilla, isolated, hydrogen sulfide, sludge, wastewater, treatment plants, Strains D-427, D-430, spiral cells, motile, bipolar flagellum bundles, mucous sheaths, phase-contrast microscope, bundles, Spheroplasts, stationary growth phase, strains, obligate, organotrophs, oxidize, reduced, sulfur compounds, oxidation, sulfide, polysulfide, formation, intracellular globules, elemental sulfur, thiosulfate oxidation, results, tetrathionate, accumulation, medium, cells, reduced, sulfur compounds, energy metabolism, oxidation, chemical interaction, H2O2, O2, synthesized, electron transport chain, strains, obligate microaerophiles, optimal, oxygen concentration, gas phase, strains D-427, D-430, strains, organic acids, growth substrates, tricarboxylic-acid-cycle, intermediates, DNA, G+C content, T(m, strain D-427, strain, D-430, Phylogenetic analysis, comparison, 16S rRNA, gene sequences, isolates, sulfur spirilla, Spirillum volutans, type species, genus, similarity, genus, Spirillum, Beta-proteobacteria, species, S. winogradskii sp. nov., S. kriegii sp. nov., B-430T, BKM B-2372T, description, genus, Spirillum]]\n",
      "[[Argentina, legislation, impacts, effluent, discharges, quality, waters, physicochemical characteristics, effluents, waters, study, assess, treatment, petrochemical industry, effluents, toxicity, treated, industrial, effluents, Buenos Aires, metropolitan area, waters, Tests, Daphnia, magna, Ceriodaphnia dubia, D. magna, Spirillum volutans, Scenedesmus spinosus, Chemical analyses, removal, aromatic hydrocarbon compounds, benzene, toluene, ethylbenzene, xylene, styrene, naphthalene, petrochemical, effluents, toxicity, removal, untreated effluents, toxic, treated, effluents, toxic, toxic, acute, TUa, Physicochemical parameters, measured, Argentinian, regulations, industrial, effluents, textile, paper industries, guidelines, samples, toxic, TUa, waters, toxicity tests, moderate, toxic, results, tests, toxicity, discharged effluents, effects, waters, Argentina, regulatory purposes]]\n",
      "[[hydrogen peroxide-resistant mutant, catalase-negative microaerophile, Spirillum volutans, constitutively expresses, undetectable, non-inducible, wild-type cells, gene, encodes, protein, cloned, amino acid sequence, data, mass spectrometry, NH2-terminal sequencing, amino acid polypeptide, relatedness, rubrerythrin, nigerythrin, anaerobes, Clostridium perfringens, Desulfovibrio vulgaris, protein, similarity, putative rubrerythrin proteins, anaerobic, archeons, Archaeoglobus fulgidus, Methanococcus jannaschii, Methanobacterium thermoautotrophicum, report, protein, organism, respire, oxygen, combination, methodologies, study, cloning, genes, bacteria, genomic library]]\n",
      "[[mercury, plant, mercury, salts, organomercurials, pesticide use, soil, contamination, concentrations, organomercurial products, ethylmercury, phenylmercury, methoxyethylmercury, ethoxyethylmercury compounds, Risk assessment, sites, clean-up processes, planned, sensitive, speciation technique, organomercury, species, environmental matrices, toxicity, investigations, connection, high-performance liquid chromatography-atomic fluorescence spectrometry, technique, differentiate, presence, organomercury compounds, environmental samples, technique, methylmercury, ethylmercury, phenylmercury, organomercury, species, soil, samples, sites, mercury, plant, risk assessment, assess, toxicity, organomercurials, microbial, metabolic pathways, mercury, compounds, batteries, bioassays, evaluate, toxicity, pollutants, toxicity, genotoxicity, MeHg+, MeOEtHg+, EtHg+, EtOEtHg+, PhHg+, p-tolymercury chloride, nitromersol, bioassays, resazurin, Spirillum volutans test, nematode, toxicity, Panagrellus redivivus, Toxi-Chromotest, SOS-Chromotest, toxicity, organomercurial, SOS-Chromotest, genotoxicity, organomercurials]]\n",
      "[[Bright-field high-speed cinemicrography, record, swimming, unipolar cells, Spirillum volutans, geometrical, parameters, cells, dimensions, experimentally, cell, angular, speeds, measured, period, flagellar cycles, cycles, measurements, cell, trailing, configuration, flagellar bundle, geometry, cells, numerically, curved isoparametric boundary elements, measured, geometrical, parameters, boundary element method, program, angular, speeds, comparison, experimentally, swimming, speeds, BEM, predictions, cell, comparison, swimming, trajectory, trailing, flagellar configurations, resistive force theory, RFT, slender body theory, SBT, models, non-realistic, geometries, swimming, kinematics, BEM, model, organisms, arbitrary geometry, swimming, kinematics, experimental observations, models]]\n",
      "[[16S ribosomal DNA sequence, Taylorella equigenitalis, Haemophilus equigenitalis, causative organism, contagious equine, metritis, phylogenetic analysis, sequence, phylogenetic position, T. equigenitalis, beta subclass, class Proteobacteria, position, Haemophilus influenzae, gamma subclass, Proteobacteria, phylogenetic, relationship, T. equigenitalis, Alcaligenes xylosoxidans, Bordetella bronchiseptica, detected, Spirillum volutans, Chromobacterium fluviatile, Iodobacter fluviatile, group, removed, relationship, G + C, contents, genomes, bacteria]]\n",
      "[[mathematical model, slender, body theory, unipolar, Spirillum volutans cell, model cell, unconstrainedly, fluid, results, observation, studies, effects of, cell dimensions, investigated]]\n",
      "[[ECHA Biocide Monitor, dipstick procedure, test, effectiveness, in situ, biocides, evaluated, environmental, toxicity, assessment procedure, dipstick procedure, sediment, extracts, tested, documented, toxicant, Microtox, Daphnia magna, Spirillum volutans, samples, Daphnia magna, sensitive, indication, toxicant activity, ECHA Biocide Monitor, sensitive, procedure, sediments, presence, toxic substances, investigation]]\n",
      "[[linezolid/daptomycin combinations, Staphylococcus aureus, resistance, restriction, associated with, changes, mutant prevention concentrations, MPCs, antibiotics, combination, enrichment, resistant, mutants, in vitro, dynamic, MRSA, strains, vancomycin-intermediate resistant ATCC 700699, vancomycin-susceptible, susceptible, linezolid, daptomycin, linezolid-resistant mutants, passaging, antibiotic-containing medium, study, MPCs, antibiotics, combination, linezolid-to-daptomycin concentration ratio, ratio, AUCs, AUC24s, pharmacokinetic simulations, S. aureus, supplemented, linezolid-resistant mutants, mutation, frequency, treated with, twice-daily, linezolid, once-daily, daptomycin, combination, simulated, therapeutic, sub-therapeutic, AUC24s, linezolid-resistant mutants, increased, therapeutic, sub-therapeutic, AUC24s, daptomycin-resistant, mutants, sub-therapeutic, AUC24, drug treatments, Linezolid/daptomycin combinations, prevented, enrichment, linezolid-resistant S. aureus, enrichment, daptomycin-resistant, mutants, anti-mutant effects, combinations, lengthening, time, MPC, linezolid, daptomycin, MPCs, lowered, study, inhibition, S. aureus, resistant, mutants, linezolid/daptomycin combinations, MPCs, pharmacokinetically, antibiotic, ratios, MPC, predictor, anti-mutant efficacy, antibiotic combinations, in vitro, dynamic, models]]\n",
      "[[narrative review, epidemiology, invasive, pneumococcal diseases, nasopharyngeal carriage, antibiotic resistance, Streptococcus pneumoniae, serotypes, vaccination, coverage, children, Philippines, Epidemiological, data, availability, vaccine, infants, National Immunization Program, burden, pneumococcal disease, young children, Philippines, variability, data, studies, active, comprehensive, surveillance, accurate, estimates, pneumococcal disease, country, data, rates, pneumococcal carriage, children, Philippines, aged, years, contemporary, data, lacking, active, surveillance programs, pneumococcal, vaccines, disease, pneumococcal, serotypes, vaccines, emergence, pneumococcal disease, nonvaccine, serotypes, Surveillance, circulating, serotypes, vaccine, coverage, Antimicrobial resistance, S. pneumoniae, threat, public health, data, antibiotic resistance, young children, Philippines, reports, low, rates, antibiotic resistance, group, National immunization rates, increased, years, individuals, unprotected, pneumococcal disease, contemporary, accurate, disease surveillance, Philippines, data, estimates, pneumococcal disease, incidence, serotype, distribution, antibiotic resistance, vaccination, strategies, children, Philippines, pneumococcal disease]]\n",
      "[[ETHNOPHARMACOLOGICAL, Ma-xing-shi-gan-tang, MXSGT, documented, Treatise, Febrile Diseases, therapeutic drug, prescription, China, studies, MXSGT, pharmacological activities, anti-influenza virus activity, ameliorates, microvascular, hyperpermeability, inflammatory reactions, effect, MXSGT, treatment, bacterial pneumonia, AIM, study, potential, inhibition, MXSGT, virulence, S. pneumoniae, targeting, PLY, investigated, HPLC analysis, components, MXSGT, PLY protein, hemolysis, assay, western blot, MXSGT, inhibit, PLY, activity, production, widowed, characteristics, growth curve, S. pneumoniae, drawled, MXSGT, treatment, inhibition, MXSGT, PLY-mediated A549 cell, cytotoxicity assay, mouse, experiment, effect, MXSGT, mouse, lungs, MXSGT, TCM, prescription, effective, inhibitor, PLY, virulence factor, S. pneumoniae, pathogenicity, MXSGT, inhibits, oligomerization, PLY, affecting, S. pneumoniae, PLY, production, experimental, MXSGT, treatment, effective, S. pneumoniae infection, in vitro, in vivo, findings, potential, mechanism, Chinese herbal formula, MXSGT, treatment, pneumococcal disease, evidence, promotion, MXSGT, clinic]]\n",
      "[[Evidence, pandemics, influenza, associated with, bacterial coinfection, patients, hospitalized, influenza pneumonia, rate, coinfection, distribution, pathogens, compare, outcomes, patients, bacterial, coinfection, adults, admitted with, community-acquired pneumonia, CAP, tested, influenza, US, hospitals, Premier database, Pneumonia, International Classification of Disease, Clinical Modification, algorithm, multiple, logistic, gamma-generalized linear mixed models, assess, relationships, coinfection, inpatient, mortality, intensive care unit, length of stay, cost, patients, hospitalized, CAP, tested, influenza, positive, hospital, days, patients, influenza, positive culture, cultures, Staphylococcus aureus, Streptococcus pneumoniae, S. aureus, isolates, methicillin, resistant, influenza patients, influenza, hospital, pathogens, groups, Bacterial, coinfection, associated with, increased, odds, in-hospital mortality, aOR, CI, late ICU transfer, aOR, CI, higher, cost, risk-adjusted mean multiplier, CI, US, inpatient, sample hospitalized, influenza, CAP, S. aureus, frequent, bacterial coinfection, Coinfection, associated with, outcomes, higher, costs]]\n",
      "[[Pneumococcal capsules, pneumococcal, pathogenesis, vaccine, development, conjugate vaccines, reduction, invasive, IPD, vaccine, serotypes, serotype, prevalence, emergence, serotype 24F, countries, isolates, IPD, non-IPD, expressing, capsule type, serological profile, antigenic, biochemical, genetic bases, 24C, serotypes, 24B, Structural studies, polysaccharide backbones, beta-Ribf-(1, ->4)-alpha-Rhap-(1, ->3)-beta-GlcpNAc-(1, ->4)-beta-Rhap-(1, side chains, arabinitol-phosphate, ratio, ribitol, arabinitol, strain-dependent, 24A capsule, backbone, beta-Ribf, arabinitol-phosphate, phosphocholine side chains, structures, factor-sera 24d, arabinitol, ribitol, serology, serogroup, structures, genetically, bi-specificity, wcxG, arabinitol, ribitol, arabinitol, Arabinitol, reduced, mutations, abpA, abpB, genes, findings, pneumococci, modulate, capsule structure, immunologic, properties, genetic changes, host, immune responses, findings, potential, capsule types, serogroup]]\n",
      "[[Antimicrobial-resistant strains, Streptococcus pneumoniae, global, inappropriate, antibiotics, level, antibiotic, emergence, resistance, worldwide, study, antimicrobial resistance, profiles, multidrug resistance, patterns, S. pneumoniae, isolates, patients, suspected, pneumococcal infections, Ethiopia, hospital-based prospective study, Ababa, city, Amhara National Region State Referral Hospitals, Antimicrobial resistance tests, isolates, S. pneumoniae, pediatric, adult, patients, Samples, cerebrospinal fluid, blood, sputum, eye discharge, ear discharge, pleural, peritoneal fluids, collection sites, cultured, sheep blood agar, plates, incubated, overnight, degrees, CO2, atmosphere, Streptococcus pneumoniae, identified, colony, morphology, alpha-hemolysis, Gram staining, optochin, susceptibility, bile solubility test, Drug resistance testing, E-test method, recommendations, Clinical, isolates, resistant, penicillin, cefotaxime, ceftriaxone, Resistance, rates, erythromycin, clindamycin, tetracycline, chloramphenicol, trimethoprim-sulfamethoxazole, Multidrug resistance, MDR, isolates, pattern, co-resistance, penicillin, erythromycin, clindamycin, tetracycline, S. pneumoniae, isolates, susceptible, ceftriaxone, cefotaxime, Penicillin, drug, treating, S. pneumoniae infection, antimicrobial resistance, multidrug resistance, antibiotics, penicillin, antimicrobial resistance, patterns, empirical, treatments, management, pneumococcal infection]]\n",
      "[[Mycoplasma genus, M. pneumoniae, M. genitalium, M. hominis, U. urealyticum, species, infectious processes, species, conditions, healthcare professionals, review, Mycoplasma genus, species, isolated, human, beings, involvement, infectious pathology]]\n",
      "[[Background, objectives, Ureaplasma urealyticum, UU, Mycoplasma hominis, MH, commensal, microorganisms, urogenital microbiota, state, dysbiosis, bacteria, intrauterine infection, Material, methods, study, prevalence, UU, MH, infertile, women, Women, years, affected, group, years, prevalence, UU, MH, coinfection, detection, rate, drug susceptibility, endocervical samples, Regina Maria, Synevo, laboratories, analyses, Pristinamycin, Josamycin, efficient, antibiotics, eradicating, UU, MH, efficiency, Doxycycline, Minocycline, Tetracycline, Erythromycin, antibiograms, Clarithromycin, Roxithromycin, Levofloxacin, Azithromycin, treating, infections, hand, Clindamycin, Ciprofloxacin, UU, MH, intermediate response, resistance, efficiency, Ofloxacin, transient stage, gradual, adaptability, microorganisms, Ofloxacin, susceptible, age groups, case, women, years, antibiotics, treating, UU, MH, dual infections, efficiency]]\n",
      "[[Sexually transmitted infections, STI, global, Urethritis, STIs, complications, transmission, HIV virus, investigate, etiologic agents, urethritis, men, treated, Fundacao Alfredo da Matta, agents, urethral exudate, urine, Gram, culture tests, Thayer-Martin medium, Neisseria gonorrhoeae, polymerase chain reaction, Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, Mycoplasma genitalium, herpes simplex types 1, N. gonorrhoeae, identified, patients, C. trachomatis, U. urealyticum, M. genitalium, U. parvum, M. hominis, Herpes simplex type 2, diagnosed, patients, PCR, pathogen, cases, co-infection, frequent, N. gonorrhoeae, C. trachomatis, patients, N. gonorrhoeae, C. trachomatis, patients, N. gonorrhoeae, herpes simplex type 2, N. gonorrhoeae, U. urealyticum, relevant, N. gonorrhoeae, C. trachomatis, U. urealyticum, herpes simplex type 2, pathogens, identified, study, coinfection, N. gonorrhoeae, C. trachomatis, T. vaginalis, herpes simplex type 1, patients]]\n",
      "[[Ureaplasma urealyticum, U parvum, mollicutes, species, colonize, urogenital tract, asymptomatic, persons, associated with, symptomatic, infections, strains, isolated, German university hospital, resistance, tested, combination, commercial tests, molecular methods, determination, minimal, inhibitory, concentrations, Rates, resistance, macrolides, tetracyclines, fluoroquinolones]]\n",
      "[[Gardnerella vaginalis, GV, associated with, bacterial vaginosis, etiology, intrauterine infection, Ureaplasma urealyticum, Intrauterine GV, infection, pregnancy, outcomes, preterm birth, fetal growth restriction, neonatal, pneumonia, knowledge, GV, effects, in vivo, animal model, study, effects, fetal development, Materials, Methods, survival, mini-laparotomy, New Zealand, rabbits, gestational, day, weeks, human, pregnancy, dam, fetuses, right uterine horn, intra-amniotic, colony-forming units, GV, injections, littermate controls, left horn, sterile saline injections, laparotomy, days, Assessment, fetal, pups, histopathology, placenta, histomorphometric examination, fetal, dams, fetuses, intra-amniotic GV, fetuses, unexposed, weights, fetuses, placenta, fetal, lung, GV, group, saline-inoculated control group, GV, control, placenta weight, GV, control, fetal, GV, control, increase, multinucleated, syncytiotrophoblasts, placenta, GV, group, littermate controls, alveolar septae, GV, fetuses, control, proliferative index, interalveolar septum, GV, group, controls, alveoli, alveolar surface area, groups, Low-dose, injection, fetal growth restriction, increased, placental, multinucleated, syncytiotrophoblasts, fetal, re-modeling, characterized, alveolar septal hypertrophy, cellular proliferative changes, intra-amniotic model, studies, acute, chronic effects, GV, intrauterine infections]]\n"
     ]
    }
   ],
   "source": [
    "for i in dataframe[\"mesh\"]:\n",
    "    print(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [],
   "source": [
    "final_dataframe = dataframe[[\"doi\",\"mesh\"]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [],
   "source": [
    "final_dataframe.to_csv(\"df_mesh2.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "dataframe = pd.read_csv(\"df_mesh.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_frame.to_csv(\"test_frame.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "dataframe = pd.read_csv(\"df_mesh2.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"['AAC.00514-21 [pii]', '10.1128/AAC.00514-21 [doi]']\""
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataframe[\"doi\"][1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "ename": "AttributeError",
     "evalue": "(\"'float' object has no attribute 'strip'\", 'occurred at index 9')",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mAttributeError\u001b[0m                            Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-7-d20283b412e6>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[1;32m----> 1\u001b[1;33m \u001b[0mdataframe\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"doi\"\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mdataframe\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mapply\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;32mlambda\u001b[0m \u001b[0mx\u001b[0m\u001b[1;33m:\u001b[0m \u001b[0mx\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"doi\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstrip\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m']['\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msplit\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m', '\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0maxis\u001b[0m\u001b[1;33m=\u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;32mc:\\python\\lib\\site-packages\\pandas\\core\\frame.py\u001b[0m in \u001b[0;36mapply\u001b[1;34m(self, func, axis, broadcast, raw, reduce, result_type, args, **kwds)\u001b[0m\n\u001b[0;32m   6904\u001b[0m             \u001b[0mkwds\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mkwds\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m   6905\u001b[0m         )\n\u001b[1;32m-> 6906\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0mop\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mget_result\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m   6907\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m   6908\u001b[0m     \u001b[1;32mdef\u001b[0m \u001b[0mapplymap\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfunc\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mc:\\python\\lib\\site-packages\\pandas\\core\\apply.py\u001b[0m in \u001b[0;36mget_result\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    184\u001b[0m             \u001b[1;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mapply_raw\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    185\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 186\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mapply_standard\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    187\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    188\u001b[0m     \u001b[1;32mdef\u001b[0m \u001b[0mapply_empty_result\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mc:\\python\\lib\\site-packages\\pandas\\core\\apply.py\u001b[0m in \u001b[0;36mapply_standard\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    290\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    291\u001b[0m         \u001b[1;31m# compute the result using the series generator\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 292\u001b[1;33m         \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mapply_series_generator\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    293\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    294\u001b[0m         \u001b[1;31m# wrap results\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mc:\\python\\lib\\site-packages\\pandas\\core\\apply.py\u001b[0m in \u001b[0;36mapply_series_generator\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    319\u001b[0m             \u001b[1;32mtry\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    320\u001b[0m                 \u001b[1;32mfor\u001b[0m \u001b[0mi\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mv\u001b[0m \u001b[1;32min\u001b[0m \u001b[0menumerate\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mseries_gen\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 321\u001b[1;33m                     \u001b[0mresults\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mi\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mf\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mv\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    322\u001b[0m                     \u001b[0mkeys\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mappend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mv\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mname\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    323\u001b[0m             \u001b[1;32mexcept\u001b[0m \u001b[0mException\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0me\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m<ipython-input-7-d20283b412e6>\u001b[0m in \u001b[0;36m<lambda>\u001b[1;34m(x)\u001b[0m\n\u001b[1;32m----> 1\u001b[1;33m \u001b[0mdataframe\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"doi\"\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mdataframe\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mapply\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;32mlambda\u001b[0m \u001b[0mx\u001b[0m\u001b[1;33m:\u001b[0m \u001b[0mx\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"doi\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstrip\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m']['\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msplit\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m', '\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0maxis\u001b[0m\u001b[1;33m=\u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;31mAttributeError\u001b[0m: (\"'float' object has no attribute 'strip'\", 'occurred at index 9')"
     ]
    }
   ],
   "source": [
    "dataframe[\"doi\"] = dataframe.apply(lambda x: x[\"doi\"].strip('][').split(', '), axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
